"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2019/0322446 A1,156-457-921-081-667,2019-10-24,2019,US 201916391949 A,2019-04-23,US 201916391949 A;;US 201862661625 P,2018-04-23,BREWING CAPSULE FOR BREWED BEVERAGES,"This disclosure relates to brewing capsules designed to create less waste in so called “single-server brewing machines”. In one embodiment, a brewing capsule includes a capsule brewing receptacle defining a receptacle brewing cavity and a first receptacle opening, a receptacle divider, and a capsule cover. The capsule cover is configured to be pierceable by an inlet brewing needle and covers the first receptacle opening. The receptacle divider is configured to divide the receptacle brewing cavity into a first brewing compartment and a second brewing compartment. As such, the first brewing compartment and the second brewing compartment are partitioned by the receptacle divider. In this manner, organic brewing material can be placed in both of the brewing compartments so that the brewing capsule can be used more than once to brew a beverage. By allowing for multiple uses, the configuration of the brewing capsule reduces the production of waste.",TWO BEANS IN A POD LLC,BROWN KIMBERLY ALEXANDRA,TWO BEANS IN A POD LLC (2019-04-23),https://lens.org/156-457-921-081-667,Patent Application,yes,0,0,1,1,0,A47J31/0689;;A47J31/407;;B65D85/8043;;B65D85/8043,B65D85/804;;A47J31/40,,0,0,,,,DISCONTINUED
2,WO,A1,WO 2011/035029 A1,074-428-378-412-00X,2011-03-24,2011,US 2010/0049126 W,2010-09-16,US 24353209 P,2009-09-18,POLYPEPTIDES HAVING BETA-GLUCOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having beta-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC;;BROWN KIMBERLY;;HARRIS PAUL,BROWN KIMBERLY;;HARRIS PAUL,,https://lens.org/074-428-378-412-00X,Patent Application,yes,105,124,6,6,11,C12N15/52;;C12P7/10;;C12P19/14;;C12Y302/01021;;C12N9/2445;;Y02E50/10;;C12N15/52;;C12Y302/01021;;C12P19/14;;C12P7/10;;C12N9/2445;;Y02E50/10,C12N9/42;;C12N15/52;;C12P19/14,,190,155,070-333-389-731-762;;000-743-569-588-265;;018-222-591-852-35X;;058-313-563-307-746;;018-222-591-852-35X;;058-313-563-307-746;;060-447-603-638-044;;047-694-592-512-688;;009-052-884-271-430;;168-467-332-279-864;;023-207-730-709-584;;012-920-574-719-303;;014-625-826-302-514;;127-544-305-672-969;;121-062-956-244-546;;053-902-977-327-206;;061-537-462-842-986;;020-011-032-411-111;;081-290-558-102-206;;009-052-884-271-430;;015-734-715-035-926;;034-499-320-202-349;;010-606-868-765-729;;022-715-862-716-318;;032-728-154-591-070;;022-439-235-146-469;;009-304-049-487-981;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;083-771-782-040-353;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;039-227-503-731-991;;073-153-156-138-109;;016-587-457-958-718;;164-567-086-301-271;;029-314-535-301-390;;044-889-964-761-310;;130-197-652-144-217;;024-461-215-806-523;;002-129-848-383-652;;054-167-555-136-715;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;070-786-212-570-774;;080-478-847-113-962;;025-382-717-097-246;;060-100-774-152-775;;024-608-718-151-219;;066-174-113-969-972;;004-879-676-826-589;;119-409-570-143-716;;112-713-110-898-538;;077-184-809-518-772;;065-527-462-128-017;;038-624-922-825-362;;038-856-203-382-553;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;003-307-199-216-170;;060-909-037-461-654;;130-374-497-909-295;;036-168-690-647-51X;;122-107-077-421-078;;056-172-488-299-694;;015-652-210-164-846;;024-087-420-133-316;;113-902-635-079-219;;067-164-920-836-831;;000-183-195-092-675;;169-141-851-602-500;;025-368-788-723-477;;060-178-055-146-889;;031-589-022-231-352;;017-647-343-533-20X;;079-894-236-784-078;;069-166-427-004-435;;005-197-632-250-053;;106-322-033-242-053;;000-183-195-092-675;;029-672-278-978-420;;004-855-955-930-454;;024-107-327-163-524;;099-014-502-085-120;;002-235-158-220-337;;086-912-852-710-005;;089-469-021-381-015;;077-856-998-073-395;;074-536-892-628-290;;006-229-312-677-875;;002-068-346-610-521;;000-183-195-092-675;;076-132-223-936-79X;;118-711-156-754-483;;044-160-688-806-618;;058-145-297-843-203;;031-347-305-828-923;;076-235-786-419-94X;;023-134-630-499-263;;022-892-629-813-258;;120-034-791-945-912;;015-748-750-785-463;;000-009-413-776-570;;053-935-128-053-707;;014-622-505-292-796;;014-774-168-809-047;;001-824-374-248-456;;083-475-617-712-21X;;024-715-211-347-486;;000-531-410-112-308;;175-295-822-939-63X;;045-548-779-820-017;;029-940-225-165-635;;031-097-124-288-463;;018-434-146-384-724;;031-015-979-474-454;;021-946-971-259-170;;024-708-797-947-714;;015-065-490-448-969;;013-458-224-516-628;;008-437-576-847-072;;022-335-231-721-618;;054-661-041-031-514;;028-862-168-091-90X,10.1007/bf01025980;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-#;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-;;11930943;;16690241;;10.1016/j.biotechadv.2006.03.003;;10.1351/pac198759020257;;16690241;;10.1016/j.biotechadv.2006.03.003;;10.1351/pac198759020257;;10.1016/s0167-7799(97)01032-9;;9649743;;10.1042/bst0260173;;10.1016/0003-2697(72)90301-6;;5031119;;10.1016/0014-5793(82)81092-2;;10.1016/0014-5793(85)81260-6;;10.1111/j.1432-1033.1988.tb13736.x;;3338453;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;12831897;;10.1016/s1369-5274(03)00056-0;;10.1002/jsfa.2519;;10.1016/j.febslet.2006.07.033;;16876163;;9020869;;10.1042/bj3210375;;pmc1218079;;10.1016/0168-1656(92)90074-j;;10.1016/0003-2697(72)90301-6;;5031119;;9440512;;10.1128/jb.180.2.243-249.1998;;pmc106878;;10.1016/0960-8524(94)90214-3;;10.1007/bf02920289;;9051728;;10.1093/protein/10.1.1;;10.1016/0022-2836(70)90057-4;;5420325;;10.1016/s0168-9525(00)02024-2;;10827456;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1021/bi00109a004;;1932005;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;8508780;;pmc413497;;10.1002/j.1460-2075.1993.tb05913.x;;7973629;;10.1126/science.7973629;;10656339;;10.1016/s0168-1656(99)00191-1;;10.1128/aem.63.9.3488-3493.1997;;pmc168655;;9292999;;10.1038/nbt0595-498;;9634791;;1367012;;10.1038/nbt0491-378;;3082357;;14406087;;10.1021/bi00350a035;;10.1038/nbt0995-982;;9636275;;2516317;;10.1002/prot.340060306;;10.1016/1046-5928(91)90057-p;;1821793;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;6345791;;10.1016/s0022-2836(83)80284-8;;3041370;;10.1093/nar/16.13.6127;;pmc336852;;10.1007/bf02931600;;15530004;;pmc210093;;10.1128/jb.171.6.3583-3585.1989;;2656662;;pmc33461;;10.1073/pnas.101589398;;11353836;;10.1016/j.mimet.2005.06.001;;15987659;;pmc544212;;10.1128/aem.71.1.51-57.2005;;15640169;;pmc351592;;10.1128/iai.32.3.1295-1297.1981;;7251168;;1795653;;10473378;;pmc99703;;10.1128/aem.65.9.3800-3804.1999;;pmc281518;;6272080;;10.1128/mr.45.3.409-436.1981;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1021/bp990110d;;10514251;;pmc120791;;10.1128/mmbr.66.3.506-577.2002;;12209002;;10.1016/0141-0229(85)90114-0;;10.1002/bit.260250106;;18548538;;10.1007/bf02786945;;10.1007/10_2007_064;;17530205;;10.1007/10_2007_070;;17646946;;18599291;;10.1016/j.biortech.2008.05.027;;10.1016/j.biortech.2004.06.025;;15588770;;pmc2635757;;19325822;;10.3390/ijms9091621;;10.1002/bbb.49;;10.1016/0960-8524(95)00122-0;;12226717;;10.1007/s00253-002-1058-9;;16915665;;10.1385/abab:130:1:496;;15054274;;10.1385/abab:114:1-3:509;;10.1016/j.enzmictec.2005.12.010;;10.1016/s0960-8524(03)00167-6;;14592748;;16112483;;10.1016/j.biortech.2005.01.010;;10.1016/j.biortech.2004.06.025;;15588770;;10.1016/s0960-8524(97)00164-8;;10.1385/abab:117:1:01;;15126700;;10.1002/bit.20222;;15470714;;10.1002/jctb.1586;;10.1385/abab:98-100:1-9:23;;12018251;;10.1002/bit.21132;;16903002;;15930586;;10.1385/abab:124:1-3:1133;;16112489;;10.1016/j.biortech.2005.01.016;;15772945;;10.1002/bit.20453;;16523526;;10.1002/bit.20905;;10.1385/abab:121:1-3:0219;;15917601;;10.1007/978-1-59259-991-2_19;;10.1016/j.biortech.2004.06.025;;15588770;;10.1201/9780203752456-10;;10.1016/s0065-2164(08)70598-7;;10.1007/3-540-49194-5_9;;10533436;;10.1016/0141-0229(95)00157-3;;10.1016/0378-1119(86)90023-5;;2948877;;3384334;;10.1016/0378-1119(88)90541-0;;10.1111/j.1365-2958.1994.tb00417.x;;7984103;;10.1093/nar/18.19.5884;;pmc332333;;2216782;;10.1007/bf00311212;;7586029;;10.1016/0378-1119(90)90433-r;;2379837;;10671536;;10.1074/jbc.275.7.4973;;8964516;;10.1016/0378-1119(96)00179-5;;10.1007/s00253-005-0229-x;;16331454;;10.1007/bf02918984;;8391777;;9572962;;10.1128/aem.64.5.1852-1859.1998;;pmc106241;;10.1007/bf00167144;;pmc167730;;10.1128/aem.61.12.4184-4190.1995;;8534086;;15040955;;10.1016/j.femsyr.2004.01.003;;18600763;;10.1002/bit.260380311;;10.1002/(sici)1097-0290(19980420)58:2/3<204::aid-bit13>3.0.co;2-c;;10191391;;17791346;;10.1126/science.267.5195.240;;pmc168273;;10.1128/aem.62.12.4465-4470.1996;;8953718;;10.1007/s00253-002-1092-7;;12382043;;12172602;;10.1007/s00253-002-1046-0;;10.1016/0032-9592(95)80001-8;;18576101;;10.1007/bf02920444;;15286988;;10.1002/bit.20156;;10.2166/wst.1997.0573;;10.1016/s0961-9534(97)00020-2;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;9521922;;10.1101/gr.8.3.186;;10.1093/nar/25.17.3389;;9254694;;pmc146917,"DATABASE Geneseq [online] 28 May 2009 (2009-05-28), ""Chrysosporium lucknowense carbohydrase, SEQ ID 44."", XP002606536, retrieved from EBI accession no. GSP:AWH29250 Database accession no. AWH29250;;DATABASE Geneseq [online] 16 April 2009 (2009-04-16), ""A. thermophilum beta-glucosidase (Cel3A) enzyme, SEQ ID 24."", XP002606537, retrieved from EBI accession no. GSP:AWH58324 Database accession no. AWH58324;;DATABASE EM_EST [online] 10 June 2009 (2009-06-10), LUCAS S., ROKHSAR D., WANG M., LINDQUIST E.A., BERKA R.M.;: ""CCPH6030.b1 CCPH Thielavia terrestris pooled RNA from cells grown in MY50DE (rich medium) and minimal medium with Arbocel (cellulose) Thielavia terrestris cDNA clone CCPH6030 5', mRNA sequence."", XP002606538, Database accession no. GR258851;;BREUIL C ET AL: ""PRODUCTION AND LOCALIZATION OF CELLULASES AND .BETA.-GLUCOSIDASE FROM THE THERMOPHILIC FUNGUS THIELAVIA TERRESTRIS"", BIOTECHNOLOGY LETTERS, KEW, SURREY, GB LNKD- DOI:10.1007/BF01025980, vol. 8, no. 9, 1 January 1986 (1986-01-01), pages 673 - 676, XP009074467, ISSN: 0141-5492;;DATABASE EM_EST [online] 10 June 2009 (2009-06-10), LUCAS S., ROKHSAR D., WANG M., LINDQUIST E.A., BERKA R.M.;: ""CCPI2370.b6 CCPI Thielavia terrestris pooled RNA from cells grown in MY50 (rich medium) and minimal medium with Arbocel (cellulose) - H Thielavia terrestris cDNA clone CCPI2370 5', mRNA sequence"", XP002606539, Database accession no. GR266239;;VENTURI ET AL.: ""Extracellular beta-D-glucosidase from Chaetomium thermophilum var. coprophilum: production, purification and some biochemical properties"", J. BASIC MICROBIOL., vol. 42, 2002, pages 55 - 66;;ZHANG ET AL.: ""Outlook for cellulase improvement: Screening and selection strategies"", BIOTECHNOLOGY ADVANCES, vol. 24, 2006, pages 452 - 481, XP028005978, DOI: doi:10.1016/j.biotechadv.2006.03.003;;GHOSE: ""Measurement of cellulase activities"", PURE APPL. CHEM., vol. 59, 1987, pages 257 - 68, XP000652082;;ZHANG ET AL., BIOTECHNOLOGY ADVANCES, vol. 24, 2006, pages 452 - 481;;GHOSE, PURE AND APPL. CHEM., vol. 59, 1987, pages 257 - 268;;TEERI: ""Crystalline cellulose degradation: New insight into the function of cellobiohydrolases"", TRENDS IN BIOTECHNOLOGY, vol. 15, 1997, pages 160 - 167, XP004059844, DOI: doi:10.1016/S0167-7799(97)01032-9;;TEERI ET AL.: ""Trichoderma reesei cellobiohydrolases: why so efficient on crystalline cellulose?"", BIOCHEM. SOC. TRANS., vol. 26, 1998, pages 173 - 178;;LEVER ET AL., ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279;;TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156;;VAN TILBEURGH; CLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288;;TOMME ET AL., EUR. J. BIOCHEM., vol. 170, 1988, pages 575 - 581;;HENRISSAT B.: ""A classification of glycosyl hydrolases based on amino-acid sequence similarities"", BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT B.; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BIOCHEM. J., vol. 316, 1996, pages 695 - 696, XP001176681;;SHALLOM, D.; SHOHAM, Y: ""Microbial hemicellulases"", CURRENT OPINION IN MICROBIOLOGY, vol. 6, no. 3, 2003, pages 219 - 228, XP002666720, DOI: doi:10.1016/S1369-5274(03)00056-0;;GHOSE; BISARIA, PURE & APPL. CHEM., vol. 59, 1987, pages 1739 - 1752;;BIELY; PUCHARD: ""Recent progress in the assays of xylanolytic enzymes"", JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, vol. 86, no. 11, 2006, pages 1636 - 1647;;SPANIKOVA; BIELY: ""Glucuronoyl esterase - Novel carbohydrate esterase produced by Schizophyllum commune"", FEBS LETTERS, vol. 580, no. 19, 2006, pages 4597 - 4601, XP028061315, DOI: doi:10.1016/j.febslet.2006.07.033;;HERRMANN; VRSANSKA; JURICKOVA; HIRSCH; BIELY; KUBICEK: ""The beta-D-xylosidase of Trichoderma reesei is a multifunctional beta-D-xylan xylohydrolase"", BIOCHEMICAL JOURNAL, vol. 321, 1997, pages 375 - 381;;BAILEY; BIELY; POUTANEN: ""Interlaboratory testing of methods for assay of xylanase activity"", JOURNAL OF BIOTECHNOLOGY, vol. 23, no. 3, 1992, pages 257 - 270, XP023704921, DOI: doi:10.1016/0168-1656(92)90074-J;;LEVER: ""A new reaction for colorimetric determination of carbohydrates"", ANAL. BIOCHEM, vol. 47, 1972, pages 273 - 279, XP024820395, DOI: doi:10.1016/0003-2697(72)90301-6;;DE VRIES, J. BACTERIOL., vol. 180, 1998, pages 243 - 249;;WISELOGEL ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 105 - 118;;WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16;;LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24/25, 1990, pages 695 - 719;;MOSIER ET AL.: ""Advances in Biochemical Engineering/BiotechnoIogy"", vol. 65, 1999, SPRINGER-VERLAG, article ""Recent Progress in Bioconversion of Lignocellulosics"", pages: 23 - 40;;EBRINGEROVA ET AL., ADV. POLYM. SCI., vol. 186, 2005, pages 1 - 67;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;RICE ET AL., TRENDS GENET., vol. 16, 2000, pages 276 - 277;;J. SAMBROOK, E.F. FRITSCH; T. MANIATIS: ""Molecular Cloning, A Laboratory Manual, 2d edition,"", 1989, COLD SPRING HARBOR;;BOLTON; MCCARTHY, PROC. NATL. ACAD. SCI. USA, vol. 48, 1962, pages 1390;;H. NEURATH; R.L. HILL: ""The Proteins"", 1979, ACADEMIC PRESS;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOI. CHEM., vol. 271, 1996, pages 4699 - 4708;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEMISTRY, vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;COOPER ET AL., EMBO J., vol. 12, 1993, pages 2575 - 2583;;DAWSON ET AL., SCIENCE, vol. 266, 1994, pages 776 - 779;;MARTIN ET AL., J. IND. MICROBIOL. BIOTECHNOL., vol. 3, 2003, pages 568 - 576;;SVETINA ET AL., J. BIOTECHNOL., vol. 76, 2000, pages 245 - 251;;RASMUSSEN-WILSON ET AL., APPL. ENVIRON. MICROBIOL., vol. 63, 1997, pages 3488 - 3493;;WARD ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 498 - 503;;CONTRERAS ET AL., BIOTECHNOLOGY, vol. 9, 1991, pages 378 - 381;;EATON ET AL., BIOCHEMISTRY, vol. 25, 1986, pages 505 - 512;;COLLINS-RACIE ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 982 - 987;;CARTER ET AL., PROTEINS: STRUCTURE, FUNCTION, AND GENETICS, vol. 6, 1989, pages 240 - 248;;STEVENS, DRUG DISCOVERY WORLD, vol. 4, 2003, pages 35 - 48;;INNIS ET AL.: ""PCR: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;VILLA-KAMAROFF ET AL., PROC. NATL. ACAD. SCI. USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 80, 1983, pages 21 - 25;;GILBERT ET AL.: ""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOL. CELLULAR BIOL, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RES., vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOL. GEN. GENET., vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZEN, J. BACTERIOL., vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, J. MOL. BIOL., vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER; THORNE, J. BACTERIOL., vol. 169, 1987, pages 5271 - 5278;;HANAHAN, J. MOL. BIOL., vol. 166, 1983, pages 557 - 580;;DOWER ET AL., NUCLEIC ACIDS RES., vol. 16, 1988, pages 6127 - 6145;;GONG ET AL., FOLIA MICROBIOL. (PRAHA), vol. 49, 2004, pages 399 - 405;;MAZODIER ET AL., J. BACTERIOL., vol. 171, 1989, pages 3583 - 3585;;BURKE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 98, 2001, pages 6289 - 6294;;CHOI ET AL., J. MICROBIOL. METHODS, vol. 64, 2006, pages 391 - 397;;PINEDO; SMETS, APPL. ENVIRON. MICROBIOL., vol. 71, 2005, pages 51 - 57;;PERRY; KURAMITSU, INFECT. IMMUN., vol. 32, 1981, pages 1295 - 1297;;CATT; JOLLICK, MICROBIOS, vol. 68, 1991, pages 189 - 207;;BUCKLEY ET AL., APPL. ENVIRON. MICROBIOL., vol. 65, 1999, pages 3800 - 3804;;CLEWELL, MICROBIOL. REV., vol. 45, 1981, pages 409 - 436;;HAWKSWORTH ET AL.: ""Ainsworth and Bisby's Dictionary of The Fungi, 8th edition,"", 1995, UNIVERSITY PRESS;;SKINNER, F.A., PASSMORE, S.M., AND DAVENPORT, R.R.,: ""Soc. App. Bacteriol."", 1980, SYMPOSIUM SERIES NO. 9, article ""Biology and Activities of Yeast"";;YELTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 1470 - 1474;;CHRISTENSEN ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 1419 - 1422;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;BECKER; GUARENTE: ""Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., pages: 182 - 187;;ITO ET AL., J. BACFERIOL., vol. 153, 1983, pages 163;;HINNEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 75, 1978, pages 1920;;J.-C. JANSON AND LARS RYDEN,: ""Protein Purification"", 1989, VCH PUBLISHERS;;TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MOL. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS; CORUZZI, ANN. REV. GENET., vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT CELL PHYSIOL., vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., J. PLANT PHYSIOL., vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT CELL PHYSIOL., vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOL., vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOL. BIOL., vol. 26, 1994, pages 85 - 93;;KAGAYA ET AL., MOL. GEN. GENET., vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOL. BIOL., vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIORTECHNOLOGY, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOL. BIOL., vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT J., vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CURR. OPIN. BIOTECHNOL., vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH ET AL., PLANT MOL. BIOL., vol. 21, 1993, pages 415 - 428;;PHILIPPIDIS, G. P.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Cellulose bioconversion technology"", pages: 179 - 212;;SHEEHAN, J.; HIMMEL, M.: ""Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol"", BIOTECHNOL. PROG., vol. 15, 1999, pages 817 - 827;;LYND, L. R.; WEIMER, P. J.; VAN ZYL, W. H.; PRETORIUS, I. S.: ""Microbial cellulose utilization: Fundamentals and biotechnology"", MICROBIOL. MOL. BIOI. REVIEWS, vol. 66, 2002, pages 506 - 577, XP002551605, DOI: doi:10.1128/MMBR.66.3.506-577.2002;;FERNANDA DE CASTILHOS CORAZZA; FIAVIO FARIA DE MORAES; GISELLA MARIA ZANIN; IVO NEITZEL: ""Optimal control in fed-batch reactor for the cellobiose hydrolysis"", ACTA SCIENTIARUM. TECHNOLOGY, vol. 25, 2003, pages 33 - 38;;GUSAKOV, A. V.; SINITSYN, A. P.: ""Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical model for a batch reactor process"", ENZ. MICROB. TECHNOL., vol. 7, 1985, pages 346 - 352, XP023679176, DOI: doi:10.1016/0141-0229(85)90114-0;;RYU, S. K.; LEE, J. M.: ""Bioconversion of waste cellulose by using an attrition bioreactor"", BIOTECHNOL. BIOENG., vol. 25, 1983, pages 53 - 65, XP002397253, DOI: doi:10.1002/bit.260250106;;GUSAKOV, A. V.; SINITSYN, A. P.; DAVYDKIN, I. Y.; DAVYDKIN, V. Y.; PROTAS, O. V.: ""Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field"", APPL. BIOCHEM. BIOTECHNOL., vol. 56, 1996, pages 141 - 153, XP035176121, DOI: doi:10.1007/BF02786945;;CHANDRA ET AL.: ""Substrate pretreatment: The key to effective enzymatic hydrolysis of lignocellulosics?"", ADV. BIOCHEM. ENGIN.ÆIOTECHNOL., vol. 108, 2007, pages 67 - 93;;GALBE; ZACCHI: ""Pretreatment of lignocellulosic materials for efficient bioethanol production"", ADV. BIOCHEM. ENGIN. / BIOTECHNOL., vol. 108, 2007, pages 41 - 65, XP008113337, DOI: doi:10.1007/10_2007_070;;HENDRIKS; ZEEMAN: ""Pretreatments to enhance the digestibility of lignocellulosic biomass"", BIORESOURCE TECHNOL., vol. 100, 2009, pages 10 - 18, XP025407559, DOI: doi:10.1016/j.biortech.2008.05.027;;MOSIER ET AL.: ""Features of promising technologies for pretreatment of lignocellulosic biomass"", BIORESOURCE TECHNOL., vol. 96, 2005, pages 673 - 686, XP025313257, DOI: doi:10.1016/j.biortech.2004.06.025;;TAHERZADEH; KARIMI: ""Pretreatment of lignocellulosic wastes to improve ethanol and biogas production: A review"", INT. J. OF MOL. SCI., vol. 9, 2008, pages 1621 - 1651, XP002674403, DOI: doi:10.3390/IJMS9091621;;YANG; WYMAN: ""Pretreatment: the key to unlocking low-cost cellulosic ethanol"", BIOFUELS BIOPRODUCTS AND BIOREFINING-BIOFPR., vol. 2, 2008, pages 26 - 40, XP008150365, DOI: doi:10.1002/bbb.49;;DUFF; MURRAY, BIORESOURCE TECHNOLOGY, vol. 855, 1996, pages 1 - 33;;GALBE; ZACCHI, APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 618 - 628;;BALLESTEROS ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 129-132, 2006, pages 496 - 508;;VARGA ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 113-116, 2004, pages 509 - 523;;SASSNER ET AL., ENZYME MICROB. TECHNOL., vol. 39, 2006, pages 756 - 762;;SCHELL ET AL., BIORESOURCE TECHNOL., vol. 91, 2004, pages 179 - 188;;LEE ET AL., ADV. BIOCHEM. ENG. BIOTECHNOL., vol. 65, 1999, pages 93 - 115;;WYMAN ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 1959 - 1966;;MOSIER ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 673 - 686;;SCHMIDT; THOMSEN, BIORESOURCE TECHNOL., vol. 64, 1998, pages 139 - 151;;PALONEN ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 117, 2004, pages 1 - 17;;VARGA ET AL., BIOTECHNOL. BIOENG., vol. 88, 2004, pages 567 - 574;;MARTIN ET AL., J. CHEM. TECHNOL BIOTECHNOL., vol. 81, 2006, pages 1669 - 1677;;GOLLAPALLI ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 98, 2002, pages 23 - 35;;CHUNDAWAT ET AL., BIOTECHNOL. BIOENG., vol. 96, 2007, pages 219 - 231;;ALIZADEH ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 121, 2005, pages 1133 - 1141;;TEYMOURI ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 2014 - 2018;;PAN ET AL., BIOTECHNOL. BIOENG., vol. 90, 2005, pages 473 - 481;;PAN ET AL., BIOTECHNOL. BIOENG., vol. 94, 2006, pages 851 - 861;;KURABI ET AL., APPL. BIOCHEM. BIOTECHNOL, vol. 121, 2005, pages 219 - 230;;SCHELL ET AL., APPL. BIOCHEM. AND BIOTECHNOL., vol. 105, no. 108, 2003, pages 69 - 85;;MOSIER ET AL., BIORESOURCE TECHNOLOGY, vol. 96, 2005, pages 673 - 686;;HSU, T.-A.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Pretreatment of biomass"", pages: 179 - 212;;GHOSH; SINGH: ""Physicochemical and biological treatments for enzymatic/microbial conversion of cellulosic biomass"", ADV. APPL. MICROBIOL., vol. 39, 1993, pages 295 - 333, XP009102696, DOI: doi:10.1016/S0065-2164(08)70598-7;;MCMILLAN, J. D.: ""Enzymatic Conversion of Biomass for Fuels Production"", 1994, AMERICAN CHEMICAL SOCIETY, article ""Pretreating lignocellulosic biomass: a review"";;GONG, C. S.; CAO, N. J.; DU, J.; TSAO, G. T.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Ethanol production from renewable resources"", pages: 207 - 241;;OLSSON; HAHN-HAGERDAL: ""Fermentation of lignocellulosic hydrolysates for ethanol production"", ENZ. MICROB. TECH., vol. 18, 1996, pages 312 - 331, XP002312595, DOI: doi:10.1016/0141-0229(95)00157-3;;VALLANDER; ERIKSSON: ""Production of ethanol from lignocellulosic materials: State of the art"", ADV. BIOCHEM. ENG.LBIOTECHNOL., vol. 42, 1990, pages 63 - 95;;PENTTILA ET AL., GENE, vol. 45, 1986, pages 253 - 263;;SALOHEIMO ET AL., GENE, vol. 63, 1988, pages 11 - 22;;OKADA ET AL., APPL. ENVIRON. MICROBIOL., vol. 64, 1988, pages 555 - 563;;SALOHEIMO ET AL., MOLECULAR MICROBIOLOGY, vol. 13, 1994, pages 219 - 228;;OOI ET AL., NUCLEIC ACIDS RESEARCH, vol. 18, 1990, pages 5884;;SAKAMOTO ET AL., CURRENT GENETICS, vol. 27, 1995, pages 435 - 439;;SAARILAHTI ET AL., GENE, vol. 90, 1990, pages 9 - 14;;DAN ET AL., J. BIOL. CHEM., vol. 275, 2000, pages 4973 - 4980;;KAWAGUCHI ET AL., GENE, vol. 173, 1996, pages 287 - 288;;BENNETT, J.W. AND LASURE, L.: ""More Gene Manipulations in Fungi"", 1991, ACADEMIC PRESS;;BAILEY, J.E.; OLLIS, D.F.: ""Biochemical Engineering Fundamentals"", 1986, MCGRAW-HILL BOOK COMPANY;;LIN ET AL., APPL. MICROBIOL. BIOTECHNOL, vol. 69, 2006, pages 627 - 642;;PHILIPPIDIS, G. P.: ""Handbook on Bioethano/: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Cellulose bioconversion technology"", pages: 179 - 212;;CHEN; HO: ""Cloning and improving the expression of Pichia stipitis xylose reductase gene in Saccharomyces cerevisiae"", APPL. BIOCHEM. BIOTECHNOL., vol. 39-40, 1993, pages 135 - 147, XP009063851, DOI: doi:10.1007/BF02918984;;HO ET AL.: ""Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose"", APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 1852 - 1859;;KOTTER; CIRIACY: ""Xylose fermentation by Saccharomyces cerevisiae"", APPL. MICROBIOL. BIOTECHNOL., vol. 38, 1993, pages 776 - 783;;WALFRIDSSON ET AL.: ""Xylose-metabolizing Saccharomyces cerevisiae strains overexpressing the TKL1 and TALI genes encoding the pentose phosphate pathway enzymes transketolase and transaldolase"", APPL. ENVIRON. MICROBIOL., vol. 61, 1995, pages 4184 - 4190;;KUYPER ET AL.: ""Minimal metabolic engineering of Saccharomyces cerevisiae for efficient anaerobic xylose fermentation: a proof of principle"", FEMS YEAST RESEARCH, vol. 4, 2004, pages 655 - 664;;BEALL ET AL.: ""Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli"", BIOTECH. BIOENG., vol. 38, 1991, pages 296 - 303, XP000215006, DOI: doi:10.1002/bit.260380311;;INGRAM ET AL.: ""Metabolic engineering of bacteria for ethanol production"", BIOTECHNOL. BIOENG., vol. 58, 1998, pages 204 - 214, XP000999111, DOI: doi:10.1002/(SICI)1097-0290(19980420)58:2/3<204::AID-BIT13>3.0.CO;2-C;;ZHANG ET AL.: ""Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis"", SCIENCE, vol. 267, 1995, pages 240 - 243, XP002912123, DOI: doi:10.1126/science.267.5195.240;;DEANDA ET AL.: ""Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering"", APPL. ENVIRON. MICROBIOL., vol. 62, 1996, pages 4465 - 4470;;K. JACQUES, T.P. LYONS AND D.R. KELSALL,: ""The Alcohol Textbook"", 1999, NOTTINGHAM UNIVERSITY PRESS;;ALFENORE ET AL.: ""Improving ethanol production and viability of Saccharomyces cerevisiae by a vitamin feeding strategy during fed-batch process"", 2002, SPRINGER-VERLAG;;SILVEIRA, M. M.; JONAS, R.: ""The biotechnological production of sorbitol"", APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 400 - 408;;NIGAM, P.; SINGH, D.: ""Processes for fermentative production of xylitol - a sugar substitute"", PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124;;EZEJI, T. C.; QURESHI, N.; BLASCHEK, H. P.: ""Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping"", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603;;CHEN, R.; LEE, Y. Y.: ""Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass"", APPL. BIOCHEM. BIOTECHNOL., vol. 63-65, 1997, pages 435 - 448, XP008087560, DOI: doi:10.1007/BF02920444;;RICHARD, A.; MARGARITIS, A.: ""Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515;;KATAOKA, N.; A. MIYA; K. KIRIYAMA: ""Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria"", WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 41 - 47;;GUNASEELAN V.N., BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114;;MARTINEZ ET AL., NATURE BIOTECHNOL., vol. 26, 2008, pages 553 - 560;;EWING; GREEN, GENOME RES., vol. 8, 1998, pages 186 - 194;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402",PENDING
3,US,B2,US 8609933 B2,122-559-448-992-759,2013-12-17,2013,US 200913131551 A,2009-11-30,US 200913131551 A;;US 11996408 P;;US 2009/0066085 W,2008-12-04,Polypeptides having feruloyl esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",BOHAN DOREEN;;BROWN KIMBERLY;;NOVOZYMES INC,BOHAN DOREEN;;BROWN KIMBERLY,NOVOZYMES INC (2011-06-02),https://lens.org/122-559-448-992-759,Granted Patent,yes,4,0,5,5,10,C12N9/18;;C12P7/10;;C12P19/00;;C12P21/02;;C12Y301/01073;;Y02E50/10;;C12N9/18;;C12P7/10;;C12P19/00;;C12P21/02;;C12Y301/01073;;Y02E50/10,C12N15/56;;C12N9/42;;C12N15/82;;C12P21/02,800/284;;800/298;;435/200;;435/71.1;;536/23.2;;424/93.2,13,10,088-956-744-893-796;;055-003-061-629-507;;078-792-343-849-240;;084-667-057-884-082;;046-412-992-347-12X;;096-668-571-480-195;;004-737-263-977-895;;034-554-107-359-733;;011-059-930-612-536;;036-794-281-968-249,16702605;;10.1385/abab:133:2:87;;10.1073/pnas.0403255101;;pmc438954;;15197260;;12169619;;10.1128/jb.184.17.4925-4929.2002;;pmc135289;;8679110;;17973091;;10.1007/s10529-007-9564-6;;10.1016/j.procbio.2007.01.007;;1663152;;10.1099/00221287-137-10-2339;;10.1099/00221287-140-4-779;;pmc168785;;9406381;;10.1128/aem.63.12.4638-4644.1997;;10.1016/0141-0229(92)90050-x,"Uniprot. 2006. Accession Q0CEE7. 2 pages.;;Uniprot. 2011. Accession G2R873. p. 1-2.;;Wong. 2006. Feruloyl Esterase: A key enzyme in biomass degradation. Appl. Biochem. 133:87-112.;;Guo et al. 2004. Protein tolerance to random amino acid change. 101(25):9205-9210.;;Uniprot. 2006. Accession Q0CEE7.;;Nagy et al. 2002. The membrane-bound alpha-glucuronidase from Pseudomonas cellulosa hydrolyzes 4-O-methyl-d-Glucuronoxylooligosaccharides but not 4-O-methyl-d-Glucuronoxylan. J. Bac. 184(17):4925-4929.;;Kroon et al 1996, Biotechnol Appl Biochem 23, 255-26.;;Benoit et al., Biotechnol Lett (2008) 30: 387-396.;;Topakas et al., Process Biochemistry 42 (2007) 497-509.;;Faulds et al., 1991, J. Gen Microbiol, 137, 2339-2345.;;Faulds et al., 1994, Microbiology, 140, 779-787.;;De Vries et al., 1997, Appl. Environ. Microbiol. 63: 4638-4644.;;Castanares et al., 1992, Enzyme Microbiol. Technol. 14: 875-884.",INACTIVE
4,WO,A1,WO 2010/053838 A1,121-631-405-624-638,2010-05-14,2010,US 2009/0062785 W,2009-10-30,US 11291008 P,2008-11-10,POLYPEPTIDES HAVING FERULOYL ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC;;BROWN KIMBERLY;;BOHAN DOREEN,BROWN KIMBERLY;;BOHAN DOREEN,,https://lens.org/121-631-405-624-638,Patent Application,yes,4,125,5,5,9,C12N9/18;;C12N9/18;;C12N15/11;;C12N15/1137;;C12N15/1137;;C12N15/82;;C12N2310/11;;C12N2310/11;;C12N2310/14;;C12N2310/14;;C12Y301/01073;;C12Y301/01073,C07K14/37;;C12N9/24;;C12N15/82,,8,4,030-861-357-228-781;;136-501-366-348-202;;046-412-992-347-12X;;041-606-854-625-551,10.1385/abab:111:3:153;;14665735;;10.1111/j.1745-7270.2007.00348.x;;17989872;;17973091;;10.1007/s10529-007-9564-6;;10.1007/s00253-003-1476-3;;14661116,"DATABASE UniProt [online] 17 October 2006 (2006-10-17), ""SubName: Full=Putative uncharacterized protein;"", XP002567343, retrieved from EBI accession no. UNIPROT:Q0CEE7 Database accession no. Q0CEE7;;DATABASE UniProt [online] 5 July 2005 (2005-07-05), ""SubName: Full=Tannase, putative; EC=<A HREF=""http://srs.ebi.ac.uk/srsbin/cgi-bin/wgetz?[enzyme-ECNumber:3.1.1.20]+-e"">3.1.1.20</A>;"", XP002567703, retrieved from EBI accession no. UNIPROT:Q4W9W7 Database accession no. Q4W9W7;;DATABASE UniProt [online] 23 January 2007 (2007-01-23), ""SubName: Full=Tannase and feruloyl esterase family protein;"", XP002567704, retrieved from EBI accession no. UNIPROT:A1D9T4 Database accession no. A1D9T4;;REY MICHAEL W ET AL: ""Cloning, heterologous expression, and characterization of Thielavia terrestris glucoamylase"", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, HUMANA PRESS, INC, US, vol. 111, no. 3, 1 December 2003 (2003-12-01), pages 153 - 166, XP002489740, ISSN: 0273-2289;;FAZARY AHMED E ET AL: ""Feruloyl esterases as biotechnological tools: Current and future perspectives"", ACTA BIOCHIMICA ET BIOPHYSICA SINICA, vol. 39, no. 11, November 2007 (2007-11-01), pages 811 - 828, XP002567849, ISSN: 1005-9628;;ISABELLE BENOIT ET AL: ""Biotechnological applications and potential of fungal feruloyl esterases based on prevalence, classification and biochemical diversity"", BIOTECHNOLOGY LETTERS, KLUWER ACADEMIC PUBLISHERS, DO, vol. 30, no. 3, 1 November 2007 (2007-11-01), pages 387 - 396, XP019570012, ISSN: 1573-6776;;CREPIN V F ET AL: ""Functional classification of the microbial feruloyl esterases"", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 63, no. 6, 1 February 2004 (2004-02-01), pages 647 - 652, XP002511091, ISSN: 0175-7598, [retrieved on 20031206];;See also references of EP 2356136A1",PENDING
5,US,A1,US 2013/0337510 A1,134-954-330-326-131,2013-12-19,2013,US 201314010199 A,2013-08-26,US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",BROWN KIMBERLY;;ABBATE ERIC;;NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/134-954-330-326-131,Patent Application,yes,0,2,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12P19/14,435/99,0,0,,,,INACTIVE
6,CN,A,CN 102112603 A,139-756-758-525-11X,2011-06-29,2011,CN 200980130147 A,2009-07-29,US 2009/0052100 W;;US 8454308 P,2008-07-29,Polypeptides having alpha-glucuronidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-glucuronidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MICHELLE MARANTA;;KIMBERLY BROWN,,https://lens.org/139-756-758-525-11X,Patent Application,no,0,3,10,10,0,C12Y302/01139;;C12N9/2402;;C12Y302/01139;;C12N9/2402,C12N9/24,,0,0,,,,DISCONTINUED
7,US,B2,US 8129590 B2,020-507-905-721-194,2012-03-06,2012,US 32734708 A,2008-12-03,US 32734708 A;;US 99299507 P,2007-12-06,Polypeptides having acetylxylan esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",MARANTA MICHELLE;;BROWN KIMBERLY;;NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,NOVOZYMES A/S (2008-12-08),https://lens.org/020-507-905-721-194,Granted Patent,yes,6,2,14,14,11,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,C12N15/31;;A01H5/00;;C12N15/10;;C12N15/52;;C12N15/82,800/288;;800/284;;800/295;;800/278;;435/320.1;;435/468;;536/23.1;;536/23.2;;536/23.7,6,3,062-344-560-749-131;;014-625-826-302-514;;127-544-305-672-969,8647098;;10.1111/j.1432-1033.1996.0553p.x;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404,"Margolles-Clark et al., Accetyl xylan esterase from Trichoderma reesei contains an active-site serine residue and a cellulose-binding domain, 1996, Eur. J. Biochem. 237: 553-560.;;Henrissat B., A classification of glycosyl hydrolases based on amino acid sequence similarities, 1991, Biochem. J. 280: 309-316.;;Henrissat et al., Updating the sequence-based classification of glycosyl hydrolases, 1996, Biochem. J. 316: 695-696.;;Sundberg et al, 1991, Biotechnol. Appl. Biochem. 13: 1-11.;;Sundberg et al, Purification and Properties of Two Acetylxylan Esterases of Trichoderma reesei, 1991, Biotechnol. Appl. Biochem. 13: 1-11.;;Written Opinion of the International Searching Authority for PCT/US2008/085380.",ACTIVE
8,WO,A1,WO 2010/014880 A1,040-949-734-058-298,2010-02-04,2010,US 2009/0052368 W,2009-07-31,US 8511608 P,2008-07-31,POLYPEPTIDES HAVING ACETYLXYLAN ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;MARANTA MICHELLE;;BROWN KIMBERLY,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/040-949-734-058-298,Patent Application,yes,5,126,8,8,13,C12N9/18;;C12N9/18;;C12N1/22;;C12N1/22;;C12P7/10;;C12P7/10;;Y02E50/10;;Y02E50/10,C12N9/24;;C12N9/18,,4,1,042-774-093-200-91X,10.1016/j.jbiotec.2005.07.015;;16129506,"DATABASE UniProt [online] 15 December 2003 (2003-12-15), ""SubName: Full=Acetylxylan esterase;"", XP002546990, retrieved from EBI accession no. UNIPROT:Q7S259 Database accession no. Q7S259;;KOSEKI T. ET AL.: ""An Aspergillus oryzae acetyl xylan esterase: Molecular cloning and characteristics of recombinant enzyme expressed in Pichia pastoris"", JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 121, no. 3, 10 February 2006 (2006-02-10), pages 381 - 389, XP024956899, ISSN: 0168-1656, [retrieved on 20060210];;DATABASE EMBL [online] 15 July 1996 (1996-07-15), ""T.reesei mRNA for acetyl xylan esterase"", XP002546991, retrieved from EBI accession no. EMBL:Z69256 Database accession no. Z69256;;ANONYMOUS: ""Information on EC 3.1.1.72 - Acetylxylan esterase"", INTERNET ARTICLE, 00-00-00, XP002547268, Retrieved from the Internet <URL:p://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.1.72> [retrieved on 20090924]",PENDING
9,BR,A2,BR PI0821088 A2,076-065-782-837-213,2015-09-15,2015,BR PI0821088 A,2008-12-03,US 2008/0085341 W;;US 1215207 P,2007-12-07,"construção de ácido nucléico, célula hospedeira microbiana transgênica, e, métodos para produzir um polipeptídeo tendo atividade de feruloil esterase, para produzir um mutante de uma célula-mãe, para inibir a expressão de um polipeptídeo tendo atividade de feruloil esterase em uma célula, para produzir uma proteína, e, para degradar um material contendo xilano.",,NOVOZYMES AS,BROWN KIMBERLY;;MARANTA MICHELLE,,https://lens.org/076-065-782-837-213,Patent Application,no,0,0,7,7,0,C12N15/8243;;C12N15/8243;;C12N9/18;;C12N9/18;;C12N15/8257;;C12N15/8257,C12N15/82;;C12N9/18,,0,0,,,,DISCONTINUED
10,EP,A1,EP 2224822 A1,183-582-294-509-477,2010-09-08,2010,EP 08858011 A,2008-12-03,US 2008/0085380 W;;US 99299507 P,2007-12-06,POLYPEPTIDES HAVING ACETYLXYLAN ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/183-582-294-509-477,Patent Application,yes,0,0,14,14,0,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,A23K1/165;;C12N9/18,,1,0,,,See references of WO 2009073709A1,ACTIVE
11,US,A1,US 2014/0212932 A1,006-024-147-543-689,2014-07-31,2014,US 201414248039 A,2014-04-08,US 201414248039 A;;US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11660508 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/006-024-147-543-689,Patent Application,yes,0,1,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12P7/14,435/109;;435/106;;435/110;;435/115;;435/116;;435/126;;435/136;;435/137;;435/139;;435/140;;435/141;;435/144;;435/145;;435/146;;435/148;;435/150;;435/155;;435/157;;435/158;;435/159;;435/160;;435/162;;435/167;;435/168,0,0,,,,INACTIVE
12,WO,A3,WO 2010/059424 A3,036-068-874-750-169,2010-07-15,2010,US 2009/0063249 W,2009-11-04,US 11582908 P;;US 17422109 P,2008-11-18,METHODS AND COMPOSITIONS FOR DEGRADING CELLULOSIC MATERIAL,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC;;BROWN KIMBERLY;;ABBATE ERIC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/036-068-874-750-169,Search Report,yes,10,0,17,17,0,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12N9/24;;C12N9/42;;C12P19/14,,7,6,017-684-136-290-674;;043-717-617-452-997;;035-863-987-433-406;;026-807-638-108-848;;117-206-818-045-405;;003-546-581-906-613,17058283;;10.1002/bit.21238;;10.1016/j.enzmictec.2006.07.026;;17221887;;10.1002/bit.21329;;10.1016/j.biortech.2007.09.064;;18006303;;17589813;;10.1007/10_2007_065;;10.1007/s10295-008-0327-8;;18338189,"BERLIN A ET AL: ""Optimization of enzyme complexes for lignocellulose hydrolysis"", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, vol. 97, no. 2, 1 January 2007 (2007-01-01), pages 287 - 296, XP002548813, ISSN: 0006-3592, [retrieved on 20061020];;SORENSEN ET AL: ""Synergistic enzyme mechanisms and effects of sequential enzyme additions on degradation of water insoluble wheat arabinoxylan"", ENZYME AND MICROBIAL TECHNOLOGY, STONEHAM, MA, US, vol. 40, no. 4, 16 February 2007 (2007-02-16), pages 908 - 918, XP005892515, ISSN: 0141-0229;;GUSAKOV ALEXANDER V ET AL: ""Design of highly efficient cellulase mixtures for enzymatic hydrolysis of cellulose."", BIOTECHNOLOGY AND BIOENGINEERING 1 AUG 2007, vol. 97, no. 5, 1 August 2007 (2007-08-01), pages 1028 - 1038, XP002565359, ISSN: 0006-3592;;SELIG M J ET AL: ""Synergistic enhancement of cellobiohydrolase performance on pretreated corn stover by addition of xylanase and esterase activities"", BIORESOURCE TECHNOLOGY, ELSEVIER BV, GB, vol. 99, no. 11, 1 July 2008 (2008-07-01), pages 4997 - 5005, XP022606313, ISSN: 0960-8524, [retrieved on 20071119];;VIIKARI L ET AL: ""Thermostable enzymes in lignocellulose hydrolysis"", ADVANCES IN BIOCHEMICAL ENGINEERING, BIOTECHNOLOGY, SPRINGER, BERLIN, DE, vol. 108, 23 June 2007 (2007-06-23), pages 121 - 145, XP002510178, ISSN: 0724-6145, [retrieved on 20070623];;RAJ KUMAR ET AL: ""Bioconversion of lignocellulosic biomass: biochemical and molecular perspectives"", JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY ; OFFICIAL JOURNAL OF THE SOCIETY FOR INDUSTRIAL MICROBIOLOGY, SPRINGER, BERLIN, DE, vol. 35, no. 5, 13 March 2008 (2008-03-13), pages 377 - 391, XP019596328, ISSN: 1476-5535;;See also references of EP 2358872A2",PENDING
13,EP,A2,EP 2358872 A2,054-080-008-004-172,2011-08-24,2011,EP 09748201 A,2009-11-04,US 2009/0063249 W;;US 11582908 P;;US 17422109 P,2008-11-18,METHODS AND COMPOSITIONS FOR DEGRADING CELLULOSIC MATERIAL,,NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/054-080-008-004-172,Patent Application,yes,0,0,17,17,0,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12N9/24;;C12N9/42;;C12P19/14,,1,1,033-423-822-755-165,18478401;;10.1007/s12010-007-9064-0,"MARÍA P. GARCÍA-APARICIO ET AL: ""Xylanase contribution to the efficiency of cellulose enzymatic hydrolysis of barley straw"", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 137-140, no. 1-12, 1 April 2007 (2007-04-01), pages 353 - 365, XP055022555, ISSN: 0273-2289, DOI: 10.1007/s12010-007-9064-0",DISCONTINUED
14,CN,A,CN 101909461 A,063-560-885-714-474,2010-12-08,2010,CN 200880124751 A,2008-12-03,US 2008/0085380 W;;US 99299507 P,2007-12-06,Polypeptides having acetylxylan esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MICHELLE MARANTA;;KIMBERLY BROWN,,https://lens.org/063-560-885-714-474,Patent Application,no,0,5,14,14,0,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,A23K1/165;;C12N9/18,,0,0,,,,INACTIVE
15,US,B2,US 8338666 B2,069-957-066-022-582,2012-12-25,2012,US 201213410177 A,2012-03-01,US 201213410177 A;;US 32734708 A;;US 99299507 P,2007-12-06,Polypeptides having acetylxylan esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",MARANTA MICHELLE;;BROWN KIMBERLY;;NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/069-957-066-022-582,Granted Patent,yes,7,0,14,14,11,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,C12N15/31;;A01H5/00;;C12N15/10;;C12N15/82,800/288;;800/284;;800/295;;800/278;;435/320.1;;435/468;;536/23.1;;536/23.2;;536/23.7,5,3,062-344-560-749-131;;014-625-826-302-514;;127-544-305-672-969,8647098;;10.1111/j.1432-1033.1996.0553p.x;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404,"Written Opinion of the International Searching Authority for PCT/US2008/085380.;;Margolles-Clark et al., Accetyl xylan esterase from Trichoderma reesei contains an active-site serine residue and a cellulose-binding domain, 1996, Eur. J. Biochem. 237: 553-560.;;Henrissat B., A classification of glycosyl hydrolases based on amino acid sequence similarities, 1991, Biochem. J. 280: 309-316.;;Henrissat et al., Updating the sequence-based classification of glycosyl hydrolases, 1996, Biochem. J. 316: 695-696.;;Sundberg et al, 1991, Biotechnol. Appl. Biochem. 13: 1-11.",ACTIVE
16,DE,D1,DE 60328802 D1,065-290-558-359-28X,2009-09-24,2009,DE 60328802 T,2003-08-29,US 40717002 P;;US 0327074 W,2002-08-30,VERFAHREN ZUR HERSTELLUNG VON SÄUGETIER-TRYPSINEN,"The present invention relates to methods for producing a mammalian trypsin in a Fusarium venenatum host strain, the method comprising (a) cultivating the Fusarium venenatum host strain in a culture medium under conditions suitable for expression of the mammalian trypsin and secretion thereof into the medium, wherein the Fusarium venenatum host strain comprises a nucleic acid construct comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen; and (b) recovering the mammalian trypsin from the medium. The present invention also relates to constructs comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen, and to vectors and Fusarium venenatum host strains comprising such constructs.",NOVOZYMES INC,BERKA RANDY;;BROWN KIMBERLY,,https://lens.org/065-290-558-359-28X,Granted Patent,no,0,0,11,11,0,C12N9/6421;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6421,C12N1/15;;C12N9/64;;C12N9/76;;C12N15/52;;C12N15/62;;C12N15/80;;C12P21/02,,0,0,,,,EXPIRED
17,US,B2,US 8735128 B2,086-556-466-918-475,2014-05-27,2014,US 51137109 A,2009-07-29,US 51137109 A;;US 8454308 P,2008-07-29,Polypeptides having alpha-glucuronidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-glucuronidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",MARANTA MICHELLE;;BROWN KIMBERLY;;NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,NOVOZYMES A/S (2009-08-05),https://lens.org/086-556-466-918-475,Granted Patent,yes,4,0,10,10,12,C12Y302/01139;;C12N9/2402;;C12Y302/01139;;C12N9/2402,C12N9/24;;C07H21/04;;C12P7/02;;D21C1/00,435/200;;435/155;;435/277;;536/23.2,19,10,061-859-656-899-093;;132-695-844-930-786;;015-734-715-035-926;;052-186-686-935-921;;002-428-866-794-076;;146-744-233-062-074;;046-820-574-177-052;;007-189-170-296-008;;029-517-745-045-938;;013-085-340-348-394,15029827;;10.1017/s0033583503003901;;10.1021/bi990993h;;10512619;;9440512;;10.1128/jb.180.2.243-249.1998;;pmc106878;;pmc2441463;;10.1186/gb-2008-9-5-r77;;18460219;;8654984;;10.1016/0378-1119(96)00167-9;;10.1016/j.enzmictec.2005.07.018;;10.1016/0141-0229(94)90041-8;;10.1016/0003-9861(89)90464-5;;2802623;;10.1128/aem.61.3.1077-1081.1995;;pmc1388390;;16534958;;10.1016/j.enzmictec.2007.05.014,"Whisstock et al. Quaterly Reviews of Biophysics, 2003, ""Prediction of protein function from protein sequence and structure"", 36(3): 307-340.;;Witkowski et al. Conversion of a beta-ketoacyl synthase to a malonyl decarboxylase by replacement of the active-site cysteine with glutamine, Biochemistry. Sep. 7, 1999;38(36)11643-50.;;Database EMBL: AF439788, 2001, XP002558275.;;Database EMBL: Y15405, 1998, XP002558276.;;De Vries et al., aguA, The gene encoding an extracellular alpha-glucuronidase from Aspergillus tubingensis, is specifically induced on xylose and not on glucuronic acid, Journal of Bacteriology, American Society for Microbiology, 1998, v. 180, p. 243-249.;;Database UNIPROT: 042814, 1998, XP002559108.;;Database UNIPROT: B2APQ4, 2008, XP002559109.;;Database EMBL: CU633876, 2008, XP002559110.;;Espagne et al., The genome sequence of the model ascomycete fungus Podospora anserina, Genome Biology, 2008, v. 9, p. R77.;;Database UNIPROT: Q5AQZ4, 2005, XP002558277.;;Database UNIPROT: Q2GPV7, 2006, XP002559111.;;Margolles-Clark et al., The alpha-glucuronidase-encoding gene of Trichoderma reesei, Gene, 1996, v. 172, p. 171-172.;;De Wet et al., Characterization of the Aureobasidium pulluland alpha-glucuronidase expressed in Saccharomyces cerevisiae, Enzyme and Microbial Technology, 2006, v. 38, p. 649-656.;;Siika-Aho et al., An alpha-glucuronidase from Trichoderma reesei RUT C-30, 1994, Enzyme Microb. Technol. 16: 813-819.;;Uchida et al., Purification and Characterization of Intracellular alpha-Glucuronidase from Aspergillus niger 5-16, 1992, Biosci. Biotech. Biochem. 56: 1608-1615.;;Khandke et al., Purification and Characterization of an alpha-Glucuronidase from a Termophilic Fungus, Thermoascus aurantiacus, 1989, Arch. Biochem. Biophys. 274: 511-517.;;Shao et al., Purification and Characterization of the alpha-Glucuronidase from Thermoanaerobacterium sp. Strain JW/SL-YS485, an Important Enzyme for the Utilization of Substituted Xylans, 1995, Appl. Environ. Microbiol. 61: 1077-1081.;;Heneghan et al, 2007, Enzyme Microbial Technol 41, 677-682.;;Ishihara et al, 1990, Bull For For Prod Res Inst 359, 141-157.",ACTIVE
18,US,B2,US 8609931 B2,124-675-068-913-319,2013-12-17,2013,US 88624410 A,2010-09-20,US 88624410 A;;US 24353209 P,2009-09-18,Polypeptides having beta-glucosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having beta-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",BROWN KIMBERLY;;HARRIS PAUL;;NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL,NOVOZYMES INC (2010-09-30),https://lens.org/124-675-068-913-319,Granted Patent,yes,7,0,6,6,11,C12N15/52;;C12P7/10;;C12P19/14;;C12Y302/01021;;C12N9/2445;;Y02E50/10;;C12N15/52;;C12Y302/01021;;C12P19/14;;C12P7/10;;C12N9/2445;;Y02E50/10,C12N9/42;;C12N15/56;;C12N15/82;;C12P21/02,800/284;;800/298;;435/200;;435/71.1;;536/23.2;;424/93.2,8,5,105-676-187-931-902;;055-003-061-629-507;;037-694-385-435-98X;;040-285-223-611-187;;012-495-969-917-14X,21964414;;10.1038/nbt.1976;;10.1073/pnas.0403255101;;pmc438954;;15197260;;10.1126/science.1137016;;17289988;;20138890;;10.1016/j.jmb.2010.01.072;;10.2210/pdb2wt3/pdb;;15193129;;10.1023/b:biry.0000029853.34093.13,"Berka et al. 2011. Comparative genomic analysis of the thermophilic biomass-degrading fungi Myceliophthora thermophilia and Thielavia terrestris. Nature. 29(10):922-929.;;Berka et al. 2011 (as stated above) Supplementary Data and Figures, pp. 1-46).;;Guo et al. 2004. Protein tolerance to random amino acid change. PNAS. 101(25):9205-9210.;;Himmel et al. 2007. Biomass recalcitrance: Engineering plants and enzymes for biofuels production. Science. 315:804-807.;;Pozzo et al. 2010. Structural and functional analyses of beta-glucosidase 3B from Thermotoga neapolitana: A thermostable three-domain representative of glycoside hydrolase 3. J Mol Biol. 397:724-739.;;Bukhtojarov et al. 2004. Cellulase complex of the fungus Chrysosporium lucknowense: Isolation and characterization of endoglucanases and cellobiohydrolases. Biochemistry (Moscow). 69(5):542-551.;;Alapuranen, M., US 2009 042266-Access No. AWH58324.;;Gosink, M., WO 2009-018537-Access No. AWH29250.",INACTIVE
19,CA,A1,CA 2707847 A1,141-096-865-649-151,2009-06-11,2009,CA 2707847 A,2008-12-03,US 99299507 P;;US 2008/0085380 W,2007-12-06,POLYPEPTIDES HAVING ACETYLXYLAN ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/141-096-865-649-151,Patent Application,no,0,0,14,14,11,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,A23K1/165;;C12N9/18,,0,0,,,,DISCONTINUED
20,WO,A1,WO 2010/014706 A1,176-307-125-651-093,2010-02-04,2010,US 2009/0052100 W,2009-07-29,US 8454308 P,2008-07-29,POLYPEPTIDES HAVING ALPHA-GLUCURONIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having alpha-glucuronidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;MARANTA MICHELLE;;BROWN KIMBERLY,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/176-307-125-651-093,Patent Application,yes,4,125,10,10,12,C12Y302/01139;;C12N9/2402;;C12Y302/01139;;C12N9/2402,C12N9/24,,7,2,002-428-866-794-076;;146-744-233-062-074,8654984;;10.1016/0378-1119(96)00167-9;;10.1016/j.enzmictec.2005.07.018,"DATABASE EMBL [online] 20 November 2001 (2001-11-20), ""Talaromyces emersonii alpha-glucuronidase (aGlu) gene, complete cds."", XP002558275, retrieved from EBI accession no. EMBL:AF439788 Database accession no. AF439788;;DATABASE EMBL [online] 5 February 1998 (1998-02-05), ""Aspergillus tubingensis aguA gene"", XP002558276, retrieved from EBI accession no. EMBL:Y15405 Database accession no. Y15405;;DATABASE UniProt [online] 20 May 2008 (2008-05-20), ""SubName: Full=Predicted CDS Pa_5_11170;"", XP002559109, retrieved from EBI accession no. UNIPROT:B2APQ4 Database accession no. B2APQ4;;DATABASE UniProt [online] 26 April 2005 (2005-04-26), ""SubName: Full=Putative uncharacterized protein;"", XP002558277, retrieved from EBI accession no. UNIPROT:Q5AQZ4 Database accession no. Q5AQZ4;;DATABASE UniProt [online] 21 March 2006 (2006-03-21), ""SubName: Full=Putative uncharacterized protein;"", XP002559111, retrieved from EBI accession no. UNIPROT:Q2GPV7 Database accession no. Q2GPV7;;MARGOLLES-CLARK E ET AL: ""The alpha-glucuronidase-encoding gene of Trichoderma reesei"", GENE, ELSEVIER, AMSTERDAM, NL, vol. 172, no. 1, 12 June 1996 (1996-06-12), pages 171 - 172, XP004042732, ISSN: 0378-1119;;DE WET ET AL: ""Characterization of the Aureobasidium pullulans alpha-glucuronidase expressed in Saccharomyces cerevisiae"", ENZYME AND MICROBIAL TECHNOLOGY, STONEHAM, MA, US, vol. 38, no. 5, 2 March 2006 (2006-03-02), pages 649 - 656, XP005252251, ISSN: 0141-0229",PENDING
21,EP,A1,EP 2225370 A1,004-205-625-333-679,2010-09-08,2010,EP 08860153 A,2008-12-03,US 2008/0085341 W;;US 1215207 P,2007-12-07,POLYPEPTIDES HAVING FERULOYL ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/004-205-625-333-679,Patent Application,yes,0,0,7,7,0,C12N15/8243;;C12N15/8243;;C12N9/18;;C12N9/18;;C12N15/8257;;C12N15/8257,C12N9/18;;C12N15/82,,1,0,,,See references of WO 2009076122A1,DISCONTINUED
22,US,B2,US 9677102 B2,186-806-831-548-527,2017-06-13,2017,US 201514849204 A,2015-09-09,US 201514849204 A;;US 201414248039 A;;US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11660508 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/186-806-831-548-527,Granted Patent,yes,13,0,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12N9/24;;C12N9/42;;C12P7/14;;C12P19/02;;C12P19/14,,8,8,033-423-822-755-165;;075-066-659-352-42X;;017-684-136-290-674;;043-717-617-452-997;;035-863-987-433-406;;026-807-638-108-848;;117-206-818-045-405;;003-546-581-906-613,18478401;;10.1007/s12010-007-9064-0;;10.1016/j.enzmictec.2008.01.017;;17058283;;10.1002/bit.21238;;10.1016/j.enzmictec.2006.07.026;;17221887;;10.1002/bit.21329;;10.1016/j.biortech.2007.09.064;;18006303;;17589813;;10.1007/10_2007_065;;10.1007/s10295-008-0327-8;;18338189,"Garcia-Aparicio et al, 2007, Biochem Biotechnol 137-140(1-12), 352-365.;;Ustinov et al., Comparison of properties and mode of action of six secreted xylanases from Chrysosporium lucknowense, Enzyme and Microbial Technology, vol. 43, 2008, pp. 56-65.;;Berlin et al., Optimization of enzyme complexes for lignocelluloses hydrolysis, Biotechnology and Bioengineering, vol. 97, 2007, pp. 287-296.;;Sorensen et al., Synergistic enzyme mechanisms and effects of sequential enzyme additions on degradation of water insoluble wheat arabinoxylan, Enzymes and Microbial Technology, vol. 40, 2007, pp. 908-918.;;Gusakov et al., Design of highly efficient cellulose mixtures for enzymatic hydrolysis of cellulose, Biotechnology and Bioengineering, vol. 97, 2007, pp. 1028-1038.;;Selig et al., Synergistic enhancement of cellobiohydrolase performance on pretreated corn stover by addition of xylanase and esterase activities, Bioresource Technology, vol. 99, 2008, pp. 4997-5005.;;Viikari et al., Thermostable enzymes in lignocelluloses hydrolysis, Advances in Biochemical Engineering, vol. 108, 2007, pp. 121-145.;;Kumar et al., Bioconversion of lignocellulosic biomass: biochemical and molecular perspectives, Journal of Industrial Microbiology & Biotechnology, vol. 35, 2008, pp. 377-391.",ACTIVE
23,US,A1,US 2010/0122380 A1,065-822-155-973-837,2010-05-13,2010,US 60957009 A,2009-10-30,US 60957009 A;;US 11291008 P,2008-11-10,Polypeptides having feruloyl esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;BOHAN DOREEN,NOVOZYMES INC (2009-11-02),https://lens.org/065-822-155-973-837,Patent Application,yes,2,6,5,5,9,C12N9/18;;C12N9/18;;C12N15/11;;C12N15/1137;;C12N15/1137;;C12N15/82;;C12N2310/11;;C12N2310/11;;C12N2310/14;;C12N2310/14;;C12Y301/01073;;C12Y301/01073,A01H5/00;;C07H21/02;;C07H21/04;;C12N5/04;;C12N9/18;;C12N15/01;;C12P19/00;;C12P21/00,800/295;;435/197;;536/23.2;;435/71.1;;435/69.1;;435/440;;435/419;;536/24.5;;435/72,0,0,,,,INACTIVE
24,WO,A1,WO 2009/073709 A1,099-082-584-025-328,2009-06-11,2009,US 2008/0085380 W,2008-12-03,US 99299507 P,2007-12-06,POLYPEPTIDES HAVING ACETYLXYLAN ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;MARANTA MICHELLE;;BROWN KIMBERLY,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/099-082-584-025-328,Patent Application,yes,30,180,14,14,11,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,A23K1/165;;C12N9/18,,100,75,014-625-826-302-514;;127-544-305-672-969;;062-344-560-749-131;;022-715-862-716-318;;032-728-154-591-070;;022-439-235-146-469;;022-439-235-146-469;;009-304-049-487-981;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;016-587-457-958-718;;164-567-086-301-271;;029-314-535-301-390;;044-889-964-761-310;;130-197-652-144-217;;024-461-215-806-523;;002-129-848-383-652;;054-167-555-136-715;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;070-786-212-570-774;;080-478-847-113-962;;025-382-717-097-246;;060-100-774-152-775;;024-608-718-151-219;;066-174-113-969-972;;004-879-676-826-589;;119-409-570-143-716;;112-713-110-898-538;;077-184-809-518-772;;065-527-462-128-017;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;017-950-663-195-977;;003-307-199-216-170;;060-909-037-461-654;;070-718-550-259-060;;047-341-291-675-260;;079-709-277-214-373,10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;8647098;;10.1111/j.1432-1033.1996.0553p.x;;9051728;;10.1093/protein/10.1.1;;10.1016/0022-2836(70)90057-4;;5420325;;10.1016/s0168-9525(00)02024-2;;10827456;;10.1016/s0168-9525(00)02024-2;;10827456;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;10656339;;10.1016/s0168-1656(99)00191-1;;10.1128/aem.63.9.3488-3493.1997;;pmc168655;;9292999;;10.1038/nbt0595-498;;9634791;;1367012;;10.1038/nbt0491-378;;3082357;;14406087;;10.1021/bi00350a035;;10.1038/nbt0995-982;;9636275;;2516317;;10.1002/prot.340060306;;10.1016/1046-5928(91)90057-p;;1821793;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;6345791;;10.1016/s0022-2836(83)80284-8;;3041370;;10.1093/nar/16.13.6127;;pmc336852;;10.1007/bf02931600;;15530004;;pmc210093;;10.1128/jb.171.6.3583-3585.1989;;2656662;;pmc33461;;10.1073/pnas.101589398;;11353836;;10.1016/j.mimet.2005.06.001;;15987659;;pmc544212;;10.1128/aem.71.1.51-57.2005;;15640169;;pmc351592;;10.1128/iai.32.3.1295-1297.1981;;7251168;;1795653;;10473378;;pmc99703;;10.1128/aem.65.9.3800-3804.1999;;pmc281518;;6272080;;10.1128/mr.45.3.409-436.1981;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1016/s0958-1669(05)80029-1;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1002/bit.260320214;;18584740;;9512532;;10.1093/nar/26.7.1628;;pmc147464;;16752410;;10.1002/bit.20908,"DATABASE UniProt [online] 21 March 2006 (2006-03-21), ""SubName: Full=Putative uncharacterized protein;"", XP002513219, retrieved from EBI accession no. UNIPROT:Q2HEP2 Database accession no. Q2HEP2;;DATABASE BRENDA-ENZYMES [online] 3 February 2009 (2009-02-03), ""Acetylxylan esterase"", XP002513218, retrieved from BRENDA Database accession no. EC 3.1.1.72;;HENRISSAT B., BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT; BAIROCH, BIOCHEM. J., vol. 316, 1996, pages 695 - 696;;MARGOLLES-CLARK ET AL., EUR. J. BIOCHEM., vol. 237, 1996, pages 553 - 560;;SUNDBERG; POUTANEN, BIOTECHNOL. APPL. BIOCHEM., vol. 13, 1991, pages 1 - 11;;COUTINHO; HENRISSAT: ""The Royal Society of Chemistry"", 1999, CAMBRIDGE, article ""Recent Advances in Carbohydrate Bioengineering"", pages: 3 - 12;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;EMBOSS: THE EUROPEAN MOLECULAR BIOLOGY OPEN SOFTWARE SUITE;;RICE ET AL., TRENDS IN GENETICS, vol. 16, 2000, pages 276 - 277;;PEARSON, W.R.: ""Bioinformatics Methods and Protocols"", 1999, pages: 185 - 219;;J. SAMBROOK; E.F. FRITSCH; T. MANIATIS: ""Molecular Cloning, A Laboratory Manual"", 1989, COLD SPRING HARBOR;;BOLTON; MCCARTHY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 48, 1962, pages 1390;;H. NEURATH; R.L. HILL: ""In, The Proteins"", 1979, ACADEMIC PRESS;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708;;VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEM, vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;MARTIN ET AL., J. IND. MICROBIOL. BIOTECHNOL., vol. 3, 2003, pages 568 - 76;;SVETINA ET AL., J. BIOTECHNOL., vol. 76, 2000, pages 245 - 251;;RASMUSSEN-WILSON ET AL., APPL. ENVIRON. MICROBIOL., vol. 63, 1997, pages 3488 - 3493;;WARD ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 498 - 503;;CONTRERAS ET AL., BIOTECHNOLOGY, vol. 9, 1991, pages 378 - 381;;EATON ET AL., BIOCHEM., vol. 25, 1986, pages 505 - 512;;COLLINS-RACIE ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 982 - 987;;CARTER ET AL., PROTEINS: STRUCTURE, FUNCTION, AND GENETICS, vol. 6, 1989, pages 240 - 248;;STEVENS, DRUG DISCOVERY WORLD, vol. 4, 2003, pages 35 - 48;;INNIS ET AL.: ""PCR: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;VILLA-KAMAROFF, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 80, 1983, pages 21 - 25;;""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOLECULAR CELLULAR BIOLOGY, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOLECULAR GENERAL GENETICS, vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZEN, JOURNAL OF BACTERIOLOGY, vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, JOURNAL OF MOLECULAR BIOLOGY, vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER; THORNE, JOURNAL OF BACTERIOLOGY, vol. 169, 1987, pages 5271 - 5278;;HANAHAN, J. MOL. BIOL., vol. 166, 1983, pages 557 - 580;;DOWER ET AL., NUCLEIC ACIDS RES., vol. 16, 1988, pages 6127 - 6145;;GONG ET AL., FOLIA MICROBIOL. (PRAHA, vol. 49, 2004, pages 399 - 405;;MAZODIER ET AL., J. BACTERIOL., vol. 171, 1989, pages 3583 - 3585;;BURKE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 98, 2001, pages 6289 - 6294;;CHOI ET AL., J. MICROBIOL. METHODS, vol. 64, 2006, pages 391 - 397;;PINEDO; SMETS, APPL. ENVIRON. MICROBIOL., vol. 71, 2005, pages 51 - 57;;PERRY; KURAMITSU, INFECT. IMMUN., vol. 32, 1981, pages 1295 - 1297;;CATT; JOLLICK, MICROBIOS., vol. 68, 1991, pages 189 - 2070;;BUCKLEY ET AL., APPL. ENVIRON. MICROBIOL., vol. 65, 1999, pages 3800 - 3804;;CLEWELL, MICROBIOL. REV., vol. 45, 1981, pages 409 - 436;;HAWKSWORTH ET AL.: ""In, Ainsworth and Bisby's Dictionary of The Fungi"", 1995, CAB INTERNATIONAL, UNIVERSITY PRESS, CAMBRIDGE;;SKINNER, F.A.; PASSMORE, S.M.; DAVENPORT, R.R: ""Biology and Activities of Yeast"", SOC. APP. BACTERIOL. SYMPOSIUM SERIES, no. 9, 1980;;YELTON ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1984, pages 1470 - 1474;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;""Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., pages: 182 - 187;;ITO ET AL., JOURNAL OF BACTERIOLOGY, vol. 153, 1983, pages 163;;HINNEN ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1920;;""Protein Purification"", 1989, VCH PUBLISHERS;;TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MO. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS & CORUZZI, ANN. REV. GENET., vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., JOURNAL OF PLANT PHYSIOLOGY, vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOLOGY, vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOLECULAR BIOLOGY, vol. 26, 1994, pages 85 - 93;;KAGAYA ET AL., MOLECULAR AND GENERAL GENETICS, vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOLECULAR BIOLOGY, vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIOLTECHNOLOGY, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOLECULAR BIOLOGY, vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT JOURNAL, vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CURRENT OPINION BIOTECHNOLOGY, vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH ET AL., PLANT MOLECULAR BIOLOGY, vol. 21, 1993, pages 415 - 428;;BEDFORD, PROCEEDINGS OF THE 1 ST SYMPOSIUM ON ENZYMES IN ANIMAL NUTRITION, 1993, pages 73 - 77;;ERIKSSON, WOOD SCIENCE AND TECHNOLOGY, vol. 24, 1990, pages 79 - 101;;PAICE ET AL., BIOTECHNOL. AND BIOENG., vol. 32, 1988, pages 235 - 239;;POMMIER ET AL., TAPPI JOURNAL, 1989, pages 187 - 191;;VI6TOR ET AL., J. INST. BREW., vol. 99, 1993, pages 243 - 248;;ROSE ET AL., NUCLEIC ACIDS RESEARCH, vol. 26, 1998, pages 1628 - 1635;;""BD Biosciences"", PALO ALTO;;""Agricultural Research Service Patent Culture Collection, Northern Regional Research Center"", 20 November 2007, PEORIA, IL;;CHRISTENSEN ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 1419 - 1422;;RASMUSSEN ET AL., BIOTECHNOLOGY AND BIOENGINEERING, vol. 94, 2006, pages 869 - 876",PENDING
25,AT,T1,AT E439432 T1,021-812-167-624-743,2009-08-15,2009,AT 03755759 T,2003-08-29,US 40717002 P;;US 0327074 W,2002-08-30,VERFAHREN ZUR HERSTELLUNG VON SÄUGETIER-TRYPSINEN,"The present invention relates to methods for producing a mammalian trypsin in a Fusarium venenatum host strain, the method comprising (a) cultivating the Fusarium venenatum host strain in a culture medium under conditions suitable for expression of the mammalian trypsin and secretion thereof into the medium, wherein the Fusarium venenatum host strain comprises a nucleic acid construct comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen; and (b) recovering the mammalian trypsin from the medium. The present invention also relates to constructs comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen, and to vectors and Fusarium venenatum host strains comprising such constructs.",NOVOZYMES INC,BERKA RANDY;;BROWN KIMBERLY,,https://lens.org/021-812-167-624-743,Granted Patent,no,0,0,11,11,0,C12N9/6421;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6421,C12N1/15;;C12N9/64;;C12N9/76;;C12N15/80,,0,0,,,,EXPIRED
26,EP,A1,EP 1546302 A1,018-827-981-757-835,2005-06-29,2005,EP 03755759 A,2003-08-29,US 0327074 W;;US 40717002 P,2002-08-30,METHODS FOR PRODUCING MAMMALIAN TRYPSINS,"The present invention relates to methods for producing a mammalian trypsin in a Fusarium venenatum host strain, the method comprising (a) cultivating the Fusarium venenatum host strain in a culture medium under conditions suitable for expression of the mammalian trypsin and secretion thereof into the medium, wherein the Fusarium venenatum host strain comprises a nucleic acid construct comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen; and (b) recovering the mammalian trypsin from the medium. The present invention also relates to constructs comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen, and to vectors and Fusarium venenatum host strains comprising such constructs.",NOVOZYMES INC,BERKA RANDY;;BROWN KIMBERLY,,https://lens.org/018-827-981-757-835,Patent Application,yes,0,0,11,11,12,C12N9/6421;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6421,C12N9/76;;C12N1/15;;C12N9/64;;C12N15/52;;C12N15/62;;C12N15/80;;C12P21/02,,0,0,,,,EXPIRED
27,AU,A1,AU 2003/273256 A1,052-516-950-998-542,2004-03-19,2004,AU 2003/273256 A,2003-08-29,US 40717002 P;;US 0327074 W,2002-08-30,METHODS FOR PRODUCING MAMMALIAN TRYPSINS,"The present invention relates to methods for producing a mammalian trypsin in a Fusarium venenatum host strain, the method comprising (a) cultivating the Fusarium venenatum host strain in a culture medium under conditions suitable for expression of the mammalian trypsin and secretion thereof into the medium, wherein the Fusarium venenatum host strain comprises a nucleic acid construct comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen; and (b) recovering the mammalian trypsin from the medium. The present invention also relates to constructs comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen, and to vectors and Fusarium venenatum host strains comprising such constructs.",NOVOZYMES BIOTECH INC,BERKA RANDY;;BROWN KIMBERLY,,https://lens.org/052-516-950-998-542,Patent Application,no,0,0,11,11,0,C12N9/6421;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6421,C12N1/15;;C12N9/64;;C12N9/76;;C12N15/80,,0,0,,,,DISCONTINUED
28,US,A1,US 2017/0247730 A1,074-665-110-918-279,2017-08-31,2017,US 201715591935 A,2017-05-10,US 201715591935 A;;US 201514849204 A;;US 201414248039 A;;US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11660508 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/074-665-110-918-279,Patent Application,yes,0,3,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12P19/14;;C12N9/24;;C12N9/42;;C12P19/02,,0,0,,,,INACTIVE
29,US,A1,US 2009/0151026 A1,064-119-963-556-854,2009-06-11,2009,US 32723908 A,2008-12-03,US 32723908 A;;US 1215207 P,2007-12-07,Polypeptides having feruloyl esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,NOVOZYMES A/S (2008-12-09),https://lens.org/064-119-963-556-854,Patent Application,yes,1,5,7,7,11,C12N15/8243;;C12N15/8243;;C12N9/18;;C12N9/18;;C12N15/8257;;C12N15/8257,A01H5/00;;C07H21/02;;C12N1/19;;C12N9/16;;C12N15/00;;C12N15/11;;C12P21/04,800/298;;435/196;;536/23.2;;435/320.1;;435/254.3;;435/69.1;;536/24.5;;435/276,0,0,,,,INACTIVE
30,US,A1,US 2010/0031399 A1,078-790-776-831-67X,2010-02-04,2010,US 51137109 A,2009-07-29,US 51137109 A;;US 8454308 P,2008-07-29,Polypeptides having alpha-glucuronidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-glucuronidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,NOVOZYMES A/S (2009-08-05),https://lens.org/078-790-776-831-67X,Patent Application,yes,0,3,10,10,12,C12Y302/01139;;C12N9/2402;;C12Y302/01139;;C12N9/2402,A01H5/00;;C07H21/02;;C12N1/19;;C12N9/24;;C12N15/11;;C12P7/02;;C12P21/02,800/298;;435/200;;536/23.2;;435/254.2;;435/69.1;;435/440;;536/24.5;;435/277;;435/155,2,2,061-859-656-899-093;;132-695-844-930-786,15029827;;10.1017/s0033583503003901;;10.1021/bi990993h;;10512619,"Whisstock et al. Quaterly Reviews of Biophysics, 2003, ""Prediction of protein function from protein sequence and structure"", 36(3): 307-340.;;Witkowski et al. Conversion of a beta-ketoacyl synthase to a malonyl decarboxylase by replacement of the active-site cysteine with glutamine, Biochemistry. 1999 Sep 7;38(36):11643-50.",ACTIVE
31,CA,A1,CA 2743049 A1,086-080-725-178-66X,2010-05-14,2010,CA 2743049 A,2009-10-30,US 11291008 P;;US 2009/0062785 W,2008-11-10,POLYPEPTIDES HAVING FERULOYL ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;BOHAN DOREEN,,https://lens.org/086-080-725-178-66X,Patent Application,no,0,0,5,5,9,C12N9/18;;C12N9/18;;C12N15/11;;C12N15/1137;;C12N15/1137;;C12N15/82;;C12N2310/11;;C12N2310/11;;C12N2310/14;;C12N2310/14;;C12Y301/01073;;C12Y301/01073,C07K14/37;;C12N9/24;;C12N15/82,,0,0,,,,DISCONTINUED
32,US,B2,US 8518684 B2,112-133-603-903-453,2013-08-27,2013,US 61240109 A,2009-11-04,US 61240109 A;;US 17422109 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",BROWN KIMBERLY;;ABBATE ERIC;;NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,NOVOZYMES INC (2010-01-15),https://lens.org/112-133-603-903-453,Granted Patent,yes,13,24,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12N9/00;;C07K1/00,435/183;;530/350,8,8,017-684-136-290-674;;043-717-617-452-997;;035-863-987-433-406;;026-807-638-108-848;;117-206-818-045-405;;003-546-581-906-613;;075-066-659-352-42X;;033-423-822-755-165,17058283;;10.1002/bit.21238;;10.1016/j.enzmictec.2006.07.026;;17221887;;10.1002/bit.21329;;10.1016/j.biortech.2007.09.064;;18006303;;17589813;;10.1007/10_2007_065;;10.1007/s10295-008-0327-8;;18338189;;10.1016/j.enzmictec.2008.01.017;;18478401;;10.1007/s12010-007-9064-0,"Berlin et al., Optimization of enzyme complexes for lignocelluloses hydrolysis, Biotechnology and Bioengineering, vol. 97, 2007, pp. 287-296.;;Sorensen et al., Synergistic enzyme mechanisms and effects of sequential enzyme additions on degradation of water insoluble wheat arabinoxylan, Enzymes and Microbial Technology, vol. 40, 2007, pp. 908-918.;;Gusakov et al., Design of highly efficient cellulose mixtures for enzymatic hydrolysis of cellulose, Biotechnology and Bioengineering, vol. 97, 2007, pp. 1028-1038.;;Selig et al., Synergistic enhancement of cellobiohydrolase performance on pretreated corn stover by addition of xylanase and esterase activities, Bioresource Technology, vol. 99, 2008, pp. 4997-5005.;;Viikari et al., Thermostable enzymes in lignocelluloses hydrolysis, Advances in Biochemical Engineering, vol. 108, 2007, pp. 121-145.;;Kumar et al., Bioconversion of lignocellulosic biomass: biochemical and molecular perspectives, Journal of Industrial Microbiology & Biotechnology, vol. 35, 2008, pp. 377-391.;;Ustinov et al., Comparison of properties and mode of action of six secreted xylanases from Chrysosporium lucknowense, Enzyme and Microbial Technology, vol. 43, 2008, pp. 56-65.;;Garcia-Aparicio et al, 2007, Biochem Biotechnol 137-140(1-12), 352-365.",INACTIVE
33,EP,B1,EP 2310497 B1,109-225-843-314-578,2016-05-04,2016,EP 09790933 A,2009-07-29,US 2009/0052100 W;;US 8454308 P,2008-07-29,POLYPEPTIDES HAVING ALPHA-GLUCURONIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/109-225-843-314-578,Granted Patent,yes,4,0,10,10,0,C12Y302/01139;;C12N9/2402;;C12Y302/01139;;C12N9/2402,C12N9/24,,7,0,,,"DATABASE EMBL [Online] 20 November 2001 (2001-11-20), ""Talaromyces emersonii alpha-glucuronidase (aGlu) gene, complete cds."" XP002558275 retrieved from EBI accession no. EMBL:AF439788 Database accession no. AF439788 -& HENEGHAN ET AL: ""Cloning, characterisation and expression analysis of alpha-glucuronidase from the thermophilic fungus Talaromyces emersonii"" ENZYME AND MICROBIAL TECHNOLOGY, STONEHAM, MA, US, vol. 41, no. 6-7, 5 September 2007 (2007-09-05), pages 677-682, XP022231120 ISSN: 0141-0229 -& DATABASE UniProt [Online] 1 March 2002 (2002-03-01), ""SubName: Full=Alpha-glucuronidase;"" XP002559107 retrieved from EBI accession no. UNIPROT:Q8X211 Database accession no. Q8X211;;DATABASE EMBL [Online] 5 February 1998 (1998-02-05), ""Aspergillus tubingensis aguA gene"" XP002558276 retrieved from EBI accession no. EMBL:Y15405 Database accession no. Y15405 -& DE VRIES RONALD P ET AL: ""aguA, The gene encoding an extracellular alpha-glucuronidase from Aspergillus tubingensis, is specifically induced on xylose and not on glucuronic acid"" JOURNAL OF BACTERIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 180, no. 2, 1 January 1998 (1998-01-01), pages 243-249, XP002474958 ISSN: 0021-9193 -& DATABASE UniProt [Online] 1 June 1998 (1998-06-01), ""RecName: Full=Alpha-glucuronidase; EC=<A HREF=""http://srs.ebi.ac.uk/srsbin/cgi-bin/ wgetz?[enzyme-ECNumber:3.2.1.139]+-e"">3.2. 1.139</A>; AltName: Full=Alpha-glucosiduronase; Flags: Precursor;"" XP002559108 retrieved from EBI accession no. UNIPROT:O42814 Database accession no. O42814;;DATABASE UniProt [Online] 20 May 2008 (2008-05-20), ""SubName: Full=Predicted CDS Pa_5_11170;"" XP002559109 retrieved from EBI accession no. UNIPROT:B2APQ4 Database accession no. B2APQ4 -& DATABASE EMBL [Online] 26 March 2008 (2008-03-26), ""Podospora anserina genomic DNA chromosome 5, supercontig 10."" XP002559110 retrieved from EBI accession no. EMBL:CU633876 Database accession no. CU633876 -& ESPAGNE ERIC ET AL: ""The genome sequence of the model ascomycete fungus Podospora anserina."" GENOME BIOLOGY 2008, vol. 9, no. 5, 6 May 2008 (2008-05-06), page R77, XP002558274 ISSN: 1465-6914;;DATABASE UniProt [Online] 26 April 2005 (2005-04-26), ""SubName: Full=Putative uncharacterized protein;"" XP002558277 retrieved from EBI accession no. UNIPROT:Q5AQZ4 Database accession no. Q5AQZ4 & GALAGAN JAMES E ET AL: ""Sequencing of Aspergillus nidulans and comparative analysis with A-fumigatus and A-oryzae"" NATURE, NATURE PUBLISHING GROUP, LONDON, UK, vol. 438, no. 7071, 1 December 2005 (2005-12-01), pages 1105-1115, XP002415976 ISSN: 0028-0836;;DATABASE UniProt [Online] 21 March 2006 (2006-03-21), ""SubName: Full=Putative uncharacterized protein;"" XP002559111 retrieved from EBI accession no. UNIPROT:Q2GPV7 Database accession no. Q2GPV7;;MARGOLLES-CLARK E ET AL: ""The alpha-glucuronidase-encoding gene of Trichoderma reesei"" GENE, ELSEVIER, AMSTERDAM, NL, vol. 172, no. 1, 12 June 1996 (1996-06-12), pages 171-172, XP004042732 ISSN: 0378-1119;;DE WET ET AL: ""Characterization of the Aureobasidium pullulans alpha-glucuronidase expressed in Saccharomyces cerevisiae"" ENZYME AND MICROBIAL TECHNOLOGY, STONEHAM, MA, US, vol. 38, no. 5, 2 March 2006 (2006-03-02), pages 649-656, XP005252251 ISSN: 0141-0229",ACTIVE
34,EP,A1,EP 2356136 A1,052-111-318-153-532,2011-08-17,2011,EP 09748197 A,2009-10-30,US 2009/0062785 W;;US 11291008 P,2008-11-10,POLYPEPTIDES HAVING FERULOYL ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC,BROWN KIMBERLY;;BOHAN DOREEN,,https://lens.org/052-111-318-153-532,Patent Application,yes,0,0,5,5,9,C12N9/18;;C12N9/18;;C12N15/11;;C12N15/1137;;C12N15/1137;;C12N15/82;;C12N2310/11;;C12N2310/11;;C12N2310/14;;C12N2310/14;;C12Y301/01073;;C12Y301/01073,C07K14/37;;C12N9/24;;C12N15/82,,3,2,087-312-494-083-028;;119-327-548-675-071,10.1042/bj3630377;;10.1042/0264-6021:3630377;;11931668;;pmc1222489;;19644688;;10.1007/s00253-009-2148-8,"VRIES DE R P ET AL: ""The Aspergillus niger faeB gene encodes a second feruloyl esterase involved in pectin and xylan degradation and is specifically induced in the presence of aromatic compounds"", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, GB, vol. 363, no. 2, 15 April 2002 (2002-04-15), pages 377 - 386, XP002362630, ISSN: 0264-6021, DOI: 10.1042/0264-6021:3630377;;TAKUYA KOSEKI ET AL: ""Occurrence, properties, and applications of feruloyl esterases"", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, SPRINGER, BERLIN, DE, vol. 84, no. 5, 31 July 2009 (2009-07-31), pages 803 - 810, XP019737791, ISSN: 1432-0614, DOI: 10.1007/S00253-009-2148-8;;See also references of WO 2010053838A1",DISCONTINUED
35,CA,A1,CA 2708268 A1,103-794-919-723-354,2009-06-18,2009,CA 2708268 A,2008-12-03,US 1215207 P;;US 2008/0085341 W,2007-12-07,POLYPEPTIDES HAVING FERULOYL ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isoiaied polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the pafypeptides. The invention also refates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/103-794-919-723-354,Patent Application,no,0,1,7,7,11,C12N15/8243;;C12N15/8243;;C12N9/18;;C12N9/18;;C12N15/8257;;C12N15/8257,C12N9/18;;C12N15/82,,0,0,,,,DISCONTINUED
36,EP,B1,EP 1546302 B1,112-991-008-296-370,2009-08-12,2009,EP 03755759 A,2003-08-29,US 0327074 W;;US 40717002 P,2002-08-30,METHODS FOR PRODUCING MAMMALIAN TRYPSINS,"The present invention relates to methods for producing a mammalian trypsin in a Fusarium venenatum host strain, the method comprising (a) cultivating the Fusarium venenatum host strain in a culture medium under conditions suitable for expression of the mammalian trypsin and secretion thereof into the medium, wherein the Fusarium venenatum host strain comprises a nucleic acid construct comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen; and (b) recovering the mammalian trypsin from the medium. The present invention also relates to constructs comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen, and to vectors and Fusarium venenatum host strains comprising such constructs.",NOVOZYMES INC,BERKA RANDY;;BROWN KIMBERLY,,https://lens.org/112-991-008-296-370,Granted Patent,yes,6,0,11,11,0,C12N9/6421;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6421,C12N9/76;;C12N1/15;;C12N9/64;;C12N15/52;;C12N15/62;;C12N15/80;;C12P21/02,,0,0,,,,EXPIRED
37,US,A1,US 2010/0043105 A1,167-119-332-358-207,2010-02-18,2010,US 32734708 A,2008-12-03,US 32734708 A;;US 99299507 P,2007-12-06,Polypeptides having acetylxylan esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,NOVOZYMES A/S (2008-12-08),https://lens.org/167-119-332-358-207,Patent Application,yes,1,6,14,14,11,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,A01H5/00;;C07H21/02;;C07H21/04;;C12N5/10;;C12N9/16;;C12N15/63;;C12N15/82;;C12P21/06,800/298;;435/196;;536/23.2;;435/320.1;;435/419;;435/69.1;;435/468;;536/24.5,0,0,,,,ACTIVE
38,US,B2,US 10400259 B2,171-386-443-531-595,2019-09-03,2019,US 201816052082 A,2018-08-01,US 201816052082 A;;US 201715591935 A;;US 201514849204 A;;US 201414248039 A;;US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/171-386-443-531-595,Granted Patent,yes,13,0,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12N9/24;;C12N9/42;;C12P7/14;;C12P19/02;;C12P19/14,,8,8,033-423-822-755-165;;075-066-659-352-42X;;017-684-136-290-674;;043-717-617-452-997;;035-863-987-433-406;;026-807-638-108-848;;117-206-818-045-405;;003-546-581-906-613,18478401;;10.1007/s12010-007-9064-0;;10.1016/j.enzmictec.2008.01.017;;17058283;;10.1002/bit.21238;;10.1016/j.enzmictec.2006.07.026;;17221887;;10.1002/bit.21329;;10.1016/j.biortech.2007.09.064;;18006303;;17589813;;10.1007/10_2007_065;;10.1007/s10295-008-0327-8;;18338189,"Garcia-Aparicio et al, 2007, Biochem Biotechnol 137-140(1-12), 352-365.;;Ustinov et al., Comparison of properties and mode of action of six secreted xylanases from Chrysosporium lucknowense, Enzyme and Microbial Technology, vol. 43, 2008, pp. 56-65.;;Berlin et al., Optimization of enzyme complexes for lignocelluloses hydrolysis, Biotechnology and Bioengineering, vol. 97, 2007, pp. 287-296.;;Sorensen et al., Synergistic enzyme mechanisms and effects of sequential enzyme additions on degradation of water insoluble wheat arabinoxylan, Enzymes and Microbial Technology, vol. 40, 2007, pp. 908-918.;;Gusakov et al., Design of highly efficient cellulose mixtures for enzymatic hydrolysis of cellulose, Biotechnology and Bioengineering, vol. 97, 2007, pp. 1028-1038.;;Selig et al., Synergistic enhancement of cellobiohydrolase performance on pretreated corn stover by addition of xylanase and esterase activities, Bioresource Technology, vol. 99, 2008, pp. 4997-5005.;;Viikari et al., Thermostable enzymes in lignocelluloses hydrolysis, Advances in Biochemical Engineering, vol. 108, 2007, pp. 121-145.;;Kumar et al., Bioconversion of lignocellulosic biomass: biochemical and molecular perspectives, Journal of Industrial Microbiology & Biotechnology, vol. 35, 2008, pp. 377-391.",INACTIVE
39,US,A1,US 2018/0340200 A1,046-257-242-092-394,2018-11-29,2018,US 201816052082 A,2018-08-01,US 201816052082 A;;US 201715591935 A;;US 201514849204 A;;US 201414248039 A;;US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/046-257-242-092-394,Patent Application,yes,0,0,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12P19/14;;C12N9/24;;C12N9/42;;C12P7/14;;C12P19/02,,0,0,,,,INACTIVE
40,US,A1,US 2019/0360012 A1,079-569-635-025-918,2019-11-28,2019,US 201916539862 A,2019-08-13,US 201916539862 A;;US 201816052082 A;;US 201715591935 A;;US 201514849204 A;;US 201414248039 A;;US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/079-569-635-025-918,Patent Application,yes,0,1,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12P19/14;;C12N9/24;;C12N9/42;;C12P7/14;;C12P19/02,,0,0,,,,ACTIVE
41,US,B2,US 10883129 B2,119-638-208-603-58X,2021-01-05,2021,US 201916539862 A,2019-08-13,US 201916539862 A;;US 201816052082 A;;US 201715591935 A;;US 201514849204 A;;US 201414248039 A;;US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/119-638-208-603-58X,Granted Patent,yes,13,0,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12N9/24;;C12N9/42;;C12P7/14;;C12P19/02;;C12P19/14,,8,8,033-423-822-755-165;;075-066-659-352-42X;;017-684-136-290-674;;043-717-617-452-997;;035-863-987-433-406;;026-807-638-108-848;;117-206-818-045-405;;003-546-581-906-613,18478401;;10.1007/s12010-007-9064-0;;10.1016/j.enzmictec.2008.01.017;;17058283;;10.1002/bit.21238;;10.1016/j.enzmictec.2006.07.026;;17221887;;10.1002/bit.21329;;10.1016/j.biortech.2007.09.064;;18006303;;17589813;;10.1007/10_2007_065;;10.1007/s10295-008-0327-8;;18338189,"Garcia-Aparicio et al, 2007, Biochem Biotechnol 137-140(1-12), 352-365.;;Ustinov et al., Comparison of properties and mode of action of six secreted xylanases from Chrysosporium lucknowense, Enzyme and Microbial Technology, vol. 43, 2008, pp. 56-65.;;Berlin et al., Optimization of enzyme complexes for lignocelluloses hydrolysis, Biotechnology and Bioengineering, vol. 97, 2007, pp. 287-296.;;Sorensen et al., Synergistic enzyme mechanisms and effects of sequential enzyme additions on degradation of water insoluble wheat arabinoxylan, Enzymes and Microbial Technology, vol. 40, 2007, pp. 908-918.;;Gusakov et al., Design of highly efficient cellulose mixtures for enzymatic hydrolysis of cellulose, Biotechnology and Bioengineering, vol. 97, 2007, pp. 1028-1038.;;Selig et al., Synergistic enhancement of cellobiohydrolase performance on pretreated corn stover by addition of xylanase and esterase activities, Bioresource Technology, vol. 99, 2008, pp. 4997-5005.;;Viikari et al., Thermostable enzymes in lignocelluloses hydrolysis, Advances in Biochemical Engineering, vol. 108, 2007, pp. 121-145.;;Kumar et al., Bioconversion of lignocellulosic biomass: biochemical and molecular perspectives, Journal of Industrial Microbiology & Biotechnology, vol. 35, 2008, pp. 377-391.",ACTIVE
42,US,B2,US 10059972 B2,132-192-085-710-947,2018-08-28,2018,US 201715591935 A,2017-05-10,US 201715591935 A;;US 201514849204 A;;US 201414248039 A;;US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11660508 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/132-192-085-710-947,Granted Patent,yes,13,0,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12P7/14;;C12N9/24;;C12N9/42;;C12P19/02;;C12P19/14,,8,8,033-423-822-755-165;;075-066-659-352-42X;;017-684-136-290-674;;043-717-617-452-997;;035-863-987-433-406;;026-807-638-108-848;;117-206-818-045-405;;003-546-581-906-613,18478401;;10.1007/s12010-007-9064-0;;10.1016/j.enzmictec.2008.01.017;;17058283;;10.1002/bit.21238;;10.1016/j.enzmictec.2006.07.026;;17221887;;10.1002/bit.21329;;10.1016/j.biortech.2007.09.064;;18006303;;17589813;;10.1007/10_2007_065;;10.1007/s10295-008-0327-8;;18338189,"Garcia-Aparicio et al, 2007, Biochem Biotechnol 137-140(1-12), 352-365.;;Ustinov et al., Comparison of properties and mode of action of six secreted xylanases from Chrysosporium lucknowense, Enzyme and Microbial Technology, vol. 43, 2008, pp. 56-65.;;Berlin et al., Optimization of enzyme complexes for lignocelluloses hydrolysis, Biotechnology and Bioengineering, vol. 97, 2007, pp. 287-296.;;Sorensen et al., Synergistic enzyme mechanisms and effects of sequential enzyme additions on degradation of water insoluble wheat arabinoxylan, Enzymes and Microbial Technology, vol. 40, 2007, pp. 908-918.;;Gusakov et al., Design of highly efficient cellulose mixtures for enzymatic hydrolysis of cellulose, Biotechnology and Bioengineering, vol. 97, 2007, pp. 1028-1038.;;Selig et al., Synergistic enhancement of cellobiohydrolase performance on pretreated corn stover by addition of xylanase and esterase activities, Bioresource Technology, vol. 99, 2008, pp. 4997-5005.;;Viikari et al., Thermostable enzymes in lignocelluloses hydrolysis, Advances in Biochemical Engineering, vol. 108, 2007, pp. 121-145.;;Kumar et al., Bioconversion of lignocellulosic biomass: biochemical and molecular perspectives, Journal of Industrial Microbiology & Biotechnology, vol. 35, 2008, pp. 377-391.",INACTIVE
43,US,B2,US 8034995 B2,130-745-788-711-238,2011-10-11,2011,US 32723908 A,2008-12-03,US 32723908 A;;US 1215207 P,2007-12-07,Polypeptides having feruloyl esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,NOVOZYMES A/S (2008-12-09),https://lens.org/130-745-788-711-238,Granted Patent,yes,1,4,7,7,11,C12N15/8243;;C12N15/8243;;C12N9/18;;C12N9/18;;C12N15/8257;;C12N15/8257,C12N15/31;;A01H5/00;;C12N15/10;;C12N15/52;;C12N15/82,800/288;;800/284;;800/295;;800/278;;435/320.1;;435/468;;536/23.1;;536/23.2;;536/23.7,9,8,004-737-263-977-895;;034-554-107-359-733;;084-667-057-884-082;;011-059-930-612-536;;036-794-281-968-249;;070-999-894-117-481;;034-183-137-702-424;;122-544-071-723-302,1663152;;10.1099/00221287-137-10-2339;;10.1099/00221287-140-4-779;;8679110;;pmc168785;;9406381;;10.1128/aem.63.12.4638-4644.1997;;10.1016/0141-0229(92)90050-x;;10.1042/bj20020917;;pmc1223187;;12435269;;10.1002/jsfa.2480;;10.1016/s0144-8617(00)00259-9,"Faulds and Williamson, The purification and characterization of 4-hydroxy-3-methixycinnamic (ferulic) acid esterase from Streptomyces olivochromogenes, 1991, J. Gen. Microbiol. 137: 2339-2345.;;Faulds and Williamson, Purification and characterization of a ferulic acid esterase (FAE-III) from Aspergillus niger: specificity for the phenolic moiety and binding to microcrystalline cellulose, 1994, Microbiology 140: 779-787.;;Kroon et al., Purification and characterization of a novel esterase induced by growth of Aspergillus niger on sugar-beet pulp, 1996, Biotechnol. Appl. Biochem. 23: 255-262.;;deVries et al., The faeA Genes from Aspergillus niger and Aspergillus tubingensis Encode Ferulic Acid Esterases Involved in Degradation of Complex Cell Wall Polysaccharides, 1997, Appl. Environ. Microbiol. 63: 4638-4644.;;Castanares et al., Purification and properties of a feruloyl/p-coumaroyl esterase from the fungus Penicillium pinophilum, 1992, Enzyme Microbiol. Technol. 14: 875-884.;;Crepin et al., A non-modular type B feruloyl esterase from Neurospora crassa exhibits concentration-dependent substrate inhibition, Mar. 1, 2003, The Biochemical Journal. 370: 417-427.;;Faulds et al., Influence of the arabinoxylan composition on the susceptibility of mono- and dimeric ferulic acid release by Humicola insolens feruloyl esterases, 2006, Journal of the Science of Food and Agriculture, 86: 1623-1630.;;Saulnier et al., Thermal and enzymatic treatments for the release of free ferulic acid from maize bran, 2001, Carbohydrate Polymers, Applied Science, Publishers, Ltd. Barking, GB. 45: 269-275.;;Database UniProt, XP002517454, May 15, 2007.",INACTIVE
44,DK,T3,DK 2224822 T3,164-295-969-839-642,2014-08-25,2014,DK 08858011 T,2008-12-03,US 99299507 P;;US 2008/0085380 W,2007-12-06,"POLYPEPTIDER MED ACETYLXYLANESTERASE-AKTIVITET OG POLYNUKLEOTIDER, DER KODER FOR DISSE",,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/164-295-969-839-642,Granted Patent,no,0,0,14,14,0,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,A23K1/165;;C12N9/18,,0,0,,,,ACTIVE
45,US,B2,US 9145569 B2,194-055-692-629-532,2015-09-29,2015,US 201414248039 A,2014-04-08,US 201414248039 A;;US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11660508 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/194-055-692-629-532,Granted Patent,yes,13,3,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12N9/24;;C12N9/32;;C12N9/42;;C12P7/14;;C12P19/14,,8,8,033-423-822-755-165;;075-066-659-352-42X;;017-684-136-290-674;;043-717-617-452-997;;035-863-987-433-406;;026-807-638-108-848;;117-206-818-045-405;;003-546-581-906-613,18478401;;10.1007/s12010-007-9064-0;;10.1016/j.enzmictec.2008.01.017;;17058283;;10.1002/bit.21238;;10.1016/j.enzmictec.2006.07.026;;17221887;;10.1002/bit.21329;;10.1016/j.biortech.2007.09.064;;18006303;;17589813;;10.1007/10_2007_065;;10.1007/s10295-008-0327-8;;18338189,"Garcia-Aparicio et al, 2007, Biochem Biotechnol 137-140(1-12), 352-365.;;Ustinov et al., Comparison of properties and mode of action of six secreted xylanases from Chrysosporium lucknowense, Enzyme and Microbial Technology, vol. 43, 2008, pp. 56-65.;;Berlin et al., Optimization of enzyme complexes for lignocelluloses hydrolysis, Biotechnology and Bioengineering, vol. 97, 2007, pp. 287-296.;;Sorensen et al., Synergistic enzyme mechanisms and effects of sequential enzyme additions on degradation of water insoluble wheat arabinoxylan, Enzymes and Microbial Technology, vol. 40, 2007, pp. 908-918.;;Gusakov et al., Design of highly efficient cellulose mixtures for enzymatic hydrolysis of cellulose, Biotechnology and Bioengineering, vol. 97, 2007, pp. 1028-1038.;;Selig et al., Synergistic enhancement of cellobiohydrolase performance on pretreated corn stover by addition of xylanase and esterase activities, Bioresource Technology, vol. 99, 2008, pp. 4997-5005.;;Viikari et al., Thermostable enzymes in lignocelluloses hydrolysis, Advances in Biochemical Engineering, vol. 108, 2007, pp. 121-145.;;Kumar et al., Bioconversion of lignocellulosic biomass: biochemical and molecular perspectives, Journal of Industrial Microbiology & Biotechnology, vol. 35, 2008, pp. 377-391.",INACTIVE
46,US,B2,US 8071335 B2,007-361-235-750-155,2011-12-06,2011,US 53325909 A,2009-07-31,US 53325909 A;;US 8511608 P,2008-07-31,Polypeptides having acetylxylan esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",MARANTA MICHELLE;;BROWN KIMBERLY;;NOVOZYMES INC,MARANTA MICHELLE;;BROWN KIMBERLY,NOVOZYMES A/S (2009-08-05),https://lens.org/007-361-235-750-155,Granted Patent,yes,9,0,8,8,13,C12N9/18;;C12N9/18;;C12N1/22;;C12N1/22;;C12P7/10;;C12P7/10;;Y02E50/10;;Y02E50/10,C12P21/02;;C12N15/00;;C12N15/09;;C12N15/10;;C12N15/62;;C12N15/63,435/69.8;;536/23.2;;536/23.7;;536/23.1;;435/69.1;;435/320.1,8,4,042-774-093-200-91X;;014-625-826-302-514;;127-544-305-672-969;;062-344-560-749-131,10.1016/j.jbiotec.2005.07.015;;16129506;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;8647098;;10.1111/j.1432-1033.1996.0553p.x,"Database UNIPROT, XP002546990, Dec. 15, 2003.;;Database EMBL Z69256, XP002546991, Jul. 15, 1996.;;Database GENESEQ GSP: AWH29289, XP002546989, May 28, 2009.;;Koseki et al., An Aspergillus oryzae acetyl xylan esterase: Molecular cloning and characteristics of recombinant enzyme expressed in Pichia pastoris, 2006, Journal of Biotehcnology, 121: 381-389.;;Henrissat B., A classification of glycosyl hydrolases based on amino acid sequence similarities, 1991, Biochem. J. 280: 309-316.;;Henrissat and Bairoch, Updating the sequence-based classification of glycosyl hydrolases, 1996, Biochem. J. 316: 695-696.;;Margolles-Clark et al., Example of a section of the glycosyl hydrolase classification document, 1996, Eur. J. Biochem. 237: 553-560.;;Sundberg and Poutanen, Purification and Properties of Two Acetylxylan Esterases of Trichoderma reesei, 1991, Biotechnol. Appl. Biochem. 13: 1-11.",INACTIVE
47,US,A1,US 2004/0043455 A1,015-746-704-810-147,2004-03-04,2004,US 65179003 A,2003-08-29,US 65179003 A;;US 40717002 P,2002-08-30,Methods for producing mammalian trypsins,"
    The present invention relates to methods for producing a mammalian trypsin in a Fusarium venenatum host strain, the method comprising (a) cultivating the Fusarium venenatum host strain in a culture medium under conditions suitable for expression of the mammalian trypsin and secretion thereof into the medium, wherein the Fusarium venenatum host strain comprises a nucleic acid construct comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen; and (b) recovering the mammalian trypsin from the medium. The present invention also relates to constructs comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen, and to vectors and Fusarium venenatum host strains comprising such constructs. 
",NOVOZYMES BIOTECH INC,BERKA RANDY;;BROWN KIMBERLY,NOVOZYMES INC (2005-08-29);;NOVOZYMES BIOTECH INC (2003-08-27),https://lens.org/015-746-704-810-147,Patent Application,yes,4,2,11,11,12,C12N9/6421;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6421,C12N1/15;;C12N9/64;;C12N9/76;;C12N15/80,435/69.1;;435/320.1;;435/254.7,0,0,,,,DISCONTINUED
48,BR,B1,BR PI0914835 B1,023-252-901-486-702,2019-04-24,2019,BR PI0914835 A,2009-07-29,US 8454308 P;;US 2009/0052100 W,2008-07-29,"célula hospedeira microbiana transgênica, métodos para produzir um polipeptídeo e para produzir uma proteína, construções de ácido nucléico, e, vetor de expressão.","célula hospedeira microbiana transgênica, métodos para produzir um polipeptídeo e para produzir uma proteína, construções de ácido nucleico, e, vetor de expressão. a presente invenção diz respeito a polipeptídeos isolados tendo atividade de alfa-glucuronidase e polinucleotídeos isolados que codificam os polipeptídeos. a invenção também diz respeito a construções de ácido nucleico, vetores e células hospedeiras que compreendem os polinucleotídeos bem como métodos de produzir e usar os polipeptídeos.",NOVOZYMES AS,KIMBERLY BROWN;;MICHELLE MARANTA,,https://lens.org/023-252-901-486-702,Granted Patent,no,0,0,10,10,0,C12Y302/01139;;C12N9/2402;;C12Y302/01139;;C12N9/2402,C12N9/24,,0,0,,,,ACTIVE
49,WO,A1,WO 2010/065448 A1,010-329-579-896-420,2010-06-10,2010,US 2009/0066085 W,2009-11-30,US 11996408 P,2008-12-04,POLYPEPTIDES HAVING FERULOYL ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC;;BOHAN DOREEN;;BROWN KIMBERLY,BOHAN DOREEN;;BROWN KIMBERLY,,https://lens.org/010-329-579-896-420,Patent Application,yes,2,124,5,5,10,C12N9/18;;C12P7/10;;C12P19/00;;C12P21/02;;C12Y301/01073;;Y02E50/10;;C12N9/18;;C12P7/10;;C12P19/00;;C12P21/02;;C12Y301/01073;;Y02E50/10,C07K14/37;;C12N9/16,,4,2,046-412-992-347-12X;;096-668-571-480-195,17973091;;10.1007/s10529-007-9564-6;;10.1016/j.procbio.2007.01.007,"DATABASE UniProt [online] 17 October 2006 (2006-10-17), ""SubName: Full=Putative uncharacterized protein;"", XP002568830, retrieved from EBI accession no. UNIPROT:Q0CEE7 Database accession no. Q0CEE7;;DATABASE UniProt [online] 5 July 2005 (2005-07-05), ""SubName: Full=Tannase, putative; EC=<A HREF=""http://srs.ebi.ac.uk/srsbin/cgi-bin/wgetz?[enzyme-ECNumber:3.1.1.20]+-e"">3.1.1.20</A>;"", XP002568831, retrieved from EBI accession no. UNIPROT:Q4W9W7 Database accession no. Q4W9W7;;ISABELLE BENOIT ET AL: ""Biotechnological applications and potential of fungal feruloyl esterases based on prevalence, classification and biochemical diversity"", BIOTECHNOLOGY LETTERS, KLUWER ACADEMIC PUBLISHERS, DO, vol. 30, no. 3, 1 November 2007 (2007-11-01), pages 387 - 396, XP019570012, ISSN: 1573-6776;;TOPAKAS ET AL: ""Microbial production, characterization and applications of feruloyl esterases"", PROCESS BIOCHEMISTRY, ELSEVIER, NL, vol. 42, no. 4, 19 March 2007 (2007-03-19), pages 497 - 509, XP005933457, ISSN: 1359-5113",PENDING
50,US,A1,US 2010/0124769 A1,062-085-223-439-323,2010-05-20,2010,US 61240109 A,2009-11-04,US 61240109 A;;US 17422109 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,NOVOZYMES INC (2010-01-15),https://lens.org/062-085-223-439-323,Patent Application,yes,1,51,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12P19/04;;C12N9/42;;C12P7/02;;C12P7/26;;C12P7/40;;C12P13/04,435/101;;435/209;;435/155;;435/136;;435/148;;435/106,0,0,,,,INACTIVE
51,US,A1,US 2010/0031400 A1,073-715-500-447-974,2010-02-04,2010,US 53325909 A,2009-07-31,US 53325909 A;;US 8511608 P,2008-07-31,Polypeptides having acetylxylan esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,NOVOZYMES A/S (2009-08-05),https://lens.org/073-715-500-447-974,Patent Application,yes,3,3,8,8,13,C12N9/18;;C12N9/18;;C12N1/22;;C12N1/22;;C12P7/10;;C12P7/10;;Y02E50/10;;Y02E50/10,A01H5/00;;C07H21/02;;C08B37/00;;C12N1/19;;C12N5/04;;C12N9/16;;C12N15/11;;C12N15/87;;C12P7/02;;C12P21/02,800/298;;435/69.1;;435/155;;435/440;;435/196;;435/419;;435/254.3;;435/274;;536/23.2;;536/24.5,0,0,,,,INACTIVE
52,US,A,US 6033891 A,169-030-937-836-488,2000-03-07,2000,US 26510899 A,1999-03-09,US 26510899 A,1999-03-09,Nucleic acids encoding polypeptides having cellobiose dehydrogenase activity,"The present invention relates to isolated nucleic acid sequences encoding polypeptides having cellobiose dehydrogenase activity. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as recombinant methods for producing the polypeptides.",NOVO NORDISK BIOTECH INC,GOLIGHTLY ELIZABETH;;BROWN KIMBERLY,NOVOZYMES INC (2005-08-29);;NOVOZYMES BIOTECH INC (1999-03-10),https://lens.org/169-030-937-836-488,Granted Patent,yes,1,14,1,2,0,C12N9/0006;;C12N9/0006,C12N9/04,435/190;;435/252.3;;435/325;;435/320.1;;435/6;;536/23.2,10,9,123-062-455-649-02X;;028-777-132-884-821;;069-965-125-721-819;;106-586-527-181-798;;037-620-158-813-547;;013-075-640-132-609;;102-184-390-646-402;;007-125-648-584-242;;033-322-884-773-569,10.3891/acta.chem.scand.28b-0204;;10.3891/acta.chem.scand.28b-0209;;710416;;10.1111/j.1432-1033.1978.tb12588.x;;10.1099/00221287-120-2-309;;10.1007/bf00131151;;10.1016/0550-3213(82)90031-1;;10.1099/00221287-131-8-1917;;pmc1219174;;9461557;;10.1042/bj3300565;;10.1016/0014-5793(95)00758-2;;7649263,"Westermark & Eriksson, 1974, Acta Chem. Scand. Ser. B28: 204 208.;;Westermark & Eriksson, 1974, Acta. Chem. Scand. Ser. B28: 209 214.;;Ayers et al., 1978, European Journal of Biochemistry 90: 171 181.;;Schmidhlater & Canevascini, 1992, Applied Microbiology Biotechnology 37: 431 436.;;Dekker, 1980, Journal of General Microbiology 120: 309 316.;;F a hnrich & Irrgang, 1982 Biotechnology Lettters 4: 775 780.;;Coudrray et al., 1982 Biochemical Journal 203: 277 284.;;Sadana & Patil, 1985, Journal of General Microbiology 131: 1917 1923.;;Schou et al., 1998, Biochemical Journal 330: 565 571.;;Raices et al., 1995, FEBS Letters 369: 233 238.",EXPIRED
53,US,A1,US 2012/0149078 A1,161-906-159-613-618,2012-06-14,2012,US 201213410177 A,2012-03-01,US 201213410177 A;;US 32734708 A;;US 99299507 P,2007-12-06,Polypeptides Having Acetylxylan Esterase Activity And Polynucleotides Encoding Same,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",MARANTA MICHELLE;;BROWN KIMBERLY;;NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/161-906-159-613-618,Patent Application,yes,1,0,14,14,11,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,C12N9/18;;A01H5/00;;C07H21/02;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/00;;C12N15/55;;C12N15/63;;C12P7/40,435/136;;435/197;;536/23.2;;435/320.1;;435/252.31;;435/252.3;;435/252.35;;435/252.33;;435/252.34;;435/325;;435/348;;435/419;;435/254.11;;435/254.2;;435/254.22;;435/254.23;;435/254.21;;435/254.3;;435/254.7;;435/254.8;;435/254.4;;435/254.5;;435/440;;800/298;;536/24.5;;435/375,0,0,,,,ACTIVE
54,DK,T3,DK 2310497 T3,199-235-754-015-908,2016-07-25,2016,DK 09790933 T,2009-07-29,US 8454308 P;;US 2009/0052100 W,2008-07-29,"Polypeptider med alfa-glucuronidaseaktivitet og polynukleotider, der koder for dem",,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/199-235-754-015-908,Granted Patent,no,0,0,10,10,0,C12Y302/01139;;C12N9/2402;;C12Y302/01139;;C12N9/2402,C12N9/24,,0,0,,,,ACTIVE
55,US,A1,US 2011/0269188 A1,191-052-837-856-865,2011-11-03,2011,US 200913131551 A,2009-11-30,US 200913131551 A;;US 11996408 P;;US 2009/0066085 W,2008-12-04,Polypeptides having feruloyl esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,BOHAN DOREEN;;BROWN KIMBERLY,NOVOZYMES INC (2011-06-02),https://lens.org/191-052-837-856-865,Patent Application,yes,2,2,5,5,10,C12N9/18;;C12P7/10;;C12P19/00;;C12P21/02;;C12Y301/01073;;Y02E50/10;;C12N9/18;;C12P7/10;;C12P19/00;;C12P21/02;;C12Y301/01073;;Y02E50/10,C12P19/00;;A01H5/00;;C07H21/00;;C12N5/00;;C12N5/10;;C12N9/18;;C12P1/00;;C12P21/06,435/72;;435/197;;536/23.2;;435/325;;800/295;;536/24.5;;536/23.1;;435/69.1;;435/41,6,3,088-956-744-893-796;;055-003-061-629-507;;078-792-343-849-240,16702605;;10.1385/abab:133:2:87;;10.1073/pnas.0403255101;;pmc438954;;15197260;;12169619;;10.1128/jb.184.17.4925-4929.2002;;pmc135289,Uniprot. 2006. Accession Q0CEE7. 2 pages.;;Uniprot. 2011. Accession G2R873. Pg:1-2;;Wong. 2006. Feruloyl Esterase: A key enzyme in biomass degradation. Appl. Biochem. 133:87-112.;;Guo et al. 2004. Protein tolerance to random amino acid change. 101(25):9205-9210.;;Uniprot. 2006. Accession Q0CEE7.;;Nagy et al. 2002. The membrane-bound alpha-glucuronidase from Pseudomonas cellulosa hydrolyzes 4-O-methyl-d-Glucuronoxylooligosaccharides but not 4-O-methyl-d-Glucuronoxylan. J. Bac. 184(17):4925-4929.,INACTIVE
56,EP,A4,EP 1546302 A4,199-991-087-672-261,2006-08-16,2006,EP 03755759 A,2003-08-29,US 0327074 W;;US 40717002 P,2002-08-30,METHODS FOR PRODUCING MAMMALIAN TRYPSINS,"The present invention relates to methods for producing a mammalian trypsin in a Fusarium venenatum host strain, the method comprising (a) cultivating the Fusarium venenatum host strain in a culture medium under conditions suitable for expression of the mammalian trypsin and secretion thereof into the medium, wherein the Fusarium venenatum host strain comprises a nucleic acid construct comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen; and (b) recovering the mammalian trypsin from the medium. The present invention also relates to constructs comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen, and to vectors and Fusarium venenatum host strains comprising such constructs.",NOVOZYMES INC,BERKA RANDY;;BROWN KIMBERLY,,https://lens.org/199-991-087-672-261,Search Report,no,2,0,11,11,0,C12N9/6421;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6421,C12N9/76;;C12N1/15;;C12N9/64;;C12N15/52;;C12N15/62;;C12N15/80;;C12P21/02,,0,0,,,,EXPIRED
57,BR,A2,BR PI0914685 A2,107-598-808-437-117,2019-09-24,2019,BR PI0914685 A,2009-07-31,US 2009/0052368 W;;US 8511608 P,2008-07-31,"peptídeo e polinucleotídeo isolados, célula hospedeira recombinante, métodos para produzir o polipeptídeo, um mutante de uma célula precursora, uma proteína, e um produto de fermentação, para inibir a expressão de um polipeptídeo, para degradar ou converter e para fermentar um material celulósico ou contendo xilano, planta transgênica, parte de planta ou célula de planta, e, molécula de rna inibidora de filamento duplo",,NOVOZYMES AS,KIMBERLY BROWN;;MICHELLE MARANTA,,https://lens.org/107-598-808-437-117,Patent Application,no,0,0,8,8,0,C12N9/18;;C12N9/18;;C12N1/22;;C12N1/22;;C12P7/10;;C12P7/10;;Y02E50/10;;Y02E50/10,C12N9/24;;C12N9/18,,0,0,,,,DISCONTINUED
58,DK,T3,DK 1546302 T3,043-696-746-023-97X,2009-12-14,2009,DK 03755759 T,2003-08-29,US 40717002 P;;US 0327074 W,2002-08-30,Fremgangsmåder til fremstilling af pattedyrs-trypsiner,"The present invention relates to methods for producing a mammalian trypsin in a Fusarium venenatum host strain, the method comprising (a) cultivating the Fusarium venenatum host strain in a culture medium under conditions suitable for expression of the mammalian trypsin and secretion thereof into the medium, wherein the Fusarium venenatum host strain comprises a nucleic acid construct comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen; and (b) recovering the mammalian trypsin from the medium. The present invention also relates to constructs comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen, and to vectors and Fusarium venenatum host strains comprising such constructs.",NOVOZYMES INC,BERKA RANDY;;BROWN KIMBERLY,,https://lens.org/043-696-746-023-97X,Granted Patent,no,0,0,11,11,0,C12N9/6421;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6421,C12N9/76;;C12N1/15;;C12N9/64;;C12N15/52;;C12N15/62;;C12N15/80;;C12P21/02,,0,0,,,,EXPIRED
59,CN,A,CN 102112604 A,058-916-807-109-563,2011-06-29,2011,CN 200980130325 A,2009-07-31,US 2009/0052368 W;;US 8511608 P,2008-07-31,Polypeptides having acetylxylan esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MICHELLE MARANTA;;KIMBERLY BROWN,,https://lens.org/058-916-807-109-563,Patent Application,no,0,3,8,8,0,C12N9/18;;C12N9/18;;C12N1/22;;C12N1/22;;C12P7/10;;C12P7/10;;Y02E50/10;;Y02E50/10,C12N9/24;;C12N9/18,,0,0,,,,INACTIVE
60,CN,A,CN 1694953 A,084-698-333-554-47X,2005-11-09,2005,CN 03824737 A,2003-08-29,US 0327074 W;;US 40717002 P,2002-08-30,Methods for producing mammalian trypsins,"The present invention relates to methods for producing a mammalian trypsin in a Fusarium venenatum host strain, the method comprising (a) cultivating the Fusarium venenatum host strain in a culture medium under conditions suitable for expression of the mammalian trypsin and secretion thereof into the medium, wherein the Fusarium venenatum host strain comprises a nucleic acid construct comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen; and (b) recovering the mammalian trypsin from the medium. The present invention also relates to constructs comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen, and to vectors and Fusarium venenatum host strains comprising such constructs.",NOVOZYMES BIOTECH INC,KIMBERLY BERKA RANDY BROWN,,https://lens.org/084-698-333-554-47X,Patent Application,no,0,4,11,11,0,C12N9/6421;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6421,C12N1/15;;C12N9/64;;C12N9/76;;C12N15/80,,0,0,,,,EXPIRED
61,WO,A1,WO 2004/020612 A1,089-835-938-214-785,2004-03-11,2004,US 0327074 W,2003-08-29,US 40717002 P,2002-08-30,METHODS FOR PRODUCING MAMMALIAN TRYPSINS,"The present invention relates to methods for producing a mammalian trypsin in a Fusarium venenatum host strain, comprising (a) cultivating the Fusarium venenatum host strain in a culture medium under conditions suitable for expression of the mammalian trypsin and secretion thereof into the medium, wherein the Fusarium venenatum host strain comprises a nucleic acid construct comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen; and (b) recovering the mammalian trypsin from the medium. The present invention also relates to constructs comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen, and to vectors and Fusarium venenatum host strains comprising such constructs.",NOVOZYMES BIOTECH INC,BERKA RANDY;;BROWN KIMBERLY,,https://lens.org/089-835-938-214-785,Patent Application,yes,22,4,11,11,0,C12N9/6421;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6421,C12N1/15;;C12N9/64;;C12N9/76;;C12N15/80,,18,11,083-105-058-694-116;;034-328-650-978-645;;158-261-806-420-924;;158-261-806-420-924;;031-274-313-092-421;;023-805-924-410-732;;038-856-203-382-553;;014-838-854-923-114;;149-091-707-097-038;;076-007-707-904-054;;020-201-555-491-656,10.1016/0141-0229(92)90174-m;;1368397;;10.1016/0076-6879(79)68010-2;;396436;;10.1016/s0040-4039(01)90461-7;;10.1016/s0040-4039(01)90461-7;;9501478;;10.1006/fgbi.1997.1027;;10.1006/fgbi.1997.1018;;9501477;;2670677;;10.1016/0378-1119(89)90322-3;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10512673;;10.1006/fgbi.1999.1162;;10.1016/0378-1119(89)90359-4;;2744488,"LAVALLIE ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, 1993, pages 2331 - 23317;;GAERTNER; PUIGSERVER, ENZYME MICROB. TECHNOL., vol. 14, 1992, pages 150;;INNIS ET AL.: ""PCR Protocols: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;SAMBROOK, SUPRA, 1989;;NARANG ET AL., METHODS OF ENZYMOLOGY, vol. 68, 1979, pages 90 - 99;;BROWN ET AL., METHODS OF ENZYMOLOGY, vol. 68, 1979, pages 109 - 151;;BEAUCAGE ET AL., TETRAHEDRON LETTERS, vol. 22, 1981, pages 1859 - 1862;;BEAUCAGE; CAROTHERS, TETRAHEDRON LETTERS, vol. 22, 1981, pages 1859 - 1862;;YODER; CHRISTIANSON, FUNGAL GENETICS AND BIOLOGY, vol. 23, 1998, pages 62 - 80;;O'DONNELL ET AL., FUNGAL GENETICS AND BIOLOGY, vol. 23, 1998, pages 57 - 67;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;GEMS, GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;J. SAMBROOK; E.F. FRITSCH; T. MANIATUS: ""Molecular Cloning, A Laboratory Manual"", 1989, COLD SPRING HARBOR;;""Protein Purification"", 1989, VCH PUBLISHERS;;""Food Chemistry"", 1985, MARCEL DEKKER;;ROYER ET AL., FUNGAL GENET. BIOL., vol. 28, 1999, pages 68 - 78;;HORTON ET AL., GENE, vol. 77, 1989, pages 61 - 68",PENDING
62,CA,A1,CA 2732099 A1,129-445-863-087-536,2010-02-04,2010,CA 2732099 A,2009-07-31,US 8511608 P;;US 2009/0052368 W,2008-07-31,POLYPEPTIDES HAVING ACETYLXYLAN ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having acetylxylan esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/129-445-863-087-536,Patent Application,no,0,0,8,8,13,C12N9/18;;C12N9/18;;C12N1/22;;C12N1/22;;C12P7/10;;C12P7/10;;Y02E50/10;;Y02E50/10,C12N9/24;;C12N9/18,,0,0,,,,DISCONTINUED
63,EP,A1,EP 2313499 A1,135-166-947-787-295,2011-04-27,2011,EP 09791034 A,2009-07-31,US 2009/0052368 W;;US 8511608 P,2008-07-31,POLYPEPTIDES HAVING ACETYLXYLAN ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/135-166-947-787-295,Patent Application,yes,0,0,8,8,0,C12N9/18;;C12N9/18;;C12N1/22;;C12N1/22;;C12P7/10;;C12P7/10;;Y02E50/10;;Y02E50/10,C12N9/24;;C12N9/18,,1,0,,,See references of WO 2010014880A1,DISCONTINUED
64,BR,B1,BR PI0820615 B1,185-904-975-814-022,2020-05-12,2020,BR PI0820615 A,2008-12-03,US 99299507 P;;US 2008/0085380 W,2007-12-06,"célula microbiana hospedeira recombinante, métodos para produzir um polipeptídeo tendo atividade de acetil-xilano esterase, método para produzir uma proteína e método de degradar um material contendo xilano","célula microbiana hospedeira recombinante, métodos para produzir um polipeptídeo tendo atividade de acetil-xilano esterase, método para produzir uma proteína e método de degradar um material contendo xilano a presente invenção refere-se aos polipeptídeos isolados tendo atividade de acetil-xilano-esterase e aos polinucleotídeos isolados codificadores dos polipeptídeos. a invenção também se refere aos construtos de ácido nucleico, vetores, e células hospedeiras compreendendo os polinucleotídeos bem como aos métodos de produzir e de usar os polipeptídeos.",NOVOZYMES AS,KIMBERLY BROWN;;MICHELLE MARANTA,,https://lens.org/185-904-975-814-022,Granted Patent,no,0,0,14,14,0,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,C12N9/18;;A23K10/30,,0,0,,,,INACTIVE
65,CA,A1,CA 2732122 A1,015-940-759-291-320,2010-02-04,2010,CA 2732122 A,2009-07-29,US 8454308 P;;US 2009/0052100 W,2008-07-29,POLYPEPTIDES HAVING ALPHA-GLUCURONIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having alpha-glucuronidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/015-940-759-291-320,Patent Application,no,0,0,10,10,12,C12Y302/01139;;C12N9/2402;;C12Y302/01139;;C12N9/2402,C12N9/24,,0,0,,,,DISCONTINUED
66,EP,A1,EP 2478095 A1,074-069-919-911-249,2012-07-25,2012,EP 10757142 A,2010-09-16,US 24353209 P;;US 2010/0049126 W,2009-09-18,POLYPEPTIDES HAVING BETA-GLUCOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL,,https://lens.org/074-069-919-911-249,Patent Application,yes,0,0,6,6,0,C12N15/52;;C12P7/10;;C12P19/14;;C12Y302/01021;;C12N9/2445;;Y02E50/10;;C12N15/52;;C12Y302/01021;;C12P19/14;;C12P7/10;;C12N9/2445;;Y02E50/10,C12N9/42;;C12N15/52;;C12P19/14,,0,0,,,,DISCONTINUED
67,US,B2,US 8703464 B2,078-771-047-552-351,2014-04-22,2014,US 201314010199 A,2013-08-26,US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",BROWN KIMBERLY;;ABBATE ERIC;;NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/078-771-047-552-351,Granted Patent,yes,12,0,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12N9/24;;C12N9/32;;C12N9/42,435/200;;435/204;;435/209,8,8,033-423-822-755-165;;075-066-659-352-42X;;017-684-136-290-674;;043-717-617-452-997;;035-863-987-433-406;;026-807-638-108-848;;117-206-818-045-405;;003-546-581-906-613,18478401;;10.1007/s12010-007-9064-0;;10.1016/j.enzmictec.2008.01.017;;17058283;;10.1002/bit.21238;;10.1016/j.enzmictec.2006.07.026;;17221887;;10.1002/bit.21329;;10.1016/j.biortech.2007.09.064;;18006303;;17589813;;10.1007/10_2007_065;;10.1007/s10295-008-0327-8;;18338189,"Garcia-Aparicio et al, 2007, Biochem Biotechnol 137-140(1-12), 352-365.;;Ustinov et al., Comparison of properties and mode of action of six secreted xylanases from Chrysosporium lucknowense, Enzyme and Microbial Technology, vol. 43, 2008, pp. 56-65.;;Berlin et al., Optimization of enzyme complexes for lignocelluloses hydrolysis, Biotechnology and Bioengineering, vol. 97, 2007, pp. 287-296.;;Sorensen et al., Synergistic enzyme mechanisms and effects of sequential enzyme additions on degradation of water insoluble wheat arabinoxylan, Enzymes and Microbial Technology, vol. 40, 2007, pp. 908-918.;;Gusakov et al., Design of highly efficient cellulose mixtures for enzymatic hydrolysis of cellulose, Biotechnology and Bioengineering, vol. 97, 2007, pp. 1028-1038.;;Selig et al., Synergistic enhancement of cellobiohydrolase performance on pretreated corn stover by addition of xylanase and esterase activities, Bioresource Technology, vol. 99, 2008, pp. 4997-5005.;;Viikari et al., Thermostable enzymes in lignocelluloses hydrolysis, Advances in Biochemical Engineering, vol. 108, 2007, pp. 121-145.;;Kumar et al., Bioconversion of lignocellulosic biomass: biochemical and molecular perspectives, Journal of Industrial Microbiology & Biotechnology, vol. 35, 2008, pp. 377-391.",INACTIVE
68,ES,T3,ES 2490608 T3,080-809-420-880-744,2014-09-04,2014,ES 08858011 T,2008-12-03,US 99299507 P;;US 2008/0085380 W,2007-12-06,Polipéptidos con actividad de esterasa de acetilxilano y polinucleótidos que codifican los mismos,"Un polipéptido aislado con actividad de acetilxilano esterasa, seleccionado del grupo que consiste en: un polipéptido que comprende una secuencia de aminoácidos con al menos un 85% de identidad con el polipéptido maduro de la SEQ ID nº: 2; un polipéptido codificado por un polinucleótido que se hibrida al menos bajo condiciones de astringencia altas con (i) la secuencia codificante del polipéptido maduro de la SEQ ID nº: 1, (ii) la secuencia de ADNc contenida en la secuencia codificante del polipéptido maduro de la SEQ ID nº: 1, o (iii) una cadena complementaria entera de (i) o (ii); (c) un polipéptido codificado por un polinucleótido que comprende una secuencia de nucleótidos que tiene al menos un 85% de identidad con la secuencia codificante del polipéptido maduro de la SEQ ID nº: 1.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/080-809-420-880-744,Granted Patent,no,0,0,14,14,0,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,A23K1/165;;C12N9/18,,0,0,,,,ACTIVE
69,WO,A1,WO 2009/076122 A1,173-126-425-931-909,2009-06-18,2009,US 2008/0085341 W,2008-12-03,US 1215207 P,2007-12-07,POLYPEPTIDES HAVING FERULOYL ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isoiaied polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the pαfypeptides. The invention also refates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;MARANTA MICHELLE;;BROWN KIMBERLY,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/173-126-425-931-909,Patent Application,yes,0,181,7,7,11,C12N15/8243;;C12N15/8243;;C12N9/18;;C12N9/18;;C12N15/8257;;C12N15/8257,C12N9/18;;C12N15/82,,4,3,070-999-894-117-481;;034-183-137-702-424;;122-544-071-723-302,10.1042/bj20020917;;pmc1223187;;12435269;;10.1002/jsfa.2480;;10.1016/s0144-8617(00)00259-9,"CREPIN VALERIE F ET AL: ""A non-modular type B feruloyl esterase from Neurospora crassa exhibits concentration-dependent substrate inhibition."", THE BIOCHEMICAL JOURNAL 1 MAR 2003, vol. 370, no. Pt 2, 1 March 2003 (2003-03-01), pages 417 - 427, XP002517452, ISSN: 0264-6021;;FAULDS CRAIG B ET AL: ""Influence of the arabinoxylan composition on the susceptibility of mono- and dimeric ferulic acid release by Humicola insolens feruloyl esterases"", JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, vol. 86, no. 11, August 2006 (2006-08-01), pages 1623 - 1630, XP002517453, ISSN: 0022-5142;;SAULNIER L ET AL: ""Thermal and enzymatic treatments for the release of free ferulic acid from maize bran"", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS, LTD. BARKING, GB, vol. 45, no. 3, 1 July 2001 (2001-07-01), pages 269 - 275, XP004362760, ISSN: 0144-8617;;DATABASE UniProt [online] 15 May 2007 (2007-05-15), ""SubName: Full=Putative uncharacterized protein;"", XP002517454, retrieved from EBI accession no. UNIPROT:A4RIA6 Database accession no. A4RIA6",PENDING
70,EP,A1,EP 2310497 A1,181-052-484-745-736,2011-04-20,2011,EP 09790933 A,2009-07-29,US 2009/0052100 W;;US 8454308 P,2008-07-29,POLYPEPTIDES HAVING ALPHA-GLUCURONIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/181-052-484-745-736,Patent Application,yes,0,0,10,10,0,C12Y302/01139;;C12N9/2402;;C12Y302/01139;;C12N9/2402,C12N9/24,,0,0,,,,ACTIVE
71,US,A1,US 2015/0368685 A1,194-042-511-790-894,2015-12-24,2015,US 201514849204 A,2015-09-09,US 201514849204 A;;US 201414248039 A;;US 201314010199 A;;US 61240109 A;;US 17422109 P;;US 11660508 P;;US 11582908 P,2008-11-18,Methods and compositions for degrading cellulosic material,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/194-042-511-790-894,Patent Application,yes,0,1,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12P19/14;;C12P19/02,,0,0,,,,ACTIVE
72,CA,A1,CA 2745608 A1,094-349-765-469-225,2010-06-10,2010,CA 2745608 A,2009-11-30,US 11996408 P;;US 2009/0066085 W,2008-12-04,POLYPEPTIDES HAVING FERULOYL ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,BOHAN DOREEN;;BROWN KIMBERLY,,https://lens.org/094-349-765-469-225,Patent Application,no,0,0,5,5,10,C12N9/18;;C12P7/10;;C12P19/00;;C12P21/02;;C12Y301/01073;;Y02E50/10;;C12N9/18;;C12P7/10;;C12P19/00;;C12P21/02;;C12Y301/01073;;Y02E50/10,C07K14/37;;C12N9/16,,0,0,,,,DISCONTINUED
73,EP,B1,EP 2224822 B1,016-842-630-619-572,2014-05-21,2014,EP 08858011 A,2008-12-03,US 2008/0085380 W;;US 99299507 P,2007-12-06,POLYPEPTIDES HAVING ACETYLXYLAN ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/016-842-630-619-572,Granted Patent,yes,2,0,14,14,0,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,A23K1/165;;C12N9/18,,2,0,,,"DATABASE UniProt [Online] 21 March 2006 (2006-03-21), ""SubName: Full=Putative uncharacterized protein;"" XP002513219 retrieved from EBI accession no. UNIPROT:Q2HEP2 Database accession no. Q2HEP2;;DATABASE BRENDA-ENZYMES [Online] 3 February 2009 (2009-02-03), ""Acetylxylan esterase"" XP002513218 retrieved from BRENDA Database accession no. EC 3.1.1.72",ACTIVE
74,US,A1,US 2011/0072540 A1,027-616-347-763-10X,2011-03-24,2011,US 88624410 A,2010-09-20,US 88624410 A;;US 24353209 P,2009-09-18,Polypeptides having beta-glucosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having beta-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL,NOVOZYMES INC (2010-09-30),https://lens.org/027-616-347-763-10X,Patent Application,yes,3,5,6,6,11,C12N15/52;;C12P7/10;;C12P19/14;;C12Y302/01021;;C12N9/2445;;Y02E50/10;;C12N15/52;;C12Y302/01021;;C12P19/14;;C12P7/10;;C12N9/2445;;Y02E50/10,C07H21/02;;A01H5/00;;C07H21/04;;C12N5/00;;C12N5/10;;C12N9/42;;C12P19/14;;C12P21/00,800/298;;435/209;;536/23.2;;435/419;;536/24.5;;435/375;;536/23.1;;435/69.1;;435/99,6,5,105-676-187-931-902;;055-003-061-629-507;;037-694-385-435-98X;;040-285-223-611-187;;012-495-969-917-14X,21964414;;10.1038/nbt.1976;;10.1073/pnas.0403255101;;pmc438954;;15197260;;10.1126/science.1137016;;17289988;;20138890;;10.1016/j.jmb.2010.01.072;;10.2210/pdb2wt3/pdb;;15193129;;10.1023/b:biry.0000029853.34093.13,"Berka et al. 2011. Comparative genomic analysis of the thermophilic biomass-degrading fungi Myceliophthora thermophilia and Thielavia terrestris. Nature. 29(10):922-929;;Berka et al. 2011 (as stated above) Supplementary Data and Figures, Pages 1-46).;;Guo et al. 2004. Protein tolerance to random amino acid change. PNAS. 101(25):9205-9210.;;Himmel et al. 2007. Biomass recalcitrance: Engineering plants and enzymes for biofuels production. Science. 315:804-807.;;Pozzo et al. 2010. Structural and functional analyses of beta-glucosidase 3B from Thermotoga neapolitana: A thermostable three-domain representative of glycoside hydrolase 3. J Mol Biol. 397:724-739.;;Bukhtojarov et al. 2004. Cellulase complex of the fungus Chrysosporium lucknowense: Isolation and characterization of endoglucanases and cellobiohydrolases. Biochemistry (Moscow). 69(5):542-551.",INACTIVE
75,WO,A2,WO 2010/059424 A2,039-118-234-371-592,2010-05-27,2010,US 2009/0063249 W,2009-11-04,US 11582908 P;;US 17422109 P,2008-11-18,METHODS AND COMPOSITIONS FOR DEGRADING CELLULOSIC MATERIAL,"The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.",NOVOZYMES INC;;BROWN KIMBERLY;;ABBATE ERIC,BROWN KIMBERLY;;ABBATE ERIC,,https://lens.org/039-118-234-371-592,Patent Application,yes,0,34,17,17,119,C12N9/2437;;C12P19/14;;C12N9/2437;;C12N9/248;;C12N9/248;;C12N9/2482;;C12N9/2482;;C12P7/14;;C12P19/02;;C12P2201/00;;C12Y302/01004;;C12Y302/01004;;C12Y302/01008;;C12Y302/01008;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091;;Y02E50/10,C12N9/24;;C12N9/42;;C12P19/14,,1,0,,,See references of EP 2358872A2,PENDING
76,EP,A1,EP 2373684 A1,078-141-332-133-029,2011-10-12,2011,EP 09760691 A,2009-11-30,US 2009/0066085 W;;US 11996408 P,2008-12-04,POLYPEPTIDES HAVING FERULOYL ESTERASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC,BOHAN DOREEN;;BROWN KIMBERLY,,https://lens.org/078-141-332-133-029,Patent Application,yes,0,0,5,5,0,C12N9/18;;C12P7/10;;C12P19/00;;C12P21/02;;C12Y301/01073;;Y02E50/10;;C12N9/18;;C12P7/10;;C12P19/00;;C12P21/02;;C12Y301/01073;;Y02E50/10,C07K14/37;;C12N9/16,,0,0,,,,DISCONTINUED
77,CN,A,CN 102712916 A,178-768-288-646-509,2012-10-03,2012,CN 201080051966 A,2010-09-16,US 2010/0049126 W;;US 24353209 P,2009-09-18,Polypeptides having beta-glucosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having beta-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,KIMBERLY BROWN;;PAUL HARRIS,,https://lens.org/178-768-288-646-509,Patent Application,no,3,8,6,6,0,C12N15/52;;C12P7/10;;C12P19/14;;C12Y302/01021;;C12N9/2445;;Y02E50/10;;C12N15/52;;C12Y302/01021;;C12P19/14;;C12P7/10;;C12N9/2445;;Y02E50/10,C12N9/42;;C12N15/52;;C12P19/14,,1,0,,,"C. BREUIL等: ""Production and localization of cellulases and β-glucosidase from the thermophilic fungus Thielavia terrestris"", 《BIOTECHNOLOGY LETTERS》",INACTIVE
78,BR,A2,BR PI0914835 A2,067-351-430-547-627,2015-08-11,2015,BR PI0914835 A,2009-07-29,US 8454308 P;;US 2009/0052100 W,2008-07-29,"Polipeptídeo isolado, polinucleotídeo isolado, célula hospedeira recombinante, métodos para produzir o polipeptídeo, para produzir um mutante de um célula precursora, para inibir a expressão de um polipeptídeo tendo atividade de alfa-glucuronidase em uma célula, para produzir uma proteína, para degradar ou converter um material celulósico ou contendo xilano, para produzir um produto de fermentação e para fermentar um material celulósico ou contendo xilano, planta transgênica, parte de planta ou célula de planta, e, molécula de rna inibidora de filamento duplo",,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/067-351-430-547-627,Patent Application,no,0,0,10,10,0,C12Y302/01139;;C12N9/2402;;C12Y302/01139;;C12N9/2402,C12N9/24,,0,0,,,,ACTIVE
79,CN,B,CN 1694953 B,100-477-108-181-223,2010-05-12,2010,CN 03824737 A,2003-08-29,US 0327074 W;;US 40717002 P,2002-08-30,Methods for producing mammalian trypsins,"The present invention relates to methods for producing a mammalian trypsin in a Fusarium venenatum host strain, comprising (a) cultivating the Fusarium venenatum host strain in a culture medium underconditions suitable for expression of the mammalian trypsin and secretion thereof into the medium, wherein the Fusarium venenatum host strain comprises a nucleic acid construct comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen; and (b) recovering the mammalian trypsin from the medium. The present invention also relates to constructs comprising a nucleic acid sequence encoding the mature coding sequence of a mammalian trypsin operably linked to nucleotides 58 to 129 of SEQ ID NO: 1 encoding the signal peptide and propeptide of Fusarium oxysporum trypsinogen, and to vectors and Fusarium venenatum host strains comprising such constructs.",NOVOZYMES BIOTECH INC,RANDY BERKA;;KIMBERLY BROWN,,https://lens.org/100-477-108-181-223,Granted Patent,no,0,0,11,11,0,C12N9/6421;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6427;;C12N15/80;;C12Y304/21004;;C12N9/6421,C12N1/15;;C12N9/64;;C12N9/76;;C12N15/00;;C12N15/63;;C12N15/80;;C12P21/00,,0,0,,,,EXPIRED
80,BR,A2,BR PI0820615 A2,130-553-360-146-307,2014-10-14,2014,BR PI0820615 A,2008-12-03,US 99299507 P;;US 2008/0085380 W,2007-12-06,"CONSTRUTO DE ÁCIDO NUCLEICO, CÉLULA MICROBIANA HOSPEDEIRA RECOMBINANTE, MÉTODOS PARA PRODUZIR UM POLIPEPTÍDEO TENDO ATIVIDADE DE ACETIL-XILANO ESTERASE, PARA PRODUZIR UM MUTANTE DE UMA CÉLULA PRECURSORA, DE INIBIR A EXPRESSÃO DE UM POLIPEPTÍDEO, PARA PRODUZIR UMA PROTEÍNA E PARA DEGRADAR UM MATERIAL CONTENDO XILANO",,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY,,https://lens.org/130-553-360-146-307,Patent Application,no,0,0,14,14,0,A23K10/14;;A23K10/14;;A23K20/147;;A23K20/147;;A23K20/189;;A23K20/189;;C12N9/18;;C12N9/18,A23K1/165;;C12N9/18,,0,0,,,,INACTIVE
81,CN,A,CN 101939420 A,160-805-907-579-728,2011-01-05,2011,CN 200880126491 A,2008-12-03,US 2008/0085341 W;;US 1215207 P,2007-12-07,Polypeptides having feruloyl esterase activity and polynucleotides encoding same,"The present invention relates to isoiaied polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the pafypeptides. The invention also refates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MICHELLE MARANTA;;KIMBERLY BROWN,,https://lens.org/160-805-907-579-728,Patent Application,no,0,2,7,7,0,C12N15/8243;;C12N15/8243;;C12N9/18;;C12N9/18;;C12N15/8257;;C12N15/8257,C12N9/18;;C12N15/82,,0,0,,,,DISCONTINUED
82,US,B2,US 8058513 B2,188-486-237-139-459,2011-11-15,2011,US 60957009 A,2009-10-30,US 60957009 A;;US 11291008 P,2008-11-10,Polypeptides having feruloyl esterase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having feruloyl esterase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",BROWN KIMBERLY;;BOHAN DOREEN;;NOVOZYMES INC,BROWN KIMBERLY;;BOHAN DOREEN,NOVOZYMES INC (2009-11-02),https://lens.org/188-486-237-139-459,Granted Patent,yes,6,4,5,5,9,C12N9/18;;C12N9/18;;C12N15/11;;C12N15/1137;;C12N15/1137;;C12N15/82;;C12N2310/11;;C12N2310/11;;C12N2310/14;;C12N2310/14;;C12Y301/01073;;C12Y301/01073,C12N15/31;;A01H5/00;;C12N15/10;;C12N15/52;;C12N15/82,800/288;;800/284;;800/295;;800/278;;435/320.1;;435/468;;536/23.1;;536/23.2;;536/23.7,12,9,030-861-357-228-781;;136-501-366-348-202;;046-412-992-347-12X;;041-606-854-625-551;;004-737-263-977-895;;034-554-107-359-733;;084-667-057-884-082;;011-059-930-612-536;;036-794-281-968-249,10.1385/abab:111:3:153;;14665735;;10.1111/j.1745-7270.2007.00348.x;;17989872;;17973091;;10.1007/s10529-007-9564-6;;10.1007/s00253-003-1476-3;;14661116;;1663152;;10.1099/00221287-137-10-2339;;10.1099/00221287-140-4-779;;8679110;;pmc168785;;9406381;;10.1128/aem.63.12.4638-4644.1997;;10.1016/0141-0229(92)90050-x,"UniProt Accession No. Q0CEE7, 2004.;;UniProt Accession No. Q4W9W7, 2005.;;UniProt Accession No. A1D9T4, 2007.;;Rey et al., Cloning, heterologous expression, and characterization of Thielavia terrestris glucoamylase, 2003, Appl. Biochem. And Biotech., 111: 153-166.;;Fazary et al., Feruloyl esterases as biotechnological tools: Current and future perspectives, 2007, ACTA Biochimica ET Biophysica Sinica, 39: 811-828.;;Benoit et al., Biotechnological applications and potential of fungal feruloyl esterases based on prevalence, classification and biochemical diversity, 2007, Biotechnology Letters, 30: 387-396.;;Crepin et al., Functional classification of the microbial feruloyl esterases, 2004, Applied Microbiology and Biotechnology, 63: 647-652.;;Faulds et al., The purification and characterization of 4-hydroxy-3-methixycinnamic (ferulic) acid esterase from Streptomyces olivochromogenes1991, J. Gen. Microbiol. 137: 2339-2345.;;Faulds et al., Purification and characterization of a ferulic acid esterase (FAE-III) from Aspergillus niger : specificity for the phenolic moiety and binding to microcrystalline cellulose, 1994, Microbiology 140: 779-787.;;Kroon et al., Purification and characterization of a novel esterase induced by growth of Aspergillus niger on sugar-beet pulp, 1996, Biotechnol. Appl. Biochem. 23: 255-262.;;Devries et al., The faeA Genes from Aspergillus niger and Aspergillus tubingensis Encode Ferulic Acid Esterases Involved in Degradation of Complex Cell Wall Polysaccharides, 1997, Appl. Environ. Microbiol. 63: 4638-4644.;;Castanares et al., Purification and properties of a feruloyl/p-coumaroyl esterase from the fungus Penicillium pinophilum, 1992, Enzyme Microbiol. Technol. 14: 875-884.",INACTIVE
83,CN,A,CN 1980953 A,006-252-293-100-055,2007-06-13,2007,CN 200580010730 A,2005-01-28,US 2005/0003525 W;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES BIOTECH INC,LEO BROWN KIMBERLY HARRIS PAUL,,https://lens.org/006-252-293-100-055,Patent Application,no,0,7,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
84,US,A1,US 2012/0144247 A1,164-960-336-719-568,2012-06-07,2012,US 201113311062 A,2011-12-05,US 201113311062 A;;US 41980510 P,2010-12-03,"SYSTEM, APPARATUS AND METHOD FOR PROVIDING TRAINING THROUGH INCORPORATION OF METAPHORICAL EXPRESSIONS","A system, apparatus and method for providing training through incorporation of metaphorical expressions are provided. A method includes receiving selected user preferences via a computer. The method also includes displaying a story board based on the selected user preferences, where the display shows text and images and the computer simultaneously plays vocals. Further, the method includes prompting the user to perform a task. Where the user successfully completes the task, the method includes taking the user to a next task. If the user does not successfully complete the task, the method includes repeating the story board and prompting the user to attempt the task again until the task is successfully completed.",BROWN KIMBERLY ANN;;JEAN HUGUENS;;AMETHYST TECHNOLOGIES LLC,BROWN KIMBERLY ANN;;JEAN HUGUENS,,https://lens.org/164-960-336-719-568,Patent Application,yes,3,7,1,1,0,G06F3/048;;G09B5/02;;G09B19/00;;G09B23/28;;G06F3/048;;G09B19/00;;G09B5/02;;G09B23/28,G06F3/048;;G06F11/07;;G06F9/46,714/47.1;;718/100;;715/772;;X714E11024,0,0,,,,DISCONTINUED
85,US,A1,US 2006/0252126 A1,043-044-690-263-697,2006-11-09,2006,US 48930106 A,2006-07-18,US 48930106 A;;US 61557100 A;;US 42607299 A,1999-10-21,Polypeptides having phospholipase B activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having phospholipase B activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,HARRIS PAUL;;BROWN KIMBERLY M,,https://lens.org/043-044-690-263-697,Patent Application,yes,1,1,6,6,4,C12N9/20;;C12N9/20,C12P21/06;;C07H21/04;;C12N9/20;;C12N15/12,435/69.1;;435/198;;435/320.1;;435/325;;536/23.2,2,2,030-315-747-492-600;;074-630-886-241-728,10.1371/journal.pcbi.1000349;;pmc2664478;;19381264;;pmc3048372;;21408208;;10.1371/journal.pgen.1001321,"Bloom et al, Inferring Stabilizing Mutations from Protein Phylogenies: Application to Influenza Hemagglutinin, PLoS Computational Biology, 2009, Volume 5 pages 1-19;;Salverda et al, Initial Mutations Direct Alternative Pathways of Protein Evolution, PLoS Computational Biology, 2011, Volume 7(3) pages 1-11",DISCONTINUED
86,WO,A2,WO 2001/029222 A2,052-503-700-151-928,2001-04-26,2001,US 0029140 W,2000-10-20,US 42607299 A,1999-10-21,POLYPEPTIDES HAVING PHOSPHOLIPASE B ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having phospholipase B activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK BIOTECH INC,HARRIS PAUL;;BROWN KIMBERLY M,,https://lens.org/052-503-700-151-928,Patent Application,yes,0,11,6,6,4,C12N9/20;;C12N9/20,C12N9/20;;C12N15/12,,0,0,,,,PENDING
87,WO,A3,WO 2001/029222 A3,158-296-750-470-665,2002-02-14,2002,US 0029140 W,2000-10-20,US 42607299 A,1999-10-21,POLYPEPTIDES HAVING PHOSPHOLIPASE B ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having phospholipase B activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK BIOTECH INC,HARRIS PAUL;;BROWN KIMBERLY M,,https://lens.org/158-296-750-470-665,Search Report,yes,3,0,6,6,0,C12N9/20;;C12N9/20,C12N9/20;;C12N15/12,,0,0,,,,PENDING
88,US,B1,US 7091003 B1,162-949-703-043-345,2006-08-15,2006,US 61557100 A,2000-07-13,US 61557100 A;;US 42607299 A,1999-10-21,Polypeptides having phospholipase B activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having phospholipase B activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,HARRIS PAUL;;BROWN KIMBERLY M,NOVOZYMES INC (2005-08-29);;NOVOZYMES BIOTECH INC (2001-05-11),https://lens.org/162-949-703-043-345,Granted Patent,yes,2,6,6,6,4,C12N9/20;;C12N9/20,C12P21/02;;C07H21/04;;C12N1/15;;C12N1/20;;C12N9/20;;C12N15/12;;C12N15/55;;C12N15/70;;C12N15/80,435/69.1;;435/320.1;;435/254.11;;435/252.3;;435/471;;435/198;;536/23.1;;536/23.2;;536/23.7;;536/23.74;;536/24.1,20,15,082-140-050-351-597;;103-932-348-507-545;;037-469-234-874-765;;028-267-786-362-133;;049-601-122-903-390;;072-867-662-458-568;;004-717-126-095-951;;072-286-434-215-26X;;055-529-301-662-872;;052-875-332-452-678;;037-469-234-874-765;;047-967-448-843-571;;000-789-688-396-470;;010-703-907-211-37X;;059-570-672-059-538,9290241;;10.1006/fgbi.1997.0995;;10.1007/978-1-4684-6831-1_14;;8051052;;10.1016/s0021-9258(17)32081-1;;1646934;;10.1016/0076-6879(91)97170-4;;9009289;;10.1128/iai.65.2.405-411.1997;;pmc174609;;10.1016/0378-1135(95)00195-6;;8734639;;5402;;10.1093/oxfordjournals.jbchem.a130839;;1722456;;10.1111/j.1432-1033.1991.tb16433.x;;10.1016/0032-9592(94)00030-1;;10.1080/00021369.1985.10866845;;8051052;;10.1016/s0021-9258(17)32081-1;;10.1016/0378-1097(94)90328-x;;8001766;;10.1111/j.1574-6968.1994.tb07257.x;;8782402;;10.1271/bbb.60.1087;;10.1016/0003-9861(81)90106-5;;6452858;;10.1080/00021369.1979.10863481,"Agnan et al., Cloning Heterologous Gene: Problems and Approches, 1997, Fungal Genetics and Biology, vol. 21, pp. 292-301.;;Ngo et al., ""Computational complexity, protein structure prediction, and the Levinthal paradox"", in The Protein Folding Problem and Tertiary Structure Prediction, Merz et al. (eds.), Birkhauser Boston: Boston, MA, pp. 433 and 492-495.;;Rudinger, ""Characteristics of the amino acid as componants of a peptide hormone sequence"", in Peptide Hormones, Parsons (ed.), University Park Press: Baltimore, MD, pp. 1-7.;;Lee et al., ""The Saccharomyces cerevisiae PLB 1 gene encodes a protein required for lysophosphplipase and phopholipase B activity,"" J. Biol. Chem. 269 (31): 19725-19730, Aug. 1994.;;www.chem.qmul.ac.uk/iubmb/enzyme/EC3/1/-""Enzyme Nomenclature. Recommendations EC 3.1, acting on ester bonds,"" Nomenclature Committee of the INternational Union of Biochemistry and Molecular Biology (NC-IUBMB).;;www.chem.qmul.ac.uk/iubmb/enzyme/EC3/1/1/-""Enzyme Nomenclature. Recommendations EC3.1.1, Carboxylic Ester Hydrolases,"" Nomenclature Committee of the INternational Union of Biochemistry and Molecular Biology (NC-IUBMB).;;www.chem.qmul.ac.uk/iubmb/enzyme/EC3/1/4/-""Enzyme Nomenclature. Recommendations EC 3.1.1, Phosphoric Diester Hydrolases,"" Nomenclature Committee of the INternational Union of Biochemistry and Molecular Biology (NC-IUBMB).;;Saito et al., 1991, Methods in Enzymology 197: 446-456.;;Chen et al., Infection & Immunity 65: 405-411.;;Fifis et al., 1996, Veterinary Microbiology 49: 219-233.;;Kawaski, 1975, Journal of Biochemistry 77: 1233-1244.;;Masuda et al., European Journal of Biochemistry 202: 783-787.;;Mustranta et al., 1995, Process Biochemistry 30: 393-401.;;Ichimasa et al., 1985, Agric. Biol. Chem. 49: 1083-1089.;;Lee et al., 1994, Journal of Biological Chemistry 269: 19725-19730.;;Kuwabara, 1998, Agric. Biol. Chem. 52: 2451-2458.;;Watanabe et al., 1994, FEMS Microbiological Letters 124: 29-34.;;Oishi et al., 1996, Biosci. Biotech. Biochem. 60:1087-1092.;;Chakravarti et al., 1981, Archives of Biochemistry & Biophysics 206: 393-402.;;Uehara et al., 1979, Agric. Biol. Chem. 43: 517-525.",EXPIRED
89,US,A,US 6146869 A,146-768-112-077-479,2000-11-14,2000,US 42607299 A,1999-10-21,US 42607299 A,1999-10-21,Polypeptides having phospholipase B activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having phospholipase B activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK BIOTECH INC,HARRIS PAUL;;BROWN KIMBERLY M,NOVOZYMES INC (2005-08-29);;NOVOZYMES BIOTECH INC (1999-10-21),https://lens.org/146-768-112-077-479,Granted Patent,yes,0,55,6,6,4,C12N9/20;;C12N9/20,C12N9/20;;C12N15/12,435/198;;435/69.1;;435/183;;435/195;;530/350;;530/371,5,5,031-682-025-225-632;;020-186-689-610-531;;196-661-770-706-71X;;072-286-434-215-26X;;072-286-434-215-26X,9748287;;10.1074/jbc.273.40.26078;;10.1080/02681219980000091;;10.1046/j.1365-280x.1999.00190.x;;10200936;;10.1016/0378-1097(83)90126-x;;1722456;;10.1111/j.1432-1033.1991.tb16433.x;;1722456;;10.1111/j.1432-1033.1991.tb16433.x,"Leidich et al., Cloning and Disruption of caPLB1, a Phospholipase B Gene Involved in the Pathogenicity of Candida albicans, J. Biol. Chem. 273 (40): 26078 26086, Oct. 1998.;;Sugiyama et al. Molecular Coning of a second phospholipase B gene, caPLB2 from Candida albicans, Nedical Mycology 37: 61 67, Sep. 1998.;;Memon et al., Phospholipase B activity in mycelia of Asperigillus niger, FEMS Microbiology Letters 18: 15 18, 1983.;;Masuda et al., Primary structure of the protein moiety of Penicillium notatum phospholipase B deduced from the cDNA, Eur. J. Biochem. 202: 783 787, 1991.;;Masuda et al., Primary structure of the protein moiety of Penicillium notatum phospholipase B decuded from the cDNA, Eur. J. Biochem. 202: 783 787, Oct. 1998.",EXPIRED
90,AU,A,AU 2001/012229 A,127-512-956-168-129,2001-04-30,2001,AU 2001/012229 A,2000-10-20,US 42607299 A;;US 0029140 W,1999-10-21,Polypeptides having phospholipase b activity and nucleic acids encoding same,,NOVO NORDISK BIOTECH INC,HARRIS PAUL;;BROWN KIMBERLY M,,https://lens.org/127-512-956-168-129,Patent Application,no,0,0,6,6,0,C12N9/20;;C12N9/20,C12N9/20;;C12N15/12,,0,0,,,,DISCONTINUED
91,AU,A8,AU 2003/275172 A8,074-137-732-607-353,2004-04-19,2004,AU 2003/275172 A,2003-09-24,US 41305702 P;;US 0329964 W,2002-09-24,Microbial trypsin variants having chymotrypsin activity and nucleic acids encoding same,,NOVOZYMES BIOTECH INC,ZARETSKY ELIZABETH;;KLOTZ ALAN;;BROWN KIMBERLY,,https://lens.org/074-137-732-607-353,Patent Application,no,0,0,19,19,0,C12N9/58;;C12N9/58,C12N9/58,,0,0,,,,DISCONTINUED
92,CA,A1,CA 2776336 A1,072-148-011-679-112,2011-05-19,2011,CA 2776336 A,2010-10-28,US 25607409 P;;US 2010/0054484 W,2009-10-29,POLYPEPTIDES HAVING CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC;;NOVOZYMES AS,BROWN KIMBERLY;;ABBATE ERIC;;SPODSBERG NIKOLAJ,,https://lens.org/072-148-011-679-112,Patent Application,no,0,0,7,7,141,C12Y302/01091;;C12N9/2437;;Y02E50/10;;C12Y302/01091;;C12N9/2437;;Y02E50/10,C12N9/42;;C12N15/80,,0,0,,,,DISCONTINUED
93,US,A1,US 2012/0260371 A1,115-894-501-667-918,2012-10-11,2012,US 201013503835 A,2010-10-28,US 201013503835 A;;US 25607409 P;;US 2010/0054484 W,2009-10-29,Polypeptides Having Cellobiohydrolase Activity and Polynucleotides Encoding Same,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",BROWN KIMBERLY;;ABBATE ERIC;;SPODSBERG NIKOLAJ;;NOVOZYMES AS;;NOVOZYMES INC,BROWN KIMBERLY;;ABBATE ERIC;;SPODSBERG NIKOLAJ,NOVOZYMES INC (2012-04-27);;NOVOZYMES A/S (2012-04-27),https://lens.org/115-894-501-667-918,Patent Application,yes,3,7,7,7,141,C12Y302/01091;;C12N9/2437;;Y02E50/10;;C12Y302/01091;;C12N9/2437;;Y02E50/10,C12N9/42;;A01H5/00;;C07H21/02;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/99;;C12N15/09;;C12N15/31;;C12N15/56;;C12P7/10;;C12P21/00,800/298;;435/209;;536/23.2;;435/252.31;;435/252.3;;435/252.35;;435/252.33;;435/252.34;;435/325;;435/348;;435/419;;435/254.11;;435/254.2;;435/254.22;;435/254.23;;435/254.21;;435/254.3;;435/254.7;;435/254.8;;435/254.4;;435/254.5;;435/254.6;;435/440;;536/24.5;;435/184;;536/23.74;;435/69.1;;435/165,2,2,058-474-639-508-622;;008-744-511-384-732,10.1263/jbb.95.627;;16233469;;10.1016/s1389-1723(03)80174-3;;pmc91575;;10.1128/aem.65.10.4340-4345.1999;;10508057,Kanamasa et al. 2003. Overexpression of Aspergillus aculeatus cellobiohydrolase I in Aspergillus oryzae. J. Biosci. Bioeng. 95(6):627-629.;;Gielkens et al. 1999. Two cellobiohydrolase-encoding genes from Aspergillus niger requireD-xylose and the xylanolytic transcriptional activator XlnR for their expression. Appl. Enbiron. Microbiol. 65(10):4340-4345.,DISCONTINUED
94,EP,A1,EP 2235048 A1,119-184-561-449-786,2010-10-06,2010,EP 08867623 A,2008-12-17,US 2008/0087273 W;;US 1502507 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/119-184-561-449-786,Patent Application,yes,0,0,7,7,0,C07K14/37;;C11D3/38645;;C12N9/2434;;C12N9/2434;;C07K14/37;;C11D3/38645,C07K14/37;;C11D3/386;;C12N9/42;;C12N15/74,,0,0,,,,DISCONTINUED
95,US,A1,US 2010/0306881 A1,175-298-719-042-22X,2010-12-02,2010,US 74599308 A,2008-12-17,US 74599308 A;;US 1492007 P;;US 2008/0087231 W,2007-12-19,Polypeptides having Cellulolytic Enhancing Activity and Polynucleotides Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/175-298-719-042-22X,Patent Application,yes,3,8,7,7,67,C07K14/37;;C12N9/2434;;C07K14/37;;C12N9/2434,A01H5/00;;C07H21/02;;C07H21/04;;C07K14/39;;C12N5/00;;C12N5/10;;C12N15/01;;C12N15/63;;C12P7/04;;C12P7/26;;C12P7/40;;C12P21/02,800/298;;530/371;;536/23.74;;435/320.1;;435/325;;435/71.1;;435/69.1;;435/440;;536/24.5;;435/375;;435/136;;435/157;;435/148;;435/419,1,0,,,"Birren et al UNIprot XP001229931.1, 03/2006, alignment provided",DISCONTINUED
96,BR,A2,BR PI1015197 A2,038-482-031-423-131,2020-08-18,2020,BR PI1015197 A,2010-04-22,US 2010/0032034 W;;US 17423709 P,2009-04-30,"polipeptídeo isolado, polinucleotídeo isolado, célula hospedeira recombinante, métodos para produzir um polipeptídeo, um mutante de uma célula percursora, uma proteina, e um produto de fermentação, planta transgênica, parte da planta ou célula de planta, molécula de rna, método para inibir a expressão de um polipeptídeo, e, métodos para degradar ou converter, e para fermentar um material celulósico ou contendo xilano","polipeptídeo isolado, polinucleotídeo isolado, célula hospedeia recombinante, métodos para produzir um polipeptídeo, um mutante de uma célula precursora, uma proteína, e um produto de fermentação, planta transgênica, parte da planta ou célula de planta, molécula de rna, métodos para degradar ou converter, e para fermentar um material celulósico ou contendo xilano a presente invenção diz respeito aos polipeptídeos isolados com atividade de xilanase e polinucleotídeos isolados que codificam os polipeptídeos. a invenção também diz respeito aos construtos de ácido nucleico, vetores e células hospedeiras que compreendem os polinucleotídeos, bem como aos métodos de produzir e usar os polipeptídeos.",NOVOZYMES INC,ERIC ABBATE;;KIMBERLY BROWN;;MICHELLE MARANTA,,https://lens.org/038-482-031-423-131,Patent Application,no,0,0,8,8,0,C12N9/248;;C12N9/248;;C08H1/00;;C08H1/00;;C08L89/00;;C08L89/00;;C12N15/8242;;C12N15/8242;;C12N15/8246;;C12N15/8246;;C12N15/8257;;C12N15/8257;;C12P7/10;;C12P7/10;;C12P19/02;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2203/00;;C12P2203/00;;C12Y302/01091;;C12Y302/01091;;D21C5/005;;D21C5/005;;Y02E50/10;;Y02E50/10,C12N9/42;;C12N15/82;;D21C5/00,,0,0,,,,DISCONTINUED
97,WO,A3,WO 2009/085859 A3,061-457-676-257-694,2009-08-27,2009,US 2008/0087231 W,2008-12-17,US 1492007 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY;;NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/061-457-676-257-694,Search Report,yes,3,0,7,7,0,C07K14/37;;C12N9/2434;;C07K14/37;;C12N9/2434,C07K14/39;;C12N9/42,,0,0,,,,PENDING
98,DK,T3,DK 1546318 T3,128-777-026-692-506,2010-04-26,2010,DK 03759441 T,2003-09-24,US 41305702 P;;US 0329964 W,2002-09-24,"Mikrobielle trypsin-varianter, der har chymotrypsin-aktivitet, og nukleinsyrer, der koder for samme",,NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY;;ZARETSKY ELIZABETH,,https://lens.org/128-777-026-692-506,Granted Patent,no,0,0,19,19,0,C12N9/58;;C12N9/58,C12N9/48;;C12N9/58,,0,0,,,,EXPIRED
99,EP,A1,EP 2424995 A1,130-961-449-228-619,2012-03-07,2012,EP 10714828 A,2010-04-22,US 2010/0032034 W;;US 17423709 P,2009-04-30,POLYPEPTIDES HAVING XYLANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC,BROWN KIMBERLY;;MARANTA MICHELLE;;ABBATE ERIC,,https://lens.org/130-961-449-228-619,Patent Application,yes,1,0,8,8,0,C12N9/248;;C12N9/248;;C08H1/00;;C08H1/00;;C08L89/00;;C08L89/00;;C12N15/8242;;C12N15/8242;;C12N15/8246;;C12N15/8246;;C12N15/8257;;C12N15/8257;;C12P7/10;;C12P7/10;;C12P19/02;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2203/00;;C12P2203/00;;C12Y302/01091;;C12Y302/01091;;D21C5/005;;D21C5/005;;Y02E50/10;;Y02E50/10,C12N15/82;;C12N9/42;;D21C5/00,,1,0,,,See also references of WO 2010126772A1,DISCONTINUED
100,CN,B,CN 102482680 B,184-302-612-876-246,2014-09-10,2014,CN 201080029709 A,2010-04-22,US 2010/0032034 W;;US 17423709 P,2009-04-30,Polypeptides having xylanase activity and polynucleotides encoding same,,NOVOZYMES INC,BROWN KIMBERLY;;MARANTA MICHELLE;;ABBATE ERIC,,https://lens.org/184-302-612-876-246,Granted Patent,no,0,0,8,8,0,C12N9/248;;C12N9/248;;C08H1/00;;C08H1/00;;C08L89/00;;C08L89/00;;C12N15/8242;;C12N15/8242;;C12N15/8246;;C12N15/8246;;C12N15/8257;;C12N15/8257;;C12P7/10;;C12P7/10;;C12P19/02;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2203/00;;C12P2203/00;;C12Y302/01091;;C12Y302/01091;;D21C5/005;;D21C5/005;;Y02E50/10;;Y02E50/10,C12N15/82;;C12N9/42;;D21C5/00,,0,0,,,,INACTIVE
101,US,B1,US 6280976 B1,034-211-690-538-258,2001-08-28,2001,US 47926400 A,2000-01-05,US 47926400 A;;US 26510899 A,1999-03-09,Nucleic acids encoding polypeptides having cellobiose dehydrogenase activity,"The present invention relates to isolated nucleic acid sequences encoding polypeptides having cellobiose dehydrogenase activity. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as recombinant methods for producing the polypeptides.",NOVOZYMES BIOTECH INC,GOLIGHTLY ELIZABETH J;;BROWN KIMBERLY M,NOVO NORDISK BIOTECH INC (2000-01-05);;NOVOZYMES INC (2005-08-29),https://lens.org/034-211-690-538-258,Granted Patent,yes,0,10,1,2,4,C12N9/0006;;C12N9/0006,C12N9/04,435/69.8;;435/69.1;;435/320.1;;435/252.3;;435/325;;435/189;;435/193;;435/195;;435/232;;435/233,12,8,123-062-455-649-02X;;028-777-132-884-821;;069-965-125-721-819;;106-586-527-181-798;;013-966-630-174-61X;;102-184-390-646-402;;007-125-648-584-242;;033-322-884-773-569,10.3891/acta.chem.scand.28b-0204;;10.3891/acta.chem.scand.28b-0209;;710416;;10.1111/j.1432-1033.1978.tb12588.x;;10.1099/00221287-120-2-309;;10.1042/bj2030277;;7103940;;pmc1158220;;10.1099/00221287-131-8-1917;;pmc1219174;;9461557;;10.1042/bj3300565;;10.1016/0014-5793(95)00758-2;;7649263,"Subramaniam et al., SPTREMBL Database, Accession No. 074240, Nov. 1998.*;;Hillier et al., EST Database, Accession No. H91018, Nov. 1995.*;;Westermark & Eriksson. 1974. Acta Chem. Scand. Ser. B28:204-208.;;Westermark & Eriksson. 1974. Acta Chem. Scand. Ser. B28:209-214.;;Avers et al.. 1978. European Journal of Biochemistry 90:171-181.;;Schmidhalter & Canevascini. 1992. Applied Microbiology Biotechnology 37:431-436.;;Dekker. 1980. Journal of General Microbilogy 120: 309-316.;;Fähnrich & Irrgang. Biotechnology Letters 4: 775-780.;;Coudray et al., 1982. Biochemical Journal 203: 277-284.;;Sadana & Patil. 1985. Journal of General Microbiology 131: 1917-1923.;;Schou et al., 1998. Biochemical Journal 330: 565-571.;;Raices et al., 1995. FEBS Letters 369: 233-238.",EXPIRED
102,EP,B1,EP 2238243 B1,113-468-611-607-823,2019-01-09,2019,EP 08857507 A,2008-11-20,US 2008/0084209 W;;US 99148407 P,2007-11-30,POLYPEPTIDES HAVING ARABINOFURANOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,,https://lens.org/113-468-611-607-823,Granted Patent,yes,1,0,14,14,0,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N9/24,,0,0,,,,ACTIVE
103,US,A1,US 2023/0015266 A1,142-849-116-545-574,2023-01-19,2023,US 202017780843 A,2020-11-30,US 202017780843 A;;US 201962942001 P;;US 2020/0062580 W,2019-11-29,NEONATAL FIBRIN SCAFFOLDS FOR PROMOTING WOUND HEALING,Disclosed are methods of promoting wound healing in a patient in need thereof comprising administering to the patient a composition comprising a neonatal fibrin scaffold. Further disclosed are in vitro methods for evaluating a target composition on human wound healing comprising a neonatal porcine plasma scaffold with the target composition and evaluating scaffold properties of the plasma sample.,UNIV NORTH CAROLINA STATE,BROWN ASHLEY C;;NELLENBACH KIMBERLY A,NORTH CAROLINA STATE UNIVERSITY (2020-02-06),https://lens.org/142-849-116-545-574,Patent Application,yes,0,0,2,2,0,A61L15/32;;A61L15/44;;A61L15/46;;A61L2300/404;;A61L2300/402;;A61L2300/41;;A61L15/40;;A61L26/0042;;A61L26/0057;;A61L26/0066;;C12N5/0656;;C12N2533/56;;C12N2513/00;;A61L27/225;;A61L27/227;;A61L27/54;;A61L2300/402;;A61L2300/404;;A61L2300/41;;A61L2400/12,A61L27/22;;A61L27/54,,0,0,,,,PENDING
104,WO,A2,WO 2004/029202 A2,134-741-074-151-539,2004-04-08,2004,US 0329964 W,2003-09-24,US 41305702 P,2002-09-24,MICROBIAL TRYPSIN VARIANTS HAVING CHYMOTRYPSIN ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to microbial trypsin variants having chymotrypsin-like activity, comprising: (a) a one or more substitutions corresponding to positions 144, S193A, 198, 201, 218, 223, 227, 228, 229, 230, and 231 of amino acids 25 to 248 of SEQ ID NO: 2; (b) one or more deletions corresponding to positions 192, 197, and 226 of amino acids 25 to 248 of SEQ ID NO: 2; and (c) an insertion between positions corresponding to positions 224 and 225 of amino acids 25 to 248 of SEQ ID NO: 2. The present invention further relates to nucleotide sequences encoding microbial trypsin variants having chymotrypsin-like activity; nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; and methods of producing microbial trypsin variants having chymotrypsin-like activity or a precursor thereof.",NOVOZYMES BIOTECH INC,KLOTZ ALAN;;BROWN KIMBERLY;;ZARETSKY ELIZABETH,,https://lens.org/134-741-074-151-539,Patent Application,yes,0,9,19,19,0,C12N9/58;;C12N9/58,C12N9/58,,0,0,,,,PENDING
105,DK,T3,DK 2238243 T3,176-708-449-453-111,2019-04-15,2019,DK 08857507 T,2008-11-20,US 99148407 P;;US 2008/0084209 W,2007-11-30,"Polypeptider med arabinofuranosidaseaktivitet og polynukleotider, der koder for dem",,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,,https://lens.org/176-708-449-453-111,Granted Patent,no,0,0,14,14,0,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N9/24,,0,0,,,,ACTIVE
106,CN,A,CN 101952420 A,062-882-574-200-746,2011-01-19,2011,CN 200880127123 A,2008-12-18,US 2008/0087402 W;;US 1490007 P;;US 1498007 P,2007-12-19,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,PAUL HARRIS;;SUCHINDRA MAIYURAN;;KIMBERLY BROWN,,https://lens.org/062-882-574-200-746,Patent Application,no,0,0,18,19,0,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;C12N1/15;;C12N1/21;;C12N5/10;;C12N9/42;;C12N15/56;;C12P19/14;;C12S3/02,,0,0,,,,DISCONTINUED
107,BR,A2,BR PI0822090 A2,133-875-519-720-755,2017-05-23,2017,BR PI0822090 A,2008-12-17,US 2008/0087258 W;;US 1499907 P,2007-12-19,"polipeptídeo isolado, polinucleotídeo isolado, construção de ácido nucléico, célula hospedeira recombinante, métodos para produzir o polipeptídeo, para produzir um mutante de uma célula precursora, de inibir a expressão de um polipeptídeo, para produzir uma proteína, para degradar ou converter um material celulósico, para a produção de um produto de fermentação, para fermentar um material celulósico, planta transgênica, parte vegetal ou célula vegetal, molécula de rna inibidora de duplo filamento",,NOVOZYMES AS,KIMBERLY BROWN;;PAUL HARRIS;;SUCHINDRA MAIYURAN,,https://lens.org/133-875-519-720-755,Patent Application,no,0,0,8,8,0,C07K14/37;;C12N9/2434;;C12P19/14;;C12N9/2434;;C12P19/14;;C07K14/37,C07K14/39;;C12N9/42,,0,0,,,,DISCONTINUED
108,US,A1,US 2010/0299789 A1,126-674-000-845-530,2010-11-25,2010,US 74600308 A,2008-12-17,US 74600308 A;;US 1499907 P;;US 2008/0087258 W,2007-12-19,Polypeptides having Cellulolytic Enhancing Activity and Polynucleotides Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/126-674-000-845-530,Patent Application,yes,3,7,8,8,67,C07K14/37;;C12N9/2434;;C12P19/14;;C12N9/2434;;C12P19/14;;C07K14/37,A01H5/00;;C07H21/02;;C07H21/04;;C07K14/39;;C12N5/00;;C12N5/10;;C12N15/01;;C12N15/63;;C12P7/04;;C12P7/26;;C12P7/40;;C12P21/02,800/298;;530/371;;536/23.74;;435/320.1;;435/325;;435/71.1;;435/69.1;;435/440;;435/410;;536/24.5;;435/375;;435/136;;435/157;;435/148,3,3,055-003-061-629-507;;011-469-898-256-819;;008-249-728-514-317,10.1073/pnas.0403255101;;pmc438954;;15197260;;10.1007/s00253-007-1274-4;;18071646;;10.1007/s12010-011-9231-1;;21484273,"GUO, H. H., J. Choe, L. A. Loeb. Protein tolerance to random amino acid change. 2004. P.N.A.S. 101(25):9205-9210.;;Koseki, T., Y. Mese, S. Fushinobu, K. Masaki, T. Fujii, K. Ito, Y. Shiono, T. Murayama, H. Iefuji. Biochemical characterization of a glycoside hydrolase family 61 endoglucanase from Aspergillus kawachii. 2008. Appl. Microbiol. Biotechnol. 77:1279-1285.;;Zhao, Y., H. Luo, K. Meng, P. Shi, G. Wang, P. Yang, T. Yuan, B. Yao. A xylanase gene directly cloned from the genomic DNA of alkaline wastewater sludge showing application potential in the paper industry. Appl. Microbiol. Biotechnol. 2011. 165:35-46.",INACTIVE
109,AU,A1,AU 2003/275172 A1,123-853-545-405-994,2004-04-19,2004,AU 2003/275172 A,2003-09-24,US 41305702 P;;US 0329964 W,2002-09-24,MICROBIAL TRYPSIN VARIANTS HAVING CHYMOTRYPSIN ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,,NOVOZYMES BIOTECH INC,KLOTZ ALAN;;BROWN KIMBERLY;;ZARETSKY ELIZABETH,,https://lens.org/123-853-545-405-994,Patent Application,no,0,0,19,19,0,C12N9/58;;C12N9/58,C12N9/58,,0,0,,,,DISCONTINUED
110,MX,A,MX 2010006629 A,157-228-779-025-265,2010-07-16,2010,MX 2010006629 A,2010-06-05,US 1490007 P;;US 1498007 P,2007-12-19,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,,NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/157-228-779-025-265,Patent Application,no,0,0,18,19,0,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,,,0,0,,,,ACTIVE
111,KR,A,KR 20100105849 A,157-178-681-910-677,2010-09-30,2010,KR 20107015628 A,2008-12-18,US 1490007 P;;US 1498007 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/157-178-681-910-677,Patent Application,no,0,0,18,19,148,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/42;;C12N5/10;;C12N15/56;;C12P19/14,,0,0,,,,DISCONTINUED
112,WO,A3,WO 2001/014534 A3,052-638-121-316-677,2001-06-21,2001,US 0023521 W,2000-08-25,US 38430599 A,1999-08-26,POLYPEPTIDES HAVING PECTIN ACETYLESTERASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having pectin acetylesterase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES BIOTECH INC,THOMAS MICHAEL D;;BROWN KIMBERLY M,,https://lens.org/052-638-121-316-677,Search Report,yes,1,0,7,7,0,C07K2319/02;;C12N9/18;;C12N9/18;;C07K2319/02,C12N9/18,,4,2,055-529-044-240-440;;164-563-488-832-931,10.1046/j.1365-2958.1997.4331800.x;;9218776;;10.1007/bf00180635;;1367534,"DATABASE TREMBL [online] 1 November 1995 (1995-11-01), YOSHIDA K.-I. ET AL.: ""HYPOTHETICAL 41.8 KDA PROTEIN IN WAPA-LICT INTERGENIC REGION PRECURSOR"", XP002159384, retrieved from EBI Database accession no. P42304;;DATABASE EMBL [online] 23 January 1997 (1997-01-23), YOSHIDA K. ET AL.: ""gene=""yxiM"""", XP002159385, retrieved from EBI Database accession no. D83026;;SHEVCHIK VLADIMIR E ET AL: ""Identification of a bacterial pectin acetyl esterase in Erwinia chrysanthemi 3937."", MOLECULAR MICROBIOLOGY, vol. 24, no. 6, 1997, pages 1285 - 1301, XP000979450, ISSN: 0950-382X;;HEIKINHEIMO R ET AL: ""PRODUCTION OF PECTIN METHYLESTERASE FROM ERWINIA-CHRYSANTHEMI B374 IN BACILLUS-SUBTILIS"", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 35, no. 1, 1991, pages 51 - 55, XP000979445, ISSN: 0175-7598",PENDING
113,WO,A3,WO 2009/085935 A3,069-796-840-624-781,2009-10-15,2009,US 2008/0087402 W,2008-12-18,US 1490007 P;;US 1498007 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/069-796-840-624-781,Search Report,yes,3,0,18,19,0,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;C12N1/15;;C12N1/21;;C12N5/10;;C12N9/42;;C12N15/56;;C12P19/14;;C12S3/02,,6,2,005-624-155-034-991;;057-571-652-345-301,10.1111/j.1574-6968.2006.00433.x;;16978358;;pmc129927;;10.1128/aem.68.11.5765-5768.2002;;12406778,"DATABASE UniProt [online] 15 December 2003 (2003-12-15), ""SubName: Full=Putative uncharacterized protein;"", XP002520367, retrieved from EBI accession no. UNIPROT:Q7S439 Database accession no. Q7S439;;ALAN RADFORD, FUNGAL GENETICS NEWSLETTER, vol. 53, 2006, pages 12 - 14, XP002520364, ISSN: 1556-1275, Retrieved from the Internet <URL:http://www.fgsc.net/fgn53/radford/fgn53radford.htm>;;DING SHAOJUN ET AL: ""Cloning of multiple cellulase cDNAs from Volvariella volvacea and their differential expression during substrate colonization and fruiting"", FEMS MICROBIOLOGY LETTERS, vol. 263, no. 2, October 2006 (2006-10-01), pages 207 - 213, XP002520365, ISSN: 0378-1097;;WYMELENBERG A. VAN DEN ET AL: ""Transcript analysis of genes encoding a family 61 endoglucanase and a putative membrane-anchored family 9 glycosyl hydrolase from Phanerochaete chrysosporium."", APPLIED AND ENVIRONMENTAL MICROBIOLOGY NOV 2002, vol. 68, no. 11, November 2002 (2002-11-01), pages 5765 - 5768, XP002520366, ISSN: 0099-2240;;INTERNET CITATION, XP002269954, Retrieved from the Internet <URL:http://afmb.cnrs.fr/CAZY/GH_61.html> [retrieved on 20040210];;See also references of EP 2235173A2",PENDING
114,AT,T1,AT E452184 T1,083-489-830-279-002,2010-01-15,2010,AT 03759441 T,2003-09-24,US 41305702 P;;US 0329964 W,2002-09-24,MIKROBIELLE TRYPSINVARIANTEN MIT CHYMOTRYPSINAKTIVITÄT UND DIESE CODIERENDE NUKLEINSÄUREN,,NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY;;ZARETSKY ELIZABETH,,https://lens.org/083-489-830-279-002,Granted Patent,no,0,0,19,19,0,C12N9/58;;C12N9/58,C12N9/58,,0,0,,,,EXPIRED
115,CN,A,CN 101978049 A,102-527-793-356-671,2011-02-16,2011,CN 200880125640 A,2008-11-20,US 2008/0084209 W;;US 99148407 P,2007-11-30,Polypeptides having arabinofuranosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MICHELLE MARANTA;;KIMBERLY BROWN;;JAMES LANGSTON,,https://lens.org/102-527-793-356-671,Patent Application,no,0,3,14,14,0,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N9/24,,0,0,,,,INACTIVE
116,EP,A1,EP 1374803 A1,133-925-290-990-230,2004-01-02,2004,EP 03253909 A,2003-06-20,US 17772002 A,2002-06-21,Hip joint having a variety of trochanteric flange sizes,"The present invention provides a hip prosthesis (38) with a modular or integral trochanteric flange (56). The prosthesis (38) includes a stem (42) for insertion within a reamed out femoral canal and a head (50) for articulation within an acetabulum of a hip bone, the head (50) and stem (42) being connected by a neck (44). The neck (44) contains an attachment region (54) for securing the trochanteric flange (56) to the prosthesis (38). The trochanteric flange (56) is selected from a variety of trochanteric flanges differing in length. The specific trochanteric flange (56) selected depends upon the amount of hip joint soft tissue resected from a particular patient. If a large amount of soft tissue is resected an elongated trochanteric flange (56) will be selected. However, if little or no soft tissue is resected, a shorter trochanteric flange (56) will be selected. The ability to customize the size of the trochanteric flange (56) allows the physician to better recreate the natural relationship between the greater trochanter and the soft tissue of the hip joint, thus allowing the soft tissue to be secured to the trochanteric flange (56) without having to stretch the soft tissue or otherwise cause undesirable tension within the soft tissue.",BIOMET INC,BROWN DAVID R;;LES KIMBERLY A,,https://lens.org/133-925-290-990-230,Patent Application,yes,6,2,1,1,0,A61B17/06166;;A61B17/86;;A61F2/0811;;A61F2/30739;;A61F2/30767;;A61F2/32;;A61F2/36;;A61F2/367;;A61F2/3676;;A61F2002/30153;;A61F2002/3021;;A61F2002/30322;;A61F2002/30332;;A61F2002/30383;;A61F2002/30385;;A61F2002/30387;;A61F2002/30433;;A61F2002/30449;;A61F2002/30485;;A61F2002/30492;;A61F2002/30604;;A61F2002/30616;;A61F2002/30785;;A61F2002/30787;;A61F2002/30789;;A61F2002/3081;;A61F2002/3401;;A61F2002/3611;;A61F2002/3625;;A61F2002/365;;A61F2002/3674;;A61F2002/4631;;A61F2220/0025;;A61F2220/0033;;A61F2220/0041;;A61F2220/005;;A61F2230/0019;;A61F2230/0067;;A61F2250/0026;;A61F2310/00017;;A61F2310/00023;;A61F2310/00029;;A61F2002/30339;;A61F2002/30367;;A61F2002/305;;A61F2002/30507;;A61F2002/3079,A61B17/06;;A61B17/86;;A61F2/00;;A61F2/08;;A61F2/30;;A61F2/32;;A61F2/34;;A61F2/36;;A61F2/46,,0,0,,,,DISCONTINUED
117,MX,B,MX 293208 B,144-745-233-381-480,2011-12-06,2011,MX 2010006629 A,2010-06-05,US 1490007 P;;US 1498007 P,2007-12-19,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,,NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/144-745-233-381-480,Granted Patent,no,0,0,18,19,0,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,,,0,0,,,,ACTIVE
118,WO,A2,WO 2001/014534 A2,157-164-782-025-282,2001-03-01,2001,US 0023521 W,2000-08-25,US 38430599 A,1999-08-26,POLYPEPTIDES HAVING PECTIN ACETYLESTERASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having pectin acetylesterase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES BIOTECH INC,THOMAS MICHAEL D;;BROWN KIMBERLY M,,https://lens.org/157-164-782-025-282,Patent Application,yes,0,2,7,7,25,C07K2319/02;;C12N9/18;;C12N9/18;;C07K2319/02,C12N9/18,,0,0,,,,PENDING
119,WO,A1,WO 2010/126772 A1,019-234-929-909-11X,2010-11-04,2010,US 2010/0032034 W,2010-04-22,US 17423709 P,2009-04-30,POLYPEPTIDES HAVING XYLANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having xylanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC;;BROWN KIMBERLY;;MARANTA MICHELLE;;ABBATE ERIC,BROWN KIMBERLY;;MARANTA MICHELLE;;ABBATE ERIC,,https://lens.org/019-234-929-909-11X,Patent Application,no,1,147,8,8,23,C12N9/248;;C12N9/248;;C08H1/00;;C08H1/00;;C08L89/00;;C08L89/00;;C12N15/8242;;C12N15/8242;;C12N15/8246;;C12N15/8246;;C12N15/8257;;C12N15/8257;;C12P7/10;;C12P7/10;;C12P19/02;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2203/00;;C12P2203/00;;C12Y302/01091;;C12Y302/01091;;D21C5/005;;D21C5/005;;Y02E50/10;;Y02E50/10,C12N15/82;;C12N9/42;;D21C5/00,,170,151,007-825-245-642-652;;018-222-591-852-35X;;058-313-563-307-746;;018-222-591-852-35X;;058-313-563-307-746;;060-447-603-638-044;;047-694-592-512-688;;168-467-332-279-864;;023-207-730-709-584;;000-743-569-588-265;;014-625-826-302-514;;127-544-305-672-969;;053-902-977-327-206;;061-537-462-842-986;;020-011-032-411-111;;081-290-558-102-206;;009-052-884-271-430;;015-734-715-035-926;;034-499-320-202-349;;010-606-868-765-729;;022-715-862-716-318;;032-728-154-591-070;;022-439-235-146-469;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;083-771-782-040-353;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;039-227-503-731-991;;073-153-156-138-109;;079-834-082-826-604;;016-587-457-958-718;;164-567-086-301-271;;029-314-535-301-390;;044-889-964-761-310;;130-197-652-144-217;;024-461-215-806-523;;002-129-848-383-652;;054-167-555-136-715;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;070-786-212-570-774;;080-478-847-113-962;;025-382-717-097-246;;060-100-774-152-775;;024-608-718-151-219;;066-174-113-969-972;;004-879-676-826-589;;119-409-570-143-716;;112-713-110-898-538;;077-184-809-518-772;;065-527-462-128-017;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;003-307-199-216-170;;060-909-037-461-654;;130-374-497-909-295;;036-168-690-647-51X;;122-107-077-421-078;;056-172-488-299-694;;015-652-210-164-846;;024-087-420-133-316;;113-902-635-079-219;;067-164-920-836-831;;000-183-195-092-675;;169-141-851-602-500;;025-368-788-723-477;;060-178-055-146-889;;031-589-022-231-352;;017-647-343-533-20X;;079-894-236-784-078;;069-166-427-004-435;;005-197-632-250-053;;106-322-033-242-053;;000-183-195-092-675;;029-672-278-978-420;;004-855-955-930-454;;024-107-327-163-524;;099-014-502-085-120;;002-235-158-220-337;;086-912-852-710-005;;089-469-021-381-015;;077-856-998-073-395;;074-536-892-628-290;;006-229-312-677-875;;002-068-346-610-521;;000-183-195-092-675;;118-711-156-754-483;;058-145-297-843-203;;031-347-305-828-923;;076-235-786-419-94X;;162-096-376-612-739;;023-134-630-499-263;;022-892-629-813-258;;120-034-791-945-912;;015-748-750-785-463;;000-009-413-776-570;;053-935-128-053-707;;014-622-505-292-796;;014-774-168-809-047;;001-824-374-248-456;;083-475-617-712-21X;;024-715-211-347-486;;000-531-410-112-308;;175-295-822-939-63X;;045-548-779-820-017;;029-940-225-165-635;;031-097-124-288-463;;031-015-979-474-454;;021-946-971-259-170;;024-708-797-947-714;;015-065-490-448-969;;013-458-224-516-628;;008-437-576-847-072;;070-718-550-259-060;;047-341-291-675-260;;136-261-375-157-758,10.1016/s0960-8524(96)00094-6;;16690241;;10.1016/j.biotechadv.2006.03.003;;10.1351/pac198759020257;;16690241;;10.1016/j.biotechadv.2006.03.003;;10.1351/pac198759020257;;10.1016/s0167-7799(97)01032-9;;9649743;;10.1042/bst0260173;;10.1016/0014-5793(82)81092-2;;10.1016/0014-5793(85)81260-6;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-#;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-;;11930943;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;10.1002/jsfa.2519;;10.1016/j.febslet.2006.07.033;;16876163;;9020869;;10.1042/bj3210375;;pmc1218079;;10.1016/0168-1656(92)90074-j;;10.1016/0003-2697(72)90301-6;;5031119;;9440512;;10.1128/jb.180.2.243-249.1998;;pmc106878;;10.1016/0960-8524(94)90214-3;;10.1007/bf02920289;;9051728;;10.1093/protein/10.1.1;;10.1016/0022-2836(70)90057-4;;5420325;;10.1016/s0168-9525(00)02024-2;;10827456;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1021/bi00109a004;;1932005;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;8508780;;pmc413497;;10.1002/j.1460-2075.1993.tb05913.x;;7973629;;10.1126/science.7973629;;14513384;;10.1007/s10295-003-0083-8;;10656339;;10.1016/s0168-1656(99)00191-1;;10.1128/aem.63.9.3488-3493.1997;;pmc168655;;9292999;;10.1038/nbt0595-498;;9634791;;1367012;;10.1038/nbt0491-378;;3082357;;14406087;;10.1021/bi00350a035;;10.1038/nbt0995-982;;9636275;;2516317;;10.1002/prot.340060306;;10.1016/1046-5928(91)90057-p;;1821793;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;6345791;;10.1016/s0022-2836(83)80284-8;;3041370;;10.1093/nar/16.13.6127;;pmc336852;;10.1007/bf02931600;;15530004;;pmc210093;;10.1128/jb.171.6.3583-3585.1989;;2656662;;pmc33461;;10.1073/pnas.101589398;;11353836;;10.1016/j.mimet.2005.06.001;;15987659;;pmc544212;;10.1128/aem.71.1.51-57.2005;;15640169;;pmc351592;;10.1128/iai.32.3.1295-1297.1981;;7251168;;1795653;;10473378;;pmc99703;;10.1128/aem.65.9.3800-3804.1999;;pmc281518;;6272080;;10.1128/mr.45.3.409-436.1981;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1021/bp990110d;;10514251;;pmc120791;;10.1128/mmbr.66.3.506-577.2002;;12209002;;10.1016/0141-0229(85)90114-0;;10.1002/bit.260250106;;18548538;;10.1007/bf02786945;;10.1007/10_2007_064;;17530205;;10.1007/10_2007_070;;17646946;;18599291;;10.1016/j.biortech.2008.05.027;;10.1016/j.biortech.2004.06.025;;15588770;;pmc2635757;;19325822;;10.3390/ijms9091621;;10.1002/bbb.49;;10.1016/0960-8524(95)00122-0;;12226717;;10.1007/s00253-002-1058-9;;16915665;;10.1385/abab:130:1:496;;15054274;;10.1385/abab:114:1-3:509;;10.1016/j.enzmictec.2005.12.010;;10.1016/s0960-8524(03)00167-6;;14592748;;16112483;;10.1016/j.biortech.2005.01.010;;10.1016/j.biortech.2004.06.025;;15588770;;10.1016/s0960-8524(97)00164-8;;10.1385/abab:117:1:01;;15126700;;10.1002/bit.20222;;15470714;;10.1002/jctb.1586;;10.1385/abab:98-100:1-9:23;;12018251;;10.1002/bit.21132;;16903002;;15930586;;10.1385/abab:124:1-3:1133;;16112489;;10.1016/j.biortech.2005.01.016;;15772945;;10.1002/bit.20453;;16523526;;10.1002/bit.20905;;10.1385/abab:121:1-3:0219;;15917601;;10.1007/978-1-59259-991-2_19;;10.1016/j.biortech.2004.06.025;;15588770;;10.1016/s0065-2164(08)70598-7;;10.1016/0141-0229(95)00157-3;;10.1016/0378-1119(86)90023-5;;2948877;;3384334;;10.1016/0378-1119(88)90541-0;;10.1111/j.1432-1033.1997.00584.x;;9370370;;10.1111/j.1365-2958.1994.tb00417.x;;7984103;;10.1093/nar/18.19.5884;;pmc332333;;2216782;;10.1007/bf00311212;;7586029;;10.1016/0378-1119(90)90433-r;;2379837;;10671536;;10.1074/jbc.275.7.4973;;8964516;;10.1016/0378-1119(96)00179-5;;10.1007/s00253-005-0229-x;;16331454;;10.1007/bf02918984;;8391777;;9572962;;10.1128/aem.64.5.1852-1859.1998;;pmc106241;;10.1007/bf00167144;;pmc167730;;10.1128/aem.61.12.4184-4190.1995;;8534086;;15040955;;10.1016/j.femsyr.2004.01.003;;18600763;;10.1002/bit.260380311;;10.1002/(sici)1097-0290(19980420)58:2/3<204::aid-bit13>3.0.co;2-c;;10191391;;17791346;;10.1126/science.267.5195.240;;pmc168273;;10.1128/aem.62.12.4465-4470.1996;;8953718;;12172602;;10.1007/s00253-002-1046-0;;10.1016/0032-9592(95)80001-8;;18576101;;10.1007/bf02920444;;15286988;;10.1002/bit.20156;;10.2166/wst.1997.0573;;10.1016/s0961-9534(97)00020-2;;10.1002/bit.260320214;;18584740;;9512532;;10.1093/nar/26.7.1628;;pmc147464;;10.1016/0166-0934(92)90168-d;;1322932,"HALTRICH D ET AL: ""Production of fungal xylanases"", BIORESOURCE TECHNOLOGY 199611 GB LNKD- DOI:10.1016/S0960-8524(96)00094-6, vol. 58, no. 2, November 1996 (1996-11-01), pages 137 - 161, XP002584524, ISSN: 0960-8524;;See also references of EP 2424995A1;;ZHANG ET AL.: ""Outlook for cellulase improvement: Screening and selection strategies"", BIOTECHNOLOGY ADVANCES, vol. 24, 2006, pages 452 - 481, XP028005978, DOI: doi:10.1016/j.biotechadv.2006.03.003;;GHOSE: ""Measurement of cellulase activities"", PURE APPL. CHEM., vol. 59, 1987, pages 257 - 68, XP000652082;;ZHANG ET AL., BIOTECHNOLOGY ADVANCES, vol. 24, 2006, pages 452 - 481;;GHOSE, PURE AND APPL. CHEM., vol. 59, 1987, pages 257 - 268;;TEERI: ""Crystalline cellulose degradation: New insight into the function of cellobiohydrolases"", TRENDS IN BIOTECHNOLOGY, vol. 15, 1997, pages 160 - 167, XP004059844, DOI: doi:10.1016/S0167-7799(97)01032-9;;TEERI ET AL.: ""Trichoderma reesei cellobiohydrolases: why so efficient on crystalline cellulose?"", BIOCHEM. SOC. TRANS., vol. 26, 1998, pages 173 - 178;;TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156;;TILBEURGH; CLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288;;VENTURI ET AL.: ""Extracellular beta-D-glucosidase from Chaetomium thermophilum var. coprophilum: production, purification and some biochemical properties"", J. BASIC MICROBIOL., vol. 42, 2002, pages 55 - 66;;HENRISSAT B.: ""A classification of glycosyl hydrolases based on amino-acid sequence similarities"", BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT B.; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BIOCHEM. J., vol. 316, 1996, pages 695 - 696, XP001176681;;BIELY; PUCHARD: ""Recent progress in the assays of xylanolytic enzymes"", JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, vol. 86, no. 11, 2006, pages 1636 - 1647;;SPANIKOVA; BIELY: ""Glucuronoyl esterase - Novel carbohydrate esterase produced by Schizophyllum commune"", FEBS LETTERS, vol. 580, no. 19, 2006, pages 4597 - 4601, XP028061315, DOI: doi:10.1016/j.febslet.2006.07.033;;HERRMANN; VRSANSKA; JURICKOVA; HIRSCH; BIELY; KUBICEK: ""The beta-D-xylosidase of Trichoderma reesei is a multifunctional beta-D-xylan xylohydrolase"", BIOCHEMICAL JOURNAL, vol. 321, 1997, pages 375 - 381;;BAILEY; BIELY; POUTANEN: ""Interlaboratory testing of methods for assay of xylanase activity"", JOURNAL OF BIOTECHNOLOGY, vol. 23, no. 3, 1992, pages 257 - 270, XP023704921, DOI: doi:10.1016/0168-1656(92)90074-J;;ANAL. BIOCHEM, vol. 47, pages 273 - 279;;DE VRIES, J. BACTERIOL., vol. 180, 1998, pages 243 - 249;;WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16;;LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24/25, 1990, pages 695 - 719;;EBRINGEROVA ET AL., ADV. POLYM. SCI., vol. 186, 2005, pages 1 - 67;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;RICE ET AL., TRENDS GENET., vol. 16, 2000, pages 276 - 277;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEMISTRY, vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;COOPER ET AL., EMBO J., vol. 12, 1993, pages 2575 - 2583;;DAWSON ET AL., SCIENCE, vol. 266, 1994, pages 776 - 779;;MARTIN, J. IND. MICROBIOL. BIOTECHNOL., vol. 3, 2003, pages 568 - 576;;SVETINA ET AL., J. BIOTECHNOL., vol. 76, 2000, pages 245 - 251;;RASMUSSEN-WILSON ET AL., APPL. ENVIRON. MICROBIOL., vol. 63, 1997, pages 3488 - 3493;;WARD ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 498 - 503;;CONTRERAS ET AL., BIOTECHNOLOGY, vol. 9, 1991, pages 378 - 381;;EATON ET AL., BIOCHEMISTRY, vol. 25, 1986, pages 505 - 512;;COLLINS-RACIE ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 982 - 987;;CARTER ET AL., PROTEINS: STRUCTURE, FUNCTION, AND GENETICS, vol. 6, 1989, pages 240 - 248;;STEVENS, DRUG DISCOVERY WORLD, vol. 4, 2003, pages 35 - 48;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;VILLA-KAMAROFF ET AL., PROC. NAFL. ACAD. SCI. USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 80, 1983, pages 21 - 25;;GILBERT ET AL., SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOL. CELLULAR BIOI, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS ET AL., GENE 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RES., vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOL. GEN. GENET., vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZEN, J. BACTERIOL., vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, J. MOL. BIOL., vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER; THORNE, J. BACTERIOL., vol. 169, 1987, pages 5271 - 5278;;HANAHAN, J. MOL. BIOL., vol. 166, 1983, pages 557 - 580;;DOWER ET AL., NUCLEIC ACIDS RES., vol. 16, 1988, pages 6127 - 6145;;GONG ET AL., FOLIA MICROBIOL. (PRAHA), vol. 49, 2004, pages 399 - 405;;MAZODIER, J. BACTERIOL., vol. 171, 1989, pages 3583 - 3585;;BURKE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 98, 2001, pages 6289 - 6294;;CHOI ET AL., J. MICROBIOL. METHODS, vol. 64, 2006, pages 391 - 397;;PINEDO; SMETS, APPL. ENVIRON. MICROBIOL., vol. 71, 2005, pages 51 - 57;;PERRY; KURAMITSU, INFECT. IMMUN., vol. 32, 1981, pages 1295 - 1297;;CATT; JOLLICK, MICROBIOS, vol. 68, 1991, pages 189 - 207;;BUCKLEY ET AL., APPL. ENVIRON. MICROBIOL., vol. 65, 1999, pages 3800 - 3804;;CLEWELL, MICROBIOL. REV., vol. 45, 1981, pages 409 - 436;;YELTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 1470 - 1474;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;ITO, J. BACTERIOL., vol. 153, 1983, pages 163;;HINNEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 75, 1978, pages 1920;;TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MOL. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS; CORUZZI, ANN. REV. GENET., vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT CELL PHYSIOL., vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., J. PLANT PHYSIOL., vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT CELL PHYSIOL., vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOL., vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOL. BIOL., vol. 26, 1994, pages 85 - 93;;KAGAYA, MOL. GEN. GENET., vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOL. BIOL., vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIOLTECHNOLOGY, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOL. BIOL., vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT J., vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CURR. OPIN. BIOTECHNOL., vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH ET AL., PLANT MOL. BIOL., vol. 21, 1993, pages 415 - 428;;SHEEHAN, J.; HIMMEL, M.: ""Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol"", BIOTECHNOL. PROG., vol. 15, 1999, pages 817 - 827;;LYND, L. R.; WEIMER, P. J.; VAN ZYL, W. H.; PRETORIUS, . S.: ""Microbial cellulose utilization: Fundamentals and biotechnology"", MICROBIOL. MOL. BIOL. REVIEWS, vol. 66, 2002, pages 506 - 577, XP002551605, DOI: doi:10.1128/MMBR.66.3.506-577.2002;;FERNANDA DE CASTILHOS CORAZZA; FLAVIO FARIA DE MORAES; GISELLA MARIA ZANIN; IVO NEITZEL: ""Optimal control in fed-batch reactor for the cellobiose hydrolysis"", ACTA SCIENTIARUM. TECHNOLOGY, vol. 25, 2003, pages 33 - 38;;GUSAKOV, A. V.; SINITSYN, A. P.: ""Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical model for a batch reactor process"", ENZ. MICROB. TECHNOL., vol. 7, 1985, pages 346 - 352, XP023679176, DOI: doi:10.1016/0141-0229(85)90114-0;;RYU, S. K.; LEE, J. M.: ""Bioconversion of waste cellulose by using an attrition bioreactor"", BIOTECHNOL. BIOENG., vol. 25, 1983, pages 53 - 65, XP002397253, DOI: doi:10.1002/bit.260250106;;GUSAKOV, A. V.; SINITSYN, A. P.; DAVYDKIN, . Y.; DAVYDKIN, V. Y.; PROTAS, O. V.: ""Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field"", APPL. BIOCHEM. BIOTECHNOL., vol. 56, 1996, pages 141 - 153, XP035176121, DOI: doi:10.1007/BF02786945;;CHANDRA ET AL.: ""Substrate pretreatment: The key to effective enzymatic hydrolysis of lignocellulosics?"", ADV. BIOCHEM. ENGIN./BIOTECHNOL., vol. 108, 2007, pages 67 - 93;;GALBE; ZACCHI: ""Pretreatment of lignocellulosic materials for efficient bioethanol production"", ADV. BIOCHEM. ENGIN. / BIOTECHNOL., vol. 108, 2007, pages 41 - 65, XP008113337, DOI: doi:10.1007/10_2007_070;;HENDRIKS; ZEEMAN: ""Pretreatments to enhance the digestibility of lignocellulosic biomass"", BIORESOURCE TECHNOL., vol. 100, 2009, pages 10 - 18, XP025407559, DOI: doi:10.1016/j.biortech.2008.05.027;;MOSIER ET AL.: ""Features of promising technologies for pretreatment of lignocellulosic biomass"", BIORESOURCE TECHNOL., vol. 96, 2005, pages 673 - 686, XP025313257, DOI: doi:10.1016/j.biortech.2004.06.025;;TAHERZADEH; KARIMI: ""Pretreatment of lignocellulosic wastes to improve ethanol and biogas production: A review"", INT. J. OF MOL. SCI., vol. 9, 2008, pages 1621 - 1651, XP002674403, DOI: doi:10.3390/IJMS9091621;;YANG; WYMAN: ""Pretreatment: the key to unlocking low-cost cellulosic ethanol"", BIOFUELS BIOPRODUCTS AND BIOREFINING-BIOFPR., vol. 2, 2008, pages 26 - 40, XP008150365, DOI: doi:10.1002/bbb.49;;DUFF; MURRAY, BIORESOURCE TECHNOLOGY, vol. 855, 1996, pages 1 - 33;;GALBE; ZACCHI, APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 618 - 628;;BALLESTEROS ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 129-132, 2006, pages 496 - 508;;VARGA ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 113-116, 2004, pages 509 - 523;;SASSNER ET AL., ENZYME MICROB. TECHNOL., vol. 39, 2006, pages 756 - 762;;SCHELL ET AL., BIORESOURCE TECHNOL., vol. 91, 2004, pages 179 - 188;;LEE ET AL., ADV. BIOCHEM. ENG. BIOTECHNOL., vol. 65, 1999, pages 93 - 115;;WYMAN ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 1959 - 1966;;MOSIER ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 673 - 686;;SCHMIDT; THOMSEN, BIORESOURCE TECHNOL., vol. 64, 1998, pages 139 - 151;;PALONEN ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 117, 2004, pages 1 - 17;;VARGA ET AL., BIOTECHNOL. BIOENG., vol. 88, 2004, pages 567 - 574;;MARTIN ET AL., J. CHEM. TECHNOL BIOTECHNOL., vol. 81, 2006, pages 1669 - 1677;;GOLLAPALLI ET AL., APPL BIOCHEM. BIOTECHNOL., vol. 98, 2002, pages 23 - 35;;CHUNDAWAT ET AL., BIOTECHNOL. BIOENG., vol. 96, 2007, pages 219 - 231;;ALIZADEH ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 121, 2005, pages 1133 - 1141;;TEYMOURI ET AL., BIORESOURCE TECHNOL, vol. 96, 2005, pages 2014 - 2018;;PAN ET AL., BIOTECHNOL. BIOENG., vol. 90, 2005, pages 473 - 481;;PAN ET AL., BIOTECHNOL. BIOENG., vol. 94, 2006, pages 851 - 861;;KURABI ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 121, 2005, pages 219 - 230;;SCHELL ET AL., APPL. BIOCHEM. AND BIOTECHNOL., vol. 105, no. 108, 2003, pages 69 - 85;;MOSIER ET AL., BIORESOURCE TECHNOLOGY, vol. 96, 2005, pages 673 - 686;;GHOSH; SINGH: ""Physicochemical and biological treatments for enzymatic/microbial conversion of cellulosic biomass"", ADV. APPL. MICROBIOL., vol. 39, 1993, pages 295 - 333, XP009102696, DOI: doi:10.1016/S0065-2164(08)70598-7;;OLSSON; HAHN-HAGERDAL: ""Fermentation of lignocellulosic hydrolysates for ethanol production"", ENZ. MICROB. TECH., vol. 18, 1996, pages 312 - 331, XP002312595, DOI: doi:10.1016/0141-0229(95)00157-3;;VALLANDER; ERIKSSON: ""Production of ethanol from lignocellulosic materials: State of the art"", ADV. BIOCHEM. ENG.LBIOTECHNOL., vol. 42, 1990, pages 63 - 95;;PENTTILA, GENE, vol. 45, 1986, pages 253 - 263;;SALOHEIMO ET AL., GENE, vol. 63, 1988, pages 11 - 22;;OKADA ET AL., APPL. ENVIRON. MICROBIOL., vol. 64, 1988, pages 555 - 563;;SALOHEIMO ET AL., EUR. J. BIOCHEM., vol. 249, 1997, pages 584 - 591;;SALOHEIMO ET AL., MOLECULAR MICROBIOLOGY, vol. 13, 1994, pages 219 - 228;;OOI ET AL., NUCLEIC ACIDS RESEARCH, vol. 18, 1990, pages 5884;;SAKAMOTO ET AL., CURRENT GENETICS, vol. 27, 1995, pages 435 - 439;;SAARILAHTI ET AL., GENE, vol. 90, 1990, pages 9 - 14;;DAN ET AL., J. BIOL. CHEM., vol. 275, 2000, pages 4973 - 4980;;KAWAGUCHI, GENE, vol. 173, 1996, pages 287 - 288;;LIN ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 69, 2006, pages 627 - 642;;CHEN; HO: ""Cloning and improving the expression of Pichia stipitis xylose reductase gene in Saccharomyces cerevisiae"", APPL. BIOCHEM. BIOTECHNOL., vol. 39-40, 1993, pages 135 - 147, XP009063851, DOI: doi:10.1007/BF02918984;;HO ET AL.: ""Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose"", APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 1852 - 1859;;KOTTER; CIRIACY: ""Xylose fermentation by Saccharomyces cerevisiae"", APPL. MICROBIOL. BIOTECHNOL., vol. 38, 1993, pages 776 - 783;;WALFRIDSSON: ""Xylose-metabolizing Saccharomyces cerevisiae strains overexpressing the TKL1 and TAL1 genes encoding the pentose phosphate pathway enzymes transketolase and transaldolase"", APPL. ENVIRON. MICROBIOL., vol. 61, 1995, pages 4184 - 4190, XP002053306;;KUYPER ET AL.: ""Minimal metabolic engineering of Saccharomyces cerevisiae for efficient anaerobic xylose fermentation: a proof of principle"", FEMS YEAST RESEARCH, vol. 4, 2004, pages 655 - 664;;BEALL ET AL.: ""Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli"", BIOTECH. BIOENG., vol. 38, 1991, pages 296 - 303, XP000215006, DOI: doi:10.1002/bit.260380311;;INGRAM ET AL.: ""Metabolic engineering of bacteria for ethanol production"", BIOTECHNOL. BIOENG., vol. 58, 1998, pages 204 - 214, XP000999111, DOI: doi:10.1002/(SICI)1097-0290(19980420)58:2/3<204::AID-BIT13>3.0.CO;2-C;;ZHANG ET AL.: ""Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis"", SCIENCE, vol. 267, 1995, pages 240 - 243, XP002912123, DOI: doi:10.1126/science.267.5195.240;;DEANDA ET AL.: ""Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering"", APPL. ENVIRON. MICROBIOL., vol. 62, 1996, pages 4465 - 4470;;SILVEIRA, M. M.; JONAS, R.: ""The biotechnological production of sorbitol"", APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 400 - 408;;NIGAM, P.; SINGH, D.: ""Processes for fermentative production of xylitol - a sugar substitute"", PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124;;EZEJI, T. C.; QURESHI, N.; BLASCHEK, H. P.: ""Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping"", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603;;CHEN, R.; LEE, Y. Y.: ""Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass"", APPL. BIOCHEM. BIOTECHNOL., vol. 63-65, 1997, pages 435 - 448, XP008087560, DOI: doi:10.1007/BF02920444;;RICHARD, A.; MARGARITIS, A.: ""Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515;;KATAOKA, N.; A. MIYA; K. KIRIYAMA: ""Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria"", WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 41 - 47;;GUNASEELAN V.N., BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114;;BEDFORD ET AL., PROCEEDINGS OF THE 1ST SYMPOSIUM ON ENZYMES IN ANIMAL NUTRITION, 1993, pages 73 - 77;;ERIKSSON, WOOD SCIENCE AND TECHNOLOGY, vol. 24, 1990, pages 79 - 101;;PAICE ET AL., BIOTECHNOL. AND BIOENG., vol. 32, 1988, pages 235 - 239;;POMMIER ET AL., TAPPI JOURNAL, 1989, pages 187 - 191;;VIËTOR ET AL., J. INST BREW., vol. 99, 1993, pages 243 - 248;;ROSE ET AL., NUCLEIC ACIDS RESEARCH, vol. 26, 1998, pages 1628 - 1635;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;NEEDLEMAN; WUNSCH, J. MOL. BIOL, vol. 48, 1970, pages 443 - 453;;CHRISTENSEN ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 1419 - 1422",PENDING
120,CA,A1,CA 2709367 A1,024-112-661-268-627,2009-07-09,2009,CA 2709367 A,2008-12-17,US 1499907 P;;US 2008/0087258 W,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/024-112-661-268-627,Patent Application,no,0,0,8,8,67,C07K14/37;;C12N9/2434;;C12P19/14;;C12N9/2434;;C12P19/14;;C07K14/37,C07K14/39;;C12N9/42,,0,0,,,,DISCONTINUED
121,EP,A2,EP 2235173 A2,043-009-823-155-179,2010-10-06,2010,EP 08868044 A,2008-12-18,US 2008/0087402 W;;US 1490007 P;;US 1498007 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/043-009-823-155-179,Patent Application,yes,1,0,18,19,0,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;C12N1/15;;C12N1/21;;C12N5/10;;C12N9/42;;C12N15/56;;C12P19/14,,1,0,,,See also references of WO 2009085935A2,DISCONTINUED
122,US,B2,US 8323944 B2,147-152-188-626-658,2012-12-04,2012,US 74598508 A,2008-12-18,US 74598508 A;;US 1490007 P;;US 1498007 P;;US 2008/0087402 W,2007-12-19,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY;;NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,NOVOZYMES A/S (2012-07-10),https://lens.org/147-152-188-626-658,Granted Patent,yes,10,10,18,19,75,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/14;;C12N15/00;;C12N15/09;;C12N15/10,435/195;;435/320.1;;536/23.1;;536/23.7;;800/278,4,3,037-038-468-750-525;;005-624-155-034-991;;057-571-652-345-301,10.4148/1941-4765.1107;;10.1111/j.1574-6968.2006.00433.x;;16978358;;pmc129927;;10.1128/aem.68.11.5765-5768.2002;;12406778,"Alan Radford, Glycosyl Hydrolase Genes and Enzymes of Neurospora crassa, Fungal Genetics Newsletter 53:12-14, 2006.;;Ding et al., Cloning of multiple ceilulase cDNAsf rom Voivarieiia voivacea and their differential expression during substrate colonization and Fruiting, FEMS MicroBio Letters 263 (2006) 207-213.;;Wymelenberg et al., Transcript Analysis of Genes Encoding a Family 61 Endoglucanase and a Putative Membrane-Anchored Family 9 Glycosyl Hydrolase from Phanerochaete chrysosporium, Applied and Environmental Microbiology. Nov. 2002. p. 5765-5768.;;GeneBank XP002269954, 2004.",INACTIVE
123,EP,B1,EP 1546318 B1,155-093-881-359-589,2009-12-16,2009,EP 03759441 A,2003-09-24,US 0329964 W;;US 41305702 P,2002-09-24,MICROBIAL TRYPSIN VARIANTS HAVING CHYMOTRYPSIN ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,,NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY;;ZARETSKY ELIZABETH,,https://lens.org/155-093-881-359-589,Granted Patent,yes,2,2,19,19,0,C12N9/58;;C12N9/58,C12N9/48;;C12N9/58,,3,0,,,"DATABASE Geneseq [Online] 25 September 2000 (2000-09-25), ""Pre-pro-trypsin gene."" XP002401741 retrieved from EBI accession no. GSN:AAA53331 Database accession no. AAA53331;;RYPNIEWSKI W R ET AL: ""The sequence and X-ray structure of the trypsin from Fusarium oxysporum"" PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 6, no. 4, 1993, pages 341-348, XP009056968 ISSN: 0269-2139;;AWAD W.M. ET AL.: 'The proteolytic enzymes of the K-1 strain of streptomyces griseus obtained from a commercial preparation (Pronase). I. Purification of four serine endopeptidases' J. BIOL. CHEM. vol. 247, no. 13, July 1972, pages 4144 - 4154, XP008051386",EXPIRED
124,WO,A2,WO 2009/085864 A2,000-097-348-075-104,2009-07-09,2009,US 2008/0087258 W,2008-12-17,US 1499907 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/000-097-348-075-104,Patent Application,yes,0,207,8,8,67,C07K14/37;;C12N9/2434;;C12P19/14;;C12N9/2434;;C12P19/14;;C07K14/37,C07K14/39;;C12N9/42,,0,0,,,,PENDING
125,US,B2,US 8455233 B2,075-042-103-611-012,2013-06-04,2013,US 74602208 A,2008-12-17,US 74602208 A;;US 1502507 P;;US 2008/0087273 W,2007-12-19,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY;;NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,NOVOZYMES A/S (2012-07-10),https://lens.org/075-042-103-611-012,Granted Patent,yes,11,2,7,7,67,C07K14/37;;C11D3/38645;;C12N9/2434;;C12N9/2434;;C07K14/37;;C11D3/38645,C12N9/42;;C12N15/00;;C12N15/56;;C12P7/02;;C12P7/14;;C12P21/04,435/200;;435/71.1;;435/195;;435/163;;800/298;;536/23.2;;424/93.2,6,4,055-003-061-629-507;;011-469-898-256-819;;008-249-728-514-317;;068-301-509-352-604,10.1073/pnas.0403255101;;pmc438954;;15197260;;10.1007/s00253-007-1274-4;;18071646;;10.1007/s12010-011-9231-1;;21484273;;10.1038/nature01554;;12712197,"Guo, H.H., J. Choe, and L.A. Loeb. Protein tolerance to random amino acid change. 2004. PNAS. 101(25):9205-9210.;;Koseki, T., Y. Mese, S. Fushinobu, K. Masaki, T. Fujii, K. Ito, Y. Shiono, T. Murayama, and H. Lefuji. Biochemical characterization of a glycoside hydrolase family 61 endoglucanase from Aspergillus kawachii. 2008. Appl Microbiol Biotechnol. 77:1279-1285.;;Zhao, Y., H. Luo, K. Meng, P. Shi, G. Wang, P. Yang, T. Yuan, and B. Yao. A xylanase gene directly cloned from te genomic DNA of alkaline wastewater sludge showing application potential in the paper industry. Appl Microbiol Biotechnol. 2011. 165:35-46.;;Uniprot. 2006. Accession No. Q2GW98. http://www.uniprot.org/uniprot/Q2GW98.;;Galagan et al., The genome sequence of the filamentous fungus Neurospora crassa, Nature, Apr. 24, 2003, v. 422, p. 859-868.;;Genebank, Accession No. AB055432, XP-002516019.",INACTIVE
126,WO,A1,WO 2021/108791 A1,120-847-613-712-153,2021-06-03,2021,US 2020/0062580 W,2020-11-30,US 201962942001 P,2019-11-29,NEONATAL FIBRIN SCAFFOLDS FOR PROMOTING WOUND HEALING,Disclosed are methods of promoting wound healing in a patient in need thereof comprising administering to the patient a composition comprising a neonatal fibrin scaffold. Further disclosed are in vitro methods for evaluating a target composition on human wound healing comprising a neonatal porcine plasma scaffold with the target composition and evaluating scaffold properties of the plasma sample.,UNIV NORTH CAROLINA STATE,BROWN ASHLEY C;;NELLENBACH KIMBERLY A,,https://lens.org/120-847-613-712-153,Patent Application,yes,4,0,2,2,0,A61L15/32;;A61L15/44;;A61L15/46;;A61L2300/404;;A61L2300/402;;A61L2300/41;;A61L15/40;;A61L26/0042;;A61L26/0057;;A61L26/0066;;C12N5/0656;;C12N2533/56;;C12N2513/00;;A61L27/225;;A61L27/227;;A61L27/54;;A61L2300/402;;A61L2300/404;;A61L2300/41;;A61L2400/12,A61L27/22;;A61L27/38;;A61L27/54;;C12N5/077,,0,0,,,,PENDING
127,CN,B,CN 101978049 B,179-945-762-829-881,2013-11-06,2013,CN 200880125640 A,2008-11-20,US 2008/0084209 W;;US 99148407 P,2007-11-30,Polypeptides having arabinofuranosidase activity and polynucleotides encoding same,,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,,https://lens.org/179-945-762-829-881,Granted Patent,no,0,0,14,14,0,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N9/24,,0,0,,,,INACTIVE
128,US,A1,US 2013/0117892 A1,013-886-184-028-363,2013-05-09,2013,US 201213692835 A,2012-12-03,US 201213692835 A;;US 74598510 A;;US 2008/0087402 W;;US 1490007 P;;US 1498007 P,2007-12-19,Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC;;NOVOZYMES INC,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/013-886-184-028-363,Patent Application,yes,2,2,18,19,75,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24,800/298;;435/105;;435/471;;435/209;;435/252.33;;435/254.3;;435/320.1;;435/277;;536/23.1;;536/23.2,0,0,,,,DISCONTINUED
129,US,A1,US 2010/0281582 A1,042-237-299-994-635,2010-11-04,2010,US 76535810 A,2010-04-22,US 76535810 A;;US 17423709 P,2009-04-30,Polypeptides having xylanase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having xylanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;MARANTA MICHELLE;;ABBATE ERIC,NOVOZYMES INC (2010-04-26),https://lens.org/042-237-299-994-635,Patent Application,yes,1,10,8,8,23,C12N9/248;;C12N9/248;;C08H1/00;;C08H1/00;;C08L89/00;;C08L89/00;;C12N15/8242;;C12N15/8242;;C12N15/8246;;C12N15/8246;;C12N15/8257;;C12N15/8257;;C12P7/10;;C12P7/10;;C12P19/02;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2203/00;;C12P2203/00;;C12Y302/01091;;C12Y302/01091;;D21C5/005;;D21C5/005;;Y02E50/10;;Y02E50/10,A01H5/00;;C07H21/00;;C07H21/02;;C12N5/10;;C12N9/24;;C12P1/00;;C12P19/02;;C12P21/00,800/295;;435/200;;536/23.2;;435/419;;536/24.5;;536/23.1;;435/69.1;;435/105;;435/41,0,0,,,,ACTIVE
130,WO,A1,WO 2011/059740 A1,041-602-982-940-443,2011-05-19,2011,US 2010/0054484 W,2010-10-28,US 25607409 P,2009-10-29,POLYPEPTIDES HAVING CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC;;NOVOZYMES AS;;BROWN KIMBERLY;;ABBATE ERIC;;SPODSBERG NIKOLAJ,BROWN KIMBERLY;;ABBATE ERIC;;SPODSBERG NIKOLAJ,,https://lens.org/041-602-982-940-443,Patent Application,yes,103,117,7,7,141,C12Y302/01091;;C12N9/2437;;Y02E50/10;;C12Y302/01091;;C12N9/2437;;Y02E50/10,C12N9/42;;C12N15/80,,189,158,058-474-639-508-622;;008-167-109-693-53X;;060-447-603-638-044;;047-694-592-512-688;;009-052-884-271-430;;168-467-332-279-864;;023-207-730-709-584;;012-920-574-719-303;;079-268-448-560-326;;018-222-591-852-35X;;058-313-563-307-746;;018-222-591-852-35X;;058-313-563-307-746;;000-743-569-588-265;;014-625-826-302-514;;127-544-305-672-969;;121-062-956-244-546;;053-902-977-327-206;;061-537-462-842-986;;020-011-032-411-111;;081-290-558-102-206;;009-052-884-271-430;;015-734-715-035-926;;034-499-320-202-349;;010-606-868-765-729;;022-715-862-716-318;;032-728-154-591-070;;022-439-235-146-469;;009-304-049-487-981;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;083-771-782-040-353;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;039-227-503-731-991;;073-153-156-138-109;;016-587-457-958-718;;164-567-086-301-271;;029-314-535-301-390;;044-889-964-761-310;;130-197-652-144-217;;024-461-215-806-523;;002-129-848-383-652;;054-167-555-136-715;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;070-786-212-570-774;;080-478-847-113-962;;025-382-717-097-246;;060-100-774-152-775;;024-608-718-151-219;;066-174-113-969-972;;004-879-676-826-589;;119-409-570-143-716;;112-713-110-898-538;;077-184-809-518-772;;065-527-462-128-017;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;003-307-199-216-170;;060-909-037-461-654;;130-374-497-909-295;;036-168-690-647-51X;;122-107-077-421-078;;056-172-488-299-694;;015-652-210-164-846;;024-087-420-133-316;;113-902-635-079-219;;067-164-920-836-831;;000-183-195-092-675;;169-141-851-602-500;;025-368-788-723-477;;060-178-055-146-889;;031-589-022-231-352;;017-647-343-533-20X;;079-894-236-784-078;;069-166-427-004-435;;005-197-632-250-053;;106-322-033-242-053;;000-183-195-092-675;;029-672-278-978-420;;004-855-955-930-454;;024-107-327-163-524;;099-014-502-085-120;;002-235-158-220-337;;086-912-852-710-005;;089-469-021-381-015;;077-856-998-073-395;;074-536-892-628-290;;006-229-312-677-875;;002-068-346-610-521;;000-183-195-092-675;;076-132-223-936-79X;;118-711-156-754-483;;044-160-688-806-618;;058-145-297-843-203;;031-347-305-828-923;;076-235-786-419-94X;;023-134-630-499-263;;022-892-629-813-258;;120-034-791-945-912;;015-748-750-785-463;;000-009-413-776-570;;053-935-128-053-707;;070-817-840-532-786;;014-622-505-292-796;;014-774-168-809-047;;001-824-374-248-456;;083-475-617-712-21X;;024-715-211-347-486;;000-531-410-112-308;;175-295-822-939-63X;;045-548-779-820-017;;029-940-225-165-635;;031-097-124-288-463;;018-434-146-384-724;;031-015-979-474-454;;021-946-971-259-170;;024-708-797-947-714;;015-065-490-448-969;;013-458-224-516-628;;008-437-576-847-072;;157-022-853-195-606;;032-728-154-591-070,10.1263/jbb.95.627;;16233469;;10.1016/s1389-1723(03)80174-3;;10.1271/bbb.62.1615;;9757570;;10.1016/s0167-7799(97)01032-9;;9649743;;10.1042/bst0260173;;10.1016/0003-2697(72)90301-6;;5031119;;10.1016/0014-5793(82)81092-2;;10.1016/0014-5793(85)81260-6;;10.1111/j.1432-1033.1988.tb13736.x;;3338453;;4039269;;10.1111/j.1432-1033.1985.tb08843.x;;16690241;;10.1016/j.biotechadv.2006.03.003;;10.1351/pac198759020257;;16690241;;10.1016/j.biotechadv.2006.03.003;;10.1351/pac198759020257;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-#;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-;;11930943;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;12831897;;10.1016/s1369-5274(03)00056-0;;10.1002/jsfa.2519;;10.1016/j.febslet.2006.07.033;;16876163;;9020869;;10.1042/bj3210375;;pmc1218079;;10.1016/0168-1656(92)90074-j;;10.1016/0003-2697(72)90301-6;;5031119;;9440512;;10.1128/jb.180.2.243-249.1998;;pmc106878;;10.1016/0960-8524(94)90214-3;;10.1007/bf02920289;;9051728;;10.1093/protein/10.1.1;;10.1016/0022-2836(70)90057-4;;5420325;;10.1016/s0168-9525(00)02024-2;;10827456;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1021/bi00109a004;;1932005;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;8508780;;pmc413497;;10.1002/j.1460-2075.1993.tb05913.x;;7973629;;10.1126/science.7973629;;10656339;;10.1016/s0168-1656(99)00191-1;;10.1128/aem.63.9.3488-3493.1997;;pmc168655;;9292999;;10.1038/nbt0595-498;;9634791;;1367012;;10.1038/nbt0491-378;;3082357;;14406087;;10.1021/bi00350a035;;10.1038/nbt0995-982;;9636275;;2516317;;10.1002/prot.340060306;;10.1016/1046-5928(91)90057-p;;1821793;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;6345791;;10.1016/s0022-2836(83)80284-8;;3041370;;10.1093/nar/16.13.6127;;pmc336852;;10.1007/bf02931600;;15530004;;pmc210093;;10.1128/jb.171.6.3583-3585.1989;;2656662;;pmc33461;;10.1073/pnas.101589398;;11353836;;10.1016/j.mimet.2005.06.001;;15987659;;pmc544212;;10.1128/aem.71.1.51-57.2005;;15640169;;pmc351592;;10.1128/iai.32.3.1295-1297.1981;;7251168;;1795653;;10473378;;pmc99703;;10.1128/aem.65.9.3800-3804.1999;;pmc281518;;6272080;;10.1128/mr.45.3.409-436.1981;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1021/bp990110d;;10514251;;pmc120791;;10.1128/mmbr.66.3.506-577.2002;;12209002;;10.1016/0141-0229(85)90114-0;;10.1002/bit.260250106;;18548538;;10.1007/bf02786945;;10.1007/10_2007_064;;17530205;;10.1007/10_2007_070;;17646946;;18599291;;10.1016/j.biortech.2008.05.027;;10.1016/j.biortech.2004.06.025;;15588770;;pmc2635757;;19325822;;10.3390/ijms9091621;;10.1002/bbb.49;;10.1016/0960-8524(95)00122-0;;12226717;;10.1007/s00253-002-1058-9;;16915665;;10.1385/abab:130:1:496;;15054274;;10.1385/abab:114:1-3:509;;10.1016/j.enzmictec.2005.12.010;;10.1016/s0960-8524(03)00167-6;;14592748;;16112483;;10.1016/j.biortech.2005.01.010;;10.1016/j.biortech.2004.06.025;;15588770;;10.1016/s0960-8524(97)00164-8;;10.1385/abab:117:1:01;;15126700;;10.1002/bit.20222;;15470714;;10.1002/jctb.1586;;10.1385/abab:98-100:1-9:23;;12018251;;10.1002/bit.21132;;16903002;;15930586;;10.1385/abab:124:1-3:1133;;16112489;;10.1016/j.biortech.2005.01.016;;15772945;;10.1002/bit.20453;;16523526;;10.1002/bit.20905;;10.1385/abab:121:1-3:0219;;15917601;;10.1007/978-1-59259-991-2_19;;10.1016/j.biortech.2004.06.025;;15588770;;10.1201/9780203752456-10;;10.1016/s0065-2164(08)70598-7;;10.1007/3-540-49194-5_9;;10533436;;10.1016/0141-0229(95)00157-3;;10.1016/0378-1119(86)90023-5;;2948877;;3384334;;10.1016/0378-1119(88)90541-0;;10.1111/j.1365-2958.1994.tb00417.x;;7984103;;10.1093/nar/18.19.5884;;pmc332333;;2216782;;10.1007/bf00311212;;7586029;;10.1016/0378-1119(90)90433-r;;2379837;;10671536;;10.1074/jbc.275.7.4973;;8964516;;10.1016/0378-1119(96)00179-5;;10.1074/jbc.271.9.4699;;8617735;;10.1007/s00253-005-0229-x;;16331454;;10.1007/bf02918984;;8391777;;9572962;;10.1128/aem.64.5.1852-1859.1998;;pmc106241;;10.1007/bf00167144;;pmc167730;;10.1128/aem.61.12.4184-4190.1995;;8534086;;15040955;;10.1016/j.femsyr.2004.01.003;;18600763;;10.1002/bit.260380311;;10.1002/(sici)1097-0290(19980420)58:2/3<204::aid-bit13>3.0.co;2-c;;10191391;;17791346;;10.1126/science.267.5195.240;;pmc168273;;10.1128/aem.62.12.4465-4470.1996;;8953718;;10.1007/s00253-002-1092-7;;12382043;;12172602;;10.1007/s00253-002-1046-0;;10.1016/0032-9592(95)80001-8;;18576101;;10.1007/bf02920444;;15286988;;10.1002/bit.20156;;10.2166/wst.1997.0573;;10.1016/s0961-9534(97)00020-2;;17202162;;pmc1899100;;10.1016/0022-2836(70)90057-4;;5420325,"KANAMASA SHIN ET AL: ""Overexpression of Aspergillus aculeatus cellobiohydrolase I in Aspergillus oryzae."", JOURNAL OF BIOSCIENCE AND BIOENGINEERING, vol. 95, no. 6, June 2003 (2003-06-01), pages 627 - 629, XP002621735, ISSN: 1389-1723;;TAKADA GORO ET AL: ""Expression of Aspergillus aculeatus No. F-50 cellobiohydrolase I (cbhI) and beta-glucosidase 1 (bgl1) genes by Saccharomyces cerevisiae"", BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, vol. 62, no. 8, August 1998 (1998-08-01), pages 1615 - 1618, XP002621736, ISSN: 0916-8451;;TEERI: ""Crystalline cellulose degradation: New insight into the function of cellobiohydrolases"", TRENDS IN BIOTECHNOLOGY, vol. 15, 1997, pages 160 - 167, XP004059844, DOI: doi:10.1016/S0167-7799(97)01032-9;;TEERI ET AL.: ""Trichoderma reesei cellobiohydrolases: why so efficient on crystalline cellulose?"", BIOCHEM. SOC. TRANS., vol. 26, 1998, pages 173 - 178;;LEVER ET AL., ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279;;VAN TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156;;VAN TILBEURGH; CLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288;;TOMME ET AL., EUR. J. BIOCHEM., vol. 170, 1988, pages 575 - 581;;VAN TILBEURGH ET AL., EUR. J. BIOCHEM., vol. 148, 1985, pages 329 - 334;;ZHANG ET AL.: ""Outlook for cellulase improvement: Screening and selection strategies"", BIOTECHNOLOGY ADVANCES, vol. 24, 2006, pages 452 - 481, XP028005978, DOI: doi:10.1016/j.biotechadv.2006.03.003;;GHOSE: ""Measurement of cellulase activities"", PURE APPL. CHEM., vol. 59, 1987, pages 257 - 68, XP000652082;;ZHANG ET AL., BIOTECHNOLOGY ADVANCES, vol. 24, 2006, pages 452 - 481;;GHOSE, PURE AND APPL. CHEM., vol. 59, 1987, pages 257 - 268;;VENTURI ET AL.: ""Extracellular beta-D-glucosidase from Chaetomium thermophilum var. coprophilum: production, purification and some biochemical properties"", J. BASIC MICROBIOL., vol. 42, 2002, pages 55 - 66;;HENRISSAT B.: ""A classification of glycosyl hydrolases based on amino-acid sequence similarities"", BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT B.; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BIOCHEM. J., vol. 316, 1996, pages 695 - 696, XP001176681;;SHALLOM, D.; SHOHAM, Y.: ""Microbial hemicellulases"", CURRENT OPINION IN MICROBIOLOGY, vol. 6, no. 3, 2003, pages 219 - 228, XP002666720, DOI: doi:10.1016/S1369-5274(03)00056-0;;GHOSE; BISARIA, PURE & APPL. CHEM., vol. 59, 1987, pages 1739 - 1752;;BIELY; PUCHARD: ""Recent progress in the assays of xylanolytic enzymes"", JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, vol. 86, no. 11, 2006, pages 1636 - 1647;;SPANIKOVA; BIELY: ""Glucuronoyl esterase - Novel carbohydrate esterase produced by Schizophyllum commune"", FEBS LETTERS, vol. 580, no. 19, 2006, pages 4597 - 4601, XP028061315, DOI: doi:10.1016/j.febslet.2006.07.033;;HERRMANN; VRSANSKA; JURICKOVA; HIRSCH; BIELY; KUBICEK: ""The beta-D-xylosidase of Trichoderma reesei is a multifunctional beta-D-xylan xylohydrolase"", BIOCHEMICAL JOURNAL, vol. 321, 1997, pages 375 - 381;;BAILEY; BIELY; POUTANEN: ""Interlaboratory testing of methods for assay of xylanase activity"", JOURNAL OF BIOTECHNOLOGY, vol. 23, no. 3, 1992, pages 257 - 270, XP023704921, DOI: doi:10.1016/0168-1656(92)90074-J;;LEVER: ""A new reaction for colorimetric determination of carbohydrates"", ANAL. BIOCHEM, vol. 47, 1972, pages 273 - 279, XP024820395, DOI: doi:10.1016/0003-2697(72)90301-6;;DE VRIES, J. BACTERIOL., vol. 180, 1998, pages 243 - 249;;WISELOGEL ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 105 - 118;;WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16;;LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24/25, 1990, pages 695 - 719;;MOSIER ET AL.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Recent Progress in Bioconversion of Lignocellulosics"", pages: 23 - 40;;EBRINGEROVA ET AL., ADV. POLYM. SCI., vol. 186, 2005, pages 1 - 67;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;RICE ET AL., TRENDS GENET., vol. 16, 2000, pages 276 - 277;;J. SAMBROOK; E.F. FRITSCH; T. MANIATIS: ""Molecular Cloning, A Laboratory Manual 2d edition,"", 1989, COLD SPRING HARBOR;;BOLTON; MCCARTHY, PROC. NATL. ACAD. SCI. USA, vol. 48, 1962, pages 1390;;H. NEURATH; R.L. HILL: ""The Proteins"", 1979, ACADEMIC PRESS;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEMISTRY, vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;COOPER ET AL., EMBO J., vol. 12, 1993, pages 2575 - 2583;;DAWSON ET AL., SCIENCE, vol. 266, 1994, pages 776 - 779;;MARTIN ET AL., J. IND. MICROBIOL. BIOTECHNOL., vol. 3, 2003, pages 568 - 576;;SVETINA ET AL., J. BIOTECHNOL., vol. 76, 2000, pages 245 - 251;;RASMUSSEN-WILSON ET AL., APPL. ENVIRON. MICROBIOL., vol. 63, 1997, pages 3488 - 3493;;WARD ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 498 - 503;;CONTRERAS ET AL., BIOTECHNOLOGY, vol. 9, 1991, pages 378 - 381;;EATON ET AL., BIOCHEMISTRY, vol. 25, 1986, pages 505 - 512;;COLLINS-RACIE ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 982 - 987;;CARTER ET AL., PROTEINS: STRUCTURE, FUNCTION, AND GENETICS, vol. 6, 1989, pages 240 - 248;;STEVENS, DRUG DISCOVERY WORLD, vol. 4, 2003, pages 35 - 48;;INNIS ET AL.: ""PCR: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;VILLA-KAMAROFF ET AL., PROC. NATL. ACAD. SCI. USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 80, 1983, pages 21 - 25;;GILBERT ET AL.: ""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOL. CELLULAR BIOL., vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RES., vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOL. GEN. GENET., vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZEN, J. BACTERIOL., vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, J. MOL. BIOL., vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER; THORNE, J. BACTERIOL., vol. 169, 1987, pages 5271 - 5278;;HANAHAN, J. MOL. BIOL., vol. 166, 1983, pages 557 - 580;;DOWER ET AL., NUCLEIC ACIDS RES., vol. 16, 1988, pages 6127 - 6145;;GONG ET AL., FOLIA MICROBIOL., vol. 49, 2004, pages 399 - 405;;MAZODIER ET AL., J. BACTERIOL., vol. 171, 1989, pages 3583 - 3585;;BURKE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 98, 2001, pages 6289 - 6294;;CHOI ET AL., J. MICROBIOL. METHODS, vol. 64, 2006, pages 391 - 397;;PINEDO; SMETS, APPL. ENVIRON. MICROBIOL., vol. 71, 2005, pages 51 - 57;;PERRY; KURAMITSU, INFECT. IMMUN., vol. 32, 1981, pages 1295 - 1297;;CATT; JOLLICK, MICROBIOS, vol. 68, 1991, pages 189 - 207;;BUCKLEY ET AL., APPL. ENVIRON. MICROBIOL., vol. 65, 1999, pages 3800 - 3804;;CLEWELL, MICROBIOL. REV., vol. 45, 1981, pages 409 - 436;;HAWKSWORTH ET AL.: ""Ainsworth and Bisby's Dictionary of The Fungi, 8th edition,"", 1995, UNIVERSITY PRESS;;SKINNER, F.A., PASSMORE, S.M., AND DAVENPORT, R.R.,: ""Biology and Activities of Yeast"", 1980, SOC. APP. BACTERIOL. SYMPOSIUM SERIES NO. 9;;YELTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 1470 - 1474;;CHRISTENSEN ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 1419 - 1422;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;BECKER; GUARENTE: ""Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., article ""Guide to Yeast Genetics and Molecular Biology"", pages: 182 - 187;;ITO ET AL., J. BACTERIOL., vol. 153, 1983, pages 163;;HINNEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 75, 1978, pages 1920;;J.-C. JANSON AND LARS RYDEN: ""Protein Purification"", 1989, VCH PUBLISHERS;;TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MOL. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS; CORUZZI, ANN. REV. GENET., vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT CELL PHYSIOL., vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., J. PLANT PHYSIOL., vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT CELL PHYSIOL., vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOL., vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOL. BIOL., vol. 26, 1994, pages 85 - 93;;KAGAYA ET AL., MOL. GEN. GENET., vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOL. BIOL., vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIOLTECHNOLOGY, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOL. BIOL., vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT J., vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CURR OPIN. BIOTECHNOL., vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH ET AL., PLANT MOL. BIOL., vol. 21, 1993, pages 415 - 428;;WYMAN, C. E.,: ""Handbook on Bioethanol: Production and Utilization"", TAYLOR & FRANCIS, pages: 179 - 212;;SHEEHAN, J.; HIMMEL, M.: ""Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol"", BIOTECHNOL. PROG., vol. 15, 1999, pages 817 - 827;;LYND, L. R.; WEIMER, P. J.; VAN ZYL, W. H.; PRETORIUS, I. S.: ""Microbial cellulose utilization: Fundamentals and biotechnology"", MICROBIOL. MOL. BIOL. REVIEWS, vol. 66, 2002, pages 506 - 577, XP002551605, DOI: doi:10.1128/MMBR.66.3.506-577.2002;;FERNANDA DE CASTILHOS CORAZZA; FLAVIO FARIA DE MORAES; GISELLA MARIA ZANIN; IVO NEITZEL: ""Optimal control in fed-batch reactor for the cellobiose hydrolysis"", ACTA SCIENTIARUM. TECHNOLOGY, vol. 25, 2003, pages 33 - 38;;GUSAKOV, A. V.; SINITSYN, A. P.: ""Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical model for a batch reactor process"", ENZ. MICROB. TECHNOL., vol. 7, 1985, pages 346 - 352, XP023679176, DOI: doi:10.1016/0141-0229(85)90114-0;;RYU, S. K.; LEE, J. M.: ""Bioconversion of waste cellulose by using an attrition bioreactor"", BIOTECHNOL. BIOENG., vol. 25, 1983, pages 53 - 65, XP002397253, DOI: doi:10.1002/bit.260250106;;GUSAKOV, A. V.; SINITSYN, A. P.; DAVYDKIN, . Y.; DAVYDKIN, V. Y.; PROTAS, O. V.: ""Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field"", APPL. BIOCHEM. BIOTECHNOL., vol. 56, 1996, pages 141 - 153, XP035176121, DOI: doi:10.1007/BF02786945;;CHANDRA ET AL.: ""Substrate pretreatment: The key to effective enzymatic hydrolysis of lignocellulosics?"", ADV. BIOCHEM. ENGIN./BIOTECHNOL., vol. 108, 2007, pages 67 - 93;;GALBE; ZACCHI: ""Pretreatment of lignocellulosic materials for efficient bioethanol production"", ADV. BIOCHEM. ENGIN. / BIOTECHNOL., vol. 108, 2007, pages 41 - 65, XP008113337, DOI: doi:10.1007/10_2007_070;;HENDRIKS; ZEEMAN: ""Pretreatments to enhance the digestibility of lignocellulosic biomass"", BIORESOURCE TECHNOL., vol. 100, 2009, pages 10 - 18, XP025407559, DOI: doi:10.1016/j.biortech.2008.05.027;;MOSIER ET AL.: ""Features of promising technologies for pretreatment of lignocellulosic biomass"", BIORESOURCE TECHNOL., vol. 96, 2005, pages 673 - 686, XP025313257, DOI: doi:10.1016/j.biortech.2004.06.025;;TAHERZADEH; KARIMI: ""Pretreatment of lignocellulosic wastes to improve ethanol and biogas production: A review"", INT. J. OF MOL. SCI., vol. 9, 2008, pages 1621 - 1651, XP002674403, DOI: doi:10.3390/IJMS9091621;;YANG; WYMAN: ""Pretreatment: the key to unlocking low-cost cellulosic ethanol"", BIOFUELS BIOPRODUCTS AND BIOREFINING-BIOFPR., vol. 2, 2008, pages 26 - 40, XP008150365, DOI: doi:10.1002/bbb.49;;DUFF; MURRAY, BIORESOURCE TECHNOLOGY, vol. 855, 1996, pages 1 - 33;;GALBE; ZACCHI, APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 618 - 628;;BALLESTEROS ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 129-132, 2006, pages 496 - 508;;VARGA ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 113-116, 2004, pages 509 - 523;;SASSNER ET AL., ENZYME MICROB. TECHNOL., vol. 39, 2006, pages 756 - 762;;SCHELL ET AL., BIORESOURCE TECHNOL., vol. 91, 2004, pages 179 - 188;;LEE ET AL., ADV. BIOCHEM. ENG. BIOTECHNOL., vol. 65, 1999, pages 93 - 115;;WYMAN ET AL., BIORESOURCE TECHNOL, vol. 96, 2005, pages 1959 - 1966;;MOSIER ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 673 - 686;;SCHMIDT; THOMSEN, BIORESOURCE TECHNOL., vol. 64, 1998, pages 139 - 151;;PALONEN ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 117, 2004, pages 1 - 17;;VARGA ET AL., BIOTECHNOL. BIOENG., vol. 88, 2004, pages 567 - 574;;MARTIN ET AL., J. CHEM. TECHNOL. BIOTECHNOL., vol. 81, 2006, pages 1669 - 1677;;GOLLAPALLI ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 98, 2002, pages 23 - 35;;CHUNDAWAT ET AL., BIOTECHNOL. BIOENG., vol. 96, 2007, pages 219 - 231;;ALIZADEH ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 121, 2005, pages 1133 - 1141;;TEYMOURI ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 2014 - 2018;;PAN ET AL., BIOTECHNOL. BIOENG., vol. 90, 2005, pages 473 - 481;;PAN ET AL., BIOTECHNOL. BIOENG., vol. 94, 2006, pages 851 - 861;;KURABI ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 121, 2005, pages 219 - 230;;SCHELL ET AL., APPL. BIOCHEM. AND BIOTECHNOL, vol. 105, no. 108, 2003, pages 69 - 85;;MOSIER ET AL., BIORESOURCE TECHNOLOGY, vol. 96, 2005, pages 673 - 686;;HSU, T.-A.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Pretreatment of biomass"", pages: 179 - 212;;GHOSH; SINGH: ""Physicochemical and biological treatments for enzymatic/microbial conversion of cellulosic biomass"", ADV. APPL. MICROBIOL., vol. 39, 1993, pages 295 - 333, XP009102696, DOI: doi:10.1016/S0065-2164(08)70598-7;;MCMILLAN, J. D.: ""Enzymatic Conversion of Biomass for Fuels Production"", vol. 566, 1994, AMERICAN CHEMICAL SOCIETY, article ""Pretreating lignocellulosic biomass: a review"";;GONG, C. S.; CAO, N. J.; DU, J.; TSAO, G. T.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Ethanol production from renewable resources"", pages: 207 - 241;;OLSSON; HAHN-HAGERDAL: ""Fermentation of lignocellulosic hydrolysates for ethanol production"", ENZ. MICROB. TECH., vol. 18, 1996, pages 312 - 331, XP002312595, DOI: doi:10.1016/0141-0229(95)00157-3;;VALLANDER; ERIKSSON: ""Production of ethanol from lignocellulosic materials: State of the art"", ADV. BIOCHEM. ENG.LBIOTECHNOL., vol. 42, 1990, pages 63 - 95;;PENTTILA ET AL., GENE, vol. 45, 1986, pages 253 - 263;;SALOHEIMO ET AL., GENE, vol. 63, 1988, pages 11 - 22;;OKADA ET AL., APPL. ENVIRON. MICROBIOL., vol. 64, 1988, pages 555 - 563;;SALOHEIMO ET AL., MOLECULAR MICROBIOLOGY, vol. 13, 1994, pages 219 - 228;;OOI ET AL., NUCLEIC ACIDS RESEARCH, vol. 18, 1990, pages 5884;;SAKAMOTO ET AL., CURRENT GENETICS, vol. 27, 1995, pages 435 - 439;;SAARILAHTI ET AL., GENE, vol. 90, 1990, pages 9 - 14;;DAN ET AL., J. BIOL. CHEM., vol. 275, 2000, pages 4973 - 4980;;KAWAGUCHI ET AL., GENE, vol. 173, 1996, pages 287 - 288;;HILTON ET AL., J. BIOI. CHEM., vol. 271, 1996, pages 4699 - 4708;;BENNETT, J.W. AND LASURE, L.: ""More Gene Manipulations in Fungi"", 1991, ACADEMIC PRESS;;BAILEY, J.E.; OLLIS, D.F.: ""Biochemical Engineering Fundamentals"", 1986, MCGRAW-HILL BOOK COMPANY;;LIN ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 69, 2006, pages 627 - 642;;PHILIPPIDIS, G. P.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Cellulose bioconversion technology"", pages: 179 - 212;;CHEN; HO: ""Cloning and improving the expression of Pichia stipitis xylose reductase gene in Saccharomyces cerevisiae"", APPL. BIOCHEM. BIOTECHNOL., vol. 39-40, 1993, pages 135 - 147, XP009063851, DOI: doi:10.1007/BF02918984;;HO ET AL.: ""Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose"", APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 1852 - 1859;;KOTTER; CIRIACY: ""Xylose fermentation by Saccharomyces cerevisiae"", APPL. MICROBIOL. BIOTECHNOL., vol. 38, 1993, pages 776 - 783;;WALFRIDSSON ET AL.: ""Xylose-metabolizing Saccharomyces cerevisiae strains overexpressing the TKL1 and TALL genes encoding the pentose phosphate pathway enzymes transketolase and transaldolase"", APPL. ENVIRON. MICROBIOL., vol. 61, 1995, pages 4184 - 4190;;KUYPER ET AL.: ""Minimal metabolic engineering of Saccharomyces cerevisiae for efficient anaerobic xylose fermentation: a proof of principle"", FEMS YEAST RESEARCH, vol. 4, 2004, pages 655 - 664;;BEALL ET AL.: ""Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli"", BIOTECH. BIOENG., vol. 38, 1991, pages 296 - 303, XP000215006, DOI: doi:10.1002/bit.260380311;;INGRAM ET AL.: ""Metabolic engineering of bacteria for ethanol production"", BIOTECHNOL. BIOENG., vol. 58, 1998, pages 204 - 214, XP000999111, DOI: doi:10.1002/(SICI)1097-0290(19980420)58:2/3<204::AID-BIT13>3.0.CO;2-C;;ZHANG ET AL.: ""Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis"", SCIENCE, vol. 267, 1995, pages 240 - 243, XP002912123, DOI: doi:10.1126/science.267.5195.240;;DEANDA ET AL.: ""Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering"", APPL. ENVIRON. MICROBIOL., vol. 62, 1996, pages 4465 - 4470;;K. JACQUES, T.P. LYONS AND D.R. KELSALL,: ""The Alcohol Textbook"", 1999, NOTTINGHAM UNIVERSITY PRESS;;ALFENORE ET AL.: ""Improving ethanol production and viability of Saccharomyces cerevisiae by a vitamin feeding strategy during fed-batch process"", 2002, SPRINGER-VERLAG;;SILVEIRA, M. M.; JONAS, R.: ""The biotechnological production of sorbitol"", APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 400 - 408;;NIGAM, P.; SINGH, D.: ""Processes for fermentative production of xylitol - a sugar substitute"", PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124;;EZEJI, T. C.; QURESHI, N.; BLASCHEK, H. P.: ""Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping"", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603;;CHEN, R.; LEE, Y. Y.: ""Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass"", APPL. BIOCHEM. BIOTECHNOL., vol. 63-65, 1997, pages 435 - 448, XP008087560, DOI: doi:10.1007/BF02920444;;RICHARD, A.; MARGARITIS, A.: ""Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515;;KATAOKA, N.; A. MIYA; K. KIRIYAMA: ""Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria"", WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 41 - 47;;GUNASEELAN V.N., BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114;;MULDER ET AL., NUCLEIC ACIDS RES., vol. 35, 2007, pages D224 - D228;;NEEDLEMAN; WUNSCH, J. MOL. BIOI., vol. 48, 1970, pages 443 - 453;;LEVER, BIOCHEM. MED., vol. 7, 1973, pages 274 - 287",PENDING
131,CA,A1,CA 2709490 A1,078-651-252-714-552,2009-07-09,2009,CA 2709490 A,2008-12-18,US 1490007 P;;US 1498007 P;;US 2008/0087402 W,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/078-651-252-714-552,Patent Application,no,0,0,18,19,75,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;C12N1/15;;C12N1/21;;C12N5/10;;C12N9/42;;C12N15/56;;C12P19/14;;C12S3/02,,0,0,,,,DISCONTINUED
132,AU,A1,AU 2008/343105 A1,113-966-858-814-850,2009-07-09,2009,AU 2008/343105 A,2008-12-18,US 1490007 P;;US 1498007 P;;US 2008/0087402 W,2007-12-19,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,,NOVOZYMES AS,HARRIS PAUL;;BROWN KIMBERLY;;MAIYURAN SUCHINDRA,,https://lens.org/113-966-858-814-850,Patent Application,no,0,0,18,19,0,C12N9/2434;;C12P19/14;;C12Y302/01004;;C12Y302/01021;;C12Y302/01091;;C12N9/2437;;C12Y302/01004;;C12Y302/01091;;C12P19/14;;C12N9/2434;;C12Y302/01021;;C12N9/2437,C12N1/15;;C12N1/21;;C12N5/10;;C12N9/24;;C12N9/42;;C12N15/56;;C12P19/14;;C12S3/02,,0,0,,,,DISCONTINUED
133,WO,A1,WO 2021/040871 A1,060-714-453-089-943,2021-03-04,2021,US 2020/0039407 W,2020-06-24,US 201916550072 A,2019-08-23,QUANTIFIYING PRIVACY IMPACT,"This document relates to evaluating privacy impact for organization risk management. For example, quantifiable methods are provided by way of a privacy impact model to calculate a relative value for privacy impact can be used to calculate risk and prioritize risk mitigations and take corrective actions.",MICROSOFT TECHNOLOGY LICENSING LLC,LUCY KIMBERLY;;TRIM SAMUEL;;BROWN NICHOLAS,,https://lens.org/060-714-453-089-943,Patent Application,yes,2,0,5,5,0,G06Q40/08;;G06F3/04842;;G06F21/604;;G06F3/048,G06Q40/08,,0,0,,,,PENDING
134,BR,A2,BR 112012006847 A2,078-982-975-363-916,2015-09-08,2015,BR 112012006847 A,2010-10-28,US 2010/0054484 W;;US 25607409 P,2009-10-29,"polipeptídeo polinucleotídeo, célula hospedeira recombinante, métodos para produzir o polipeptídeo para produzir um mutante de uma célula parental, para inibir a expressão de um polipeptídeo, para produzir uma proteína, para degradar ou converter um material celulósico, para produzir um produto de fermentação, para produzir um produto de fermentação e pra fermentar um material celulósico, planta transgênica, parte da planta ou célula da planta, molécula de rna inibitória de filamento duplo, e, composição.","polipeptídeo, polinucleotídeo, célula hospedeira recombinate, métodos para produzir o polipeptídeo, para produzir um mutante de uma célula parental, para inibir a expressão de um polipeptídeo, para produzir uma proteína, para degradar ou converter um material celulósico, para produzir um produto de fermentação, para produzir um produto de fermentação e para fermentar um material celulósico, planta transgênica, parte da planta ou célula da planta, molécula de rna inibitória de filamento duplo, e, composição. a presente invenção diz respeito a polipeptídeos isolados com atividade de celobioidrolase e polinucleotídeos isolados que codificam os polipeptídeos. a invenção também diz respeito a construtos de ácido nucleico, vetores e células hospedeiras que compreendem os polinucleotídeos, bem como métodos para produzir e usar os polipeptídeos.",NOVOZYMES AS;;NOVOZYMES INC,ABBATE ERIC;;BROWN KIMBERLY;;SPODSBERG NIKOLAJ,,https://lens.org/078-982-975-363-916,Patent Application,no,0,0,7,7,0,C12Y302/01091;;C12N9/2437;;Y02E50/10;;C12Y302/01091;;C12N9/2437;;Y02E50/10,C12N9/42;;C12N15/80,,0,0,,,,DISCONTINUED
135,US,A1,US 2011/0131687 A1,086-717-604-046-594,2011-06-02,2011,US 27477408 A,2008-11-20,US 27477408 A;;US 99148407 P,2007-11-30,Polypeptides having arabinofuranosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,NOVOZYMES A/S (2008-11-20),https://lens.org/086-717-604-046-594,Patent Application,yes,0,1,14,14,13,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,A01H5/00;;C07H21/00;;C07H21/02;;C12N5/04;;C12N5/10;;C12N9/24;;C12N15/63;;C12N15/82;;C12P1/00;;C12P21/02,800/298;;435/200;;536/23.2;;435/320.1;;435/419;;435/468;;435/420;;536/24.5;;435/69.1;;435/41,0,0,,,,INACTIVE
136,BR,A2,BR PI0822031 A2,105-908-630-080-795,2017-06-13,2017,BR PI0822031 A,2008-12-17,US 2008/0087273 W;;US 1502507 P,2007-12-19,"polipeptídeo e polinicleotídeo isolados, construção de ácido nucleico, célula hospedeira recombinante, métodos para produzir o polipeptídeo, um mutante de uma célula precursora, uma proteína e um produto de fermentação, para inibir a expressão de um polipeptídeo, para degradar ou converter um material celulósico, e para fermentar um material celulósico, planta transgênica, parte de planta ou célula de planta, e, molécula de rna inibidora",,NOVOZYMES AS,KIMBERLY BROWN;;PAUL HARRIS;;SUCHINDRA MAIYURAN,,https://lens.org/105-908-630-080-795,Patent Application,no,0,0,7,7,0,C07K14/37;;C11D3/38645;;C12N9/2434;;C12N9/2434;;C07K14/37;;C11D3/38645,C07K14/37;;C11D3/386;;C12N9/42;;C12N15/74,,0,0,,,,DISCONTINUED
137,DE,D1,DE 60330579 D1,107-369-294-318-591,2010-01-28,2010,DE 60330579 T,2003-09-24,US 41305702 P;;US 0329964 W,2002-09-24,MIKROBIELLE TRYPSINVARIANTEN MIT CHYMOTRYPSINAKTIVITÄT UND DIESE CODIERENDE NUKLEINSÄUREN,,NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY;;ZARETSKY ELIZABETH,,https://lens.org/107-369-294-318-591,Granted Patent,no,0,0,19,19,0,C12N9/58;;C12N9/58,C12N9/48;;C12N9/58,,0,0,,,,EXPIRED
138,BR,A8,BR PI0820647 A8,161-879-121-088-917,2017-06-06,2017,BR PI0820647 A,2008-11-20,US 99148407 P;;US 2008/0084209 W,2007-11-30,"CONSTRUÇÃO DE ÁCIDO NUCLEICO, CÉLULA MICROBIANA HOSPEDEIRA RECOMBINANTE, MÉTODOS PARA PRODUZIR O POLIPEPTÍDEO TENDO ATIVIDADE DE ALFA-LARABINOFURANOSIDASE, E PARA DEGRADAR UM MATERIAL 5 CONTENDO XILANO","CONSTRUÇÃO DE ÁCIDO NUCLEICO, CÉLULA MICROBIANA HOSPEDEIRA RECOMBINANTE, MÉTODOS PARA PRODUZIR O POLIPEPTÍDEO TENDO ATIVIDADE DE ALFA-L-ARABINOFURANOSIDASE, PARA PRODUZIR UM MUTANTE DE UMA CÉLULA PRECURSORA, PARA INIBIR A EXPRESSÃO DE UM POLIPEPTÍDEO, E PARA DEGRADAR UM MATERIAL CONTENDO XILANO. A presente invenção diz respeito a polipeptídeos isolados tendo atividade de alfa-L-arabinofuranosidase e polinucleotídeos isolados codificando os polipeptídeos. A invenção também diz respeito a construções de ácido nucleico, vetores e células hospedeiras compreendendo os polinucleotídeos, bem como a métodos de produzir e usar os polipeptídeos.",NOVOZYMES AS,MICHELLE MARANTA;;KIMBERLY BROWN;;JAMES LANGSTON,,https://lens.org/161-879-121-088-917,Patent Application,no,0,0,14,14,0,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N15/56;;C12N1/21;;C12N9/24;;C12N15/113;;C12N15/70;;C12R1/19,,0,0,,,,DISCONTINUED
139,BR,A2,BR PI0820647 A2,179-575-086-309-745,2014-11-04,2014,BR PI0820647 A,2008-11-20,US 99148407 P;;US 2008/0084209 W,2007-11-30,"POLIPEPTÍDEO ISOLADO, POLINUCLEOTÍDEO ISOLADO, CONSTRUÇÃO DE ÁCIDO NUCLEICO, CÉLULA HOSPEDEIRA RECOMBINANTE, MÉTODOS PARA PRODUZIR O POLIPEPTÍDEO E UM MUTANTE DE UMA CÉLULA PERCURSORA, CÉLULA MUTANTE, PLANTA TRANSGÊNICA, PARTE DE PLANTA OU CÉLULA DE PLANTA, MOLÉCULA DE RNA INIBIDORA DE FILAMENTO DUPLO, E, MÉTODOS PARA INIBIR A EXPRESSÃO DE UM POLIPEPTÍDEO UM UMA CÉLULA E PARA PRODUZIR UMA PROTEÍNA E PARA DEGRADAR UM XILANO",,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,,https://lens.org/179-575-086-309-745,Patent Application,no,0,0,14,14,0,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N9/24,,0,0,,,,DISCONTINUED
140,AU,A,AU 2000/078262 A,002-407-760-865-099,2001-03-19,2001,AU 2000/078262 A,2000-08-25,US 38430599 A;;US 0023521 W,1999-08-26,Polypeptides having pectin acetylesterase activity and nucleic acids encoding same,,NOVOZYMES BIOTECH INC,THOMAS MICHAEL D;;BROWN KIMBERLY M,,https://lens.org/002-407-760-865-099,Patent Application,no,0,0,7,7,0,C07K2319/02;;C12N9/18;;C12N9/18;;C07K2319/02,C12N9/18,,0,0,,,,DISCONTINUED
141,CN,A,CN 102666847 A,044-458-916-882-391,2012-09-12,2012,CN 201080049011 A,2010-10-28,US 2010/0054484 W;;US 25607409 P,2009-10-29,Polypeptides having cellobiohydrolase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC;;NOVOZYMES AS,KIMBERLY BROWN;;ERIC ABBATE;;NIKOLAJ SPODSBERG,,https://lens.org/044-458-916-882-391,Patent Application,no,6,1,7,7,0,C12Y302/01091;;C12N9/2437;;Y02E50/10;;C12Y302/01091;;C12N9/2437;;Y02E50/10,C12N9/42;;C12N15/80,,3,0,,,"孙正茂 等: ""真菌木质素降解酶系的研究进展"", 《广东饲料》;;TAKADA GORO等: ""Expression of Aspergillus aculeatus No.F-50 cellobiohydrolase I(cbhI) and beta-glucosidase(bgl1) genes by Saccharomyces cerevisiae"", 《BIOSCI.BIOTECHNOL.BIOCHEM》;;阎伯旭等: ""外切葡聚糖纤维二糖水解酶的分离纯化和部分性质研究"", 《生物化学杂志》",INACTIVE
142,US,A1,US 2013/0052686 A1,079-156-172-344-094,2013-02-28,2013,US 201213661612 A,2012-10-26,US 201213661612 A;;US 201113269887 A;;US 27477408 A;;US 99148407 P,2007-11-30,Polypeptides having arabinofuranosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES;;NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,,https://lens.org/079-156-172-344-094,Patent Application,yes,0,0,14,14,13,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12P21/02;;C12N1/15;;C12N1/19;;C12N1/21;;C12N15/63,435/69.8;;435/320.1;;435/252.3;;435/252.31;;435/252.35;;435/252.33;;435/252.34;;435/254.11;;435/254.2;;435/254.22;;435/254.23;;435/254.21;;435/254.3;;435/254.7;;435/254.8;;435/254.4;;435/254.5;;435/254.6,0,0,,,,DISCONTINUED
143,EP,A1,EP 2653539 A1,064-465-571-788-973,2013-10-23,2013,EP 12195927 A,2008-12-18,US 1490007 P;;US 1498007 P;;EP 08868044 A,2007-12-19,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,HARRIS PAUL;;BROWN KIMBERLY;;MIYURAN SUCHINDRA,,https://lens.org/064-465-571-788-973,Patent Application,yes,100,0,18,19,75,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;C12N9/42;;C12P19/00;;C12P19/14,,166,137,057-571-652-345-301;;058-313-563-307-746;;009-052-884-271-430;;168-467-332-279-864;;023-207-730-709-584;;000-743-569-588-265;;014-625-826-302-514;;127-544-305-672-969;;034-499-320-202-349;;010-606-868-765-729;;022-715-862-716-318;;032-728-154-591-070;;022-439-235-146-469;;022-439-235-146-469;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;016-587-457-958-718;;164-567-086-301-271;;029-314-535-301-390;;044-889-964-761-310;;130-197-652-144-217;;024-461-215-806-523;;002-129-848-383-652;;054-167-555-136-715;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;070-786-212-570-774;;080-478-847-113-962;;025-382-717-097-246;;060-100-774-152-775;;024-608-718-151-219;;066-174-113-969-972;;004-879-676-826-589;;119-409-570-143-716;;112-713-110-898-538;;077-184-809-518-772;;065-527-462-128-017;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;017-950-663-195-977;;003-307-199-216-170;;060-909-037-461-654;;130-374-497-909-295;;036-168-690-647-51X;;122-107-077-421-078;;056-172-488-299-694;;015-652-210-164-846;;060-178-055-146-889;;031-589-022-231-352;;017-647-343-533-20X;;079-894-236-784-078;;069-166-427-004-435;;005-197-632-250-053;;106-322-033-242-053;;000-183-195-092-675;;029-672-278-978-420;;024-107-327-163-524;;099-014-502-085-120;;002-235-158-220-337;;086-912-852-710-005;;089-469-021-381-015;;077-856-998-073-395;;074-536-892-628-290;;006-229-312-677-875;;002-068-346-610-521;;000-183-195-092-675;;076-132-223-936-79X;;118-711-156-754-483;;044-160-688-806-618;;058-145-297-843-203;;014-622-505-292-796;;014-774-168-809-047;;001-824-374-248-456;;083-475-617-712-21X;;024-715-211-347-486;;000-531-410-112-308;;175-295-822-939-63X;;045-548-779-820-017;;029-940-225-165-635;;031-097-124-288-463;;018-434-146-384-724;;044-160-688-806-618;;031-015-979-474-454;;021-946-971-259-170;;024-708-797-947-714;;015-065-490-448-969;;013-458-224-516-628;;008-437-576-847-072;;031-347-305-828-923;;076-235-786-419-94X;;162-096-376-612-739;;023-134-630-499-263;;022-892-629-813-258;;120-034-791-945-912;;015-748-750-785-463;;000-009-413-776-570;;053-935-128-053-707;;127-544-305-672-969;;041-904-704-723-944;;136-261-375-157-758;;032-728-154-591-070,pmc129927;;10.1128/aem.68.11.5765-5768.2002;;12406778;;10.1351/pac198759020257;;10.1016/0003-2697(72)90301-6;;5031119;;10.1016/0014-5793(82)81092-2;;10.1016/0014-5793(85)81260-6;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-#;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-;;11930943;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;10.1016/0960-8524(94)90214-3;;10.1007/bf02920289;;9051728;;10.1093/protein/10.1.1;;10.1016/0022-2836(70)90057-4;;5420325;;10.1016/s0168-9525(00)02024-2;;10827456;;10.1016/s0168-9525(00)02024-2;;10827456;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;10656339;;10.1016/s0168-1656(99)00191-1;;10.1128/aem.63.9.3488-3493.1997;;pmc168655;;9292999;;10.1038/nbt0595-498;;9634791;;1367012;;10.1038/nbt0491-378;;3082357;;14406087;;10.1021/bi00350a035;;10.1038/nbt0995-982;;9636275;;2516317;;10.1002/prot.340060306;;10.1016/1046-5928(91)90057-p;;1821793;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;6345791;;10.1016/s0022-2836(83)80284-8;;3041370;;10.1093/nar/16.13.6127;;pmc336852;;10.1007/bf02931600;;15530004;;pmc210093;;10.1128/jb.171.6.3583-3585.1989;;2656662;;pmc33461;;10.1073/pnas.101589398;;11353836;;10.1016/j.mimet.2005.06.001;;15987659;;pmc544212;;10.1128/aem.71.1.51-57.2005;;15640169;;pmc351592;;10.1128/iai.32.3.1295-1297.1981;;7251168;;1795653;;10473378;;pmc99703;;10.1128/aem.65.9.3800-3804.1999;;pmc281518;;6272080;;10.1128/mr.45.3.409-436.1981;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1016/s0958-1669(05)80029-1;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1021/bp990110d;;10514251;;pmc120791;;10.1128/mmbr.66.3.506-577.2002;;12209002;;10.1016/0141-0229(85)90114-0;;10.1002/bit.260250106;;18548538;;10.1007/bf02786945;;10.1016/0960-8524(95)00122-0;;12226717;;10.1007/s00253-002-1058-9;;16915665;;10.1385/abab:130:1:496;;15054274;;10.1385/abab:114:1-3:509;;10.1016/j.enzmictec.2005.12.010;;10.1016/s0960-8524(03)00167-6;;14592748;;16112483;;10.1016/j.biortech.2005.01.010;;10.1016/j.biortech.2004.06.025;;15588770;;10.1016/s0960-8524(97)00164-8;;10.1002/bit.20222;;15470714;;10.1002/jctb.1586;;10.1385/abab:98-100:1-9:23;;12018251;;10.1002/bit.21132;;16903002;;15930586;;10.1385/abab:124:1-3:1133;;16112489;;10.1016/j.biortech.2005.01.016;;15772945;;10.1002/bit.20453;;16523526;;10.1002/bit.20905;;10.1385/abab:121:1-3:0219;;15917601;;10.1007/978-1-59259-991-2_19;;10.1016/j.biortech.2004.06.025;;15588770;;10.1201/9780203752456-10;;10.1016/s0065-2164(08)70598-7;;10.1007/3-540-49194-5_9;;10533436;;10.1016/0141-0229(95)00157-3;;10.1007/s00253-005-0229-x;;16331454;;10.1007/bf02918984;;8391777;;9572962;;10.1128/aem.64.5.1852-1859.1998;;pmc106241;;10.1007/bf00167144;;pmc167730;;10.1128/aem.61.12.4184-4190.1995;;8534086;;15040955;;10.1016/j.femsyr.2004.01.003;;18600763;;10.1002/bit.260380311;;10.1002/(sici)1097-0290(19980420)58:2/3<204::aid-bit13>3.0.co;2-c;;10191391;;17791346;;10.1126/science.267.5195.240;;pmc168273;;10.1128/aem.62.12.4465-4470.1996;;8953718;;10.1007/s00253-002-1092-7;;12382043;;10.1007/3-540-49194-5_9;;10533436;;12172602;;10.1007/s00253-002-1046-0;;10.1016/0032-9592(95)80001-8;;18576101;;10.1007/bf02920444;;15286988;;10.1002/bit.20156;;10.2166/wst.1997.0573;;10.1016/s0961-9534(97)00020-2;;10.1016/0378-1119(86)90023-5;;2948877;;3384334;;10.1016/0378-1119(88)90541-0;;10.1111/j.1432-1033.1997.00584.x;;9370370;;10.1111/j.1365-2958.1994.tb00417.x;;7984103;;10.1093/nar/18.19.5884;;pmc332333;;2216782;;10.1007/bf00311212;;7586029;;10.1016/0378-1119(90)90433-r;;2379837;;10671536;;10.1074/jbc.275.7.4973;;8964516;;10.1016/0378-1119(96)00179-5;;10.1042/bj3160695;;8687420;;pmc1217404;;10.1016/0378-1119(83)90230-5;;6198242;;10.1016/0166-0934(92)90168-d;;1322932;;10.1016/0022-2836(70)90057-4;;5420325,"WYMELENBERG A. VAN DEN ET AL: ""Transcript analysis of genes encoding a family 61 endoglucanase and a putative membrane-anchored family 9 glycosyl hydrolase from Phanerochaete chrysosporium."", APPLIED AND ENVIRONMENTAL MICROBIOLOGY NOV 2002, vol. 68, no. 11, November 2002 (2002-11-01), pages 5765 - 5768, XP002520366, ISSN: 0099-2240;;GHOSE, PURE AND APPL. CHEM., vol. 59, 1987, pages 257 - 268;;LEVER ET AL., ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279;;VAN TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156;;VAN TILBEURGH; CLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288;;VENTURI ET AL., J. BASIC MICROBIOL., vol. 42, 2002, pages 55 - 66;;HENRISSAT B.: ""A classification of glycosyl hydrolases based on amino-acid sequence similarities"", BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT B.; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BLOCHEM. J., vol. 316, 1996, pages 695 - 696, XP001176681;;WISELOGEL: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 105 - 118;;WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16;;LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24/25, 1990, pages 695 - 719;;MOSIER ET AL.: ""Advances in Biochemical EngineeringiBiotechnoiogy"", vol. 65, 1999, SPRINGER-VERLAG, article ""Recent Progress in Bioconversion of Lignocellulosics"", pages: 23 - 40;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;NEEDTEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;RICE ET AL.: ""EMBOSS: The European Molecular Biology Open Software Suite"", TRENDS IN GENETICS, vol. 16, 2000, pages 276 - 277, XP004200114, DOI: doi:10.1016/S0168-9525(00)02024-2;;RICE ET AL., EMBOSS: THE EUROPEAN MOLECULAR BIOLOGY OPEN SOFTWARE SUITE, 2000;;PEARSON, W.R.: ""Bioinformatics Methods and Protocols"", 1999, pages: 185 - 219;;H. NEURATH; R.L. HILL: ""The Proteins"", 1979, ACADEMIC PRESS;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOL CHEM., vol. 271, 1996, pages 4699 - 4708;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER, FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NAIL ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEM., vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;MARTIN ET AL., J. IND. MICROBIOL. BIOTECHNOL., vol. 3, 2003, pages 568 - 76;;SVETINA ET AL., J. BIOTECHNOL., vol. 76, 2000, pages 245 - 251;;RASMUSSEN- WILSON ET AL., APPL. ENVIRON. MICROBLOL., vol. 63, 1997, pages 3488 - 3493;;WARD ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 498 - 503;;CONTRERAS, BIOTECHNOLOGY, vol. 9, 1991, pages 378 - 381;;EATON, BIOCHEM., vol. 25, 1986, pages 505 - 512;;COLLINS-RACIE ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 982 - 987;;CARTER, PROTEINS: STRUCTURE, FUNCTION, AND GENETICS, vol. 6, 1989, pages 240 - 248;;STEVENS, DRUG DISCOVERY WORLD, vol. 4, 2003, pages 35 - 48;;INNIS ET AL.: ""PCR: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;VILLA-KAMAROFF ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 80, 1983, pages 21 - 25;;""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOLECULAR CELLULAR BIOLOGY, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS, GENE, vol. 98, 1991, pages 61 - 67;;CULLEN, NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOLECULAR GENERAL GENETICS, vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZEN, JOURNAL OF BACTERIOLOGY, vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, JOURNAL OF MOLECULAR BIOLOGY, vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER; THOME, JOURNAL OF BACTERIOLOGY, vol. 169, 1987, pages 5271 - 5278;;HANAHAN, J. MOL. BIOL., vol. 166, 1983, pages 557 - 580;;DOWER ET AL., NUCLEIC ACIDS RES., vol. 16, 1988, pages 6127 - 6145;;GONG, FOLIA MICROBIOL., vol. 49, 2004, pages 399 - 405;;MAZODIER ET AL., J. BACTERIOL., vol. 171, 1989, pages 3583 - 3585;;BURKE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 98, 2001, pages 6289 - 6294;;CHOI ET AL., J. MICROBIOL. METHODS, vol. 64, 2006, pages 391 - 397;;PINEDO; SMETS, APPL. ENVIRON. MICROBIOL., vol. 71, 2005, pages 51 - 57;;PERRY; KURAMITSU, INFECT. IMMUN., vol. 32, 1981, pages 1295 - 1297;;CATT; JOLLICK, MICROBIOS., vol. 68, 1991, pages 189 - 2070;;BUCKLEY ET AL., APPL. ENVIRON. MICROBIOL., vol. 65, 1999, pages 3800 - 3804;;CLEWELL, MICROBIOL. REV., vol. 45, 1981, pages 409 - 436;;HAWKSWORTH ET AL.: ""Ainsworth and Bisby's Dictionary of The Fungi"", 1995, UNIVERSITY PRESS;;SKINNER, F.A., PASSMORE, S.M., AND DAVENPORT,R.R.,: ""Biology and Activities of Yeast"", 1980, SOC. APP. BACTERIOL. SYMPOSIUM SERIES NO. 9;;YELTON ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1984, pages 1470 - 1474;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;BECKER AND GUARENTE, IN ABELSON, J.N. AND SIMON, M.I.,: ""Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., article ""Guide to Yeast Genetics and Molecular Biology"", pages: 182 - 187;;ITO ET AL., JOUMAL OF BACTERIOLOGY, vol. 153, 1983, pages 163;;HINNEN ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1920;;J.-C. JANSON AND LARS RYDEN,: ""Protein Purification"", 1989, VCH PUBLISHERS;;TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MOL. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS; CORUZZI, ANN. REV. GENET., vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., JOUMAL OF PLANT PHYSIOLOGY, vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOLOGY, vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOLECULAR BIOLOGY, vol. 26, 1994, pages 85 - 93;;KAGAYA ET AL., MOLECULAR AND GENERAL GENETICS, vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOLECULAR BIOLOGY, vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIO/TECHNOLOGY, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOLECULAR BIOLOGY, vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT JOURNAL, vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CUNENI OPINION BIOTECHNOLOGY, vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIO/TACHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH, PLANT MOLECULAR BIOLOGY, vol. 21, 1993, pages 415 - 428;;PHILIPPIDIS, G. P.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Cellulose bioconversion technology"", pages: 179 - 212;;SHEEHAN, J.; HIMMEL, M.: ""Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol"", BIOTECHNOL. PROG., vol. 15, 1999, pages 817 - 827;;LYND, L. R.; WEIMER, P. J.; VAN ZYL, W. H.; PRETORIUS, I. S.: ""Microbial cellulose utilization: Fundamentals and biotechnology"", MICROBIOL. MOL. BIOL. REVIEWS, vol. 66, 2002, pages 506 - 577, XP002551605, DOI: doi:10.1128/MMBR.66.3.506-577.2002;;FEMANDA DE CASTILHOS CORAZZA; FTAVIO FARIA DE MORAES; GISELLA MARIA ZANIN; IVO NEITZEL: ""Optimal control in fed-batch reactor for the cellobiose hydrolysis"", ACTA SCIENTIARUM. TECHNOLOGY, vol. 25, 2003, pages 33 - 38;;GUSAKOV, A. V.; SINITSYN, A. P.: ""Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical -model for a batch reactor process"", ENZ. MICROB. TECHNOL., vol. 7, 1985, pages 346 - 352, XP023679176, DOI: doi:10.1016/0141-0229(85)90114-0;;RYU, S. K.; LEE, J. M.: ""Bioconversion of waste cellulose by using an attrition bioreactor"", BIOTECHNOL. BIOENG., vol. 25, 1983, pages 53 - 65, XP002397253, DOI: doi:10.1002/bit.260250106;;GUSAKOV, A. V.; SINITSYN, A. P.; DAVYDKIN, I. Y.; DAVYDKIN, V. Y.; PROTAS, O. V.: ""Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field"", APPL. BIOCHEM. BIOTECHNOL., vol. 56, 1996, pages 141 - 153, XP035176121, DOI: doi:10.1007/BF02786945;;DUFF; MURRAY, BIORESOURCE TECHNOLOGY, vol. 855, 1996, pages 1 - 33;;GALBE; ZACCHI, APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 618 - 628;;BALLESTEROS ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 129-132, 2006, pages 496 - 508;;VARGA, APPL. BIOCHEM. BIOTECHNOL., vol. 113-116, 2004, pages 509 - 523;;SASSNER ET AL., ENZYME MICROB. TECHNOL., vol. 39, 2006, pages 756 - 762;;SCHELL ET AL., BIORESOURCE TECHNOL., vol. 91, 2004, pages 179 - 188;;LEE ET AL., ADV. BIOCHEM. ENG. BIOTECHNOL., vol. 65, 1999, pages 93 - 115;;WYMAN ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 1959 - 1966;;MOSIER ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 673 - 686;;SCHMIDT; THOMSEN, BIORESOURCE TECHNOL., vol. 64, 1998, pages 139 - 151;;PALONEN ET AL., APPF. BIOCHEM. BIOTECHNOL., vol. 117, 2004, pages 1 - 17;;VARGA ET AL., BIOTECHNOL. BIOENG., vol. 88, 2004, pages 567 - 574;;MARTIN ET AL., J. CHEM. TECHNOL. BIOTECHNOL., vol. 81, 2006, pages 1669 - 1677;;GOLLAPALLI ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 98, 2002, pages 23 - 35;;CHUNDAWAT ET AL., BIOTECHNOL. BIOENG., vol. 96, 2007, pages 219 - 231;;ALIZADEH ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 121, 2005, pages 1133 - 1141;;TEYMOURI ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 2014 - 2018;;PAN ET AL., BIOTECHNO/. BIOENG., vol. 90, 2005, pages 473 - 481;;PAN ET AL., BIOTECHNOL. BIOENG., vol. 94, 2006, pages 851 - 861;;KURABI, APPL. BIOCHEM. BIOTECHNOL., vol. 121, 2005, pages 219 - 230;;SCHELL ET AL., APPL. BIOCHEM. AND BIOTECHNOL., vol. 105, no. 108, 2003, pages 69 - 85;;MOSIER ET AL., BIORESOURCE TECHNOLOGY, vol. 96, 2005, pages 673 - 686;;HSU, T.-A.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Pretreatment of biomass"", pages: 179 - 212;;GHOSH; SINGH: ""Physicochemical and biological treatments for enzymatic/microbial conversion of cellulosic biomass"", ADV. APPL. MICROBIOL., vol. 39, 1993, pages 295 - 333, XP009102696, DOI: doi:10.1016/S0065-2164(08)70598-7;;MCMILLAN, J. D.: ""Enzymatic Conversion of Biomass for Fuels Production"", 1994, AMERICAN CHEMICAL SOCIETY, article ""Pretreating lignocellulosic biomass: a review"";;GONG, C. S.; CAO, N. J.; DU, J.; TSAO, G. T.: ""Advances in Biochemical EngineeringlBiotechnology"", vol. 65, 1999, SPRINGER-VERTAG, article ""Ethanol production from renewable resources"", pages: 207 - 241;;OLSSON; HAHN- HAGERDAL: ""Fermentation of lignocellulosic hydrolysates for ethanol production"", ENZ. MICROB. TECH., vol. 18, 1996, pages 312 - 331, XP002312595, DOI: doi:10.1016/0141-0229(95)00157-3;;VALLANDER; ERIKSSON: ""Production of ethanol from lignocellulosic materials: State of the art"", ADV. BIOCHEM. ENG.LBIOTECHNOL., vol. 42, 1990, pages 63 - 95;;UN ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 69, 2006, pages 627 - 642;;CHEN; HO: ""Cloning and improving the expression of Pichia stipitis xylose reductase gene In Saccharomyces cerevlslae"", APPL. BLOCHEM. BIOTECHNOL., vol. 39-40, pages 135 - 147;;HO ET AL.: ""Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose"", APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 1852 - 1859;;KOTTER; CIRIACY: ""Xylose fermentation by Saccharomyces cerevisiae"", APPL. MICROBIOL. BIOTECHNOL., vol. 38, 1993, pages 776 - 783;;WALFRIDSSON ET AL.: ""Xylose- metabolizing Saccharomyces cerevisiae strains overexpressing the TKL1 and TALI genes encoding the pentose phosphate pathway enzymes transketolase and transaldolase"", APPL. ENVIRON. MICROBIAL., vol. 61, 1995, pages 4184 - 4190;;KUYPER ET AL.: ""Minimal metabolic engineering of Saccharomyces cerevisiae for efficient anaerobic xylose fermentation: a proof of principle"", FEMS YEAST RESEARCH, vol. 4, 2004, pages 655 - 664;;BEALL ET AL.: ""Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli"", BIOTECH. BIOENG., vol. 38, 1991, pages 296 - 303, XP000215006, DOI: doi:10.1002/bit.260380311;;INGRAM ET AL.: ""Metabolic engineering of bacteria for ethanol production"", BIOTECHNOL. BIOENG., vol. 58, 1998, pages 204 - 214, XP000999111, DOI: doi:10.1002/(SICI)1097-0290(19980420)58:2/3<204::AID-BIT13>3.0.CO;2-C;;ZHANG ET AL.: ""Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis"", SCIENCE, vol. 267, 1995, pages 240 - 243, XP002912123, DOI: doi:10.1126/science.267.5195.240;;DEANDA ET AL.: ""Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering"", APPL. ENVIRON. MICROBIOL., vol. 62, 1996, pages 4465 - 4470;;K. JACQUES, T.P. LYONS AND D.R. KELSALL,: ""The Alcohol Textbook"", 1999, NOTTINGHAM UNIVERSITY PRESS;;ALFENORE ET AL.: ""Improving ethanol production and viability of Saccharomyces cerevisiae by a vitamin feeding strategy during fed-batch process"", 2002, SPRINGER-VERLAG;;GONG, C. S.; CAO, N. J.; DU, J.; TSAO, G. T.: ""Advances in Biochemical EngineeringlBiotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Ethanol production from renewable resources"", pages: 207 - 241;;SILVEIRA, M. M.; JONAS, R.: ""The biotechnological production of sorbitol"", APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 400 - 408;;NIGAM, P.; SINGH, D.: ""Processes for fermentative production of xylitol - a sugar substitute"", PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124;;EZEJI, T. C.; QURESHI, N.; BLASCHEK, H. P.: ""Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping"", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603;;CHEN, R.; LEE, Y. Y.: ""Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass"", APPL. BIOCHEM. BIOTECHNOL., vol. 63-65, 1997, pages 435 - 448, XP008087560, DOI: doi:10.1007/BF02920444;;RICHARD, A.; MARGARITIS, A.: ""Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515;;KATAOKA, N.; A. MIYA; K. KIRIYAMA: ""Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria"", WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 41 - 47;;GUNASEELAN V.N., BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114;;PENTTILA ET AL., GENE, vol. 45, 1986, pages 253 - 263;;SALOHEIMO ET AL., GENE, vol. 63, 1988, pages 11 - 22;;OKADA ET AL., APPL. ENVIRON. MICROBIOL., vol. 64, 1988, pages 555 - 563;;SALOHEIMO ET AL., EUR. J. BIOCHEM., vol. 249, 1997, pages 584 - 591;;SALOHEIMO ET AL., MOLECULAR MICROBIOLOGY, vol. 13, 1994, pages 219 - 228;;OOI ET AL., NUCLEIC ACIDS RESEARCH, vol. 18, 1990, pages 5884;;SAKAMOTO, CURRENT GENETICS, vol. 27, 1995, pages 435 - 439;;SAARILAHTI ET AL., GENE, vol. 90, 1990, pages 9 - 14;;DAN ET AL., J. BIOL. CHEM., vol. 275, 2000, pages 4973 - 4980;;KAWAGUCHI ET AL., GENE, vol. 173, 1996, pages 287 - 288;;HENRISSAT B.; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BIOCHEM. J., vol. 316, 1996, pages 695 - 696, XP001176681;;BENNETT, J.W. AND LASURE, L.: ""More Gene Manipulations in Fungi"", 1991, ACADEMIC PRESS;;BAILEY, J.E.; OLLIS, D.F.: ""Biochemical Engineering Fundamentals"", 1986, MCGRAW-HILL BOOK COMPANY;;GUBLER; HOFFMAN, GENE, vol. 25, 1983, pages 263 - 269;;SAMBROOK ET AL.: ""Molecular cloning: A laboratory manual"", 1989, COLD SPRING HARBOR LAB.;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;CHRISTENSEN ET AL., BIO/TECHNOLOGY, vol. 6, 1988, pages 1419 - 1422",DISCONTINUED
144,CA,A1,CA 2707017 A1,065-619-650-131-14X,2009-06-11,2009,CA 2707017 A,2008-11-20,US 99148407 P;;US 2008/0084209 W,2007-11-30,POLYPEPTIDES HAVING ARABINOFURANOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,,https://lens.org/065-619-650-131-14X,Patent Application,no,0,0,14,14,13,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N9/24,,0,0,,,,DISCONTINUED
145,EP,A2,EP 1212435 A2,173-874-319-213-923,2002-06-12,2002,EP 00968327 A,2000-08-25,US 0023521 W;;US 38430599 A,1999-08-26,POLYPEPTIDES HAVING PECTIN ACETYLESTERASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,,NOVOZYMES BIOTECH INC,THOMAS MICHAEL D;;BROWN KIMBERLY M,,https://lens.org/173-874-319-213-923,Patent Application,yes,0,0,7,7,0,C07K2319/02;;C12N9/18;;C12N9/18;;C07K2319/02,C12N9/18,,0,0,,,,DISCONTINUED
146,US,A1,US 2010/0304434 A1,004-052-504-600-035,2010-12-02,2010,US 74598508 A,2008-12-18,US 74598508 A;;US 1490007 P;;US 1498007 P;;US 2008/0087402 W,2007-12-19,Polypeptides having Cellulolytic Enhancing Activity and Polynucleotides Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/004-052-504-600-035,Patent Application,yes,2,7,18,19,75,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12P21/02;;A01H5/00;;C07H21/04;;C07K14/37;;C12N1/15;;C12N5/02;;C12N5/10;;C12N15/01;;C12N15/63;;C12P1/02;;C12P1/04;;C12P19/00,435/69.1;;530/350;;536/23.74;;435/320.1;;435/254.3;;435/440;;800/298;;435/419;;536/24.5;;536/23.4;;435/72;;435/420;;435/171;;435/170,0,0,,,,INACTIVE
147,US,B2,US 8298803 B2,019-244-977-277-136,2012-10-30,2012,US 201113269887 A,2011-10-10,US 201113269887 A;;US 27477408 A;;US 99148407 P,2007-11-30,Polypeptides having arabinofuranosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES;;NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,,https://lens.org/019-244-977-277-136,Granted Patent,yes,4,0,14,14,13,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N9/24;;C07H21/04;;C12N1/20;;C12N5/00;;C12N5/10;;C12N15/00,435/200;;435/252.3;;435/320.1;;435/410;;435/419;;536/23.2,7,6,053-382-918-122-482;;043-112-432-028-055;;056-311-920-276-692;;085-981-100-559-149;;066-581-981-821-976;;052-184-852-868-404,10.1007/s00253-006-0543-y;;16944135;;17269676;;10.1021/bp0601701;;10.1128/aem.62.1.168-173.1996;;pmc167784;;8572693;;10.1016/s0005-2795(70)80008-3;;5452669;;10.1016/0005-2744(71)90193-8;;5143344;;10.1016/s0008-6215(00)80570-4,"Sorensen et al., Humicola insolens: mode of action and synergy with GH51 [alpha]-1-arabinofuranosidases on wheat arabinoxylan, 2006, Applied Microbiology and Biotechnology, 73, 850-861.;;Sorensen et al., Enzymatic hydrolysis of wheat arabinoxylan by a recombinant ""minimal"" enzyme cocktail containing beta-xylosidase and novel endo-1, 4-beta-xylanase and alpha-(L)-arabinofuranosidase activities, Biotechnology Progress, 2007, 23, 100-107.;;Database Geneseq, XP002520700, Xylanase from an environmental sample seq id 54, Apr. 22, 2004.;;Filho 1996, Appl Environ Microbiol 62 (1), 168-173.;;Kaji 1970, Biochim Biophys Acta 207, 456-464.;;Kaji 1971, Biochim Biophys Acta 250, 367-371.;;Tagawa 1969, Carbohydr Res 11, 293-301.",ACTIVE
148,EP,A1,EP 2238243 A1,077-411-811-064-711,2010-10-13,2010,EP 08857507 A,2008-11-20,US 2008/0084209 W;;US 99148407 P,2007-11-30,POLYPEPTIDES HAVING ARABINOFURANOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,,https://lens.org/077-411-811-064-711,Patent Application,yes,0,0,14,14,0,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N9/24,,0,0,,,,ACTIVE
149,US,A1,US 2012/0028334 A1,069-514-667-866-753,2012-02-02,2012,US 201113269887 A,2011-10-10,US 201113269887 A;;US 27477408 A;;US 99148407 P,2007-11-30,Polypeptides having arabinofuranosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES;;NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,,https://lens.org/069-514-667-866-753,Patent Application,yes,0,0,14,14,13,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N9/24;;A01H5/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/56;;C12N15/63,435/200;;536/23.2;;435/320.1;;800/298;;435/252.31;;435/252.3;;435/252.35;;435/252.34;;435/252.33;;435/254.11;;435/325;;435/348;;435/419;;435/254.2;;435/254.21;;435/254.23;;435/254.22;;435/254.3;;435/254.6;;435/254.7,0,0,,,,ACTIVE
150,WO,A2,WO 2009/085859 A2,098-129-578-260-056,2009-07-09,2009,US 2008/0087231 W,2008-12-17,US 1492007 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/098-129-578-260-056,Patent Application,yes,0,235,7,7,67,C07K14/37;;C12N9/2434;;C07K14/37;;C12N9/2434,C07K14/39;;C12N9/42,,0,0,,,,PENDING
151,WO,A1,WO 2009/073383 A1,190-195-709-001-004,2009-06-11,2009,US 2008/0084209 W,2008-11-20,US 99148407 P,2007-11-30,POLYPEPTIDES HAVING ARABINOFURANOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,,https://lens.org/190-195-709-001-004,Patent Application,yes,2,173,14,14,13,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N9/24,,3,2,053-382-918-122-482;;043-112-432-028-055,10.1007/s00253-006-0543-y;;16944135;;17269676;;10.1021/bp0601701,"DATABASE Geneseq [online] 22 April 2004 (2004-04-22), ""Xylanase from an environmental sample seq id 54."", XP002520700, retrieved from EBI accession no. GSP:ADJ34838 Database accession no. ADJ34838;;HANNE R SÖRENSEN ET AL: ""A novel GH43 [alpha]-l-arabinofuranosidase from Humicola insolens: mode of action and synergy with GH51 [alpha]-l-arabinofuranosidases on wheat arabinoxylan"", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, SPRINGER, BERLIN, DE, vol. 73, no. 4, 30 August 2006 (2006-08-30), pages 850 - 861, XP019458762, ISSN: 1432-0614;;SORENSEN HANNE R ET AL: ""Enzymatic hydrolysis of wheat arabinoxylan by a recombinant ""minimal"" enzyme cocktail containing beta-xylosidase and novel endo-1,4-beta-xylanase and alpha-(L)-arabinofuranosidase activities"", BIOTECHNOLOGY PROGRESS, vol. 23, no. 1, January 2007 (2007-01-01), pages 100 - 107, XP002520699, ISSN: 8756-7938",PENDING
152,EP,A2,EP 2235049 A2,044-493-218-382-30X,2010-10-06,2010,EP 08868796 A,2008-12-17,US 2008/0087258 W;;US 1499907 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/044-493-218-382-30X,Patent Application,yes,0,0,8,8,0,C07K14/37;;C12N9/2434;;C12P19/14;;C12N9/2434;;C12P19/14;;C07K14/37,C07K14/39;;C12N9/42,,0,0,,,,DISCONTINUED
153,NZ,A,NZ 586014 A,077-351-620-097-228,2012-07-27,2012,NZ 58601408 A,2008-12-18,US 1490007 P;;US 1498007 P;;US 2008/0087402 W,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"Disclosed is an isolated polypeptide having cellulolytic enhancing activity, selected from the group consisting of: (a) a polypeptide comprising an amino acid sequence having at least 80% identity to the mature polypeptide of SEQ ID NO: 2; (b) a polypeptide encoded by a polynucleotide comprising a nucleotide sequence having at least 90% identity to the mature polypeptide coding sequence of SEQ ID NO: 1; and",NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/077-351-620-097-228,Patent Application,no,0,0,18,19,0,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12S3/02;;C12N1/15;;C12N1/21;;C12N5/10;;C12N9/24;;C12N9/42;;C12N15/56;;C12P19/14,,0,0,,,,DISCONTINUED
154,CA,A1,CA 2709371 A1,098-963-115-654-352,2009-07-09,2009,CA 2709371 A,2008-12-17,US 1492007 P;;US 2008/0087231 W,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/098-963-115-654-352,Patent Application,no,0,0,7,7,67,C07K14/37;;C12N9/2434;;C07K14/37;;C12N9/2434,C07K14/39;;C12N9/42,,0,0,,,,DISCONTINUED
155,US,A1,US 2010/0299788 A1,132-315-644-279-469,2010-11-25,2010,US 74602208 A,2008-12-17,US 74602208 A;;US 1502507 P;;US 2008/0087273 W,2007-12-19,Polypeptides having Cellulolytic Enhancing Activity and Polynucleotides Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/132-315-644-279-469,Patent Application,yes,6,6,7,7,67,C07K14/37;;C11D3/38645;;C12N9/2434;;C12N9/2434;;C07K14/37;;C11D3/38645,A01H5/00;;C07H21/04;;C12N1/00;;C12N5/10;;C12N9/42;;C12N15/63;;C12P19/00;;C12P21/00,800/295;;435/209;;536/23.2;;435/320.1;;435/243;;435/419;;536/24.5;;435/69.1;;435/72,4,3,055-003-061-629-507;;011-469-898-256-819;;008-249-728-514-317,10.1073/pnas.0403255101;;pmc438954;;15197260;;10.1007/s00253-007-1274-4;;18071646;;10.1007/s12010-011-9231-1;;21484273,"Guo, H.H., J. Choe, and L.A. Loeb. Protein tolerance to random amino acid change. 2004. PNAS. 101(25):9205-9210.;;Koseki, T., Y. Mese, S. Fushinobu, K. Masaki, T. Fujii, K. Ito, Y. Shiono, T. Murayama, and H. Lefuji. Biochemical characterization of a glycoside hydrolase family 61 endoglucanase from Aspergillus kawachii. 2008. Appl Microbiol Biotechnol. 77:1279-1285.;;Zhao, Y., H. Luo, K. Meng, P. Shi, G. Wang, P. Yang, T. Yuan, and B. Yao. A xylanase gene directly cloned from te genomic DNA of alkaline wastewater sludge showing application potential in the paper industry. Appl Microbiol Biotechnol. 2011. 165:35-46.;;Uniprot. 2006. Accession Number Q2GW98. http://www.uniprot.org/uniprot/Q2GW98",INACTIVE
156,US,B2,US 8575426 B2,159-472-175-292-335,2013-11-05,2013,US 74600308 A,2008-12-17,US 74600308 A;;US 1499907 P;;US 2008/0087258 W,2007-12-19,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY;;NOVOZYMES INC,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,NOVOZYMES A/S (2012-07-10),https://lens.org/159-472-175-292-335,Granted Patent,yes,8,2,8,8,67,C07K14/37;;C12N9/2434;;C12P19/14;;C12N9/2434;;C12P19/14;;C07K14/37,C12P21/02;;A01N63/00;;C12N9/42;;C12N15/56;;C12N15/82,800/284;;800/298;;435/200;;435/71.1;;424/93.2,4,4,055-003-061-629-507;;011-469-898-256-819;;008-249-728-514-317;;068-301-509-352-604,10.1073/pnas.0403255101;;pmc438954;;15197260;;10.1007/s00253-007-1274-4;;18071646;;10.1007/s12010-011-9231-1;;21484273;;10.1038/nature01554;;12712197,"Guo, H. H., J. Choe, L. A. Loeb. Protein tolerance to random amino acid change. 2004. P.N.A.S. 101(25):9205-9210.;;Koseki, T., Y. Mese, S. Fushinobu, K. Masaki, T. Fujii, K. Ito, Y. Shiono, T. Murayama, H. Iefuji. Biochemical characterization of a glycoside hydrolase family 61 endoglucanase from Aspergillus kawachii. 2008. Appl. Microbiol. Biotechnol. 77:1279-1285.;;Zhao, Y., H. Luo, K. Meng, P. Shi, G. Wang, P. Yang, T. Yuan, B. Yao. A xylanase gene directly cloned from the genomic DNA of alkaline wastewater sludge showing application potential in the paper industry. Appl. Microbiol. Biotechnol. 2011. 165:35-46.;;Galagan et al., The genome sequence of the filamentous fungus Neurospora crassa, Nature, Apr. 24, 2003, v. 422, p. 859-868.",INACTIVE
157,WO,A2,WO 2009/085935 A2,176-016-425-319-674,2009-07-09,2009,US 2008/0087402 W,2008-12-18,US 1490007 P;;US 1498007 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/176-016-425-319-674,Patent Application,yes,98,231,18,19,75,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;C12N1/15;;C12N1/21;;C12N5/10;;C12N9/42;;C12N15/56;;C12P19/14;;C12S3/02,,163,133,058-313-563-307-746;;009-052-884-271-430;;168-467-332-279-864;;023-207-730-709-584;;000-743-569-588-265;;014-625-826-302-514;;127-544-305-672-969;;034-499-320-202-349;;010-606-868-765-729;;022-715-862-716-318;;032-728-154-591-070;;022-439-235-146-469;;022-439-235-146-469;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;016-587-457-958-718;;164-567-086-301-271;;029-314-535-301-390;;044-889-964-761-310;;130-197-652-144-217;;024-461-215-806-523;;002-129-848-383-652;;054-167-555-136-715;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;070-786-212-570-774;;080-478-847-113-962;;025-382-717-097-246;;060-100-774-152-775;;024-608-718-151-219;;066-174-113-969-972;;004-879-676-826-589;;119-409-570-143-716;;112-713-110-898-538;;077-184-809-518-772;;065-527-462-128-017;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;017-950-663-195-977;;003-307-199-216-170;;060-909-037-461-654;;130-374-497-909-295;;036-168-690-647-51X;;122-107-077-421-078;;056-172-488-299-694;;015-652-210-164-846;;060-178-055-146-889;;031-589-022-231-352;;017-647-343-533-20X;;079-894-236-784-078;;069-166-427-004-435;;005-197-632-250-053;;106-322-033-242-053;;000-183-195-092-675;;029-672-278-978-420;;004-855-955-930-454;;024-107-327-163-524;;099-014-502-085-120;;002-235-158-220-337;;086-912-852-710-005;;089-469-021-381-015;;077-856-998-073-395;;074-536-892-628-290;;006-229-312-677-875;;002-068-346-610-521;;000-183-195-092-675;;076-132-223-936-79X;;118-711-156-754-483;;044-160-688-806-618;;058-145-297-843-203;;014-622-505-292-796;;014-774-168-809-047;;001-824-374-248-456;;083-475-617-712-21X;;024-715-211-347-486;;000-531-410-112-308;;175-295-822-939-63X;;045-548-779-820-017;;029-940-225-165-635;;031-097-124-288-463;;031-015-979-474-454;;021-946-971-259-170;;024-708-797-947-714;;015-065-490-448-969;;013-458-224-516-628;;008-437-576-847-072;;031-347-305-828-923;;076-235-786-419-94X;;162-096-376-612-739;;023-134-630-499-263;;022-892-629-813-258;;120-034-791-945-912;;015-748-750-785-463;;000-009-413-776-570;;053-935-128-053-707;;041-904-704-723-944;;136-261-375-157-758,10.1351/pac198759020257;;10.1016/0003-2697(72)90301-6;;5031119;;10.1016/0014-5793(82)81092-2;;10.1016/0014-5793(85)81260-6;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-#;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-;;11930943;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;10.1016/0960-8524(94)90214-3;;10.1007/bf02920289;;9051728;;10.1093/protein/10.1.1;;10.1016/0022-2836(70)90057-4;;5420325;;10.1016/s0168-9525(00)02024-2;;10827456;;10.1016/s0168-9525(00)02024-2;;10827456;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;10656339;;10.1016/s0168-1656(99)00191-1;;10.1128/aem.63.9.3488-3493.1997;;pmc168655;;9292999;;10.1038/nbt0595-498;;9634791;;1367012;;10.1038/nbt0491-378;;3082357;;14406087;;10.1021/bi00350a035;;10.1038/nbt0995-982;;9636275;;2516317;;10.1002/prot.340060306;;10.1016/1046-5928(91)90057-p;;1821793;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;6345791;;10.1016/s0022-2836(83)80284-8;;3041370;;10.1093/nar/16.13.6127;;pmc336852;;10.1007/bf02931600;;15530004;;pmc210093;;10.1128/jb.171.6.3583-3585.1989;;2656662;;pmc33461;;10.1073/pnas.101589398;;11353836;;10.1016/j.mimet.2005.06.001;;15987659;;pmc544212;;10.1128/aem.71.1.51-57.2005;;15640169;;pmc351592;;10.1128/iai.32.3.1295-1297.1981;;7251168;;1795653;;10473378;;pmc99703;;10.1128/aem.65.9.3800-3804.1999;;pmc281518;;6272080;;10.1128/mr.45.3.409-436.1981;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1016/s0958-1669(05)80029-1;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1021/bp990110d;;10514251;;pmc120791;;10.1128/mmbr.66.3.506-577.2002;;12209002;;10.1016/0141-0229(85)90114-0;;10.1002/bit.260250106;;18548538;;10.1007/bf02786945;;10.1016/0960-8524(95)00122-0;;12226717;;10.1007/s00253-002-1058-9;;16915665;;10.1385/abab:130:1:496;;15054274;;10.1385/abab:114:1-3:509;;10.1016/j.enzmictec.2005.12.010;;10.1016/s0960-8524(03)00167-6;;14592748;;16112483;;10.1016/j.biortech.2005.01.010;;10.1016/j.biortech.2004.06.025;;15588770;;10.1016/s0960-8524(97)00164-8;;10.1385/abab:117:1:01;;15126700;;10.1002/bit.20222;;15470714;;10.1002/jctb.1586;;10.1385/abab:98-100:1-9:23;;12018251;;10.1002/bit.21132;;16903002;;15930586;;10.1385/abab:124:1-3:1133;;16112489;;10.1016/j.biortech.2005.01.016;;15772945;;10.1002/bit.20453;;16523526;;10.1002/bit.20905;;10.1385/abab:121:1-3:0219;;15917601;;10.1007/978-1-59259-991-2_19;;10.1016/j.biortech.2004.06.025;;15588770;;10.1201/9780203752456-10;;10.1016/s0065-2164(08)70598-7;;10.1007/3-540-49194-5_9;;10533436;;10.1016/0141-0229(95)00157-3;;10.1007/s00253-005-0229-x;;16331454;;10.1007/bf02918984;;8391777;;9572962;;10.1128/aem.64.5.1852-1859.1998;;pmc106241;;10.1007/bf00167144;;pmc167730;;10.1128/aem.61.12.4184-4190.1995;;8534086;;15040955;;10.1016/j.femsyr.2004.01.003;;18600763;;10.1002/bit.260380311;;10.1002/(sici)1097-0290(19980420)58:2/3<204::aid-bit13>3.0.co;2-c;;10191391;;17791346;;10.1126/science.267.5195.240;;pmc168273;;10.1128/aem.62.12.4465-4470.1996;;8953718;;12172602;;10.1007/s00253-002-1046-0;;10.1016/0032-9592(95)80001-8;;18576101;;10.1007/bf02920444;;15286988;;10.1002/bit.20156;;10.2166/wst.1997.0573;;10.1016/s0961-9534(97)00020-2;;10.1016/0378-1119(86)90023-5;;2948877;;3384334;;10.1016/0378-1119(88)90541-0;;10.1111/j.1432-1033.1997.00584.x;;9370370;;10.1111/j.1365-2958.1994.tb00417.x;;7984103;;10.1093/nar/18.19.5884;;pmc332333;;2216782;;10.1007/bf00311212;;7586029;;10.1016/0378-1119(90)90433-r;;2379837;;10671536;;10.1074/jbc.275.7.4973;;8964516;;10.1016/0378-1119(96)00179-5;;10.1016/0378-1119(83)90230-5;;6198242;;10.1016/0166-0934(92)90168-d;;1322932,"GHOSE, PURE AND APPL. CHEM., vol. 59, 1987, pages 257 - 268;;LEVER ET AL., ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279;;VAN TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156;;VAN TILBEURGH; CLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288;;VENTURI ET AL., J. BASIC MICROBIOL., vol. 42, 2002, pages 55 - 66;;HENRISSAT B.: ""A classification of glycosyl hydrolases based on amino-acid sequence similarities"", BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT B.; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BIOCHEM. J., vol. 316, 1996, pages 695 - 696, XP001176681;;WISELOGEL ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 105 - 118;;WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16;;LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24-25, 1990, pages 695 - 719;;MOSIER ET AL.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Recent Progress in Bioconversion of Lignocellulosics"", pages: 23 - 40;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;RICE ET AL.: ""EMBOSS: The European Molecular Biology Open Software Suite"", TRENDS IN GENETICS, vol. 16, 2000, pages 276 - 277, XP004200114, DOI: doi:10.1016/S0168-9525(00)02024-2;;RICE ET AL., EMBOSS: THE EUROPEAN MOLECULAR BIOLOGY OPEN SOFTWARE SUITE, 2000;;PEARSON, W.R.: ""Bioinformatics Methods and Protocols"", 1999, pages: 185 - 219;;H. NEURATH; R.L. HILL: ""The Proteins"", 1979, ACADEMIC PRESS;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEM., vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;MARTIN ET AL., J. IND. MICROBIOL. BIOTECHNOL., vol. 3, 2003, pages 568 - 76;;SVETINA ET AL., J. BIOTECHNOL., vol. 76, 2000, pages 245 - 251;;RASMUSSEN-WILSON ET AL., APPL. ENVIRON. MICROBIOL., vol. 63, 1997, pages 3488 - 3493;;WARD ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 498 - 503;;CONTRERAS ET AL., BIOTECHNOLOGY, vol. 9, 1991, pages 378 - 381;;EATON ET AL., BIOCHEM., vol. 25, 1986, pages 505 - 512;;COLLINS-RACIE ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 982 - 987;;CARTER ET AL., PROTEINS: STRUCTURE, FUNCTION, AND GENETICS, vol. 6, 1989, pages 240 - 248;;STEVENS, DRUG DISCOVERY WORLD, vol. 4, 2003, pages 35 - 48;;INNIS ET AL.: ""PCR: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;VILLA-KAMAROFF ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 80, 1983, pages 21 - 25;;""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOLECULAR CELLULAR BIOLOGY, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOLECULAR GENERAL GENETICS, vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZEN, JOURNAL OF BACTERIOLOGY, vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, JOURNAL OF MOLECULAR BIOLOGY, vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER; THORNE, JOURNAL OF BACTERIOLOGY, vol. 169, 1987, pages 5271 - 5278;;HANAHAN, J. MOL. BIOL., vol. 166, 1983, pages 557 - 580;;DOWER ET AL., NUCLEIC ACIDS RES., vol. 16, 1988, pages 6127 - 6145;;GONG ET AL., FOLIA MICROBIOL. (PRAHA, vol. 49, 2004, pages 399 - 405;;MAZODIER ET AL., J. BACTERIOL., vol. 171, 1989, pages 3583 - 3585;;BURKE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 98, 2001, pages 6289 - 6294;;CHOI ET AL., J. MICROBIOL. METHODS, vol. 64, 2006, pages 391 - 397;;PINEDO; SMETS, APPL. ENVIRON. MICROBIOL., vol. 71, 2005, pages 51 - 57;;PERRY; KURAMITSU, INFECT. IMMUN., vol. 32, 1981, pages 1295 - 1297;;CATT; JOLLICK, MICROBIOS, vol. 68, 1991, pages 189 - 2070;;BUCKLEY ET AL., APPL. ENVIRON. MICROBIOL., vol. 65, 1999, pages 3800 - 3804;;CLEWELL, MICROBIOL. REV., vol. 45, 1981, pages 409 - 436;;HAWKSWORTH ET AL.: ""Ainsworth and Bisby's Dictionary of The Fungi, 8th edition,"", 1995, CAB INTERNATIONAL, UNIVERSITY PRESS;;SKINNER, F.A., PASSMORE, S.M., AND DAVENPORT, R.R.,: ""Biology and Activities of Yeast"", 1980, SOC. APP. BACTERIOL. SYMPOSIUM SERIES NO. 9;;YELTON ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1984, pages 1470 - 1474;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;BECKER; GUARENTE: ""Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., pages: 182 - 187;;ITO ET AL., JOURNAL OF BACTERIOLOGY, vol. 153, 1983, pages 163;;HINNEN ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1920;;J.-C. JANSON AND LARS RYDEN,: ""Protein Purification"", 1989, VCH PUBLISHERS;;TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MOL. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS; CORUZZI, ANN. REV. GENET., vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., JOURNAL OF PLANT PHYSIOLOGY, vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOLOGY, vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOLECULAR BIOLOGY, vol. 26, 1994, pages 85 - 93;;KAGAYA ET AL., MOLECULAR AND GENERAL GENETICS, vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOLECULAR BIOLOGY, vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIOLTECHNOLOGY, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOLECULAR BIOLOGY, vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT JOURNAL, vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CURRENT OPINION BIOTECHNOLOGY, vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH ET AL., PLANT MOLECULAR BIOLOGY, vol. 21, 1993, pages 415 - 428;;PHILIPPIDIS, G. P.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, WASHINGTON, article ""Cellulose bioconversion technology"", pages: 179 - 212;;SHEEHAN, J.; HIMMEL, M.: ""Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol"", BIOTECHNOL. PROG., vol. 15, 1999, pages 817 - 827;;LYND, L. R.; WEIMER, P. J.; VAN ZYL, W. H.; PRETORIUS, . S.: ""Microbial cellulose utilization: Fundamentals and biotechnology"", MICROBIOL. MOL. BIOL. REVIEWS, vol. 66, 2002, pages 506 - 577, XP002551605, DOI: doi:10.1128/MMBR.66.3.506-577.2002;;FERNANDA DE CASTILHOS CORAZZA; FLAVIO FARIA DE MORAES; GISELLA MARIA ZANIN; IVO NEITZEL: ""Optimal control in fed-batch reactor for the cellobiose hydrolysis"", ACTA SCIENTIARUM. TECHNOLOGY, vol. 25, 2003, pages 33 - 38;;GUSAKOV, A. V.; SINITSYN, A. P.: ""Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical model for a batch reactor process"", ENZ. MICROB. TECHNOL., vol. 7, 1985, pages 346 - 352, XP023679176, DOI: doi:10.1016/0141-0229(85)90114-0;;RYU, S. K.; LEE, J. M.: ""Bioconversion of waste cellulose by using an attrition bioreactor"", BIOTECHNOL. BIOENG., vol. 25, 1983, pages 53 - 65, XP002397253, DOI: doi:10.1002/bit.260250106;;GUSAKOV, A. V.; SINITSYN, A. P.; DAVYDKIN, . Y.; DAVYDKIN, V. Y.; PROTAS, O. V.: ""Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field"", APPL. BIOCHEM. BIOTECHNOL., vol. 56, 1996, pages 141 - 153, XP035176121, DOI: doi:10.1007/BF02786945;;DUFF; MURRAY, BIORESOURCE TECHNOLOGY, vol. 855, 1996, pages 1 - 33;;GALBE; ZACCHI, APPL. MICROBIOL. BIOTECHNOL, vol. 59, 2002, pages 618 - 628;;BALLESTEROS ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 129-132, 2006, pages 496 - 508;;VARGA ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 113-116, 2004, pages 509 - 523;;SASSNER ET AL., ENZYME MICROB. TECHNOL., vol. 39, 2006, pages 756 - 762;;SCHELL, BIORESOURCE TECHNOL., vol. 91, 2004, pages 179 - 188;;LEE, ADV. BIOCHEM. ENG. BIOTECHNOL., vol. 65, 1999, pages 93 - 115;;WYMAN ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 1959 - 1966;;MOSIER ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 673 - 686;;SCHMIDT; THOMSEN, BIORESOURCE TECHNOL., vol. 64, 1998, pages 139 - 151;;PALONEN ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 117, 2004, pages 1 - 17;;VARGA ET AL., BIOTECHNOL. BIOENG., vol. 88, 2004, pages 567 - 574;;MARTIN, J. CHEM. TECHNOL. BIOTECHNOL., vol. 81, 2006, pages 1669 - 1677;;GOLLAPALLI, APPL. BIOCHEM. BIOTECHNOL., vol. 98, 2002, pages 23 - 35;;CHUNDAWAT ET AL., BIOTECHNOL. BIOENG., vol. 96, 2007, pages 219 - 231;;ALIZADEH, APPL. BIOCHEM. BIOTECHNOL., vol. 121, 2005, pages 1133 - 1141;;TEYMOURI ET AL., BIORESOURCE TECHNOL., vol. 96, 2005, pages 2014 - 2018;;PAN ET AL., BIOTECHNOL. BIOENG., vol. 90, 2005, pages 473 - 481;;PAN ET AL., BIOTECHNOL. BIOENG., vol. 94, 2006, pages 851 - 861;;KURABI ET AL., APPL. BIOCHEM. BIOTECHNOL., vol. 121, 2005, pages 219 - 230;;SCHELL ET AL., APPL. BIOCHEM. AND BIOTECHNOL., vol. 105, no. 108, 2003, pages 69 - 85;;MOSIER ET AL., BIORESOURCE TECHNOLOGY, vol. 96, 2005, pages 673 - 686;;HSU, T.-A.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Pretreatment of biomass"", pages: 179 - 212;;GHOSH; SINGH: ""Physicochemical and biological treatments for enzymatic/microbial conversion of cellulosic biomass"", ADV. APPL. MICROBIOL., vol. 39, 1993, pages 295 - 333, XP009102696, DOI: doi:10.1016/S0065-2164(08)70598-7;;MCMILLAN, J. D.: ""Enzymatic Conversion of Biomass for Fuels Production"", 1994, ACS SYMPOSIUM SERIES 566, AMERICAN CHEMICAL SOCIETY, article ""Pretreating lignocellulosic biomass: a review"";;GONG, C. S.; CAO, N. J.; DU, J.; TSAO, G. T.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG BERLIN HEIDELBERG, article ""Ethanol production from renewable resources"", pages: 207 - 241;;OLSSON; HAHN-HAGERDAL: ""Fermentation of lignocellulosic hydrolysates for ethanol production"", ENZ. MICROB. TECH., vol. 18, 1996, pages 312 - 331, XP002312595, DOI: doi:10.1016/0141-0229(95)00157-3;;VALLANDER; ERIKSSON: ""Production of ethanol from lignocellulosic materials: State of the art"", ADV. BIOCHEM. ENG.LBIOTECHNOL., vol. 42, 1990, pages 63 - 95;;LIN ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 69, 2006, pages 627 - 642;;PHILIPPIDIS, G. P.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Cellulose bioconversion technology"", pages: 179 - 212;;CHEN; HO: ""Cloning and improving the expression of Pichia stipitis xylose reductase gene in Saccharomyces cerevisiae"", APPL. BIOCHEM. BIOTECHNOL., vol. 39-40, 1993, pages 135 - 147, XP009063851, DOI: doi:10.1007/BF02918984;;HO ET AL.: ""Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose"", APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 1852 - 1859;;KOTTER; CIRIACY: ""Xylose fermentation by Saccharomyces cerevisiae"", APPL. MICROBIOL. BIOTECHNOL., vol. 38, 1993, pages 776 - 783;;WALFRIDSSON ET AL.: ""Xylose- metabolizing Saccharomyces cerevisiae strains overexpressing the TKL1 and TALL genes encoding the pentose phosphate pathway enzymes transketolase and transaldolase"", APPL. ENVIRON. MICROBIOL., vol. 61, 1995, pages 4184 - 4190;;KUYPER ET AL.: ""Minimal metabolic engineering of Saccharomyces cerevisiae for efficient anaerobic xylose fermentation: a proof of principle"", FEMS YEAST RESEARCH, vol. 4, 2004, pages 655 - 664;;BEALL ET AL.: ""Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli"", BIOTECH. BIOENG., vol. 38, 1991, pages 296 - 303, XP000215006, DOI: doi:10.1002/bit.260380311;;INGRAM ET AL.: ""Metabolic engineering of bacteria for ethanol production"", BIOTECHNOL. BIOENG., vol. 58, 1998, pages 204 - 214, XP000999111, DOI: doi:10.1002/(SICI)1097-0290(19980420)58:2/3<204::AID-BIT13>3.0.CO;2-C;;ZHANG ET AL.: ""Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis"", SCIENCE, vol. 267, 1995, pages 240 - 243, XP002912123, DOI: doi:10.1126/science.267.5195.240;;DEANDA ET AL.: ""Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering"", APPL. ENVIRON. MICROBIOL., vol. 62, 1996, pages 4465 - 4470;;K. JACQUES, T.P. LYONS AND D.R. KELSALL,: ""The Alcohol Textbook"", 1999, NOTTINGHAM UNIVERSITY PRESS;;SILVEIRA, M. M.; JONAS, R.: ""The biotechnological production of sorbitol"", APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 400 - 408;;NIGAM, P.; SINGH, D.: ""Processes for fermentative production of xylitol - a sugar substitute"", PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124;;EZEJI, T. C.; QURESHI, N.; BLASCHEK, H. P.: ""Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping"", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603;;CHEN, R.; LEE, Y. Y.: ""Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass"", APPL. BIOCHEM. BIOTECHNOL., vol. 63-65, 1997, pages 435 - 448, XP008087560, DOI: doi:10.1007/BF02920444;;RICHARD, A.; MARGARITIS, A.: ""Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515;;KATAOKA, N.; A. MIYA; K. KIRIYAMA: ""Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria"", WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 41 - 47;;GUNASEELAN V.N., BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114;;PENTTILA ET AL., GENE, vol. 45, 1986, pages 253 - 263;;SALOHEIMO ET AL., GENE, vol. 63, 1988, pages 11 - 22;;OKADA ET AL., APPL. ENVIRON. MICROBIOL, vol. 64, 1988, pages 555 - 563;;SALOHEIMO ET AL., EUR. J. BIOCHEM., vol. 249, 1997, pages 584 - 591;;SALOHEIMO ET AL., MOLECULAR MICROBIOLOGY, vol. 13, 1994, pages 219 - 228;;OOI ET AL., NUCLEIC ACIDS RESEARCH, vol. 18, 1990, pages 5884;;SAKAMOTO ET AL., CURRENT GENETICS, vol. 27, 1995, pages 435 - 439;;SAARILAHTI ET AL., GENE, vol. 90, 1990, pages 9 - 14;;DAN ET AL., J. BIOL. CHEM., vol. 275, 2000, pages 4973 - 4980;;KAWAGUCHI ET AL., GENE, vol. 173, 1996, pages 287 - 288;;BENNETT, J.W. AND LASURE, L.: ""More Gene Manipulations in Fungi"", 1991, ACADEMIC PRESS;;BAILEY, J.E.; OLLIS, D.F.: ""Biochemical Engineering Fundamentals"", 1986, MCGRAW-HILL BOOK COMPANY;;GUBLER; HOFFMAN, GENE, vol. 25, 1983, pages 263 - 269;;SAMBROOK ET AL.: ""Molecular cloning: A laboratory manual"", 1989, COLD SPRING HARBOR LAB.;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;CHRISTENSEN ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 1419 - 1422;;See also references of EP 2235173A2",PENDING
158,EP,A2,EP 2245050 A2,015-379-054-646-143,2010-11-03,2010,EP 08867611 A,2008-12-17,US 2008/0087231 W;;US 1492007 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/015-379-054-646-143,Patent Application,yes,0,0,7,7,0,C07K14/37;;C12N9/2434;;C07K14/37;;C12N9/2434,C07K14/39;;C12N9/42,,0,0,,,,DISCONTINUED
159,NZ,A,NZ 598403 A,053-448-406-561-835,2012-07-27,2012,NZ 59840308 A,2008-12-18,US 1490007 P;;US 1498007 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"An isolated polypeptide having cellulolytic enhancing activity, selected from the group consisting of: (a) a polypeptide comprising an amino acid sequence having at least 85% identity to the mature polypeptide of SEQ ID NO: 4; (b) a polypeptide encoded by a polynucleotide that hybridizes under at least very high stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 3 (ii) the cDNA sequence contained in the mature polypeptide coding sequence of SEQ 10 NO: 3 or (iii) a full-length complementary strand of (i) or (ii); (c) a polypeptide encoded by a polynucleotide comprising a nucleotide sequence having at least 85% identity to the mature polypeptide coding sequence of SEQ ID NO: 3; and (d) a variant comprising a substitution, deletion, and/or insertion of one or more amino acids of the mature polypeptide of SEQ ID NO: 4.",NOVOZYMES AS,MAIYURAN SUCHINDRA;;BROWN KIMBERLY;;HARRIS PAUL,,https://lens.org/053-448-406-561-835,Patent Application,no,0,0,18,19,0,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12S3/02;;C12N1/15;;C12N1/21;;C12N5/10;;C12N9/24;;C12N9/42;;C12N15/56;;C12P19/14,,0,0,,,,DISCONTINUED
160,WO,A9,WO 2001/014534 A9,068-441-291-701-019,2001-07-12,2001,US 0023521 W,2000-08-25,US 38430599 A,1999-08-26,POLYPEPTIDES HAVING PECTIN ACETYLESTERASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having pectin acetylesterase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES BIOTECH INC,THOMAS MICHAEL D;;BROWN KIMBERLY M,,https://lens.org/068-441-291-701-019,Patent Application,no,0,0,7,7,0,C07K2319/02;;C12N9/18;;C12N9/18;;C07K2319/02,C12N9/18,,0,0,,,,PENDING
161,EP,A4,EP 1546318 A4,086-258-775-388-476,2007-02-14,2007,EP 03759441 A,2003-09-24,US 0329964 W;;US 41305702 P,2002-09-24,MICROBIAL TRYPSIN VARIANTS HAVING CHYMOTRYPSIN ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,,NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY;;ZARETSKY ELIZABETH,,https://lens.org/086-258-775-388-476,Search Report,no,2,0,19,19,0,C12N9/58;;C12N9/58,C12N9/58,,2,1,164-535-231-106-32X,8332590;;10.1093/protein/6.4.341,"DATABASE Geneseq [online] 25 September 2000 (2000-09-25), ""Pre-pro-trypsin gene."", XP002401741, retrieved from EBI accession no. GSN:AAA53331 Database accession no. AAA53331;;RYPNIEWSKI W R ET AL: ""The sequence and X-ray structure of the trypsin from Fusarium oxysporum"", PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 6, no. 4, 1993, pages 341 - 348, XP009056968, ISSN: 0269-2139",EXPIRED
162,UA,C2,UA 102832 C2,093-137-064-879-159,2013-08-27,2013,UA A201008853 A,2008-12-18,US 1490007 P;;US 2008/0087402 W,2007-12-19,POLYPEPTIDE WITH CELLULOSE-DECOMPOSING ENHANCED CAPACITY AND POLYNUCLEOTIDE CODING IT,"The invention relates to isolated polypeptides with cellulose-decomposing enhanced capacity and to isolated polynucleotides, coding these polypeptides, and also to nucleic acid constructs, vectors and host cell, containing polynucleotides, and to the methods for production of these polypeptides.",NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/093-137-064-879-159,Limited Patent,no,0,0,1,19,0,,C12N9/24;;C12N1/15;;C12N1/21;;C12N5/10;;C12N15/56;;C12P19/14,,0,0,,,,EXPIRED
163,CN,A,CN 101970471 A,134-939-661-935-980,2011-02-09,2011,CN 200880127121 A,2008-12-17,US 2008/0087231 W;;US 1492007 P,2007-12-19,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,PAUL HARRIS;;SUCHINDRA MAIYURAN;;KIMBERLY BROWN,,https://lens.org/134-939-661-935-980,Patent Application,no,3,0,7,7,0,C07K14/37;;C12N9/2434;;C07K14/37;;C12N9/2434,C07K14/39;;C12N9/42,,0,0,,,,DISCONTINUED
164,WO,A3,WO 2004/029202 A3,172-801-289-492-859,2005-03-10,2005,US 0329964 W,2003-09-24,US 41305702 P,2002-09-24,MICROBIAL TRYPSIN VARIANTS HAVING CHYMOTRYPSIN ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to microbial trypsin variants having chymotrypsin-like activity, comprising: (a) a one or more substitutions corresponding to positions 144, S193A, 198, 201, 218, 223, 227, 228, 229, 230, and 231 of amino acids 25 to 248 of SEQ ID NO: 2; (b) one or more deletions corresponding to positions 192, 197, and 226 of amino acids 25 to 248 of SEQ ID NO: 2; and (c) an insertion between positions corresponding to positions 224 and 225 of amino acids 25 to 248 of SEQ ID NO: 2. The present invention further relates to nucleotide sequences encoding microbial trypsin variants having chymotrypsin-like activity; nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; and methods of producing microbial trypsin variants having chymotrypsin-like activity or a precursor thereof.",NOVOZYMES BIOTECH INC,KLOTZ ALAN;;BROWN KIMBERLY;;ZARETSKY ELIZABETH,,https://lens.org/172-801-289-492-859,Search Report,yes,0,0,19,19,0,C12N9/58;;C12N9/58,C12N9/58,,1,1,032-201-018-354-205,4624704;;10.1016/s0021-9258(19)45052-7,"AWAD W.M. ET AL.: ""The proteolytic enzymes of the K-1 strain of streptomyces griseus obtained from a commercial preparation (Pronase). I. Purification of four serine endopeptidases"", J. BIOL. CHEM., vol. 247, no. 13, July 1972 (1972-07-01), pages 4144 - 4154, XP008051386",PENDING
165,EP,A2,EP 1546318 A2,047-297-922-164-50X,2005-06-29,2005,EP 03759441 A,2003-09-24,US 0329964 W;;US 41305702 P,2002-09-24,MICROBIAL TRYPSIN VARIANTS HAVING CHYMOTRYPSIN ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,,NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY;;ZARETSKY ELIZABETH,,https://lens.org/047-297-922-164-50X,Patent Application,yes,0,0,19,19,23,C12N9/58;;C12N9/58,C12N9/58,,0,0,,,,EXPIRED
166,CN,A,CN 101945889 A,052-714-732-111-576,2011-01-12,2011,CN 200880127124 A,2008-12-17,US 2008/0087273 W;;US 1502507 P,2007-12-19,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,PAUL HARRIS;;SUCHINDRA MAIYURAN;;KIMBERLY BROWN,,https://lens.org/052-714-732-111-576,Patent Application,no,3,0,7,7,0,C07K14/37;;C11D3/38645;;C12N9/2434;;C12N9/2434;;C07K14/37;;C11D3/38645,C07K14/37;;C11D3/386;;C12N9/42;;C12N15/74,,0,0,,,,DISCONTINUED
167,WO,A1,WO 2009/085868 A1,056-198-725-228-87X,2009-07-09,2009,US 2008/0087273 W,2008-12-17,US 1502507 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/056-198-725-228-87X,Patent Application,yes,2,213,7,7,67,C07K14/37;;C11D3/38645;;C12N9/2434;;C12N9/2434;;C07K14/37;;C11D3/38645,C07K14/37;;C11D3/386;;C12N9/42;;C12N15/74,,1,0,,,"DATABASE EMBL 2 August 2001 (2001-08-02), XP002516019, Database accession no. AB055432",PENDING
168,EP,A1,EP 2494042 A1,096-267-247-876-49X,2012-09-05,2012,EP 10773509 A,2010-10-28,US 25607409 P;;US 2010/0054484 W,2009-10-29,POLYPEPTIDES HAVING CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC;;NOVOZYMES AS,BROWN KIMBERLY;;ABBATE ERIC;;SPODSBERG NIKOLAJ,,https://lens.org/096-267-247-876-49X,Patent Application,yes,0,0,7,7,0,C12Y302/01091;;C12N9/2437;;Y02E50/10;;C12Y302/01091;;C12N9/2437;;Y02E50/10,C12N9/42;;C12N15/80,,0,0,,,,DISCONTINUED
169,CN,A,CN 101952304 A,123-898-384-553-783,2011-01-19,2011,CN 200880127100 A,2008-12-17,US 2008/0087258 W;;US 1499907 P,2007-12-19,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,PAUL HARRIS;;SUCHINDRA MAIYURAN;;KIMBERLY BROWN,,https://lens.org/123-898-384-553-783,Patent Application,no,3,1,8,8,0,C07K14/37;;C12N9/2434;;C12P19/14;;C12N9/2434;;C12P19/14;;C07K14/37,C07K14/39;;C12N9/42,,0,0,,,,DISCONTINUED
170,US,B1,US 6184028 B1,064-671-495-106-674,2001-02-06,2001,US 38430599 A,1999-08-26,US 38430599 A,1999-08-26,Polypeptides having pectin acetylesterase activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having pectin acetylesterase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK BIOTECH INC,THOMAS MICHAEL D;;BROWN KIMBERLY M,NOVOZYMES INC (2005-08-29);;NOVOZYMES BIOTECH INC (1999-08-25),https://lens.org/064-671-495-106-674,Granted Patent,yes,1,1,7,7,0,C07K2319/02;;C12N9/18;;C12N9/18;;C07K2319/02,C12N9/18,435/275;;435/196;;435/71.1,5,5,042-847-357-191-709;;043-314-177-133-258;;055-529-044-240-440;;070-902-768-187-637;;055-023-286-711-294,10.1099/13500872-142-11-3113;;8969509;;10.1038/36786;;9384377;;10.1046/j.1365-2958.1997.4331800.x;;9218776;;8690073;;10.1016/0014-5793(96)00510-8;;7592973;;10.1074/jbc.270.45.27172,"Yoshida et al. Sequencing of a 65 kb region of the Bacillus subtilis genome containing the lic and cel loci, and creation of a 177 kb contig covering the gnt-sacXY region. Microbiology (1996) 142, 3113-3123, Nov. 1996.;;Kunst et al. The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 390 (6657): 249-256, Nov. 1997.;;Shevchik et al., 1997, Molecular Microbiology 24: 1285-1301.;;Breton et al., 1996, FEBS Letters 388: 139-142.;;Kauppinen et al., 1995, Journal of Biological Chemistry 270: 27172-27178.",EXPIRED
171,BR,A2,BR PI0821048 A2,057-785-311-664-199,2015-06-16,2015,BR PI0821048 A,2008-12-17,US 1492007 P;;US 2008/0087231 W,2007-12-19,"Polipeptídeo e polinucleotídeo isolados, construção de ácido nucléico, célula hospedeira recombinante, métodos para produzir o polipeptídeo, um mutante de uma célula precursora, uma proteína e um produto de fermentação, para inibir a expressão de um polipeptídeo, para degradar ou converter um material celulósico, e para fermentar um material celulósico, planta trangênica, parte vegetal ou célula vegetal, e, melécula de rna inibidora",,NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/057-785-311-664-199,Patent Application,no,0,0,7,7,0,C07K14/37;;C12N9/2434;;C07K14/37;;C12N9/2434,C07K14/39;;C12N9/42,,0,0,,,,DISCONTINUED
172,US,B2,US 8034599 B2,079-931-741-673-547,2011-10-11,2011,US 27477408 A,2008-11-20,US 27477408 A;;US 99148407 P,2007-11-30,Polypeptides having arabinofuranosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,MARANTA MICHELLE;;BROWN KIMBERLY;;LANGSTON JAMES,NOVOZYMES A/S (2008-11-20),https://lens.org/079-931-741-673-547,Granted Patent,yes,4,0,14,14,13,C12N15/8245;;C12N15/8246;;C12N2310/14;;C12P19/14;;C12Y302/01055;;C12N9/2402;;C12P19/14;;C12N15/8246;;C12Y302/01055;;C12N15/8245;;C12N2310/14;;C12N9/2402,C12N9/24,435/200;;536/23.2,7,5,085-981-100-559-149;;066-581-981-821-976;;056-311-920-276-692;;053-382-918-122-482;;043-112-432-028-055,10.1016/s0005-2795(70)80008-3;;5452669;;10.1016/0005-2744(71)90193-8;;5143344;;10.1128/aem.62.1.168-173.1996;;pmc167784;;8572693;;10.1007/s00253-006-0543-y;;16944135;;17269676;;10.1021/bp0601701,"Kaji et al., Purification, crystallization and amino acid composition of a-L-Arabionofuranosidase from Aspergillus niger, 1970, Biochim. Biophys. Acta 207 456-464.;;Kaji et al., Properties of Purified a-L-Arabinofuranosidase from Corticium RolfsII, 1971, Biochim. Biophys. Acta 250 367-371.;;Tagawa et al., Preparation of L-Arabinosr-Containing Polysaccharides and the action of an a-L-Arabinofuranosidase on these Polysaccharides, 1969, Carbohydr. Res. 11: 293-301.;;Filho et al., Purification and Characterization of Two Arabinofuranosidases from Solid-State Cultures of the Fungus Penicillium capsulatum, 1996, Appl. Environ. Microbiol. 62: 168-173.;;Sorensen et al., Humicola insolens: mode of action and synergy with GH51 [alpha]-1-arabinofuranosidases on wheat arabinoxylan, 2006, Applied Microbiology and Biotechnology, 73, 850-861.;;Sorensen et al., Enzymatic hydrolysis of wheat arabinoxylan by a recombinant ""minimal"" enzyme cocktail containing beta-xylosidase and novel endo-1, 4-beta-xylanase and alpha-(L)-arabinofuranosidase activities, Biotechnology Progress, 2007, 23, 100-107.;;Database Geneseq, XP002520700, Xylanase from an environmental sample seq id 54, Apr. 22, 2004.",INACTIVE
173,WO,A3,WO 2009/085864 A3,095-045-210-726-949,2009-08-27,2009,US 2008/0087258 W,2008-12-17,US 1499907 P,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY;;NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/095-045-210-726-949,Search Report,yes,3,0,8,8,0,C07K14/37;;C12N9/2434;;C12P19/14;;C12N9/2434;;C12P19/14;;C07K14/37,C07K14/39;;C12N9/42,,0,0,,,,PENDING
174,CN,A,CN 102482680 A,109-914-477-239-988,2012-05-30,2012,CN 201080029709 A,2010-04-22,US 2010/0032034 W;;US 17423709 P,2009-04-30,Polypeptides having xylanase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having xylanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,KIMBERLY BROWN;;MICHELLE MARANTA;;ERIC ABBATE,,https://lens.org/109-914-477-239-988,Patent Application,no,1,3,8,8,0,C12N9/248;;C12N9/248;;C08H1/00;;C08H1/00;;C08L89/00;;C08L89/00;;C12N15/8242;;C12N15/8242;;C12N15/8246;;C12N15/8246;;C12N15/8257;;C12N15/8257;;C12P7/10;;C12P7/10;;C12P19/02;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2203/00;;C12P2203/00;;C12Y302/01091;;C12Y302/01091;;D21C5/005;;D21C5/005;;Y02E50/10;;Y02E50/10,C12N15/82;;C12N9/42;;D21C5/00,,1,1,007-825-245-642-652,10.1016/s0960-8524(96)00094-6,"DIETMAR HALTRICH ET AL.: ""Production of fungal xylanases"", 《BIORESOURCE TECHNOLOGY》, vol. 58, no. 2, 30 November 1996 (1996-11-30), pages 137 - 161, XP002584524",INACTIVE
175,BR,A2,BR PI0821230 A2,107-314-417-943-840,2019-09-24,2019,BR PI0821230 A,2008-12-18,US 2008/0087402 W;;US 1490007 P;;US 1498007 P,2007-12-19,"""constructo de ácido nucleico, cédula microbiana hospedeira recombinante, métodos para priduzir um polipeptídeo tendo atividade intensificadora celulolítica, para produzir um mutante de uma cédula precursora, para inibir a expressão de um polipeptídeo com atividade de intensificação celulolítica em uma célula, para produzir uma proteína, para degradar ou converter um material celulósico, e, para fermentar um material celulósico""",,NOVOZYMES AS,KIMBERLY BROWN;;PAUL HARRIS;;SUCHINDRA MAIYURAN,,https://lens.org/107-314-417-943-840,Patent Application,no,0,0,18,19,0,C12N9/2437;;C12N9/2437;;C12N9/2434;;C12N9/2434;;C12P19/14;;C12P19/14;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N1/15;;C12N1/21;;C12N5/10;;C12N9/24;;C12N9/42;;C12N15/56;;C12P19/14,,0,0,,,,DISCONTINUED
176,CA,A1,CA 2795934 A1,121-853-157-958-885,2010-11-04,2010,CA 2795934 A,2010-04-22,US 17423709 P;;US 2010/0032034 W,2009-04-30,POLYPEPTIDES HAVING XYLANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having xylanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;MARANTA MICHELLE;;ABBATE ERIC,,https://lens.org/121-853-157-958-885,Patent Application,no,0,0,8,8,0,C12N9/248;;C12N9/248;;C08H1/00;;C08H1/00;;C08L89/00;;C08L89/00;;C12N15/8242;;C12N15/8242;;C12N15/8246;;C12N15/8246;;C12N15/8257;;C12N15/8257;;C12P7/10;;C12P7/10;;C12P19/02;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2203/00;;C12P2203/00;;C12Y302/01091;;C12Y302/01091;;D21C5/005;;D21C5/005;;Y02E50/10;;Y02E50/10,C12N15/82;;C12N9/42;;D21C5/00,,0,0,,,,DISCONTINUED
177,US,B2,US 8129591 B2,171-758-568-653-46X,2012-03-06,2012,US 76535810 A,2010-04-22,US 76535810 A;;US 17423709 P,2009-04-30,Polypeptides having xylanase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having xylanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",BROWN KIMBERLY;;MARANTA MICHELLE;;ABBATE ERIC;;NOVOZYMES INC,BROWN KIMBERLY;;MARANTA MICHELLE;;ABBATE ERIC,NOVOZYMES INC (2010-04-26),https://lens.org/171-758-568-653-46X,Granted Patent,yes,2,6,8,8,23,C12N9/248;;C12N9/248;;C08H1/00;;C08H1/00;;C08L89/00;;C08L89/00;;C12N15/8242;;C12N15/8242;;C12N15/8246;;C12N15/8246;;C12N15/8257;;C12N15/8257;;C12P7/10;;C12P7/10;;C12P19/02;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2203/00;;C12P2203/00;;C12Y302/01091;;C12Y302/01091;;D21C5/005;;D21C5/005;;Y02E50/10;;Y02E50/10,C12N15/31;;A01H5/00;;C12N15/10;;C12N15/52;;C12N15/82,800/288;;800/284;;800/295;;800/278;;435/320.1;;435/468;;536/23.1;;536/23.2;;536/23.7,1,1,007-825-245-642-652,10.1016/s0960-8524(96)00094-6,"Haltrich et al., Production of Fungal Xylanases, Bioresource Technology 58 (1996) 137-161.",ACTIVE
178,CA,A1,CA 2709485 A1,190-854-663-971-940,2009-07-09,2009,CA 2709485 A,2008-12-17,US 1502507 P;;US 2008/0087273 W,2007-12-19,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,HARRIS PAUL;;MAIYURAN SUCHINDRA;;BROWN KIMBERLY,,https://lens.org/190-854-663-971-940,Patent Application,no,0,0,7,7,67,C07K14/37;;C11D3/38645;;C12N9/2434;;C12N9/2434;;C07K14/37;;C11D3/38645,C07K14/37;;C11D3/386;;C12N9/42;;C12N15/74,,0,0,,,,DISCONTINUED
179,CA,A1,CA 2619528 A1,037-703-623-083-150,2007-02-22,2007,CA 2619528 A,2006-08-16,US 70852505 P;;US 2006/0031955 W,2005-08-16,HOLDER DEVICE FOR DENTAL X-RAY DIGITAL SENSOR,"A sensor holder (10) includes a frame member (20) that bounds a void area (2 1) and which is configured to receive a sensor (11). A retaining means (50, 51) is provided to hold the sensor (11) to the frame (20) such that a connecting cable (12) affixed to the sensor (11) is secured and positioned by the void area (21) for a subsequent imaging procedure.",DENTSPLY INT INC,STECK JOHN E;;SULLIVAN NICOLE;;BROWN KIMBERLY,,https://lens.org/037-703-623-083-150,Patent Application,no,0,0,10,10,0,A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512;;A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512,G03B42/04;;A61B6/14,,0,0,,,,ACTIVE
180,WO,A1,WO 2007/022246 A1,129-206-996-992-849,2007-02-22,2007,US 2006/0031955 W,2006-08-16,US 70852505 P,2005-08-16,HOLDER DEVICE FOR DENTAL X-RAY DIGITAL SENSOR,"A sensor holder (10) includes a frame member (20) that bounds a void area (21) and which is configured to receive a sensor (11). A retaining means (50, 51) is provided to hold the sensor (11) to the frame (20) such that a connecting cable (12) affixed to the sensor (11) is secured and positioned by the void area (21) for a subsequent imaging procedure.",DENTSPLY INT INC;;STECK JOHN E;;BROWN KIMBERLY;;SULLIVAN NICOLE,STECK JOHN E;;BROWN KIMBERLY;;SULLIVAN NICOLE,,https://lens.org/129-206-996-992-849,Patent Application,yes,6,5,10,10,0,A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512;;A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512,A61B6/14;;G03B42/04,,0,0,,,,PENDING
181,EP,A1,EP 1917561 A1,181-932-354-193-158,2008-05-07,2008,EP 06813480 A,2006-08-16,US 2006/0031955 W;;US 70852505 P,2005-08-16,Holder device for a digital dental X-ray sensor,,DENTSPY INTERNATIONAL INC,STECK JOHN E;;BROWN KIMBERLY;;SULLIVAN NICOLE,,https://lens.org/181-932-354-193-158,Patent Application,yes,0,0,10,10,0,A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512;;A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512,G03B42/04;;A61B6/14;;G03C3/00,,0,0,,,,ACTIVE
182,CA,C,CA 2807541 C,038-378-735-214-610,2018-01-16,2018,CA 2807541 A,2011-08-04,US 85862310 A;;US 2011/0046527 W,2010-08-18,CURABLE ACRYLATE BASED PRINTING MEDIUM,"An acrylate-based curable printing medium is disclosed. Acrylates, in the form of monomers, dimers, trimers and oligomers, as well as resins, form an interpenetrating polymer network by crosslinking, which is effected by heat, and optionally peroxide curing agents. Formulations can be tailored to achieve desired properties of the cured polymer including film hardness, burnout properties, and adhesion to glass. Such properties are adjusted by manipulating the relative proportions of the acrylic monomers, oligomers and resins that are used as a ceramic medium or vehicle.",FERRO CORP,BROWN TERRY J;;DURAISAMY THIRUMALAI;;STEWART KIMBERLY,,https://lens.org/038-378-735-214-610,Granted Patent,no,0,0,15,15,0,C03C2217/72;;H01L31/022425;;C09D11/101;;C03C17/32;;C03C17/04;;C08F220/301;;C08F222/103;;C08F222/102;;C08F290/08;;C08F283/008;;C03C2217/72;;H01L31/022425;;C09D11/101;;C03C17/32;;Y02E10/50;;C08F220/301;;C08F222/102;;C08F222/103;;C03C17/04;;C09D133/10;;H01L31/18,C08L33/04;;B05D3/02;;C03C17/28;;C08J3/24;;C09D4/02,,0,0,,,,ACTIVE
183,US,B2,US 9150750 B2,103-863-323-422-389,2015-10-06,2015,US 201414333559 A,2014-07-17,US 201414333559 A;;US 85862310 A,2010-08-18,Curable acrylate based printing medium,"An acrylate-based curable printing medium is disclosed. Acrylates, in the form of monomers, dimers, trimers and oligomers, as well as resins, form an interpenetrating polymer network by crosslinking, which is effected by heat, and optionally peroxide curing agents. Formulations can be tailored to achieve desired properties of the cured polymer including film hardness, burnout properties, and adhesion to glass. Such properties are adjusted by manipulating the relative proportions of the acrylic monomers, oligomers and resins that are used as a ceramic medium or vehicle.",FERRO CORP,BROWN TERRY J;;STEWART KIMBERLY;;DURAISAMY THIRUMALAI,FERRO CORPORATION (2010-09-08),https://lens.org/103-863-323-422-389,Granted Patent,yes,27,2,15,15,0,C03C17/04;;C03C17/04;;C03C17/32;;C03C17/32;;C03C2217/72;;C03C2217/72;;C08F220/301;;C08F220/301;;C08F222/102;;C08F222/102;;C08F222/103;;C08F222/103;;C08F283/008;;C08F290/08;;C09D11/101;;C09D11/101;;C09D133/10;;H01L31/022425;;H01L31/022425;;H01L31/18;;Y02E10/50,C09D133/10;;C03C17/04;;C03C17/32;;C08F220/30;;C08F222/10;;C08F283/00;;C08F290/08;;C09D11/101;;H01L31/0224;;H01L31/18,,7,0,,,"http ://infohouse.p2ric. org/ref/17/16643 .pdf, Apr. 1996.;;http://www.chemicalbook.com/ChemicalProductProperty-EN-CB4852296.htm, May 2010.;;International Search Report for corresponding PCT/US2011/046527 mailed Dec. 16, 2011, two pages.;;http://infohouse.p2ric.org/ref/17/16643.pdf, Apr. 1996.;;http://www.chemicalbook.com/ChemicalProductProperty-EN-CB4852296.htm, May 20, 2010.;;English translation of JP 58-174477 published Oct. 13, 1983, 17 pages.;;http://en.wikipedia.org/wiki/Dimethylformamide.",ACTIVE
184,CA,C,CA 2619528 C,134-844-987-180-512,2013-11-26,2013,CA 2619528 A,2006-08-16,US 70852505 P;;US 2006/0031955 W,2005-08-16,HOLDER DEVICE FOR DENTAL X-RAY DIGITAL SENSOR,"A sensor holder (10) includes a frame member (20) that bounds a void area (21) and which is configured to receive a sensor (11). A retaining means (50, 51) is provided to hold the sensor (11) to the frame (20) such that a connecting cable (12) affixed to the sensor (11) is secured and positioned by the void area (21) for a subsequent imaging procedure.",DENTSPLY INT INC,STECK JOHN E;;BROWN KIMBERLY;;SULLIVAN NICOLE,,https://lens.org/134-844-987-180-512,Granted Patent,no,0,0,10,10,0,A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512;;A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512,G03B42/04;;A61B6/14,,0,0,,,,ACTIVE
185,EP,B1,EP 1917561 B1,138-111-380-434-384,2013-04-10,2013,EP 06813480 A,2006-08-16,US 2006/0031955 W;;US 70852505 P,2005-08-16,Holder device for a digital dental X-ray sensor,,DENTSPLY INT INC,STECK JOHN E;;BROWN KIMBERLY;;SULLIVAN NICOLE,,https://lens.org/138-111-380-434-384,Granted Patent,yes,6,0,10,10,0,A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512;;A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512,G03B42/04;;A61B6/14;;G03C3/00,,0,0,,,,ACTIVE
186,US,A1,US 2012/0042694 A1,045-891-739-544-343,2012-02-23,2012,US 85862310 A,2010-08-18,US 85862310 A,2010-08-18,Curable Acrylate Based Printing Medium,"An acrylate-based curable printing medium is disclosed. Acrylates, in the form of monomers, dimers, trimers and oligomers, as well as resins, form an interpenetrating polymer network by crosslinking, which is effected by heat, and optionally peroxide curing agents. Formulations can be tailored to achieve desired properties of the cured polymer including film hardness, burnout properties, and adhesion to glass. Such properties are adjusted by manipulating the relative proportions of the acrylic monomers, oligomers and resins that are used as a ceramic medium or vehicle.",BROWN TERRY J;;STEWART KIMBERLY;;DURAISAMY THIRUMALAI;;FERRO CORP,BROWN TERRY J;;STEWART KIMBERLY;;DURAISAMY THIRUMALAI,FERRO CORPORATION (2010-09-08),https://lens.org/045-891-739-544-343,Patent Application,yes,5,14,15,15,0,C03C17/04;;C03C17/04;;C03C17/32;;C03C17/32;;C03C2217/72;;C03C2217/72;;C08F220/301;;C08F220/301;;C08F222/102;;C08F222/102;;C08F222/103;;C08F222/103;;C08F283/008;;C08F290/08;;C09D11/101;;C09D11/101;;C09D133/10;;H01L31/022425;;H01L31/022425;;H01L31/18;;Y02E10/50,C08L33/00;;B05D3/02;;C03B23/20;;C08J7/18,65/36;;525/308;;525/303;;427/389.7;;427/388.2;;427/393.6;;427/487,4,0,,,"JP 58174477A, 10-1983, English translation;;http://en.wikipedia.org/wiki/Dimethylformamide;;http://infohouse.p2ric.org/ref/17/16643.pdf, 04-1996;;http://www.chemicalbook.com/ChemicalProductProperty_EN_CB4852296.htm, 5-20-2010",ACTIVE
187,US,B2,US 8816012 B2,010-626-362-125-239,2014-08-26,2014,US 85862310 A,2010-08-18,US 85862310 A,2010-08-18,Curable acrylate based printing medium,"An acrylate-based curable printing medium is disclosed. Acrylates, in the form of monomers, dimers, trimers and oligomers, as well as resins, form an interpenetrating polymer network by crosslinking, which is effected by heat, and optionally peroxide curing agents. Formulations can be tailored to achieve desired properties of the cured polymer including film hardness, burnout properties, and adhesion to glass. Such properties are adjusted by manipulating the relative proportions of the acrylic monomers, oligomers and resins that are used as a ceramic medium or vehicle.",BROWN TERRY J;;STEWART KIMBERLY;;DURAISAMY THIRUMALAI;;FERRO CORP,BROWN TERRY J;;STEWART KIMBERLY;;DURAISAMY THIRUMALAI,FERRO CORPORATION (2010-09-08),https://lens.org/010-626-362-125-239,Granted Patent,yes,26,8,15,15,0,C03C17/04;;C03C17/04;;C03C17/32;;C03C17/32;;C03C2217/72;;C03C2217/72;;C08F220/301;;C08F220/301;;C08F222/102;;C08F222/102;;C08F222/103;;C08F222/103;;C08F283/008;;C08F290/08;;C09D11/101;;C09D11/101;;C09D133/10;;H01L31/022425;;H01L31/022425;;H01L31/18;;Y02E10/50,C08L33/00;;C03C17/04;;C08F2/06;;C08F220/30;;C08F222/10;;C08L33/04;;H01L31/0224,525/308;;525/309;;525/263,5,0,,,"JP 58174477A, Oct. 1983, English translation.;;http://en.wikipedia.org/wiki/Dimethylformamide.;;http://infohouse.p2ric.org/ref/17/16643.pdf, Apr. 1996.;;http://www.chemicalbook.com/ChemicalProductProperty-EN-CB4852296.htm, May 20, 2010.;;International Search Report, International Application No. PCT/US 11/46527, International Filing Date, Aug. 4, 2011, two pages.",ACTIVE
188,US,B1,US 6518044 B1,088-162-056-439-843,2003-02-11,2003,US 99920101 A,2001-10-30,US 99920101 A;;US 53440700 A;;US 27444999 A;;US 14533999 P,1999-03-22,Promoters for expressing genes in a fungal cell,"
    The present invention relates to methods for producing a polypeptide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising a promoter foreign to the nucleic acid sequence, wherein the promoter comprises a sequence selected from the group consisting of nucleotides 1 to 3949 of SEQ ID NO:1, nucleotides 1 to 938 of SEQ ID NO:2, and nucleotides 1 to 3060 of SEQ ID NO:3, and a subsequence thereof; and mutant, hybrid, and tandem promoters thereof; and (b) isolating the polypeptide from the cultivation medium. The present invention also relates to the isolated promoter sequences and to constructs, vectors, and fungal host cells comprising the promoter sequences operably linked to nucleic acid sequences encoding polypeptides. 
",NOVOZYMES BIOTECH INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,NOVOZYMES INC (2005-08-29),https://lens.org/088-162-056-439-843,Granted Patent,yes,3,1,4,4,40,C12N9/2428;;C12N9/2428;;C07K14/37;;C07K14/37;;C12N15/80;;C12N15/80,C07K14/37;;C12N9/34;;C12N15/80,435/69.1;;536/24.1,0,0,,,,EXPIRED
189,WO,A3,WO 2000/056900 A3,161-049-870-506-001,2002-01-31,2002,US 0007815 W,2000-03-22,US 27444999 A,1999-03-22,PROMOTER SEQUENCES DERIVED FROM FUSARIUM VENENATUM AND USES THEREOF,"The present invention relates to methods for producing a polypetide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising a promoter foreign to the nucleic acid sequence, wherein the promoter comprises a sequence selected from the group consisting of nucleotides 1 to 3949 of SEQ ID NO. 1, nucleotides 1 to 938 of SEQ ID NO. 2, and nucleotides 1 to 3060 of SEQ ID NO. 3, and a subsequence thereof; and mutant, hybrid, and tandem promoters thereof; and (b) isolating the polypeptide from the cultivation medium. The present invention also relates to the isolated promoter sequences and to constructs, vectors, and fungal host cells comprising the promoter sequences operably linked to nucleic acid sequences encoding polypetides.",NOVO NORDISK BIOTECH INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,,https://lens.org/161-049-870-506-001,Search Report,yes,2,0,22,22,0,C12N9/2428;;C07K14/37;;C12N15/80,C12N15/09;;C07K14/37;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/34;;C12N15/80;;C12P21/02,,4,2,103-934-330-253-339;;005-915-472-937-326,10.1016/s0953-7562(09)80575-3;;9430709;;10.1074/jbc.273.3.1654,"DATABASE EMBL 1 January 1900 (1900-01-01), HUNT I. E., ET AL: ""NEUROSPORA CRASSA WORONIN BODY MAJOR PROTEIN GENE, COMPLETE CDS"", XP002159031, Database accession no. AF001033;;DATABASE SWISSPROT 1 January 1900 (1900-01-01), NAKAZAWA T.: ""EPD1 PROTEIN PRECURSOR (ESENTIAL FOR PSEUDOHYPHAL DEVELOPMENT 1)."", XP002159033, Database accession no. P56092;;WIEBE, M.G. ET AL.: ""Appearance of morphological (colonial) mutants in glucose-limited, continous flow cultures of Fusarium graminearum A3/5"", MYCOLOGICAL RESEARCH, vol. 95, no. 11, 1991, pages 1284 - 1288, XP000197035;;KIMURA, M. ET AL.: ""Trichothecene 3-O-Acetyltransferase Protects Both the Producing Organism and Transformed Yeast from Related Mycotoxins"", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 273, no. 3, 16 January 1998 (1998-01-16), pages 1654 - 1661, XP002125091",PENDING
190,JP,A,JP 2013121361 A,007-136-036-467-188,2013-06-20,2013,JP 2013021169 A,2013-02-06,US 27444999 A,1999-03-22,PROMOTER FOR EXPRESSING GENE IN FUNGAL CELL,"PROBLEM TO BE SOLVED: To provide a new method for producing a polypeptide.SOLUTION: The method for producing a polypeptide includes (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising a promoter foreign to the nucleic acid sequence, wherein the promoter comprises a sequence selected from the group consisting of specific sequence, a subsequence thereof and hybrid and tandem promoters thereof and (b) isolating the polypeptide from the cultivation medium.",NOVOZYMES INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,,https://lens.org/007-136-036-467-188,Patent Application,no,4,0,22,22,40,C12N9/2428;;C07K14/37;;C12N15/80,C12N15/09;;C07K14/37;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/34;;C12N15/80;;C12P21/02,,0,0,,,,DISCONTINUED
191,US,A1,US 2003/0148452 A1,012-242-974-970-441,2003-08-07,2003,US 28167302 A,2002-10-28,US 28167302 A;;US 53440700 A;;US 27444999 A;;US 14533999 P,1999-03-22,Promoters for expressing genes in a fungal cell,"
   The present invention relates to methods for producing a polypeptide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising a promoter foreign to the nucleic acid sequence, wherein the promoter comprises a sequence selected from the group consisting of nucleotides 1 to 3949 of SEQ ID NO. 1, nucleotides 1 to 938 of SEQ ID NO. 2, and nucleotides 1 to 3060 of SEQ ID NO. 3, and a subsequence thereof; and mutant, hybrid, and tandem promoters thereof; and (b) isolating the polypeptide from the cultivation medium. The present invention also relates to the isolated promoter sequences and to constructs, vectors, and fungal host cells comprising the promoter sequences operably linked to nucleic acid sequences encoding polypeptides. 
",NOVOZYMES BIOTECH INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,NOVOZYMES INC (2005-08-29),https://lens.org/012-242-974-970-441,Patent Application,yes,0,1,4,4,40,C12N9/2428;;C12N9/2428;;C07K14/37;;C07K14/37;;C12N15/80;;C12N15/80,C07K14/37;;C12N9/34;;C12N15/80,435/69.1;;435/320.1;;435/254.2;;536/23.2;;435/483,0,0,,,,EXPIRED
192,AU,A,AU 2000/040257 A,112-719-077-639-063,2000-10-09,2000,AU 2000/040257 A,2000-03-22,US 27444999 A;;US 0007815 W,1999-03-22,Promoters for expressing genes in a fungal cell,,NOVO NORDISK BIOTECH INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,,https://lens.org/112-719-077-639-063,Patent Application,no,0,0,22,22,0,C12N9/2428;;C07K14/37;;C12N15/80,C12N15/09;;C07K14/37;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/34;;C12N15/80;;C12P21/02,,0,0,,,,DISCONTINUED
193,DK,T3,DK 2278016 T3,142-560-930-122-739,2012-11-26,2012,DK 10180302 T,2000-03-22,US 27444999 A;;EP 00919596 A,1999-03-22,Promotorsekvenser fra Fusarium Venenatum og anvendelse deraf,,NOVOZYMES INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,,https://lens.org/142-560-930-122-739,Granted Patent,no,0,0,22,22,0,C12N9/2428;;C07K14/37;;C12N15/80,C12N9/34;;C12N15/09;;C07K14/37;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/80;;C12P21/02,,0,0,,,,EXPIRED
194,US,B1,US 6361973 B1,000-800-498-325-756,2002-03-26,2002,US 53440700 A,2000-03-22,US 53440700 A;;US 27444999 A;;US 14533999 P,1999-03-22,Promoters for expressing genes in a fungal cell,"
    The present invention relates to methods for producing a polypeptide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising a promoter foreign to the nucleic acid sequence, wherein the promoter comprises a sequence selected from the group consisting of nucleotides 1 to 3949 of SEQ ID NO:1, nucleotides 1 to 938 of SEQ ID NO:2, and nucleotides 1 to 3060 of SEQ ID NO:3, and a subsequence thereof; and mutant, hybrid, and tandem promoters thereof; and (b) isolating the polypeptide from the cultivation medium. The present invention also relates to the isolated promoter sequences and to constructs, vectors, and fungal host cells comprising the promoter sequences operably linked to nucleic acid sequences encoding polypeptides. 
",NOVOZYMES BIOTECH INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,NOVOZYMES INC (2005-08-29);;NOVOZYMES BIOTECH INC (2000-03-20),https://lens.org/000-800-498-325-756,Granted Patent,yes,3,16,4,4,40,C12N9/2428;;C12N9/2428;;C07K14/37;;C07K14/37;;C12N15/80;;C12N15/80,C07K14/37;;C12N9/34;;C12N15/80,435/69.1;;536/24.1,0,0,,,,EXPIRED
195,EP,B1,EP 2278016 B1,144-508-660-498-676,2012-09-26,2012,EP 10180302 A,2000-03-22,EP 00919596 A;;US 27444999 A,1999-03-22,Promoter sequences derived from Fusarium Venenatum and uses thereof,,NOVOZYMES INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,,https://lens.org/144-508-660-498-676,Granted Patent,yes,2,0,22,22,0,C12N9/2428;;C07K14/37;;C12N15/80,C12N9/34;;C12N15/09;;C07K14/37;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/80;;C12P21/02,,1,0,,,"ROYER J C ET AL: ""FUSARIUM GRAMINEARUM A 3/5 AS A NOVEL HOST FOR HETEROLOGOUS PROTEINPRODUCTION"", BIO/TECHNOLOGY, NATURE PUBLISHING CO. NEW YORK, US, vol. 13, 1 December 1995 (1995-12-01), pages 1479-1483, XP000674732, ISSN: 0733-222X, DOI: DOI:10.1038/NBT1295-1479",EXPIRED
196,JP,A,JP 2010227108 A,108-071-804-810-549,2010-10-14,2010,JP 2010109995 A,2010-05-12,US 27444999 A,1999-03-22,PROMOTER FOR EXPRESSING GENE IN FUNGAL CELL,"<P>PROBLEM TO BE SOLVED: To provide a new method for producing a polypeptide. <P>SOLUTION: The method for producing a polypeptide comprises: (a) cultivating a fungal host cell in a medium conducive for production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide and operably linked to a second nucleic acid sequence comprising a promoter foreign to the nucleic acid sequence, wherein the promoter contains a sequence selected from specific nucleic acid sequences and its subsequences; and hybrids and their tandem promoters; and (b) isolating the polypeptide from the culture medium. <P>COPYRIGHT: (C)2011,JPO&INPIT",NOVOZYMES INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,,https://lens.org/108-071-804-810-549,Patent Application,no,1,0,22,22,40,C12N9/2428;;C07K14/37;;C12N15/80,C12N15/09;;C07K14/37;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/34;;C12N15/80;;C12P21/02,,2,0,,,"JPN6012041721; Ｄａｔａｂａｓｅ ＧｅｎＢａｎｋ［ｏｎｌｉｎｅ］， Ａｃｃｅｓｓｉｏｎ Ｎｏ． ＡＦ００１０３３ , 19970617;;JPN6012041722; Ｆｕｎｇａｌ Ｇｅｎｅｔ． Ｂｉｏｌ． Ｖｏｌ．２５, 1998, ｐ．７５， Ａｒｔｉｃｌｅ Ｎｏ． ＦＧ９８１０９０",INACTIVE
197,EP,A1,EP 2278016 A1,022-525-467-133-721,2011-01-26,2011,EP 10180302 A,2000-03-22,EP 00919596 A;;US 27444999 A,1999-03-22,Promoter sequences derived from Fusarium Venenatum and uses thereof,"The present invention relates to methods for producing a polypeptide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising a promoter foreign to the nucleic acid sequence, wherein the promoter comprises a sequence selected from the group consisting of nucleotides 1 to 3949 of SEQ ID NO. 1, nucleotides 1 to 938 of SEQ ID NO. 2, and nucleotides 1 to 3060 of SEQ ID NO. 3, and a subsequence thereof; and mutant, hybrid, and tandem promoters thereof; and (b) isolating the polypeptide from the cultivation medium. The present invention also relates to the isolated promoter sequences and to constructs, vectors, and fungal host cells comprising the promoter sequences operably linked to nucleic acid sequences encoding polypeptides.",NOVOZYMES INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,,https://lens.org/022-525-467-133-721,Patent Application,yes,12,0,22,22,40,C12N9/2428;;C07K14/37;;C12N15/80,C12N9/34;;C12N15/09;;C07K14/37;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/80;;C12P21/02,,34,20,012-080-214-127-41X;;128-525-405-434-397;;008-316-267-912-706;;031-274-313-092-421;;023-805-924-410-732;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;038-383-743-124-048;;082-474-862-036-218;;009-304-049-487-981;;103-934-330-253-339;;070-895-194-004-930;;041-904-704-723-944;;136-261-375-157-758;;022-715-862-716-318;;010-095-597-422-529;;012-573-093-823-392;;028-106-465-999-558;;074-931-020-985-514,10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;10.1073/pnas.75.3.1433;;418413;;pmc411486;;9501478;;10.1006/fgbi.1997.1027;;10.1006/fgbi.1997.1018;;9501477;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1093/bioinformatics/5.2.151;;2720464;;pmc393452;;6572363;;10.1073/pnas.80.3.726;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;10.1016/s0953-7562(09)80575-3;;10.1016/0092-8674(81)90030-1;;7034956;;10.1016/0378-1119(83)90230-5;;6198242;;10.1016/0166-0934(92)90168-d;;1322932;;9051728;;10.1093/protein/10.1.1;;10.1128/aem.64.11.4423-4427.1998;;9797301;;pmc106663;;9636307;;3043184;;10.1128/mcb.8.6.2589-2596.1988;;pmc363460;;10.1128/mcb.8.6.2589;;pmc553668;;10.1002/j.1460-2075.1987.tb02538.x;;16453790,"ROYER J C ET AL: ""FUSARIUM GRAMINEARUM A 3/5 AS A NOVEL HOST FOR HETEROLOGOUS PROTEINPRODUCTION"", BIO/TECHNOLOGY, NATURE PUBLISHING CO. NEW YORK, US, vol. 13, 1 December 1995 (1995-12-01), pages 1479 - 1483, XP000674732, ISSN: 0733-222X, DOI: 10.1038/NBT1295-1479;;J.-C. JANSON AND LARS RYDEN,: ""Protein Purification"", 1989, VCH PUBLISHERS;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;INNIS ET AL.: ""PCR Protocols: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;GUO; SHERMAN, MOLECULAR CELLULAR BIOLOGY, vol. 15, 1995, pages 5983 - 5990;;EHRLICH, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1433;;HAWKSWORTH ET AL.: ""CAB International, 8th edition,"", 1995, UNIVERSITY PRESS, article ""In, Ainsworth and Bisby's Dictionary of The Fungi"";;SKINNER, F.A.: ""Soc. App. Bacteriol. Symposium Series"", 1980;;YODER; CHRISTIANSON, FUNGAL GENETICS AND BIOLOGY, vol. 23, 1998, pages 62 - 80;;O'DONNELL ET AL., FUNGAL GENETICS AND BIOLOGY, vol. 23, 1998, pages 57 - 67;;YELTON ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1984, pages 1470 - 1474;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;ABELSON, J.N. AND SIMON, M.I.: ""Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., article BECKER,GUARENTE: ""Guide to Yeast Genetics and Molecular Biology"", pages: 182 - 187;;ITO ET AL., JOURNAL OF BACTERIOLOGY, vol. 153, 1983, pages 163;;HINNEN ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1920;;HIGGINS, CABIOS, vol. 5, 1989, pages 151 - 153;;WILBUR; LIPMAN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 80, 1983, pages 726 - 730;;J. SAMBROOK; E.F. FRITSCH; T. MANIATUS: ""Molecular Cloning, A Laboratory Manual, 2d edition,"", 1989, COLD SPRING HARBOR;;BOLTON; MCCARTHY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 48, 1962, pages 1390;;H. NEURATH; R.L. HILL: ""The Proteins"", 1979, ACADEMIC PRESS;;WIEBE ET AL., MYCOLOGICAL RESEARCH, vol. 95, 1991, pages 1284 - 1288;;TIMBERLAKE; BARNARD, CELL, vol. 26, 1981, pages 29 - 37;;DAVIS ET AL.: ""Basic Methods in Molecular Biology"", 1986, ELSEVIER SCIENCE PUBLISHING CO., INC.;;GUBLER; HOFFMAN, GENE, vol. 25, 1983, pages 263 - 269;;MILLER: ""A Short Course in Bacterial Genetics. A Laboratory Manual and Handbook for Escherichia coli and Related Bacteria"", 1992, COLD SPRING HARBOR PRESS;;UTTERBACK ET AL., GENOME SCI. TECHNOL., vol. 1, 1995, pages 1 - 8;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;BERKA ET AL., APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 4423 - 4427;;DAVIS, R.W.; BOTSTEIN, D.; ROTH, J.R.: ""Advanced Bacterial Genetics, A Manual for Genetic Engineering"", 1980, COLD SPRING HARBOR PRESS, article ""Advanced Bacterial Genetics, A Manual for Genetic Engineering"";;D'ALESSIO ET AL., FOCUS@, vol. 14, 1992, pages 76;;ROYER ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 1479 - 1483;;HYNES ET AL., MOL. CELL. BIOL., vol. 8, 1988, pages 2589 - 2596;;THOMPSON ET AL., EMBO JOURNAL, vol. 6, 1987, pages 2519 - 2514",EXPIRED
198,US,B2,US 6692940 B2,048-832-363-204-20X,2004-02-17,2004,US 28167302 A,2002-10-28,US 28167302 A;;US 53440700 A;;US 27444999 A;;US 14533999 P,1999-03-22,Promoters for expressing genes in a fungal cell,"
    The present invention relates to methods for producing a polypeptide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising a promoter foreign to the nucleic acid sequence, wherein the promoter comprises a sequence selected from the group consisting of nucleotides 1 to 3949 of SEQ ID NO. 1, nucleotides 1 to 938 of SEQ ID NO. 2, and nucleotides 1 to 3060 of SEQ ID NO. 3, and a subsequence thereof; and mutant, hybrid, and tandem promoters thereof; and (b) isolating the polypeptide from the cultivation medium. The present invention also relates to the isolated promoter sequences and to constructs, vectors, and fungal host cells comprising the promoter sequences operably linked to nucleic acid sequences encoding polypeptides. 
",NOVOZYMES BIOTECH INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,NOVOZYMES INC (2005-08-29),https://lens.org/048-832-363-204-20X,Granted Patent,yes,3,0,4,4,40,C12N9/2428;;C12N9/2428;;C07K14/37;;C07K14/37;;C12N15/80;;C12N15/80,C07K14/37;;C12N9/34;;C12N15/80,435/69.1;;536/24.1,0,0,,,,EXPIRED
199,EP,A2,EP 1194572 A2,118-064-708-864-878,2002-04-10,2002,EP 00919596 A,2000-03-22,US 0007815 W;;US 27444999 A,1999-03-22,PROMOTER SEQUENCES DERIVED FROM FUSARIUM VENENATUM AND USES THEREOF,,NOVOZYMES BIOTECH INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,"NOVOZYMES, INC. (2005-06-22)",https://lens.org/118-064-708-864-878,Patent Application,yes,0,0,22,22,0,C12N9/2428;;C07K14/37;;C12N15/80,C12N15/09;;C07K14/37;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/34;;C12N15/80;;C12P21/02,,1,0,,,See references of WO 0056900A3,DISCONTINUED
200,CN,B,CN 1526820 B,054-376-464-920-740,2010-05-26,2010,CN 200410031492 A,2000-03-22,US 27444999 A,1999-03-22,Promotor for expressing gene in fungal cell,"The present invention relates to methods for producing a polypetide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal hostcell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising a promoter foreign to the nucleic acid sequence, wherein the promoter comprises a sequence selected from the group consisting of nucleotides 1 to 3949 of SEQ ID NO. 1, nucleotides 1 to 938 of SEQ ID NO. 2, and nucleotides 1 to 3060 of SEQ ID NO. 3, and a subsequence thereof; and mutant, hybrid, and tandem promoters thereof; and (b) isolating the polypeptide from the cultivation medium. The present invention also relates to the isolated promoter sequences and to constructs, vectors, and fungal host cells comprising the promoter sequences operably linked to nucleic acid sequences encoding polypetides.",NOVOZYMES BIOTECH INC,BERKA RANDY M;;REY MICHAEL W;;KIMBERLY BROWN;;BROWN STEPHEN H,,https://lens.org/054-376-464-920-740,Granted Patent,no,0,0,22,22,0,C12N9/2428;;C07K14/37;;C12N15/80,C12N15/09;;C12N15/80;;C07K14/37;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/34;;C12N15/67;;C12P21/00;;C12P21/02,,0,0,,,,EXPIRED
201,US,S,US D0819411 S,076-516-984-008-35X,2018-06-05,2018,US 201729594582 F,2017-02-21,US 201729594582 F,2017-02-21,Combined knife holder and cutting board,,H GERSTNER & SONS INC,CAMPBELL BROWN KIMBERLY A;;BROWN MAURICE L;;WILSON III DELBERT F,H. GERSTNER & SONS INC (2017-02-17),https://lens.org/076-516-984-008-35X,Design Right,no,0,3,1,1,0,,,0799;;D 7638;;D7/698,0,0,,,,ACTIVE
202,WO,A2,WO 2000/056900 A2,190-252-086-073-340,2000-09-28,2000,US 0007815 W,2000-03-22,US 27444999 A,1999-03-22,PROMOTERS FOR EXPRESSING GENES IN A FUNGAL CELL,"The present invention relates to methods for producing a polypetide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising a promoter foreign to the nucleic acid sequence, wherein the promoter comprises a sequence selected from the group consisting of nucleotides 1 to 3949 of SEQ ID NO. 1, nucleotides 1 to 938 of SEQ ID NO. 2, and nucleotides 1 to 3060 of SEQ ID NO. 3, and a subsequence thereof; and mutant, hybrid, and tandem promoters thereof; and (b) isolating the polypeptide from the cultivation medium. The present invention also relates to the isolated promoter sequences and to constructs, vectors, and fungal host cells comprising the promoter sequences operably linked to nucleic acid sequences encoding polypetides.",NOVO NORDISK BIOTECH INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,,https://lens.org/190-252-086-073-340,Patent Application,yes,0,592,22,22,40,C12N9/2428;;C07K14/37;;C12N15/80,C12N15/09;;C07K14/37;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/34;;C12N15/80;;C12P21/02,,0,0,,,,PENDING
203,JP,A,JP 2013121360 A,081-862-486-456-937,2013-06-20,2013,JP 2013021124 A,2013-02-06,US 27444999 A,1999-03-22,PROMOTER FOR EXPRESSING GENE IN FUNGAL CELL,"PROBLEM TO BE SOLVED: To provide a new method for producing a polypeptide.SOLUTION: The method for producing a polypeptide includes (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked to a second nucleic acid sequence comprising a promoter foreign to the nucleic acid sequence, wherein the promoter comprises a sequence selected from the group consisting of specific nucleotides 1 to 3,949, nucleotides 1 to 938, and nucleotides 1 to 3,060 and a subsequence thereof and hybrid and tandem promoters thereof and (b) isolating the polypeptide from the cultivation medium.",NOVOZYMES INC,BERKA RANDY M;;REY MICHAEL W;;BROWN KIMBERLY;;BROWN STEPHEN H,,https://lens.org/081-862-486-456-937,Patent Application,no,1,0,22,22,40,C12N9/2428;;C07K14/37;;C12N15/80,C12N15/09;;C07K14/37;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/26;;C12N9/34;;C12N15/80;;C12P21/02,,0,0,,,,PENDING
204,AU,A1,AU 2013/213750 A1,014-862-433-203-303,2013-08-29,2013,AU 2013/213750 A,2013-08-09,AU 2007/281737 A;;AU 2013/213750 A,2007-08-06,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,"T-cell-mediated inflammation of the pancreas in a mammal is decreased by administering to the mammal a microsphere composition, in which the microspheres comprise oligonucleotides that are antisense to and targeted to bind to primary transcripts selected from the group consisting of CD40, CD80 and CD86 primary transcripts, and combinations thereof, composition being administered in an amount effective to ameliorate the symptoms of Type I diabetes in the mammal.",BAXTER INT;;BAXTER HEALTHCARE SA;;UNIV PITTSBURGH,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,,https://lens.org/014-862-433-203-303,Patent Application,no,0,0,2,2,0,,A61K48/00,,0,0,,,,ACTIVE
205,US,A1,US 2012/0252068 A1,055-800-506-373-260,2012-10-04,2012,US 201213476542 A,2012-05-21,US 201213476542 A;;US 201113238755 A;;US 13072208 A;;US 94123407 P,2007-05-31,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",LOPEZ DE LEON ALFREDO;;DING HANSHU;;BROWN KIMBERLY;;NOVOZYMES INC,LOPEZ DE LEON ALFREDO;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/055-800-506-373-260,Patent Application,yes,0,2,12,12,82,C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12P21/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N15/63,435/69.1;;435/320.1;;435/252.31;;435/252.35;;435/252.33;;435/252.34;;435/254.11;;435/254.2;;435/254.22;;435/254.23;;435/254.21;;435/254.3;;435/254.7;;435/254.8;;435/254.4;;435/254.5;;435/254.6;;435/252.3,0,0,,,,DISCONTINUED
206,US,B2,US 8177428 B2,117-672-790-382-861,2012-05-15,2012,US 21769708 A,2008-07-08,US 21769708 A;;US 50508706 A;;US 70852505 P,2005-08-16,Holder device for dental x-ray digital sensor,"A sensor holder ( 10 ) includes a frame member ( 20 ) that bounds a void area ( 21 ) and which is configured to receive a sensor ( 11 ). A retaining means ( 50, 51 ) is provided to hold the sensor ( 11 ) to the frame ( 20 ) such that a connecting cable ( 12 ) affixed to the sensor ( 11 ) is secured and positioned by the void area ( 21 ) for a subsequent imaging procedure.",STECK JOHN E;;BROWN KIMBERLY C;;SULLIVAN NICOLE;;DENTSPLY INT INC,STECK JOHN E;;BROWN KIMBERLY C;;SULLIVAN NICOLE,,https://lens.org/117-672-790-382-861,Granted Patent,yes,14,10,10,10,0,A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512;;A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512,A61B6/14,378/170;;378/168,1,0,,,"Koch, Paul E., Snap Fit Design [online], (Sep. 2, 2003), [retrieved on Aug. 27, 2011], Retrieved from the Internet: <URL: http://web.archive.org/web/20030902170204/http://engr.bd.psu.edu/pkoch/plasticdesign/snap-design.htm>.",ACTIVE
207,CA,A1,CA 2942128 A1,199-527-894-285-971,2008-02-14,2008,CA 2942128 A,2007-08-06,US 83574206 P;;US 86491406 P;;CA 2657517 A,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,,BAXTER HEALTHCARE SA;;BAXTER INT;;UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,,https://lens.org/199-527-894-285-971,Patent Application,no,0,0,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K31/7088;;A61K9/14;;A61P3/10,,0,0,,,,ACTIVE
208,MX,A,MX 2009001226 A,054-891-489-009-220,2009-03-20,2009,MX 2009001226 A,2007-08-06,US 83574206 P;;US 86491406 P;;US 2007/0075292 W,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES.,"AS-oIigonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER INT,GIANNOUKAKIS NICK;;BROWN LARRY R;;GILLIS KIMBERLY A,,https://lens.org/054-891-489-009-220,Patent Application,no,0,0,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K31/7088;;A61K38/28;;A61P3/10;;A61P37/00,,0,0,,,,ACTIVE
209,CA,A1,CA 2657517 A1,179-261-401-030-591,2008-02-14,2008,CA 2657517 A,2007-08-06,US 83574206 P;;US 86491406 P;;US 2007/0075292 W,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,"AS-oIigonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A proc ess includes using an antisense approach to reverse an autoimmune diabetes c ondition in NOD mice in vivo. The oligonucleotides are targeted to bind to p rimary transcripts CD40, CD80, CD86 and their combinations.",UNIV PITTSBURGH;;BAXTER HEALTHCARE SA;;BAXTER INT,BROWN LARRY R;;GILLIS KIMBERLY A;;GIANNOUKAKIS NICK,,https://lens.org/179-261-401-030-591,Patent Application,no,0,0,24,24,3,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K48/00,,0,0,,,,ACTIVE
210,EP,A4,EP 2056883 A4,032-586-244-080-986,2010-10-27,2010,EP 07813820 A,2007-08-06,US 2007/0075292 W;;US 83574206 P;;US 86491406 P,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,,BAXTER INT;;BAXTER HEALTHCARE SA;;UNIV PITTSBURGH,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,BAXTER HEALTHCARE S.A. (2010-01-06);;BAXTER INTERNATIONAL INC. (2010-01-06);;UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYS (2010-01-06),https://lens.org/032-586-244-080-986,Search Report,no,4,0,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,C12N15/11;;A61K9/16;;A61K9/50;;A61K31/713,,4,4,045-583-226-081-588;;014-193-579-163-943;;115-340-139-860-808;;029-728-293-685-159,10.1016/s0378-5173(97)04887-4;;pmc2713034;;18316361;;10.2337/db07-0507;;10.1146/annurev.immunol.23.021704.115643;;15771578;;10.2337/db07-1817;;18971435;;pmc2570380,"AKHTAR S ET AL: ""Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres"", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL LNKD- DOI:10.1016/S0378-5173(97)04887-4, vol. 151, 1 January 1997 (1997-01-01), pages 57 - 67, XP002099631, ISSN: 0378-5173;;PHILLIPS B ET AL: ""A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes"", DIABETES, AMERICAN DIABETES ASSOCIATION, US LNKD- DOI:10.2337/DB07-0507, vol. 57, no. 6, 1 June 2008 (2008-06-01), pages 1544 - 1555,1, XP002541959, ISSN: 0012-1797, [retrieved on 20080226];;MARK S. ANDERSON ET AL: ""THE NOD MOUSE: A Model of Immune Dysregulation"", ANNUAL REVIEW OF IMMUNOLOGY, vol. 23, no. 1, 1 April 2005 (2005-04-01), pages 447 - 485, XP055051268, ISSN: 0732-0582, DOI: 10.1146/annurev.immunol.23.021704.115643;;AKIRAV EITAN ET AL: ""beta-Cell Mass and Type 1 Diabetes Going, Going, Gone?"", DIABETES, vol. 57, no. 11, November 2008 (2008-11-01), pages 2883 - 2888, ISSN: 0012-1797(print)",ACTIVE
211,EP,A1,EP 2195424 A1,084-631-089-343-323,2010-06-16,2010,EP 08833449 A,2008-09-26,US 2008/0077864 W;;US 97620707 P,2007-09-28,POLYPEPTIDES HAVING CELLOBIOHYDROLASE II ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/084-631-089-343-323,Patent Application,yes,0,0,14,14,0,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C12N9/42;;C11D3/386;;C12N5/10;;C12N15/56,,0,0,,,,ACTIVE
212,WO,A2,WO 2008/019346 A2,146-496-502-626-086,2008-02-14,2008,US 2007/0075292 W,2007-08-06,US 83574206 P;;US 86491406 P,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,"AS-oIigonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER INT;;BAXTER HEALTHCARE SA;;CHILDREN S HOSPITAL OF PITTSBU;;BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,,https://lens.org/146-496-502-626-086,Patent Application,yes,0,7,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K38/28;;A61K31/7088;;A61P3/10;;A61P37/00,,0,0,,,,PENDING
213,CA,C,CA 2942128 C,012-794-402-256-109,2019-11-26,2019,CA 2942128 A,2007-08-06,US 83574206 P;;US 86491406 P;;CA 2657517 A,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,"AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER HEALTHCARE SA;;BAXTER INT;;UNIV OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATN,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,,https://lens.org/012-794-402-256-109,Granted Patent,no,0,0,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K31/7088;;A61K9/14;;A61P3/10,,0,0,,,,ACTIVE
214,CA,A1,CA 2687609 A1,043-128-527-445-245,2008-12-04,2008,CA 2687609 A,2008-05-30,US 94123407 P;;US 2008/0065393 W,2007-05-31,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolyti c enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host ce lls comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,DING HANSHU;;BROWN KIMBERLY;;LOPEZ DE LEON ALFREDO,,https://lens.org/043-128-527-445-245,Patent Application,no,0,0,12,12,82,C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;A01K67/027;;C12N5/10;;C12N15/11;;C12N15/56,,0,0,,,,DISCONTINUED
215,CA,C,CA 2657517 C,133-161-696-476-402,2016-11-01,2016,CA 2657517 A,2007-08-06,US 83574206 P;;US 86491406 P;;US 2007/0075292 W,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,"AS-oIigonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER INT;;BAXTER HEALTHCARE SA;;UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,,https://lens.org/133-161-696-476-402,Granted Patent,no,0,0,24,24,3,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K31/7088;;A61K38/28;;A61P3/10,,0,0,,,,ACTIVE
216,US,B2,US 8114635 B2,163-805-212-106-747,2012-02-14,2012,US 70843310 A,2010-02-18,US 70843310 A;;US 2277108 A;;US 66975703 A;;US 41305702 P,2002-09-24,Methods for obtaining microbial trypsin mutants having chymotrypsin activity,"The present invention relates to microbial trypsin variants having chymotrypsin-like activity, comprising: (a) a one or more substitutions corresponding to positions 144, 193, 198, 201, 218, 223, 227, 228, 229, 230, and 231 of amino acids 25 to 248 of SEQ ID NO: 2, (b) one or more deletions corresponding to positions 192, 197, and 226 of amino acids 25 to 248 of SEQ ID NO: 2; and (c) an insertion between positions corresponding to positions 224 and 225 of amino acids 25 to 248 of SEQ ID NO: 2. The present invention further relates to nucleotide sequences encoding microbial trypsin variants having chymotrypsin-like activity; nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; and methods of producing microbial trypsin variants having chymotrypsin-like activity or a precursor thereof.",KLOTZ ALAN;;BROWN KIMBERLY M;;ZARETSKY ELIZABETH J;;NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY M;;ZARETSKY ELIZABETH J,,https://lens.org/163-805-212-106-747,Granted Patent,yes,3,1,19,19,24,C12N9/58;;C12N9/58,C12P21/00;;C12N9/58,435/71.1,19,15,002-333-131-519-098;;074-227-642-330-054;;023-932-274-931-430;;015-792-604-341-547;;102-386-782-042-574;;132-695-844-930-786;;002-460-257-894-311;;153-464-593-185-446;;164-535-231-106-32X;;007-684-399-045-694;;072-221-743-752-07X;;025-361-294-794-310;;055-003-061-629-507;;062-381-962-971-993;;032-201-018-354-205,10.1016/0076-6879(91)02031-4;;1784193;;7910748;;10.1139/o93-067;;10.1074/jbc.275.9.6689;;10692479;;10.1126/science.1546324;;1546324;;10.1093/oxfordjournals.jbchem.a122488;;3149277;;10.1021/bi990993h;;10512619;;7592916;;10.1074/jbc.270.45.26782;;10.1002/elps.1150180815;;9298654;;8332590;;10.1093/protein/6.4.341;;1755852;;10.1016/0006-291x(91)91248-b;;10.1128/jb.169.8.3778-3784.1987;;3112129;;pmc212465;;14151403;;10.1038/2011284a0;;10.1073/pnas.0403255101;;pmc438954;;15197260;;5764436;;10.1038/221337a0;;4624704;;10.1016/s0021-9258(19)45052-7,"Hedstrom et al, Methods Enzymol. 1991;202:671-87. Modulation of enzyme specificity by site-directed mutagenesis.;;Sidhu et al., 1993, Biochem. Cell. Biol. 71: 454-461.;;Screen and St. Leger, 2000, Journal of Biological Chemistry 275: 6689-6694.;;Hedstrom et al., 1992, Science 255: 1249-1253.;;Yoshida, 1988, J Biochem 104, 451-456.;;Witkowski, 1999, Biochemistry 38, 11643-11650.;;Wisharti, 1995, J Biol Chem 270 (15), 26783-26785.;;Wise, 1997, Electrophoresis 18, 1399-1409.;;Rypniewski, 1993, Protein Engineering 6 (4), 341-348.;;Kim, 1991, Biochem Biophys Res Com 181 (2), 707-713.;;Henderson, 1987, J Bacteriol 169 (8), 377S-3784.;;Hartley, 1964, Nature 201, 1284-1287.;;Hames, In: Gel electrophoresis of proteins. Oxford University Press. pp. 30-32.;;Guo, 2004, Proc Natl Acad Sci USA 101 (25), 920S-9210.;;Geneseq, Accession No. AAA53331 from Yoder US patent 6060305 May 9, 2000.;;Gencor Accession No. P00766 from Blow et al Nature 221 (5178), 337-340 (1969).;;Gagne, 1993, Food Biotechnol 7 (3), 257-263.;;Cosby, 2002, Promega Notes Magazine 61, 12-1.;;Awad, 1972, J Biol Chem 247 (13), 4144-4154.",EXPIRED
217,US,A1,US 2012/0011619 A1,176-090-459-669-651,2012-01-12,2012,US 201113238755 A,2011-09-21,US 201113238755 A;;US 13072208 A;;US 94123407 P,2007-05-31,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",LOPEZ DE LEON ALFREDO;;DING HANSHU;;BROWN KIMBERLY;;NOVOZYMES INC,LOPEZ DE LEON ALFREDO;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/176-090-459-669-651,Patent Application,yes,0,1,12,12,82,C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C07K14/37;;A01H5/00;;C07H21/02;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/04;;C12N5/07;;C12N15/09;;C12N15/31;;C12N15/63;;C12N15/82;;C12P1/00;;C12P21/00,800/288;;530/350;;536/23.74;;435/320.1;;435/252.31;;435/252.3;;435/252.35;;435/252.33;;435/325;;435/348;;435/419;;435/254.11;;435/254.2;;435/254.22;;435/254.23;;435/254.21;;435/254.3;;435/254.7;;435/254.8;;435/254.4;;435/254.5;;435/254.6;;435/71.1;;435/69.1;;435/440;;800/298;;536/24.5;;435/375;;435/41,0,0,,,,ACTIVE
218,WO,A2,WO 2008/131129 A2,022-615-029-772-047,2008-10-30,2008,US 2008/0060669 W,2008-04-17,US 91232007 P;;US 93812307 P,2007-04-17,NUCLEIC ACID MICROPARTICLES FOR PULMONARY DELIVERY,"The present disclosure is related to microparticle compositions, in which the microparticles are made of nucleic acids and non-polymeric cations, which are suitable for administration to moist or aqueous target locations (e.g., the lung tissue), where the substantially spherical nucleic acid microparticles release the nucleic acids through dissolution, allowing the released nucleic acids to freely interact with the target cells.",BAXTER INT;;BAXTER HEALTHCARE SA;;BROWN LARRY R;;GILLIS KIMBERLY A;;GALLO MICHAEL,BROWN LARRY R;;GILLIS KIMBERLY A;;GALLO MICHAEL,,https://lens.org/022-615-029-772-047,Patent Application,yes,0,5,13,13,0,A61K9/0075;;A61K9/1611;;A61K9/1617;;A61K9/1688;;A61K9/1611;;A61K9/0075;;A61K9/1688;;A61K9/1617;;A61K9/50;;A61K9/5031;;A61K38/28,A61K9/16;;A61K9/12,,0,0,,,,PENDING
219,WO,A3,WO 2008/131129 A3,117-640-267-511-79X,2009-05-14,2009,US 2008/0060669 W,2008-04-17,US 91232007 P;;US 93812307 P,2007-04-17,NUCLEIC ACID MICROPARTICLES FOR PULMONARY DELIVERY,"The present disclosure is related to microparticle compositions, in which the microparticles are made of nucleic acids and non-polymeric cations, which are suitable for administration to moist or aqueous target locations (e.g., the lung tissue), where the substantially spherical nucleic acid microparticles release the nucleic acids through dissolution, allowing the released nucleic acids to freely interact with the target cells.",BAXTER INT;;BAXTER HEALTHCARE SA;;BROWN LARRY R;;GILLIS KIMBERLY A;;GALLO MICHAEL,BROWN LARRY R;;GILLIS KIMBERLY A;;GALLO MICHAEL,,https://lens.org/117-640-267-511-79X,Search Report,yes,5,0,13,13,0,A61K9/0075;;A61K9/1611;;A61K9/1617;;A61K9/1688;;A61K9/1611;;A61K9/0075;;A61K9/1688;;A61K9/1617;;A61K9/50;;A61K9/5031;;A61K38/28,A61K9/16;;A61K9/12,,1,1,082-993-309-276-456,14698577;;10.1016/j.ijpharm.2003.08.019,"YAPING LI ET AL: ""Stability and release characteristics of poly(D,L-lactide-co-glycolide) encapsulated CaPi-DNA coprecipitation"", INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 269, 2004, pages 61 - 70, XP002518514",PENDING
220,EP,A2,EP 2146691 A2,159-407-683-976-302,2010-01-27,2010,EP 08733209 A,2008-04-17,US 2008/0060669 W;;US 91232007 P;;US 93812307 P,2007-04-17,NUCLEIC ACID MICROPARTICLES FOR PULMONARY DELIVERY,,BAXTER INT;;BAXTER HEALTHCARE SA,BROWN LARRY R;;GILLIS KIMBERLY A;;GALLO MICHAEL,,https://lens.org/159-407-683-976-302,Patent Application,yes,0,0,13,13,0,A61K9/0075;;A61K9/1611;;A61K9/1617;;A61K9/1688;;A61K9/1611;;A61K9/0075;;A61K9/1688;;A61K9/1617;;A61K9/50;;A61K9/5031;;A61K38/28,A61K9/12;;A61K9/16,,5,5,020-163-925-146-311;;069-208-260-031-206;;021-944-102-451-233;;060-154-035-700-962;;143-531-287-915-88X,10.1002/adma.200305782;;12408712;;10.1021/jm020233w;;17459519;;pmc7103292;;10.1016/j.addr.2007.03.003;;10.1038/nature04263;;16306938;;10.1016/j.ijbiomac.2005.01.011;;15811473,"Y. KAKIZAWA ET AL: ""Size-Controlled Formation of a Calcium Phosphate-Based Organic-Inorganic Hybrid Vector for Gene Delivery Using Poly(ethylene glycol)-block-poly(aspartic acid)"", ADVANCED MATERIALS, vol. 16, no. 8, 19 April 2004 (2004-04-19), DE, pages 699 - 702, XP055425318, ISSN: 0935-9648, DOI: 10.1002/adma.200305782;;EWERT KAI ET AL: ""Efficient synthesis and cell-transfection properties of a new multivalent cationic lipid for nonviral gene delivery"", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 45, no. 23, 7 November 2002 (2002-11-07), pages 5023 - 5029, XP002298596, ISSN: 0022-2623, DOI: 10.1021/JM020233W;;THOMAS ET AL: ""Non-viral siRNA delivery to the lung"", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM, NL, vol. 59, no. 2-3, 30 March 2007 (2007-03-30), pages 124 - 133, XP022087319, ISSN: 0169-409X, DOI: 10.1016/J.ADDR.2007.03.003;;PALLISER DEBORAH ET AL: ""An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection"", NATURE, MACMILLAN JOURNALS LTD., ETC, vol. 439, no. 7072, 5 January 2006 (2006-01-05), pages 89 - 94, XP002550734, ISSN: 0028-0836, [retrieved on 20051123], DOI: 10.1038/NATURE04263;;HACKL E V ET AL: ""DNA structural transitions induced by divalent metal ions in aqueous solutions"", INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, ELSEVIER BV, NL, vol. 35, no. 3-4, 1 April 2005 (2005-04-01), pages 175 - 191, XP027766730, ISSN: 0141-8130, [retrieved on 20050401]",DISCONTINUED
221,US,B2,US 8227667 B2,172-685-805-617-051,2012-07-24,2012,US 201213405988 A,2012-02-27,US 201213405988 A;;US 68043310 A;;US 2008/0077864 W;;US 97620707 P,2007-09-28,Polypeptides having cellobiohydrolase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY;;NOVOZYMES AS,MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/172-685-805-617-051,Granted Patent,yes,5,3,14,14,9,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C07H21/04;;A01H9/00;;C12N1/20;;C12N5/00;;C12N9/26,800/295;;435/201;;435/252.33;;435/254.1;;435/410;;536/23.2,2,1,035-863-987-433-406,17221887;;10.1002/bit.21329,"Gusakov et al., 2007, Design of Highly Efficient Cellulase Mixtures for Enzymatic Hydrolysis of Cellulose, Biotechnology Bioengineering 97: 1028-1038.;;Gusakov et al. (Jan. 24, 2008)N-Geneseq, Accession No. ALL33729.",ACTIVE
222,WO,A1,WO 2008/148131 A1,179-501-353-188-000,2008-12-04,2008,US 2008/0065393 W,2008-05-30,US 94123407 P,2007-05-31,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC;;LOPEZ DE LEON ALFREDO;;DING HANSHU;;BROWN KIMBERLY,LOPEZ DE LEON ALFREDO;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/179-501-353-188-000,Patent Application,yes,3,214,12,12,82,C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;A01K67/027;;C12N5/10;;C12N15/11;;C12N15/56,,4,3,030-861-357-228-781;;001-318-502-705-964;;070-333-389-731-762,10.1385/abab:111:3:153;;14665735;;1886523;;10.1128/mr.55.2.303-315.1991;;10.1128/mmbr.55.2.303-315.1991;;pmc372816;;10.1007/bf01025980,"REY MICHAEL W ET AL: ""Cloning, heterologous expression, and characterization of Thielavia terrestris glucoamylase."", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY DEC 2003, vol. 111, no. 3, December 2003 (2003-12-01), pages 153 - 166, XP002489740, ISSN: 0273-2289;;DATABASE UniProt [online] 15 December 2003 (2003-12-15), ""SubName: Full=Putative uncharacterized protein;"", XP002489741, retrieved from EBI accession no. UNIPROT:Q7S439 Database accession no. Q7S439;;GILKES N R ET AL: ""DOMAINS IN MICROBIAL BETA-1,4-GLYCANASES: SEQUENCE CONSERVATION, FUNCTION, AND ENZYME FAMILIES"", MICROBIOLOGICAL REVIEWS, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, vol. 55, no. 2, 1 June 1991 (1991-06-01), pages 303 - 315, XP000614304, ISSN: 0146-0749;;BREUIL C ET AL: ""PRODUCTION AND LOCALIZATION OF CELLULASES AND .BETA.-GLUCOSIDASE FROM THE THERMOPHILIC FUNGUS THIELAVIA TERRESTRIS"", BIOTECHNOLOGY LETTERS, KEW, SURREY, GB, vol. 8, no. 9, 1 January 1986 (1986-01-01), pages 673 - 676, XP009074467, ISSN: 0141-5492",PENDING
223,US,B2,US 7364892 B2,180-820-351-916-864,2008-04-29,2008,US 66975703 A,2003-09-24,US 66975703 A;;US 41305702 P,2002-09-24,Microbial trypsin mutants having chymotrypsin activity and nucleic acids encoding same,"The present invention relates to microbial trypsin variants having chymotrypsin-like activity, comprising: (a) a one or more substitutions corresponding to positions 144, 193, 198, 201, 218, 223, 227, 228, 229, 230, and 231 of amino acids 25 to 248 of SEQ ID NO: 2, (b) one or more deletions corresponding to positions 192, 197, and 226 of amino acids 25 to 248 of SEQ ID NO: 2; and (c) an insertion between positions corresponding to positions 224 and 225 of amino acids 25 to 248 of SEQ ID NO: 2. The present invention further relates to nucleotide sequences encoding microbial trypsin variants having chymotrypsin-like activity; nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; and methods of producing microbial trypsin variants having chymotrypsin-like activity or a precursor thereof.",NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY M;;ZARETSKY ELIZABETH J,NOVOZYMES INC (2005-08-29);;NOVOZYMES BIOTECH INC (2003-09-27),https://lens.org/180-820-351-916-864,Granted Patent,yes,1,2,19,19,24,C12N9/58;;C12N9/58,C12N9/48;;C07H21/04;;C12N9/58;;C12N9/64;;C12N15/00;;C12P21/06,435/212;;536/23.2;;435/69.1;;435/226;;435/440,9,7,132-695-844-930-786;;002-460-257-894-311;;055-003-061-629-507;;025-361-294-794-310;;074-227-642-330-054;;023-932-274-931-430;;015-792-604-341-547,10.1021/bi990993h;;10512619;;7592916;;10.1074/jbc.270.45.26782;;10.1073/pnas.0403255101;;pmc438954;;15197260;;14151403;;10.1038/2011284a0;;7910748;;10.1139/o93-067;;10.1074/jbc.275.9.6689;;10692479;;10.1126/science.1546324;;1546324,"Witkowski et al, Conversion of a beta-ketoacyl synthase to a malonyl decarboxylase by replacement of the active-site cysteine with glutamine. Biochemistry. Sep. 7, 1999;38(36):11643-11650.;;Wishart et al. A single mutation converts a novel phosphotyrosine binding domain into a dual-specificity phosphatase. J Biol Chem. Nov. 10, 1995;270(45):26782-26785.;;Guo et al, Protein tolerance to random amino acid change. Proc Natl Acad Sci U S A. Jun. 22, 2004;101(25):9205-9210. Epub Jun. 14, 2004.;;USPTO STIC in-house alignment of GenBank Accession No. P00766, residues 16-245, with SEQ ID No. 2, residues 25-248.;;Hartley et al, Amino-Acid Sequence of Bovine Chymotrypsinogen-A. Nature. Mar. 28, 1964;201:1284-7.;;Hames et al, Preparation and electrophoresis of polyacrylamide gels. In: Gel electrophoresis of proteins. Oxford University Press. pp. 30-32.;;Sidhu et al., 1993, Biochem. Cell. Biol. 71: 454-461.;;Screen and St. Leger, 2000, Journal of Biological Chemistry 275: 6689-6694.;;Hedstrom et al., 1992, Science 255: 1249-1253.",EXPIRED
224,US,A1,US 2012/0142075 A1,029-870-018-021-881,2012-06-07,2012,US 201213372185 A,2012-02-13,US 201213372185 A;;US 70843310 A;;US 2244108 A;;US 66975703 A;;US 41305702 P,2002-09-24,Microbial Trypsin Mutants having Chymotrypsin Activity And Nucleic Acids Encoding Same,"The present invention relates to microbial trypsin variants having chymotrypsin-like activity, comprising: (a) a one or more substitutions corresponding to positions 144, S193, 198, 201, 218, 223, 227, 228, 229, 230, and 231 of amino acids 25 to 248 of SEQ ID NO: 2, (b) one or more deletions corresponding to positions 192, 197, and 226 of amino acids 25 to 248 of SEQ ID NO: 2; and (c) an insertion between positions corresponding to positions 224 and 225 of amino acids 25 to 248 of SEQ ID NO: 2. The present invention further relates to nucleotide sequences encoding microbial trypsin variants having chymotrypsin-like activity; nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; and methods of producing microbial trypsin variants having chymotrypsin-like activity or a precursor thereof.",KLOTZ ALAN;;BROWN KIMBERLY M;;ZARETSKY ELIZABETH J;;NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY M;;ZARETSKY ELIZABETH J,,https://lens.org/029-870-018-021-881,Patent Application,yes,0,0,19,19,24,C12N9/58;;C12N9/58,C12N9/76;;C12N9/58,435/213,0,0,,,,DISCONTINUED
225,MX,A,MX 2009012846 A,025-737-944-536-632,2009-12-14,2009,MX 2009012846 A,2008-05-30,US 94123407 P;;US 2008/0065393 W,2007-05-31,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME.,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;LEON ALFREDO LOPEZ DE;;DING HANSHU,,https://lens.org/025-737-944-536-632,Patent Application,no,0,0,12,12,0,C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;A01K67/027;;C12N5/10;;C12N15/11;;C12N15/56,,0,0,,,,ACTIVE
226,EP,B1,EP 2056883 B1,053-076-714-142-451,2021-09-22,2021,EP 07813820 A,2007-08-06,US 2007/0075292 W;;US 83574206 P;;US 86491406 P,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,,BAXTER INT;;BAXTER HEALTHCARE SA;;UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,BAXTER HEALTHCARE S.A. (2010-01-06);;BAXTER INTERNATIONAL INC. (2010-01-06);;UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYS (2010-01-06),https://lens.org/053-076-714-142-451,Granted Patent,yes,4,0,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,C12N15/11;;A61K9/16;;A61K9/50;;A61K31/713,,6,0,,,"AKHTAR S ET AL: ""Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres"" INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL LNKD- DOI:10.1016/S0378-5173(97)04887-4, vol. 151, 1 January 1997 (1997-01-01), pages 57-67, XP002099631 ISSN: 0378-5173;;PHILLIPS B ET AL: ""A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes"" DIABETES, AMERICAN DIABETES ASSOCIATION, US LNKD- DOI:10.2337/DB07-0507, vol. 57, no. 6, 1 June 2008 (2008-06-01), pages 1544-1555,1, XP002541959 ISSN: 0012-1797 [retrieved on 2008-02-26];;MACHEN ET AL.: 'Antisense oligonucleotides down-regulating costimulation confer diabetes- preventtive properties to nonobese diabeteic mouse dendritic cells.' JOURNAL OF IMMUNOLOGY vol. 173, 2004, pages 4331 - 4341, XP002591643;;DE ROSA ET AL.: 'A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes.' INTERNATIONAL JOURNAL OF PHARMACEUTICS. vol. 254, 2003, pages 89 - 93, XP008103973;;Mark S. Anderson ET AL: ""THE NOD MOUSE: A Model of Immune Dysregulation"", Annual Review of Immunology, vol. 23, no. 1, 1 April 2005 (2005-04-01), pages 447-485, XP055051268, ISSN: 0732-0582, DOI: 10.1146/annurev.immunol.23.021704.115643;;AKIRAV EITAN ET AL: ""beta-Cell Mass and Type 1 Diabetes Going, Going, Gone?"", DIABETES, vol. 57, no. 11, November 2008 (2008-11), pages 2883-2888, ISSN: 0012-1797(print)",ACTIVE
227,MX,A,MX 2009011218 A,097-442-945-823-266,2010-02-11,2010,MX 2009011218 A,2008-04-17,US 91232007 P;;US 93812307 P;;US 2008/0060669 W,2007-04-17,NUCLEIC ACID MICROPARTICLES FOR PULMONARY DELIVERY.,"The present disclosure is related to microparticle compositions, in which the microparticles are made of nucleic acids and non-polymeric cations, which are suitable for administration to moist or aqueous target locations (e.g., the lung tissue), where the substantially spherical nucleic acid microparticles release the nucleic acids through dissolution, allowing the released nucleic acids to freely interact with the target cells.",BAXTER INT,BROWN LARRY R;;GILLIS KIMBERLY A;;GALLO MICHAEL,,https://lens.org/097-442-945-823-266,Patent Application,no,0,0,13,13,0,A61K9/0075;;A61K9/1611;;A61K9/1617;;A61K9/1688;;A61K9/1611;;A61K9/0075;;A61K9/1688;;A61K9/1617;;A61K9/50;;A61K9/5031;;A61K38/28,A61K9/12;;A61K9/16,,0,0,,,,ACTIVE
228,DK,T3,DK 2195424 T3,164-064-908-579-017,2019-01-07,2019,DK 08833449 T,2008-09-26,US 97620707 P;;US 2008/0077864 W,2007-09-28,"Polypeptider med cellobiohydrolase II-aktivitet og polynukleotider, som koder for dem",,NOVOZYMES AS,MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/164-064-908-579-017,Granted Patent,no,0,0,14,14,0,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C12N9/42;;C11D3/386;;C12N5/10;;C12N15/56,,0,0,,,,ACTIVE
229,CN,A,CN 101874109 A,159-133-281-479-471,2010-10-27,2010,CN 200880117634 A,2008-09-26,US 2008/0077864 W;;US 97620707 P,2007-09-28,Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS,SUCHINDRA MAIYURAN;;PAUL HARRIS;;HANSHU DING;;KIMBERLY BROWN,,https://lens.org/159-133-281-479-471,Patent Application,no,0,1,14,14,0,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C12N9/42;;C11D3/386;;C12N5/10;;C12N15/56,,0,0,,,,INACTIVE
230,AU,B2,AU 2013/213750 B2,155-652-630-459-751,2013-09-26,2013,AU 2013/213750 A,2013-08-09,AU 2007/281737 A;;AU 2013/213750 A,2007-08-06,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,"T-cell-mediated inflammation of the pancreas in a mammal is decreased by administering to the mammal a microsphere composition, in which the microspheres comprise oligonucleotides that are antisense to and targeted to bind to primary transcripts selected from the group consisting of CD40, CD80 and CD86 primary transcripts, and combinations thereof, composition being administered in an amount effective to ameliorate the symptoms of Type I diabetes in the mammal.",BAXTER HEALTHCARE SA;;BAXTER INT;;UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,,https://lens.org/155-652-630-459-751,Granted Patent,no,2,0,2,2,0,,A61K48/00,,0,0,,,,ACTIVE
231,AU,B2,AU 2008/242842 B2,150-637-611-164-440,2014-06-05,2014,AU 2008/242842 A,2008-04-17,US 93812307 P;;US 91232007 P;;US 2008/0060669 W,2007-04-17,Nucleic acid microparticles for pulmonary delivery,"The present disclosure is related to microparticle compositions, in which the microparticles are made of nucleic acids and non-polymeric cations, which are suitable for administration to moist or aqueous target locations (e.g., the lung tissue), where the substantially spherical nucleic acid microparticles release the nucleic acids through dissolution, allowing the released nucleic acids to freely interact with the target cells.",BAXTER HEALTHCARE SA;;BAXTER INT,GALLO MICHAEL;;GILLIS KIMBERLY A;;BROWN LARRY R,,https://lens.org/150-637-611-164-440,Granted Patent,no,6,0,13,13,0,A61K9/0075;;A61K9/1611;;A61K9/1617;;A61K9/1688;;A61K9/1611;;A61K9/0075;;A61K9/1688;;A61K9/1617;;A61K9/50;;A61K9/5031;;A61K38/28,A61K9/12;;A61K9/16,,1,1,082-993-309-276-456,14698577;;10.1016/j.ijpharm.2003.08.019,"Li, Yaping et al. ""Stability and release characteristics of poly(D,L-lactide-co-glycolide) encapsulated CaPi-DNA coprecipitation"" International Journal of Pharmaceutics (2004) Vol.269 pages 61 to 70",INACTIVE
232,JP,A,JP 2012180376 A,033-166-085-855-38X,2012-09-20,2012,JP 2012142190 A,2012-06-25,US 83574206 P;;US 86491406 P,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,"PROBLEM TO BE SOLVED: To provide an antisense approach to prevent and/or reverse an autoimmune diabetes condition in NOD mice.SOLUTION: AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER INT;;BAXTER HEALTHCARE SA;;UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,,https://lens.org/033-166-085-855-38X,Patent Application,no,2,0,24,24,3,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K48/00;;A61K9/127;;A61K31/7088;;A61K38/28;;A61P3/10;;A61P5/48;;A61P43/00;;C12N15/113,,0,0,,,,ACTIVE
233,AU,A1,AU 2007/281737 A1,062-154-573-315-327,2008-02-14,2008,AU 2007/281737 A,2007-08-06,US 86491406 P;;US 83574206 P;;US 2007/0075292 W,2006-08-04,Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes,,BAXTER HEALTHCARE SA;;BAXTER INT;;UNIV PITTSBURGH,GIANNOUKAKIS NICK;;GILLIS KIMBERLY A;;BROWN LARRY R,,https://lens.org/062-154-573-315-327,Patent Application,no,0,0,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K48/00,,0,0,,,,ACTIVE
234,CN,B,CN 101686939 B,085-899-472-707-752,2013-03-27,2013,CN 200880020654 A,2008-04-17,US 2008/0060669 W;;US 91232007 P;;US 93812307 P,2007-04-17,Nucleic acid microparticles for pulmonary delivery,,BAXTER INT;;BAXTER HEALTHCARE SA,BROWN LARRY R;;GILLIS KIMBERLY A;;GALLO MICHAEL,,https://lens.org/085-899-472-707-752,Granted Patent,no,0,0,13,13,0,A61K9/0075;;A61K9/1611;;A61K9/1617;;A61K9/1688;;A61K9/1611;;A61K9/0075;;A61K9/1688;;A61K9/1617;;A61K9/50;;A61K9/5031;;A61K38/28,A61K9/12;;A61K9/16,,0,0,,,,INACTIVE
235,WO,A1,WO 2009/042871 A1,092-903-127-036-858,2009-04-02,2009,US 2008/0077864 W,2008-09-26,US 97620707 P,2007-09-28,POLYPEPTIDES HAVING CELLOBIOHYDROLASE II ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY,MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/092-903-127-036-858,Patent Application,yes,3,118,14,14,9,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C12N9/42;;C11D3/386;;C12N5/10;;C12N15/56,,1,0,,,"MAIYURAN S ET AL: ""T. reesei cellobiohydrolase II (Cel6A) cDNA"", GENESEQ,, 23 June 2005 (2005-06-23), XP002492982",PENDING
236,CA,A1,CA 2682135 A1,118-020-760-931-869,2008-10-30,2008,CA 2682135 A,2008-04-17,US 91232007 P;;US 93812307 P;;US 2008/0060669 W,2007-04-17,NUCLEIC ACID MICROPARTICLES FOR PULMONARY DELIVERY,"The present disclosure is related to microparticle compositions, in which the microparticles are made of nucleic acids and non-polymeric cations, whi ch are suitable for administration to moist or aqueous target locations (e.g ., the lung tissue), where the substantially spherical nucleic acid micropar ticles release the nucleic acids through dissolution, allowing the released nucleic acids to freely interact with the target cells.",BAXTER INT;;BAXTER HEALTHCARE SA,GILLIS KIMBERLY A;;GALLO MICHAEL;;BROWN LARRY R,,https://lens.org/118-020-760-931-869,Patent Application,no,0,0,13,13,0,A61K9/0075;;A61K9/1611;;A61K9/1617;;A61K9/1688;;A61K9/1611;;A61K9/0075;;A61K9/1688;;A61K9/1617;;A61K9/50;;A61K9/5031;;A61K38/28,A61K9/12;;A61K9/16,,0,0,,,,DISCONTINUED
237,US,A1,US 2009/0019608 A1,134-371-791-591-291,2009-01-15,2009,US 13072208 A,2008-05-30,US 13072208 A;;US 94123407 P,2007-05-31,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,LOPEZ DE LEON ALFREDO;;DING HANSHU;;BROWN KIMBERLY,NOVOZYMES INC (2008-05-30),https://lens.org/134-371-791-591-291,Patent Application,yes,2,39,12,12,82,C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,A01H5/00;;C07H21/02;;C07H21/04;;C12N1/21;;C12N5/06;;C12N9/42;;C12N15/63;;C12P19/00;;C12P21/02,800/298;;435/209;;536/23.2;;435/320.1;;435/252.3;;435/69.1;;536/24.5;;435/375;;435/72,0,0,,,,INACTIVE
238,EP,A1,EP 2069489 A1,032-815-273-144-957,2009-06-17,2009,EP 08756561 A,2008-05-30,US 2008/0065393 W;;US 94123407 P,2007-05-31,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC,LOPEZ DE LEON ALFREDO;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/032-815-273-144-957,Patent Application,yes,0,0,12,12,0,C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;A01K67/027;;C12N5/10;;C12N15/11;;C12N15/56,,1,0,,,See references of WO 2008148131A1,DISCONTINUED
239,BR,B1,BR PI0817474 B1,057-679-414-115-468,2018-04-24,2018,BR PI0817474 A,2008-09-26,US 2008/0077864 W;;US 97620707 P,2007-09-28,"célula hospedeira microbiana transgênica, construção de ácido nucleico, vetor de expressão, composição detergente, e, métodos para produzir uma proteína, para degradar ou converter um material celulósico, e para produzir um produto de fermentação",,NOVOZYMES AS,HANSHU DING;;KIMBERLY BROWN;;PAUL HARRIS;;SUCHINDRA MAIYURAN,,https://lens.org/057-679-414-115-468,Granted Patent,no,0,0,14,14,0,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C11D3/386;;C12N5/10;;C12N9/42;;C12N15/56,,0,0,,,,INACTIVE
240,EP,B1,EP 2195424 B1,181-923-073-159-434,2018-11-14,2018,EP 08833449 A,2008-09-26,US 2008/0077864 W;;US 97620707 P,2007-09-28,POLYPEPTIDES HAVING CELLOBIOHYDROLASE II ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES AS,MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/181-923-073-159-434,Granted Patent,yes,2,0,14,14,0,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C12N9/42;;C11D3/386;;C12N5/10;;C12N15/56,,0,0,,,,ACTIVE
241,CN,B,CN 101874109 B,000-460-009-188-810,2013-07-10,2013,CN 200880117634 A,2008-09-26,US 2008/0077864 W;;US 97620707 P,2007-09-28,Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same,,NOVOZYMES AS,MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/000-460-009-188-810,Granted Patent,no,0,0,14,14,0,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C12N9/42;;A01H1/00;;C07K14/195;;C11D3/386;;C12N5/10;;C12N15/56,,0,0,,,,INACTIVE
242,CN,A,CN 101686939 A,028-715-487-264-732,2010-03-31,2010,CN 200880020654 A,2008-04-17,US 2008/0060669 W;;US 91232007 P;;US 93812307 P,2007-04-17,Nucleic acid microparticles for pulmonary delivery,"The present disclosure is related to microparticle compositions, in which the microparticles are made of nucleic acids and non-polymeric cations, which are suitable for administration to moist or aqueous target locations (e.g., the lung tissue), where the substantially spherical nucleic acid microparticles release the nucleic acids through dissolution, allowing the released nucleic acids to freely interact with the target cells.",BAXTER INT;;BAXTER HEALTHCARE SA,BROWN LARRY R;;GILLIS KIMBERLY A;;MICHAEL GALLO,,https://lens.org/028-715-487-264-732,Patent Application,no,0,0,13,13,0,A61K9/0075;;A61K9/1611;;A61K9/1617;;A61K9/1688;;A61K9/1611;;A61K9/0075;;A61K9/1688;;A61K9/1617;;A61K9/50;;A61K9/5031;;A61K38/28,A61K9/12;;A61K9/16,,0,0,,,,INACTIVE
243,BR,A2,BR PI0812035 A2,095-902-868-296-109,2014-10-14,2014,BR PI0812035 A,2008-05-30,US 94123407 P;;US 2008/0065393 W,2007-05-31,"POLIPEPTÍDEO ISOLA, POLINUCLEOTÍDEO ISOLADO, CONSTRUÇÃO DE ÁCIDOS NUCLEICOS, VETOR DE EXPRESSÃO RECOMBINANTE, CÉLULA HOSPEDEIRA RECOMBINANTE, MÉTODOS PARA PRODUZIR UM POLIPEPTÍDEO, UM MUTANTE DE UMA CÉLULA ORIGINÁRIA E UMA PROTEÍNA, PARA INIBIR A EXPRESSÃO DE UM POLIPEPTÍDEO EM UMA CÉLULA, PARA DEGRADAR OU CONVERTER UM MATERIAL CONTENDO CELULOSE E PARA PRODUZIR UM PRODUTO DE FERMENTAÇÃO, CÉLULA MUTANTE, PLANTA, PARTE DE PLANTA OU CÉLULA DE PLANTA TRANGÊNICA, E, MOLÉCULA DE RNA INIBIDOR DE FITA DUPLA",,NOVOZYMES INC,LEON ALFREDO LOPEZ DE;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/095-902-868-296-109,Patent Application,no,0,0,12,12,0,C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;A01K67/027;;C12N5/10;;C12N15/11;;C12N15/56,,0,0,,,,DISCONTINUED
244,US,B2,US 7705137 B2,104-773-422-849-895,2010-04-27,2010,US 2277108 A,2008-01-30,US 2277108 A;;US 66975703 A;;US 41305702 P,2002-09-24,Microbial trypsin mutants having chymotrypsin activity and nucleic acids encoding same,"The present invention relates to microbial trypsin variants having chymotrypsin-like activity, comprising: (a) a one or more substitutions corresponding to positions 144, S193A, 198, 201, 218, 223, 227, 228, 229, 230, and 231 of amino acids 25 to 248 of SEQ ID NO: 2, (b) one or more deletions corresponding to positions 192, 197, and 226 of amino acids 25 to 248 of SEQ ID NO: 2; and (c) an insertion between positions corresponding to positions 224 and 225 of amino acids 25 to 248 of SEQ ID NO: 2. The present invention further relates to nucleotide sequences encoding microbial trypsin variants having chymotrypsin-like activity; nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; and methods of producing microbial trypsin variants having chymotrypsin-like activity or a precursor thereof.",NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY M;;ZARETSKY ELIZABETH J,,https://lens.org/104-773-422-849-895,Granted Patent,yes,1,0,19,19,24,C12N9/58;;C12N9/58,C12N9/58;;C07H21/04;;C12N9/64,536/23.1;;435/226,5,5,153-464-593-185-446;;095-479-540-440-589;;074-227-642-330-054;;023-932-274-931-430;;015-792-604-341-547,10.1002/elps.1150180815;;9298654;;10.1080/08905439309549861;;7910748;;10.1139/o93-067;;10.1074/jbc.275.9.6689;;10692479;;10.1126/science.1546324;;1546324,"Wise et al, Peptide-mass fingerprinting and the ideal covering set for protein characterisation. Electrophoresis. Aug. 1997;18(8):1399-409.;;Gagne et al, Use of proteolytic enzymes to facilitate the recovery of chitin from shrimp wastes. Food biotechnology (New York, N.Y.) (USA) v. 7(3) p. 253-263 (1993).;;Sidhu et al., 1993, Biochem. Cell. Biol. 71: 454-461.;;Screen and St. Leger, 2000, Journal of Biological Chemistry 275: 6689-6694.;;Hedstrom et al., 1992, Science 255: 1249-1253.",EXPIRED
245,US,A1,US 2005/0037368 A1,110-602-236-036-082,2005-02-17,2005,US 66975703 A,2003-09-24,US 66975703 A;;US 41305702 P,2002-09-24,Microbial trypsin mutants having chymotrypsin activity and nucleic acids encoding same,"The present invention relates to microbial trypsin variants having chymotrypsin-like activity, comprising: (a) a one or more substitutions corresponding to positions 144, S193A, 198, 201, 218, 223, 227, 228, 229, 230, and 231 of amino acids 25 to 248 of SEQ ID NO: 2, (b) one or more deletions corresponding to positions 192, 197, and 226 of amino acids 25 to 248 of SEQ ID NO: 2; and (c) an insertion between positions corresponding to positions 224 and 225 of amino acids 25 to 248 of SEQ ID NO: 2. The present invention further relates to nucleotide sequences encoding microbial trypsin variants having chymotrypsin-like activity; nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; and methods of producing microbial trypsin variants having chymotrypsin-like activity or a precursor thereof.",NOVOZYMES BIOTECH INC,KLOTZ ALAN;;BROWN KIMBERLY M;;ZARETSKY ELIZABETH J,NOVOZYMES INC (2005-08-29);;NOVOZYMES BIOTECH INC (2003-09-27),https://lens.org/110-602-236-036-082,Patent Application,yes,1,3,19,19,23,C12N9/58;;C12N9/58,C12N9/58,435/6;;435/69.1;;435/213;;435/252.3;;435/320.1;;536/23.5,0,0,,,,EXPIRED
246,CN,A,CN 105168146 A,129-560-402-020-367,2015-12-23,2015,CN 201510351313 A,2007-08-06,US 83574206 P;;US 86491406 P;;CN 200780028951 A,2006-08-04,Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes,"The invention relates to a microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes. Especially the invention adopts AS-oligonucleotides which are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER INT;;BAXTER HEALTHCARE SA;;UNIV PITTSBURG OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,,https://lens.org/129-560-402-020-367,Patent Application,no,0,0,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K9/16;;A61K31/711;;A61K48/00;;A61P3/10,,0,0,,,,DISCONTINUED
247,AU,B2,AU 2007/281737 B2,186-427-631-250-283,2013-09-19,2013,AU 2007/281737 A,2007-08-06,US 86491406 P;;US 83574206 P;;US 2007/0075292 W,2006-08-04,Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes,"AS-oIigonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER HEALTHCARE SA;;BAXTER INT;;UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION,BROWN LARRY R;;GILLIS KIMBERLY A;;GIANNOUKAKIS NICK,,https://lens.org/186-427-631-250-283,Granted Patent,no,2,0,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K48/00,,0,0,,,,ACTIVE
248,US,A,US 5332286 A,020-068-535-100-574,1994-07-26,1994,US 95801792 A,1992-10-07,US 95801792 A,1992-10-07,Booster seat apparatus,"An invertible booster seat apparatus is provided for a chair having a supporting seat and a laterally curved seat back. The booster seat includes a pair of spaced apart side supports, each having a first support portion for engaging the supporting seat and a second support portion for defining an armrest. The side support portions are invertible such that the second support portions engage the supporting seat and the first support portions define armrests. A seat section interconnects the side supports between the first support portions and the second support portions. The seat section has a first seat surface for supporting a person thereon when the first support portions engage the supporting seat and an opposite second seat surface for supporting a person thereon when the second support portions engages the supporting seat. The seat section further has a convexly curved rearward edge portion for engaging the curved seat back of the chair. A substantially fully open first back region is formed adjacent the first seat surface and between the second side support portions for cooperating with the curved seat back of the chair to define a seat back for a person seated on the first seat surface. A substantially fully open second back region is formed adjacent the second seat surface in between the first side support portions for cooperating with the curved seat back of the chair to define a seat back for a person seated on the second seat surface.",ATHERTON JESSICA A;;ATHERTON ANN;;BROWN KIMBERLY S,ATHERTON JESSICA A;;ATHERTON ANN;;BROWN KIMBERLY S,KOALA CORPORATION A CO CORP (1994-08-05);;BOBRICK WASHROOM EQUIPMENT INC (2004-05-06),https://lens.org/020-068-535-100-574,Granted Patent,yes,15,36,1,1,0,A47D1/103;;A47D1/103,A47D1/10,297/256.11;;297/194,0,0,,,,EXPIRED
249,US,B1,US 6800467 B1,095-857-093-247-140,2004-10-05,2004,US 8012798 A,1998-05-15,US 8012798 A;;US 85788697 A;;US 6289397 P,1997-05-16,Polypeptides having aminopeptidase activity and nucleic acids encoding same,"
    The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides. 
",NOVOZYMES BIOTECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY,NOVOZYMES INC (2005-08-29);;NOVOZYMES A/S (2001-10-29);;NOVOZYMES BIOTECH INC (1998-05-22),https://lens.org/095-857-093-247-140,Granted Patent,yes,6,7,16,52,9,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/09;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N15/57;;C12P21/02;;C12P21/06;;C12R1/69,435/183;;530/300;;530/350,13,8,001-474-003-742-829;;063-640-832-834-034;;173-895-997-627-60X;;022-378-368-953-890;;050-857-506-269-557;;049-365-732-118-873;;007-822-064-014-928;;003-849-961-384-35X,5418942;;pmc376746;;10.1128/am.19.4.598-603.1970;;10631780;;10.1016/s0167-7799(99)01398-0;;10.1271/bbb1961.37.775;;10.1271/bbb1961.37.767;;8175800;;10.1016/s0021-9258(17)36879-5;;10.1101/gr.3.5.s77;;8038692;;10.1128/mcb.8.3.1247-1252.1988;;10.1128/mcb.8.3.1247;;pmc363269;;3285178;;1699952;;pmc2116333;;10.1083/jcb.111.5.2129,"Kundu et al., Applied Microbiology, Apr. 1970, pp. 598-603.*;;Skolnick et al., Trends in Biotech., 18(1):34-39, 2000.*;;Nakadai et al., Agr. Biol. Chem., 37(4):775-782, 1973.*;;Nakadai et al., Agr. Biol. Chem., 37(4):767-774, 1973.*;;Nishizawa et al., J. Biol. Chem., 269(18):13651-55, 1994.*;;Jenkins et al., PCR Methods and Applications, S77-82, 1994.*;;Choh, PNAS., 77(6):3211-14, 1980.*;;Lazar et al, Mol.and Cell Biol 8:1247-1252, 1988.*;;Burgess et al, J.Cell Bio. 111:2129-2138, 1990.*;;Abstract, File Medline, Stn. Medline Ceasar Accession No. 1870 (XP-002077232), May 1977.;;Abstract, File Medline, Stn Medline Caesar Accession No. 1872 (XP-002077233), Oct. 1976.;;Database WPI, Section Ch, Week 9130, (XP-002077234).;;Database WPI, Section Ch, Week 9710, (XP-002076623).",EXPIRED
250,US,B2,US 8044264 B2,084-551-855-480-360,2011-10-25,2011,US 13072208 A,2008-05-30,US 13072208 A;;US 94123407 P,2007-05-31,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,LOPEZ DE LEON ALFREDO;;DING HANSHU;;BROWN KIMBERLY,NOVOZYMES INC (2008-05-30),https://lens.org/084-551-855-480-360,Granted Patent,yes,5,14,12,12,82,C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N15/31;;A01H5/00;;C12N15/10;;C12N15/52;;C12N15/82,800/288;;800/284;;800/295;;800/278;;435/320.1;;435/468;;536/23.1;;536/23.2;;536/23.7,3,3,070-333-389-731-762;;001-318-502-705-964;;030-861-357-228-781,10.1007/bf01025980;;1886523;;10.1128/mr.55.2.303-315.1991;;10.1128/mmbr.55.2.303-315.1991;;pmc372816;;10.1385/abab:111:3:153;;14665735,"Breuil et al., Production and localization of cellulases and Beta-glucosidase from the thermophilic fungus Thielavia terrestris, Biotechnology Letters, 1986, vol. 8, No. 9, pp. 673-676.;;Gilkes et al., Domains in microbial Beta-1,4-glycanases: sequences conservation, function, and enzyme families, Microbiological Reviews, Jun. 1991, vol. 55, No. 2, pp. 303-315.;;Rey et al., Cloning, heterologous expression, and characterization of Thielavia terrestris glucoamylase, Applied Biochemistry and Biotechnology, 2003, vol. 111, No. 3, pp. 153-166.",INACTIVE
251,EP,A2,EP 2647712 A2,057-958-165-347-277,2013-10-09,2013,EP 13175410 A,2007-08-06,US 83574206 P;;US 86491406 P;;EP 07813820 A,2006-08-04,Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes,"AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER INT;;BAXTER HEALTHCARE SA;;UNIV PITTSBURGH,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,,https://lens.org/057-958-165-347-277,Patent Application,yes,18,0,24,24,3,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,C12N15/11;;A61K9/16;;A61K9/50;;A61K31/7088;;A61P3/10;;C12N15/113,,0,0,,,,DISCONTINUED
252,US,A1,US 2010/0151515 A1,134-337-057-830-869,2010-06-17,2010,US 70843310 A,2010-02-18,US 70843310 A;;US 2277108 A;;US 66975703 A;;US 41305702 P,2002-09-24,Microbial trypsin mutants having chymotrypsin activity and nucleic acids encoding same,"The present invention relates to microbial trypsin variants having chymotrypsin-like activity, comprising: (a) a one or more substitutions corresponding to positions 144, S193A, 198, 201, 218, 223, 227, 228, 229, 230, and 231 of amino acids 25 to 248 of SEQ ID NO: 2, (b) one or more deletions corresponding to positions 192, 197, and 226 of amino acids 25 to 248 of SEQ ID NO: 2; and (c) an insertion between positions corresponding to positions 224 and 225 of amino acids 25 to 248 of SEQ ID NO: 2. The present invention further relates to nucleotide sequences encoding microbial trypsin variants having chymotrypsin-like activity; nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; and methods of producing microbial trypsin variants having chymotrypsin-like activity or a precursor thereof.",NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY M;;ZARETSKY ELIZABETH J,,https://lens.org/134-337-057-830-869,Patent Application,yes,2,0,19,19,24,C12N9/58;;C12N9/58,C12N9/58;;C12P21/02,435/68.1,0,0,,,,EXPIRED
253,AU,A1,AU 2008/242842 A1,099-239-681-316-859,2008-10-30,2008,AU 2008/242842 A,2008-04-17,US 93812307 P;;US 91232007 P;;US 2008/0060669 W,2007-04-17,Nucleic acid microparticles for pulmonary delivery,,BAXTER INT;;BAXTER HEALTHCARE SA,BROWN LARRY R;;GILLIS KIMBERLY A;;GALLO MICHAEL,,https://lens.org/099-239-681-316-859,Patent Application,no,0,0,13,13,0,A61K9/0075;;A61K9/1611;;A61K9/1617;;A61K9/1688;;A61K9/1611;;A61K9/0075;;A61K9/1688;;A61K9/1617;;A61K9/50;;A61K9/5031;;A61K38/28,A61K9/12;;A61K9/16,,0,0,,,,INACTIVE
254,US,A1,US 2009/0035820 A1,106-179-883-109-145,2009-02-05,2009,US 2277108 A,2008-01-30,US 2277108 A;;US 66975703 A;;US 41305702 P,2002-09-24,Microbial Trypsin Mutants Having Chymotrypsin Activity And Nucleic Acids Encoding Same,"The present invention relates to microbial trypsin variants having chymotrypsin-like activity, comprising: (a) a one or more substitutions corresponding to positions 144, S193A, 198, 201, 218, 223, 227, 228, 229, 230, and 231 of amino acids 25 to 248 of SEQ ID NO: 2, (b) one or more deletions corresponding to positions 192, 197, and 226 of amino acids 25 to 248 of SEQ ID NO: 2; and (c) an insertion between positions corresponding to positions 224 and 225 of amino acids 25 to 248 of SEQ ID NO: 2. The present invention further relates to nucleotide sequences encoding microbial trypsin variants having chymotrypsin-like activity; nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; and methods of producing microbial trypsin variants having chymotrypsin-like activity or a precursor thereof.",NOVOZYMES INC,KLOTZ ALAN;;BROWN KIMBERLY M;;ZARETSKY ELIZABETH J,,https://lens.org/106-179-883-109-145,Patent Application,yes,0,1,19,19,24,C12N9/58;;C12N9/58,C12N1/20;;C12P21/04;;C12N9/58;;C12N15/00;;C12N15/11,435/69.1;;536/23.7;;435/320.1;;435/252.33,0,0,,,,EXPIRED
255,EP,A3,EP 2647712 A3,154-034-764-713-773,2013-11-20,2013,EP 13175410 A,2007-08-06,US 83574206 P;;US 86491406 P;;EP 07813820 A,2006-08-04,Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes,"AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER INT;;BAXTER HEALTHCARE SA;;UNIV PITTSBURGH,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,,https://lens.org/154-034-764-713-773,Search Report,yes,4,0,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,C12N15/11;;A61K9/16;;A61K9/50;;A61K31/7088;;A61P3/10;;C12N15/113,,5,5,024-794-940-793-652;;052-224-457-964-942;;022-513-680-221-802;;045-583-226-081-588;;014-193-579-163-943,15383562;;10.4049/jimmunol.173.7.4331;;12419284;;10.1006/jaut.2002.0605;;15690148;;10.1007/s00125-004-1645-7;;10.1016/s0378-5173(97)04887-4;;pmc2713034;;18316361;;10.2337/db07-0507,"MACHEN ET AL: ""Antisense oligonucleosides down-regulating costimulation confer diabetes-preventtive properties to nonobese diabetic mouse dendritic cells"", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 173, 1 October 2004 (2004-10-01), pages 4331 - 4341, XP008103972, ISSN: 0022-1767;;MOORE WAYNE V ET AL: ""Prevention of autoimmune diabetes in the DRBB rat by CD40/154 blockade"", JOURNAL OF AUTOIMMUNITY, LONDON, GB, vol. 19, no. 3, 30 October 2002 (2002-10-30), pages 139 - 145, XP002443303, ISSN: 0896-8411, DOI: 10.1006/JAUT.2002.0605;;KLEIN D ET AL: ""A functional CD40 receptor is expressed in pancreatic beta cells"", DIABETOLOGIA ; CLINICAL AND EXPERIMENTAL DIABETES AND METABOLISM, SPRINGER, BERLIN, DE, vol. 48, no. 2, 3 February 2005 (2005-02-03), pages 268 - 276, XP019322454, ISSN: 1432-0428, DOI: 10.1007/S00125-004-1645-7;;AKHTAR S ET AL: ""Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres"", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL LNKD- DOI:10.1016/S0378-5173(97)04887-4, vol. 151, 12 May 1997 (1997-05-12), pages 57 - 67, XP002099631, ISSN: 0378-5173;;PHILLIPS B ET AL: ""A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes"", DIABETES, AMERICAN DIABETES ASSOCIATION, US LNKD- DOI:10.2337/DB07-0507, vol. 57, no. 6, 3 March 2008 (2008-03-03), pages 1544 - 1555,1, XP002541959, ISSN: 0012-1797, [retrieved on 20080226]",DISCONTINUED
256,BR,A2,BR PI0817474 A2,177-278-794-697-01X,2017-05-23,2017,BR PI0817474 A,2008-09-26,US 2008/0077864 W;;US 97620707 P,2007-09-28,"polipeptídeo isolado, construção de ácido nucleico, célula hospedeira recombinante, métodos para produzir polipeptídeo, um mutante de uma célula precursora, e uma substância, para inibir a expressão de um polipeptídeo em uma célula, e para degradar ou converter um material celulósico, planta, parte de planta ou célula de planta transgênica, molécula de rna inibidora de filamento duplo, e, composição detergente.",,NOVOZYMES AS,HANSHU DING;;KIMBERLY BROWN;;PAUL HARRIS;;SUCHINDRA MAIYURAN,,https://lens.org/177-278-794-697-01X,Patent Application,no,0,0,14,14,0,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C11D3/386;;C12N5/10;;C12N9/42;;C12N15/56,,0,0,,,,INACTIVE
257,WO,A3,WO 2002/046429 A3,189-652-655-101-370,2004-02-19,2004,US 0150686 W,2001-11-01,US 70444900 A,2000-11-01,POLYPEPTIDES HAVING GLUCOAMYLASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having glucoamylase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES BIOTECH INC,REY MICHAEL;;XU FENG;;GOLIGHTLY ELIZABETH;;BROWN KIMBERLY,,https://lens.org/189-652-655-101-370,Search Report,yes,1,0,4,4,0,C12N9/2428;;C12N9/2428;;C12Y302/01003;;C12Y302/01003,C12N9/34;;C12N15/56,,4,2,025-057-733-757-276;;015-266-887-425-600,10.1016/0141-0229(89)90010-0;;10.1128/aem.53.2.284-291.1987;;16347277;;pmc203653,"DATABASE SWISSPROT [online] 1 October 2000 (2000-10-01), SCHULTE, U. ET AL.: ""GLUCAN-1,4-ALPHA-GLUCOSIDASE"", XP002231290, retrieved from EBI Database accession no. Q9P5U5;;DATABASE SWISSPROT [online] 1 April 1990 (1990-04-01), STONE, P.J. ET AL.: ""Glucoamylase precursor (EC 3.2.1.3)"", XP002231291, retrieved from EBI Database accession no. P14804;;KOH-LUAR S I ET AL: ""EXPORTED PROTEINS OF NEUROSPORA-CRASSA 1 GLUCOAMYLASE"", ENZYME AND MICROBIAL TECHNOLOGY, vol. 11, no. 10, 1989, pages 692 - 695, XP009005942, ISSN: 0141-0229;;STEVENS C A ET AL: ""PRODUCTION OF MICROBIAL BIOMASS PROTEIN FROM POTATO PROCESSING WASTES BY CEPHALOSPORIUM-EICHHORNIAE"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 53, no. 2, 1987, pages 284 - 291, XP009005940, ISSN: 0099-2240",PENDING
258,WO,A3,WO 2008/019346 A3,188-700-457-986-005,2008-11-13,2008,US 2007/0075292 W,2007-08-06,US 83574206 P;;US 86491406 P,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,"AS-oIigonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER INT;;BAXTER HEALTHCARE SA;;CHILDREN S HOSPITAL OF PITTSBU;;BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,,https://lens.org/188-700-457-986-005,Search Report,yes,0,0,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K48/00,,2,2,024-794-940-793-652;;034-667-111-517-352,15383562;;10.4049/jimmunol.173.7.4331;;12615416;;10.1016/s0378-5173(02)00689-0,"MACHEN ET AL.: ""Antisense oligonucleotides down-regulating costimulation confer diabetes- preventtive properties to nonobese diabeteic mouse dendritic cells."", JOURNAL OF IMMUNOLOGY, vol. 173, 2004, pages 4331 - 4341, XP002591643;;DE ROSA ET AL.: ""A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes."", INTERNATIONAL JOURNAL OF PHARMACEUTICS., vol. 254, 2003, pages 89 - 93, XP008103973",PENDING
259,US,B2,US 8207400 B2,117-830-054-311-96X,2012-06-26,2012,US 201113238755 A,2011-09-21,US 201113238755 A;;US 13072208 A;;US 94123407 P,2007-05-31,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",LOPEZ DE LEON ALFREDO;;DING HANSHU;;BROWN KIMBERLY;;NOVOZYMES INC,LOPEZ DE LEON ALFREDO;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/117-830-054-311-96X,Granted Patent,yes,5,0,12,12,82,C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N15/31;;A01H5/00;;C12N15/10;;C12N15/52;;C12N15/82,800/288;;800/284;;800/295;;800/278;;435/320.1;;435/468;;536/23.1;;536/23.2;;536/23.7,4,1,030-861-357-228-781,10.1385/abab:111:3:153;;14665735,"Breuil et al., 1986, Biotechnol Lett 8 (9), 673-676.;;Gikes et al., 1991, Microbiol Rev 55 (2), 305-315.;;Rey et al., 2003, Appl Biochem Biotechnol 111, 153-166.;;UNIPROTKB, XP-002489741, Accession No. Q7S439, 2003.",ACTIVE
260,EP,A2,EP 2056883 A2,038-756-752-565-098,2009-05-13,2009,EP 07813820 A,2007-08-06,US 2007/0075292 W;;US 83574206 P;;US 86491406 P,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,,BAXTER INT;;BAXTER HEALTHCARE SA;;UNIV PITTSBURGH,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,BAXTER HEALTHCARE S.A. (2010-01-06);;BAXTER INTERNATIONAL INC. (2010-01-06);;UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYS (2010-01-06),https://lens.org/038-756-752-565-098,Patent Application,yes,0,0,24,24,0,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K9/16;;C12N15/11;;A61K9/50;;A61K31/713,,0,0,,,,ACTIVE
261,US,A1,US 2012/0276640 A1,082-721-813-377-695,2012-11-01,2012,US 201213548706 A,2012-07-13,US 201213548706 A;;US 201213405988 A;;US 68043310 A;;US 2008/0077864 W;;US 97620707 P,2007-09-28,Polypeptides Having Cellobiohydrolase Activity And Polynucleotides Encoding Same,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY;;NOVOZYMES AS,MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/082-721-813-377-695,Patent Application,yes,0,0,14,14,9,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C12N1/15;;C12N9/42;;C12N1/21;;C12N15/63;;C12N15/70;;C12N15/80,435/484;;435/471;;435/476;;435/252.33;;435/254.11;;435/209,0,0,,,,INACTIVE
262,US,A1,US 2008/0039369 A1,114-701-806-104-366,2008-02-14,2008,US 83455007 A,2007-08-06,US 83455007 A;;US 83574206 P;;US 86491406 P,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,"AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER INT;;BAXTER HEALTHCARE SA,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A,BAXTER HEALTHCARE S.A (2007-09-05);;UNIVERSITY OF PITTSBURGH (2008-04-29);;UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (2008-07-08);;BAXTER INTERNATIONAL INC (2007-09-05),https://lens.org/114-701-806-104-366,Patent Application,yes,99,1,24,24,3,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K38/28;;A61K31/7088;;A61P3/10;;A61P37/00,514/4;;514/44,0,0,,,,ACTIVE
263,CN,A,CN 101784659 A,144-397-030-934-411,2010-07-21,2010,CN 200880101361 A,2008-05-30,US 2008/0065393 W;;US 94123407 P,2007-05-31,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES INC,ALFREDO LOPEZ DE LEON;;HANSHU DING;;KIMBERLY BROWN,,https://lens.org/144-397-030-934-411,Patent Application,no,0,8,12,12,0,C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12Y302/01004;;C12Y302/01004;;C12Y302/01021;;C12Y302/01021;;C12Y302/01091;;C12Y302/01091,C12N9/24;;A01K67/027;;C12N5/10;;C12N15/11;;C12N15/56,,0,0,,,,INACTIVE
264,US,A1,US 2012/0156755 A1,180-306-843-936-659,2012-06-21,2012,US 201213405988 A,2012-02-27,US 201213405988 A;;US 68043310 A;;US 2008/0077864 W;;US 97620707 P,2007-09-28,POLYPEPTIDES HAVING CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY;;NOVOZYMES AS,MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/180-306-843-936-659,Patent Application,yes,0,0,14,14,9,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C12N9/42;;A01H5/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N15/56;;C12N15/63,435/209;;536/23.2;;435/320.1;;800/298;;435/419;;435/252.31;;435/252.35;;435/252.33;;435/252.34;;435/325;;435/348;;435/254.11;;435/254.2;;435/254.21;;435/254.22;;435/254.23;;435/254.3;;435/254.7;;435/254.8;;435/254.4;;435/254.5;;435/254.6,0,0,,,,ACTIVE
265,US,B2,US 8377693 B2,192-068-392-802-073,2013-02-19,2013,US 201213548706 A,2012-07-13,US 201213548706 A;;US 201213405988 A;;US 68043310 A;;US 2008/0077864 W;;US 97620707 P,2007-09-28,Polypeptides having cellobiohydrolase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.",NOVOZYMES AS;;MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY,MAIYURAN SUCHINDRA;;HARRIS PAUL;;DING HANSHU;;BROWN KIMBERLY,,https://lens.org/192-068-392-802-073,Granted Patent,yes,5,2,14,14,9,C11D3/38645;;C12Y302/01091;;C12N9/2437;;C12N9/2437;;C11D3/38645;;C12Y302/01091,C12N1/00;;C12N15/79,435/471;;435/254.11;;536/23.2,2,1,035-863-987-433-406,17221887;;10.1002/bit.21329,"Gusakov et al., 2007, Design of Highly Efficient Cellulase Mixtures for Enzymatic Hydrolysis of Cellulose, Biotechnology Bioengineering 97: 1028-1038.;;Guskov et al, Jan. 24, 2008, Geneseq, Access No. ALK33729.",INACTIVE
266,US,A1,US 2010/0322386 A1,014-787-884-681-438,2010-12-23,2010,US 21769708 A,2008-07-08,US 21769708 A;;US 50508706 A;;US 70852505 P,2005-08-16,Holder device for dental x-ray digital sensor,"A sensor holder ( 10 ) includes a frame member ( 20 ) that bounds a void area ( 21 ) and which is configured to receive a sensor ( 11 ). A retaining means ( 50, 51 ) is provided to hold the sensor ( 11 ) to the frame ( 20 ) such that a connecting cable ( 12 ) affixed to the sensor ( 11 ) is secured and positioned by the void area ( 21 ) for a subsequent imaging procedure.",STECK JOHN E;;BROWN KIMBERLY C;;SULLIVAN NICOLE L,STECK JOHN E;;BROWN KIMBERLY C;;SULLIVAN NICOLE L,,https://lens.org/014-787-884-681-438,Patent Application,yes,11,2,10,10,0,A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512;;A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512,A61B6/14,378/191,0,0,,,,ACTIVE
267,US,A1,US 2013/0217463 A1,064-779-874-534-833,2013-08-22,2013,US 201213402612 A,2012-02-22,US 201213402612 A,2012-02-22,GAMING SYSTEM AND METHOD DISPLAYING ONE OR MORE ADDITIONAL SYMBOLS OF A GROUP OF DESIGNATED SYMBOLS WHEN LESS THAN ALL OF THE DESIGNATED SYMBOLS OF THE GROUP ARE DISPLAYED,"In various embodiments, the gaming system is configured to operate a slot game including a plurality of reels, one of which includes a plurality of designated symbols adjacent to one another on the reel forming a group of designated symbols. For a play of the game, if at least a first quantity of the designated symbols of the group of designated symbols but less than a second greater quantity of the designated symbols of the group of designated symbols is displayed, the gaming system displays one or more other designated symbols of the group of designated symbols in addition to the displayed designated symbols of the group of designated symbols such that the second greater quantity of the designated symbols is displayed. The gaming system determines and provides any awards based on the displayed symbols including any displayed designated symbols of the second greater quantity of the designated symbols.",HUGHES WILLIAM K;;BROWN BRADFORD D;;LEFEVER KIMBERLY N;;IGT RENO NEV,HUGHES WILLIAM K;;BROWN BRADFORD D;;LEFEVER KIMBERLY N,IGT (2012-02-21),https://lens.org/064-779-874-534-833,Patent Application,yes,5,19,4,4,0,G07F17/3213;;G07F17/3213;;G07F17/3244;;G07F17/3244;;G07F17/3267;;G07F17/3267;;G07F17/34;;G07F17/34,A63F9/24,463/20,0,0,,,,ACTIVE
268,IN,B,IN 190892 B,107-142-898-938-509,2003-08-30,2003,IN 372MA2000 A,2000-05-12,IN 372MA2000 A;;IN 1064MA1998 A;;US 5788497 A,1997-05-18,A method for obtaining a hydrolysate from a proteinaceous substrate,,NOVOZYMES BIOTECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL W;;BYUN TONY,,https://lens.org/107-142-898-938-509,Granted Patent,no,0,1,1,1,0,,A23L27/21;;C08H1/00,,0,0,,,,EXPIRED
269,WO,A1,WO 2023/283572 A1,174-669-417-034-471,2023-01-12,2023,US 2022/0073455 W,2022-07-06,US 202163218783 P,2021-07-06,SYSTEMS AND METHODS FOR TROCAR SIMULATION WITH ADMITTANCE HAPTIC FEEDBACK,"Devices, systems and methods to provide an admittance haptic feedback in response to an external force input applied to an elongated member in order to simulate a trocar insertion. In certain embodiments, the admittance haptic feedback is configured to simulate penetration of and advancement through a plurality of layers of tissue of a patient, and in particular embodiments, the admittance haptic feedback is configured to simulate penetration of and advancement through a skin layer, a muscle and fat layer, and a peritoneum layer.",UNIV TEXAS,FEY ANN;;KHO KIMBERLY;;GALVAN ALDO;;WILLIAMS-BROWN MARIAN,,https://lens.org/174-669-417-034-471,Patent Application,yes,4,0,1,1,0,A61B17/34;;G09B23/285,G09B23/28;;A61B17/34;;A61B34/00;;A61B90/50;;G06F3/01;;G09B9/00,,1,0,,,"CHOLLANGI RAVIKIRAN: ""Design and development of a haptic device for a trocar insertion minimum invasive procedure simulator "", PROQUEST DISSERTATIONS, 14 August 2014 (2014-08-14), XP093023447, [retrieved on 20230214]",PENDING
270,US,B2,US 9251653 B2,018-787-223-612-537,2016-02-02,2016,US 201213402612 A,2012-02-22,US 201213402612 A,2012-02-22,Gaming system and method displaying one or more additional symbols of a group of designated symbols when less than all of the designated symbols of the group are displayed,"In various embodiments, the gaming system is configured to operate a slot game including a plurality of reels, one of which includes a plurality of designated symbols adjacent to one another on the reel forming a group of designated symbols. For a play of the game, if at least a first quantity of the designated symbols of the group of designated symbols but less than a second greater quantity of the designated symbols of the group of designated symbols is displayed, the gaming system displays one or more other designated symbols of the group of designated symbols in addition to the displayed designated symbols of the group of designated symbols such that the second greater quantity of the designated symbols is displayed. The gaming system determines and provides any awards based on the displayed symbols including any displayed designated symbols of the second greater quantity of the designated symbols.",HUGHES WILLIAM K;;BROWN BRADFORD D;;LEFEVER KIMBERLY N;;IGT RENO NEV,HUGHES WILLIAM K;;BROWN BRADFORD D;;LEFEVER KIMBERLY N,IGT (2012-02-21),https://lens.org/018-787-223-612-537,Granted Patent,yes,104,2,4,4,0,G07F17/3213;;G07F17/3213;;G07F17/3244;;G07F17/3244;;G07F17/3267;;G07F17/3267;;G07F17/34;;G07F17/34,A63F9/24;;G07F17/32;;G07F17/34,,0,0,,,,ACTIVE
271,US,A1,US 2007/0121789 A1,162-688-636-331-722,2007-05-31,2007,US 50508706 A,2006-08-16,US 50508706 A;;US 70852505 P,2005-08-16,Holder device for dental x-ray digital sensor,"A sensor holder ( 10 ) includes a frame member ( 20 ) that bounds a void area ( 21 ) and which is configured to receive a sensor ( 11 ). A retaining means ( 50, 51 ) is provided to hold the sensor ( 11 ) to the frame ( 20 ) such that a connecting cable ( 12 ) affixed to the sensor ( 11 ) is secured and positioned by the void area ( 21 ) for a subsequent imaging procedure.",DENTSPLY RES AND DEV CORP,STECK JOHN E;;BROWN KIMBERLY C;;SULLIVAN NICOLE L,,https://lens.org/162-688-636-331-722,Patent Application,yes,9,6,10,10,0,A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512;;A61B6/4233;;G03B42/042;;G03C3/003;;A61B6/512,A61B6/14;;G03B42/02;;G03C5/16,378/168,0,0,,,,DISCONTINUED
272,US,B2,US 11507674 B2,136-427-660-365-983,2022-11-22,2022,US 201916550072 A,2019-08-23,US 201916550072 A,2019-08-23,Quantifying privacy impact,"This document relates to evaluating privacy impact for organization risk management. For example, quantifiable methods are provided by way of a privacy impact model to calculate a relative value for privacy impact can be used to calculate risk and prioritize risk mitigations and take corrective actions.",MICROSOFT TECHNOLOGY LICENSING LLC,LUCY KIMBERLY DENISE;;TRIM SAMUEL TERRENCE;;BROWN NICHOLAS GREGG,,https://lens.org/136-427-660-365-983,Granted Patent,yes,9,1,5,5,0,G06Q40/08;;G06F3/04842;;G06F21/604;;G06F3/048,G06F3/048;;G06F3/04842;;G06F21/60,,3,0,,,"“Guidelines on Data Protection Impact Assessment (DPIA)”, In Guidelines of Article 29 Data Protection Working Party, wp248rev.01, Oct. 13, 2017, 22 Pages.;;“Information Technology—Security Techniques—Information Security Risk Management”, In International Standard, ISO/IEC JTC 1/SC 27 N17973, Reference No. ISO/IEC FDIS 27005:2018(E), Apr. 12, 2018, 67 Pages.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2020/039407”, dated Aug. 10, 2020, 13 Pages.",ACTIVE
273,EP,B1,EP 2508134 B1,183-458-277-804-003,2019-04-17,2019,EP 12004974 A,2006-11-16,US 73749905 P;;EP 06837936 A;;US 2006/0044714 W,2005-11-17,HOLDER DEVICE FOR DENTAL X-RAY DIGITAL SENSOR,,DENTSPLY SIRONA INC,STECK JOHN E;;BROWN KIMBERLY C;;SULLIVAN NICOLE L,DENTSPLY SIRONA INC. (2018-01-17),https://lens.org/183-458-277-804-003,Granted Patent,yes,9,0,8,8,0,G03B42/042;;A61B6/4435;;A61B6/512,A61B6/14;;G03B42/04,,0,0,,,,ACTIVE
274,US,A1,US 2011/0190518 A1,009-548-429-616-758,2011-08-04,2011,US 65789610 A,2010-01-29,US 65789610 A,2010-01-29,Propylene oxide process,"A process for producing propylene oxide from propylene is disclosed. The process comprises reacting propylene and an oxidant selected from the group consisting of hydrogen peroxide and oxygen in a slurry comprising a catalyst and a solvent having a boiling point of 110° C. or lower to produce a reaction mixture. The reaction mixture including the catalyst is distilled to produce a vapor stream comprising propylene, propylene oxide, and at least a portion of the solvent, and a slurry stream comprising the solvent and the catalyst. At least a portion of the slurry stream is recycled to the reaction step.",WOLFF RICHARD J;;PETRY KIMBERLY A;;BROWN BLAKE S,WOLFF RICHARD J;;PETRY KIMBERLY A;;BROWN BLAKE S,LYONDELL CHEMICAL TECHNOLOGY L.P (2010-01-26),https://lens.org/009-548-429-616-758,Patent Application,yes,30,4,2,2,0,C07D301/06;;C07D301/12;;Y02P20/584;;C07D301/06;;C07D301/12;;Y02P20/584,C07D301/06;;C07D301/12,549/531;;549/533,0,0,,,,INACTIVE
275,US,B2,US 10347074 B2,099-645-879-140-688,2019-07-09,2019,US 201615001917 A,2016-01-20,US 201615001917 A;;US 201213402612 A,2012-02-22,Gaming system and method displaying one or more additional symbols of a group of designated symbols when less than all of the designated symbols of the group are displayed,"In various embodiments, the gaming system is configured to operate a slot game including a plurality of reels, one of which includes a plurality of designated symbols adjacent to one another on the reel forming a group of designated symbols. For a play of the game, if at least a first quantity of the designated symbols of the group of designated symbols but less than a second greater quantity of the designated symbols of the group of designated symbols is displayed, the gaming system displays one or more other designated symbols of the group of designated symbols in addition to the displayed designated symbols of the group of designated symbols such that the second greater quantity of the designated symbols is displayed. The gaming system determines and provides any awards based on the displayed symbols including any displayed designated symbols of the second greater quantity of the designated symbols.",IGT RENO NEV,HUGHES WILLIAM K;;BROWN BRADFORD D;;LEFEVER KIMBERLY N,IGT (2012-02-21),https://lens.org/099-645-879-140-688,Granted Patent,yes,301,0,4,4,0,G07F17/3213;;G07F17/3213;;G07F17/3244;;G07F17/3244;;G07F17/3267;;G07F17/3267;;G07F17/34;;G07F17/34,G07F17/32;;G07F17/34,,0,0,,,,ACTIVE
276,EP,A1,EP 3997657 A1,060-294-268-267-893,2022-05-18,2022,EP 20740456 A,2020-06-24,US 201916550072 A;;US 2020/0039407 W,2019-08-23,QUANTIFIYING PRIVACY IMPACT,,MICROSOFT TECHNOLOGY LICENSING LLC,LUCY KIMBERLY DENISE;;TRIM SAMUEL TERRENCE;;BROWN NICHOLAS GREGG,,https://lens.org/060-294-268-267-893,Patent Application,yes,0,0,5,5,0,G06Q40/08;;G06F3/04842;;G06F21/604;;G06F3/048,G06Q40/08,,0,0,,,,PENDING
277,US,A1,US 2016/0140797 A1,083-599-862-036-715,2016-05-19,2016,US 201615001917 A,2016-01-20,US 201615001917 A;;US 201213402612 A,2012-02-22,GAMING SYSTEM AND METHOD DISPLAYING ONE OR MORE ADDITIONAL SYMBOLS OF A GROUP OF DESIGNATED SYMBOLS WHEN LESS THAN ALL OF THE DESIGNATED SYMBOLS OF THE GROUP ARE DISPLAYED,"In various embodiments, the gaming system is configured to operate a slot game including a plurality of reels, one of which includes a plurality of designated symbols adjacent to one another on the reel forming a group of designated symbols. For a play of the game, if at least a first quantity of the designated symbols of the group of designated symbols but less than a second greater quantity of the designated symbols of the group of designated symbols is displayed, the gaming system displays one or more other designated symbols of the group of designated symbols in addition to the displayed designated symbols of the group of designated symbols such that the second greater quantity of the designated symbols is displayed. The gaming system determines and provides any awards based on the displayed symbols including any displayed designated symbols of the second greater quantity of the designated symbols.",IGT RENO NEV,HUGHES WILLIAM K;;BROWN BRADFORD D;;LEFEVER KIMBERLY N,IGT (2012-02-21),https://lens.org/083-599-862-036-715,Patent Application,yes,6,0,4,4,0,G07F17/3213;;G07F17/3213;;G07F17/3244;;G07F17/3244;;G07F17/3267;;G07F17/3267;;G07F17/34;;G07F17/34,G07F17/32;;G07F17/34,,0,0,,,,ACTIVE
278,US,B2,US 8207360 B2,082-636-552-333-101,2012-06-26,2012,US 65789610 A,2010-01-29,US 65789610 A,2010-01-29,Propylene oxide process,"A process for producing propylene oxide from propylene is disclosed. The process comprises reacting propylene and an oxidant selected from the group consisting of hydrogen peroxide and oxygen in a slurry comprising a catalyst and a solvent having a boiling point of 110° C. or lower to produce a reaction mixture. The reaction mixture including the catalyst is distilled to produce a vapor stream comprising propylene, propylene oxide, and at least a portion of the solvent, and a slurry stream comprising the solvent and the catalyst. At least a portion of the slurry stream is recycled to the reaction step.",WOLFF RICHARD J;;PETRY KIMBERLY A;;BROWN BLAKE S;;LYONDELL CHEMICAL TECH LP,WOLFF RICHARD J;;PETRY KIMBERLY A;;BROWN BLAKE S,LYONDELL CHEMICAL TECHNOLOGY L.P (2010-01-26),https://lens.org/082-636-552-333-101,Granted Patent,yes,30,0,2,2,0,C07D301/06;;C07D301/12;;Y02P20/584;;C07D301/06;;C07D301/12;;Y02P20/584,C07D301/12;;C07D301/06,549/533;;549/531;;549/532,5,5,031-633-930-957-859;;050-945-924-552-953;;003-730-684-934-473;;004-060-727-206-078;;062-471-846-674-173,10.1080/01614949709353777;;10.1038/378159a0;;10.1038/368321a0;;8127366;;10.1039/a709093e;;10.1016/s0920-5861(99)00036-x,"George N. Vayssilov, ""Structural and Physicochemical Features of Titanium Silicalites,"" Catal. Rev.-Sci. Eng., 1997, 39(3), pp. 209-251, Marcel Dekker, Inc.;;Thomas Maschmeyer et al., ""Heterogeneous catalysts obtained by grafting metallocene complexes onto mesoporous silica,"" Nature, 1995, vol. 378, pp. 159-162.;;Peter T. Tanev et al., ""Titanium-containing mesoporous molecular sieves for catalytic oxidation of aromatic compounds,"" Nature, 1994, vol. 368, pp. 321-323.;;Avelino Corma et al. ""Synthesis of Si and Ti-Si-MCM-48 mesoporous materials with controlled pore sizes in the absence of polar organic additives and alkali metal ions,"" Chem. Commun., 1998, pp. 579-580.;;Di Wei et al., ""Catalytic behavior of vanadium substituted mesoporous molecular sieves,"" Catalysis Today 51, 1999, pp. 501-511, Elsevier.",INACTIVE
279,US,B2,US 8808747 B2,142-820-937-308-155,2014-08-19,2014,US 10521308 A,2008-04-17,US 10521308 A;;US 91232007 P;;US 93812307 P,2007-04-17,Nucleic acid microparticles for pulmonary delivery,"The present disclosure is related to microparticle compositions, in which the microparticles are made of nucleic acids and non-polymeric cations, which are suitable for administration to moist or aqueous target locations (e.g., the lung tissue), where the substantially spherical nucleic acid microparticles release the nucleic acids through dissolution, allowing the released nucleic acids to freely interact with the target cells.",BROWN LARRY R;;GILLIS KIMBERLY A;;GALLO MICHAEL V;;BAXTER INT;;BAXTER HEALTHCARE SA,BROWN LARRY R;;GILLIS KIMBERLY A;;GALLO MICHAEL V,BAXTER HEALTHCARE S.A (2008-05-25);;BAXTER INTERNATIONAL INC (2008-05-25),https://lens.org/142-820-937-308-155,Granted Patent,yes,101,5,13,13,0,A61K9/0075;;A61K9/1611;;A61K9/1617;;A61K9/1688;;A61K9/1611;;A61K9/0075;;A61K9/1688;;A61K9/1617;;A61K9/50;;A61K9/5031;;A61K38/28,A61K9/50;;A61K38/28,424/489;;424/490,28,14,013-579-391-170-434;;074-651-230-981-494;;082-993-309-276-456;;080-116-623-771-28X;;060-154-035-700-962;;042-141-681-245-225;;011-742-171-197-453;;020-603-043-979-22X;;045-037-679-495-988;;096-890-332-732-065;;036-752-040-947-900;;124-633-490-849-185;;014-151-529-676-200;;032-160-986-739-702,10.4049/jimmunol.165.3.1438;;10903748;;10.1007/s11248-007-9107-x;;17594530;;14698577;;10.1016/j.ijpharm.2003.08.019;;12074364;;10.1089/108729002760070849;;10.1038/nature04263;;16306938;;10.1634/stemcells.2007-0241;;17615263;;10.1038/nbt1339;;17873866;;10.1080/10611860400003858;;15545089;;10.1002/jat.727;;11180276;;6527103;;6780722;;10.1007/bf01478928;;10.1016/s0167-4889(02)00204-5;;12063176;;10.1023/a:1007526301331;;11205729;;10.1016/s0168-3659(03)00194-9;;12880694,"Kingston, et al. (1999) Transfection and Expression of Cloned DNA. Curr. Prot. Immun., Unit 10.13:1-9.;;Jiang, et al. (2000) The Role of Cell Surface Receptors in the Activation of Human B Cells by Phosphorothioate Oligonucleotides, The Journal of Immunology, v.165:1438-45.;;US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;Guo et al., Transgenic Research, 16:829-834 (2007).;;International Search Report and Written Opinion from PCT/US2008/060669 dated Mar. 23, 2009.;;Li et al., ""Stability and release characteristics of poly(D,L-lactide-co-glycolide) encapsulated CaPi-DNA coprecipitation,"" International Journal of Pharmaceutics 269:61-70 (2004).;;M. Manoharan Antisense & Nucleic Acid Drug Development 12:103-128 (2002).;;Pallisner, et al., Nature 439:89-94 (2006).;;Skobridis et al., ARKIVOC (vi) 459-469 (2005).;;Swenson, et al., Stem Cells, 25:2593-2600 (2007).;;Wolfram, et al., Nature Biotechnology 25:1149-1157 (2007).;;Khan et al., Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and Ribozymes: In vitro and in vivo studies. J. Drug Targeting, 12(6): 393-404 (2004).;;Diehl et al., A good practice guide to the administration of substances and removal of blood, including routes and volumes, J. Appl. Toxicol., 21: 15-33 (2001).;;Falkenberg et al., Polyclonal and monoclonal antibodies as reagents in biochemical and in clinical-chemical analysis, J. Clin. Chem. Biochem., 22: 867-82 (1984).;;Huber et al., Spatial structure of immunoglobulin molecules. Klin. Wochenscher., 58: 1217-31 (1998).;;Moghimi et al., Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers, Biochim. Biophys. Acta, 1590: 131-9 (2002).;;Morita et al., Formation and isolation of spherical fine protein microparticles through lyophilization of protein-poly(ethylene glycol) aqueous mixture, Pharma. Res., 17(11): 1367-63 (2000).;;Sinha et al., Biodegradable microspheres for protein delivery, J. Controlled Release, 90(3): 261-80 (2003).;;Non-Final Office Action issued in connection with U.S. Appl. No. 10/894,430, dated Feb. 27, 2008.;;Final Office Action issued in connection with U.S. Appl. No. 10/894,430, dated Aug. 18, 2009.;;Non-Final Office Action issued in connection with U.S. Appl. No. 10/894,430, dated Dec. 19, 2010.;;Notice of Allowance issued in connection with U.S. Appl. No. 10/894,430, dated Sep. 13, 2011.;;Non-Final Office Action issued in connection with U.S. Appl. No. 11/127,704, dated Jul. 17, 2006.;;Non-Final Office Action issued in connection with U.S. Appl. No. 11/127,704, dated Dec. 12, 2007.;;Non-Final Office Action issued in connection with U.S. Appl. No. 11/127,704, dated Jun. 2, 2009.;;Final Office Action issued in connection with U.S. Appl. No. 11/127,704, dated Jun. 14, 2012.;;Notice of Allowance issued in connection with U.S. Appl. No. 11/127,704, dated Aug. 14, 2012.;;International Search Report issued in connection with International Application No. PCT/US2005/016651, dated Sep. 5, 2005.",ACTIVE
280,US,A1,US 2009/0017124 A1,056-802-602-590-025,2009-01-15,2009,US 10521308 A,2008-04-17,US 10521308 A;;US 91232007 P;;US 93812307 P,2007-04-17,Nucleic Acid Microparticles for Pulmonary Delivery,"The present disclosure is related to microparticle compositions, in which the microparticles are made of nucleic acids and non-polymeric cations, which are suitable for administration to moist or aqueous target locations (e.g., the lung tissue), where the substantially spherical nucleic acid microparticles release the nucleic acids through dissolution, allowing the released nucleic acids to freely interact with the target cells.",BAXTER INT;;BAXTER HEALTHCARE SA,BROWN LARRY R;;GILLIS KIMBERLY A;;GALLO MICHAEL V,BAXTER HEALTHCARE S.A (2008-05-25);;BAXTER INTERNATIONAL INC (2008-05-25),https://lens.org/056-802-602-590-025,Patent Application,yes,99,8,13,13,0,A61K9/0075;;A61K9/1611;;A61K9/1617;;A61K9/1688;;A61K9/1611;;A61K9/0075;;A61K9/1688;;A61K9/1617;;A61K9/50;;A61K9/5031;;A61K38/28,A61K9/14;;A61K31/7088,424/489;;514/44,0,0,,,,ACTIVE
281,EP,A1,EP 1968450 A1,072-722-466-735-110,2008-09-17,2008,EP 06837936 A,2006-11-16,US 2006/0044714 W;;US 73749905 P,2005-11-17,HOLDER DEVICE FOR DENTAL X-RAY DIGITAL SENSOR,,DENTSPLY INT INC,STECK JOHN E;;BROWN KIMBERLY C;;SULLIVAN NICOLE L,,https://lens.org/072-722-466-735-110,Patent Application,yes,0,0,8,8,0,G03B42/042;;A61B6/4435;;A61B6/512,A61B6/14;;G03B42/04,,0,0,,,,DISCONTINUED
282,CA,C,CA 2619888 C,162-147-507-546-370,2016-04-12,2016,CA 2619888 A,2006-11-16,US 73749905 P;;US 2006/0044714 W,2005-11-17,HOLDER DEVICE FOR DENTAL X-RAY DIGITAL SENSOR,A sensor holder includes a frame member that bounds a void area and which is configured to receive a sensor. A retaining means is provided to hold the sensor to the frame such that a connecting cable affixed to the sensor is secured and positioned by the void area for a subsequent imaging procedure .,DENTSPLY INT INC,STECK JOHN E;;BROWN KIMBERLY C;;SULLIVAN NICOLE L,,https://lens.org/162-147-507-546-370,Granted Patent,no,0,0,8,8,0,G03B42/042;;A61B6/4435;;A61B6/512,A61B6/14;;G03B42/04,,0,0,,,,ACTIVE
283,US,A1,US 2021/0056213 A1,185-555-952-873-975,2021-02-25,2021,US 201916550072 A,2019-08-23,US 201916550072 A,2019-08-23,QUANTIFIYING PRIVACY IMPACT,"This document relates to evaluating privacy impact for organization risk management. For example, quantifiable methods are provided by way of a privacy impact model to calculate a relative value for privacy impact can be used to calculate risk and prioritize risk mitigations and take corrective actions.",MICROSOFT TECHNOLOGY LICENSING LLC,LUCY KIMBERLY DENISE;;TRIM SAMUEL TERRENCE;;BROWN NICHOLAS GREGG,MICROSOFT TECHNOLOGY LICENSING LLC (2019-09-10),https://lens.org/185-555-952-873-975,Patent Application,yes,0,3,5,5,0,G06Q40/08;;G06F3/04842;;G06F21/604;;G06F3/048,G06F21/60;;G06F3/0484,,0,0,,,,ACTIVE
284,WO,A1,WO 2007/061865 A1,197-793-740-704-757,2007-05-31,2007,US 2006/0044714 W,2006-11-16,US 73749905 P,2005-11-17,HOLDER DEVICE FOR DENTAL X-RAY DIGITAL SENSOR,A sensor holder includes a frame member that bounds a void area and which is configured to receive a sensor. A retaining means is provided to hold the sensor to the frame such that a connecting cable affixed to the sensor is secured and positioned by the void area for a subsequent imaging procedure .,DENTSPLY INT INC;;STECK JOHN E;;BROWN KIMBERLY C;;SULLIVAN NICOLE L,STECK JOHN E;;BROWN KIMBERLY C;;SULLIVAN NICOLE L,,https://lens.org/197-793-740-704-757,Patent Application,yes,6,4,8,8,0,G03B42/042;;A61B6/4435;;A61B6/512,A61B6/14;;G03B42/04,,0,0,,,,PENDING
285,US,A,US 3343227 A,049-100-367-758-923,1967-09-26,1967,US 51335765 A,1965-12-13,US 51335765 A,1965-12-13,Fastening method and apparatus,,BROWN JOHN M;;KIMBERLY NED P;;SEGERSTROM FREDERICK W,BROWN JOHN M;;KIMBERLY NED P;;SEGERSTROM FREDERICK W,,https://lens.org/049-100-367-758-923,Granted Patent,no,1,17,1,1,0,E04F13/0801;;E04F13/0835;;Y10T29/49833;;Y10T29/49838;;Y10T29/49879;;Y10T29/49833;;Y10T29/49838;;Y10T29/49879;;E04F13/0835;;E04F13/0801,E04F13/08,,0,0,,,,EXPIRED
286,CA,A1,CA 2619888 A1,015-215-612-837-710,2007-03-31,2007,CA 2619888 A,2006-11-16,US 73749905 P;;US 2006/0044714 W,2005-11-17,HOLDER DEVICE FOR DENTAL X-RAY DIGITAL SENSOR,,DENTSPLY INT INC,BROWN KIMBERLY C;;SULLIVAN NICOLE L;;STECK JOHN E,,https://lens.org/015-215-612-837-710,Patent Application,no,0,0,8,8,0,G03B42/042;;A61B6/4435;;A61B6/512,A61B6/14;;G03B42/04,,0,0,,,,ACTIVE
287,EP,A1,EP 2508134 A1,166-331-929-410-532,2012-10-10,2012,EP 12004974 A,2006-11-16,US 73749905 P;;EP 06837936 A;;US 2006/0044714 W,2005-11-17,HOLDER DEVICE FOR DENTAL X-RAY DIGITAL SENSOR,"A holder for a digital dental x-ray sensor of the type having a connecting cable, the holder being designed to securely retain, centrally align, and perpendicularly align said sensor to an x-ray source, said holder comprising: 
a bite block affixed to an upstanding frame; said frame further provided with a plurality of latch fingers configured to resiliently receive the sensor in a snap-fit relation so as to removeably secure the sensor to said frame  characterized in that 
(v) sensor retention is provided by means of tension pinch applied by integrated and opposing clamping arms of sufficient distance apart so that perpendicular alignment by means of this pinch is provided in conjunction with a contact surface of the clamping arms, 
(vi) assembly of the sensor is facilitated by means of a flex slot between said clamping arms which allows the unit to dynamically overcome the clamp arm tension pinch without putting excessive loading on said sensor, 
(vii) central alignment of said sensor to an x-ray source is facilitated by means of a stiffening rib to minimize deflection of the holder relative to an attached alignment bar and ring, and 
(viii) cord retention of said sensor is provided by means of an integrated cord clip.",DENTSPLY INT INC,STECK JOHN E;;BROWN KIMBERLY C;;SULLIVAN NICOLE L,DENTSPLY SIRONA INC. (2018-01-17),https://lens.org/166-331-929-410-532,Patent Application,yes,11,0,8,8,0,G03B42/042;;A61B6/4435;;A61B6/512,A61B6/14;;G03B42/04,,0,0,,,,ACTIVE
288,CA,A1,CA 2593246 A1,109-581-732-592-699,2006-07-13,2006,CA 2593246 A,2006-01-06,US 64227405 P;;US 2006/0000659 W,2005-01-06,POLYPEPTIDES HAVING CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/109-581-732-592-699,Patent Application,no,0,0,20,20,17,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,INACTIVE
289,WO,A3,WO 2006/074435 A3,088-230-972-141-526,2006-08-31,2006,US 2006/0000659 W,2006-01-06,US 64227405 P,2005-01-06,POLYPEPTIDES HAVING CELLOBIOHYDRLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/088-230-972-141-526,Search Report,yes,2,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,4,3,007-543-030-043-518;;123-688-920-928-02X;;053-935-128-053-707,10.1016/0378-1119(87)90472-0;;3596237;;10584016;;10.1128/aem.65.12.5546-5553.1999;;pmc91756;;8964516;;10.1016/0378-1119(96)00179-5,"KAZUHISA MIYAMOTO: ""Renewable biological systems for alternative sustainable energy production (FAO Agricultural Services Bulletin - 128)"", 1997, FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATION, XP002380509;;TEERI T T ET AL: ""Homologous domains in Trichoderma reesei cellulolytic enzymes: Gene sequence and expression of cellobiohydrolase II"", GENE, ELSEVIER, AMSTERDAM, NL, vol. 51, no. 1, 1987, pages 43 - 52, XP002282656, ISSN: 0378-1119;;IWASHITA K ET AL: ""The bglA gene of Aspergillus kawachii encodes both extracellular and cell wall-bound beta-glucosidases"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 65, no. 12, December 1999 (1999-12-01), pages 5546 - 5553, XP002226970, ISSN: 0099-2240;;KAWAGUCHI T ET AL: ""Cloning and sequencing of the cDNA encoding beta-glucosidase 1 from Aspergillus aculeatus"", GENE, ELSEVIER, AMSTERDAM, NL, vol. 173, no. 2, 16 September 1996 (1996-09-16), pages 287 - 288, XP004043232, ISSN: 0378-1119",PENDING
290,EP,A2,EP 1836299 A2,111-757-870-924-610,2007-09-26,2007,EP 06733650 A,2006-01-06,US 2006/0000659 W;;US 64227405 P,2005-01-06,POLYPEPTIDES HAVING CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/111-757-870-924-610,Patent Application,yes,0,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,ACTIVE
291,AT,T1,AT E414775 T1,145-725-908-499-099,2008-12-15,2008,AT 98921134 T,1998-05-12,US 85788497 A;;US 6289297 P,1997-05-16,POLYPEPTIDE MIT PROLYLDIPEPTIDYLAMINOPEPTIDASE- AKTIVITÄT UND DAFÜR KODIERENDE NUKLEINSÄUREN,"The present invention relates to isolated polypeptides having dipeptidyl aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL;;KLOTZ ALAN;;BYUN TONY,,https://lens.org/145-725-908-499-099,Granted Patent,no,0,0,14,15,0,A21D2/267;;A21D8/042;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A21D8/042;;A23J3/34;;A23L27/21,C12N15/09;;A21D2/26;;A21D8/04;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12N15/57;;C12P21/06;;C12R1/69,,0,0,,,,EXPIRED
292,US,B2,US 10096050 B2,173-059-989-432-198,2018-10-09,2018,US 201514820781 A,2015-08-07,US 201514820781 A;;US 201462035106 P,2014-08-08,Systems and methods for managing group chats during ecommerce sessions,"A computer implemented method for managing a group chat during an ecommerce session is provided. The method includes initiating a chat session between at least a first client computer device associated with a first participant and a second client computer device associated with a second participant, and sharing at least one view of an ecommerce website with the first client computer device and the second client computer device. The first client computer device and the second client computer device are configured to display the at least one view of the ecommerce website. The at least one view includes at least one purchasable item. The method also includes initiating a purchase transaction for the at least one purchasable item included in the at least one view, receiving payment information for the purchase transaction, and completing the purchase transaction based on the payment information.",MASTERCARD INTERNATIONAL INC,PURCELL KIMBERLY;;HOSP ADAM K;;SINGH MALAVIKA;;BROWN DAVID C,MASTERCARD INTERNATIONAL INCORPORATED (2015-08-19),https://lens.org/173-059-989-432-198,Granted Patent,yes,30,1,9,9,0,G06Q30/0613;;G06Q30/0613;;G06Q30/0613;;G06Q20/12;;G06Q20/12;;G06Q20/12;;G06Q30/0605;;G06Q30/0605;;G06Q30/0617;;G06Q30/0617;;G06Q30/0619;;G06Q30/0619;;G06Q30/0641;;G06Q30/0641;;G06Q30/0643;;G06Q30/0643;;G06Q30/0643;;H04L12/1813;;H04L12/1822;;H04L12/1822;;H04L12/1822;;H04L12/185;;H04L12/185;;H04L12/185;;H04L51/10;;H04L51/10,G06Q30/06;;G06Q20/12;;H04L12/18;;H04L12/58,,4,0,,,"Brown, E., “9 Ways to Win on the Web,” Fortune, vol. 139, Issue 10, pp. 112-121, May 24, 1999.;;PCT International Search Report and Written Opinion for related PCT Application No. PCT/US2015/044172 dated Nov. 19, 2015; 11 pp.;;KR Office Action for related application 10-2017-700634 dated Jun. 11, 2018; 11 pp.;;JP Office Action for related application 2017-506832 dated May 14, 2018; 4 pp.",ACTIVE
293,EP,A2,EP 1781681 A2,000-507-616-961-84X,2007-05-09,2007,EP 05770178 A,2005-07-06,US 2005/0023987 W;;US 58610304 P,2004-07-06,POLYPEPTIDES HAVING ALPHA-GLUCOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC,YAVER DEBBIE;;LIN JANINE;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL,,https://lens.org/000-507-616-961-84X,Patent Application,yes,0,0,12,12,10,C12N9/2411;;C12N9/2411;;C12C5/004;;C12C5/004;;C12C11/003;;C12C11/003;;C12C12/02;;C12C12/02;;C12N9/2408;;C12N9/2408,C12N15/56;;A01H5/00;;C12C11/00;;C12N1/15;;C12N9/26;;C12N15/63;;C12P21/00,,0,0,,,,DISCONTINUED
294,US,A1,US 2008/0274499 A1,018-714-135-784-235,2008-11-06,2008,US 5383108 A,2008-03-24,US 5383108 A;;US 17686405 A;;US 58610304 P,2004-07-06,Polypeptides having alpha-glucosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,YAVER DEBBIE;;LIN JANINE;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL,,https://lens.org/018-714-135-784-235,Patent Application,yes,1,0,12,12,10,C12N9/2411;;C12N9/2411;;C12C5/004;;C12C5/004;;C12C11/003;;C12C11/003;;C12C12/02;;C12C12/02;;C12N9/2408;;C12N9/2408,C12P21/04;;C12N1/20;;C12N15/00;;C12N15/11,435/69.1;;536/23.2;;435/320.1;;435/252.33,0,0,,,,INACTIVE
295,EP,B2,EP 1836299 B2,012-360-367-639-121,2014-03-12,2014,EP 06733650 A,2006-01-06,US 2006/0000659 W;;US 64227405 P,2005-01-06,POLYPEPTIDES HAVING CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/012-360-367-639-121,Granted Patent,yes,2,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,4,0,,,"KAZUHISA MIYAMOTO: ""Renewable biological systems for alternative sustainable energy production (FAO Agricultural Services Bulletin - 128)"" 1997, FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATION , XP002380509 Chapter 3.2.1 amd 3.2.2 tables 3-1;;TEERI T T ET AL: ""Homologous domains in Trichoderma reesei cellulolytic enzymes: Gene sequence and expression of cellobiohydrolase II"" GENE, ELSEVIER, AMSTERDAM, NL, vol. 51, no. 1, 1987, pages 43-52, XP002282656 ISSN: 0378-1119;;IWASHITA K ET AL: ""The bglA gene of Aspergillus kawachii encodes both extracellular and cell wall-bound beta-glucosidases"" APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 65, no. 12, December 1999 (1999-12), pages 5546-5553, XP002226970 ISSN: 0099-2240;;KAWAGUCHI T ET AL: ""Cloning and sequencing of the cDNA encoding beta-glucosidase 1 from Aspergillus aculeatus"" GENE, ELSEVIER, AMSTERDAM, NL, vol. 173, no. 2, 16 September 1996 (1996-09-16), pages 287-288, XP004043232 ISSN: 0378-1119",ACTIVE
296,CA,C,CA 2593246 C,008-586-695-530-958,2016-06-21,2016,CA 2593246 A,2006-01-06,US 64227405 P;;US 2006/0000659 W,2005-01-06,POLYPEPTIDES HAVING CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/008-586-695-530-958,Granted Patent,no,0,0,20,20,17,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,INACTIVE
297,AU,A,AU 1996/068603 A,021-479-970-642-733,1997-03-19,1997,AU 1996/068603 A,1996-08-20,US 280095 P;;US 9613728 W,1995-08-25,Purified coprinus laccases and nucleic acids encoding same,"The present invention relates to polypeptides having laccase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides.",NOVO NORDISK AS;;NOVO NORDISK BIOTECH INC,YAVER DEBBIE SUE;;BROWN KIMBERLY M;;KAUPPINEN SAKARI;;HALKIER TORBEN,,https://lens.org/021-479-970-642-733,Patent Application,no,0,0,12,12,0,C07K14/37;;C12N9/0061;;C12N9/0061;;C07K14/37,C07K14/37;;C12N1/21;;C12N9/02;;C12N15/53,,0,0,,,,PENDING
298,EP,A2,EP 0788547 A2,037-641-663-785-80X,1997-08-13,1997,EP 96929060 A,1996-08-20,US 9613728 W;;US 280095 P,1995-08-25,PURIFIED COPRINUS LACCASES AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to polypeptides having laccase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS,YAVER DEBBIE SUE;;BROWN KIMBERLY M;;KAUPPINEN SAKARI;;HALKIER TORBEN,"NOVO NORDISK BIOTECH, INC. (2001-01-24);;NOVOZYMES, INC. (2005-06-22);;NOVOZYMES A/S (2005-06-22);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/037-641-663-785-80X,Patent Application,yes,0,10,12,12,0,C07K14/37;;C12N9/0061;;C12N9/0061;;C07K14/37,C07K14/37;;C12N1/21;;C12N9/02;;C12N15/53,,0,0,,,,EXPIRED
299,WO,A2,WO 2006/074435 A2,094-024-916-946-207,2006-07-13,2006,US 2006/0000659 W,2006-01-06,US 64227405 P,2005-01-06,POLYPEPTIDES HAVING CELLOBIOHYDRLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/094-024-916-946-207,Patent Application,yes,0,121,20,20,17,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,PENDING
300,ES,T3,ES 2358243 T3,052-608-713-086-310,2011-05-06,2011,ES 06733650 T,2006-01-06,US 64227405 P;;US 2006/0000659 W,2005-01-06,POLIPEPTIDOS CON ACTIVIDAD CELOBIOHIDROLASA Y POLINUCLEOTIDOS QUE LOS CODIFICAN.,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/052-608-713-086-310,Granted Patent,no,0,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,ACTIVE
301,US,A1,US 2010/0192260 A1,061-670-126-881-225,2010-07-29,2010,US 69645310 A,2010-01-29,US 69645310 A;;US 5383108 A;;US 17686405 A;;US 58610304 P,2004-07-06,Polypeptides having alpha-glucosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,YAVER DEBBIE;;LIN JANINE;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL,,https://lens.org/061-670-126-881-225,Patent Application,yes,1,0,12,12,10,C12N9/2411;;C12N9/2411;;C12C5/004;;C12C5/004;;C12C11/003;;C12C11/003;;C12C12/02;;C12C12/02;;C12N9/2408;;C12N9/2408,A01H5/00;;C12N5/10;;C12N9/24;;C12P21/00,800/295;;435/419;;435/69.1;;435/200,0,0,,,,INACTIVE
302,EP,A4,EP 1511443 A4,060-729-515-346-522,2009-07-08,2009,EP 03757358 A,2003-06-06,US 0317755 W;;US 16576302 A,2002-06-07,ENDOVASCULAR GRAFT WITH SENSORS DESIGN AND ATTACHMENT METHODS,,ENDOVASCULAR TECH INC,BROWN PETER S;;LEMERE MARK T;;BARKMAN KIMBERLY;;KOVAC TIM,,https://lens.org/060-729-515-346-522,Search Report,no,3,0,6,6,0,A61B5/0028;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61B5/076;;A61B7/001;;A61B2560/0219;;A61F2/07;;A61F2002/065;;A61F2002/067;;A61F2250/0002;;A61B5/076;;A61B5/0028;;A61B2560/0219;;A61F2002/065;;A61B7/001;;A61F2250/0002;;A61F2002/067;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61F2/07,A61B5/00;;A61F2/02;;A61F2/06,,1,0,,,See also references of WO 03103539A1,EXPIRED
303,US,B2,US 7220565 B2,085-558-829-315-327,2007-05-22,2007,US 32782106 A,2006-01-06,US 32782106 A;;US 64227405 P,2005-01-06,Polypeptides having cellobiohydrolase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,NOVOZYMES INC (2006-01-05),https://lens.org/085-558-829-315-327,Granted Patent,yes,3,19,20,20,17,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42;;C07H21/04;;C11D3/00;;C12N1/20;;C12P19/02;;C12P19/34;;C12P21/06,435/209;;435/69.1;;435/91.1;;435/91.4;;435/105;;435/252.33;;435/320.1;;435/471;;435/476;;510/320;;536/23.2,4,3,059-498-703-815-196;;007-543-030-043-518;;123-688-920-928-02X,10.1046/j.1432-1327.1998.2560119.x;;9746354;;10.1016/0378-1119(87)90472-0;;3596237;;10584016;;10.1128/aem.65.12.5546-5553.1999;;pmc91756,"Harrison et al., Modified glycosylation of cellobiohydrolase I from a high cellulase-producing mutant strain of Trichoderma reesei. Eur. J. Biochem., 1998. vol. 256: 119-127.;;Miyamoto, Kazuhisa, Renewable biological systems for alternative sustainable energy production (FAO Agricultural Services Bulletin-128), Food and Agriculture Organization, Chapter 3.2.1 and 3.2.2 tables 3-1, 1997.;;Teeri, Tuula. T., et al., Homologous domains in Trichoderma reesei cellulolytic enzymes: cellobiohydrolase II, Gene, 1987, vol. 51, No. 1, pp. 43-52.;;Iwashita, Kazuhiro et al., The bglA Gene of Aspergillus kawachii Encodes Both Extracellular and Cell Wall-Bound beta-Glucosidases, Applied and Enbironmental Microbiology, vol. 65, No. 12, Dec. 1999, pp. 5546-5553.",ACTIVE
304,WO,A3,WO 1997/008325 A3,147-313-252-559-002,1997-03-06,1997,US US9613728,1996-08-20,"US 60/0/002,800",1995-08-25,PURIFIED COPRINUS LACCASES AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to polypeptides having laccase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides.","NOVO NORDISK BIOTECH, INC.;;NOVO NORDISK A/S","YAVER, Debbie, Sue;;BROWN, Kimberly, M.;;KAUPPINEN, Sakari;;HALKIER, Torben",,https://lens.org/147-313-252-559-002,Search Report,yes,0,0,1,1,0,,C12N9/02,,0,0,,,,UNKNOWN
305,US,A1,US 2011/0171347 A1,184-804-267-295-271,2011-07-14,2011,US 201113042090 A,2011-03-07,US 201113042090 A;;US 69645310 A;;US 5383108 A;;US 17686405 A;;US 58610304 P,2004-07-06,Polypeptides having Alpha-glucosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,YAVER DEBBIE;;LIN JANINE;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL,,https://lens.org/184-804-267-295-271,Patent Application,yes,1,0,12,12,10,C12N9/2411;;C12N9/2411;;C12C5/004;;C12C5/004;;C12C11/003;;C12C11/003;;C12C12/02;;C12C12/02;;C12N9/2408;;C12N9/2408,C12C11/00;;C12N9/26,426/16;;435/201,0,0,,,,DISCONTINUED
306,MX,A,MX 2007008050 A,195-166-454-972-683,2007-08-21,2007,MX 2007008050 A,2006-01-06,US 64227405 P;;US 2006/0000659 W,2005-01-06,POLYPEPTIDES HAVING CELLOBIOHYDRLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME.,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,HARRIS PAUL;;BROWN KIMBERLY;;LEON ALFREDO LOPEZ DE;;MERINO SANDRA,,https://lens.org/195-166-454-972-683,Patent Application,no,0,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,ACTIVE
307,US,B2,US 8389493 B2,060-468-361-671-951,2013-03-05,2013,US 201113103433 A,2011-05-09,US 201113103433 A;;US 83455007 A;;US 83574206 P;;US 86491406 P,2006-08-04,Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes,"AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A;;TRUCCO MASSIMO;;BAXTER INT;;BAXTER HEALTHCARE SA;;UNIV PITTSBURGH,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A;;TRUCCO MASSIMO,,https://lens.org/060-468-361-671-951,Granted Patent,yes,100,5,24,24,3,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K48/00,514/44;;536/24.5;;536/24.31;;536/24.1,83,58,007-406-253-662-34X;;002-748-091-679-023;;045-583-226-081-588;;198-819-702-009-402;;036-034-789-927-905;;120-311-605-439-411;;038-019-988-265-171;;072-487-682-024-009;;055-461-471-769-340;;037-762-989-997-774;;036-732-560-335-942;;010-971-137-962-986;;000-947-805-254-30X;;059-831-261-344-986;;046-759-373-855-603;;034-667-111-517-352;;011-585-325-479-722;;032-604-045-425-685;;008-786-372-163-563;;120-394-707-943-615;;010-790-026-257-851;;016-331-988-429-170;;093-294-077-197-893;;098-906-883-100-044;;070-782-408-343-794;;051-273-988-404-72X;;021-670-038-221-963;;038-294-345-491-120;;062-744-200-413-055;;024-794-940-793-652;;040-320-497-976-387;;079-746-932-885-599;;009-852-354-311-269;;124-633-490-849-185;;014-151-529-676-200;;051-314-107-433-28X;;058-347-045-682-672;;170-855-224-291-395;;014-193-579-163-943;;033-317-943-182-464;;044-348-525-505-460;;009-014-629-401-886;;139-391-786-427-817;;095-044-716-233-418;;032-160-986-739-702;;004-861-765-797-104;;105-857-936-174-498;;064-135-255-782-383;;009-252-860-081-68X;;122-480-174-036-96X;;006-319-293-405-872;;066-673-794-240-138;;003-392-051-017-959;;044-648-085-375-520;;080-640-811-843-632;;094-380-364-802-862;;025-426-595-005-199;;166-766-603-034-613,11943404;;10.1016/s0168-3659(01)00547-8;;12490373;;10.1016/s0168-3659(02)00322-x;;10.1016/s0378-5173(97)04887-4;;10.1201/9780824747343.ch14;;10.1038/32588;;9521319;;10.1016/s0167-4889(96)00111-5;;9030197;;10.1073/pnas.92.16.7297;;pmc41326;;7638184;;10.1023/a:1011954516233;;9619774;;10.1023/a:1007551006782;;11205728;;12406385;;10.1046/j.1440-1711.2002.01122.x;;14563367;;10.1016/j.molimm.2003.08.001;;10.1038/420116a;;12432349;;12432357;;10.1002/jgm.237;;11828391;;2172955;;10.1023/a:1015908831507;;10.1126/science.270.5235.404;;7569994;;12615416;;10.1016/s0378-5173(02)00689-0;;10.1152/ajplung.2000.279.5.l872;;11053022;;10.1021/je970228a;;10.1038/337387a0;;2463491;;pmc2326930;;10.1046/j.1365-2567.1999.00863.x;;10540214;;10.1007/978-1-4684-6822-9_16;;10.1007/s11095-005-6021-x;;16132358;;10.1023/a:1016044609972;;8692733;;11338932;;8608176;;10.1021/bc00036a001;;10.1021/ma961217+;;10.1023/a:1015836829670;;1448419;;3063445;;10.1007/978-3-642-74006-0_38;;12882913;;10.2337/diabetes.52.8.1976;;15383562;;10.4049/jimmunol.173.7.4331;;10.1023/a:1012187414126;;9244140;;9114006;;pmc20739;;10.1073/pnas.94.9.4430;;1608446;;10.1038/357455a0;;10.1016/s0167-4889(02)00204-5;;12063176;;10.1023/a:1007526301331;;11205729;;10.1201/9781315150901-16;;15906179;;10.1007/s11095-005-2600-0;;8476501;;pmc2713034;;18316361;;10.2337/db07-0507;;10.1002/macp.1994.021950508;;10.1021/la010201w;;9012343;;10.1126/science.275.5301.810;;7730957;;10.3109/02652049509051127;;10.1038/sj.gt.3300795;;10435113;;10.1016/s0168-3659(03)00194-9;;12880694;;12874000;;10.1006/bbrc.1993.1142;;8094959;;10.1016/s0928-0987(03)00102-7;;12885383;;12615436;;10.1016/s0264-410x(02)00686-2;;10.1177/088391150001500202;;9145231;;10.1248/bpb.20.455;;10.1557/proc-667-g5.5;;12782786;;10.1073/pnas.1131899100;;pmc165808;;10.1006/jcis.2000.7325;;11161522;;pmc38085;;10.1073/pnas.93.21.11493;;8876163;;8937468;;10.1016/s0006-2952(96)00555-2;;14687897;;10.1016/j.cccn.2003.09.007;;10.1093/intimm/7.12.1885;;8746558,"US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;Ahn et al., Biodegradable poly(ethylenimine) for plasmid DNA delivery, J. Control. Rel., 80:273-282 (2002).;;Al et al., Nano-encapsulation of furosemid microcrystals for controlled drug release, J. Control. Rel., 86:59-68 (2003).;;Akhtar et al., Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres. Int. J. Pharma., 151: 57-67 (1997).;;Ariga et al., Self-assembly of functional protein multilayers: from planar films to microtemplate encapsulation, pp. 367-391, IN: Malmsten (ed.), Biopolymers at Interfaces, 2nd ed., Marcel Dekker (2003).;;Banchereau et al., Dendritic cells and the control of immunity, Nature, 392:245-252 (1998).;;Berton et al., Improved oligonucleotide uptake and stability by a new drug carrier, the supramolecular bio vector (SMBV), Biochim. Biophys. Acta, 1355:7-19 (1997).;;Bisker-Leib et al., Factor VII monoclonal antibody microspheres, IN: Proc. 2004 Am. Assoc. Pharm. Scientists Natl. Biotech. Conf., p. 76 (2004).;;Bisker-Leib et al., Uniform microsphere formation from small organic molecules, Transactions, 31st Ann. Meeting Control. Release Soc., #631A (2004).;;Boussif et al., A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine, Proc. Natl. Acad. Sci. USA, 92:7297-7301 (1995).;;Brazeau et al., In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery, Pharm. Res., 15:680-684 (1998).;;Brown et al., PROMAXX microsphere characterization, Respiratory Drug Delivery IX, 2:477-479 (2004).;;Brown et al., Pulmonary delivery of novel insulin microspheres, Respiratory Drug Delivery VIII, 2:431-434 (2002).;;Bustami et al., Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide, Pharm. Res., 17:1360-1366 (2000).;;Byrne et al., Dendritic cells: making progress with tumour regression? Immunol. Cell Biol., 80:520-530 (2002).;;Chamarthy et al., A cationic peptide consists of ornithine and histidine repeats augments gene transfer in dendritic cells, Mol. Immunol., 40:483-490 (2003).;;Check, A tragic setback, Nature, 420:116-118 (2002).;;Chollet et al., Side-effects of a systemic injection of linear polythylenimine-DNA complexes, J. Gene Med., 41:84-91 (2002).;;Chu et al., Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture, Pharm. Res., 7:824-834 (1990).;;Couvreur et al., pH-sensitive liposomes: an intelligent design system for the delivery of antisense oligonucleotides, J. Liposome Res., 7:1-18 (1997).;;Crystal, Transfer of genes to humans: early lessons and obstacles for success, Science, 270:404-410 (1995).;;De Rosa et al., A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleimine solid complexes. Int. J. Pharmaceut., 254: 89-93 (2003).;;Dokka et al., Inhibition of endotoxin-induced lung inflammation by interleukin-10 gene transfer in mice, Am. J. Physiol. Lung Cell Mol. Physiol., 279:L872-L877 (2000).;;Eliassi et al., Densities of poly(ethylene glycol) + water mixtures in the 298. 15-328.15 K temperature, J. Chem. Eng. Data, 43:719-721 (1998).;;Felgner et al., Cationic liposome-mediated transfection, Nature, 337:387-388 (1989).;;Gao et al., CD4-deficient dendritic cells producing interleukin-10 but not interleukin-12 induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection. Immunology, 98: 159-170 (1991).;;Glorioso et al., Development of herpes simplex virus vectors for gene transfer to the central nervous system, pp. 281-302, IN: WOLFF (ed.), Gene Therapeutics: Methods and Applications of Direct Gene Transfer (1993).;;Govardhan et al., Novel long-acting crystal formulation of human growth hormone, Pharm. Res., 22:1461-1470 (2005).;;Hudson et al., Biodegradable polymer matrices for the sustained exogenous delivery of a biologically active c-myc hammerhead ribozymes, Int. J. Pharm., 136:23-29 (1996).;;Hughes et al., Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides, Pharm. Res., 13:404-410 (1996).;;Hwang et al., Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration, Curr. Opin. Mol. Ther., 3:183-191 (2001).;;Kabanov et al., Water-soluble block polycations as carriers for oligonucleotide delivery, Bioconjugate Chem., 6:639-643 (1995).;;Kataoka et al., Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline, Macromolecules, 29:8556-8557 (1996).;;Larionova et al., Encapsulation of proteins in polyelectrolyte microcapsules. Factors regulating the protein release, Proc. Intl. Symp. Control. Release Bloact. Mater., 28:1398-1399 (2001).;;Leaversuch, Materials renewable PLA polymer gets 'green light' for packaging uses. pp. 1-4. Retrieved from the Internet Sep. 2007, .;;Legendre, Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes, Pharm. Res., 9:1235-1242 (1992).;;Loke et al., Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis, Curr. Top. Microbiol. Immunol., 141:282-289 (1988).;;Lvov et al., Nanoengineered shells for encapsulation and controlled release, pp. 1-3, NSF Nanoscale Science and Engineering Grantees Conference (Dec. 16-18, 2003).;;Ma et al., Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor kB activity. Diabetes, 52: 1976-85 (2003).;;Machen et al., Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese mouse dendritic cells. J. Immunol. 173:4331-41 (2004).;;Mahato et al., Cationic lipid-based gene delivery systems: pharmaceutical perspectives, Pharm. Res., 14:853-859 (1997).;;Meiri et al., Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat, Proc. Natl. Acad. Sci. USA, 94:4430-4434 (1997).;;Middaugh, Oligonucleotide delivery, In: Mathiowitz (ed.), Encyclopedia of Controlled Drug Delivery, vol. 2, pp. 691-697, John Wiley & Sons (1999).;;Miller, Human gene therapy comes of age, Nature, 357:455-460 (1992).;;Moghimi, Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers, Biochimica et Biophysica Acta, 1590:131-139 (2000).;;Morita et al., Formation and isolation of spherical fine protein microparticles through lyophilization of protein-poly (ethylene glycol) aqueous mixture, Pharm. Res., 17:1367-1373 (2000).;;Oberhouser et al., Enhancing endosomal exit of nucleic acids using pH-sensitive viral fusion peptides, pp. 247-266, In: Akhtar (ed.), Delivery Strategies for Antisense Oligonucleotides Therapeutics, Boca Raton, FL: CRC Press (1995).;;Pargaonkar et al., Controlled release of dexamethasone from microcapsules produced by polyelectrolyte layer by layer nanoassembly, Pharm. Res., 22:826-835 (2005).;;Perlaky et al., Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expression, Anti-Cancer Drug Des., 8:3-14 (1993).;;Phillips et al., A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes. Diabetes, 57(6): 1544-55 (2008).;;Pommersheim et al., Immobilization of enzymes by multilayer microcapsules, Macromol. Chem. Phys., 195:1557-1567 (1994).;;Qiu et al., Studies on the drug release properties of polysaccharide multilayers encapsulated ibuprofen microparticles, Langmuir, 17:5375-5380 (2001).;;Radler et al., Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes, Science, 275:810-814 (1997).;;Rashba-Step et al., Albumin microspheres as drug delivery vehicle for multiple routes of administration, Proc. Intl. Symp. Control. Release Bioact. Mater., vol. 28 (2001).;;Rashba-Step et al., PROMAXX protein matrix microspheres for delivery of alpha-1 antitrypsin via the pulmonary route, Transactions 31st Annual Meeting Control. Release. Soc., #474 (2004).;;Sah et al., Biodegradable microcapsules prepared by a w/o/w technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release, J. Microencap., 12:59-69 (1995).;;Schwartz et al., Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo, Gene Ther., 6:282-292 (1999).;;Sinha et al., Biodegradable microspheres for protein delivery, J. Control. Release, 90:261-280 (2003).;;Sukhorukov et al., Controlling release and permeability properties of militilayer polyelectrolyte capsules, Proc. Intl. Symp. Control. Release Bioact. Mater., 28:1402-1403 (2001).;;Sweeney et al., Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model, Cancer Res., 63:4017-4020 (2003).;;Thierry et al., Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides, Biochem. Biophys. Res. Commun., 190:952-960 (1993).;;Tiourina et al., Encapsulation of alpha chymotrypsin onto the hollow polyelectrolyte microcapsules, Proc. Intl. Symp. Control. Release Bioact. Mater., 28:1400-1401 (2001).;;Tiyaboonchai et al., Formulation and characterization of DNA-polyethylenimine-dextran sulfate nanoparticles, Eur. J. Pharm. Sci., 19:191-202 (2003).;;Tomlinson et al., Controllable gene therapy: pharmaceutics of non-viral gene delivery systems, J. Control. Release, 39:357-372 (1996).;;Van Der Lubben et al., Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice, Vaccine, 21:1400-1408 (2003).;;Vanderkerken et al., Synthesis and evaluation of poly(ethylene glycol)-polylysine block copolymers as carriers for gene delivery, J. Bioactive Compatible Polymers, 15:115-138 (2000).;;Yamakawa et al., Release behavior of poly(lactic acid-co-glycolic acid) implants containing phosphorothioate oligodeoxynucleotide, Biol. Pharm. Bull., 20:455-459 (1997).;;Yang et al., Novel fluorescent labels prepared by layer-to-layer assembly on colloids for biodetection systems, Mat. Res. Soc. Symp. Proc., 667:G5.5.1-G5.5.6 (2001).;;Yang, et al., Crystalline monoclonal antibodies for subcutaneous delivery, Proc. Natl. Acad. Sci (USA), 100: 6934-6939 (2003).;;Yang, et al., Layer-by-layer construction of novel biofunctional fluorescent microparticles for immunoassay applications, J. Colloid Interface Sci., 234: 356-362 (2001).;;Zahr et al., Fabrication of Core-Shell Drug Nanoparticles for Therapeutic Delivery, Polymeric Materials: Science & Engineering, 93: 802-803 (2005).;;Zelphati et al, Mechanism of oligonucleotide release from cationic lipids, Proc. Natl. Acad. Sci (USA), 100: 11493-11498 (1996).;;Zhao et al., Modulation of oligonucleotide-induced immune stimulation by cyclodextrin analogs, Biochem. Pharmacol., 52: 1537-1544 (1996).;;European Supplemental Search Report, EP 04 80 9503, dated Aug. 22, 2007.;;European Supplemental Search Report, EP 07 81 3820, dated Sep. 17, 2010.;;International Search Report and Written Opinion of the International Searching Authority, PCT/US2004/016651, dated Feb. 14, 2005.;;International Search Report and Written Opinion of the International Searching Authority, PCT/US2004/016660, dated Dec. 6, 2005.;;International Search Report and Written Opinion of the International Searching Authority, PCT/US2004/023182, dated Nov. 3, 2005.;;International Search Report and Written Opinion of the International Searching Authority, PCT/US2005/016689, dated Nov. 29, 2005.;;International Search Report and Written Opinion of the International Searching Authority, PCT/US2006/015918, dated Sep. 18, 2006.;;International Search Report and Written Opinion of the International Searching Authority, PCT/US2007/075292, dated Aug. 25, 2008.;;Jinchuan et al., Upregulation of CD40-CD40 ligand system in patients with diabetes mellitus, Clinica Chimica Acta, 339(1-2), 85-90 (2004).;;Stephens et al., Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse, Int Immunol., 7(12), 1885-95 (1995).",ACTIVE
308,ZA,B,ZA 967173 B,094-036-478-990-328,1997-03-12,1997,ZA 967173 A,1996-08-23,US 280095 P,1995-08-25,Purified coprinus laccases and nucleic acids and encoding same,"The present invention relates to polypeptides having laccase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS,YAVER DEBBE SUE;;BROWN KIMBERLY M;;KAUPPINEN SAKARI;;HALKIER TROBEN,,https://lens.org/094-036-478-990-328,Granted Patent,no,0,0,12,12,0,C07K14/37;;C12N9/0061;;C12N9/0061;;C07K14/37,C07K14/37;;C12N1/21;;C12N9/02;;C12N15/53,,0,0,,,,EXPIRED
309,US,B2,US 7964574 B2,137-656-187-395-882,2011-06-21,2011,US 83455007 A,2007-08-06,US 83455007 A;;US 83574206 P;;US 86491406 P,2006-08-04,Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes,"AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER INT;;BAXTER HEALTHCARE SA;;UNIV PITTSBURGH & MDASH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A;;TRUCCO MASSIMO,BAXTER HEALTHCARE S.A (2007-09-05);;UNIVERSITY OF PITTSBURGH (2008-04-29);;UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (2008-07-08);;BAXTER INTERNATIONAL INC (2007-09-05),https://lens.org/137-656-187-395-882,Granted Patent,yes,101,6,24,24,3,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K48/00,514/44;;536/24.5;;536/24.31;;536/24.1,85,56,024-794-940-793-652;;034-667-111-517-352;;120-394-707-943-615;;062-744-200-413-055;;007-406-253-662-34X;;002-748-091-679-023;;198-819-702-009-402;;036-034-789-927-905;;120-311-605-439-411;;038-019-988-265-171;;072-487-682-024-009;;055-461-471-769-340;;037-762-989-997-774;;036-732-560-335-942;;010-971-137-962-986;;000-947-805-254-30X;;059-831-261-344-986;;046-759-373-855-603;;011-585-325-479-722;;032-604-045-425-685;;008-786-372-163-563;;010-790-026-257-851;;016-331-988-429-170;;093-294-077-197-893;;098-906-883-100-044;;070-782-408-343-794;;051-273-988-404-72X;;021-670-038-221-963;;038-294-345-491-120;;040-320-497-976-387;;079-746-932-885-599;;009-852-354-311-269;;124-633-490-849-185;;014-151-529-676-200;;051-314-107-433-28X;;058-347-045-682-672;;170-855-224-291-395;;033-317-943-182-464;;044-348-525-505-460;;009-014-629-401-886;;139-391-786-427-817;;095-044-716-233-418;;032-160-986-739-702;;004-861-765-797-104;;105-857-936-174-498;;064-135-255-782-383;;009-252-860-081-68X;;122-480-174-036-96X;;006-319-293-405-872;;066-673-794-240-138;;003-392-051-017-959;;044-648-085-375-520;;080-640-811-843-632;;094-380-364-802-862;;045-583-226-081-588;;014-193-579-163-943,15383562;;10.4049/jimmunol.173.7.4331;;12615416;;10.1016/s0378-5173(02)00689-0;;pmc2326930;;10.1046/j.1365-2567.1999.00863.x;;10540214;;12882913;;10.2337/diabetes.52.8.1976;;11943404;;10.1016/s0168-3659(01)00547-8;;12490373;;10.1016/s0168-3659(02)00322-x;;10.1201/9780824747343.ch14;;10.1038/32588;;9521319;;10.1016/s0167-4889(96)00111-5;;9030197;;10.1073/pnas.92.16.7297;;pmc41326;;7638184;;10.1023/a:1011954516233;;9619774;;10.1023/a:1007551006782;;11205728;;12406385;;10.1046/j.1440-1711.2002.01122.x;;14563367;;10.1016/j.molimm.2003.08.001;;10.1038/420116a;;12432349;;12432357;;10.1002/jgm.237;;11828391;;2172955;;10.1023/a:1015908831507;;10.1126/science.270.5235.404;;7569994;;10.1152/ajplung.2000.279.5.l872;;11053022;;10.1021/je970228a;;10.1038/337387a0;;2463491;;10.1007/978-1-4684-6822-9_16;;10.1007/s11095-005-6021-x;;16132358;;10.1023/a:1016044609972;;8692733;;11338932;;8608176;;10.1021/bc00036a001;;10.1021/ma961217+;;10.1023/a:1015836829670;;1448419;;3063445;;10.1007/978-3-642-74006-0_38;;10.1023/a:1012187414126;;9244140;;9114006;;pmc20739;;10.1073/pnas.94.9.4430;;1608446;;10.1038/357455a0;;10.1016/s0167-4889(02)00204-5;;12063176;;10.1023/a:1007526301331;;11205729;;10.1201/9781315150901-16;;15906179;;10.1007/s11095-005-2600-0;;8476501;;10.1002/macp.1994.021950508;;10.1021/la010201w;;9012343;;10.1126/science.275.5301.810;;7730957;;10.3109/02652049509051127;;10.1038/sj.gt.3300795;;10435113;;10.1016/s0168-3659(03)00194-9;;12880694;;12874000;;10.1006/bbrc.1993.1142;;8094959;;10.1016/s0928-0987(03)00102-7;;12885383;;12615436;;10.1016/s0264-410x(02)00686-2;;10.1177/088391150001500202;;9145231;;10.1248/bpb.20.455;;10.1557/proc-667-g5.5;;12782786;;10.1073/pnas.1131899100;;pmc165808;;10.1006/jcis.2000.7325;;11161522;;pmc38085;;10.1073/pnas.93.21.11493;;8876163;;8937468;;10.1016/s0006-2952(96)00555-2;;10.1016/s0378-5173(97)04887-4;;pmc2713034;;18316361;;10.2337/db07-0507,"Machen et al. Antisense Oligonucleotides Down-Regulating Costimulation Confer Diabetes-Preventive Properties to Nonobese Diabetic Mouse Dendritic Cells. Journal of Immunology 2004, vol. 173: 4331-4341.;;De Rosa et al. A new delivery system for antisense therapy:PLGA microspheres encapsulating oligonucleotide/polyethyleimine solid complexes. International Journal of Pharmaceutics 2003, vol. 254: 89-93.;;Gao et al. CD4- deficient dendritic cells producing interleukin-10 but not interleukin 12 induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection. Immunology 1991: 98:159-170.;;Ma et al. Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor kB activity. Diabetes vol. 52 2003: 1976-1985.;;US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn);;Ahn et al., ""Biodegradable poly(ethylenimine) for plasmid DNA delivery,"" J. Control. Rel., 80:273-282 (2002).;;Al et al., ""Nano-encapsulation of furosemid microcrystals for controlled drug release,"" J. Control. Rel., 86:59-68 (2003).;;Ariga et al., ""Self-assembly of functional protein multilayers: from planar films to microtemplate encapsulation,"" pp. 367-391, in: Malmsten (ed.), Biopolymers at Interfaces, 2nd ed., Marcel Dekker (2003).;;Banchereau et al., ""Dendritic cells and the control of immunity,"" Nature, 392:245-252 (1998).;;Berton et al., ""Improved oligonucleotide uptake and stability by a new drug carrier, the supramolecular bio vector (SMBV),"" Biochim. Biophys. Acta, 1355:7-19 (1997).;;Bisker-Leib et al., ""Factor VII monoclonal antibody microspheres,"" in: Proc. 2004 Am. Assoc. Pharm. Scientists Natl. Biotech. Conf, p. 76 (2004).;;Bisker-Leib et al., ""Uniform microsphere formation from small organic molecules,""Transactions, 31st Ann. Meeting Control. Release Soc., #631A (2004).;;Boussif et al., ""A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine,"" Proc. Natl. Acad. Sci. USA, 92:7297-7301 (1995).;;Brazeau et al., ""In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery,"" Pharm. Res., 15:680-684 (1998).;;Brown et al., ""PROMAXX microsphere characterization,"" Respiratory Drug Delivery IX, 2:477-479 (2004).;;Brown et al., ""Pulmonary delivery of novel insulin microspheres,"" Respiratory Drug Delivery VIII, 2:431-434 (2002).;;Bustami et al., ""Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide,"" Pharm. Res., 17:1360-1366 (2000).;;Byrne et al., ""Dendritic cells: making progress with tumour regression?"" Immunol. Cell Biol., 80:520-530 (2002).;;Chamarthy et al., ""A cationic peptide consists of ornithine and histidine repeats augments gene transfer in dendritic cells,"" Mol. Immunol., 40:483-490 (2003).;;Check, ""A tragic setback,"" Nature, 420:116-118 (2002).;;Chollet et al., ""Side-effects of a systemic injection of linear polythylenimine-DNA complexes,"" J. Gene Med., 41:84-91 (2002).;;Chu et al., ""Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture,""Pharm. Res., 7:824-834 (1990).;;Couvreur et al., ""pH-sensitive liposomes: an intelligent design system for the delivery of antisense oligonucleotides,"" J. Liposome Res., 7:1-18 (1997).;;Crystal, ""Transfer of genes to humans: early lessons and obstacles for success,"" Science, 270:404-410 (1995).;;Dokka et al., ""Inhibition of endotoxin-induced lung inflammation by interleukin-10 gene transfer in mice,"" Am. J. Physiol. Lung Cell Mol. Physiol., 279:L872-L877 (2000).;;Eliassi et al., ""Densities of poly(ethylene glycol) + water mixtures in the 298. 15-328.15 K temperature,"" J. Chem. Eng. Data, 43:719-721 (1998).;;Felgner et al., ""Cationic liposome-mediated transfection,"" Nature, 337:387-388 (1989).;;Glorioso et al., ""Development of herpes simplex virus vectors for gene transfer to the central nervous system,"" pp. 281-302, in: Wolff (ed.), Gene Therapeutics: Methods and Applications of Direct Gene Transfer (1993).;;Govardhan et al., ""Novel long-acting crystal formulation of human growth hormone,""Pharm. Res., 22:1461-1470 (2005).;;Hudson et al., ""Biodegradable polymer matrices for the sustained exogenous delivery of a biologically active c-myc hammerhead ribozymes,"" Int. J. Pharm., 136:23-29 (1996).;;Hughes et al., ""Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides,"" Pharm. Res., 13:404-410 (1996).;;Hwang et al., ""Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration,"" Curr Opin. Mol. Ther., 3:183-191 (2001).;;Kabanov et al., ""Water-soluble block polycations as carriers for oligonucleotide delivery,"" Bioconjugate Chem., 6:639-643 (1995).;;Kataoka et al., ""Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline,""Macromolecules, 29:8556-8557 (1996).;;Larionova et al., ""Encapsulation of proteins in polyelectrolyte microcapsules. Factors regulating the protein release,"" Proc. Intl. Symp. Control. Release Bioact. Mater., 28:1398-1399 (2001).;;Leaversuch, ""Materials renewable PLA polymer gets 'green light' for packaging uses."" pp. 1-4. Retrieved from the Internet Sep. 2007, .;;Legendre, ""Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes,"" Pharm. Res., 9:1235-1242 (1992).;;Loke et al., ""Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis,"" Curr. Top. Microbiol. Immunol., 141:282-289 (1988).;;Lvov et al., ""Nanoengineered shells for encapsulation and controlled release,"" pp. 1-3, NSF Nanoscale Science and Engineering Grantees Conference (Dec. 16-18, 2003).;;Mahato et al., ""Cationic lipid-based gene delivery systems: pharmaceutical perspectives,"" Pharm. Res., 14:853-859 (1997).;;Meiri et al., ""Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat,"" Proc. Natl. Acad. Sci. USA, 94:4430-4434 (1997).;;Middaugh, ""Oligonucleotide delivery,"" in: Mathiowitz (ed.), Encyclopedia of Controlled Drug Delivery, vol. 2, pp. 691-697, John Wiley & Sons (1999).;;Miller, ""Human gene therapy comes of age,"" Nature, 357:455-460 (1992).;;Moghimi, ""Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers,"" Biochimica et Biophysica Acta, 1590:131-139 (2000).;;Morita et al., ""Formation and isolation of spherical fine protein microparticles through lyophilization of protein-poly (ethylene glycol) aqueous mixture,"" Pharm. Res., 17:1367-1373 (2000).;;Oberhouser et al., ""Enhancing endosomal exit of nucleic acids using pH-sensitive viral fusion peptides,"" pp. 247-266, in: Akhtar (ed.), Delivery Strategies for Antisense Oligonucleotides Therapeutics, Boca Raton, FL: CRC Press (1995).;;Opinion of the International Searching Authority, PCT/US04/016651, pp. 1-12, Feb. 14, 2005.;;Opinion of the International Searching Authority, PCT/US04/23182, pp. 1-3, Nov. 3, 2005.;;Opinion of the International Searching Authority, PCT/US04/016660, pp. 1-6, Dec. 6, 2005.;;Opinion of the International Searching Authority, PCT/US05/16689, pp. 1-7, Nov. 29, 2005.;;Opinion of the International Searching Authority, PCT/US2006/015918, pp. 1-8, Sep. 18, 2006.;;Pargaonkar et al., ""Controlled release of dexamethasone from microcapsules produced by polyelectrolyte layer by layer nanoassembly,"" Pharm. Res., 22:826-835 (2005).;;Perlaky et al., ""Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expression,"" Anti-Cancer Drug Des., 8:3-14 (1993).;;Pommersheim et al., ""Immobilization of enzymes by multilayer microcapsules,"" Macromol. Chem. Phys., 195:1557-1567 (1994).;;Qiu et al., ""Studies on the drug release properties of polysaccharide multilayers encapsulated ibuprofen microparticles,"" Langmuir, 17:5375-5380 (2001).;;Radler et al., ""Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes,"" Science, 275:810-814 (1997).;;Rashba-Step et al., ""Albumin microspheres as drug delivery vehicle for multiple routes of administration,"" Proc. Intl. Symp. Control. Release Bioact. Mater., vol. 28 (2001).;;Rashba-Step et al., ""Promaxx protein matrix microspheres for delivery of alpha-1 antitrypsin via the pulmonary route,"" Transactions 31st Annual Meeting Control. Release. Soc., #474 (2004).;;Report of the International Searching Authority PCT/US04/016660, pp. 1-3, Dec. 6, 2005.;;Report of the International Searching Authority, PCT/US04/016651, pp. 1-7, Feb. 14, 2005.;;Report of the International Searching Authority, PCT/US04/23182, pp. 1-3, Nov. 3, 2005.;;Report of the International Searching Authority, PCT/US05/16689, pp. 1-5, Nov. 29, 2005.;;Report of the International Searching Authority, PCT/US2006/015918, pp. 1-6, Sep. 18, 2006.;;Sah et al., ""Biodegradable microcapsules prepared by a w/o/w technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release,"" J. Microencap., 12:59-69 (1995).;;Schwartz et al., ""Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo,"" Gene Ther., 6:282-292 (1999).;;Sinha et al., ""Biodegradable microspheres for protein delivery,"" J. Control. Release, 90:261-280 (2003).;;Sukhorukov et al., ""Controlling release and permeability properties of militilayer polyelectrolyte capsules,"" Proc. Intl. Symp. Control. Release Bioact. Mater., 28:1402-1403(2000).;;Supplementary European Search Report for European patent application 04809503, dated Aug. 22, 2007.;;Sweeney et al., ""Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model,"" Cancer Res., 63:4017-4020 (2003).;;Thierry et al., ""Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides,"" Biochem. Biophys. Res. Commun., 190:952-960 (1993).;;Tiourina et al., ""Encapsulation of alpha chymotrypsin onto the hollow polyelectrolyte microcapsules,"" Proc. Intl. Symp. Control. Release Bioact. Mater., 28:1400-1401 (2001).;;Tiyaboonchai et al., ""Formulation and characterization of DNA-polyethylenimine-dextran sulfate nanoparticles,"" Eur. J. Pharm. Sci., 19:191-202 (2003).;;Tomlinson et al., ""Controllable gene therapy: pharmaceutics of non-viral gene delivery systems,"" J. Control. Release, 39:357-372 (1996).;;Van Der Lubben et al., ""Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice,"" Vaccine, 21:1400-1408 (2003).;;Vanderkerken et al., ""Synthesis and evaluation of poly(ethylene glycol)-polylysine block copolymers as carriers for gene delivery,"" J. Bioactive Compatible Polymers, 15:115-138 (2000).;;Yamakawa et al., ""Release behavior of poly(lactic acid-co-glycolic acid) implants containing phosphorothioate oligodeoxynucleotide,"" Biol. Pharm. Bull., 20:455-459 (1997).;;Yang et al., ""Novel fluorescent labels prepared by layer-to-layer assembly on colloids for biodetection systems,"" Mat. Res. Soc. Symp. Proc., 667:G5.5.1-G5.5.6 (2001).;;Yang, et al., ""Crystalline monoconal antibodies for subcutaneous delivery,"" Proc. Natl. Acad. Sci (USA), 100:6934-6939 (2003).;;Yang, et al., ""Layer-by-layer construction of novel biofunctional fluorescent microparticles for immunoassay applications,"" J. Colloid Interface Sci., 234:356-362 (2001).;;Zahr et al., ""Fabrication of Core-Shell Drug Nanoparticles for Therapeutic Delivery,"" Polymeric Materials: Science & Engineering, 93:802-803 (2005).;;Zelphati et al., ""Mechanism of oligonucleotide release from cationic lipids,"" Proc. Natl. Acad. Sci (USA), 100: 11493-11498 (1996).;;Zhao et al., ""Modulation of olignucleotide-induced immune stimulation by cyclodextrin analogs,""Biochem. Pharmacol., 52:1537-1544 (1996).;;Akhtar et al., Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres. Int. J. Pharma. 151: 57-67 (1997).;;Phillips et al., A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes. Diabetes, 57(6): 1544-55 (2008).;;European Supplemental Search Report, EP 07 81 3820, dated Sep. 17, 2010.",ACTIVE
310,WO,A2,WO 2006/014490 A2,049-206-372-459-499,2006-02-09,2006,US 2005/0023987 W,2005-07-06,US 58610304 P,2004-07-06,POLYPEPTIDES HAVING ALPHA-GLUCOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having alpha-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,YAVER DEBBIE;;LIN JANINE;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL,,https://lens.org/049-206-372-459-499,Patent Application,yes,0,0,12,12,0,C12N9/2411;;C12N9/2411;;C12C5/004;;C12C5/004;;C12C11/003;;C12C11/003;;C12C12/02;;C12C12/02;;C12N9/2408;;C12N9/2408,C07H21/02;;C12N15/00;;C12N1/22;;C12N9/00;;C12N15/74;;C12Q1/37;;C12Q1/40,,1,0,,,See references of EP 1781681A4,PENDING
311,WO,A3,WO 2012/109364 A3,039-344-041-434-37X,2012-11-15,2012,US 2012/0024346 W,2012-02-08,US 201161440859 P;;US 201113172120 A,2011-02-08,GRAPHIC NOTIFICATION FEEDBACK FOR INDICATING INDUCTIVE COUPLING AMONGST DEVICES,A computing device is operated to detect a signal generated from an inductive signal interface. The detected signal may be generated by the device's inductive signal interface being in operational proximity to an inductive signal interface of another device. A notification feedback is generated that confirms an event related to the first and second computing device inductively signaling one another.,HEWLETT PACKARD DEVELOPMENT CO;;BERG SAMANTHA;;LENOX KIMBERLY;;BROWN ROBERT;;KRUGLIKOV VITALY;;CAHTTERJEE MANJIRNATH,BERG SAMANTHA;;LENOX KIMBERLY;;BROWN ROBERT;;KRUGLIKOV VITALY;;CAHTTERJEE MANJIRNATH,,https://lens.org/039-344-041-434-37X,Search Report,yes,3,0,2,61,0,G06F3/0481;;H02J50/10;;H02J50/80;;H02J50/90;;H02J7/342;;H04B5/24;;H04B5/79;;H02J50/10;;G06F3/0481;;H02J50/80;;H02J50/90,H04W92/18;;G06K17/00;;H02J17/00,,0,0,,,,PENDING
312,US,A1,US 2006/0218671 A1,062-481-249-892-323,2006-09-28,2006,US 32782106 A,2006-01-06,US 32782106 A;;US 64227405 P,2005-01-06,Polypeptides having cellobiohydrolase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,NOVOZYMES INC (2006-01-05),https://lens.org/062-481-249-892-323,Patent Application,yes,1,20,20,20,17,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,A01H5/00;;C07H21/04;;C11D3/386;;C12N5/04;;C12N9/42;;C12N15/82;;C12P19/02;;C12P21/06,800/284;;510/320;;435/69.1;;435/105;;435/209;;435/419;;435/468;;536/23.2,0,0,,,,ACTIVE
313,WO,A1,WO 2003/103539 A1,099-768-600-277-207,2003-12-18,2003,US 0317755 W,2003-06-06,US 16576302 A,2002-06-07,ENDOVASCULAR GRAFT WITH SENSORS DESIGN AND ATTACHMENT METHODS,"A endovascular graft (30) having sensing devices (16) attached thereto to facilitate measurement of pertinent parameters within the vasculature into which the graft (30) is implanted. Power sources and transmitters (12) may be attached to the graft to facilitate transmission of measurements to a receiving device outside the patient&apos;s body. The sensing devices (16) may be electrically passive or integrated devices with measurement and transmission capability. The sensing devices may be attached to specific locations on the graft material or attached to the lumen, thereby providing pertinent parameters from critical points inside the vasculature, or may be dispersed over the surface of the graft material or within the lumen to provide a profile of pertinent parameters. The sensing devices (16) may be attached to the graft material with one suture (70) using a running stitch to minimize graft bulk and may be coated with a material to inhibit or control tissue growth.",ENDOVASCULAR TECH INC,BROWN PETER S;;LEMERE MARK T;;BARKMAN KIMBERLY;;KOVAC TIM,,https://lens.org/099-768-600-277-207,Patent Application,yes,6,0,6,6,0,A61B5/0028;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61B5/076;;A61B7/001;;A61B2560/0219;;A61F2/07;;A61F2002/065;;A61F2002/067;;A61F2250/0002;;A61B5/076;;A61B5/0028;;A61B2560/0219;;A61F2002/065;;A61B7/001;;A61F2250/0002;;A61F2002/067;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61F2/07,A61B5/00;;A61F2/02;;A61F2/06,,1,0,,,See also references of EP 1511443A4,PENDING
314,CN,A,CN 106716473 A,193-265-752-949-618,2017-05-24,2017,CN 201580051114 A,2015-08-07,US 201462035106 P;;US 2015/0044172 W,2014-08-08,Systems and methods for managing group chats during ecommerce sessions,"A computer implemented method for managing a group chat during an ecommerce session is provided. The method includes initiating a chat session between at least a first client computer device associated with a first participant and a second client computer device associated with a second participant, and sharing at least one view of an ecommerce website with the first client computer device and the second client computer device. The first client computer device and the second client computer device are configured to display the at least one view of the ecommerce website. The at least one view includes at least one purchasable item. The method also includes initiating a purchase transaction for the at least one purchasable item included in the at least one view, receiving payment information for the purchase transaction, and completing the purchase transaction based on the payment information.",MASTERCARD INTERNATIONAL INC,PURCELL KIMBERLY;;HOSP ADAM K;;SINGH MALAVIKA;;BROWN DAVID C,,https://lens.org/193-265-752-949-618,Patent Application,no,5,0,9,9,0,G06Q30/0613;;G06Q30/0613;;G06Q30/0613;;G06Q20/12;;G06Q20/12;;G06Q20/12;;G06Q30/0605;;G06Q30/0605;;G06Q30/0617;;G06Q30/0617;;G06Q30/0619;;G06Q30/0619;;G06Q30/0641;;G06Q30/0641;;G06Q30/0643;;G06Q30/0643;;G06Q30/0643;;H04L12/1813;;H04L12/1822;;H04L12/1822;;H04L12/1822;;H04L12/185;;H04L12/185;;H04L12/185;;H04L51/10;;H04L51/10,G06Q30/02;;G06Q30/06;;G06Q50/30,,0,0,,,,DISCONTINUED
315,AT,T1,AT E492633 T1,006-368-350-159-390,2011-01-15,2011,AT 06733650 T,2006-01-06,US 64227405 P;;US 2006/0000659 W,2005-01-06,POLYPEPTIDE MIT CELLOBIOHYDROLASEAKTIVITÄT UND DAFÜR KODIERENDE POLYNUKLEOTIDE,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/006-368-350-159-390,Granted Patent,no,0,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,,,0,0,,,,INACTIVE
316,US,B2,US 7368271 B2,022-658-661-462-608,2008-05-06,2008,US 17686405 A,2005-07-06,US 17686405 A;;US 58610304 P,2004-07-06,Polypeptides having alpha-glucosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,YAVER DEBBIE;;LIN JANINE;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL,NOVOZYMES INC (2005-07-06),https://lens.org/022-658-661-462-608,Granted Patent,yes,1,0,12,12,10,C12N9/2411;;C12N9/2411;;C12C5/004;;C12C5/004;;C12C11/003;;C12C11/003;;C12C12/02;;C12C12/02;;C12N9/2408;;C12N9/2408,C12N9/24;;C07H21/02;;C07H21/04;;C12N1/20;;C12N15/00;;C12P21/06,435/200;;435/69.1;;435/252.3;;435/252.33;;435/320.1;;536/23.1;;536/23.2,15,13,020-656-215-494-712;;086-480-350-136-756;;002-508-233-344-948;;091-359-396-398-387;;102-900-403-237-865;;020-656-215-494-712;;025-447-017-174-620;;155-436-565-467-31X;;038-174-623-847-558;;034-700-344-154-697;;073-655-571-184-153;;113-837-888-520-14X;;131-599-058-601-030,11872475;;pmc123785;;10.1128/aem.68.3.1250-1256.2002;;10.1046/j.1365-2672.2000.01185.x;;11119157;;15288024;;10.1016/j.fgb.2004.06.002;;10.1016/0003-9861(74)90262-8;;10.1080/00275514.1981.12021448;;11872475;;pmc123785;;10.1128/aem.68.3.1250-1256.2002;;380468;;10.1016/0003-9861(79)90058-4;;10.1515/bchm2.1926.154.1-3.64;;12506981;;10.1271/bbb.66.2415;;10.1080/00021369.1977.10862726;;5010298;;10.1016/0005-2744(72)90241-0;;10.1080/00021369.1976.10862111;;10.1080/00021369.1977.10862688,"Kato et al., Novel alpha-glucosidase from Aspergillus nidulans with strong transglycosylation activity. Appl. Environ. Microbiol. 2002, vol. 68: 1250-1256.;;Kato et al., Sequence Alignment Accession No. Q9C1S7 (TreEMBIrel), 2002.;;2000WO-US07781 (Berka et al.) database GenBank, US National Library of Medicine, (Bethesda, MD, USA) No.: AAF 07600, Mar. 22, 2000. Sequence alignment.;;Keshiri G. et al., Detection and differentiation between mycotoxigenic and non-mycotoxigenic strains of two Fusarium spp. Using volatile production profiles and hydrolytic enzymes., Appl. Microbiol., 2000, vol. 89, pp. 825-833.;;Schmoll M., et al., Cloning of genes expressed early during cellulase induction in Hypocrea jecorina by a rapid subtraction hybridization approach. Fungal Genetics and Biology, 2004, vol. 41, pp. 877-887.;;Rudick and Elbein, 1974, Archives of Biochemistry and Biophysics 1611: 281-290.;;Olutiola, 1981, Mycologia 73: 1130-1142.;;Kato et al., 2002, Appl. Environ. Microbiol. 68: 1250-1256.;;Rudick et al., 1979, Archives of Biochemistry and Biophysics 193: 509.;;Leibowitz and Mechlinski, 1926, Hoppe-Seyler's Zeitschrift für Physiologische Chemie 154: 64-84.;;Tanaka et al., 2002, Biosci. Biotechnol. Biochem. 66: 2415-2423.;;Yamasaki et al., 1977, Agricultural and Biological Chemistry 41: 1553-1558.;;Flores-Carreon and Ruiz-Herrera, 1972, Biochemica et Biophysica Acta 258: 496-505.;;Yamasaki et al., 1976, Agricultural and Biological Chemistry 40: 669-676.;;Yamasaki et al., 1977, Agricultural and Biological Chemistry 41: 1451-1458.",INACTIVE
317,JP,A,JP 2019083069 A,027-566-046-147-407,2019-05-30,2019,JP 2019030435 A,2019-02-22,US 201462035106 P,2014-08-08,SYSTEMS AND METHODS FOR MANAGING GROUP CHATS DURING E-COMMERCE SESSIONS,"To provide a computer implemented method for managing a group chat during an e-commerce session.SOLUTION: A method includes the steps of initiating a chat session between a first client computer device associated with a first participant and a second client computer device associated with a second participant, and sharing at least one view of an e-commerce website with the first client computer device and the second client computer device. The first client computer device and the second client computer device are configured to display the at least one view of the e-commerce website. The at least one view includes at least one purchasable item.SELECTED DRAWING: Figure 6",MASTERCARD INTERNATIONAL INC,KIMBERLY PURCELL;;ADAM K HOSP;;MALAVIKA SINGH;;DAVID C BROWN,,https://lens.org/027-566-046-147-407,Patent Application,no,0,0,9,9,0,H04L12/1822;;H04L12/185;;G06Q20/12;;G06Q30/0613;;G06Q30/0643;;G06Q30/0605;;G06Q30/0617;;G06Q30/0641;;G06Q30/0619;;G06Q20/12;;G06Q30/0613;;G06Q30/0643;;H04L12/1822;;H04L12/185;;H04L51/10;;G06Q30/0613;;G06Q30/0643;;H04L51/10;;G06Q30/0605;;H04L12/1813;;G06Q30/0617;;G06Q30/0641;;G06Q30/0619;;G06Q20/12;;H04L12/1822;;H04L12/185,G06Q30/06,,0,0,,,,ACTIVE
318,US,A1,US 2011/0274758 A1,045-485-879-364-746,2011-11-10,2011,US 201113103433 A,2011-05-09,US 201113103433 A;;US 83455007 A;;US 83574206 P;;US 86491406 P,2006-08-04,MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES,"AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.",BAXTER INT;;UNIV PITTSBURGH;;BAXTER HEALTHCARE SA,BROWN LARRY R;;GIANNOUKAKIS NICK;;GILLIS KIMBERLY A;;TRUCCO MASSIMO,,https://lens.org/045-485-879-364-746,Patent Application,yes,1,0,24,24,3,A61K9/0024;;A61K9/1641;;A61K9/19;;A61K31/7088;;A61K38/28;;C12N15/111;;C12N15/1138;;C12N2310/11;;C12N2310/315;;C12N2320/32;;A61P29/00;;A61P37/00;;A61P37/06;;A61P43/00;;A61P5/48;;A61P3/10;;A61K31/7088;;C12N15/1138;;A61K9/19;;A61K38/28;;C12N15/111;;A61K9/1641;;C12N2310/315;;C12N2310/11;;A61K9/0024;;C12N2320/32,A61K31/711;;A61K9/14;;A61K38/28;;A61P3/10,424/489;;X514 44  A;;514/6.5,0,0,,,,ACTIVE
319,US,B2,US 7910804 B2,134-271-304-716-31X,2011-03-22,2011,US 69645310 A,2010-01-29,US 69645310 A;;US 5383108 A;;US 17686405 A;;US 58610304 P,2004-07-06,Polypeptides having alpha-glucosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,YAVER DEBBIE;;LIN JANINE;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL,,https://lens.org/134-271-304-716-31X,Granted Patent,yes,1,0,12,12,10,C12N9/2411;;C12N9/2411;;C12C5/004;;C12C5/004;;C12C11/003;;C12C11/003;;C12C12/02;;C12C12/02;;C12N9/2408;;C12N9/2408,A01H9/00;;C07H21/04;;C12N1/20;;C12N5/04;;C12N9/24;;C12N15/00;;C12N15/82;;C12P21/06,800/295;;800/278;;800/284;;435/200;;435/419;;435/69.1;;435/252.3;;435/252.33;;435/320.1;;536/23.1;;536/23.2;;536/23.7,14,12,091-359-396-398-387;;051-998-325-986-35X;;020-656-215-494-712;;025-447-017-174-620;;155-436-565-467-31X;;038-174-623-847-558;;034-700-344-154-697;;073-655-571-184-153;;113-837-888-520-14X;;086-480-350-136-756;;002-508-233-344-948;;131-599-058-601-030,10.1016/0003-9861(74)90262-8;;10.2307/3759683;;11872475;;pmc123785;;10.1128/aem.68.3.1250-1256.2002;;380468;;10.1016/0003-9861(79)90058-4;;10.1515/bchm2.1926.154.1-3.64;;12506981;;10.1271/bbb.66.2415;;10.1080/00021369.1977.10862726;;5010298;;10.1016/0005-2744(72)90241-0;;10.1080/00021369.1976.10862111;;10.1046/j.1365-2672.2000.01185.x;;11119157;;15288024;;10.1016/j.fgb.2004.06.002;;10.1080/00021369.1977.10862688,"Rudick and Elbein, 1974, Archives of Biochemistry and Biophysics 1611: 281-290.;;Olutiola, 1981, Mycologia 73: 1130.;;Kato et al., 2002, Appl. Environ. Microbiol. 68: 1250-1256.;;Rudick et al., 1979, Archives of Biochemistry and Biophysics 193: 509.;;Leibowitz and Mechlinski, 1926, Hoppe-Seyler's Zeitschrift für Physiologische Chemie 154: 64.;;Tanaka et al., 2002, Biosci. Biotechnol. Biochem. 66: 2415-2423.;;Yamasaki et al., 1977, Agricultural and Biological Chemistry 41: 1553.;;Flores-Carreon and Ruiz-Herrera, 1972, Biochemica et Biophysica Acta 258: 496.;;Yamasaki et al., 1976, Agricultural and Biological Chemistry 40: 669.;;Kato et al., Sequence Alignment Accession No. Q9C1S7 (TreEMBIrel) Jun. 1, 2001.;;2000WO-US07781 (Berka et al.) database GenBank, US National Library of Medicine, (Bethesda, MD, USA) No. AAF 07600, Mar. 22, 2000 Sequence alignment.;;Keshiri G. et al., Detection and differentiation between mycotoxigenic and non-mycotoxigenic strains of two Fusarium spp. Using volatile production profiles and hydrolytic enzymes., Appl. Microbiol., 2000, vol. 89, pp. 825-833.;;Schmoll M., et al., Cloning of genes expressed early during cellulase induction in Hypocrea jecorina by a rapid subtraction hybridization approach. Fungal Genetics and Biology, 2004, vol. 41, pp. 877-887.;;Yamasaki et al., 1977, Agricultural and Biological Chemistry 41: 1451.",INACTIVE
320,EP,B1,EP 0788547 B1,131-332-610-436-030,2005-11-16,2005,EP 96929060 A,1996-08-20,US 9613728 W;;US 280095 P,1995-08-25,PURIFIED COPRINUS LACCASES AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to polypeptides having laccase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides.",NOVOZYMES INC;;NOVOZYMES AS,YAVER DEBBIE SUE;;BROWN KIMBERLY M;;KAUPPINEN SAKARI;;HALKIER TORBEN,"NOVO NORDISK BIOTECH, INC. (2001-01-24);;NOVOZYMES, INC. (2005-06-22);;NOVOZYMES A/S (2005-06-22);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/131-332-610-436-030,Granted Patent,yes,0,0,12,12,0,C07K14/37;;C12N9/0061;;C12N9/0061;;C07K14/37,C07K14/37;;C12N1/21;;C12N9/02;;C12N15/53,,5,1,063-783-182-481-895,7925304;;pmc395397;;10.1002/j.1460-2075.1994.tb06786.x,"MARZULLO L ET AL: ""A cDNA encoding for a phenol oxidase isoenzyme in Pleurotus ostreatus"", EMFUN DATABASE ENTRY POPOX2R, ACCESSION NUMBER Z34848,, 30 June 1994 (1994-06-30);;SANTAMARIA RI ET AL: ""Basidiomycete gene for laccase"", EMFUN DATABASE ENTRY BLACCASEG, ACCESSION NUMBER Z12156, 24 September 1992 (1992-09-24);;OJI PAPER KK.: ""Phenol oxidase gene"", GCG_GENESEQ_D DATABASE ENTRY Q03573, ACCESSION NUMBER Q03573, 15 August 1990 (1990-08-15);;KOJIMA Y ET AL: ""C. hirsutus ligninolytic phenoloxidase gene"", EMFUN DATABASE ENTRY CHLIGPHE, ACCESSION NUMBER M60560, 29 July 1990 (1990-07-29);;DATABASE EMBL 17 November 1992 (1992-11-17), SZWEYKOWSKA-KULINSKA Z AT AL: ""Intron-dependent formation of pseudouridines in the anticodon of Saccharomyces cerevisiae minor tRNA-Ile""",EXPIRED
321,AT,T1,AT E310090 T1,181-465-125-282-907,2005-12-15,2005,AT 96929060 T,1996-08-20,US 280095 P;;US 9613728 W,1995-08-25,GEREINIGTE COPRINUS LACCASEN UND NUKLEINSÄUREN WELCHE DAFÜR KODIEREN,"The present invention relates to polypeptides having laccase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides.",NOVOZYMES INC;;NOVOZYMES AS,YAVER DEBBIE SUE;;BROWN KIMBERLY M;;KAUPPINEN SAKARI;;HALKIER TORBEN,,https://lens.org/181-465-125-282-907,Granted Patent,no,0,0,12,12,0,C07K14/37;;C12N9/0061;;C12N9/0061;;C07K14/37,C07K14/37;;C12N1/21;;C12N9/02;;C12N15/53,,0,0,,,,EXPIRED
322,WO,A3,WO 2006/014490 A3,051-082-771-398-064,2006-11-30,2006,US 2005/0023987 W,2005-07-06,US 58610304 P,2004-07-06,POLYPEPTIDES HAVING ALPHA-GLUCOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having alpha-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,YAVER DEBBIE;;LIN JANINE;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL,,https://lens.org/051-082-771-398-064,Search Report,yes,0,0,12,12,0,C12N9/2411;;C12N9/2411;;C12C5/004;;C12C5/004;;C12C11/003;;C12C11/003;;C12C12/02;;C12C12/02;;C12N9/2408;;C12N9/2408,C07H21/02;;C12N1/22;;C12N9/00;;C12N15/00;;C12N15/74;;C12Q1/37;;C12Q1/40,,5,2,086-480-350-136-756;;002-508-233-344-948,10.1046/j.1365-2672.2000.01185.x;;11119157;;15288024;;10.1016/j.fgb.2004.06.002,"DATABASE EBI [online] KATO N. ET AL.: ""Novel alpha-glucosidase from Aspergillus nidulans with strong transglycosylation activity"", XP003002381, accession no. EMBL Database accession no. (Q9C1S7);;DATABASE EMBL [online] 22 March 2000 (2000-03-22), BERKA ET AL., XP003002382, Database accession no. (AAF07600);;KESHRI G. ET AL.: ""Detection and differentiation between mycotoxigenic and non-mycotoxigenic strains of two Fusarium spp. using volatile production profiles and hydrolytic enzymes"", JRNL OF APPL. MICROBIOL., vol. 89, November 2000 (2000-11-01), pages 825 - 833, XP003002383;;SCHMOLL M. ET AL.: ""Cloning of genes expressed early during cellulase induction in Hypocrea jecorina by a rapid subtraction hybridization approach"", FUNGAL GENETICS AND BIOLOGY, vol. 41, 2004, pages 877 - 887, XP003002384;;See also references of EP 1781681A4",PENDING
323,WO,A1,WO 2016/022898 A1,176-125-247-385-849,2016-02-11,2016,US 2015/0044172 W,2015-08-07,US 201462035106 P,2014-08-08,SYSTEMS AND METHODS FOR MANAGING GROUP CHATS DURING ECOMMERCE SESSIONS,"A computer implemented method for managing a group chat during an ecommerce session is provided. The method includes initiating a chat session between at least a first client computer device associated with a first participant and a second client computer device associated with a second participant, and sharing at least one view of an ecommerce website with the first client computer device and the second client computer device. The first client computer device and the second client computer device are configured to display the at least one view of the ecommerce website. The at least one view includes at least one purchasable item. The method also includes initiating a purchase transaction for the at least one purchasable item included in the at least one view, receiving payment information for the purchase transaction, and completing the purchase transaction based on the payment information.",MASTERCARD INTERNATIONAL INC,PURCELL KIMBERLY;;HOSP ADAM K;;SINGH MALAVIKA;;BROWN DAVID C,,https://lens.org/176-125-247-385-849,Patent Application,yes,5,5,9,9,0,G06Q30/0613;;G06Q30/0613;;G06Q30/0613;;G06Q20/12;;G06Q20/12;;G06Q20/12;;G06Q30/0605;;G06Q30/0605;;G06Q30/0617;;G06Q30/0617;;G06Q30/0619;;G06Q30/0619;;G06Q30/0641;;G06Q30/0641;;G06Q30/0643;;G06Q30/0643;;G06Q30/0643;;H04L12/1813;;H04L12/1822;;H04L12/1822;;H04L12/1822;;H04L12/185;;H04L12/185;;H04L12/185;;H04L51/10;;H04L51/10,G06Q30/02;;G06Q30/06;;G06Q50/30,,0,0,,,,PENDING
324,EP,B1,EP 1511443 B1,059-473-619-192-984,2012-08-01,2012,EP 03757358 A,2003-06-06,US 0317755 W;;US 16576302 A,2002-06-07,ENDOVASCULAR GRAFT WITH SENSORS,,ENDOVASCULAR TECH INC,BROWN PETER S;;LEMERE MARK T;;BARKMAN KIMBERLY;;KOVAC TIM,,https://lens.org/059-473-619-192-984,Granted Patent,yes,9,0,6,6,0,A61B5/0028;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61B5/076;;A61B7/001;;A61B2560/0219;;A61F2/07;;A61F2002/065;;A61F2002/067;;A61F2250/0002;;A61B5/076;;A61B5/0028;;A61B2560/0219;;A61F2002/065;;A61B7/001;;A61F2250/0002;;A61F2002/067;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61F2/07,A61F2/00;;A61B5/00;;A61B5/103;;A61F2/02;;A61F2/06,,0,0,,,,EXPIRED
325,US,B2,US 7662605 B2,070-867-370-002-400,2010-02-16,2010,US 5383108 A,2008-03-24,US 5383108 A;;US 17686405 A;;US 58610304 P,2004-07-06,Polypeptides having alpha-glucosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,YAVER DEBBIE;;LIN JANINE;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL,,https://lens.org/070-867-370-002-400,Granted Patent,yes,1,0,12,12,10,C12N9/2411;;C12N9/2411;;C12C5/004;;C12C5/004;;C12C11/003;;C12C11/003;;C12C12/02;;C12C12/02;;C12N9/2408;;C12N9/2408,C12N9/24;;C07H21/02;;C07H21/04;;C12N1/20;;C12N9/26;;C12N15/00;;C12P21/06,435/200;;435/201;;435/69.1;;435/252.3;;435/252.33;;435/320.1;;536/23.1;;536/23.2,17,15,055-003-061-629-507;;023-481-904-534-57X;;132-695-844-930-786;;091-359-396-398-387;;051-998-325-986-35X;;020-656-215-494-712;;025-447-017-174-620;;155-436-565-467-31X;;038-174-623-847-558;;034-700-344-154-697;;073-655-571-184-153;;113-837-888-520-14X;;086-480-350-136-756;;002-508-233-344-948;;131-599-058-601-030,10.1073/pnas.0403255101;;pmc438954;;15197260;;pmc95154;;11274097;;10.1128/jb.183.8.2405-2410.2001;;10.1021/bi990993h;;10512619;;10.1016/0003-9861(74)90262-8;;10.2307/3759683;;11872475;;pmc123785;;10.1128/aem.68.3.1250-1256.2002;;380468;;10.1016/0003-9861(79)90058-4;;10.1515/bchm2.1926.154.1-3.64;;12506981;;10.1271/bbb.66.2415;;10.1080/00021369.1977.10862726;;5010298;;10.1016/0005-2744(72)90241-0;;10.1080/00021369.1976.10862111;;10.1046/j.1365-2672.2000.01185.x;;11119157;;15288024;;10.1016/j.fgb.2004.06.002;;10.1080/00021369.1977.10862688,"Guo et al., Protein tolerance to random amino acid change. PNAS., 2004, vol. 101 (25): 9205-9210.;;Seffernick et al., Melamine deaminase and Atrazine chlorohydrolase: 98 percent identical but functionally different. J. Bacteriol.,2001, vol. 183 (8): 2405-2410.;;Witkowski et al., Conversion of b-ketoacyl synthase to a malonyl decarboxylase by replacemnt of the active-site cysteine with glutamine. Biochemistry, 1999, vol. 38: 11643-11650.;;Rudick and Elbein, 1974, Archives of Biochemistry and Biophysics 1611: 281-290.;;Olutiola, 1981, Mycologia 73: 1130.;;Kato et al., 2002, Appl. Environ. Microbiol. 68: 1250-1256.;;Rudick et al., 1979, Archives of Biochemistry and Biophysics 193: 509.;;Leibowitz and Mechlinski, 1926, Hoppe-Seyler's Zeitschrift für Physiologische Chemie 154: 64.;;Tanaka et al., 2002, Biosci. Biotechnol. Biochem. 66: 2415-2423.;;Yamasaki et al., 1977, Agricultural and Biological Chemistry 41: 1553.;;Flores-Carreon and Ruiz-Herrera, 1972, Biochemica et Biophysica Acta 258: 496.;;Yamasaki et al., 1976, Agricultural and Biological Chemistry 40: 669.;;Kato et al., Sequence Alignment Accession No. Q9C1S7 (TreEMBIrel), Jun. 1, 2001.;;2000WO-US07781 (Berka et al.) database GenBank, US National Library of Medicine, (Bethesda, MD, USA) No. AAF 07600, Mar. 22, 2000. Sequence alignment.;;Keshiri G. et al., Detection and differentiation between mycotoxigenic and non-mycotoxigenic strains of two Fusarium spp. Using volatile production profiles and hydrolytic enzymes., Appl. Microbiol., 2000, vol. 89, pp. 825-833.;;Schmoll M., et al., Cloning of genes expressed early during cellulase induction in Hypocrea jecorina by a rapid subtraction hybridization approach. Fungal Genetics and Biology, 2004, vol. 41, pp. 877-887.;;Yamasaki et al., 1977, Agricultural and Biological Chemistry 41:1451.",INACTIVE
326,EP,B1,EP 1836299 B1,163-328-759-745-199,2010-12-22,2010,EP 06733650 A,2006-01-06,US 2006/0000659 W;;US 64227405 P,2005-01-06,POLYPEPTIDES HAVING CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/163-328-759-745-199,Granted Patent,yes,2,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,4,0,,,"KAZUHISA MIYAMOTO: ""Renewable biological systems for alternative sustainable energy production (FAO Agricultural Services Bulletin - 128)"" 1997, FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATION , XP002380509 Chapter 3.2.1 amd 3.2.2 tables 3-1;;TEERI T T ET AL: ""Homologous domains in Trichoderma reesei cellulolytic enzymes: Gene sequence and expression of cellobiohydrolase II"" GENE, ELSEVIER, AMSTERDAM, NL, vol. 51, no. 1, 1987, pages 43-52, XP002282656 ISSN: 0378-1119;;IWASHITA K ET AL: ""The bglA gene of Aspergillus kawachii encodes both extracellular and cell wall-bound beta-glucosidases"" APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 65, no. 12, December 1999 (1999-12), pages 5546-5553, XP002226970 ISSN: 0099-2240;;KAWAGUCHI T ET AL: ""Cloning and sequencing of the cDNA encoding beta-glucosidase 1 from Aspergillus aculeatus"" GENE, ELSEVIER, AMSTERDAM, NL, vol. 173, no. 2, 16 September 1996 (1996-09-16), pages 287-288, XP004043232 ISSN: 0378-1119",ACTIVE
327,CN,A,CN 101137750 A,038-881-570-296-82X,2008-03-05,2008,CN 200680007263 A,2006-01-06,US 2006/0000659 W;;US 64227405 P,2005-01-06,Polypeptides having cellobiohydrolase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,KIMBERLY BROWN;;PAUL HARRIS;;ALFREDO LOPEZ DE LEON;;SANDRA MERINO,,https://lens.org/038-881-570-296-82X,Patent Application,no,0,4,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,INACTIVE
328,WO,A2,WO 2012/109364 A2,188-968-130-211-58X,2012-08-16,2012,US 2012/0024346 W,2012-02-08,US 201161440859 P;;US 201113172120 A,2011-02-08,GRAPHIC NOTIFICATION FEEDBACK FOR INDICATING INDUCTIVE COUPLING AMONGST DEVICES,A computing device is operated to detect a signal generated from an inductive signal interface. The detected signal may be generated by the device's inductive signal interface being in operational proximity to an inductive signal interface of another device. A notification feedback is generated that confirms an event related to the first and second computing device inductively signaling one another.,HEWLETT PACKARD DEVELOPMENT CO;;BERG SAMANTHA;;LENOX KIMBERLY;;BROWN ROBERT;;KRUGLIKOV VITALY;;CAHTTERJEE MANJIRNATH,BERG SAMANTHA;;LENOX KIMBERLY;;BROWN ROBERT;;KRUGLIKOV VITALY;;CAHTTERJEE MANJIRNATH,,https://lens.org/188-968-130-211-58X,Patent Application,yes,0,1,2,61,0,G06F3/0481;;H02J50/10;;H02J50/80;;H02J50/90;;H02J7/342;;H04B5/24;;H04B5/79;;H02J50/10;;G06F3/0481;;H02J50/80;;H02J50/90,G06K17/00;;H04W92/18;;H02J17/00,,0,0,,,,PENDING
329,KR,A,KR 20170039739 A,005-109-499-432-970,2017-04-11,2017,KR 20177006364 A,2015-08-07,US 201462035106 P;;US 2015/0044172 W,2014-08-08,SYSTEMS AND METHODS FOR MANAGING GROUP CHATS DURING ECOMMERCE SESSIONS,"전자상거래 세션 동안 그룹 채팅을 관리하기 위한 컴퓨터 구현 방법이 제공된다. 방법은 적어도 제1 참여자와 연관된 제1 클라이언트 컴퓨터 디바이스와 제2 참여자와 연관된 제2 클라이언트 컴퓨터 디바이스 사이의 채팅 세션을 개시하는 단계, 및 전자상거래 웹사이트의 적어도 하나의 뷰를 제1 클라이언트 컴퓨터 디바이스 및 제2 클라이언트 컴퓨터 디바이스와 공유하는 단계를 포함한다. 제1 클라이언트 컴퓨터 디바이스 및 제2 클라이언트 컴퓨터 디바이스는 전자상거래 웹사이트의 적어도 하나의 뷰를 디스플레이하도록 구성된다. 적어도 하나의 뷰는 적어도 하나의 구매가능한 아이템을 포함한다. 방법은 적어도 하나의 뷰에 포함되는 적어도 하나의 구매가능한 아이템에 대한 구매 트랜잭션을 개시하는 단계, 구매 트랜잭션에 대한 지불 정보를 수신하는 단계, 및 지불 정보에 기초하여 구매 트랜잭션을 완료하는 단계를 또한 포함한다.",MASTERCARD INTERNATIONAL INC,PURCELL KIMBERLY;;HOSP ADAM K;;SINGH MALAVIKA;;BROWN DAVID C,,https://lens.org/005-109-499-432-970,Patent Application,no,2,0,9,9,0,G06Q30/0613;;G06Q30/0613;;G06Q30/0613;;G06Q20/12;;G06Q20/12;;G06Q20/12;;G06Q30/0605;;G06Q30/0605;;G06Q30/0617;;G06Q30/0617;;G06Q30/0619;;G06Q30/0619;;G06Q30/0641;;G06Q30/0641;;G06Q30/0643;;G06Q30/0643;;G06Q30/0643;;H04L12/1813;;H04L12/1822;;H04L12/1822;;H04L12/1822;;H04L12/185;;H04L12/185;;H04L12/185;;H04L51/10;;H04L51/10,G06Q30/06;;G06Q20/12;;H04L12/18;;H04L12/58,,0,0,,,,ACTIVE
330,EP,A1,EP 1511443 A1,072-523-789-294-856,2005-03-09,2005,EP 03757358 A,2003-06-06,US 0317755 W;;US 16576302 A,2002-06-07,ENDOVASCULAR GRAFT WITH SENSORS,,ENDOVASCULAR TECH INC,BROWN PETER S;;LEMERE MARK T;;BARKMAN KIMBERLY;;KOVAC TIM,,https://lens.org/072-523-789-294-856,Patent Application,yes,0,0,6,6,0,A61B5/0028;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61B5/076;;A61B7/001;;A61B2560/0219;;A61F2/07;;A61F2002/065;;A61F2002/067;;A61F2250/0002;;A61B5/076;;A61B5/0028;;A61B2560/0219;;A61F2002/065;;A61B7/001;;A61F2250/0002;;A61F2002/067;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61F2/07,A61B5/00;;A61F2/02;;A61F2/06,,0,0,,,,EXPIRED
331,CN,B,CN 101137750 B,118-892-802-640-030,2014-05-21,2014,CN 200680007263 A,2006-01-06,US 2006/0000659 W;;US 64227405 P,2005-01-06,Polypeptides having cellobiohydrolase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;LOPEZ DE LEON ALFREDO;;HARRIS PAUL;;MERINO SANDRA,,https://lens.org/118-892-802-640-030,Granted Patent,no,0,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,INACTIVE
332,US,B1,US 7261733 B1,143-223-919-173-307,2007-08-28,2007,US 16576302 A,2002-06-07,US 16576302 A,2002-06-07,Endovascular graft with sensors design and attachment methods,"A endovascular graft having sensing devices attached thereto to facilitate measurement of pertinent parameters within the vasculature into which the graft is implanted. Power sources and transmitters may be attached to the graft to facilitate transmission of measurements to a receiving device outside the patient's body. The sensing devices, may be electrically passive or integrated devices with measurement and transmission capability. The sensing devices may be attached to specific locations on the graft material or attached to the lumen, thereby providing pertinent parameters from critical points inside the vasculature, or may be dispersed over the surface of the graft material or within the lumen to provide a profile of pertinent parameters. The sensing devices may be attached to the graft material with one suture using a running stitch to minimize graft bulk and may be coated with a material to inhibit or control tissue growth.",ENDOVASCULAR TECH INC,BROWN PETER S;;LEMERE MARK T;;BARKMAN KIMBERLY;;KOVAC TIM,ENDOVASCULAR TECHNOLOGIES INC (2002-09-13);;ACACIA RESEARCH GROUP LLC (2012-12-20);;LIFESHIELD SCIENCES LLC (2013-05-15),https://lens.org/143-223-919-173-307,Granted Patent,yes,106,46,6,6,0,A61B5/0028;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61B5/076;;A61B7/001;;A61B2560/0219;;A61F2/07;;A61F2002/065;;A61F2002/067;;A61F2250/0002;;A61B5/076;;A61B5/0028;;A61B2560/0219;;A61F2002/065;;A61B7/001;;A61F2250/0002;;A61F2002/067;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61F2/07,A61B5/00;;A61B5/02;;A61B5/04;;A61F2/02;;A61F2/06,623/1.34;;606/488,0,0,,,,EXPIRED
333,US,A1,US 2006/0156437 A1,054-627-464-576-162,2006-07-13,2006,US 17686405 A,2005-07-06,US 17686405 A;;US 58610304 P,2004-07-06,Polypeptides having alpha-glucosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,YAVER DEBBIE;;LIN JANINE;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL,NOVOZYMES INC (2005-07-06),https://lens.org/054-627-464-576-162,Patent Application,yes,2,7,12,12,10,C12N9/2411;;C12N9/2411;;C12C5/004;;C12C5/004;;C12C11/003;;C12C11/003;;C12C12/02;;C12C12/02;;C12N9/2408;;C12N9/2408,A01H1/00;;C12C11/00;;C12N5/04;;C12N9/24;;C12N15/82,800/284;;435/419;;435/468;;435/200;;426/16,0,0,,,,INACTIVE
334,DK,T4,DK 1836299 T4,131-531-682-641-545,2014-03-31,2014,DK 06733650 T,2006-01-06,US 64227405 P;;US 2006/0000659 W,2005-01-06,"Polypeptider, der har cellobiohydrolaseaktivitet, og polynukleotider, der koder for disse","The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/131-531-682-641-545,Amended Patent,no,0,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,ACTIVE
335,DE,D1,DE 602006019050 D1,007-913-992-109-683,2011-02-03,2011,DE 602006019050 T,2006-01-06,US 64227405 P;;US 2006/0000659 W,2005-01-06,POLYPEPTIDE MIT CELLOBIOHYDROLASEAKTIVITÄT UND DAFÜR KODIERENDE POLYNUKLEOTIDE,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/007-913-992-109-683,Granted Patent,no,0,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,ACTIVE
336,WO,A3,WO 1997/008325 A3,077-638-832-041-363,1997-04-17,1997,US 9613728 W,1996-08-20,US 280095 P,1995-08-25,PURIFIED COPRINUS LACCASES AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to polypeptides having laccase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS,YAVER DEBBIE SUE;;BROWN KIMBERLY M;;KAUPPINEN SAKARI;;HALKIER TORBEN,,https://lens.org/077-638-832-041-363,Search Report,yes,2,0,12,12,0,C07K14/37;;C12N9/0061;;C12N9/0061;;C07K14/37,C07K14/37;;C12N1/21;;C12N9/02;;C12N15/53,,3,2,061-041-223-414-723;;050-136-444-648-403,10.1016/s0021-9258(18)77245-1;;2394718;;10.1111/j.1432-1033.1996.00508.x;;8654395,"KIM, SOON-JA ET AL: ""Selection of laccase over-secreting mutant in Coprinus congregatus"", J. MICROBIOL. (SEOUL), 146-8, June 1995 (1995-06-01), XP000609897;;KOJIMA Y ET AL: ""Cloning, sequence analysis, and expression of ligninolytic phenoloxidase genes of the white-rot basidiomycete Coriolus hirsutus"", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 265, no. 25, 1990, MD US, pages 15224 - 15230, XP002025940;;GIARDINA P ET AL: ""The gene, protein and glycan structures of laccase from Pleurotus ostreatus"", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 235, no. 3, February 1996 (1996-02-01), pages 508 - 515, XP000644722",PATENTED
337,DK,T3,DK 1836299 T3,105-635-437-814-004,2011-04-04,2011,DK 06733650 T,2006-01-06,US 64227405 P;;US 2006/0000659 W,2005-01-06,"Polypeptider, der har cellobiohydrolaseaktivitet, og polynekleotider, der koder for disse","The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/105-635-437-814-004,Granted Patent,no,0,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,ACTIVE
338,ES,T5,ES 2358243 T5,035-486-214-892-722,2014-06-09,2014,ES 06733650 T,2006-01-06,US 64227405 P;;US 2006/0000659 W,2005-01-06,Polipéptidos con actividad celobiohidrolasa y polinucleótidos que los codifican,"The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;MERINO SANDRA,,https://lens.org/035-486-214-892-722,Amended Patent,no,0,0,20,20,0,C11D3/38636;;C12Y302/01091;;C12N9/2437;;C12Y302/01091;;C11D3/38636;;C12N9/2437,C12N9/42,,0,0,,,,ACTIVE
339,EP,A4,EP 1781681 A4,063-549-789-914-882,2007-08-22,2007,EP 05770178 A,2005-07-06,US 2005/0023987 W;;US 58610304 P,2004-07-06,POLYPEPTIDES HAVING ALPHA-GLUCOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC,YAVER DEBBIE;;LIN JANINE;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL,,https://lens.org/063-549-789-914-882,Search Report,no,2,0,12,12,0,C12N9/2411;;C12N9/2411;;C12C5/004;;C12C5/004;;C12C11/003;;C12C11/003;;C12C12/02;;C12C12/02;;C12N9/2408;;C12N9/2408,C12N15/56;;A01H5/00;;C12C11/00;;C12N1/15;;C12N9/26;;C12N15/63;;C12P21/00,,2,1,020-656-215-494-712,11872475;;pmc123785;;10.1128/aem.68.3.1250-1256.2002,"KATO NAOKI ET AL: ""Novel alpha-glucosidase from Aspergillus nidulans with strong transglycosylation activity"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 68, no. 3, March 2002 (2002-03-01), pages 1250 - 1256, XP002278024, ISSN: 0099-2240;;PAL B ET AL: ""EXTRACELLULAR AND INTRA CELLULAR ENZYME MAKE-UP OF 2 SPECIES OF FUSARIUM CAUSING MALFORMATION OF GANDHARAJ GARDENIA-JASMINOIDES AND MANGO MANGIFERA-INDICA"", INDIAN BIOLOGIST, vol. 11, no. 1-2, 1979, pages 6 - 8, XP008081062, ISSN: 0302-7554",DISCONTINUED
340,US,A1,US 2016/0042420 A1,004-773-514-476-453,2016-02-11,2016,US 201514820781 A,2015-08-07,US 201514820781 A;;US 201462035106 P,2014-08-08,SYSTEMS AND METHODS FOR MANAGING GROUP CHATS DURING ECOMMERCE SESSIONS,"A computer implemented method for managing a group chat during an ecommerce session is provided. The method includes initiating a chat session between at least a first client computer device associated with a first participant and a second client computer device associated with a second participant, and sharing at least one view of an ecommerce website with the first client computer device and the second client computer device. The first client computer device and the second client computer device are configured to display the at least one view of the ecommerce website. The at least one view includes at least one purchasable item. The method also includes initiating a purchase transaction for the at least one purchasable item included in the at least one view, receiving payment information for the purchase transaction, and completing the purchase transaction based on the payment information.",MASTERCARD INTERNATIONAL INC,PURCELL KIMBERLY;;HOSP ADAM K;;SINGH MALAVIKA;;BROWN DAVID C,MASTERCARD INTERNATIONAL INCORPORATED (2015-08-19),https://lens.org/004-773-514-476-453,Patent Application,yes,0,10,9,9,0,G06Q30/0613;;G06Q30/0613;;G06Q30/0613;;G06Q20/12;;G06Q20/12;;G06Q20/12;;G06Q30/0605;;G06Q30/0605;;G06Q30/0617;;G06Q30/0617;;G06Q30/0619;;G06Q30/0619;;G06Q30/0641;;G06Q30/0641;;G06Q30/0643;;G06Q30/0643;;G06Q30/0643;;H04L12/1813;;H04L12/1822;;H04L12/1822;;H04L12/1822;;H04L12/185;;H04L12/185;;H04L12/185;;H04L51/10;;H04L51/10,G06Q30/06;;G06Q20/10;;H04L12/58,,0,0,,,,ACTIVE
341,US,A1,US 2006/0200220 A1,146-473-580-998-094,2006-09-07,2006,US 41754906 A,2006-05-04,US 41754906 A;;US 16576302 A,2002-06-07,Endovascular graft with sensors design and attachment methods,"A endovascular graft having sensing devices attached thereto to facilitate measurement of pertinent parameters within the vasculature into which the graft is implanted. Power sources and transmitters may be attached to the graft to facilitate transmission of measurements to a receiving device outside the patient's body. The sensing devices, may be electrically passive or integrated devices with measurement and transmission capability. The sensing devices may be attached to specific locations on the graft material or attached to the lumen, thereby providing pertinent parameters from critical points inside the vasculature, or may be dispersed over the surface of the graft material or within the lumen to provide a profile of pertinent parameters. The sensing devices may be attached to the graft material with one suture using a running stitch to minimize graft bulk and may be coated with a material to inhibit or control tissue growth.",BROWN PETER S;;LEMERE MARK T;;BARKMAN KIMBERLY;;KOVAC TIM,BROWN PETER S;;LEMERE MARK T;;BARKMAN KIMBERLY;;KOVAC TIM,ACACIA RESEARCH GROUP LLC (2012-12-20);;LIFESHIELD SCIENCES LLC (2013-05-15),https://lens.org/146-473-580-998-094,Patent Application,yes,97,24,6,6,0,A61B5/0028;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61B5/076;;A61B7/001;;A61B2560/0219;;A61F2/07;;A61F2002/065;;A61F2002/067;;A61F2250/0002;;A61B5/076;;A61B5/0028;;A61B2560/0219;;A61F2002/065;;A61B7/001;;A61F2250/0002;;A61F2002/067;;A61B5/0031;;A61B5/02007;;A61B5/02014;;A61F2/07,A61B5/00;;A61B5/0215;;A61B5/026;;A61F2/02;;A61F2/06,623/1.1;;623/1.16;;600/486;;600/505,0,0,,,,DISCONTINUED
342,WO,A2,WO 1997/008325 A2,175-595-762-700-84X,1997-03-06,1997,US 9613728 W,1996-08-20,US 280095 P,1995-08-25,PURIFIED COPRINUS LACCASES AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to polypeptides having laccase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS,YAVER DEBBIE SUE;;BROWN KIMBERLY M;;KAUPPINEN SAKARI;;HALKIER TORBEN,,https://lens.org/175-595-762-700-84X,Patent Application,no,0,188,12,12,36,C07K14/37;;C12N9/0061;;C12N9/0061;;C07K14/37,C07K14/37;;C12N1/21;;C12N9/02;;C12N15/53,,0,0,,,,PATENTED
343,CA,A1,CA 2839048 A1,082-461-698-019-850,2007-07-13,2007,CA 2839048 A,2007-01-08,US 33188606 A;;CA 2573095 A,2006-01-13,A METHOD FOR REDUNDANT CONTROLLER SYNCHRONIZATION FOR BUMP-LESS FAILOVER DURING NORMAL AND MISMATCH CONDITIONS,"The present invention relates generally to process control systems and devices and, more particularly, to an apparatus for and a method of implementing redundant controller synchronization for bump-less failover during normal and mismatch conditions at the redundant controllers. The redundant controllers are configured to transmit state information of the process control areas of the primary controller to the backup controller that is necessary for synchronizing the redundant controllers but is not typically transmitted to other devices during the performance of process control functions. Synchronization messages are transmitted from the primary controller to the backup controller each time one of the control areas executes to perform process control functions. In other aspects, the redundant controllers are configured to determine state information at the backup controller from other process control network information during-a failover of the primary controller where a mismatch condition exists between the control areas of the two controllers during the downloading of reconfigurations, and to initialize the backup controller at startup when the mismatch condition exists.",EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/082-461-698-019-850,Patent Application,no,0,0,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B9/03;;G05B7/02;;G05B19/02;;G05B23/00,,0,0,,,,ACTIVE
344,GB,B,GB 2477237 B,149-687-055-130-986,2011-09-07,2011,GB 201106151 A,2007-01-12,US 33188606 A;;GB 0700569 A,2006-01-13,A method for redundant controller synchronization for bump-less failover during normal and mismatch conditions,,EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/149-687-055-130-986,Granted Patent,no,3,0,6,24,0,G05B9/03;;G06F11/1658;;G06F11/2033;;G06F11/2038;;G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097,G05B9/03;;G06F11/16;;G06F11/20,,0,0,,,,ACTIVE
345,US,A1,US 2008/0032331 A1,157-448-980-399-597,2008-02-07,2008,US 83666507 A,2007-08-09,US 83666507 A;;US 8012798 A;;US 85788697 A,1997-05-16,Polypeptides having aminopeptidase activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFED LENE V,,https://lens.org/157-448-980-399-597,Patent Application,yes,0,0,2,52,9,A21D2/265;;A21D2/268;;A21D8/042;;A23J3/34;;C12N9/48;;C12P21/06;;A23K20/147;;A23K20/142;;A23K20/189;;A23L27/24;;A21D2/265;;A21D2/268;;A23J3/34;;C12N9/48;;C12P21/06;;A21D8/042;;A23K20/189;;A23K20/147;;A23K20/142;;A23L27/24,C12P21/06;;C07B41/00;;C07K14/00,435/68.1;;530/350,0,0,,,,DISCONTINUED
346,EP,B1,EP 0981631 B1,003-446-505-279-293,2007-04-04,2007,EP 98922312 A,1998-05-15,US 9809940 W;;US 85788697 A;;US 6289397 P,1997-05-16,POLYPEPTIDES HAVING AMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFOD LENE V,"NOVOZYMES, INC. (2005-06-22);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/003-446-505-279-293,Granted Patent,yes,5,0,16,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/09;;C12N15/57;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12P21/02;;C12P21/06;;C12R1/69,,4,0,,,"DATABASE MEDLINE US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US IVANOVA N M ET AL: ""[Isolation and properties of leucine aminopeptidase from Aspergillus oryzae]. Vydelenie i svoistva leitsinaminopeptidazy iz Aspergillus oryzae."" XP002077232 & BIOKHIMIIA, (1977 MAY) 42 (5) 843-9. JOURNAL CODE: A28. ISSN: 0006-307X., USSR;;DATABASE MEDLINE US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US Accession no 77158195, TSYPEROVICH A S ET AL: ""[Isolation, purification and investigation of physico-chemical properties and specificity of Leu-Gly-Gly-amino peptidase]. Vydelenie, ochistka, issledovanie nekotorykh fiziko-khimicheskikh svoistv i spetsifichnosti Leu-Gly-Gly aminopeptidazy."" XP002077233 & BIOKHIMIIA, (1976 OCT) 41 (10) 1871-7. JOURNAL CODE: A28. ISSN: 0006-307X., USSR;;DATABASE WPI Section Ch, Week 9130 Derwent Publications Ltd., London, GB; Class D13, AN 91-220330 XP002077234 & JP 03 143394 A (SHOKUHIN SANGYO BIOREACTOR), 18 June 1991;;DATABASE WPI Section Ch, Week 9710 Derwent Publications Ltd., London, GB; Class B04, AN 97-100651 XP002076623 & CN 1 078 495 A (UNIV BEIJING)",EXPIRED
347,EP,B1,EP 0981630 B1,071-225-009-874-904,2008-11-19,2008,EP 98921134 A,1998-05-12,US 9809629 W;;US 85788497 A;;US 6289297 P,1997-05-16,POLYPEPTIDES HAVING PROLYL PIPEPTIDYL AMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having dipeptidyl aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL W;;KLOTZ ALAN;;BYUN TONY,"NOVOZYMES, INC. (2005-06-22);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/071-225-009-874-904,Granted Patent,yes,3,0,14,15,0,A21D2/267;;A21D8/042;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A21D8/042;;A23J3/34;;A23L27/21,C12N15/09;;C12N15/57;;A21D2/26;;A21D8/04;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06;;C12R1/69,,8,0,,,"TACHI H ET AL: ""AN X PROLYL DIPEPTIDYL -AMINOPEPTIDASE FROM ASPERGILLUS -ORYZAE."" PHYTOCHEMISTRY (OXF) 31 (11). 1992. 3707-3709. CODEN: PYTCAS ISSN: 0031-9422, XP002047735;;BEAUVAIS A ET AL: ""Biochemical and antigenic characterization of a new dipeptidyl- peptidase isolated from Aspergillus fumigatus."" JOURNAL OF BIOLOGICAL CHEMISTRY 272 (10). 1997. 6238-6244. ISSN: 0021-9258, XP002047736;;HEYMANN E ET AL: ""COMPLEMENTARY ACTION OF DIPEPTIDYL PEPTIDASE IV AND AMINOPEPTIDASE M IN THE DIGESTION OF BETA CASEIN."" J DAIRY RES 53 (2). 1986. 229-236. CODEN: JDRSAN ISSN: 0022-0299, XP002052650;;CHEMICAL ABSTRACTS, vol. 124, no. 21, 20 May 1996 Columbus, Ohio, US; abstract no. 287456, TACHI, HIROSHI: ""X-prolyl- dipeptidyl -aminopeptidase activity during soy sauce fermentation"" XP002051874 & NIPPON JOZO KYOKAISHI (1996), 91(2), 138-40 CODEN: NJKYES;ISSN: 0914-7314, 1996,;;DATABASE WPI Section Ch, Week 9527 Derwent Publications Ltd., London, GB; Class D13, AN 95-202831 XP002047737 & JP 07 115 969 A (ASAHI KASEI KOGYO KK) , 9 May 1995;;DATABASE WPI Section Ch, Week 9710 Derwent Publications Ltd., London, GB; Class B04, AN 97-100651 XP002076623 & CN 1 078 495 A (UNIV BEIJING);;BEAUVAIS A ET AL: ""Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans"" INFECTION AND IMMUNITY, vol. 65, no. 8, August 1997, pages 3042-3047, XP002076492 WASHINGTON US;;EMBL/GENBANK DATABASES, Accession no AJ002369, Sequence reference AODPPIV 2 March 1998 DOUMAS A ET AL: ""Characterization of the prolyl dipeptidyl peptidase-encoding gene (dppIV) from the koji mould Aspergillus oryzae"" XP002076626",EXPIRED
348,EP,A1,EP 0981631 A1,124-836-457-339-001,2000-03-01,2000,EP 98922312 A,1998-05-15,US 9809940 W;;US 85788697 A;;US 6289397 P,1997-05-16,POLYPEPTIDES HAVING AMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK BIOTECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFOD LENE V,"NOVOZYMES, INC. (2005-06-22);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/124-836-457-339-001,Patent Application,yes,0,0,16,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/09;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N15/57;;C12P21/02;;C12P21/06;;C12R1/69,,0,0,,,,EXPIRED
349,US,A1,US 2007/0168058 A1,008-268-029-740-458,2007-07-19,2007,US 33188606 A,2006-01-13,US 33188606 A,2006-01-13,Method for redundant controller synchronization for bump-less failover during normal and program mismatch conditions,"The present invention relates generally to process control systems and devices and, more particularly, to an apparatus for and a method of implementing redundant controller synchronization for bump-less failover during normal and mismatch conditions at the redundant controllers. The redundant controllers are configured to transmit state information of the process control areas of the primary controller to the backup controller that is necessary for synchronizing the redundant controllers but is not typically transmitted to other devices during the performance of process control functions. Synchronization messages are transmitted from the primary controller to the backup controller each time one of the control areas executes to perform process control functions. In other aspects, the redundant controllers are configured to determine state information at the backup controller from other process control network information during a fallover of the primary controller where a mismatch condition exists between the control areas of the two controllers during the downloading of reconfigurations, and to initialize the backup controller at startup when the mismatch condition exists.",EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/008-268-029-740-458,Patent Application,yes,20,99,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B9/02,700/82,0,0,,,,ACTIVE
350,US,A1,US 2004/0171104 A1,172-908-726-951-030,2004-09-02,2004,US 72380703 A,2003-11-25,US 72380703 A;;US 7959298 A;;US 85788497 A;;US 6289297 P,1997-05-16,Polypeptides having dipeptidyl aminopeptidase activity and nucleic acids encoding same,"
   The present invention relates to isolated polypeptides having dipeptidyl aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides. 
",NOVOZYMES BIOTECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL W;;KLOTZ ALAN;;BYUN TONY,NOVOZYMES INC (2005-08-29),https://lens.org/172-908-726-951-030,Patent Application,yes,0,0,14,15,13,A21D2/267;;A21D8/042;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A21D8/042;;A23J3/34;;A23L27/21,C12N15/09;;A21D2/26;;A21D8/04;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12N15/57;;C12P21/06;;C12R1/69,435/68.1;;435/226,0,0,,,,EXPIRED
351,US,A1,US 2005/0118610 A1,180-154-696-408-038,2005-06-02,2005,US 88323804 A,2004-06-30,US 88323804 A;;US 8012798 A;;US 85788697 A;;US 6289397 P,1997-05-16,Polypeptides having aminopeptidase activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES BIOECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFOD LENE V,NOVOZYMES INC (2005-08-29),https://lens.org/180-154-696-408-038,Patent Application,yes,1,1,16,52,9,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/09;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N15/57;;C12P21/02;;C12P21/06;;C12R1/69,435/6;;435/226;;435/69.1;;435/320.1;;536/23.2;;435/254.3,0,0,,,,EXPIRED
352,IN,B,IN 187247 B,194-356-812-777-505,2002-03-09,2002,IN 1064MA1998 A,1998-05-18,US 85788497 A,1997-05-16,A method for obtaining polypeptides having dipeptidyl aminopeptidase activity,,NOVO NORDISK BIOTECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL W;;KLOTZ ALAN;;BYUN TONY,,https://lens.org/194-356-812-777-505,Granted Patent,no,0,0,1,15,0,,A23L1/305;;C07K1/08,,0,0,,,,EXPIRED
353,AT,T1,AT E358725 T1,067-377-612-531-621,2007-04-15,2007,AT 98922312 T,1998-05-15,US 85788697 A;;US 6289397 P,1997-05-16,POLYPEPTIDE MIT AMINOPEPTIDASEAKTIVITÄT UND DAFÜR KODIERENDE NUKLEINSÄUREN,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFOD LENE V,,https://lens.org/067-377-612-531-621,Granted Patent,no,0,0,16,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/09;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N15/57;;C12P21/02;;C12P21/06;;C12R1/69,,0,0,,,,EXPIRED
354,HK,A1,HK 1102843 A1,023-080-189-880-942,2007-12-07,2007,HK 07109234 A,2007-08-24,US 33188606 A,2006-01-13,A METHOD FOR REDUNDANT CONTROLLER SYNCHRONIZATION FOR BUMP-LESS FAILOVER DURING NORMAL AND MISMATCH CONDITIONS,,EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/023-080-189-880-942,Patent Application,no,0,0,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B/;;G06F/,,0,0,,,,PENDING
355,CA,C,CA 2573095 C,046-196-549-162-75X,2017-03-14,2017,CA 2573095 A,2007-01-08,US 33188606 A,2006-01-13,A METHOD FOR REDUNDANT CONTROLLER SYNCHRONIZATION FOR BUMP-LESS FAILOVER DURING NORMAL AND MISMATCH CONDITIONS,"The present invention relates generally to process control systems and devices and, more particularly, to an apparatus for and a method of implementing redundant controller synchronization for bump-less failover during normal and mismatch conditions at the redundant controllers. The redundant controllers are configured to transmit state information of the process control areas of the primary controller to the backup controller that is necessary for synchronizing the redundant controllers but is not typically transmitted to other devices during the performance of process control functions. Synchronization messages are transmitted from the primary controller to the backup controller each time one of the control areas executes to perform process control functions. In other aspects, the redundant controllers are configured to determine state information at the backup controller from other process control network information during a failover of the primary controller where a mismatch condition exists between the control areas of the two controllers during the downloading of reconfigurations, and to initialize the backup controller at startup when the mismatch condition exists.",EMERSON PROCESS MAN POWER & WATER SOLUTIONS INC,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/046-196-549-162-75X,Granted Patent,no,0,0,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B19/02;;G05B23/02;;G06F13/00,,0,0,,,,ACTIVE
356,DE,A1,DE 102007001576 A1,094-095-741-169-183,2007-09-20,2007,DE 102007001576 A,2007-01-10,US 33188606 A,2006-01-13,Verfahren zur Synchronisierung redundanter Steuerungen für stoßfreies Failover unter normalen Bedingungen und bei Fehlanpasssung,"Die vorliegende Erfindung bezieht sich allgemein auf Prozesssteuerungssysteme und -geräte sowie insbesondere auf eine Vorrichtung und ein Verfahren für die Implementierung einer Synchronisierung redundanter Steuerungen für ein stoßfreies Failover unter normalen Bedingungen und bei Fehlanpassungszuständen an den redundanten Steuerungen. Die redundanten Steuerungen sind konfiguriert, um Statusinformationen der Prozesssteuerungsbereiche der Primärsteuerung an die Backup-Steuerung zu übertragen, die erforderlich sind, um die redundanten Steuerungen zu synchronisieren, die während der Ausführung von Prozesssteuerungsfunktionen typischerweise jedoch nicht an andere Geräte übertragen werden. Synchronisierungsbotschaften werden jedes Mal von der Primärsteuerung zur Backup-Steuerung übertragen, wenn einer der Steuerungsbereiche ausgeführt wird, um Prozesssteuerungsfunktionen auszuführen. In anderer Hinsicht sind die redundanten Steuerungen konfiguriert, um Statusinformationen an der Backup-Steuerung aus anderen Prozesssteuerungsnetzwerkinformationen während eines Failover der Primärsteuerung zu ermitteln, wenn eine Fehlanpassung zwischen den Steuerungsbereichen der beiden Steuerungen während des Herunterladens neuer Konfigurationen besteht, und um die Backup-Steuerung beim Anlaufen zu initialisieren, wenn der Fehlanpassungszustand existiert.",EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/094-095-741-169-183,Patent Application,no,0,3,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B9/03;;G05B19/048;;G06F11/18,,0,0,,,,ACTIVE
357,GB,B,GB 2477238 B,143-483-848-618-145,2011-09-07,2011,GB 201106153 A,2007-01-12,US 33188606 A;;GB 0700569 A,2006-01-13,A method for redundant controller synchronisation for bump-less failover during normal and mismatch conditions,,EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/143-483-848-618-145,Granted Patent,no,2,1,6,24,0,G05B9/03;;G06F11/1658;;G06F11/2033;;G06F11/2038;;G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097,G05B9/03;;G06F11/16;;G06F11/20,,0,0,,,,ACTIVE
358,CA,C,CA 2839048 C,195-889-586-621-884,2016-06-28,2016,CA 2839048 A,2007-01-08,US 33188606 A;;CA 2573095 A,2006-01-13,A METHOD FOR REDUNDANT CONTROLLER SYNCHRONIZATION FOR BUMP-LESS FAILOVER DURING NORMAL AND MISMATCH CONDITIONS,"The present invention relates generally to process control systems and devices and, more particularly, to an apparatus for and a method of implementing redundant controller synchronization for bump-less failover during normal and mismatch conditions at the redundant controllers. The redundant controllers are configured to transmit state information of the process control areas of the primary controller to the backup controller that is necessary for synchronizing the redundant controllers but is not typically transmitted to other devices during the performance of process control functions. Synchronization messages are transmitted from the primary controller to the backup controller each time one of the control areas executes to perform process control functions. In other aspects, the redundant controllers are configured to determine state information at the backup controller from other process control network information during-a failover of the primary controller where a mismatch condition exists between the control areas of the two controllers during the downloading of reconfigurations, and to initialize the backup controller at startup when the mismatch condition exists.",EMERSON PROCESS MAN POWER & WATER SOLUTIONS INC,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/195-889-586-621-884,Granted Patent,no,0,0,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B9/03;;G05B7/02;;G05B19/02;;G05B23/00,,0,0,,,,ACTIVE
359,CN,B,CN 101004587 B,006-321-530-011-563,2010-11-03,2010,CN 200710000848 A,2007-01-12,US 33188606 A,2006-01-13,Method for redundant controller synchronization during normal and program mismatch conditions,"The present invention relates generally to process control systems and devices and, more particularly, to an apparatus for and a method of implementing redundant controller synchronization for bump-less failover during normal and mismatch conditions at the redundant controllers. The redundant controllers are configured to transmit state information of the process control areas of the primary controller to the backup controller that is necessary for synchronizing the redundant controllers but is not typically transmitted to other devices during the performance of process control functions. Synchronization messages are transmitted from the primary controller to the backup controller each time one of the control areas executes to perform process control functions. In other aspects, the redundant controllers are configured to determine state information at the backup controller from other process control network information during a fallover of the primary controller where a mismatch condition exists between the control areas of the two controllers during the downloading of reconfigurations, and to initialize the backup controller at startup when the mismatch condition exists.",EMERSON PROCESS MAN,RICHARD BROWN;;XU CHENG;;KEPHART RICHARD W;;MICHAEL DURBIN;;KIMBERLY COSTLOW,,https://lens.org/006-321-530-011-563,Granted Patent,no,0,0,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B9/03;;G05B19/418,,0,0,,,,ACTIVE
360,GB,B,GB 2434229 B,015-606-096-656-152,2011-06-22,2011,GB 0700569 A,2007-01-12,US 33188606 A,2006-01-13,A method for redundant controller synchronization for bump-less failover during normal and mismatch conditions,,EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/015-606-096-656-152,Granted Patent,no,9,0,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B9/03;;G06F11/20,,0,0,,,,ACTIVE
361,WO,A1,WO 1998/051803 A1,130-809-503-872-653,1998-11-19,1998,US 9809629 W,1998-05-12,US 85788497 A;;US 6289297 P,1997-05-16,POLYPEPTIDES HAVING PROLYL PIPEPTIDYL AMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides from Aspergillus oryzae having prolyl dipeptidyl aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK BIOTECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL W;;KLOTZ ALAN;;BYUN TONY,,https://lens.org/130-809-503-872-653,Patent Application,yes,23,12,14,15,13,A21D2/267;;A21D8/042;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A21D8/042;;A23J3/34;;A23L27/21,C12N15/09;;A21D2/26;;A21D8/04;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12N15/57;;C12P21/06;;C12R1/69,,80,51,009-251-239-804-662;;021-909-953-284-150;;045-764-815-720-977;;031-484-006-951-260;;021-909-953-284-150;;009-251-239-804-662;;038-383-743-124-048;;054-167-555-136-715;;018-694-084-068-187;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;093-852-774-499-049;;008-142-083-348-787;;024-451-445-876-667;;040-861-991-536-020;;063-430-303-566-809;;009-908-645-871-282;;038-343-735-619-757;;108-896-336-489-649;;039-567-108-541-793;;023-264-318-025-624;;011-772-323-109-190;;049-180-109-797-869;;072-722-930-671-457;;083-654-212-716-080;;003-296-375-991-31X;;130-300-082-811-251;;008-316-267-912-706;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;038-856-203-382-553;;043-147-746-491-691;;004-720-259-087-901;;004-720-259-087-901;;020-230-420-771-91X;;087-569-856-357-676;;136-261-375-157-758;;035-769-382-850-601;;062-834-673-001-172;;098-987-808-358-51X;;103-934-330-253-339;;015-521-911-661-87X,10.1016/s0031-9422(00)97513-7;;9045640;;10.1074/jbc.272.10.6238;;10.1017/s0022029900024833;;2873157;;10.1128/iai.65.8.3042-3047.1997;;pmc175429;;9234752;;9045640;;10.1074/jbc.272.10.6238;;10.1016/s0031-9422(00)97513-7;;10.1093/bioinformatics/5.2.151;;2720464;;10.1016/1046-5928(91)90057-p;;1821793;;10.1126/science.2471267;;2471267;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1002/j.1460-2075.1990.tb08250.x;;pmc551819;;1970293;;10.1007/bf00309554;;7532112;;10.1002/yea.320060402;;2204245;;8254300;;10.1099/00221287-139-10-2295;;10.1016/0968-0004(94)90169-4;;7908149;;8203019;;10.1016/0968-0004(94)90205-4;;7764565;;10.1016/0168-1656(94)90181-3;;10.1126/science.8100364;;8100364;;1731198;;10.1038/355033a0;;7907332;;10.1016/s0021-9258(17)37352-0;;10.1096/fasebj.7.15.7903263;;7903263;;10.1111/j.1365-2958.1993.tb01640.x;;8102773;;8203153;;10.1002/yea.320100107;;pmc286710;;10.1073/pnas.86.5.1434;;2646633;;10.1016/0092-8674(84)90442-2;;6430565;;10.1016/0092-8674(83)90070-3;;6339075;;10.1073/pnas.75.3.1433;;418413;;pmc411486;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/c2009-0-02655-5;;10.1016/c2009-0-02655-5;;7975897;;10.1002/yea.320100610;;10.1002/(sici)1097-0061(199607)12:9<877::aid-yea969>3.0.co;2-s;;8840505;;10.1016/0166-0934(92)90168-d;;1322932;;6423828;;10.1016/0022-2836(84)90192-x;;3516005;;10.1016/0003-2697(86)90403-3;;10.1016/s0953-7562(09)80980-5;;10.1016/s0953-7562(09)80575-3;;10.1086/282338,"TACHI H ET AL: ""AN X PROLYL DIPEPTIDYL -AMINOPEPTIDASE FROM ASPERGILLUS -ORYZAE."", PHYTOCHEMISTRY (OXF) 31 (11). 1992. 3707-3709. CODEN: PYTCAS ISSN: 0031-9422, XP002047735;;BEAUVAIS A ET AL: ""Biochemical and antigenic characterization of a new dipeptidyl- peptidase isolated from Aspergillus fumigatus."", JOURNAL OF BIOLOGICAL CHEMISTRY 272 (10). 1997. 6238-6244. ISSN: 0021-9258, XP002047736;;HEYMANN E ET AL: ""COMPLEMENTARY ACTION OF DIPEPTIDYL PEPTIDASE IV AND AMINOPEPTIDASE M IN THE DIGESTION OF BETA CASEIN."", J DAIRY RES 53 (2). 1986. 229-236. CODEN: JDRSAN ISSN: 0022-0299, XP002052650;;CHEMICAL ABSTRACTS, vol. 124, no. 21, 20 May 1996, Columbus, Ohio, US; abstract no. 287456, TACHI, HIROSHI: ""X-prolyl- dipeptidyl -aminopeptidase activity during soy sauce fermentation"" XP002051874;;DATABASE WPI Section Ch Week 9527, Derwent World Patents Index; Class D13, AN 95-202831, XP002047737;;DATABASE WPI Section Ch Week 9710, Derwent World Patents Index; Class B04, AN 97-100651, XP002076623;;BEAUVAIS A ET AL: ""Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans"", INFECTION AND IMMUNITY, vol. 65, no. 8, August 1997 (1997-08-01), WASHINGTON US, pages 3042 - 3047, XP002076492;;EMBL/GENBANK DATABASES, Accession no AJ002369, Sequence reference AODPPIV 2 March 1998 DOUMAS A ET AL: ""Characterization of the prolyl dipeptidyl peptidase-encoding gene (dppIV) from the koji mould Aspergillus oryzae"";;BEAUVAIS ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, 1997, pages 6238 - 6244;;TACHI ET AL., PHYTOCHEMISTRY, vol. 31, 1992, pages 3707 - 3709;;HIGGINS, CABIOS, vol. 5, 1989, pages 151 - 153;;H. NEURATH; R.L. HILL: ""The Proteins"", 1979, ACADEMIC PRESS;;J. SAMBROOK; E.F. FRITSCH; T. MANIATUS: ""Molecular Cloning, A Laboratory Manual"", 1989, COLD SPRING HARBOR;;""A Manual of Quantitative Immunoelectrophoresis"", 1973, BLACKWELL SCIENTIFIC PUBLICATIONS;;JOHNSTONE; THORPE: ""Immunochemistry in Practice"", 1982, BLACKWELL SCIENTIFIC PUBLICATIONS, pages: 27 - 31;;""Manual of Quantitative Immunoelectrophoresis"", 1973, BLACKWELL SCIENTIFIC PUBLICATIONS;;BOCK; AXELSEN: ""Manual of Quantitative Immunoelectrophoresis"", 1973, BLACKWELL SCIENTIFIC PUBLICATIONS;;RAPER, K.D.; FENNEL, D.I.: ""The Genus Aspergillus"", 1965, THE WILKINS COMPANY, BALTIMORE;;INNIS ET AL.: ""PCR: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., JOURNAL OF MOLECULAR BIOLOGY, vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETTERS, vol. 309, 1992, pages 59 - 64;;VILLA-KAMAROFF ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 80, 1983, pages 21 - 25;;""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOLECULAR CELLULAR BIOLOGY, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;KUDLA ET AL., EMBO JOURNAL, vol. 9, 1990, pages 1355 - 1364;;JARAI; BUXTON, CURRENT GENETICS, vol. 26, 1994, pages 2238 - 244;;VERDIER, YEAST, vol. 6, 1990, pages 271 - 297;;MACKENZIE ET AL., JOURNAL OF GENERAL MICROBIOLOGY, vol. 139, 1993, pages 2295 - 2307;;HARTL ET AL., TIBS, vol. 19, 1994, pages 20 - 25;;BERGERON ET AL., TIBS, vol. 19, 1994, pages 124 - 128;;DEMOLDER ET AL., JOURNAL OF BIOTECHNOLOGY, vol. 32, 1994, pages 179 - 189;;CRAIG, SCIENCE, vol. 260, 1993, pages 1902 - 1903;;GETHING; SAMBROOK, NATURE, vol. 355, 1992, pages 33 - 45;;PUIG; GILBERT, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 269, 1994, pages 7764 - 7771;;WANG; TSOU, THE FASEB JOURNAL, vol. 7, 1993, pages 1515 - 11157;;ROBINSON ET AL., BIOLTECHNOLOGY, vol. 1, 1994, pages 381 - 384;;JACOBS ET AL., MOLECULAR MICROBIOLOGY, vol. 8, 1993, pages 957 - 966;;ENDERLIN; OGRYDZIAK, YEAST, vol. 10, 1994, pages 67 - 79;;FULLER ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 86, 1989, pages 1434 - 1438;;JULIUS ET AL., CELL, vol. 37, 1984, pages 1075 - 1089;;JULIUS ET AL., CELL, vol. 32, 1983, pages 839 - 852;;EHRLICH, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1433;;CHANG; COHEN, MOLECULAR GENERAL GENETICS, vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZIN, JOURNAL OF BACTERIOLOGY, vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, JOURNAL OF MOLECULAR BIOLOGY, vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;HAWKSWORTH ET AL.: ""In, Ainsworth and Bisby's Dictionary of The Fungi"", 1995, UNIVERSITY PRESS;;HAWKSWORTH ET AL.: ""CAB International"", 1995, UNIVERSITY PRESS, article ""Ainsworth and Bisby's Dictionary of The Fungi"";;BIOLOGY AND ACTIVITIES OF YEAST;;""Soc. App. Bacteriol. Symposium Series"", 1980;;""Biochemistry and Genetics of Yeast"", 1987;;""The Yeasts"", 1987;;""The Molecular Biology of the Yeast Saccharomyces"", 1981;;BECKER; GUARENTE: ""Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology"", vol. 194, ACADEMIC PRESS, pages: 182 - 187;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;BECKER; GUARENTE: ""Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., article ""Guide to Yeast Genetics and Molecular Biology"", pages: 182 - 187;;ITO ET AL., JOURNAL OF BACTERIOLOGY, vol. 153, 1983, pages 163;;""More Gene Manipulations in Fungi"", 1991, ACADEMIC PRESS;;""Protein Purification"", 1989, VCH;;""More Gene Manipulations in Fungi"", 1991, ACADEMIC PRESS;;""Protein Purification"", 1989, VCH PUBLISHERS;;CEDRANGORO ET AL., ENZYMOLOGIA, vol. 29, 1965, pages 143;;ANNA-ARRIOLA; HERSKOWITZ, YEAST, vol. 10, 1994, pages 801 - 810;;GALISSON; DUJON, YEAST, vol. 12, 1996, pages 877 - 885;;D'ALESSIO ET AL., FOCUS@, vol. 14, 1992, pages 76;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;VAN HEIJNE, JOURNAL OFMOLECULAR BIOLOGY, vol. 173, 1984, pages 243 - 251;;HATTORI; SAKAKI, ANALYTICAL BIOCHEMISTRY, vol. 152, 1986, pages 232 - 237;;WIEBE ET AL., MYCOLOGICAL RESEARCH, vol. 96, 1992, pages 555 - 562;;WIEBE ET AL., MYCOLOGICAL RESEARCH, vol. 95, 1991, pages 1284 - 1288;;ADLER-NISSEN: ""Enzymic Hydrolysis of Food Proteins"", 1986, ELSEVIER APPLIED SCIENCE PUBLISHERS;;VOGEL, AM. NATURE, vol. 98, 1964, pages 435 - 446;;ADLER-NISSEN: ""Enzymic Hydrolysis of Food Proteins"", 1986, ELSEVIER APPLIED SCIENCE PUBLISHERS;;ADLER-NISSEN, AGRICULTURAL AND FOOD CHEMISTRY, vol. 17, 1979, pages 1256",PENDING
362,CA,A1,CA 2573095 A1,015-408-442-247-822,2007-07-13,2007,CA 2573095 A,2007-01-08,US 33188606 A,2006-01-13,A METHOD FOR REDUNDANT CONTROLLER SYNCHRONIZATION FOR BUMP-LESS FAILOVER DURING NORMAL AND MISMATCH CONDITIONS,"The present invention relates generally to process control systems and devices and, more particularly, to an apparatus for and a method of implementing redundant controller synchronization for bump-less failover during normal and mismatch conditions at the redundant controllers. The redundant controllers are configured to transmit state information of the process control areas of the primary controller to the backup controller that is necessary for synchronizing the redundant controllers but is not typicall y transmitted to other devices during the performance of process control functions. Synchronization messages are transmitted from the primary controller to the backup controlle r each time one of the control areas executes to perform process control functions. In other aspects, the redundant controllers are configured to determine state information at the backup controller from other process control network information during a failover of the primary controller where a mismatch condition exists between the control areas of the two controllers during the downloading of reconfigurations, and to initialize the backup controller at startup when the mismatch condition exists.",EMERSON PROCESS MANAGEMENT,COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;KEPHART RICHARD W;;BROWN RICHARD,,https://lens.org/015-408-442-247-822,Patent Application,no,0,0,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B19/02;;G05B23/02;;G06F13/00,,0,0,,,,ACTIVE
363,DE,T2,DE 69837475 T2,042-323-924-790-963,2007-12-13,2007,DE 69837475 T,1998-05-15,US 85788697 A;;US 6289397 P;;US 9809940 W,1997-05-16,POLYPEPTIDE MIT AMINOPEPTIDASEAKTIVITÄT UND DAFÜR KODIERENDE NUKLEINSÄUREN,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFOD LENE V,,https://lens.org/042-323-924-790-963,Granted Patent,no,0,0,16,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/09;;C12N15/57;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12P21/02;;C12P21/06;;C12R1/69,,0,0,,,,EXPIRED
364,US,B2,US 7279308 B2,076-700-404-031-044,2007-10-09,2007,US 88323804 A,2004-06-30,US 88323804 A;;US 8012798 A;;US 85788697 A;;US 6289397 P,1997-05-16,Polynucleotides encoding polypeptides having aminopeptidase activity,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFED LENE V,NOVOZYMES INC (2005-08-29),https://lens.org/076-700-404-031-044,Granted Patent,yes,6,0,16,52,9,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/00;;C12N15/09;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C07H21/04;;C07K14/00;;C12N1/15;;C12N1/19;;C12N1/20;;C12N1/21;;C12N5/10;;C12N9/00;;C12N9/48;;C12N15/57;;C12N15/63;;C12N15/85;;C12P21/02;;C12P21/06;;C12R1/69,435/69.1;;435/325;;435/252.3;;435/254.11;;435/320.1;;435/183;;536/23.1;;536/23.5;;536/24.31;;530/350,8,4,057-869-247-840-140;;022-378-368-953-890;;050-857-506-269-557;;001-474-003-742-829,10899618;;10.1016/s0167-4838(00)00064-9;;10.1271/bbb1961.37.767;;8175800;;10.1016/s0021-9258(17)36879-5;;5418942;;pmc376746;;10.1128/am.19.4.598-603.1970,"Blinkovsky et al., Biochim et Biophys Acta 1480: 171-181, 2000.;;Nakadai et al., Agr. Biol. Chem., 37 (4), 767-774, 1973.;;Nishizawa et al., J Biol Chem., 269: 13651-13655, 1994.;;Kundu and Das, Applied Microbiol 19:598-603, 1970.;;Abstract, File Medline, Stn. Medline Caesar Accession No. 1870 (XP-002077232), May 1977.;;Abstract, File Medline, Stn. Medline Caesar Accession No. 1872 (XP-002077233), Oct. 1976.;;Database WPI, Section Ch, Week 9130, (XP-002077234).;;Database WPI, Section Ch, Week 9710, (XP-002076623).",EXPIRED
365,GB,A,GB 2477237 A,194-369-479-943-284,2011-07-27,2011,GB 201106151 A,2007-01-12,US 33188606 A;;GB 0700569 A,2006-01-13,Redundant controllers in which a backup controller determines state information from process output values in the event of primary controller failover.,"Disclosed is a pair of redundant controllers in a process control network. The controllers are linked to each other and to the other devices of the network, each of the controllers has a set of control areas each having a process control application program for performing process control functions and a control synchronization program. When the backup controller gets a failure message from the primary controller, the control synchronization program gets process output values from the primary controller, if the backup controller determines that the controllers have different control area configurations. The control synchronization program then determines the state information for the control areas using values obtained from the output modules of the control areas of the primary controller. The backup controller then begins performing process control functions using the process control application programs.",EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/194-369-479-943-284,Patent Application,no,3,7,6,24,0,G05B9/03;;G06F11/1658;;G06F11/2033;;G06F11/2038;;G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097,G05B9/03;;G06F11/16;;G06F11/20,,0,0,,,,ACTIVE
366,DK,T3,DK 0981630 T3,002-909-195-334-913,2009-03-09,2009,DK 98921134 T,1998-05-12,US 85788497 A;;US 6289297 P;;US 9809629 W,1997-05-16,"Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme","The present invention relates to isolated polypeptides having dipeptidyl aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL W;;KLOTZ ALAN;;BYUN TONY,,https://lens.org/002-909-195-334-913,Granted Patent,no,0,0,14,15,0,A21D2/267;;A21D8/042;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A21D8/042;;A23J3/34;;A23L27/21,C12N15/09;;C12N15/57;;A21D2/26;;A21D8/04;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06;;C12R1/69,,0,0,,,,EXPIRED
367,WO,A1,WO 1998/051804 A1,011-174-982-211-818,1998-11-19,1998,US 9809940 W,1998-05-15,US 85788697 A;;US 6289397 P,1997-05-16,POLYPEPTIDES HAVING AMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides from Aspergillus oryzae having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK BIOTECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFOD LENE V,,https://lens.org/011-174-982-211-818,Patent Application,yes,5,11,16,52,9,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/09;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N15/57;;C12P21/02;;C12P21/06;;C12R1/69,,4,1,110-698-915-935-839,15640,"DATABASE MEDLINE US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; IVANOVA N M ET AL: ""[Isolation and properties of leucine aminopeptidase from Aspergillus oryzae]. Vydelenie i svoistva leitsinaminopeptidazy iz Aspergillus oryzae."", XP002077232;;DATABASE MEDLINE US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; TSYPEROVICH A S ET AL: ""[Isolation, purification and investigation of physico-chemical properties and specificity of Leu-Gly-Gly-amino peptidase]. Vydelenie, ochistka, issledovanie nekotorykh fiziko-khimicheskikh svoistv i spetsifichnosti Leu-Gly-Gly aminopeptidazy."", XP002077233;;DATABASE WPI Section Ch Week 9130, Derwent World Patents Index; Class D13, AN 91-220330, XP002077234;;DATABASE WPI Section Ch Week 9710, Derwent World Patents Index; Class B04, AN 97-100651, XP002076623",PATENTED
368,GB,A,GB 2434229 A,024-693-757-126-891,2007-07-18,2007,GB 0700569 A,2007-01-12,US 33188606 A,2006-01-13,Redundant controller synchronization for smooth failover during normal and mismatch conditions,"A process control system 100 is provided with redundant controllers 104, 106 connected via communication link 146 and both connected to field devices via field bus 112 and network devices via network bus 110. One of the redundant controllers is assigned as a primary controller and the other is assigned as the backup controller. Synchronization of the backup controller with the primary controller ensures smooth failover during normal and mismatch conditions at the redundant controllers. The redundant controllers are configured to transmit state information of the process control areas 150-154 of the primary controller to the backup controller that is necessary for synchronizing the redundant controllers but is not typically transmitted to other devices during the performance of process control functions. The backup controller may then respond with a confirmation message that the update data was received. Synchronization messages are transmitted from the primary controller to the backup controller each time one of the control areas executes to perform process control functions. In other aspects, the redundant controllers are configured to determine state information at the backup controller from other process control network information during a failover of the primary controller where a mismatch condition exists between the control areas of the two controllers during the downloading of reconfigurations, and to initialize the backup controller at startup when the mismatch condition exists.",EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/024-693-757-126-891,Patent Application,no,8,6,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G06F11/20;;G05B9/03,G3N NGK2          GK2;;G3N N392          GK2;;G4A AES           ES,0,0,,,,ACTIVE
369,AU,A,AU 1998/073810 A,033-232-118-733-649,1998-12-08,1998,AU 1998/073810 A,1998-05-12,US 85788497 A;;US 6289297 P;;US 9809629 W,1997-05-16,Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having dipeptidyl aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK BIOTECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL W;;KLOTZ ALAN;;BYUN TONY,,https://lens.org/033-232-118-733-649,Patent Application,no,0,0,14,15,0,A21D2/267;;A21D8/042;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A21D8/042;;A23J3/34;;A23L27/21,C12N15/09;;A21D2/26;;A21D8/04;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12N15/57;;C12P21/06;;C12R1/69,,0,0,,,,DISCONTINUED
370,US,B2,US 7098001 B2,192-612-013-974-323,2006-08-29,2006,US 72380703 A,2003-11-25,US 72380703 A;;US 7959298 A;;US 85788497 A;;US 6289297 P,1997-05-16,Polypeptides having dipeptidyl aminopeptidase activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having dipeptidyl aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDEER;;BROWN KIMBERLY;;REY MICHAEL W;;KLOTZ ALAN;;BYUN TONY,NOVOZYMES INC (2005-08-29),https://lens.org/192-612-013-974-323,Granted Patent,yes,2,0,14,15,13,A21D2/267;;A21D8/042;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A21D8/042;;A23J3/34;;A23L27/21,C12N15/09;;C12P21/06;;A21D2/26;;A21D8/04;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12N15/57;;C12R1/69,435/68.1;;435/212;;536/23.2,8,4,009-251-239-804-662;;021-909-953-284-150;;045-764-815-720-977;;031-484-006-951-260,10.1016/s0031-9422(00)97513-7;;9045640;;10.1074/jbc.272.10.6238;;10.1017/s0022029900024833;;2873157;;10.1128/iai.65.8.3042-3047.1997;;pmc175429;;9234752,"Tachi et al., ""An X-Prolyl Dipeptidyl-Aminopeptidase From Aspergillus oryzae"", Phytochemistry vol. 31, No. 11, pp. 3707-3709, 1992.;;Beauvais et al., ""Biochemical and Antigenic Characterization of a New Dipeptidyl-Peptidase Isolated From Aspergillys fumigatus"" Journal of Biological Chemistry 272 (10), 1997, pp. 6238-6244.;;Heymann et al., ""Complementary Action of Dipeptidyl Peptidase IV and Aminopeptidase M In The Digestion of beta-Casein"", J. Dairy Res 53, 1986, pp. 229-236.;;Chemical Abstracts, vol. 124, No. 21, May 20, 1996 (XP-002051874).;;Database WPI, Section Ch, Week 9527, May 9, 1995 (XP-002047737).;;Database WPI, Section Ch, Week 9710, (XP-002076623).;;Beauvais et al., ""Dipeptidyl-Peptidase IV Secreted by Aspergillus fumigatus, A Fungus Pathogenic to Humans"" Infection and Immunity, vol. 65, No. 8, Aug. 1997, pp. 3042-3047.;;EMBL/GENBANK Databases, Accession No. AJ002369, Sequence Reference No. A0DPPIV, Mar. 2, 1998 (XP-002076626).",EXPIRED
371,ES,T3,ES 2285771 T3,085-577-121-793-386,2007-11-16,2007,ES 98922312 T,1998-05-15,US 85788697 A;;US 6289397 P,1997-05-16,POLIPEPTIDOS CON ACTIVIDAD AMINOPAPTIDASA Y ACIDOS NUCLEICOS QUE LO CODIFICAN.,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFOD LENE V,,https://lens.org/085-577-121-793-386,Granted Patent,no,0,0,16,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/09;;C12N15/57;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12P21/02;;C12P21/06;;C12R1/69,,0,0,,,,EXPIRED
372,EP,A1,EP 0981630 A1,127-350-993-433-375,2000-03-01,2000,EP 98921134 A,1998-05-12,US 9809629 W;;US 85788497 A;;US 6289297 P,1997-05-16,POLYPEPTIDES HAVING PROLYL PIPEPTIDYL AMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having dipeptidyl aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK BIOTECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL W;;KLOTZ ALAN;;BYUN TONY,"NOVOZYMES, INC. (2005-06-22);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/127-350-993-433-375,Patent Application,yes,0,0,14,15,0,A21D2/267;;A21D8/042;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A21D8/042;;A23J3/34;;A23L27/21,C12N15/09;;A21D2/26;;A21D8/04;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12N15/57;;C12P21/06;;C12R1/69,,0,0,,,,EXPIRED
373,US,B2,US 8359112 B2,169-730-047-558-137,2013-01-22,2013,US 33188606 A,2006-01-13,US 33188606 A,2006-01-13,Method for redundant controller synchronization for bump-less failover during normal and program mismatch conditions,"The present invention relates generally to process control systems and devices and, more particularly, to an apparatus for and a method of implementing redundant controller synchronization for bump-less failover during normal and mismatch conditions at the redundant controllers. The redundant controllers are configured to transmit state information of the process control areas of the primary controller to the backup controller that is necessary for synchronizing the redundant controllers but is not typically transmitted to other devices during the performance of process control functions. Synchronization messages are transmitted from the primary controller to the backup controller each time one of the control areas executes to perform process control functions. In other aspects, the redundant controllers are configured to determine state information at the backup controller from other process control network information during a failover of the primary controller where a mismatch condition exists between the control areas of the two controllers during the downloading of reconfigurations, and to initialize the backup controller at startup when the mismatch condition exists.",EMERSON PROCESS MANAGEMENT;;KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/169-730-047-558-137,Granted Patent,yes,29,27,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B11/01;;G05B9/02;;G06F7/00;;G06F11/00;;G06F17/00;;G06F19/00,700/82;;700/25;;714/6.1;;714/13;;714/31;;714/12,5,0,,,"Combined Search and Examination Report for Application No. GB1106151.2, dated May 19, 2011.;;Examination Report for Application No. GB0700569.7, dated Jul. 12, 2010.;;First Chinese Office Action for Application No. 200710000848.4, dated Oct. 9, 2009.;;Search Report for Application No. GB0700569,7, dated May 9, 2007.;;Combined Search and Examination Report for Application No. GB1106153.8, dated May 19, 2011.",ACTIVE
374,DK,T3,DK 0981631 T3,059-872-090-695-669,2007-08-06,2007,DK 98922312 T,1998-05-15,US 85788697 A;;US 6289397 P;;US 9809940 W,1997-05-16,"Polypeptider, som har aminopeptidase-aktivitet, og nukleinsyrer, som koder for samme","The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFOD LENE V,,https://lens.org/059-872-090-695-669,Granted Patent,no,0,0,16,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/09;;C12N15/57;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12P21/02;;C12P21/06;;C12R1/69,,0,0,,,,EXPIRED
375,DE,D1,DE 69837475 D1,076-180-171-696-494,2007-05-16,2007,DE 69837475 T,1998-05-15,US 85788697 A;;US 6289397 P;;US 9809940 W,1997-05-16,POLYPEPTIDE MIT AMINOPEPTIDASEAKTIVITÄT UND DAFÜR KODIERENDE NUKLEINSÄUREN,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES AS,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFOD LENE V,,https://lens.org/076-180-171-696-494,Granted Patent,no,0,0,16,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/09;;C12N15/57;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12P21/02;;C12P21/06;;C12R1/69,,0,0,,,,EXPIRED
376,DE,D1,DE 69840230 D1,116-213-908-407-739,2009-01-02,2009,DE 69840230 T,1998-05-12,US 85788497 A;;US 6289297 P;;US 9809629 W,1997-05-16,POLYPEPTIDE MIT PROLYLDIPEPTIDYLAMINOPEPTIDASE-AKTIVITÄT UND DAFÜR KODIERENDE NUKLEINSÄUREN,"The present invention relates to isolated polypeptides having dipeptidyl aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL W;;KLOTZ ALAN;;BYUN TONY,,https://lens.org/116-213-908-407-739,Granted Patent,no,0,0,14,15,0,A21D2/267;;A21D8/042;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A21D8/042;;A23J3/34;;A23L27/21,C12N15/09;;C12N15/57;;A21D2/26;;A21D8/04;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06;;C12R1/69,,0,0,,,,EXPIRED
377,GB,A,GB 2477238 A,160-475-239-278-313,2011-07-27,2011,GB 201106153 A,2007-01-12,US 33188606 A;;GB 0700569 A,2006-01-13,Redundant controllers with a synchronisation control program that determines whether all of the state information has been received.,"Disclosed are a pair of linked redundant controllers in a process control network, each having a plurality of control areas and a process control application program for performing process control functions. Each control area includes state information that is used by the process control application program to perform the process control functions, and that is updated when the control area executes to perform process control. The primary controller uses a control synchronization program to transmit a synchronization message to the backup controller containing state information. The primary controller control synchronization program then formats and transmits a token message including configuration information of the control areas of the primary controller, the control synchronization program of the backup controller receives the token message and stores the configuration information from the token message in the backup controller. When the backup controller is powered up, the control synchronization program transmits a backup ready message if synchronization messages containing values for all of the configuration information of the primary controller have been received.",EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/160-475-239-278-313,Patent Application,no,2,1,6,24,0,G05B9/03;;G06F11/1658;;G06F11/2033;;G06F11/2038;;G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097,G05B9/03;;G06F11/16;;G06F11/20,,0,0,,,,ACTIVE
378,DE,B4,DE 102007001576 B4,036-664-719-691-219,2023-11-02,2023,DE 102007001576 A,2007-01-10,US 33188606 A,2006-01-13,Verfahren zur Synchronisierung redundanter Steuerungen für stoßfreies Failover unter normalen Bedingungen und bei Fehlanpasssung,"Paar (102) redundanter Steuerungen (104, 106) in einem Prozesssteuerungsnetzwerk (100), wobei die redundanten Steuerungen (104, 106) kommunikativ miteinander und mit den anderen Geräten des Prozesssteuerungsnetzwerks (100) verbunden sind und wobei jede der redundanten Steuerungen (104, 106) aufweist:eine Mehrzahl von Steuerungsbereichen (150-154), von denen jeder ein Prozesssteuerungsanwendungsprogramm für die Ausführung von Prozesssteuerungsfunktionen aufweist und wobei jeder Steuerungsbereich (150-154) Statusinformationen aufweist, die vom Prozesssteuerungsanwendungsprogramm für die Ausführung von Prozesssteuerungsfunktionen verwendet werden und die aktualisiert werden, wenn der Steuerungsbereich (150-154) ausgeführt wird, um eine Prozesssteuerung auszuführen, und wobei die Statusinformationen das Ergebnis von Zwischen-Berechnungen einschließen, die in den redundanten Steuerungen (104, 106) ausgeführt werden, und nicht an andere Geräte im Prozesssteuerungsnetzwerk (100) übertragen werden undein redundantes Kommunikationsmodul (162),wobei eine redundante Steuerung (104, 106) als Primärsteuerung (104) arbeitet, um eine Prozesssteuerung auszuführen, indem sie die Prozesssteuerungsanwendungen der Steuerungsbereiche (150-154) ausführt, und wobei die andere redundante Steuerung (104, 106) als Backup-Steuerung (106) arbeitet,wobei mindestens zwei der Steuerungsbereiche (150-154) der Primärsteuerung (104) mit unterschiedlichen Häufigkeiten ausgeführt werden,wobei das redundante Kommunikationsmodul(162) der Primärsteuerung (104) eine Synchronisierungsbotschaft an die Backup-Steuerung (106) sendet, nachdem das Prozesssteuerungsanwendungsprogramm eines Steuerungsbereichs (150-154) ausgeführt wurde, um eine Prozesssteuerung auszuführen, wobei die Synchronisierungsbotschaft Statusinformationen aus dem Steuerungsbereich (150-154) aufweist, undwobei die Backup-Steuerung (106) die Statusinformationen eines Steuerungsbereichs (150-154) der Backup-Steuerung (106), der dem ausgeführten Steuerungsbereich (150-154) der Primärsteuerung (104) entspricht, mit den Statusinformationen aus der Synchronisierungsbotschaft als Reaktion auf den Empfang der Synchronisierungsbotschaft bei der Backup-Steuerung (106) aktualisiert.",EMERSON PROCESS MAN POWER & WATER SOLUTIONS INC,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/036-664-719-691-219,Granted Patent,no,6,0,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B9/03;;G05B19/048;;G06F11/18,,0,0,,,,ACTIVE
379,US,B1,US 6664092 B1,102-212-239-018-695,2003-12-16,2003,US 7959298 A,1998-05-15,US 7959298 A;;US 85788497 A;;US 6289297 P,1997-05-16,Polypeptides having dipeptidyl aminopeptidase activity and nucleic acids encoding same,"
    The present invention relates to isolated polypeptides having dipeptidyl aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides. 
",NOVOZYMES BIOTECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;REY MICHAEL W;;KLOTZ ALAN;;BYUN TONY,NOVOZYMES INC (2005-08-29);;NOVOZYMES BIOTECH INC (1998-05-22),https://lens.org/102-212-239-018-695,Granted Patent,yes,3,8,14,15,13,A21D2/267;;A21D8/042;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A21D8/042;;A23J3/34;;A23L27/21,C12N15/09;;A21D2/26;;A21D8/04;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12N15/57;;C12P21/06;;C12R1/69,435/212;;435/252.33;;435/254.3;;435/320.1;;536/23.2;;536/23.1;;536/23.74;;426/533;;426/549,8,4,009-251-239-804-662;;021-909-953-284-150;;045-764-815-720-977;;031-484-006-951-260,10.1016/s0031-9422(00)97513-7;;9045640;;10.1074/jbc.272.10.6238;;10.1017/s0022029900024833;;2873157;;10.1128/iai.65.8.3042-3047.1997;;pmc175429;;9234752,"Tachi et al., ""An X-Prolyl Dipeptidyl-Aminopeptidase From Aspergillus oryzae"", Phytochemistry vol. 31, No. 11, pp. 3707-3709, 1992.;;Beauvais et al., ""Biochemical and Antigenic Characterization of a New Dipeptidyl-Peptidase Isolated From Aspergillys fumigatus"" Journal of Biological Chemistry 272 (10), 1997, pp 6238-6244.;;Heymann et al., ""Complementary Action of Dipeptidyl Peptidase IV and Aminopeptidase M In The Digestion of beta-Casein"", J. Dairy Res 53, 1986, pp. 229-236.;;Chemical Abstracts, vol. 124, No. 21, May 20, 1996 (XP-002051874).;;Database WPI, Section Ch, Week 9527, May 9, 1995 (XP-002047737).;;Database WPI, Section Ch, Week 9710, (XP-002076623) Nov. 17, 1993.;;Beauvais et al., ""Dipeptidyl-Peptidase IV Secreted by Aspergillus fumigatus, A Fungus Pathogenic to Humans"" Infection and Immunity, vol. 65, No. 8, Aug. 1997, pp. 3042-3047.;;EMBL/Genbank Databases, Accession No. AJ002369, Sequence Reference No. A0DPPIV, Mar. 2, 1998 (XP-002076626).",EXPIRED
380,HK,A1,HK 1152199 A1,127-018-855-358-616,2012-02-24,2012,HK 11111445 A,2011-10-24,US 33188606 A,2006-01-13,A METHOD FOR REDUNDANT CONTROLLER SYNCHRONISATION FOR BUMP-LESS FAILOVER DURING NORMAL AND MISMATCH CONDITIONS,,EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;XU CHENG;;BROWN RICHARD,,https://lens.org/127-018-855-358-616,Patent Application,no,0,0,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B/;;G06F/,,0,0,,,,PENDING
381,HK,A1,HK 1159766 A1,183-836-838-069-244,2012-08-03,2012,HK 11114078 A,2011-12-30,US 33188606 A,2006-01-13,A METHOD FOR REDUNDANT CONTROLLER SYNCHRONIZATION FOR BUMP-LESS FAILOVER DURING NORMAL AND MISMATCH CONDITIONS,,EMERSON PROCESS MANAGEMENT,KEPHART RICHARD W;;COSTLOW KIMBERLY;;DURBIN MICHAEL;;CHENG XU;;BROWN RICHARD,,https://lens.org/183-836-838-069-244,Patent Application,no,0,0,18,24,0,G05B9/03;;G06F11/2028;;G06F11/2038;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G05B9/03;;G06F11/2028;;G06F11/2097;;G06F11/2038,G05B/;;G06F/,,0,0,,,,PENDING
382,AU,A,AU 1998/074890 A,193-706-556-299-858,1998-12-08,1998,AU 1998/074890 A,1998-05-15,US 85788697 A;;US 6289397 P;;US 9809940 W,1997-05-16,Polypeptides having aminopeptidase activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK BIOTECH INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;KOFOD LENE V,,https://lens.org/193-706-556-299-858,Patent Application,no,0,0,16,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;A23L27/21;;C12N9/48;;A21D2/267;;A23J3/34;;A21D2/268;;A23L27/21,C12N15/09;;A21D2/26;;A23J3/30;;A23J3/34;;A23L27/21;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N15/57;;C12P21/02;;C12P21/06;;C12R1/69,,0,0,,,,DISCONTINUED
383,US,B2,US 11078510 B2,113-662-887-534-441,2021-08-03,2021,US 202016996168 A,2020-08-18,US 202016996168 A;;US 201816211632 A;;US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/113-662-887-534-441,Granted Patent,yes,17,0,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12P21/00;;C12N9/58;;C12N15/04;;C12N15/80;;C12P21/02,,39,19,084-029-071-712-731;;098-288-055-262-843;;038-043-621-343-049;;021-872-480-021-441;;142-954-370-284-714;;030-127-339-831-230;;000-154-583-799-776;;086-874-521-828-020;;022-335-231-721-618;;041-625-608-522-278;;029-932-427-231-872;;031-464-369-878-770;;022-335-231-721-618;;001-614-865-382-419;;004-344-441-114-834;;066-525-536-073-344;;023-650-636-149-863;;099-148-434-391-858;;082-023-104-660-107,10.1016/j.enzmictec.2006.08.013;;1369052;;10.1271/bbb.56.1523;;10.1016/s0167-7799(97)01020-2;;9237405;;10.1016/j.jbiotec.2004.10.017;;15707691;;14761794;;10.1016/j.fgb.2003.11.002;;10.1007/s11274-009-0128-x;;10.1007/s00294-007-0130-5;;17415567;;10.1111/j.1574-6968.2008.01403.x;;19025577;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;10.1016/0168-1656(90)90035-a;;27213181;;10.1021/acsinfecdis.6b00026;;pmc4869151;;11988504;;10.1099/00221287-148-5-1305;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;18675276;;pmc2711637;;10.1016/j.jmb.2008.07.043;;pmc3533174;;10.1111/j.1574-6968.2012.02665.x;;22924408;;27137097;;10.1016/j.riam.2015.10.003;;10.1556/amicr.52.2005.2.3;;16003937;;26309247;;10.1371/journal.pone.0134723;;pmc4550459;;pmc6901835;;10.3389/fmicb.2019.02784;;31849916,"Dienes et al, 2007, Enzy Microbial Technol 40(5), 1087-1094.;;Goto et al, 1992, Biosci Biotechnol Biochem 56(10), 1523-1528.;;Homberg et al, 1997, Trends Biotechnol 15(7), 256-263.;;Janas et al, 2003, Acta Sci Pol 2(20), 103-114.;;Mantyla et al, 1998, Tricho and Gliocladium 2, 289-310.;;Miettinen et al, 2005, J Biotechnol 116(3), 305-317.;;Pozo et al, 2004, Fungal Genet Biol 41(3), 336-348.;;Sharma et al, 2009, World J Microbial Biotechnol 25(12), 2083-2094.;;Suarez et al, 2007, Curr Genet 51(5), 331-342.;;Suarez et al, 2007, EMBL Access No. AM294978.;;Yan et al, 2009, FEMS Microbial Lett 290(1), 54-61.;;Martinez et al., 2008, Nature Biotechnology 26:553-560.;;Enesyskaya et al., 1999, Appl. Microbial. Biotechnol. 52: 226-231.;;Haab et al., 1990, J. Biotechnology 16: 187-198.;;Hagspiel et al., 1989, Appl. Microbiol. Biotechnol. 32: 61-67.;;Mantyla, 2006, Genbank No. AM168137.1.;;Anonymous, 1992, Nature 355, 117.;;Anonymous, 2019, CLUSTAL multiple sequence alignment, CAJ44684.1.;;Anonymous, 2019, NCBI Blast Rid WG7K9NZE014.;;Bogdanoff et al, 2016, ACS Infectious diseases 2, 313-321.;;Delgado-Jarana et al, 2002, Microbiology 148, 1305-1315.;;Mantyla et al, 2018, Trichoderma and gliocladium 2, 291-309.;;Mantyla, 2006, Genbank No. AM166137.1.;;Martinez et al, 1999, Nature Biotechnology 26, 553-560.;;Martinez et al, 2006, Genome Portal, project ID 16784.;;Nascimento et al, 2008, J Mol Biol 382, 763-778.;;Nascimento et al, 2008, RCSB PDB-3C9X.;;Druzhinina et al., Novel traits of Trichoderma predicted through the analysis of its secretome, FEMS Microbial Lett 337:1 (2012).;;Gonzalez et al., Secreted fungal aspartic proteases: A review, Rev Iberoam Micol. 33(2):76-82 (2016).;;Kredics et al., Extracellular Proteases of Trichoderma Species: A Review, Acta Microbiologica et Immunologica Hungarica, 52(2):169-184 (2005).;;Landowski et al., Enabling Low Cost Biopharmaceuticals: A Systematic Approach to Delete Proteases from a Well-Known Protein Production Host Trichoderma reesei, PLoS One 10(8):doi:10.1371/ pumal.pone.0134723 (2015).;;Mantyla et al., Cloning of the aspartic protease gene from Trichoderma reesei, Fungal Genetics Newsletter, No. 41A, 1994 Supplement, Abstracts from the 2nd European Conference on Fungal Genetics Apr. 28-May 1, 1994.;;Qian et al., Enhancement of Cellulase Production in Trichoderma reesei via Disruption of Multiple Protease Genes Identified by Comparative Secretomics, Frontiers in Microbiology, 10:2784 (Dec. 2019).;;U.S. Appl. No. 13/516,422, U.S. Pat. No. 8,986,974, filed Dec. 17, 2010.;;U.S. Appl. No. 14/663,118, U.S. Pat. No. 10,400,260, filed Mar. 19, 2015.;;U.S. Appl. No. 16/211,632, 2019/0093143, filed Dec. 6, 2018.;;U.S. Appl. No. 16/995,820, filed Aug. 18, 2020.;;U.S. Appl. No. 16/996,159, filed Aug. 18, 2020.;;U.S. Appl. No. 90/014,445, filed Feb. 3, 2020.",ACTIVE
384,CA,A1,CA 2784599 A1,094-139-779-355-899,2011-06-23,2011,CA 2784599 A,2010-12-17,US 28784409 P;;US 2010/0061105 W,2009-12-18,METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/094-139-779-355-899,Patent Application,no,0,0,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
385,EP,B1,EP 2513290 B1,021-491-599-051-876,2015-11-11,2015,EP 10791040 A,2010-12-17,US 28784409 P;;US 2010/0061105 W,2009-12-18,METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA,,NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/021-491-599-051-876,Granted Patent,yes,1,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
386,US,B2,US 11078508 B2,006-076-810-368-19X,2021-08-03,2021,US 201816211632 A,2018-12-06,US 201816211632 A;;US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/006-076-810-368-19X,Granted Patent,yes,16,0,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12P21/00;;C12N9/58;;C12N15/04;;C12N15/80;;C12P21/02,,39,18,098-288-055-262-843;;038-043-621-343-049;;021-872-480-021-441;;142-954-370-284-714;;030-127-339-831-230;;000-154-583-799-776;;086-874-521-828-020;;022-335-231-721-618;;041-625-608-522-278;;029-932-427-231-872;;031-464-369-878-770;;022-335-231-721-618;;001-614-865-382-419;;004-344-441-114-834;;066-525-536-073-344;;023-650-636-149-863;;099-148-434-391-858;;082-023-104-660-107,1369052;;10.1271/bbb.56.1523;;10.1016/s0167-7799(97)01020-2;;9237405;;10.1016/j.jbiotec.2004.10.017;;15707691;;14761794;;10.1016/j.fgb.2003.11.002;;10.1007/s11274-009-0128-x;;10.1007/s00294-007-0130-5;;17415567;;10.1111/j.1574-6968.2008.01403.x;;19025577;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;10.1016/0168-1656(90)90035-a;;27213181;;10.1021/acsinfecdis.6b00026;;pmc4869151;;11988504;;10.1099/00221287-148-5-1305;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;18675276;;pmc2711637;;10.1016/j.jmb.2008.07.043;;pmc3533174;;10.1111/j.1574-6968.2012.02665.x;;22924408;;27137097;;10.1016/j.riam.2015.10.003;;10.1556/amicr.52.2005.2.3;;16003937;;26309247;;10.1371/journal.pone.0134723;;pmc4550459;;pmc6901835;;10.3389/fmicb.2019.02784;;31849916,"Mantyla, 2006, Genbank No. AM168137.1.;;Dienes et al, 2007, Enzy Microbiol Technol 40(5), 1087-1094.;;Goto et al, 1992, Biosci Biotechnol Biochem 56(10), 1523-1528.;;Homberg et al, 1997, Trends Biotechnol 15(7), 256-263.;;Janas et al, 2003, Acta Sci Pol 2(20), 103-114.;;Mantyla et al, 1998,Tricho and Gliocladium 2, 289-310.;;Miettinen et al, 2005, J Biotechnol 116(3), 305-317.;;Pozo et al, 2004, Fungal Genet Biol 41(3), 336-348.;;Sharma et al, 2009, World J Microbiol Biotechnol 25(12), 2083-2094.;;Suarez et al, 2007, Curr Genet 51(5), 331-342.;;Suarez et al, 2007, EMBL Access No. AM294978.;;Yan et al, 2009, FEMS Microbiol Lett 290(1), 54-61.;;Martinez et al., 2008, Nature Biotechnology 26:553-560.;;Enesyskaya et al., 1999, Appl. Microbiol. Biotechnol. 52: 226-231.;;Haab et al., 1990, J. Biotechnology 16: 187-198.;;Hagspiel et al., 1989, Appl. Microbiol. Biotechnol. 32: 61-67.;;Anonymous, 1992, Nature 355, 117.;;Anonymous, 2019, CLUSTAL multiple sequence alignment, CAJ44684.1.;;Anonymous, 2019, NCBI Blast RID WG7K9NZE014.;;Bogdanoff et al, 2016, ACS Infectious diseases 2, 313-321.;;Delgado-Jarana et al, 2002, Microbiology 148, 1305-1315.;;Mantyla et al, 2018, Trichoderma and gliocladium 2, 291-309.;;Mantyla, 2006, Genbank No. AM166137.1.;;Martinez et al, 1999, Nature Biotechnology 26, 553-560.;;Martinez et al, 2006, Genome Portal, project ID 16784.;;Nascimento et al, 2008, J Mol Biol 382, 763-778.;;Nascimento et al, 2008, RCSB PDB—3C9X.;;Druzhinina et al., Novel traits of Trichoderma predicted through the analysis of its secretome, FEMS Microbial Lett 337:1 (2012).;;Gonzalez et al., Secreted fungal aspartic proteases: A review, Rev Iberoam Micol. 33(2):76-82 (2016).;;Kredics et al., Extracellular Proteases of Trichoderma Species: A Review, Acta Microbiologica et Immunologica Hungarica, 52(2):169-184 (2005).;;Landowski et al., Enabling Low Cost Biopharmaceuticals: A Systematic Approach to Delete Proteases from a Well-Known Protein Production Host Trichoderma reesei, PLoS ONE 10(8):doi:10.1371/ pumal.pone.0134723 (2015).;;Mantyla et al., Cloning of the aspartic protease gene from Trichoderma reesei, Fungal Genetics Newsletter, No. 41A, 1994 Supplement, Abstracts from the 2nd European Conference on Fungal Genetics Apr. 28-May 1, 1994.;;Oian et al., Enhancement of Cellulase Production in Trichoderma reesei via Disruption of Multiple Protease Genes Identified by Comparative Secretomics, Frontiers in Microbiology, 10:2784 (Dec. 2019).;;U.S. Appl. No. 13/516,422, U.S. Pat. No. 8,986,974, filed Dec. 17, 2010.;;U.S. Appl. No. 14/663,118, U.S. Pat. No. 10,400,260, filed Mar. 19, 2015.;;U.S. Appl. No. 16/995,820, filed Aug. 18, 2020.;;U.S. Appl. No. 16/996,159, filed Aug. 18, 2020.;;U.S. Appl. No. 16/996,168, filed Aug. 18, 2020.;;U.S. Appl. No. 90/014,445, filed Feb. 3, 2020.",ACTIVE
387,US,B2,US 11078509 B2,100-037-560-716-029,2021-08-03,2021,US 202016996159 A,2020-08-18,US 202016996159 A;;US 201816211632 A;;US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/100-037-560-716-029,Granted Patent,yes,17,0,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12P21/00;;C12N9/58;;C12N15/04;;C12N15/80;;C12P21/02,,39,18,004-344-441-114-834;;066-525-536-073-344;;023-650-636-149-863;;099-148-434-391-858;;082-023-104-660-107;;098-288-055-262-843;;038-043-621-343-049;;021-872-480-021-441;;142-954-370-284-714;;030-127-339-831-230;;000-154-583-799-776;;086-874-521-828-020;;022-335-231-721-618;;041-625-608-522-278;;029-932-427-231-872;;031-464-369-878-770;;022-335-231-721-618;;001-614-865-382-419,pmc3533174;;10.1111/j.1574-6968.2012.02665.x;;22924408;;27137097;;10.1016/j.riam.2015.10.003;;10.1556/amicr.52.2005.2.3;;16003937;;26309247;;10.1371/journal.pone.0134723;;pmc4550459;;pmc6901835;;10.3389/fmicb.2019.02784;;31849916;;1369052;;10.1271/bbb.56.1523;;10.1016/s0167-7799(97)01020-2;;9237405;;10.1016/j.jbiotec.2004.10.017;;15707691;;14761794;;10.1016/j.fgb.2003.11.002;;10.1007/s11274-009-0128-x;;10.1007/s00294-007-0130-5;;17415567;;10.1111/j.1574-6968.2008.01403.x;;19025577;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;10.1016/0168-1656(90)90035-a;;27213181;;10.1021/acsinfecdis.6b00026;;pmc4869151;;11988504;;10.1099/00221287-148-5-1305;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;18675276;;pmc2711637;;10.1016/j.jmb.2008.07.043,"Druzhinina et al., Novel traits of Trichoderma predicted through the analysis of its secretome, FEMS Microbiol Lett 337:1 (2012).;;Gonzalez et al., Secreted fungal aspartic proteases: A review, Rev Iberoam Micol. 33(2):76-82 (2016).;;Kredics et al., Extracellular Proteases of Trichoderma Species: A Review, Acta Microbiologica et Immunologica Hungarica, 52(2):169-184 (2005).;;Landowski et al., Enabling Low Cost Biopharmaceuticals: A Systematic Approach to Delete Proteases from a Well-Known Protein Production Host Trichoderma reesei, PLoS One 10(8):doi:10.1371/ pumal.pone.0134723 (2015).;;Mantyla et al., Cloning of the aspartic protease gene from Trichoderma reesei, Fungal Genetics Newsletter, No. 41A, 1994 Supplement, Abstracts from the 2nd European Conference on Fungal Genetics Apr. 28-May 1, 1994.;;Qian et al., Enhancement of Cellulase Production in Trichoderma reesei via Disruption of Multiple Protease Genes Identified by Comparative Secretomics, Frontiers in Microbiology, 10:2784 (Dec. 2019).;;U.S. Appl. No. 13/516,422, U.S. Pat. No. 8,986,974, filed Dec. 17, 2010.;;U.S. Appl. No. 14/663,118, U.S. Pat. No. 10,400,260, filed Mar. 19, 2015.;;U.S. Appl. No. 16/211,632, U.S. Pat. No. 2019/0093143, filed Dec. 6, 2018.;;U.S. Appl. No. 16/995,820, filed Aug. 18, 2020.;;U.S. Appl. No. 16/996,168, filed Aug. 18, 2020.;;U.S. Appl. No. 90/014,445, filed Feb. 3, 2020.;;Dienes et al, 2007, Enzy Microbiol Technol 40(5), 1087-1094.;;Goto et al, 1992, Biosci Biotechnol Biochem 56(10), 1523-1528.;;Homberg et al, 1997, Trends Biotechnol 15(7), 256-263.;;Janas et al, 2003, Acta Sci Pol 2(20), 103-114.;;Mantyla et al, 1998,Tricho and Gliocladium 2, 289-310.;;Miettinen et al, 2005, J Biotechnol 116(3), 305-317.;;Pozo et al, 2004, Fungal Genet Biol 41(3), 336-348.;;Sharma et al, 2009, World J Microbiol Biotechnol 25(12), 2083-2094.;;Suarez et al, 2007, Curr Genet 51(5), 331-342.;;Suarez et al, 2007, EMBL Access No. AM294978.;;Yan et al, 2009, FEMS Microbiol Lett 290(1), 54-61.;;Martinez et al., 2008, Nature Biotechnology 26:553-560.;;Enesyskaya et al., 1999, Appl. Microbiol. Biotechnol. 52: 226-231.;;Haab et al., 1990, J. Biotechnology 16: 187-198.;;Hagspiel et al., 1989, Appl. Microbiol. Biotechnol. 32: 61-67.;;Mantyla, 2006, Genbank No. AM168137.1.;;Anonymous, 1992, Nature 355, 117.;;Anonymous, 2019, CLUSTAL multiple sequence alignment, CAJ44684.1.;;Anonymous, 2019, NCBI BLAST RID WG7K9NZE014.;;Bogdanoff et al, 2016, ACS Infectious diseases 2, 313-321.;;Delgado-Jarana et al, 2002, Microbiology 148, 1305-1315.;;Mantyla et al, 2018, Trichoderma and gliocladium 2, 291-309.;;Mantyla, 2006, Genbank No. AM166137.1.;;Martinez et al, 1999, Nature Biotechnology 26, 553-560.;;Martinez et al, 2006, Genome Portal, project ID 16784.;;Nascimento et al, 2008, J Mol Biol 382, 763-778.;;Nascimento et al, 2008, RCSB PDB—3C9X.",ACTIVE
388,WO,A2,WO 2007/120536 A2,055-079-627-086-03X,2007-10-25,2007,US 2007/0008197 W,2007-03-29,US 39592606 A,2006-03-30,DUAL-STRING DYNAMOMETER FOR MEASURING DENTAL HANDPIECE AT HIGH AND LOW SPEED,"A dual-string tension dynamometer (1) utilizes two strings (10, 11) wrapped around approximately ninety degrees of a4est wheel (12). The lateral forces (E, F) are balanced such that the total lateral force net value is zero. The results reflect purely torsional loading.",DENTSPLY INT INC;;NOVAK EUGENE J;;BROWN KIMBERLY C;;PAPANEK TOM;;PARAFINCZUK TADEUSZ;;FANCIULLO TODD,NOVAK EUGENE J;;BROWN KIMBERLY C;;PAPANEK TOM;;PARAFINCZUK TADEUSZ;;FANCIULLO TODD,,https://lens.org/055-079-627-086-03X,Patent Application,yes,0,0,3,3,0,G01L3/18;;G01L3/18,,,0,0,,,,PENDING
389,MX,B,MX 350399 B,175-427-083-354-655,2017-09-06,2017,MX 2014013682 A,2010-12-17,US 28784409 P;;US 2010/0061105 W,2009-12-18,METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA.,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,SUCHINDRA MAIYURAN;;ABIGAIL JANG;;KIMBERLY BROWN;;SANDRA MERINO;;JEFFREY SHASKY;;ERIC ABBATE,,https://lens.org/175-427-083-354-655,Granted Patent,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N15/80;;C12N1/15;;C12N9/58;;C12P21/02,,0,0,,,,ACTIVE
390,AU,A1,AU 2021/250953 A1,155-934-100-257-453,2021-11-11,2021,AU 2021/250953 A,2021-10-15,AU 2021/250953 A;;AU 2019/222857 A;;AU 2017/254852 A;;AU 2016/201422 A;;AU 2010/330835 A;;US 28784409 P;;US 2010/0061105 W,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present imvention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants. AH26(28340366 1):RTK",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/155-934-100-257-453,Patent Application,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,PENDING
391,AU,B2,AU 2019/222857 B2,184-018-786-578-208,2021-07-22,2021,AU 2019/222857 A,2019-08-28,AU 2019/222857 A;;AU 2017/254852 A;;AU 2016/201422 A;;AU 2010/330835 A;;US 28784409 P;;US 2010/0061105 W,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/184-018-786-578-208,Granted Patent,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,2,2,022-335-231-721-618;;000-154-583-799-776,10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;10.1007/s00294-007-0130-5;;17415567,"MARTINEZ D, et al., ‘Genome sequencing and analysis of the biomass-degrading fungus Trichoderma reesei (syn. Hypocrea jecorina)’, Nat Biotechnol., 2008, Vol. 26, pages 553-560.;;BELEN SUAREZ, M. et al. ‘Characterization of genes encoding novel peptidases in the biocontrol fungus Trichoderma harzianum CECT 2413 using the TrichoEST functional genomics approach’ Current Genetics. 2007, vol. 51, pages 331-342.",ACTIVE
392,AU,A1,AU 2019/222857 A1,192-110-032-778-686,2019-09-19,2019,AU 2019/222857 A,2019-08-28,AU 2019/222857 A;;AU 2017/254852 A;;AU 2016/201422 A;;AU 2010/330835 A;;US 28784409 P;;US 2010/0061105 W,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/192-110-032-778-686,Patent Application,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
393,MX,A,MX 2012006900 A,141-377-026-006-105,2012-07-04,2012,MX 2012006900 A,2010-12-17,US 28784409 P;;US 2010/0061105 W,2009-12-18,METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA.,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,BROWN KIMBERLY;;MERINO SANDRA;;MAIYURAN SUCHINDRA;;JANG ABIGAIL;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/141-377-026-006-105,Patent Application,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
394,US,B2,US 10400260 B2,193-201-508-566-532,2019-09-03,2019,US 201514663118 A,2015-03-19,US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Protease-deficient mutants of trichoderma for producing polypeptides,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/193-201-508-566-532,Granted Patent,yes,12,5,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N9/58;;C12N15/80;;C12P21/00;;C12P21/02,,15,9,098-288-055-262-843;;038-043-621-343-049;;021-872-480-021-441;;142-954-370-284-714;;030-127-339-831-230;;000-154-583-799-776;;086-874-521-828-020;;022-335-231-721-618;;041-625-608-522-278,1369052;;10.1271/bbb.56.1523;;10.1016/s0167-7799(97)01020-2;;9237405;;10.1016/j.jbiotec.2004.10.017;;15707691;;14761794;;10.1016/j.fgb.2003.11.002;;10.1007/s11274-009-0128-x;;10.1007/s00294-007-0130-5;;17415567;;10.1111/j.1574-6968.2008.01403.x;;19025577;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;10.1016/0168-1656(90)90035-a,"Dienes et al, 2007, Enzy Microbiol Technol 40(5), 1087-1094.;;Goto et al, 1992, Biosci Biotechnol Biochem 56(10), 1523-1528.;;Homberg et al, 1997, Trends Biotechnol 15(7), 256-263.;;Janas et al, 2003, Acta Sci Pol 2(20), 103-114.;;Mantyla et al, 1998,Tricho and Gliocladium 2, 289-310.;;Miettinen et al, 2005, J Biotechnol 116(3), 305-317.;;Pozo et al, 2004, Fungal Genet Biol 41(3), 336-348.;;Sharma et al, 2009, World J Microbiol Biotechnol 25(12), 2083-2094.;;Suarez et al, 2007, Curr Genet 51(5), 331-342.;;Suarez et al, 2007, EMBL Access No. AM294978.;;Yan et al, 2009, FEMS Microbiol Lett 290(1), 54-61.;;Martinez et al., 2008, Nature Biotechnology 26:553-560.;;Enesyskaya et al., 1999, Appl. Microbiol. Biotechnol. 52: 226-231.;;Haab et al., 1990, J. Biotechnology 16: 187-198.;;Hagspiel et al., 1989, Appl. Microbiol. Biotechnol. 32: 61-67.",ACTIVE
395,BR,A2,BR 112012013205 A2,032-325-928-552-707,2015-11-24,2015,BR 112012013205 A,2010-12-17,US 2010/0061105 W;;US 28784409 P,2009-12-18,"mutante de uma cepa de trichoderma parental, e, métodos para produzir um polipeptídeo e para obter um mutante de uma cepa de trichoderma parental","mutante de uma cepa de trichoderma parental, e, métodos para produzir um polipeptídeo e para obter uma mutante de uma cepa de trichodermaparental. a presente invenção refere-se aos mutantes de uma cepa de trichoderma parental, compreendendo um polinucelotídeo codificador de um polipeptídeo e um ou mais (vários) genes selecionados do grupo consistindo de um primeiro gene de serina protease semelhante à subtilisina, um primeiro gene de protease aspártica, uma gene de serina protease semelhante à tripsina, um segundo gene de serina protease semelhante à subtilisina, e um segundo gene de protease aspártica, sendo que os um ou mais (vários) genes são modificados tornando a cepa mutante deficiente na produção de uma ou mais (várias) enzimas selecionadas do grupo consistindo de uma primeira serina protease semelhante à subtilisina, uma primeira protease aspártica, uma serina protease semelhante à tripsina, uma segunda serina protease semelhante à subtilisina, e uma segunda protease aspártica, respectivamente, comparada com a cepa de trichoderma parental quando cultivada sob condições idênticas. a presente invenção também se refere aos métodos de produzir um polipeptídeo em tais mutantes e aos métodos de produzir tais mutantes.",NOVOZYMES INC,JANG ABIGALL;;ABBATE ERIC;;SHASKY JEFFREY;;BROWN KIMBERLY;;MERINO SANDRA;;MAIYURAN SUCHINDRA,,https://lens.org/032-325-928-552-707,Patent Application,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
396,AU,B2,AU 2017/254852 B2,050-436-127-968-117,2019-06-13,2019,AU 2017/254852 A,2017-10-31,AU 2017/254852 A;;AU 2016/201422 A;;AU 2010/330835 A;;US 28784409 P;;US 2010/0061105 W,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE DEFICIENT MUTANTS OF TRICHODERMA The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/050-436-127-968-117,Granted Patent,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,1,0,,,"MANTYLA A ET AL, ""Industrial Mutants and Recombinant Strains of Trichoderma reesei"", TRICHODERMA AND GLIOCLADIUM, LONDON [U.A.] : TAYLOR & FRANCIS LTD, GB, (1998), vol. 2, ISBN 978-0-7484-0805-4, pages 289 - 310",ACTIVE
397,US,A1,US 2020/0385773 A1,066-110-784-318-385,2020-12-10,2020,US 202016996168 A,2020-08-18,US 202016996168 A;;US 201816211632 A;;US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for Producing Polypeptides in Protease-Deficient Mutants of Trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/066-110-784-318-385,Patent Application,yes,0,0,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12P21/00;;C12N9/58;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
398,US,A1,US 2012/0288892 A1,077-722-019-159-651,2012-11-15,2012,US 201013516433 A,2010-12-17,US 201013516433 A;;US 28784409 P;;US 2010/0061105 W,2009-12-18,Methods for Producing Polypeptidies in Protease-Deficient Mutants of Trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic pro-tease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC;;NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,NOVOZYMES INC (2012-06-19),https://lens.org/077-722-019-159-651,Patent Application,yes,1,13,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/19;;C12N15/80;;C12P21/00,435/68.1;;435/254.6;;435/471,0,0,,,,ACTIVE
399,CN,A,CN 111500474 A,114-200-182-254-781,2020-08-07,2020,CN 201911359760 A,2010-12-17,CN 201911359760 A;;CN 201080063993 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"The present invention relates to a method for producing a polypeptide in a protease-deficient mutant of the genus Trichoderma, particularly relates to a mutant of a parent trichoderma strain. The mutant comprises a polynucleotide, the polynucleotide encodes a polypeptide and one or more genes selected from the group consisting of a first subtilisin-like serine protease gene and a second subtilisin-like serine protease gene, a first aspartic protease gene and a second aspartic protease gene and a trypsin-like serine protease gene, wherein the one or more genes are modified such that when the mutant strain is cultured under the same conditions, the production of one or more enzymes selected from the group consisting of first and second subtilisin-like serine proteases, first and second aspartic proteases, and trypsin-like serine proteases, respectively, is deficient relative to the parent Trichoderma strain. The invention also relates to methods of producing polypeptides in such mutants,and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/114-200-182-254-781,Patent Application,no,8,1,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/15;;C12N9/24;;C12N9/42;;C12N15/57;;C12N15/80;;C12R1/885,,1,0,,,"杨丰科;姜萍;李思东;王守满;: ""丝状真菌基因工程进展"", 氨基酸和生物资源, no. 01, pages 29 - 32",ACTIVE
400,WO,A3,WO 2007/120536 A3,182-794-962-012-553,2008-03-13,2008,US 2007/0008197 W,2007-03-29,US 39592606 A,2006-03-30,DUAL-STRING DYNAMOMETER FOR MEASURING DENTAL HANDPIECE AT HIGH AND LOW SPEED,"A dual-string tension dynamometer (1) utilizes two strings (10, 11) wrapped around approximately ninety degrees of a test wheel (12). The lateral forces (E, F) are balanced such that the total lateral force net value is zero. The results reflect purely torsional loading.",DENTSPLY INT INC;;NOVAK EUGENE J;;BROWN KIMBERLY C;;PAPANEK TOM;;PARAFINCZUK TADEUSZ;;FANCIULLO TODD,NOVAK EUGENE J;;BROWN KIMBERLY C;;PAPANEK TOM;;PARAFINCZUK TADEUSZ;;FANCIULLO TODD,,https://lens.org/182-794-962-012-553,Search Report,yes,1,0,3,3,0,G01L3/18;;G01L3/18,G01L3/04;;G01L3/18;;G01L3/24,,0,0,,,,PENDING
401,CN,A,CN 105368717 A,037-365-742-312-99X,2016-03-02,2016,CN 201510645406 A,2010-12-17,US 28784409 P;;CN 201080063993 A,2009-12-18,METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/037-365-742-312-99X,Patent Application,no,3,1,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N15/01;;C12N15/57;;C12P21/00;;C12R1/885,,0,0,,,,ACTIVE
402,BR,B1,BR 122018077148 B1,039-542-682-649-212,2020-11-03,2020,BR 122018077148 A,2010-12-17,US 2010/0061105 W;;US 28784409 P;;BR 112012013205 A,2009-12-18,"mutante de uma cepa de trichoderma reesei parental isolada, e, métodos para produzir um polipeptídeo de inetresse e para obter um mutante de uma cepa de trichoderma reesei parental","a presente invenção refere-se aos mutantes de uma cepa de trichoderma parental, compreendendo um polinucleotídeo codificador de um polipeptídeo e um ou mais (vários) genes selecionados do grupo consistindo de um primeiro gene de serina protease semelhante à subtilisina, um primeiro gene de protease aspártica, um gene de serina protease semelhante à tripsina, um segundo gene de serina protease semelhante à subtilisina, e um segundo gene de protease aspártica, sendo que os um ou mais (vários) genes são modificados tornando a cepa mutante deficiente na produção de uma ou mais (várias) enzimas selecionadas do grupo consistindo de uma primeira serina protease semelhante à subtilisina, uma primeira protease aspártica, uma serina protease semelhante à tripsina, uma segunda serina protease semelhante à subtilisina, e uma segunda protease aspártica, respectivamente, comparada com a cepa de trichoderma parental quando cultivada sob condições idênticas. a presente invenção também se refere aos métodos de produzir um polipeptídeo em tais mutantes e aos métodos de produzir tais mutantes.",NOVOZYMES INC,ABIGAIL JANG;;ERIC ABBATE;;JEFFREY SHASKY;;KIMBERLY BROWN;;SANDRA MERINO;;SUCHINDRA MAIYURAN,,https://lens.org/039-542-682-649-212,Granted Patent,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
403,AU,A1,AU 2010/330835 A1,046-472-549-363-55X,2012-04-19,2012,AU 2010/330835 A,2010-12-17,US 28784409 P;;US 2010/0061105 W,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"The present invention relates to mutants of a parent strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/046-472-549-363-55X,Patent Application,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
404,CA,C,CA 2784599 C,091-223-063-788-333,2020-06-02,2020,CA 2784599 A,2010-12-17,US 28784409 P;;US 2010/0061105 W,2009-12-18,METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/091-223-063-788-333,Granted Patent,no,0,0,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
405,BR,B1,BR 122018077153 B1,118-813-124-988-725,2020-10-27,2020,BR 122018077153 A,2010-12-17,US 2010/0061105 W;;US 28784409 P;;BR 112012013205 A,2009-12-18,"mutante de uma cepa de trichoderma reesei parental,e, métodos para produzir um polipeptídeo de interesse e para obter um mutante de uma cepa de trichoderma reesei parental","a presente invenção refere-se aos mutantes de uma cepa de trichoderma parental, compreendendo um polinucleotídeo codificador de um polipeptídeo e um ou mais (vários) genes selecionados do grupo consistindo de um primeiro gene de serina protease semelhante à subtilisina, um primeiro gene de protease aspártica, um gene de serina protease semelhante à tripsina, um segundo gene de serina protease semelhante à subtilisina, e um segundo gene de protease aspártica, sendo que os um ou mais (vários) genes são modificados tornando a cepa mutante deficiente na produção de uma ou mais (várias) enzimas selecionadas do grupo consistindo de uma primeira serina protease semelhante à subtilisina, uma primeira protease aspártica, uma serina protease semelhante à tripsina, uma segunda serina protease semelhante à subtilisina, e uma segunda protease aspártica, respectivamente, comparada com a cepa de trichoderma parental quando cultivada sob condições idênticas. a presente invenção também se refere aos métodos de produzir um polipeptídeo em tais mutantes e aos métodos de produzir tais mutantes.",NOVOZYMES INC,ABIGAIL JANG;;ERIC ABBATE;;JEFFREY SHASKY;;KIMBERLY BROWN;;SANDRA MERINO;;SUCHINDRA MAIYURAN,,https://lens.org/118-813-124-988-725,Granted Patent,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
406,AU,B2,AU 2016/201422 B2,040-021-521-014-728,2017-08-31,2017,AU 2016/201422 A,2016-03-04,AU 2016/201422 A;;AU 2010/330835 A;;US 28784409 P;;US 2010/0061105 W,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE DEFICIENT MUTANTS OF TRICHODERMA The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/040-021-521-014-728,Granted Patent,no,1,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
407,US,A1,US 2019/0093143 A1,167-878-680-650-826,2019-03-28,2019,US 201816211632 A,2018-12-06,US 201816211632 A;;US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for Producing Polypeptides in Protease-Deficient Mutants of Trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/167-878-680-650-826,Patent Application,yes,0,4,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12P21/00;;C12N9/58;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
408,US,A1,US 2015/0225761 A1,017-561-017-970-95X,2015-08-13,2015,US 201514663118 A,2015-03-19,US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for Producing Polypeptides in Protease-Deficient Mutants of Trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/017-561-017-970-95X,Patent Application,yes,0,1,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12P21/00;;C12N15/80,,0,0,,,,ACTIVE
409,WO,A3,WO 2011/075677 A3,063-973-385-855-436,2011-08-11,2011,US 2010/0061105 W,2010-12-17,US 28784409 P,2009-12-18,METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC;;MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/063-973-385-855-436,Search Report,yes,4,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,10,8,000-154-583-799-776;;142-954-370-284-714;;098-288-055-262-843;;021-872-480-021-441;;038-043-621-343-049;;030-127-339-831-230;;086-874-521-828-020;;084-029-071-712-731,10.1007/s00294-007-0130-5;;17415567;;14761794;;10.1016/j.fgb.2003.11.002;;1369052;;10.1271/bbb.56.1523;;10.1016/j.jbiotec.2004.10.017;;15707691;;10.1016/s0167-7799(97)01020-2;;9237405;;10.1007/s11274-009-0128-x;;10.1111/j.1574-6968.2008.01403.x;;19025577;;10.1016/j.enzmictec.2006.08.013,"BELÉN SUÁREZ M ET AL: ""Characterization of genes encoding novel peptidases in the biocontrol fungus Trichoderma harzianum CECT 2413 using the TrichoEST functional genomics approach"", CURRENT GENETICS ; EUKARYOTES WITH EMPHASIS ON YEASTS, FUNGI, PROTISTS, CELL ORGANELLES, SPRINGER, BERLIN, DE, vol. 51, no. 5, 6 April 2007 (2007-04-06), pages 331 - 342, XP019515006, ISSN: 1432-0983, DOI: DOI:10.1007/S00294-007-0130-5;;MANTYLA A ET AL: ""Industrial Mutants and Recombinant Strains of Trichoderma reesei"", TRICHODERMA AND GLIOCLADIUM, LONDON [U.A.] : TAYLOR & FRANCIS LTD, GB, vol. 2, 1 January 1998 (1998-01-01), pages 289 - 310, XP008134641, ISBN: 978-0-7484-0805-4;;POZO MARÍA J ET AL: ""Functional analysis of tvsp1, a serine protease-encoding gene in the biocontrol agent Trichoderma virens."", FUNGAL GENETICS AND BIOLOGY : FG & B MAR 2004 LNKD- PUBMED:14761794, vol. 41, no. 3, March 2004 (2004-03-01), pages 336 - 348, XP002629498, ISSN: 1087-1845;;GOTO M ET AL: ""AN AVICEL-AFFINITY SITE IN AN AVICEL-DIGESTING EXOCELLULASE FROM A TRICHODERMA VIRIDE MUTANT"", BIOSCIENCE BIOTECHNOLOGY BIOCHEMISTRY, JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY, TOKYO, JAPAN, vol. 56, no. 10, 1 October 1992 (1992-10-01), pages 1523 - 1528, XP000604611, ISSN: 0916-8451;;MIETTINEN-OINONEN A ET AL: ""Enhanced production of cellobiohydrolases in Trichoderma reesei and evaluation of the new preparations in biofinishing of cotton"", JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 116, no. 3, 30 March 2005 (2005-03-30), pages 305 - 317, XP004737503, ISSN: 0168-1656, DOI: DOI:10.1016/J.JBIOTEC.2004.10.017;;JANAS P.: ""PRODUCTION OF EXTRACELLULAR ENZYMES BY IOW-PROTEASE MUTANTS OF THCHODERMA REESEI"", ACTA SCI.POL., TECHNOL. ALIMENT., vol. 2, no. 2, 2003, pages 103 - 114, XP002629472, ISSN: 1644-0730, Retrieved from the Internet <URL:http://www.food.actapol.net/pub/11_2_2003.pdf> [retrieved on 20110323];;VAN DEN HOMBERGH J P T W ET AL: ""Aspergillus as a host for heterologous protein production: the problem of proteases"", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 15, no. 7, 1 July 1997 (1997-07-01), pages 256 - 263, XP004092682, ISSN: 0167-7799, DOI: DOI:10.1016/S0167-7799(97)01020-2;;SHARMA RUCHIKA ET AL: ""Approaches for refining heterologous protein production in filamentous fungi"", WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, vol. 25, no. 12, 2 August 2009 (2009-08-02), pages 2083 - 2094, XP002629470, ISSN: 0959-3993;;YAN LIU ET AL: ""Cloning and heterologous expression of SS10, a subtilisin-like protease displaying antifungal activity from Trichoderma harzianum."", FEMS MICROBIOLOGY LETTERS JAN 2009 LNKD- PUBMED:19025577, vol. 290, no. 1, January 2009 (2009-01-01), pages 54 - 61, XP002629471, ISSN: 0378-1097;;DIENES ET AL: ""Identification of a trypsin-like serine protease from Trichoderma reesei QM9414"", ENZYME AND MICROBIAL TECHNOLOGY, STONEHAM, MA, US, vol. 40, no. 5, 8 March 2007 (2007-03-08), pages 1087 - 1094, XP005918023, ISSN: 0141-0229, DOI: DOI:10.1016/J.ENZMICTEC.2006.08.013",PENDING
410,EP,A1,EP 3000871 A1,075-198-701-122-033,2016-03-30,2016,EP 15193798 A,2010-12-17,US 28784409 P;;EP 10791040 A,2009-12-18,METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA,"The present invention relates to mutants of a parent  Trichoderma  strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent  Trichoderma  strain when cultivated under identical conditions. The present imvention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/075-198-701-122-033,Patent Application,yes,23,0,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,67,50,031-464-369-878-770;;038-043-621-343-049;;030-127-339-831-230;;053-299-752-450-293;;090-557-407-290-429;;022-335-231-721-618;;084-029-071-712-731;;000-659-827-476-847;;033-692-117-058-028;;012-909-015-138-206;;022-715-862-716-318;;032-728-154-591-070;;022-439-235-146-469;;022-439-235-146-469;;085-498-590-431-913;;035-407-153-607-001;;081-788-652-542-089;;020-201-555-491-656;;020-201-555-491-656;;135-137-082-731-766;;048-085-542-435-816;;081-897-337-343-664;;082-106-826-270-067;;009-304-049-487-981;;039-227-503-731-991;;073-153-156-138-109;;016-587-457-958-718;;164-567-086-301-271;;029-314-535-301-390;;044-889-964-761-310;;130-197-652-144-217;;024-461-215-806-523;;002-129-848-383-652;;014-838-854-923-114;;149-091-707-097-038;;038-856-203-382-553;;014-708-690-338-262;;064-993-641-661-927;;007-869-180-638-074;;062-094-540-176-015;;024-986-022-647-37X;;037-504-554-883-442;;125-697-312-207-082;;004-773-129-539-999;;087-104-343-683-732;;093-312-592-638-709;;125-697-312-207-082;;053-859-189-584-42X;;136-261-375-157-758;;007-587-747-513-278,11988504;;10.1099/00221287-148-5-1305;;10.1016/s0167-7799(97)01020-2;;9237405;;10.1007/s11274-009-0128-x;;10.1111/j.1432-1033.1997.00605.x;;9266703;;10.1016/j.fgb.2007.09.012;;17977034;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;10.1016/j.enzmictec.2006.08.013;;pmc2143677;;10.1002/pro.5560060301;;9070434;;1455179;;11328603;;10.1093/oxfordjournals.jbchem.a002921;;9051728;;10.1093/protein/10.1.1;;10.1016/0022-2836(70)90057-4;;5420325;;10.1016/s0168-9525(00)02024-2;;10827456;;10.1016/s0168-9525(00)02024-2;;10827456;;2994214;;10.1126/science.2994214;;pmc338413;;3045756;;10.1093/nar/16.15.7351;;8850003;;10.1016/0378-1119(89)90359-4;;2744488;;10.1016/0378-1119(89)90359-4;;2744488;;2340178;;10.1007/bf00326057;;10.1111/j.1574-6968.1997.tb12637.x;;9297833;;10.1016/s0378-1097(97)00317-0;;10.1016/s0580-9517(08)70544-0;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;8508780;;pmc413497;;10.1002/j.1460-2075.1993.tb05913.x;;7973629;;10.1126/science.7973629;;10656339;;10.1016/s0168-1656(99)00191-1;;10.1128/aem.63.9.3488-3493.1997;;pmc168655;;9292999;;10.1038/nbt0595-498;;9634791;;1367012;;10.1038/nbt0491-378;;3082357;;14406087;;10.1021/bi00350a035;;10.1038/nbt0995-982;;9636275;;2516317;;10.1002/prot.340060306;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;2670677;;10.1016/0378-1119(89)90322-3;;10.1021/ba-1979-0181.ch014;;6308396;;10.1007/bf00331067;;3323803;;10.1016/0076-6879(87)53044-0;;10.1007/s002940050512;;10654091;;10.1016/0378-1119(90)90142-e;;2121607;;3127274;;10.1016/0378-1119(87)90110-7;;10.1007/bf00301060;;8190078;;10.1111/j.1432-1033.1992.tb17048.x;;1628653;;10.1016/0076-6879(91)94004-v;;12073320;;10.1016/s0076-6879(02)50954-x;;2005794;;10.1111/j.1574-6976.1997.tb00343.x;;9299700;;10.1016/s0168-6445(97)00005-3;;10.1007/bf00301060;;8190078;;pmc1217846;;10.1042/bj3190705;;8920970;;10.1016/0166-0934(92)90168-d;;1322932;;10.1263/jbb.102.572;;17270725,"MANTYLA A ET AL: ""Industrial Mutants and Recombinant Strains of Trichoderma reesei"", TRICHODERMA AND GLIOCLADIUM, LONDON [U.A.] : TAYLOR & FRANCIS LTD, GB, vol. 2, 1998, pages 289 - 310, XP008134641, ISBN: 978-0-7484-0805-4;;DATABASE EMBL [online] 15 April 2005 (2005-04-15), ""Trichoderma harzianum proA gene for putative aspartate protease"", XP002751659, retrieved from EBI accession no. EMBL:AJ276388 Database accession no. AJ276388;;DELGADO-JARANA J ET AL: ""Aspartyl protease from Trichoderma harzianum CECT 2413: Cloning and characterization"", MICROBIOLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, GB, vol. 148, no. 5, 1 May 2002 (2002-05-01), pages 1305 - 1315, XP002382445, ISSN: 1350-0872;;JANAS P.: ""PRODUCTION OF EXTRACELLULAR ENZYMES BY LOW-PROTEASE MUTANTS OF TRICHODERMA REESEI"", vol. 2, no. 2, 2003, pages 103 - 114, XP002629472, ISSN: 1644-0730, Retrieved from the Internet <URL:http://www.food.actapol.net/pub/11_2_2003.pdf> [retrieved on 20110323];;VAN DEN HOMBERGH J P T W ET AL: ""Aspergillus as a host for heterologous protein production: the problem of proteases"", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 15, no. 7, July 1997 (1997-07-01), pages 256 - 263, XP004092682, ISSN: 0167-7799, DOI: 10.1016/S0167-7799(97)01020-2;;SHARMA RUCHIKA ET AL: ""Approaches for refining heterologous protein production in filamentous fungi"", WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, vol. 25, no. 12, 2 August 2009 (2009-08-02), pages 2083 - 2094, XP002629470, ISSN: 0959-3993;;HOMBERGH VAN DEN J P T W ET AL: ""DISRUPTION OF THREE ACID PROTEASES IN ASPERGILLUS NIGER EFFECTS ON PROTEASE SPECTRUM, INTRACELLULAR PROTEOLYSIS, AND DEGRADATION OF TARGET PROTEINS"", EUROPEAN JOURNAL OF BIOCHEMISTRY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 247, no. 2, July 1997 (1997-07-01), pages 605 - 613, XP001153668, ISSN: 0014-2956, DOI: 10.1111/J.1432-1033.1997.00605.X;;WANG ET AL: ""Isolation of four pepsin-like protease genes from Aspergillus niger and analysis of the effect of disruptions on heterologous laccase expression"", FUNGAL GENETICS AND BIOLOGY, SAN DIEGO, CA, US, vol. 45, no. 1, 29 September 2007 (2007-09-29), pages 17 - 27, XP022346803, ISSN: 1087-1845, DOI: 10.1016/J.FGB.2007.09.012;;MARTINEZ, NATURE BIOTECHNOLOGY, vol. 26, 2008, pages 553 - 560;;DIENES ET AL., ENZYME AND MICROBIAL TECHNOLOGY, vol. 40, 2007, pages 1087 - 1094;;ENEYSKAYA ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 52, 1999, pages 226 - 231;;HAUB ET AL., J. BIOTECHNOLOGY, vol. 16, 1990, pages 187 - 198;;HAGSPIEL ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 32, 1989, pages 61 - 67;;SIEZEN; LEUNISSEN, PROTEIN SCIENCE, vol. 6, 1997, pages 501 - 523;;SZECSI, SCAND. J. CLIN. LAB. IN VEST., vol. 210, 1992, pages 5 - 22;;AIKAWA ET AL., J. BIOCHEM., vol. 129, 2001, pages 791 - 794;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;RICE ET AL.: ""EMBOSS: The European Molecular Biology Open Software Suite"", TRENDS IN GENETICS, vol. 16, 2000, pages 276 - 277, XP004200114, DOI: doi:10.1016/S0168-9525(00)02024-2;;RICE ET AL., EMBOSS: THE EUROPEAN MOLECULAR BIOLOGY OPEN SOFTWARE SUITE, 2000;;BOTSTEIN; SHORTLE, SCIENCE, vol. 229, 1985, pages 4719;;LO, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1985, pages 2285;;HIGUCHI ET AL., NUCLEIC ACIDS RESEARCH, vol. 16, 1988, pages 7351;;SHIMADA, METH. MOL. BIOL., vol. 57, 1996, pages 157;;HO, GENE, vol. 77, 1989, pages 61;;HORTON, GENE, vol. 77, 1989, pages 61;;SARKAR; SOMMER, BIOTECHNIQUES, vol. 8, 1990, pages 404;;IGLESIAS; TRAUTNER, MOLECULAR GENERAL GENETICS, vol. 189, 1983, pages 73 - 76;;PARISH; STOKER, FEMS MICROBIOLOGY LETTERS, vol. 154, 1997, pages 151 - 157;;HOPWOOD: ""The Isolation of Mutants in Methods in Microbiology"", 1970, ACADEMIC PRESS, pages: 363 - 433;;BOLTON; MCCARTHY, PROC. NATL. ACAD. SCI. USA, vol. 48, 1962, pages 1390;;""Enzyme Handbook"", 1990, SPRINGER-VERLAG;;""Protein Purification"", 1989, VCH PUBLISHERS;;COOPER ET AL., EMBO J., vol. 12, 1993, pages 2575 - 2583;;DAWSON ET AL., SCIENCE, vol. 266, 1994, pages 776 - 779;;MARTIN ET AL., J. IND. MICROBIOL. BIOTECHNOL., vol. 3, 2003, pages 568 - 576;;SVETINA ET AL., J. BIOTECHNOL., vol. 76, 2000, pages 245 - 251;;RASMUSSEN-WILSON ET AL., APPL. ENVIRON. MICROBIOL., vol. 63, 1997, pages 3488 - 3493;;WARD ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 498 - 503;;CONTRERAS ET AL., BIOTECHNOLOGY, vol. 9, 1991, pages 378 - 381;;EATON ET AL., BIOCHEMISTRY, vol. 25, 1986, pages 505 - 512;;COLLINS-RACIE ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 982 - 987;;CARTER ET AL., PROTEINS: STRUCTURE, FUNCTION, AND GENETICS, vol. 6, 1989, pages 240 - 248;;STEVENS, DRUG DISCOVERY WORLD, vol. 4, 2003, pages 35 - 48;;INNIS ET AL.: ""PCR Protocols: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;J. SAMBROOK; E.F. FRITSCH; T. MANIATUS: ""Molecular Cloning, A Laboratory Manual"", 1989, COLD SPRING HARBOR;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;MONTENECOURT; EVELEIGH, ADV. CHEM. SER., vol. 181, 1979, pages 289 - 301;;BUXTON ET AL., MOLECULAR AND GENERAL GENETICS, vol. 190, 1983, pages 403 - 405;;SAMBROOK ET AL.: ""Molecular Cloning, A Laboratory Manual"", 1989, COLD SPRING HARBOR LABORATORY PRESS;;VIERA; MESSING, METHODS IN ENZYMOLOGY, vol. 153, 1987, pages 3 - 11;;CUMMINGS ET AL., CURRENT GENETICS, vol. 36, 1999, pages 371 - 382;;PUNT ET AL., GENE, vol. 3, 1990, pages 101 - 109;;PENTTILA ET AL., GENE, vol. 61, 1987, pages 155 - 164;;H. DALB0GE ET AL., MOL. GEN. GENET., vol. 243, 1994, pages 253 - 260;;MANIATIS ET AL.: ""Molecular cloning: a laboratory manual"", 1982, COLD SPRING HARBOR LABORATORY PRESS;;VAN DEN HAZEL ET AL., EUR. J. BIOCHEM., vol. 207, 1992, pages 277 - 283;;GUTHRIE ET AL.: ""Meth. Enzymol."", vol. 194, 1991, ACADEMIC PRESS;;SHERMAN, METHODS ENZYMOL., vol. 350, 2002, pages 3 - 41;;DALBØGE, FEMS MICROBIOLOGY REVIEWS, vol. 21, 2006, pages 29 - 42;;DALBOGE; HELDT-HANSEN, MOL. GEN. GENET., vol. 243, 1994, pages 253 - 260;;CHRISTGAU ET AL., BIOCHEM. J., vol. 319, 1996, pages 705 - 712;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;SUZUKI ET AL., J. BIOSCIENCE AND BIOENGINEERING, vol. 102, 2006, pages 572 - 574;;COVE, BIOCHIM. BIOPHYS. ACTA, vol. 133, 1996, pages 51 - 56",DISCONTINUED
411,US,A1,US 2020/0377921 A1,115-903-263-022-939,2020-12-03,2020,US 202016995820 A,2020-08-18,US 202016995820 A;;US 201816211632 A;;US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for Producing Polypeptides in Protease-Deficient Mutants of Trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/115-903-263-022-939,Patent Application,yes,0,0,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12P21/00;;C12N9/58;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
412,BR,B1,BR 112012013205 B1,174-426-137-194-765,2020-11-03,2020,BR 112012013205 A,2010-12-17,US 2010/0061105 W;;US 28784409 P,2009-12-18,"mutante de uma cepa parental de trichoderma reesei, e, métodos para produzir um polipeptídeo de interesse e para obter um mutante de uma cepa parental de trichoderma","mutante de uma cepa de trichoderma parental, e, métodos para produzir um polipeptídeo e para obter uma mutante de uma cepa de trichoderma parental. a presente invenção refere-se aos mutantes de uma cepa de trichoderma parental, compreendendo um polinucleotídeo codificador de um polipeptídeo e um ou mais (vários) genes selecionados do grupo consistindo de um primeiro gene de serina protease semelhante à subtilisina, um primeiro gene de protease aspártica, uma gene de serina protease semelhante à tripsina, um segundo gene de serina protease semelhante à subtilisina, e um segundo gene de protease aspártica, sendo que os um ou mais (vários) genes são modificados tornando a cepa mutante deficiente na produção de uma ou mais (várias) enzimas selecionadas do grupo consistindo de uma primeira serina protease semelhante à subtilisina, uma primeira protease aspártica, uma serina protease semelhante à tripsina, uma segunda serina protease semelhante à subtilisina, e uma segunda protease aspártica, respectivamente, comparada com a cepa de trichoderma parental quando cultivada sob condições idênticas. a presente invenção também se refere aos métodos de produzir um polipeptídeo em tais mutantes e aos métodos de produzir tais mutantes.",NOVOZYMES INC,ABIGALL JANG;;ERIC ABBATE;;JEFFREY SHASKY;;KIMBERLY BROWN;;SANDRA MERINO;;SUCHINDRA MAIYURAN,,https://lens.org/174-426-137-194-765,Granted Patent,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
413,DK,T3,DK 2513290 T3,058-607-970-062-823,2016-01-25,2016,DK 10791040 T,2010-12-17,US 28784409 P;;US 2010/0061105 W,2009-12-18,Fremgangsmåder til fremstilling af polypeptider i Trichoderma-mutanter med proteasemangel,,NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/058-607-970-062-823,Granted Patent,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
414,WO,A2,WO 2011/075677 A2,100-018-471-524-988,2011-06-23,2011,US 2010/0061105 W,2010-12-17,US 28784409 P,2009-12-18,METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC;;MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/100-018-471-524-988,Patent Application,yes,18,43,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,58,44,022-335-231-721-618;;084-029-071-712-731;;000-659-827-476-847;;033-692-117-058-028;;012-909-015-138-206;;022-715-862-716-318;;032-728-154-591-070;;022-439-235-146-469;;085-498-590-431-913;;035-407-153-607-001;;081-788-652-542-089;;020-201-555-491-656;;020-201-555-491-656;;135-137-082-731-766;;048-085-542-435-816;;081-897-337-343-664;;082-106-826-270-067;;009-304-049-487-981;;039-227-503-731-991;;073-153-156-138-109;;016-587-457-958-718;;164-567-086-301-271;;029-314-535-301-390;;044-889-964-761-310;;130-197-652-144-217;;024-461-215-806-523;;002-129-848-383-652;;014-838-854-923-114;;149-091-707-097-038;;038-856-203-382-553;;014-708-690-338-262;;064-993-641-661-927;;007-869-180-638-074;;062-094-540-176-015;;024-986-022-647-37X;;037-504-554-883-442;;125-697-312-207-082;;004-773-129-539-999;;087-104-343-683-732;;093-312-592-638-709;;125-697-312-207-082;;053-859-189-584-42X;;136-261-375-157-758;;007-587-747-513-278,10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;10.1016/j.enzmictec.2006.08.013;;pmc2143677;;10.1002/pro.5560060301;;9070434;;1455179;;11328603;;10.1093/oxfordjournals.jbchem.a002921;;9051728;;10.1093/protein/10.1.1;;10.1016/0022-2836(70)90057-4;;5420325;;10.1016/s0168-9525(00)02024-2;;10827456;;2994214;;10.1126/science.2994214;;pmc338413;;3045756;;10.1093/nar/16.15.7351;;8850003;;10.1016/0378-1119(89)90359-4;;2744488;;10.1016/0378-1119(89)90359-4;;2744488;;2340178;;10.1007/bf00326057;;10.1111/j.1574-6968.1997.tb12637.x;;9297833;;10.1016/s0378-1097(97)00317-0;;10.1016/s0580-9517(08)70544-0;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;8508780;;pmc413497;;10.1002/j.1460-2075.1993.tb05913.x;;7973629;;10.1126/science.7973629;;10656339;;10.1016/s0168-1656(99)00191-1;;10.1128/aem.63.9.3488-3493.1997;;pmc168655;;9292999;;10.1038/nbt0595-498;;9634791;;1367012;;10.1038/nbt0491-378;;3082357;;14406087;;10.1021/bi00350a035;;10.1038/nbt0995-982;;9636275;;2516317;;10.1002/prot.340060306;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;2670677;;10.1016/0378-1119(89)90322-3;;10.1021/ba-1979-0181.ch014;;6308396;;10.1007/bf00331067;;3323803;;10.1016/0076-6879(87)53044-0;;10.1007/s002940050512;;10654091;;10.1016/0378-1119(90)90142-e;;2121607;;3127274;;10.1016/0378-1119(87)90110-7;;10.1007/bf00301060;;8190078;;10.1111/j.1432-1033.1992.tb17048.x;;1628653;;10.1016/0076-6879(91)94004-v;;12073320;;10.1016/s0076-6879(02)50954-x;;2005794;;10.1111/j.1574-6976.1997.tb00343.x;;9299700;;10.1016/s0168-6445(97)00005-3;;10.1007/bf00301060;;8190078;;pmc1217846;;10.1042/bj3190705;;8920970;;10.1016/0166-0934(92)90168-d;;1322932;;10.1263/jbb.102.572;;17270725,"MARTINEZ ET AL., NATURE BIOTECHNOLOGY, vol. 26, 2008, pages 553 - 560;;DIENES ET AL., ENZYME AND MICROBIAL TECHNOLOGY, vol. 40, 2007, pages 1087 - 1094;;ENEYSKAYA ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 52, 1999, pages 226 - 231;;HAUB ET AL., J. BIOTECHNOLOGY, vol. 16, 1990, pages 187 - 198;;HAGSPIEL ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 32, 1989, pages 61 - 67;;SIEZENLEUNISSEN, PROTEIN SCIENCE, vol. 6, 1997, pages 501 - 523;;SZECSI, SCAND. J. CLIN. LAB. IN VEST., vol. 210, 1992, pages 5 - 22;;AIKAWA ET AL., J. BIOCHEM., vol. 129, 2001, pages 791 - 794;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;NEEDLEMANWUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453;;RICE ET AL.: ""EMBOSS: The European Molecular Biology Open Software Suite"", TRENDS IN GENETICS, vol. 16, 2000, pages 276 - 277;;BOTSTEINSHORTIE, SCIENCE, vol. 229, 1985, pages 4719;;LO ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1985, pages 2285;;HIGUCHI ET AL., NUCLEIC ACIDS RESEARCH, vol. 16, 1988, pages 7351;;SHIMADA, METH. MOL. BIOL., vol. 57, 1996, pages 157;;HO ET AL., GENE, vol. 77, 1989, pages 61;;HORTON ET AL., GENE, vol. 77, 1989, pages 61;;SARKARSOMMER, BIOTECHNIQUES, vol. 8, 1990, pages 404;;IGLESIASTRAUTNER, MOLECULAR GENERAL GENETICS, vol. 189, 1983, pages 73 - 76;;PARISHSTOKER, FEMS MICROBIOLOGY LETTERS, vol. 154, 1997, pages 151 - 157;;HOPWOOD: ""The Isolation of Mutants in Methods in Microbiology"", 1970, ACADEMIC PRESS, pages: 363 - 433;;BOLTONMCCARTHY, PROC. NATL. ACAD. SCI. USA, vol. 48, 1962, pages 1390;;""Enzyme Handbook"", 1990, SPRINGER-VERLAG;;""Protein Purification"", 1989, VCH PUBLISHERS;;COOPER ET AL., EMBO J., vol. 12, 1993, pages 2575 - 2583;;DAWSON ET AL., SCIENCE, vol. 266, 1994, pages 776 - 779;;MARTIN ET AL., J. IND. MICROBIOL. BIOTECHNOL., vol. 3, 2003, pages 568 - 576;;SVETINA ET AL., J. BIOTECHNOL., vol. 76, 2000, pages 245 - 251;;RASMUSSEN-WILSON ET AL., APPL ENVIRON. MICROBIOL., vol. 63, 1997, pages 3488 - 3493;;WARD ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 498 - 503;;CONTRERAS ET AL., BIOTECHNOLOGY, vol. 9, 1991, pages 378 - 381;;EATON ET AL., BIOCHEMISTRY, vol. 25, 1986, pages 505 - 512;;COLLINS-RACIE ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 982 - 987;;CARTER ET AL., PROTEINS: STRUCTURE, FUNCTION, AND GENETICS, vol. 6, 1989, pages 240 - 248;;STEVENS, DRUG DISCOVERY WORLD, vol. 4, 2003, pages 35 - 48;;INNIS ET AL.: ""PCR Protocols: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;J. SAMBROOKE.F. FRITSCHT. MANIATUS: ""Molecular Cloning, A Laboratory Manual"", 1989, COLD SPRING HARBOR;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;MONTENECOURTEVELEIGH, ADV. CHEM. SER., vol. 181, 1979, pages 289 - 301;;BUXTON ET AL., MOLECULAR AND GENERAL GENETICS, vol. 190, 1983, pages 403 - 405;;SAMBROOK ET AL.: ""Molecular Cloning, A Laboratory Manual"", 1989, COLD SPRING HARBOR LABORATORY PRESS;;VIERAMESSING, METHODS IN ENZYMOLOGY, vol. 153, 1987, pages 3 - 11;;CUMMINGS ET AL., CURRENT GENETICS, vol. 36, 1999, pages 371 - 382;;PUNT ET AL., GENE, vol. 3, 1990, pages 101 - 109;;PENTTILA ET AL., GENE, vol. 61, 1987, pages 155 - 164;;H. DALBRAGE ET AL., MOL. GEN. GENET., vol. 243, 1994, pages 253 - 260;;MANIATIS ET AL.: ""Molecular cloning: a laboratory manual"", 1982, COLD SPRING HARBOR LABORATORY PRESS;;HAZEL ET AL., EUR. J. BIOCHEM., vol. 207, 1992, pages 277 - 283;;GUTHRIE ET AL.: ""Meth. Enzymol."", vol. 194, 1991, ACADEMIC PRESS;;SHERMAN, METHODS ENZYMOL., vol. 350, 2002, pages 3 - 41;;DALBØGE, FEMS MICROBIOLOGY REVIEWS, vol. 21, 2006, pages 29 - 42;;DALBØGEHELDT-HANSEN, MOL. GEN. GENET., vol. 243, 1994, pages 253 - 260;;CHRISTGAU ET AL., BIOCHEM. J., vol. 319, 1996, pages 705 - 712;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;SUZUKI ET AL., J. BIOSCIENCE AND BIOENGINEERING, vol. 102, 2006, pages 572 - 574;;COVE, BIOCHIM. BIOPHYS. ACTA, vol. 133, 1996, pages 51 - 56",PENDING
415,US,A1,US 2020/0385772 A1,131-300-028-771-144,2020-12-10,2020,US 202016996159 A,2020-08-18,US 202016996159 A;;US 201816211632 A;;US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for Producing Polypeptides in Protease-Deficient Mutants of Trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/131-300-028-771-144,Patent Application,yes,0,0,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12P21/00;;C12N9/58;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
416,US,B2,US 11427847 B2,132-776-541-168-442,2022-08-30,2022,US 202117163033 A,2021-01-29,US 202117163033 A;;US 202016995820 A;;US 201816211632 A;;US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/132-776-541-168-442,Granted Patent,yes,17,0,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12P21/00;;C12N9/58;;C12N15/04;;C12N15/80;;C12P21/02,,40,18,098-288-055-262-843;;038-043-621-343-049;;021-872-480-021-441;;142-954-370-284-714;;030-127-339-831-230;;000-154-583-799-776;;086-874-521-828-020;;022-335-231-721-618;;041-625-608-522-278;;029-932-427-231-872;;031-464-369-878-770;;022-335-231-721-618;;001-614-865-382-419;;004-344-441-114-834;;066-525-536-073-344;;023-650-636-149-863;;099-148-434-391-858;;082-023-104-660-107,1369052;;10.1271/bbb.56.1523;;10.1016/s0167-7799(97)01020-2;;9237405;;10.1016/j.jbiotec.2004.10.017;;15707691;;14761794;;10.1016/j.fgb.2003.11.002;;10.1007/s11274-009-0128-x;;10.1007/s00294-007-0130-5;;17415567;;10.1111/j.1574-6968.2008.01403.x;;19025577;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;10.1016/0168-1656(90)90035-a;;27213181;;10.1021/acsinfecdis.6b00026;;pmc4869151;;11988504;;10.1099/00221287-148-5-1305;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;18675276;;pmc2711637;;10.1016/j.jmb.2008.07.043;;pmc3533174;;10.1111/j.1574-6968.2012.02665.x;;22924408;;27137097;;10.1016/j.riam.2015.10.003;;10.1556/amicr.52.2005.2.3;;16003937;;26309247;;10.1371/journal.pone.0134723;;pmc4550459;;pmc6901835;;10.3389/fmicb.2019.02784;;31849916,"U.S. Appl. No. 13/516,422, U.S. Pat. No. 8,986,974, filed Dec. 17, 2010.;;U.S. Appl. No. 14/663,118, U.S. Pat. No. 10,400,260, filed Mar. 19, 2015.;;U.S. Appl. No. 16/211,632, 2018/0093143, filed Dec. 6, 2018.;;U.S. Appl. No. 16/995,820, 2020/0377921, filed Aug. 18, 2020.;;U.S. Appl. No. 16/996,159, 2020/0385772, filed Aug. 18, 2020.;;U.S. Appl. No. 16/996,168, 2020/0385773, filed Aug. 18, 2020.;;U.S. Appl. No. 90/014,445, filed Feb. 3, 2020.;;Dienes et al, 2007, Enzy Microbiol Technol 40(5), 1087-1094.;;Goto et al, 1992, Biosci Biotechnol Biochem 56(10), 1523-1528.;;Homberg et al, 1997, Trends Biotechnol 15(7), 256-263.;;Janas et al, 2003, Acta Sci Pol 2(20), 103-114.;;Mantyla et al, 1998, Tricho and Gliocladium 2, 289-310.;;Miettinen et al, 2005, J Biotechnol 116(3), 305-317.;;Pozo et al, 2004, Fungal Genet Biol 41(3), 336-348.;;Sharma et al, 2009, World J Microbiol Biotechnol 25(12), 2083-2094.;;Suarez et al, 2007, Curr Genet 51(5), 331-342.;;Suarez et al, 2007, EMBL Access No. AM294978.;;Yan et al, 2009, FEMS Microbiol Lett 290(1), 54-61.;;Martinez et al., 2008, Nature Biotechnology 26:553-560.;;Enesyskaya et al., 1999, Appl. Microbiol. Biotechnol. 52: 226-231.;;Haab et al., 1990, J. Biotechnology 16: 187-198.;;Hagspiel et al., 1989, Appl. Microbiol. Biotechnol. 32: 61-67.;;Mantyla, 2006, Genbank No. AM168137.1.;;Anonymous, 1992, Nature 355, 117.;;Anonymous, 2019, CLUSTAL multiple sequence alignment, CAJ44684.1.;;Anonymous, 2019, NCBI BLAST RID WG7K9NZE014.;;Bogdanoff et al, 2016, ACS Infectious diseases 2, 313-321.;;Delgado-Jarana et al, 2002, Microbiology 148, 1305-1315.;;Mantyla et al, 2018, Trichoderma and gliocladium 2, 291-309.;;Mantyla, 2006, Genbank No. AM166137.1.;;Martinez et al, 1999, Nature Biotechnology 26, 553-560.;;Martinez et al, 2006, Genome Portal, project ID 16784.;;Nascimento et al, 2008, J Mol Biol 382, 763-778.;;Nascimento et al, 2008, RCSB PDB—3C9X.;;Druzhinina et al., Novel traits of Trichoderma predicted through the analysis of its secretome, FEMS Microbiol Lett 337:1 (2012).;;Gonzalez et al., Secreted fungal aspartic proteases: A review, Rev Iberoam Micol. 33(2):76-82 (2016).;;Kredics et al., Extracellular Proteases of Trichoderma Species: A Review, Acta Microbiologica et Immunologica Hungarica, 52(2): 169-184 (2005).;;Landowski et al., Enabling Low Cost Biopharmaceuticals: A Systematic Approach to Delete Proteases from a Well-Known Protein Production Host Trichoderma reesei, PLoS ONE 10(8):doi:10.1371/ pumal.pone.0134723 (2015).;;Mantyla et al., Cloning of the aspartic protease gene from Trichoderma reesei, Fungal Genetics Newsletter, No. 41A, 1994 Supplement, Abstracts from the 2nd European Conference on Fungal Genetics Apr. 28-May 1, 1994.;;Qian et al., Enhancement of Cellulase Production in Trichoderma reesei via Disruption of Multiple Protease Genes Identified by Comparative Secretomics, Frontiers in Microbiology, 10:2784 (Dec. 2019).",ACTIVE
417,CN,A,CN 102762714 A,146-864-446-416-661,2012-10-31,2012,CN 201080063993 A,2010-12-17,US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions.; The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,SUCHINDRA MAIYURAN;;ABIGALL JANG;;KIMBERLY BROWN;;SANDRA MERINO;;JEFFREY SHASKY;;ERIC ABBATE,,https://lens.org/146-864-446-416-661,Patent Application,no,5,3,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,2,0,,,"MARIA J. POZO等: ""Functional analysis of tvsp1,a serine protease-encoding gene in the biocontrol agent Trichoderma virens"", 《FUNGAL GENETICS AND BIOLOGY》;;M. BELEN SUAREZ等: ""Characterization of genes encoding novel peptidases in the biocontrol fungus Trichoderma harzianum CECT 2413 using the TrichoEST functional genomics approach"", 《CURR GENET》",ACTIVE
418,US,B2,US 11001869 B2,144-017-077-530-433,2021-05-11,2021,US 202016995820 A,2020-08-18,US 202016995820 A;;US 201816211632 A;;US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/144-017-077-530-433,Granted Patent,yes,17,1,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12P21/00;;C12N9/58;;C12N15/80;;C12P21/02,,39,18,098-288-055-262-843;;038-043-621-343-049;;021-872-480-021-441;;142-954-370-284-714;;030-127-339-831-230;;000-154-583-799-776;;086-874-521-828-020;;022-335-231-721-618;;041-625-608-522-278;;029-932-427-231-872;;031-464-369-878-770;;022-335-231-721-618;;001-614-865-382-419;;004-344-441-114-834;;066-525-536-073-344;;023-650-636-149-863;;099-148-434-391-858;;082-023-104-660-107,1369052;;10.1271/bbb.56.1523;;10.1016/s0167-7799(97)01020-2;;9237405;;10.1016/j.jbiotec.2004.10.017;;15707691;;14761794;;10.1016/j.fgb.2003.11.002;;10.1007/s11274-009-0128-x;;10.1007/s00294-007-0130-5;;17415567;;10.1111/j.1574-6968.2008.01403.x;;19025577;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;10.1016/0168-1656(90)90035-a;;27213181;;10.1021/acsinfecdis.6b00026;;pmc4869151;;11988504;;10.1099/00221287-148-5-1305;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;18675276;;pmc2711637;;10.1016/j.jmb.2008.07.043;;pmc3533174;;10.1111/j.1574-6968.2012.02665.x;;22924408;;27137097;;10.1016/j.riam.2015.10.003;;10.1556/amicr.52.2005.2.3;;16003937;;26309247;;10.1371/journal.pone.0134723;;pmc4550459;;pmc6901835;;10.3389/fmicb.2019.02784;;31849916,"Dienes et al, 2007, Enzy Microbiol Technol 40(5), 1087-1094.;;Goto et al, 1992, Biosci Biotechnol Biochem 56(10), 1523-1528.;;Homberg et al, 1997, Trends Biotechnol 15(7), 256-263.;;Janas et al, 2003, Acta Sci Pol 2(20), 103-114.;;Mantyla et al, 1998,Tricho and Gliocladium 2, 289-310.;;Miettinen et al, 2005, J Biotechnol 116(3), 305-317.;;Pozo et al, 2004, Fungal Genet Biol 41(3), 336-348.;;Sharma et al, 2009, World J Microbiol Biotechnol 25(12), 2083-2094.;;Suarez et al, 2007, Curr Genet 51(5), 331-342.;;Suarez et al, 2007, EMBL Access No. AM294978.;;Yan et al, 2009, FEMS Microbiol Lett 290(1), 54-61.;;Martinez et al., 2008, Nature Biotechnology 26:553-560.;;Enesyskaya et al., 1999, Appl. Microbiol. Biotechnol. 52: 226-231.;;Haab et al., 1990, J. Biotechnology 16: 187-198.;;Hagspiel et al., 1989, Appl. Microbiol. Biotechnol. 32: 61-67.;;Mantyla, 2006, Genbank No. AM168137.1.;;Anonymous, 1992, Nature 355, 117.;;Anonymous, 2019, CLUSTAL multiple sequence alignment, CAJ44684.1.;;Anonymous, 2019, NCBI BLAST RID WG7K9NZE014.;;Bogdanoff et al, 2016, ACS Infectious diseases 2, 313-321.;;Delgado-Jarana et al, 2002, Microbiology 148, 1305-1315.;;Mantyla et al, 2018, Trichoderma and gliocladium 2, 291-309.;;Mantyla, 2006, Genbank No. AM166137.1.;;Martinez et al, 1999, Nature Biotechnology 26, 553-560.;;Martinez et al, 2006, Genome Portal, project ID 16784.;;Nascimento et al, 2008, J Mol Biol 382, 763-778.;;Nascimento et al, 2008, RCSB PDB—3C9X.;;U.S. Appl. No. 13/516,422, U.S. Pat. No. 8,986,974, filed Dec. 17, 2010.;;U.S. Appl. No. 14/663,118, U.S. Pat. No. 10,400,260, filed Mar. 19, 2015.;;U.S. Appl. No. 16/211,632, 2019/0093143, filed Dec. 6, 2018.;;U.S. Appl. No. 16/996,159, filed Aug. 18, 2020.;;U.S. Appl. No. 16/996,168, filed Aug. 18, 2020.;;U.S. Appl. No. 90/014,445, filed Feb. 3, 2020.;;Druzhinina et al., Novel traits of Trichoderma predicted through the analysis of its secretome, FEMS Microbiol Lett 337:1 (2012).;;Gonzalez et al., Secreted fungal aspartic proteases: A review, Rev Iberoam Micol. 33(2):76-82 (2016).;;Kredics et al., Extracellular Proteases of Trichoderma Species: A Review, Acta Microbiologica et Immunologica Hungarica, 52(2):169-184 (2005).;;Landowski et al., Enabling Low Cost Biopharmaceuticals: A Systematic Approach to Delete Proteases from a Well-Known Protein Production Host Trichoderma reesei, PLoS One 10(8):doi:10.1371/ pumal.pone.0134723 (2015).;;Mantyla et al., Cloning of the aspartic protease gene from Trichoderma reesei, Fungal Genetics Newsletter, No. 41A, 1994 Supplement, Abstracts from the 2nd European Conference on Fungal Genetics Apr. 28-May 1, 1994.;;Qian et al., Enhancement of Cellulase Production in Trichoderma reesei via Disruption of Multiple Protease Genes identified by Comparative Secretomics, Frontiers in Microbiology, 10:2784 (Dec. 2019).",ACTIVE
419,AU,A1,AU 2017/254852 A1,000-088-290-246-948,2017-11-16,2017,AU 2017/254852 A,2017-10-31,AU 2017/254852 A;;AU 2016/201422 A;;AU 2010/330835 A;;US 28784409 P;;US 2010/0061105 W,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE DEFICIENT MUTANTS OF TRICHODERMA The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/000-088-290-246-948,Patent Application,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
420,AU,A1,AU 2016/201422 A1,016-654-121-836-570,2016-03-24,2016,AU 2016/201422 A,2016-03-04,AU 2016/201422 A;;AU 2010/330835 A;;US 28784409 P;;US 2010/0061105 W,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,"METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE DEFICIENT MUTANTS OF TRICHODERMA The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/016-654-121-836-570,Patent Application,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
421,US,A1,US 2021/0155967 A1,038-033-213-497-410,2021-05-27,2021,US 202117163033 A,2021-01-29,US 202117163033 A;;US 202016995820 A;;US 201816211632 A;;US 201514663118 A;;US 201213516433 A;;US 2010/0061105 W;;US 28784409 P,2009-12-18,Methods for Producing Polypeptides in Protease-Deficient Mutants of Trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/038-033-213-497-410,Patent Application,yes,0,0,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12P21/00;;C12N9/58;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
422,AU,B2,AU 2010/330835 B2,104-507-163-953-871,2016-02-11,2016,AU 2010/330835 A,2010-12-17,US 28784409 P;;US 2010/0061105 W,2009-12-18,Methods for producing polypeptides in protease-deficient mutants of Trichoderma,The present invention relates to mutants of a parent,NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/104-507-163-953-871,Granted Patent,no,1,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,2,1,000-154-583-799-776,10.1007/s00294-007-0130-5;;17415567,"BELEN SUAREZ, M. et al. Current Genetics. 2007, vol. 51, pages 331-342;;GenBank Accession No. AM294978.2",ACTIVE
423,US,B2,US 8986974 B2,040-150-639-528-709,2015-03-24,2015,US 201013516433 A,2010-12-17,US 201013516433 A;;US 28784409 P;;US 2010/0061105 W,2009-12-18,Methods for producing polypeptidies in protease-deficient mutants of trichoderma,"The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more (several) genes selected from the group consisting of a first subtilisin-like serine protease gene, a first aspartic protease gene, a trypsin-like serine protease gene, a second subtilisin-like serine protease gene, and a second aspartic protease gene, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of a first subtilisin-like serine protease, a first aspartic protease, a trypsin-like serine protease, a second subtilisin-like serine protease, and a second aspartic protease, respectively, compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.",MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC;;NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGAIL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,NOVOZYMES INC (2012-06-19),https://lens.org/040-150-639-528-709,Granted Patent,yes,10,12,44,44,117,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/15;;C12N9/58;;C12N15/80;;C12P21/02,435/254.1,15,9,098-288-055-262-843;;038-043-621-343-049;;021-872-480-021-441;;142-954-370-284-714;;030-127-339-831-230;;000-154-583-799-776;;086-874-521-828-020;;022-335-231-721-618;;041-625-608-522-278,1369052;;10.1271/bbb.56.1523;;10.1016/s0167-7799(97)01020-2;;9237405;;10.1016/j.jbiotec.2004.10.017;;15707691;;14761794;;10.1016/j.fgb.2003.11.002;;10.1007/s11274-009-0128-x;;10.1007/s00294-007-0130-5;;17415567;;10.1111/j.1574-6968.2008.01403.x;;19025577;;10.3410/f.1120793.577044;;10.1038/nbt1403;;18454138;;10.1016/0168-1656(90)90035-a,"Dienes et al, 2007, Enzy Microbiol Technol 40(5), 1087-1094.;;Goto et al, 1992, Biosci Biotechnol Biochem 56(10), 1523-1528.;;Homberg et al, 1997, Trends Biotechnol 15(7), 256-263.;;Janas et al, 2003, Acta Sci Pol 2(20), 103-114.;;Mantyla et al, 1998,Tricho and Gliocladium 2, 289-310.;;Miettinen et al, 2005, J Biotechnol 116(3), 305-317.;;Pozo et al, 2004, Fungal Genet Biol 41(3), 336-348.;;Sharma et al, 2009, World J Microbiol Biotechnol 25(12), 2083-2094.;;Suarez et al, 2007, Curr Genet 51(5), 331-342.;;Suarez et al, 2007, EMBL Access No. AM294978.;;Yan et al, 2009, FEMS Microbiol Lett 290(1), 54-61.;;Martinez et al., 2008, Nature Biotechnology 26:553-560.;;Enesyskaya et al., 1999, Appl. Microbiol. Biotechnol. 52: 226-231.;;Haab et al., 1990, J. Biotechnology 16: 187-198.;;Hagspiel et al., 1989, Appl. Microbiol. Biotechnol. 32: 61-67.",ACTIVE
424,EP,A2,EP 2513290 A2,104-631-383-618-811,2012-10-24,2012,EP 10791040 A,2010-12-17,US 28784409 P;;US 2010/0061105 W,2009-12-18,METHODS FOR PRODUCING POLYPEPTIDES IN PROTEASE-DEFICIENT MUTANTS OF TRICHODERMA,,NOVOZYMES INC,MAIYURAN SUCHINDRA;;JANG ABIGALL;;BROWN KIMBERLY;;MERINO SANDRA;;SHASKY JEFFREY;;ABBATE ERIC,,https://lens.org/104-631-383-618-811,Patent Application,yes,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
425,BR,B1,BR 122019011255 B1,167-336-724-323-493,2020-12-01,2020,BR 122019011255 A,2010-12-17,US 2010/0061105 W;;US 28784409 P;;BR 112012013205 A,2009-12-18,"mutante de uma cepa de trichoderma reesei parental isolada, e, métodos para produzir um polipeptídeo e para obter um mutante de uma cepa de trichoderma reesei parental","a presente invenção refere-se aos mutantes de uma cepa de trichoderma parental, compreendendo um polinucleotídeo codificador de um polipeptídeo e um ou mais (vários) genes selecionados do grupo consistindo de um primeiro gene de serina protease semelhante à subtilisina, um primeiro gene de protease aspártica, um gene de serina protease semelhante à tripsina, um segundo gene de serina protease semelhante à subtilisina, e um segundo gene de protease aspártica, sendo que os um ou mais (vários) genes são modificados tornando a cepa mutante deficiente na produção de uma ou mais (várias) enzimas selecionadas do grupo consistindo de uma primeira serina protease semelhante à subtilisina, uma primeira protease aspártica, uma serina protease semelhante à tripsina, uma segunda serina protease semelhante à subtilisina, e uma segunda protease aspártica, respectivamente, comparada com a cepa de trichoderma parental quando cultivada sob condições idênticas. a presente invenção também se refere aos métodos de produzir um polipeptídeo em tais mutantes e aos métodos de produzir tais mutantes.",NOVOZYMES INC,ABIGAIL JANG;;ERIC ABBATE;;JEFFREY SHASKY;;KIMBERLY BROWN;;SANDRA MERINO;;SUCHINDRA MAIYURAN,,https://lens.org/167-336-724-323-493,Granted Patent,no,0,0,44,44,0,C12N15/80;;C12P21/02;;C12N9/58;;C12N15/80;;C12P21/02;;C12N15/04;;C12N9/58;;C12P21/00,C12N1/14;;C12N9/58;;C12N15/57;;C12N15/80;;C12P21/02,,0,0,,,,ACTIVE
426,NZ,A,NZ 509306 A,197-491-587-724-941,2002-07-26,2002,NZ 50930699 A,1999-07-13,US 9302198 P;;US 10871698 P;;US 9915776 W,1998-07-16,Nocathiacin antibiotics,A nocathiacin compound of the given formula (I) wherein; R is H or OH; W is H or formula (II); or a pharmaceutically acceptable salt. The compound is useful in treating bacterial infections.,BRISTOL MYERS SQUIBB CO,LEET JOHN E;;AX HELEN A;;GUSTAVSON DONALD R;;BROWN DANIEL M;;TURNER LAURA;;BROWN KIMBERLY;;LAM KIN,,https://lens.org/197-491-587-724-941,Patent Application,no,0,0,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,A61K31/4353;;A61K31/437;;C12P17/18;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,0,0,,,,PENDING
427,US,B2,US 8258370 B2,027-718-149-960-513,2012-09-04,2012,US 201113253586 A,2011-10-05,US 201113253586 A;;US 29457309 A;;US 2007/0065682 W;;US 78838906 P,2006-03-30,Polypeptides having endoglucanase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY;;NOVOZYMES INC;;NOVOZYMES AS,HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,,https://lens.org/027-718-149-960-513,Granted Patent,yes,11,2,15,15,26,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N15/31;;A01H5/00;;C12N15/10;;C12N15/52;;C12N15/82,800/288;;800/284;;800/294;;800/278;;435/320.1;;435/468;;536/23.1;;536/23.2;;536/23.7,6,4,141-205-426-179-469;;048-848-212-901-012;;012-345-432-822-761;;030-861-357-228-781,10.1016/0960-8524(92)90134-j;;10.1006/jmbi.1997.1243;;9325098;;10.1016/s0960-8524(00)00037-7;;10.1385/abab:111:3:153;;14665735,"Breuil 1986, Biotechn Lett 8, 673-676.;;Gilbert 1992, Bioresource Techn 39, 147-153.;;Kleywegt 1997, J Mol Biol 272, 383-397.;;Kumar 2000, Bioresource Technology 75, 95-97.;;Kvesitadze 1995, Appl Biochem Biotechn 50, 137-144.;;Rey et al, 2003, Appl Biochem Biotechnol 111(3), 153-166.",INACTIVE
428,WO,A8,WO 2007/115201 A8,103-407-032-712-264,2009-08-06,2009,US 2007/0065682 W,2007-03-30,US 78838906 P,2006-03-30,POLYPEPTIDES HAVING ENDOGLUCANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC;;NOVOZYMES AS;;HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,,https://lens.org/103-407-032-712-264,Amended Application,yes,0,0,15,15,0,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N9/42;;C07K14/37;;C12N15/56;;C12N15/82,,0,0,,,,PENDING
429,EP,A2,EP 2004817 A2,061-064-326-255-659,2008-12-24,2008,EP 07759868 A,2007-03-30,US 2007/0065682 W;;US 78838906 P,2006-03-30,POLYPEPTIDES HAVING ENDOGLUCANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC;;NOVOZYMES AS,HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,,https://lens.org/061-064-326-255-659,Patent Application,yes,0,0,15,15,0,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N9/42;;C07K14/37;;C12N15/56;;C12N15/82,,0,0,,,,DISCONTINUED
430,US,B2,US 8063267 B2,168-092-732-066-763,2011-11-22,2011,US 29457307 A,2007-03-30,US 29457307 A;;US 78838906 P;;US 2007/0065682 W,2006-03-30,Polypeptides having endoglucanase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY;;NOVOZYMES INC;;NOVOZYMES AS,HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,NOVOZYMES INC (2011-10-10);;NOVOZYMES A/S (2011-10-10),https://lens.org/168-092-732-066-763,Granted Patent,yes,4,8,15,15,26,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N15/31;;A01H5/00;;C12N15/10;;C12N15/52;;C12N15/82,800/288;;800/284;;800/295;;800/278;;435/320.1;;435/468;;536/23.1;;536/23.2;;536/23.7,5,5,070-333-389-731-762;;014-089-417-686-952;;141-205-426-179-469;;048-848-212-901-012;;012-345-432-822-761,10.1007/bf01025980;;10.1007/bf02783450;;10.1016/0960-8524(92)90134-j;;10.1006/jmbi.1997.1243;;9325098;;10.1016/s0960-8524(00)00037-7,"Breuil et al., Production and localization of cellulases and Beta-glucosidase from thermophilic fungus Thielavia terrestris, Biotechnology Letter, vol. 8, 1986, pp. 673-676.;;Kvesitadze et al., Isolation and properties of a thermostable endoglucanase from a thermophilic mutant strain of Thielavia terrestris, Applied Biochemistry and Biotechnology, vol. 50, 1995, pp. 137-144.;;Gilbert et al., Characterization of the Enzymes Present in the Cellulase System of Thielavia terrestris 255B, Bioresource Technology, vol. 39, 1992, pp. 147-154.;;Kleywegt et al., The Crystal Structure of the Catalytic Core Domain of Endoclucanase I from Trichoderma reesei at 3.6 ÅResolution, and a Comparison with Related Enzymes, J. Mol. Biol., vol. 272, 1997, pp. 383-397.;;Kumar et al., Production of endo-1, 4-Beta-glucanase by a biocontrol fungus Cladorrhinum foecundissimum, Bioresource Technology, vol. 75, 2000, pp. 95-97.",INACTIVE
431,BR,A2,BR PI0710217 A2,106-595-121-689-166,2011-08-02,2011,BR PI0710217 A,2007-03-30,US 78838906 P;;EP 2007065682 W,2006-03-30,"polipeptìdeo, polinucleotìdeo, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, métodos para produzir o polipeptìdeo, para produzir um mutante a partir de uma célula precursora, para produzir uma proteìna, para produzir um polinucleotìdeo, para degradar ou converter um material celulósico, para produzir uma substáncia e para inibir a expressão de um polinucleotìdeo em uma célula, célula mutante, planta transgênica, parte de planta ou célula de planta, e, molécula de rna de filamento duplo","POLIPEPTIDEO, POLINUCLEOTìDEO, CONSTRUçãO DE áCIDO NUCLEICO, VETOR DE EXPRESSãO RECOMBINANTE, CéLULA HOSPEDEIRA RECOMBINANTE, MéTODOS PARA PRODUZIR O POLIPEPTIDEO, PARA PRODUZIR UM MUTANTE A PARTIR DE UMA CéLULA PRECURSORA, PARA PRODUZIR UMA PROTEINA, PARA PRODUZIR UM POLINUCLEOTIDEO, PARA DEGRADAR OU CONVERTER UM MATERIAL CELULOSICO, PARA PRODUZIR UMA SUBSTáNCIA E PARA IMBIR A EXPRESSãO DE UM POLIPEPTIDEO EM UMA CéLULA, CéLULA MUTANTE, PLANTA TRANSGêNICA, PARTE DE PLANTA OU CéLULA DE PLANTA, E, MOLéCULA DE RNA DE FILAMENTO DUPLO A presente invenção diz respeito a polipeptídeos isolados tendo atividade de endoglucanase e polinucleotídeos isolados que codificam os polipeptídeos. A invenção também diz respeito a construções de ácido nucleico, vetores e células hospedeiras que compreendem os polinucleotídeos assim como métodos para produzir e usar os polipeptídeos.",NOVOZYMES INC;;NOVOZYMES AS,HARRIS PAUL;;VLASENKO ELENA;;KAUPPINEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,,https://lens.org/106-595-121-689-166,Patent Application,no,0,0,15,15,0,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N9/42;;C07K14/37;;C12N15/56;;C12N15/82,,0,0,,,,DISCONTINUED
432,US,A1,US 2012/0023626 A1,181-882-859-784-532,2012-01-26,2012,US 201113253586 A,2011-10-05,US 201113253586 A;;US 29457309 A;;US 2007/0065682 W;;US 78838906 P,2006-03-30,Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same,"The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",HARRIS PAUL;;VLASENKO ELENA;;ZARETSKY ELIZABETH;;KAUPPINNEN MARCUS SAKARI;;TETER SARAH;;BROWN KIMBERLY;;NOVOZYMES INC;;NOVOZYMES AS,HARRIS PAUL;;VLASENKO ELENA;;ZARETSKY ELIZABETH;;KAUPPINNEN MARCUS SAKARI;;TETER SARAH;;BROWN KIMBERLY,,https://lens.org/181-882-859-784-532,Patent Application,yes,0,0,15,15,26,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N9/42;;A01H5/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/04;;C12N5/10;;C12N15/56;;C12N15/63;;C12P7/10;;C12P19/02;;C12P19/04;;C12P19/12,800/298;;536/23.2;;435/209;;435/320.1;;435/252.31;;435/252.3;;435/252.35;;435/252.33;;435/252.34;;435/325;;435/348;;435/419;;435/254.11;;435/254.2;;435/254.22;;435/254.23;;435/254.21;;435/254.3;;435/254.7;;435/254.8;;435/254.4;;435/254.5;;435/254.6;;435/105;;435/100;;435/101;;435/165,0,0,,,,INACTIVE
433,US,A1,US 2014/0322753 A1,006-101-196-495-464,2014-10-30,2014,US 201414320029 A,2014-06-30,US 201414320029 A;;US 201213562899 A;;US 201113253586 A;;US 29457309 A;;US 2007/0065682 W;;US 78838906 P,2006-03-30,Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same,"The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES AS;;NOVOZYMES INC,HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,,https://lens.org/006-101-196-495-464,Patent Application,yes,1,0,15,15,26,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N9/42;;C12N15/113;;C12P19/02;;C12P19/14;;C12P21/00,435/69.1;;435/209;;536/23.2;;435/320.1;;435/91.5;;435/419;;435/99;;435/155;;435/136;;435/148;;435/106;;435/168;;536/24.5;;435/252.31;;435/252.3;;435/252.35;;435/252.33;;435/252.34;;435/325;;435/348;;435/254.11;;435/254.2;;435/254.22;;435/254.23;;435/254.21;;435/254.3;;435/254.7;;435/254.8;;435/254.5;;435/254.4;;435/254.6;;435/375;;435/471;;435/468;;435/455,0,0,,,,DISCONTINUED
434,US,A1,US 2012/0309059 A1,053-621-311-302-263,2012-12-06,2012,US 201213562899 A,2012-07-31,US 201213562899 A;;US 201113253586 A;;US 29457309 A;;US 2007/0065682 W;;US 78838906 P,2006-03-30,Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same,"The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",HARRIS PAUL;;VLASENKO ELENA;;ZARETSKY ELIZABETH;;KAUPPINNEN MARCUS SAKARI;;TETER SARAH;;BROWN KIMBERLY;;NOVOZYMES INC;;NOVOZYMES AS,HARRIS PAUL;;VLASENKO ELENA;;ZARETSKY ELIZABETH;;KAUPPINNEN MARCUS SAKARI;;TETER SARAH;;BROWN KIMBERLY,,https://lens.org/053-621-311-302-263,Patent Application,yes,0,0,15,15,26,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N9/42;;A01H5/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N15/55;;C12P7/14;;C12P19/14,435/99;;435/209;;536/23.2;;800/298;;435/254.2;;435/254.21;;435/254.3;;435/252.3;;435/252.31;;435/252.33;;435/252.34;;435/252.35;;435/254.6;;435/254.5;;435/254.7;;435/162,0,0,,,,INACTIVE
435,CN,A,CN 101460616 A,037-184-931-437-350,2009-06-17,2009,CN 200780019316 A,2007-03-30,US 78838906 P,2006-03-30,Polypeptides having endoglucanase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,PAUL HARRIS;;ELENA VLASENKO;;SAKARI KAUPPINNEN MARCUS;;ELIZABETH ZARETSKY;;SARAH TETER;;KIMBERLY BROWN,,https://lens.org/037-184-931-437-350,Patent Application,no,0,5,15,15,0,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N9/42,,0,0,,,,DISCONTINUED
436,US,B2,US 8791328 B2,095-070-314-099-737,2014-07-29,2014,US 201213562899 A,2012-07-31,US 201213562899 A;;US 201113253586 A;;US 29457309 A;;US 2007/0065682 W;;US 78838906 P,2006-03-30,Polypeptides having endoglucanase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY;;NOVOZYMES INC,HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,,https://lens.org/095-070-314-099-737,Granted Patent,yes,13,0,15,15,26,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N15/82;;C12N15/00;;C12N15/10,800/284;;800/278;;800/295;;435/320.1;;435/468;;435/183;;536/23.1;;536/23.7,6,4,141-205-426-179-469;;048-848-212-901-012;;012-345-432-822-761;;030-861-357-228-781,10.1016/0960-8524(92)90134-j;;10.1006/jmbi.1997.1243;;9325098;;10.1016/s0960-8524(00)00037-7;;10.1385/abab:111:3:153;;14665735,"Breuil 1986, Biotechn Lett 8, 673-676.;;Gilbert 1992, Bioresource Techn 39, 147-153.;;Kleywegt 1997, J Mol Biol 272, 383-397.;;Kumar 2000, Bioresource Technology 75, 95-97.;;Kvesitadze 1995, Appl Biochem Biotechn 50, 137-144.;;Rey et al, 2003, Appl Biochem Biotechnol 111(3), 153-166.",INACTIVE
437,WO,A3,WO 2007/115201 A3,099-868-595-408-468,2008-03-06,2008,US 2007/0065682 W,2007-03-30,US 78838906 P,2006-03-30,POLYPEPTIDES HAVING ENDOGLUCANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC;;NOVOZYMES AS;;HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,,https://lens.org/099-868-595-408-468,Search Report,yes,5,1,15,15,0,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N9/42;;C07K14/37;;C12N15/56;;C12N15/82,,4,4,014-089-417-686-952;;141-205-426-179-469;;070-333-389-731-762;;048-848-212-901-012,10.1007/bf02783450;;10.1016/0960-8524(92)90134-j;;10.1007/bf01025980;;10.1006/jmbi.1997.1243;;9325098,"KVESITADZE E G ET AL: ""ISOLATION AND PROPERTIES OF A THERMOSTABLE ENDOGLUCANASE FROM A THERMOPHILIC MUTANT STRAIN OF THIELAVIA TERRESTRIS"", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, CLIFTON, NJ, US, vol. 50, no. 2, 1995, pages 137 - 143, XP009006005, ISSN: 0273-2289;;GILBERT M ET AL: ""CHARACTERIZATION OF THE ENZYMES PRESENT IN THE CELLULASE SYSTEM OF THIELAVIA TERRESTRIS 255B"", BIORESOURCE TECHNOLOGY, ELSEVIER, GB, vol. 39, no. 2, 1992, pages 147 - 153, XP009005952, ISSN: 0960-8524;;BREUIL C ET AL: ""PRODUCTION AND LOCALIZATION OF CELLULASES AND .BETA.-GLUCOSIDASE FROM THE THERMOPHILIC FUNGUS THIELAVIA TERRESTRIS"", BIOTECHNOLOGY LETTERS, KEW, SURREY, GB, vol. 8, no. 9, 1986, pages 673 - 676, XP009074467, ISSN: 0141-5492;;KLEYWEGT G J ET AL: ""The crystal structure of the catalytic core domain of endoglucanase I from Trichoderma reesei at 3.6 A resolution, and a comparison with related enzymes"", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 272, no. 3, 26 September 1997 (1997-09-26), pages 383 - 397, XP004461458, ISSN: 0022-2836",PENDING
438,WO,A2,WO 2007/115201 A2,129-113-163-119-479,2007-10-11,2007,US 2007/0065682 W,2007-03-30,US 78838906 P,2006-03-30,POLYPEPTIDES HAVING ENDOGLUCANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC;;NOVOZYMES AS;;HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,HARRIS PAUL;;VLASENKO ELENA;;KAUPPINNEN MARCUS SAKARI;;ZARETSKY ELIZABETH;;TETER SARAH;;BROWN KIMBERLY,,https://lens.org/129-113-163-119-479,Patent Application,yes,0,21,15,15,26,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,C12N9/42,,0,0,,,,PENDING
439,US,A1,US 2009/0328259 A1,043-618-013-546-235,2009-12-31,2009,US 29457307 A,2007-03-30,US 29457307 A;;US 78838906 P;;US 2007/0065682 W,2006-03-30,Polypeptides having endoglucanase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES AS;;NOVOZYMES INC,HARRIS PAUL;;VLASENKO ELENA;;ZARETSKY ELIZABETH;;KAUPPINNEN MARCUS SAKARI;;TETER SARAH;;BROWN KIMBERLY,NOVOZYMES INC (2011-10-10);;NOVOZYMES A/S (2011-10-10),https://lens.org/043-618-013-546-235,Patent Application,yes,1,17,15,15,26,A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;C12N9/244;;Y02A50/30;;Y02E50/10;;A61K38/00;;C07K14/5431;;C12N9/2437;;C12Y302/01004;;Y02A50/30;;Y02E50/10;;C12N9/244;;C12N15/1137;;C12P19/02;;C12P19/14;;C12P21/00,A01H5/00;;C07H21/00;;C07H21/04;;C12N1/21;;C12N5/06;;C12N5/10;;C12N9/42;;C12P19/00;;C12P21/02,800/298;;435/209;;536/23.2;;435/252.3;;435/69.1;;435/375;;435/419;;435/72;;536/24.5,0,0,,,,INACTIVE
440,EP,A1,EP 1096939 A1,076-629-769-168-810,2001-05-09,2001,EP 99935519 A,1999-07-13,US 9915776 W;;US 9302198 P;;US 10871698 P,1998-07-16,NOCATHIACIN ANTIBIOTICS,,BRISTOL MYERS SQUIBB CO,LEET JOHN E;;AX HELEN A;;GUSTAVSON DONALD R;;BROWN DANIEL M;;TURNER LAURA;;BROWN KIMBERLY;;LI WENYING;;LAM KIN S,,https://lens.org/076-629-769-168-810,Patent Application,yes,0,0,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,A61K31/4353;;C12P17/18;;A61K31/437;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,0,0,,,,DISCONTINUED
441,PL,A1,PL 345657 A1,161-235-492-179-515,2002-01-02,2002,PL 34565799 A,1999-07-13,US 9302198 P;;US 10871698 P,1998-07-16,NOCATHIACIN ANTIBIOTICS,,BRISTOL MYERS SQUIBB CO,LEET JOHN E;;AX HELEN A;;GUSTAVSON DONALD R;;BROWN DANIEL M;;TURNER LAURA;;BROWN KIMBERLY;;LI WENYING;;LAM KIN S,,https://lens.org/161-235-492-179-515,Patent Application,no,0,0,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,A61K31/4353;;C12P17/18;;A61K31/437;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,0,0,,,,DISCONTINUED
442,ZA,B,ZA 200006693 B,174-013-430-324-287,2001-11-16,2001,ZA 200006693 A,2000-11-16,US 9302198 P,1998-07-16,Nocathiacin antibiotics.,,BRISTOL MYERS SQUIBB CO,LEET JOHN E;;GUSTAVSON DONALD R;;TURNER LAURA;;LI WENYING;;AX HELEN A;;BROWN DANIEL M;;BROWN KIMBERLY;;LAM KIN S,,https://lens.org/174-013-430-324-287,Granted Patent,no,0,0,1,24,0,,A61K/,,0,0,,,,EXPIRED
443,US,B1,US 6218398 B1,063-908-088-587-016,2001-04-17,2001,US 35179199 A,1999-07-13,US 35179199 A;;US 10871698 P;;US 9302198 P,1998-07-16,Nocathiacin antibiotics,"Novel thiazolyl peptide antibiotic compounds, including nocathiacin I, II and III, are disclosed. Also, novel microorganism ATCC-202099 is disclosed.",BRISTOL MYERS SQUIBB CO,LEET JOHN E;;AX HELEN A;;GUSTAVSON DONALD R;;BROWN DANIEL M;;TURNER LAURA;;BROWN KIMBERLY;;LI WENYING;;LAM KIN S,BRISTOL-MYERS SQUIBB COMPANY (1999-07-13),https://lens.org/063-908-088-587-016,Granted Patent,yes,2,11,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,A61K31/4353;;A61K31/437;;C12P17/18;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,514/279;;540/450,8,8,110-840-245-157-664;;060-149-546-376-651;;074-675-818-876-763;;017-539-377-685-932;;158-471-987-997-911;;019-948-042-750-085;;038-210-054-001-178;;010-184-308-194-115,7850213;;10.1016/0966-842x(94)90623-8;;10.7164/antibiotics.51.715;;9766463;;10.1021/ja00461a039;;893891;;7379912;;10.1007/bf01975121;;10.1021/ja00070a001;;10.7164/antibiotics.47.887;;7928675;;7928676;;10.7164/antibiotics.47.894;;10.7164/antibiotics.47.901;;7928677,"Cohen, ""Antimicrobial resistance: prognosis for public health,"" Trends in Microbiology, vol. 2, No. 10, Oct. 1994, pp. 422-425.;;Sasaki, et al., ""MJ347-81F4 A & B, Novel Antibiotics from Amycolatopsis sp.: Taxonomic Characteristics, Fermentation, and Antimicrobial Activity,"" Journal of Antibiotics, vol. 51, No. 8, 1998, pp. 715-721.;;Pascard, et al., ""Highly Modified Cysteine-Containing Antibiotics. Chemical Structure and Configuration of Nosiheptide,"" J. Am. Chem. Soc., 99, 1977, pp. 6418-6423.;;Benazet, et al., ""Nosiheptide, a sulfur-containing peptide antibiotic isolated from Streptomyces actuosus 40037,"" Experientia, 36, 1980, pp. 414-416.;;Mocek, et al., ""Biosynthesis of the Modified Peptide Antibiotic Nosiheptide in Strptomyces actuosus,"" Journal of the American Chemical Society, vol. 115, No. 17, Aug. 25, 1993, pp. 7557-7568.;;Steinberg, et al., ""Glycothiohexides, Novel Antibiotics Produced by""Sebekia""sp. LL-14E605. I. Taxonomy, Fermentation and Biological Evaluation,"" Journal of Antibiotics, vol. 47, No. 8, Aug. 1994, pp. 887-893.;;Northcote, et al., ""Glycothiohexide alpha, A Novel Antibiotic Produced by""Sebekia""sp. LL-14E605. II. Isolation and Physical-chemical Characterization,"" Journal of Antibiotics, vol. 47, No. 8, Aug. 1994, pp. 894-900.;;Northcote, et al., ""Glycothiohexide alpha, A Novel Antibiotic Produced by""Sebekia""sp. LL-14E605. III. Structural Elucidation,"" Journal of Antibiotics, vol. 47, No. 8, Aug. 1994, pp. 901-908.",EXPIRED
444,AU,B2,AU 745333 B2,092-671-261-457-522,2002-03-21,2002,AU 1999/050981 A,1999-07-13,US 9302198 P;;US 10871698 P;;US 9915776 W,1998-07-16,Nocathiacin antibiotics,,BRISTOL MYERS SQUIBB CO,LEET JOHN E;;AX HELEN A;;GUSTAVSON DONALD R;;BROWN DANIEL M;;TURNER LAURA;;BROWN KIMBERLY;;LI WENYING;;LAM KIN S,,https://lens.org/092-671-261-457-522,Granted Patent,no,0,0,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,C12P17/18;;A61K31/4353;;A61K31/437;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,0,0,,,,EXPIRED
445,WO,A1,WO 2000/003722 A1,191-805-169-918-883,2000-01-27,2000,US 9915776 W,1999-07-13,US 9302198 P;;US 10871698 P,1998-07-16,NOCATHIACIN ANTIBIOTICS,"Novel thiazolyl peptide antibiotic compounds, including nocathiacin I, II and III, are disclosed. Also, novel microorganism ATCC-202099 is disclosed.",BRISTOL MYERS SQUIBB CO,LEET JOHN E;;AX HELEN A;;GUSTAVSON DONALD R;;BROWN DANIEL M;;TURNER LAURA;;BROWN KIMBERLY;;LI WENYING;;LAM KIN S,,https://lens.org/191-805-169-918-883,Patent Application,yes,0,6,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,A61K31/4353;;C12P17/18;;A61K31/437;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,1,1,060-149-546-376-651,10.7164/antibiotics.51.715;;9766463,"SASAKI ET AL: ""MJ347-81F4 A & B, Novel Antibiotics from Amycolatopis sp.: Taxonomic Characteristics, Fermentation and Antimicrobial Activity"", JOURNAL OF ANTIBIOTICS, vol. 51, no. 8, 25 August 1998 (1998-08-25), pages 715 - 721, XP002919932",PATENTED
446,EP,A4,EP 1096939 A4,118-495-563-150-798,2001-08-22,2001,EP 99935519 A,1999-07-13,US 9915776 W;;US 9302198 P;;US 10871698 P,1998-07-16,NOCATHIACIN ANTIBIOTICS,,BRISTOL MYERS SQUIBB CO,LEET JOHN E;;AX HELEN A;;GUSTAVSON DONALD R;;BROWN DANIEL M;;TURNER LAURA;;BROWN KIMBERLY;;LI WENYING;;LAM KIN S,,https://lens.org/118-495-563-150-798,Search Report,no,1,0,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,A61K31/4353;;A61K31/437;;A61K38/00;;A61P31/04;;C07D515/22;;C12P17/18;;C07K5/078;;C12N1/20;;C12R1/01,,3,2,010-184-308-194-115;;038-210-054-001-178,10.7164/antibiotics.47.901;;7928677;;7928676;;10.7164/antibiotics.47.894,"NORTHCOTE P T ET AL: ""GLYCOTHIOHEXIDE ALPHA, A NOVEL ANTIBIOTIC PRODUCED BY SEBEKIA SP., LL-14E605"", JOURNAL OF ANTIBIOTICS,JP,JAPAN ANTIBIOTICS RESEARCH ASSOCIATION, TOKYO, vol. 47, no. 8, August 1994 (1994-08-01), pages 901 - 908, XP002923906, ISSN: 0021-8820;;NORTHCOTE P T ET AL: ""GLYCOTHIOHEXIDE ALPHA, A NOVEL ANTIBIOTIC PRODUCED BY SEBEKIA SP., LL-14E605 II. ISOLATION AND PHYSICAL-CHEMICAL CHARACTERIZATION"", JOURNAL OF ANTIBIOTICS,JP,JAPAN ANTIBIOTICS RESEARCH ASSOCIATION, TOKYO, vol. 47, no. 8, August 1994 (1994-08-01), pages 894 - 900, XP002923905, ISSN: 0021-8820;;See also references of WO 0003722A1",DISCONTINUED
447,CZ,A3,CZ 2001182 A3,174-512-208-219-108,2002-01-16,2002,CZ 2001182 A,1999-07-13,US 9302198 P;;US 10871698 P,1998-07-16,Nocathiacin antibiotics,,BRISTOL MYERS SQUIBB CO,LEET JOHN E;;AX HELEN A;;GUSTAVSON DONALD R;;BROWN DANIEL M;;TURNER LAURA;;BROWN KIMBERLY;;LI WENYING;;LAM KIN S,,https://lens.org/174-512-208-219-108,Patent Application,no,0,0,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,A61K31/4353;;A61K31/437;;C12P17/18;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,0,0,,,,PENDING
448,AU,A,AU 1999/050981 A,031-197-764-802-828,2000-02-07,2000,AU 1999/050981 A,1999-07-13,US 9302198 P;;US 10871698 P;;US 9915776 W,1998-07-16,Nocathiacin antibiotics,,BRISTOL MYERS SQUIBB CO,LEET JOHN E;;AX HELEN A;;GUSTAVSON DONALD R;;BROWN DANIEL M;;TURNER LAURA;;BROWN KIMBERLY;;LI WENYING;;LAM KIN S,,https://lens.org/031-197-764-802-828,Patent Application,no,0,0,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,C12P17/18;;A61K31/4353;;A61K31/437;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,0,0,,,,EXPIRED
449,TR,T2,TR 200003587 T2,080-548-912-672-156,2001-06-21,2001,TR 200003587 T,1999-07-13,US 9302198 P;;US 10871698 P,1998-07-16,Nosatiasin antibiyotikleri.,"Nosatiasin I,II ve III de olmak üzere yeni tiazolil peptid antibiyotik bilesikleri içerilmektedir. Ayni zamanda, yeni mikroorganizma ATCC-202099 içerilmektedir.",BRISTOL MYERS SQUIBB CO,LEET JOHN E;;GUSTAVSON DONALD R;;BROWN DANIEL M;;TURNER LAURA;;BROWN KIMBERLY;;LI WENYING;;LAM KIN S;;AX HELEN A,,https://lens.org/080-548-912-672-156,Patent Application,no,0,0,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,A61K31/4353;;C12P17/18;;A61K31/437;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,0,0,,,,PENDING
450,HU,A2,HU P0102903 A2,166-446-235-219-231,2002-05-29,2002,HU P0102903 A,1999-07-13,US 9302198 P;;US 10871698 P,1998-07-16,"NOCATHIACIN ANTIBIOTICS, PROCESS FOR THEIR PREPARATION AND PHARMACAUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS","A találmány az (1) általános képletű nokatiacin antibiotikumvegyületekre és gyógyászati szempontból elfogadható sóikra vonatkozik,ahol az (1) képletben R jelentése hidrogénatom vagy hidroxilcsoport;és W jelentése hidrogénatom vagy (a) képletű csoport. A nokatiacin Imolekulájában W jelentése (a) képletű csoport, és R hidroxilcsoportotjelent; a nokatiacin II molekulájában W jelentése (a) képletű csoport,és R jelentése hidrogénatom; a nokatiacin III molekulájában Wjelentése hidrogénatom, és R hidroxilcsoportot jelent. Az újantibiotikumok előnye, hogy egérmodellen több gyógyszerrel szembenrezisztens baktériumtörzsek ellen is hatásosak. A találmány kiterjedaz (I) általános képletű vegyületek előállítási eljrására és avegyületeket tartalmazó gyógyszerkészítményekre és alkalmazásukra. Ó",BRISTOL MYERS SQUIBB CO,AX HELEN A;;BROWN DANIEL M;;BROWN KIMBERLY;;GUSTAVSON DONALD R;;LAM KIN S;;LEET JOHN E;;LI WENYING;;TURNER LAURA,,https://lens.org/166-446-235-219-231,Patent Application,no,0,0,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,A61K31/4353;;C12P17/18;;A61K31/437;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,0,0,,,,DISCONTINUED
451,ID,A,ID 27775 A,024-387-348-721-766,2001-04-26,2001,ID 20010104 A,1999-07-13,US 9302198 P;;US 10871698 P,1998-07-16,ANTIBIOTIK-ANTIBIOTIK NOKATIASIN,,BRISTOL MYERS SQUIBB CO,LEET JOHN E;;AX HELEN A;;TURNER LAURA;;LI WENYING;;LAM KIN S;;GUSTAVSON DONALD R;;BROWN DANIEL M;;BROWN KIMBERLY,,https://lens.org/024-387-348-721-766,Patent Application,no,0,0,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,A61K31/4353;;C12P17/18;;A61K31/437;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,0,0,,,,PENDING
452,BR,A,BR 9912042 A,195-482-597-446-490,2001-04-03,2001,BR 9912042 A,1999-07-13,US 9302198 P;;US 10871698 P;;US 9915776 W,1998-07-16,Antibióticos de nocatiacina,"""ANTIBIóTICOS DE NOCATIACINA"" São revelados novos compostos antibióticos de peptídeo de tiazolila, incluindo nocatiacina I, II e III. Também é revelado um novo microorganismo ATCC-202099.",BRISTOL MYERS SQUIBB CO,LEET JOHN E;;AX HELEN A;;GUSTAVSON DONALD R;;BROWN DANIEL M;;TURNER LAURA;;BROWN KIMBERLY;;LI WENYING;;LAM KING S,,https://lens.org/195-482-597-446-490,Patent Application,no,0,0,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,C12P17/18;;A61K31/4353;;A61K31/437;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,0,0,,,,DISCONTINUED
453,CA,A1,CA 2337398 A1,191-231-064-189-629,2000-01-27,2000,CA 2337398 A,1999-07-13,US 9302198 P;;US 10871698 P;;US 9915776 W,1998-07-16,NOCATHIACIN ANTIBIOTICS,"Novel thiazolyl peptide antibiotic compounds, including nocathiacin I, II an d III, are disclosed. Also, novel microorganism ATCC-202099 is disclosed.</SDO AB>",BRISTOL MYERS SQUIBB CO,TURNER LAURA;;BROWN KIMBERLY;;BROWN DANIEL M;;GUSTAVSON DONALD R;;AX HELEN A;;LAM KIN S;;LEET JOHN E;;LI WENYING,,https://lens.org/191-231-064-189-629,Patent Application,no,0,1,23,24,0,A61K31/4353;;A61K38/00;;C07K5/06139;;A61P31/00;;A61P31/04;;C12R2001/365;;C12N1/205;;A61K31/4353;;A61K38/00;;C07K5/06139;;C07K5/06139;;A61K31/4353;;A61K38/00;;C12N1/205;;C12R2001/365,C12P17/18;;A61K31/4353;;A61K31/437;;A61K38/00;;A61P31/04;;C07D515/22;;C07K5/078;;C12N1/20;;C12R1/01,,0,0,,,,DISCONTINUED
454,US,A1,US 2003/0051015 A1,067-332-004-608-980,2003-03-13,2003,US 95479601 A,2001-09-10,US 95479601 A,2001-09-10,System and method for distributing software,"
   The present disclosure relates to a system and method for distributing software. In one arrangement, the method comprises the steps of querying a user as to the needs of the user, receiving user responses to the query, characterizing the use of the user based upon the user responses, and suggesting software programs that may be beneficial to the user based upon the characterization of the use. 
",BROWN BRIAN J.;;WEBB STEVEN L.;;CULP JERLYN R.;;FARRELL MIKE A.;;BITNER KIMBERLY A.,BROWN BRIAN J;;WEBB STEVEN L;;CULP JERLYN R;;FARRELL MIKE A;;BITNER KIMBERLY A,HEWLETT-PACKARD COMPANY (2001-09-04);;HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2003-09-26),https://lens.org/067-332-004-608-980,Patent Application,yes,11,10,4,4,0,G06Q30/02;;G06Q30/02,G06Q30/02,709/222;;717/171;;717/172,0,0,,,,DISCONTINUED
455,US,A1,US 2018/0113844 A1,008-314-568-072-844,2018-04-26,2018,US 201615298985 A,2016-10-20,US 201615298985 A,2016-10-20,"COMPUTER SYSTEMS AND METHODS USING MULTIPLE NEUTRAL TYPE CHARACTERS AS DELIMITERS BETWEEN SEGMENTS IN STRUCTURED, MULTI-SEGMENT DATA VALUES","A computer system for processing bidirectional characters includes a processor and memory. An application stored in the memory includes instructions that are executable by the processor and memory and that are configured to determine an embedding direction and at least one of output, export or display data including characters using bidirectional code. While at least one of outputting, exporting or displaying the data, the instructions are configured to parse a multi-segment data value including a plurality of segments and a delimiter arranged between adjacent ones of the plurality of segments. The delimiter includes two or more neutral type characters that are arranged immediately adjacent to one another. The delimiter causes the bidirectional code to apply the embedding direction to the delimiters of the multi-segment data value to maintain relative ordering of adjacent ones of the segments in the multi-segment data value.",MICROSOFT TECHNOLOGY LICENSING LLC,OLSON APRIL MARIE;;FRANDSEN WILLIAM LESLIE;;KROETSCH KIMBERLY;;GUSTAFSON DUSTIN JAMES;;BROWN RUSSELL;;LEFOR TODD,MICROSOFT TECHNOLOGY LICENSING LLC (2016-10-19),https://lens.org/008-314-568-072-844,Patent Application,yes,5,0,2,2,0,G06F40/129;;G06F40/109;;G06F40/174;;G06F40/143;;G06F40/109;;G06F40/129;;G06F40/174;;G06F40/143,G06F40/143,,0,0,,,,ACTIVE
456,DE,A1,DE 10239792 A1,108-923-163-885-862,2003-04-03,2003,DE 10239792 A,2002-08-29,US 95479601 A,2001-09-10,"Software distribution method used for e.g. printer, involves providing software that is beneficial to user, based upon characterization of usage of printer","The usage of a peripheral device such as printer, is characterized based on responses of a user to transmitted query. Software that is beneficial to the user is provided, based upon characterization of usage of the printer. Independent claims are also included for the following: (1) software distribution device; and (2) program for software distribution.",HEWLETT PACKARD CO,BROWN BRAIN J;;WEBB STEVEN L;;CULP JERLYN R;;FARRELL MIKE A;;BITNER KIMBERLY A,"HEWLETT-PACKARD DEVELOPMENT CO., L.P., HOUSTON, TE (2005-05-25)",https://lens.org/108-923-163-885-862,Patent Application,no,0,2,4,4,0,G06Q30/02;;G06Q30/02,G06Q30/02,,0,0,,,,DISCONTINUED
457,US,B2,US 10204083 B2,020-015-408-433-377,2019-02-12,2019,US 201615298985 A,2016-10-20,US 201615298985 A,2016-10-20,"Computer systems and methods using multiple neutral type characters as delimiters between segments in structured, multi-segment data values","A computer system for processing bidirectional characters includes a processor and memory. An application stored in the memory includes instructions that are executable by the processor and memory and that are configured to determine an embedding direction and at least one of output, export or display data including characters using bidirectional code. While at least one of outputting, exporting or displaying the data, the instructions are configured to parse a multi-segment data value including a plurality of segments and a delimiter arranged between adjacent ones of the plurality of segments. The delimiter includes two or more neutral type characters that are arranged immediately adjacent to one another. The delimiter causes the bidirectional code to apply the embedding direction to the delimiters of the multi-segment data value to maintain relative ordering of adjacent ones of the segments in the multi-segment data value.",MICROSOFT TECHNOLOGY LICENSING LLC,OLSON APRIL MARIE;;FRANDSEN WILLIAM LESLIE;;KROETSCH KIMBERLY;;GUSTAFSON DUSTIN JAMES;;BROWN RUSSELL;;LEFOR TODD,MICROSOFT TECHNOLOGY LICENSING LLC (2016-10-19),https://lens.org/020-015-408-433-377,Granted Patent,yes,12,0,2,2,0,G06F40/129;;G06F40/109;;G06F40/174;;G06F40/143;;G06F40/109;;G06F40/129;;G06F40/174;;G06F40/143,G06F17/00;;G06F40/143,,5,0,,,"Ishida, Richard, “Creating HTML Pages in Arabic, Hebrew and Other Right-to-left Scripts (tutorial)”, In Publication of W3C, Mar. 22, 2005, 4 pages.;;Portaneri, et al., “Arabization of Graphical User Interfaces”, In Publication of John Wiley & Sons, Inc.—International User Interfaces, Aug. 2, 1996, 6 pages.;;“Supporting Right-to-Left Languages”, https://developer.apple.com/library/content/documentation/MacOSX/Conceptual/BPInternational/SupportingRight-To-LeftLanguages/SupportingRight-To-LeftLanguages.html, Retrieved Date: Sep. 26, 2016, 8 pages.;;Secosky, Jason, “A Sampler of What's New in Base SAS® 9.2”, In Proceedings of NorthEast SAS Users Group Conference, Sep. 14, 2008, pp. 1-15.;;Lefor, Todd, “Support for right-to-left languages: A primer on bidirectional text”, https://ax.help.dynamics.com/en/wiki/bidirectional-support/, Jul. 27, 2016, 9 pages.",ACTIVE
458,GB,A,GB 2382894 A,034-314-877-986-925,2003-06-11,2003,GB 0220324 A,2002-09-02,US 95479601 A,2001-09-10,Distributing software,"The present disclosure relates to a system and method for distributing software. In one arrangement, the method comprises the steps of querying a user as to the needs of the user (418, 518), receiving user responses to the query (420, 520), characterizing the use of the user based upon the user responses (422, 522), and providing software programs (424, 524) that may be beneficial to the user based upon the characterization of the use.",HEWLETT PACKARD CO,BROWN BRIAN J;;WEBB STEVEN L;;CULP JERLYN R;;FARRELL MIKE A;;BITNER KIMBERLY A,,https://lens.org/034-314-877-986-925,Patent Application,no,3,0,4,4,0,G06Q30/02;;G06Q30/02,G06Q30/02,G4A AUXB          UXB,2,0,,,"http://www.destinationcrm.com/articles/default.asp?ArticleID=1170, ""Steering the Sale"", Jason Compton, August 22 2001;;http://www.brightware.com/company/press_releases/article.asp?id=30&listpage=4, ""Firepond Releases SalesPerformerTM Suite 2.5"", 28 August 2001",DISCONTINUED
459,ES,T3,ES 2391826 T3,009-588-421-142-38X,2012-11-30,2012,ES 05722727 T,2005-01-28,US 54066104 P;;US 2005/0003525 W,2004-01-30,Polipéptidos con actividad de mejora celulolítica y polinucleótidos que los codifican,"Polipéptido aislado con actividad de mejora celulolítica, y con una secuencia de aminoácidos que tiene al menos 90%,y más preferiblemente al menos 95% de identidad con los aminoácidos 20 a 326 de la SEC ID nº: 2.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/009-588-421-142-38X,Granted Patent,no,0,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12N15/82;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
460,DE,D1,DE 69813212 D1,015-542-145-353-941,2003-05-15,2003,DE 69813212 T,1998-05-15,DK 146597 A;;US 85788697 A;;US 6289397 P;;US 6971997 P;;US 9809998 W,1997-05-16,VERFAHREN ZUR ERZEUGUNG VON PROTEINHYDROLYSATEN,"The present invention relates to methods of producing protein hydrolysates, comprising adding to a proteinaceous material one or more aminopeptidase(s) having glycine releasing properties and one or more additional proteases wherein the amount of glycine produced is greater than the amount of glycine produced by the one or more additional proteases alone under the same conditions.",NOVOZYMES BIOTECH INC;;NOVOZYMES AS;;ASAHI CHEMICAL IND,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;MATHIANSEN E;;KOFOD V;;FUJII MIKIO;;MARUMOTA CHIGUSA,,https://lens.org/015-542-145-353-941,Granted Patent,no,0,0,9,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;C12P21/06;;A23L27/21;;A21D2/267;;A23J3/34;;A21D2/268;;C12N9/48;;C12P21/06;;A23L27/21,A21D2/26;;A23J3/34;;A23L27/21;;C12N9/48;;C12P21/06,,0,0,,,,EXPIRED
461,EP,B1,EP 2301958 B1,034-896-702-405-052,2014-03-19,2014,EP 10180399 A,2005-01-28,EP 05722727 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPES DE LEON ALFREDO,,https://lens.org/034-896-702-405-052,Granted Patent,yes,2,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,3,0,,,"SALOHEIMO M ET AL: ""CDNA CLONING OF A TRICHODERMA REESEI CELLULASE AND DEMONSTRATION OFENDOGLUCANASE ACTIVITY BY EXPRESSION IN YEAST"", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 249, no. 2, October 1997 (1997-10), pages 584-591, XP002053367, ISSN: 0014-2956;;LEV SOPHIE ET AL: ""A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection."", PLANT CELL, vol. 15, no. 4, April 2003 (2003-04), pages 835-844, XP002415198, ISSN: 1040-4651;;GALAGAN J E ET AL: ""The genome sequence of the filamentous fungus Neurospora crassa"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 422, no. 6934, 24 April 2003 (2003-04-24), pages 859-868, XP002365858, ISSN: 0028-0836 -& DATABASE UniProt [Online] 1 June 2003 (2003-06-01), ""SubName: Full=Putative uncharacterized protein; SubName: Full=Related to cellulose binding protein CEL1;"", XP002618997, retrieved from EBI accession no. UNIPROT:Q873G1 Database accession no. Q873G1",ACTIVE
462,EP,A4,EP 1713825 A4,078-153-836-453-200,2007-07-11,2007,EP 05722727 A,2005-01-28,US 2005/0003525 W;;US 54066104 P,2004-01-30,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/078-153-836-453-200,Search Report,no,3,0,47,47,0,C11D3/38645;;C12P19/14;;C12Y302/01021;;C12N9/2445;;C07K14/37;;C11D3/38645;;C12N15/52;;C12N15/63;;C12N9/2437;;Y02E50/10;;C12N15/52;;C12N15/63;;C12N1/14;;C12N1/16;;C12N1/20;;C12N1/12;;C12Y302/01021;;C12N9/2445;;Y02E50/10;;C07K14/37;;C11D3/38645;;C12N9/2437;;C12P7/14;;C12P19/02;;C12P19/14;;C12P2201/00;;C12P2203/00,C07K14/37;;C07H21/04;;C11D3/386;;C11D7/42;;C12N1/21;;C12N9/42;;C12N15/74;;C12N15/82;;C12P7/06;;C12P7/10;;C12P21/06;;D21C1/00,,4,3,162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604,10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197,"SALOHEIMO M ET AL: ""CDNA CLONING OF A TRICHODERMA REESEI CELLULASE AND DEMONSTRATION OFENDOGLUCANASE ACTIVITY BY EXPRESSION IN YEAST"", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 249, no. 2, October 1997 (1997-10-01), pages 584 - 591, XP002053367, ISSN: 0014-2956;;LEV SOPHIE ET AL: ""A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection."", PLANT CELL, vol. 15, no. 4, April 2003 (2003-04-01), pages 835 - 844, XP002415198, ISSN: 1040-4651;;GALAGAN J E ET AL: ""The genome sequence of the filamentous fungus Neurospora crassa"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 422, no. 6934, 24 April 2003 (2003-04-24), pages 859 - 868, XP002365858, ISSN: 0028-0836;;See also references of WO 2005074647A2",ACTIVE
463,EP,B1,EP 2314605 B1,178-616-873-814-515,2014-03-19,2014,EP 10180304 A,2005-01-28,EP 05722727 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/178-616-873-814-515,Granted Patent,yes,2,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C11D3/386;;C07H21/04;;C07K14/37;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,4,0,,,"SALOHEIMO M ET AL: ""CDNA CLONING OF A TRICHODERMA REESEI CELLULASE AND DEMONSTRATION OFENDOGLUCANASE ACTIVITY BY EXPRESSION IN YEAST"", EUROPEAN JOURNAL OF BIOCHEMISTRY, BLACKWELL PUBLISHING, BERLIN, DE, vol. 249, no. 2, 1 October 1997 (1997-10-01), pages 584-591, XP002053367, ISSN: 0014-2956, DOI: DOI:10.1111/J.1432-1033.1997.00584.X;;LEV SOPHIE ET AL: ""A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection"", PLANT CELL, AMERICAN SOCIETY OF PLANT PHYSIOLOGISTS, ROCKVILLE, MD, US, vol. 15, no. 4, 1 April 2003 (2003-04-01), pages 835-844, XP002415198, ISSN: 1040-4651, DOI: DOI:10.1105/TPC.010546;;GALAGAN J E ET AL: ""The genome sequence of the filamentous fungus Neurospora crassa"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 422, no. 6934, 24 April 2003 (2003-04-24), pages 859-868, XP002365858, ISSN: 0028-0836, DOI: DOI:10.1038/NATURE01554 -& DATABASE UniProt [Online] 15 December 2003 (2003-12-15), ""SubName: Full=Putative uncharacterized protein;"", XP002618589, retrieved from EBI accession no. UNIPROT:Q7RV41 Database accession no. Q7RV41;;DATABASE UniProt [Online] 1 October 2000 (2000-10-01), ""SubName: Full=Related to cel1 protein;"", XP002618590, retrieved from EBI accession no. UNIPROT:Q9P3R7 Database accession no. Q9P3R7",ACTIVE
464,US,B2,US 7361495 B2,182-967-892-834-270,2008-04-22,2008,US 4612405 A,2005-01-28,US 4612405 A;;US 54066104 P,2004-01-30,Polypeptide from a cellulolytic fungus having cellulolytic enhancing activity,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,NOVOZYMES INC (2005-02-09),https://lens.org/182-967-892-834-270,Granted Patent,yes,6,37,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C12N9/42;;C07H21/04;;C07K14/37;;C11D3/386;;C12N1/21;;C12N9/14;;C12N15/74;;C12P7/06;;C12P21/06,435/209;;435/195;;530/371;;510/392,7,5,027-341-230-117-147;;162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604;;068-301-509-352-604,10.1111/j.1432-1033.1990.tb15664.x;;2176602;;10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197;;10.1038/nature01554;;12712197,"UniProt database search, Result 1, sequence alignment of SEQ ID No. 2 with the protein of record No. Q7RWN7, Galagan et al., ""The genome sequence of the filamentous fungus Neurospora crassa,"" Nature 422:859-868, 2003, searched Aug. 5, 2006.;;Result 1, Uniprot protein database search, alignment of Applicants' SEQ ID No. 2 with Uniprot database record No. Q7RWN7, protein from Neurospora crassa having cellulolytic activity, Galagan et al., Nature 422:859-868, 2003, search performed on Aug. 5, 2006.;;Altenschmidt et al., Evidence that enzymes of a novel aerobic 2-amino-benzoate metabolism in denitrifying Pseudomonas are coded on a small plasmid, Eur. J. Biochem., 1990, v. 194, pp. 647-653.;;Saloheimo et al., cDNA cloning of a Trichoderma reesei cellulase and demonstration of endoglucanase activity by expression in yeast, Eur. J. Biochemistry., 1997, v. 249, pp. 584-591.;;Lev Sophie et al., A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection, Plant Cell, 2003, v. 15, pp. 835-844.;;Galagan et al., The genome sequence of the filamentous fungus Neurospora crassa, Nature, 2003, v. 422, pp. 859-868.;;Database UniProt, Dec. 15, 2003 XP002415905, Accession No. Q7RWN7, Galagan et al., The Genome Sequence of the Filamentous Fungus Neurospora crassa, Nature 422:859-868, 2003.",ACTIVE
465,US,A1,US 2015/0024439 A1,064-012-577-643-984,2015-01-22,2015,US 201414500520 A,2014-09-29,US 201414500520 A;;US 201213650954 A;;US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides Having Cellulolytic Enhancing Activity And Nucleic Acids Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/064-012-577-643-984,Patent Application,yes,1,0,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C12P7/14;;C07H21/04;;C07K14/37;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P19/02;;C12P19/14;;C12P21/06,435/99;;435/209;;536/23.2;;435/320.1;;435/252.3;;435/162;;435/252.31;;435/252.35;;435/325;;435/419;;435/348;;435/254.11;;435/254.2;;435/254.21;;435/254.22;;435/254.23;;435/254.3;;435/254.7;;435/254.8;;435/254.5;;435/254.4;;435/254.6;;510/392,0,0,,,,INACTIVE
466,US,B2,US 8288140 B2,156-028-360-842-140,2012-10-16,2012,US 76018610 A,2010-04-14,US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO;;NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/156-028-360-842-140,Granted Patent,yes,7,6,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C12N9/96;;C07H21/04;;C07K14/37;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/02;;C12P21/06,435/188;;435/69.2;;536/23.74,17,6,000-757-614-552-999;;027-341-230-117-147;;162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604;;068-301-509-352-604,14538158;;10.1016/s0734-9750(97)00006-2;;10.1111/j.1432-1033.1990.tb15664.x;;2176602;;10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197;;10.1038/nature01554;;12712197,"Schulte et al., Uniprot/EMBL record No. Q9P3R7, GenBank record No. GI 9367248, Neurospora crassa DNA linkage group I BAC clone B24P7, 2000.;;Alignment of instant SEQ ID No. 3 with the polynucleotide of Schulte et al., Blast, http://blast.ncbi.nlm.nih.gov/Blast.cgi, performed on Jun. 6, 2011.;;Result 2 from a search of instant SEQ ID No. 3 in the Uniprot database, performed on Jun. 3, 2011.;;Bhat et al., Cellulose degrading enzymes and their potential industrial applications, Biotechnology Advances, vol. 15, Nos. 3/4 pp. 583-620, 1997.;;Altenschmidt et al., Evidence that enzymes of a novel aerobic 2-amino-benzoate metabolism in denitrifying Pseudomonas are coded on a small plasmid, Eur. J. Biochem., 1990, v. 194, pp. 647-653.;;Saloheimo et al., cDNA cloning of a Trichoderma reesei cellulase and demonstration of endoglucanase activity by expression in yeast, Eur. J. Biochemistry., 1997, v. 249, pp. 584-591.;;Lev Sophie et al., A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection, Plant Cell, 2003, v. 15, pp. 835-844.;;Galagan et al., The genome sequence of the filamentous fungus Neurospora crassa, Nature, 2003, v. 422, pp. 859-868.;;Galagan et al., "":The genome sequence of the filamentous fungus Neurospora crassa,"" Nature, vol. 422, No. 6934, 2003, SUBNAME: Full=Putative uncharacterized protein: XP002618589, EBI Accession No. UNIPROT: Q7RV41, Database accession No. Q7RV41.;;WO 2004/031378 A2 (Novozymes AS [DK]) Apr. 15, 2004, ""GH-61 coding sequence,"" XP002620997, EBI Accession No. GSN: ADM97934, Database accession No. ADM97934.;;Galagan et al., ""The genome sequence of the filamentous fungus Neurospora crassa,"" Nature, vol. 422, No. 6934, 2003, Uniprot Dec. 15, 2003 XP002415905, UNIPROT accession No. Q7RWN7.;;Galagan et al., ""The genome sequence of the filamentous fungus Neurospora crassa,"" Nature, vol. 422, No. 6934, 2003, Subname: Full=Putative uncharacterized protein: XP002619301, EBI accession No. UNIPROT: Q7SCJ5, Database accession No. Q7SCJ5.;;WO 2004/031378 A2 (Novozymes AS [DK]) Apr. 15, 2004, ""GH-61 coding sequence,"" XP002618999, EBI Accession No. GSN: ADM97932, Database accession No. ADM97932.;;WO 2004/031378 A2 (Novozymes AS [DK]) Apr. 15, 2004, ""GH-61 coding sequence,"" XP002618779, EBI Accession No. GSN: ADM97936, Database accession No. ADM97936.;;WO 2004/031378 A2 (Novozymes AS [DK]) Apr. 15, 2004, ""GH-61 coding sequence,"" XP002618998, EBI Accession No. GSN: ADM97937, Database accession No. ADM97937.;;Galagan et al., ""The genome sequence of the filamentous fungus Neurospora crassa,"" Nature, vol. 422, No. 6934, 2003, SUBNAME: Full=Putative uncharacterized protein, Subname: Full=Related to cellulose binding protein CEL1; XP002618997, EBI accession No. UNIPROT: Q873G1, Database accession No. Q873G1.;;Galagan et al., ""The genome sequence of the filamentous fungus Neurospora crassa,"" Nature, vol. 422, No. 6934, 2003, Database UniProt [Online], Oct. 1, 2000, ""Subname: Full=Related to cell protein;"", XP002618590, EBI accession No. UNIPROT: Q9P3R7, Database accession No. Q9P3R7.",INACTIVE
467,US,A1,US 2010/0197556 A1,199-058-734-517-324,2010-08-05,2010,US 76018610 A,2010-04-14,US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/199-058-734-517-324,Patent Application,yes,1,2,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C11D3/386;;C07H21/04;;C07K14/37;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06,510/321;;435/200;;510/392;;510/393;;510/320,0,0,,,,INACTIVE
468,US,A1,US 2011/0293073 A1,072-301-154-470-664,2011-12-01,2011,US 78789810 A,2010-05-26,US 78789810 A,2010-05-26,UNIVERSAL DENTAL X-RAY SENSOR HOLDER,"A dental x-ray sensor holder includes at least two clamping faces wherein at least one of the faces includes at least one and preferably a plurality of resiliently deformable gripping protrusions. The clamping faces are positioned in a moveable, spaced opposing relation, such that the faces may be physically moved together to physically impinge the x-ray sensor therebetween.",FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,,https://lens.org/072-301-154-470-664,Patent Application,yes,4,1,2,2,0,A61B6/512;;A61B6/512,A61B6/14,378/168,0,0,,,,ACTIVE
469,DK,T3,DK 2314605 T3,014-705-506-868-746,2014-06-16,2014,DK 10180304 T,2005-01-28,US 54066104 P;;EP 05722727 A,2004-01-30,"Polypeptider med cellulolytisk forøgende aktivitet og polynukleotider, der koder for disse",,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/014-705-506-868-746,Granted Patent,no,0,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C11D3/386;;C07H21/04;;C07K14/37;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
470,CA,A1,CA 2598183 A1,066-354-046-354-959,2006-08-24,2006,CA 2598183 A,2006-02-15,US 65355905 P;;US 2006/0005435 W,2005-02-16,UNIVERSAL DENTAL X-RAY SENSOR HOLDER,,DENTSPLY INT INC,BROWN KIMBERLY CLEMENTZ;;CHENG CUNJIANG;;FALENDYSZ GREGORY;;SUTRINA THOMAS ALBERT;;FENSKE LAWRENCE JON;;MILLER JOHN AARON,,https://lens.org/066-354-046-354-959,Patent Application,no,0,0,11,11,0,A61B6/4283;;G03B42/042;;A61B6/512,A61B6/14;;G03B42/04,,0,0,,,,ACTIVE
471,ES,T3,ES 2469874 T3,131-569-889-863-579,2014-06-20,2014,ES 10180389 T,2005-01-28,US 54066104 P,2004-01-30,Polipéptidos con actividad de mejora celulolítica y polinucleótidos que los codifican,"Polipéptido aislado con actividad de mejora celulolítica, y con una secuencia de aminoácidos que tiene al menos 85%, incluso más preferiblemente al menos 90%, de la forma más preferible al menos 95%, e incluso de forma más preferiblemente al menos 97% de identidad con los aminoácidos 20 a 258 de la SEC ID nº: 6.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPES DE LEON ALFREDO,,https://lens.org/131-569-889-863-579,Granted Patent,no,0,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C11D3/386;;C07H21/04;;C07K14/37;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
472,US,B2,US 10280201 B2,160-640-457-367-062,2019-05-07,2019,US 201715689443 A,2017-08-29,US 201715689443 A;;US 201615188731 A;;US 201414500520 A;;US 201213650954 A;;US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/160-640-457-367-062,Granted Patent,yes,15,1,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C12N9/42;;C07H21/04;;C07K14/37;;C11D3/386;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N1/21;;C12N15/52;;C12N15/63;;C12N15/74;;C12P7/06;;C12P7/14;;C12P19/02;;C12P19/14;;C12P21/06,,20,5,000-757-614-552-999;;027-341-230-117-147;;162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604,14538158;;10.1016/s0734-9750(97)00006-2;;10.1111/j.1432-1033.1990.tb15664.x;;2176602;;10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197,"Anonymous, Genseq, Access No. ADM97934, 2004.;;Bhat et al., Cellulose degrading enzymes and their potential industrial applications, Biotechnology Advances, vol. 15, Nos. 3/4 pp. 583-620, 1997.;;Galagan et al., 2000, Uniprot, Access No. Q9P3R7.;;Galagan et al., 2003, Uniprot Access No. Q7RV41.;;Galagan et al., 2003, Uniprot Access No. Q7SCJ5.;;Schnorr et al., 2004, EBI Access No. ADM97932.;;Schnorr et al., 2004, EBI Access No. ADM97936.;;Schnorr et al., 2004, GSP Access No. ADM97937.;;Galagan et al., 2003, Uniprot Access No. Q873G1.;;Altenschmidt et al., Evidence that enzymes of a novel aerobic 2-amino-benzoate metabolism in denitrifying Pseudomonas are coded on a small plasmid, Eur. J. Biochem., 1990, v. 194, pp. 647-653.;;Saloheimo et al., cDNA cloning of a trichoderma reesei cellulase and demonstration of endoglucanase activity by expression in yeast, Eur. J. Biochemistry., 1997, v. 249, pp. 584-591.;;Lev Sophie et al., A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection, Plant Cell, 2003, v. 15, pp. 835-844.;;Galagan et al., The genome sequence of the filamentous fungus Neurospora crassa, Nature, 2003, v. 422, pp. 859-868.;;DATABASE UNIPROT 1 January 1900 (1900-01-01), GALAGAN J E, ET AL: ""HYPOTHETICAL PROTEIN NCU08760.1"", XP002415905, Database accession no. Q7RWN7;;Brown—Curr Protocols Molec Biology 2.10.1-2.10.16, (1993).;;Schulte et al, 2003, GenBank Access No. BX842681.;;Schulte et al., 2011, GenCore, SEQ ID No. 3, U.S. Appl. No. 12/760,186, Accession No. Q9P3R7.;;BLAST, Basic Local Alignment Search Tool, (Jul. 13, 2009).;;Morgenstern et al., Sep. 12, 2014, Briefings in Functional Genomics, pp. 1-11.;;Gencore, U.S. Appl. No. 12/760,186, 2011, SEQ IDs.",INACTIVE
473,CN,A,CN 104726431 A,163-127-798-253-970,2015-06-24,2015,CN 201410683392 A,2005-01-28,US 54066104 P;;CN 200580010730 A,2004-01-30,Polypeptides Having Cellulolytic Enhancing Activity And Nucleic Acids Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFRED,,https://lens.org/163-127-798-253-970,Patent Application,no,3,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C12N9/42;;C07H21/04;;C07K14/37;;C11D3/386;;C11D7/42;;C12N1/21;;C12N15/56;;C12N15/74;;C12P7/06;;C12P19/14;;C12P21/06,,1,1,162-096-376-612-739,10.1111/j.1432-1033.1997.00584.x;;9370370,"MARKKU SALOHEIMO, ET AL.: ""cDNA cloning of a Trichoderma reesei cellulase and demonstration of endoglucanase activity by expression in yeast"", 《EUR. J. BIOCHEM.》",ACTIVE
474,US,A1,US 2018/0072779 A1,014-118-655-857-032,2018-03-15,2018,US 201715689443 A,2017-08-29,US 201715689443 A;;US 201615188731 A;;US 201414500520 A;;US 201213650954 A;;US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides Having Cellulolytic Enhancing Activity And Nucleic Acids Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/014-118-655-857-032,Patent Application,yes,0,0,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N1/21;;C12N9/42;;C12N15/52;;C12N15/63;;C12N15/74;;C12P7/06;;C12P7/14;;C12P19/02;;C12P19/14;;C12P21/06,,0,0,,,,INACTIVE
475,EP,B1,EP 2305702 B1,067-671-397-940-162,2014-03-19,2014,EP 10180389 A,2005-01-28,EP 05722727 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPES DE LEON ALFREDO,,https://lens.org/067-671-397-940-162,Granted Patent,yes,2,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C11D3/386;;C07H21/04;;C07K14/37;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,3,0,,,"SALOHEIMO M ET AL: ""CDNA CLONING OF A TRICHODERMA REESEI CELLULASE AND DEMONSTRATION OFENDOGLUCANASE ACTIVITY BY EXPRESSION IN YEAST"", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 249, no. 2, October 1997 (1997-10), pages 584-591, XP002053367, ISSN: 0014-2956;;LEV SOPHIE ET AL: ""A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection."", PLANT CELL, vol. 15, no. 4, April 2003 (2003-04), pages 835-844, XP002415198, ISSN: 1040-4651;;GALAGAN J E ET AL: ""The genome sequence of the filamentous fungus Neurospora crassa"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 422, no. 6934, 24 April 2003 (2003-04-24), pages 859-868, XP002365858, ISSN: 0028-0836 -& DATABASE UniProt [Online] 15 December 2003 (2003-12-15), ""SubName: Full=Putative uncharacterized protein;"", XP2618589, retrieved from EBI accession no. UNIPROT:Q7RV41 Database accession no. Q7RV41",ACTIVE
476,DK,T3,DK 2301958 T3,083-447-987-023-165,2014-06-16,2014,DK 10180399 T,2005-01-28,US 54066104 P;;EP 05722727 A,2004-01-30,"Polypeptider med cellulolytisk forøgende aktivitet og polynukleotider, der koder for disse",,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPES DE LEON ALFREDO,,https://lens.org/083-447-987-023-165,Granted Patent,no,0,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
477,EP,B1,EP 1848340 B1,094-759-988-339-796,2014-05-07,2014,EP 06720799 A,2006-02-15,US 2006/0005435 W;;US 65355905 P,2005-02-16,UNIVERSAL DENTAL X-RAY SENSOR HOLDER,,DENTSPLY INT INC,FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,,https://lens.org/094-759-988-339-796,Granted Patent,yes,7,0,11,11,0,A61B6/4283;;G03B42/042;;A61B6/512,A61B6/14;;G03B42/04,,1,0,,,"JOSEPH A. BLAES: ""Eezee-Grip  Digital Sensor Holder by Dentsply Rinn"" DENTAL ECONOMICS, [Online] November 2005 (2005-11), XP002381053 Retrieved from the Internet: URL:http://de.pennnet.com/articles/article _display.cfm?Section=ARCHI&C=Dept&ARTICLE_ ID=242750&KEYWORDS=Isolite%20&p=54> [retrieved on 2006-05-16]",ACTIVE
478,EP,B1,EP 2305703 B1,098-171-822-086-977,2014-03-12,2014,EP 10180414 A,2005-01-28,EP 05722727 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/098-171-822-086-977,Granted Patent,yes,2,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,3,0,,,"SALOHEIMO M ET AL: ""CDNA CLONING OF A TRICHODERMA REESEI CELLULASE AND DEMONSTRATION OFENDOGLUCANASE ACTIVITY BY EXPRESSION IN YEAST"", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 249, no. 2, October 1997 (1997-10), pages 584-591, XP002053367, ISSN: 0014-2956;;LEV SOPHIE ET AL: ""A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection."", PLANT CELL, vol. 15, no. 4, April 2003 (2003-04), pages 835-844, XP002415198, ISSN: 1040-4651;;GALAGAN J E ET AL: ""The genome sequence of the filamentous fungus Neurospora crassa"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 422, no. 6934, 24 April 2003 (2003-04-24), pages 859-868, XP002365858, ISSN: 0028-0836 -& DATABASE UniProt [Online] 15 December 2003 (2003-12-15), ""SubName: Full=Putative uncharacterized protein;"", XP002619301, retrieved from EBI accession no. UNIPROT:Q7SCJ5 Database accession no. Q7SCJ5",ACTIVE
479,US,A1,US 2009/0141866 A1,111-537-165-979-590,2009-06-04,2009,US 99874507 A,2007-11-30,US 99874507 A,2007-11-30,Universal dental x-ray sensor holder,"A dental x-ray sensor holder includes at least two clamping faces wherein at least one of the faces includes at least one and preferably a plurality of resiliently deformable gripping protrusions. The clamping faces are positioned in a moveable, spaced opposing relation, such that the faces may be physically moved together to physically impinge the x-ray sensor therebetween.",FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,,https://lens.org/111-537-165-979-590,Patent Application,yes,10,6,1,1,0,G03B42/042;;G03B42/042,G03C5/16,378/170,0,0,,,,DISCONTINUED
480,DE,D1,DE 69734644 D1,103-731-484-110-533,2005-12-22,2005,DE 69734644 T,1997-10-03,US 72688096 A;;US 75753496 A;;US 9717977 W,1996-10-04,CARBOXYPEPTIDASEN AUS ASPERGILLUS ORYZAE UND DIESE KODIERENDE NUKLEINSÄUREN,"The present invention relates to polypeptides having carboxypeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to methods of obtaining protein hydrolysates useful as flavor improving agents.",NOVOZYMES INC;;NOVOZYMES AS,BLINKOVSKY ALEXANDER;;BERKA RANDY;;REY MICHAEL;;GOLIGHTLY ELIZABETH;;KLOTZ ALAN;;MATHISEN ERIK;;DAMBMANN CLAUS;;BROWN KIMBERLY,,https://lens.org/103-731-484-110-533,Granted Patent,no,0,0,9,30,0,A23J3/341;;A23J3/346;;C12N9/48;;A23L27/24,C12N15/09;;A23J3/34;;A23L27/24;;C12N1/21;;C12N9/48;;C12N15/00;;C12N15/57;;C12R1/19;;C12R1/66,,0,0,,,,EXPIRED
481,EP,A1,EP 2305702 A1,147-731-549-739-188,2011-04-06,2011,EP 10180389 A,2005-01-28,EP 05722727 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPES DE LEON ALFREDO,,https://lens.org/147-731-549-739-188,Patent Application,yes,94,0,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C11D3/386;;C07H21/04;;C07K14/37;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,142,106,162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604;;014-625-826-302-514;;127-544-305-672-969;;076-132-223-936-79X;;118-711-156-754-483;;044-160-688-806-618;;058-145-297-843-203;;038-383-743-124-048;;082-474-862-036-218;;009-304-049-487-981;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;054-167-555-136-715;;046-475-261-047-666;;023-969-505-910-047;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;017-950-663-195-977;;003-307-199-216-170;;060-909-037-461-654;;034-499-320-202-349;;010-606-868-765-729;;058-313-563-307-746;;009-052-884-271-430;;168-467-332-279-864;;023-207-730-709-584;;044-918-409-011-81X;;000-743-569-588-265;;043-692-295-433-161;;001-807-171-352-291;;053-608-860-045-291;;017-893-128-543-273;;122-107-077-421-078;;056-172-488-299-694;;015-652-210-164-846;;130-374-497-909-295;;036-168-690-647-51X;;031-015-979-474-454;;021-946-971-259-170;;024-708-797-947-714;;015-065-490-448-969;;013-458-224-516-628;;008-437-576-847-072;;014-774-168-809-047;;001-824-374-248-456;;175-295-822-939-63X;;045-548-779-820-017;;029-940-225-165-635;;031-097-124-288-463;;050-772-251-736-949;;090-877-130-256-158;;039-117-124-686-257;;114-153-099-971-73X;;058-030-884-026-400;;014-708-690-338-262;;000-371-756-809-284;;136-261-375-157-758;;056-201-471-905-934;;023-907-179-348-058;;022-715-862-716-318;;001-150-252-595-427;;066-958-649-977-052;;046-589-579-918-068;;062-094-540-176-015;;028-862-168-091-90X;;009-052-884-271-430,10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;10.1201/9780203752456-10;;10.1016/s0065-2164(08)70598-7;;10.1007/3-540-49194-5_9;;10533436;;10.1016/0141-0229(95)00157-3;;10.1093/bioinformatics/5.2.151;;2720464;;pmc393452;;6572363;;10.1073/pnas.80.3.726;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;10.1016/1046-5928(91)90057-p;;1821793;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1016/s0958-1669(05)80029-1;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1016/0960-8524(94)90214-3;;10.1007/bf02920289;;10.1351/pac198759020257;;10.1016/0003-2697(72)90301-6;;5031119;;10.1016/0014-5793(82)81092-2;;10.1016/0014-5793(85)81260-6;;10.1016/s0021-9258(18)69254-3;;3093475;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-#;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-;;11930943;;10.1016/s0168-1656(97)00073-4;;9246788;;3843705;;10.1016/0003-2697(85)90442-7;;10514248;;10.1021/bp990109e;;10.1016/0141-0229(80)90063-0;;10.1016/0141-0229(85)90114-0;;10.1002/bit.260250106;;18548538;;10.1007/bf02786945;;10.1021/bp990110d;;10514251;;pmc120791;;10.1128/mmbr.66.3.506-577.2002;;12209002;;12172602;;10.1007/s00253-002-1046-0;;10.1016/0032-9592(95)80001-8;;18576101;;10.1007/bf02920444;;15286988;;10.1002/bit.20156;;10.2166/wst.1997.0573;;10.1016/s0961-9534(97)00020-2;;10.1007/bf02918984;;8391777;;9572962;;10.1128/aem.64.5.1852-1859.1998;;pmc106241;;18600763;;10.1002/bit.260380311;;10.1002/(sici)1097-0290(19980420)58:2/3<204::aid-bit13>3.0.co;2-c;;10191391;;17791346;;10.1126/science.267.5195.240;;pmc168273;;10.1128/aem.62.12.4465-4470.1996;;8953718;;3141761;;10.1128/mr.52.3.305-317.1988;;pmc373146;;10.1201/9780203752456-7;;10.1046/j.1432-1327.1999.nomen.x;;10491110;;8462873;;10.1016/0378-1119(93)90328-z;;7763981;;10.1271/bbb.57.1095;;10.1021/ba-1979-0181.ch014;;10.1002/1522-2683()22:5<919::aid-elps919>3.0.co;2-u;;10.1002/1522-2683()22:5<919::aid-elps919>3.3.co;2-l;;11332760;;10.1016/0166-0934(92)90168-d;;1322932;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;pmc50453;;1438297;;10.1073/pnas.89.22.10915;;9051728;;10.1093/protein/10.1.1;;10.1093/bioinformatics/17.9.847;;11590104;;12230035;;10.1093/bib/3.3.265;;pmc135756;;12136088;;10.1093/nar/gkf436;;10.1007/s002940050512;;10654091;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/0003-2697(72)90301-6;;5031119,"SALOHEIMO M ET AL: ""CDNA CLONING OF A TRICHODERMA REESEI CELLULASE AND DEMONSTRATION OFENDOGLUCANASE ACTIVITY BY EXPRESSION IN YEAST"", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 249, no. 2, October 1997 (1997-10-01), pages 584 - 591, XP002053367, ISSN: 0014-2956;;LEV SOPHIE ET AL: ""A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection."", PLANT CELL, vol. 15, no. 4, April 2003 (2003-04-01), pages 835 - 844, XP002415198, ISSN: 1040-4651;;GALAGAN J E ET AL: ""The genome sequence of the filamentous fungus Neurospora crassa"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 422, no. 6934, 24 April 2003 (2003-04-24), pages 859 - 868, XP002365858, ISSN: 0028-0836;;HENRISSAT B.: ""A classification of glycosyl hydrolases based on amino-acid sequence similarities"", BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT B.; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BIOCHEM. J., vol. 316, 1996, pages 695 - 696;;HSU, T.-A.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Pretreatment of biomass"", pages: 179 - 212;;GHOSH, P.; SINGH, A.: ""Physicochemical and biological treatments for enzymatic/microbial conversion of lignocellulosic biomass"", ADV. APPL. MICROBIOL., vol. 39, 1993, pages 295 - 333;;MCMILLAN, J. D.: ""Enzymatic Conversion of Biomass for Fuels Production"", 1994, AMERICAN CHEMICAL SOCIETY, article ""Pretreating lignocellulosic biomass: a review"";;GONG, C. S.; CAO, N. J.; DU, J.; TSAO, G. T.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Ethanol production from renewable resources"", pages: 207 - 241;;OLSSON, L.; HAHN-HAGERDAL, B.: ""Fermentation of lignocellulosic hydrolysates for ethanol production"", ENZ. MICROB. TECH., vol. 18, 1996, pages 312 - 331;;VALLANDER, L.; ERIKSSON, K.-E. L.: ""Production of ethanol from lignocellulosic materials: State of the art"", ADV. BIOCHEM. ENG.LBIOTECHNOL., vol. 42, 1990, pages 63 - 95;;HIGGINS, CABIOS, vol. 5, 1989, pages 151 - 153;;WATERMAN ET AL., ADV. MATH., vol. 20, 1976, pages 367;;WILBUR; LIPMAN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 80, 1983, pages 726 - 730;;J. SAMBROOK; E.F. FRITSCH; T. MANIATUS: ""Molecular Cloning, A Laboratory Manual, 2d edition,"", 1989, COLD SPRING HARBOR;;BOLTON; MCCARTHY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 48, 1962, pages 1390;;H. NEURATH; R.L. HILL: ""The Proteins"", 1979, ACADEMIC PRESS;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEM., vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;INNIS ET AL.: ""PCR: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;SMITH ET AL., JOURNAL OF MOLECULAR BIOLOGY, vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETTERS, vol. 309, 1992, pages 59 - 64;;VILLA-KAMAROFF ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 80, 1983, pages 21 - 25;;""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOLECULAR CELLULAR BIOLOGY, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOLECULAR GENERAL GENETICS, vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZIN, JOURNAL OF BACTERIOLOGY, vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, JOURNAL OF MOLECULAR BIOLOGY, vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER; THORNE, JOURNAL OF BACTERIOLOGY, vol. 169, 1987, pages 5771 - 5278;;HAWKSWORTH ET AL.: ""Ainsworth and Bisby's Dictionary of The Fungi, 8th edition,"", 1995, CAB INTERNATIONAL, UNIVERSITY PRESS;;SKINNER, F.A., PASSMORE, S.M., AND DAVENPORT, R.R.,: ""Soc. App. Bacteriol. Symposium Series"", 1980;;YELTON ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1984, pages 1470 - 1474;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;ABELSON, J.N. AND SIMON, M.I.,: ""Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., article BECKER AND GUARENTE: ""Guide to Yeast Genetics and Molecular Biology"", pages: 182 - 187;;ITO ET AL., JOURNAL OF BACTERIOLOGY, vol. 153, 1983, pages 163;;HINNEN ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1920;;J.-C. JANSON AND LARS RYDEN: ""Protein Purification"", 1989, VCH PUBLISHERS;;TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MO. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS; CORUZZI, ANN. REV. GENET., vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., JOURNAL OF PLANT PHYSIOLOGY, vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOLOGY, vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOLECULAR BIOLOGY, vol. 26, 1994, pages 85 - 93;;KAGAYA ET AL., MOLECULAR AND GENERAL GENETICS, vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOLECULAR BIOLOGY, vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIOLTECHNOLOGY, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOLECULAR BIOLOGY, vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT JOURNAL, vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CURRENT OPINION BIOTECHNOLOGY, vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH ET AL., PLANT MOLECULAR BIOLOGY, vol. 21, 1993, pages 415 - 428;;WISELOGEL ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 1 05 - 118;;WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16;;LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24/25, 1990, pages 695 - 719;;MOSIER ET AL.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Recent Progress in Bioconversion of Lignocellulosics"", pages: 23 - 40;;BENNETT, J.W. AND LASURE, L.: ""More Gene Manipulations in Fungi"", 1991, ACADEMIC PRESS;;BAILEY, J.E.; OLLIS, D.F.: ""Biochemical Engineering Fundamentals"", 1986, MCGRAW-HILL BOOK COMPANY;;GHOSE, PURE AND APPL. CHEM., vol. 59, 1987, pages 257 - 268;;LEVER ET AL., ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279;;VAN TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156;;VAN TILBEURGH; CLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288;;HIMMEL ET AL., J. BIOL. CHEM., vol. 261, 1986, pages 12948 - 12955;;VENTURI ET AL., J. BASIC MICROBIOL., vol. 42, 2002, pages 55 - 66;;BRIGHAM ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 119 - 141;;LEE, JOURNAL OF BIOTECHNOLOGY, vol. 56, 1997, pages 1 - 24;;P.K. SMITH ET AL., ANAL. BIOCHEM., vol. 150, 1985, pages 76;;LYND, L. R.; WYMAN, C. E.; GERNGROSS, T. U., BIOCOMMODITY ENGINEERING, BIOTECHNOL. PROG., vol. 15, 1999, pages 777 - 793;;PHILIPPIDIS, G. P.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Cellulose bioconversion technology"", pages: 179 - 212;;RYU, D. D. Y.; MANDELS, M.: ""Cellulases: biosynthesis and applications"", ENZ. MICROB. TECHNOL., vol. 2, 1980, pages 91 - 102;;GUSAKOV, A. V.; SINITSYN, A. P.: ""Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical model for a batch reactor process"", ENZ. MICROB. TECHNOL., vol. 7, 1985, pages 346 - 352;;RYU, S. K.; LEE, J. M.: ""Bioconversion of waste cellulose by using an attrition bioreactor"", BIOTECHNOL. BIOENG., vol. 25, 1983, pages 53 - 65;;GUSAKOV, A. V.; SINITSYN, A. P.; DAVYDKIN, I. Y.; DAVYDKIN, V. Y.; PROTAS, O. V.: ""Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field"", APPL. BIOCHEM. BIOTECHNOL., vol. 56, 1996, pages 141 - 153;;SHEEHAN, J.; HIMMEL, M.: ""Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol"", BIOTECHNOL. PROG., vol. 15, 1999, pages 817 - 827;;LYND, L. R.; WEIMER, P. J.; VAN ZYL, W. H.; PRETORIUS, I. S.: ""Microbial cellulose utilization: Fundamentals and biotechnology"", MICROBIOL. MOL. BIOL. REVIEWS, vol. 66, 2002, pages 506 - 577;;SILVEIRA, M. M.; JONAS, R.: ""The biotechnological production of sorbitol"", APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 400 - 408;;NIGAM, P.; SINGH, D.: ""Processes for fermentative production of xylitol - a sugar substitute"", PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124;;EZEJI, T. C.; QURESHI, N.; BLASCHEK, H. P.: ""Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping"", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603;;CHEN, R.; LEE, Y. Y.: ""Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass"", APPL. BIOCHEM. BIOTECHNOL., vol. 63-65, 1997, pages 435 - 448;;RICHARD, A.; MARGARITIS, A.: ""Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515;;KATAOKA, N.; A. MIYA; K. KIRIYAMA: ""Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria"", WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 41 - 47;;GUNASEELAN V.N., BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114;;CHEN, Z.; HO, N. W. Y.: ""Cloning and improving the expression of Pichia stipitis xylose reductase gene in Saccharomyces cerevisiae"", APPL. BIOCHEM. BIOTECHNOL., vol. 39-40, 1993, pages 135 - 147;;HO, N. W. Y.; CHEN, Z; BRAINARD, A. P.: ""Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose"", APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 1852 - 1859;;BEALL, D. S.; OHTA, K.; INGRAM, L. 0.: ""Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli"", BIOTECH. BIOENG., vol. 38, 1991, pages 296 - 303;;INGRAM, L. 0.; GOMES, P. F.; LAI, X.; MONIRUZZAMAN, M.; WOOD, B. E.; YOMANO, L. P.; YORK, S. W.: ""Metabolic engineering of bacteria for ethanol production"", BIOTECHNOL. BIOENG., vol. 58, 1998, pages 204 - 214;;ZHANG, M.; EDDY, C.; DEANDA, K.; FINKELSTEIN, M.; PICATAGGIO, S.: ""Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis"", SCIENCE, vol. 267, 1995, pages 240 - 243;;DEANDA, K.; ZHANG, M.; EDDY, C.; PICATAGGIO, S.: ""Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering"", APPL. ENVIRON. MICROBIOL., vol. 62, 1996, pages 4465 - 4470;;K. JACQUES, T.P. LYONS AND D.R. KELSALL,: ""The Alcohol Textbook"", 1999, NOTTINGHAM UNIVERSITY PRESS;;WONG, K.K.Y.; TAN, L. U. L.; SADDLER, J. N.: ""Multiplicity of 13-1 A-xylanase in microorganisms: Functions and applications"", MICROBIOL. REV., vol. 52, 1988, pages 305 - 317;;TENKANEN, M.; POUTANEN, K.: ""Xylans and Xylanases"", 1992, ELSEVIER, article ""Significance of esterases in the degradation of xylans"", pages: 203 - 212;;COUGHLAN, M. P.; HAZLEWOOD, G. P., HEMICELLULOSE AND HEMICELLULASES, 1993;;BRIGHAM, J. S.; ADNEY, W. S.; HIMMEL, M. E.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Hemicellulases: Diversity and applications"", pages: 119 - 141;;""Enzyme Nomenclature"", 1992, ACADEMIC PRESS;;EUR. J. BIOCHEM., vol. 223, 1994, pages 1 - 5;;EUR. J. BIOCHEM., vol. 232, 1995, pages 1 - 6;;EUR. J. BIOCHEM., vol. 237, 1996, pages 1 - 5;;EUR. J. BIOCHEM., vol. 250, 1997, pages 1 - 6;;EUR. J. BIOCHEM., vol. 264, 1999, pages 610 - 650;;KOAZE ET AL., AGR. BIOL. CHEM. JAPAN, vol. 28, 1964, pages 216;;YOSHIDA, J. AGR. CHEM. SOC. JAPAN, vol. 28, 1954, pages 66;;HAYASHIDA ET AL., AGRIC. BIOL. CHEM., vol. 42, 1977, pages 927 - 933;;A.J. BARRETT, N.D. RAWLINGS AND J.F. WOESSNER,: ""Handbook of Proteolytic Enzymes"", 1998, ACADEMIC PRESS;;BERKA ET AL., GENE, vol. 96, 1990, pages 313;;BERKA ET AL., GENE, vol. 125, 1993, pages 195 - 198;;GOMI ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 57, 1993, pages 1095 - 1100;;DARTOIS ET AL., BIOCHEMICA ET BIOPHYSICA ACTA, vol. 1131, 1993, pages 253 - 360;;MONTENECOURT; EVELEIGH, ADV. CHEM. SER., vol. 181, 1979, pages 289 - 301;;MALONE ET AL., ELECTROPHORESIS, vol. 22, 2001, pages 919 - 932;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;ALTSCHUL, J. MOL. BIOL., vol. 215, 1990, pages 403 - 410;;HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 10915 - 10919;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;ZDOBNOV; APWEILER, BIOINFORMATICS, vol. 17, 2001, pages 847 - 848;;SIGRIST ET AL., BRIEF BIOINFORM., vol. 3, 2002, pages 265 - 274;;KATOH ET AL., NUCLEIC ACIDS RESEARCH, vol. 30, 2002, pages 3059;;CHRISTENSEN ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 1419 - 1422;;CUMMINGS ET AL., CURRENT GENETICS, vol. 36, 1999, pages 371 - 82;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;LEVER, M.: ""A new reaction for colorimetric determination of carbohydrates"", ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279",ACTIVE
482,DK,T3,DK 2305703 T3,036-247-150-190-403,2014-06-16,2014,DK 10180414 T,2005-01-28,US 54066104 P;;EP 05722727 A,2004-01-30,"Polypeptider med cellulolytisk forøgende aktivitet og polynukleotider, der koder for disse",,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/036-247-150-190-403,Granted Patent,no,0,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
483,DK,T3,DK 1848340 T3,041-108-229-635-509,2014-06-30,2014,DK 06720799 T,2006-02-15,US 65355905 P;;US 2006/0005435 W,2005-02-16,UNIVERSALDENTALRØNTGENSENSORHOLDER,,DENTSPLY INT INC,FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,,https://lens.org/041-108-229-635-509,Granted Patent,no,0,0,11,11,0,A61B6/4283;;G03B42/042;;A61B6/512,A61B6/14;;G03B42/04,,0,0,,,,ACTIVE
484,US,B2,US 7741466 B2,055-970-184-232-538,2010-06-22,2010,US 5319308 A,2008-03-21,US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/055-970-184-232-538,Granted Patent,yes,5,9,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07H21/04;;C07K14/37;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/02;;C12P21/06,536/23.7;;536/23.2;;435/69.1;;435/209,12,5,019-161-961-414-470;;027-341-230-117-147;;162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604,18265178;;10.1002/0471142727.mb0210s21;;18429083;;10.1002/0471140864.psa04hs13;;10.1111/j.1432-1033.1990.tb15664.x;;2176602;;10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197,"Schulte et al., GenBank Record No. BX842681, direct submission dated Dec. 2, 2003, Neurospora crassa genomic sequence, 33 pages, printed on Jul. 13, 2009.;;Blast 2 alignment of SEQ ID No. 2 with the protein encoded by nucleotides 20,416 to 21,638 of the genomic DNA of Schulte et al., Blast performed on the NCBI Blast 2 website, at http://blast.ncbi.nlm.nih.gov/Blast.cgi on Jul. 13, 2009.;;Result 5, alignment of SEQ ID No. 1 with Schulte et al., GenBank Record No. BX842681, direct submission dated Dec. 2, 2003, Neurospora crassa genomic sequence, from a search performed in the GenEmbl polynucleotide database on Jul. 7, 2009.;;ORF finder analysis of SEQ ID No. 1, performed on the NCBI web site ORF finder on Jul. 13, 2009. http://www.ncbi.nlm.nih.gov/gorf/gorf.html.;;ORF finder analysis and translation of the longest open reading frame in SEQ ID No. 1, performed on the NCBI web site on Jul. 13, 2009, http://www.ncbi.nlm.nih.gov/gorf/orfig.cgi.;;Current Protocols in Molecular Biology, Chap. 2, Hybridization Analysis of DNA Blots, 2000.;;Blast 2 alignment of the CDS of SEQ ID No. 1 with nucleotides 20,416 to 21,638 of the genomic DNA of Schulte et al., Blast performed on the NCBI Blast 2 website, at http://blast.ncbi.nlm.nih.gov/Blast.cgi on Jul. 14, 2009.;;Altenschmidt et al., Evidence that enzymes of a novel aerobic 2-amino-benzoate metabolism in denitrifying Pseudomonas are coded on a small plasmid, Eur. J. Biochem., 1990, v. 194, pp. 647-653.;;Saloheimo et al., cDNA cloning of a trichoderma reesei cellulase and demonstration of endoglucanase activity by expression in yeast, Eur. J. Biochemistry., 1997, v. 249, pp. 584-591.;;Lev Sophie et al., A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection, Plant Cell, 2003, v. 15, pp. 835-844.;;Galagan et al., The genome sequence of the filamentous fungus Neurospora crassa, Nature, 2003, v. 422, pp. 859-868.;;Database UniProt, Dec. 15, 2003 XP002415905, Accession No. Q7RWN7, Neurospora crassa, hypothetical protein.",INACTIVE
485,US,B2,US 9751916 B2,133-551-221-442-405,2017-09-05,2017,US 201615188731 A,2016-06-21,US 201615188731 A;;US 201414500520 A;;US 201213650954 A;;US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/133-551-221-442-405,Granted Patent,yes,14,4,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C12N9/42;;C07H21/04;;C07K14/37;;C11D3/386;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N1/21;;C12N15/52;;C12N15/63;;C12N15/74;;C12P7/06;;C12P7/14;;C12P19/02;;C12P19/14;;C12P21/06,,19,5,000-757-614-552-999;;027-341-230-117-147;;162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604,14538158;;10.1016/s0734-9750(97)00006-2;;10.1111/j.1432-1033.1990.tb15664.x;;2176602;;10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197,"Genseq, Access No. ADM97934, 2004.;;Bhat et al., Cellulose degrading enzymes and their potential industrial applications, Biotechnology Advances, vol. 15, Nos. 3/4 pp. 583-620, 1997.;;Galagan et al., 2000, Uniprot, Access No. Q9P3R7.;;Galagan et al., 2003, Uniprot Access No. Q7RV41.;;Galagan et al., 2003, Uniprot Access No. Q7SCJ5.;;Schnorr et al., 2004, EBI Access No. ADM97932.;;Schnorr et al., 2004, EBI Access No. ADM97936.;;Schnorr et al., 2004, GSP Access No. ADM97937.;;Galagan et al., 2003, Uniprot Access No. Q873G1.;;Altenschmidt et al., Evidence that enzymes of a novel aerobic 2-amino-benzoate metabolism in denitrifying Pseudomonas are coded on a small plasmid, Eur. J. Biochem., 1990, V. 194, pp. 647-653.;;Saloheimo et al., cDNA cloning of a trichoderma reesei cellulase and demonstration of endoglucanase activity by expression in yeast, Eur. J. Biochemistry., 1997, v. 249, pp. 584-591.;;Lev Sophie et al., A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection, Plant Cell, 2003, v. 15, pp. 835-844.;;Galagan et al., The genome sequence of the filamentous fungus Neurospora crassa, Nature, 2003, v. 422, pp. 359-868.;;DATABASE UNIPROT 1 January 1900 (1900-01-01), GALAGAN J E, ET AL: ""HYPOTHETICAL PROTEIN NCU08760.1"", XP002415905, Database accession no. Q7RWN7;;Brown—Curr Protocols Molec Biology 2.10.1-2.10.16 (1993).;;Schulte et al, 2003, GenBank Access No. BX842681.;;Schulte et al., 2011, GenCore, SEQ ID No. 3, U.S. Appl. No. 12/760,186, Accession No. Q9P3R7.;;BLAST, Basic Local Alignment Search Tool, (Jul. 13, 2009).;;Morgenstern et al., Sep. 12, 2014, Briefings in Functional Genomics, pp. 1-11.",ACTIVE
486,DE,T2,DE 69813212 T2,026-081-191-589-939,2004-03-04,2004,DE 69813212 T,1998-05-15,DK 146597 A;;US 85788697 A;;US 6289397 P;;US 6971997 P;;US 9809998 W,1997-05-16,VERFAHREN ZUR ERZEUGUNG VON PROTEINHYDROLYSATEN,"The present invention relates to methods of producing protein hydrolysates, comprising adding to a proteinaceous material one or more aminopeptidase(s) having glycine releasing properties and one or more additional proteases wherein the amount of glycine produced is greater than the amount of glycine produced by the one or more additional proteases alone under the same conditions.",NOVOZYMES BIOTECH INC;;NOVOZYMES AS;;ASAHI CHEMICAL IND,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;MATHIANSEN E;;KOFOD V;;FUJII MIKIO;;MARUMOTA CHIGUSA,,https://lens.org/026-081-191-589-939,Granted Patent,no,0,0,9,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;C12P21/06;;A23L27/21;;A21D2/267;;A23J3/34;;A21D2/268;;C12N9/48;;C12P21/06;;A23L27/21,A21D2/26;;A23J3/34;;A23L27/21;;C12N9/48;;C12P21/06,,0,0,,,,EXPIRED
487,US,B2,US 8846888 B2,036-373-214-436-482,2014-09-30,2014,US 201213650954 A,2012-10-12,US 201213650954 A;;US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/036-373-214-436-482,Granted Patent,yes,10,5,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07H21/04;;C07K14/37;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06,536/23.2;;536/23.74;;435/69.1;;435/209;;435/254.11;;435/252.3;;435/320.1,19,5,000-757-614-552-999;;027-341-230-117-147;;162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604,14538158;;10.1016/s0734-9750(97)00006-2;;10.1111/j.1432-1033.1990.tb15664.x;;2176602;;10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197,"Schulte et al., Uniprot/EMBL record No. Q9P3R7, GenBank record No. GI 9367248, Neurospora crasa DNA linkage group I BAC clone B24P7, 2000.;;Alignment of instant SEQ ID No. 3 with the polynucleotide of Schulte et al., Blast, http://blast.ncbi.nlm.nih.gov/Blast.cgi, performed on Jun. 6, 2011.;;Result 2 from a search of instant SEQ ID No. 3 in the Uniprot database, performed on Jun. 3, 2011.;;Genseq, Access No. ADM97934, 2004.;;Bhat et al., Cellulose degrading enzymes and their potential industrial applications, Biotechnology Advances, vol. 15, Nos. 3/4 pp. 583-620, 1997.;;Galagan et al., 2000, Uniprot, Access No. Q9P3R7.;;Galagan et al., 2003, Uniprot Access No. Q7RV41.;;Galagan et al., 2003, Uniprot Access No. Q7SCJ5.;;Schnorr et al., 2004, EBI Access No. ADM97932.;;Schnorr et al., 2004, EBI Access No. ADM97936.;;Schnorr et al., 2004, GSP Access No. ADM97937.;;Galagan et al., 2003, Uniprot Access No. Q873G1.;;Altenschmidt et al., Evidence that enzymes of a novel aerobic 2-amino-benzoate metabolism in denitrifying Pseudomonas are coded on a small plasmid, Eur. J. Biochem., 1990, vol. 194, pp. 647-653.;;Saloheimo et al., cDNA cloning of a Trichoderma reesei cellulase and demonstration of endoglucanase activity by expression in yeast, Eur. J. Biochemistry., 1997, vol. 249, pp. 584-591.;;Lev Sophie et al., A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection, Plant Cell, 2003, v. 15, pp. 835-844.;;Galagan et al., The genome sequence of the filamentous fungus Neurospora crassa, Nature, 2003, v. 422, pp. 859-868.;;Database UniProt, Dec. 15, 2003 XP002415905, Accession No. Q7RWN7.;;Brown-Curr Protocols Molec Biology 2.10.1-2.10.16.;;Schulte et al, 2003, GenBank Access No. BX842681.",INACTIVE
488,US,A1,US 2014/0093940 A1,093-583-267-226-684,2014-04-03,2014,US 201213650954 A,2012-10-12,US 201213650954 A;;US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides Having Cellulolytic Enhancing Activity And Nucleic Acids Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO;;NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/093-583-267-226-684,Patent Application,yes,0,0,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C12N9/42;;C07H21/04;;C07K14/37;;C11D3/386;;C12N1/21;;C12N15/74;;C12P7/06;;C12P21/06,435/209;;536/23.2;;435/320.1;;435/252.3;;435/252.31;;435/252.35;;435/252.33;;435/252.34;;435/325;;435/348;;435/419;;435/254.11;;435/254.2;;435/254.22;;435/254.23;;435/254.21;;435/254.3;;435/254.7;;435/254.8;;435/254.4;;435/254.5;;435/254.6,0,0,,,,INACTIVE
489,US,B2,US 8641275 B2,186-738-467-907-121,2014-02-04,2014,US 78789810 A,2010-05-26,US 78789810 A,2010-05-26,Universal dental X-ray sensor holder,"A dental x-ray sensor holder includes at least two clamping faces wherein at least one of the faces includes at least one and preferably a plurality of resiliently deformable gripping protrusions. The clamping faces are positioned in a moveable, spaced opposing relation, such that the faces may be physically moved together to physically impinge the x-ray sensor therebetween.",FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ;;DENTSPLY INT INC,FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,,https://lens.org/186-738-467-907-121,Granted Patent,yes,14,5,2,2,0,A61B6/512;;A61B6/512,A61B6/14,378/168,1,0,,,Xp-002381053-Eezee-Grip Digital Sensor Holder by Dentsply Rinn Dental Economics (on-line) Nov. 2005 Joseph A. Blaes.,ACTIVE
490,DE,T2,DE 69734644 T2,024-605-089-645-238,2006-08-10,2006,DE 69734644 T,1997-10-03,US 72688096 A;;US 75753496 A;;US 9717977 W,1996-10-04,CARBOXYPEPTIDASEN AUS ASPERGILLUS ORYZAE UND DIESE KODIERENDE NUKLEINSÄUREN,"The present invention relates to polypeptides having carboxypeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to methods of obtaining protein hydrolysates useful as flavor improving agents.",NOVOZYMES INC;;NOVOZYMES AS,BLINKOVSKY ALEXANDER;;BERKA RANDY;;REY MICHAEL;;GOLIGHTLY ELIZABETH;;KLOTZ ALAN;;MATHISEN ERIK;;DAMBMANN CLAUS;;BROWN KIMBERLY,,https://lens.org/024-605-089-645-238,Granted Patent,no,0,0,9,30,0,A23J3/341;;A23J3/346;;C12N9/48;;A23L27/24,C12N15/09;;C12N15/57;;A23J3/34;;A23L27/24;;C12N1/21;;C12N9/48;;C12N15/00;;C12N15/70;;C12R1/19;;C12R1/66,,0,0,,,,EXPIRED
491,US,A1,US 2019/0023751 A1,059-954-849-555-389,2019-01-24,2019,US 201816156251 A,2018-10-10,US 201816156251 A;;US 201715689443 A;;US 201615188731 A;;US 201414500520 A;;US 201213650954 A;;US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides Having Cellulolytic Enhancing Activity And Nucleic Acids Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/059-954-849-555-389,Patent Application,yes,1,0,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N1/21;;C12N9/42;;C12N15/52;;C12N15/63;;C12N15/74;;C12P7/06;;C12P7/14;;C12P19/02;;C12P19/14;;C12P21/06,,0,0,,,,ACTIVE
492,CN,B,CN 1980953 B,076-241-406-823-651,2014-12-24,2014,CN 200580010730 A,2005-01-28,US 2005/0003525 W;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,,NOVOZYMES INC,BROWN KIMBERLY;;RE EDWARD;;MCFARLAND KEITH;;HARRIS PAUL;;LOPEZ DE LEON ALFREDO;;VLASENKO ELENA;;ZARETSKY ELIZABETH,,https://lens.org/076-241-406-823-651,Granted Patent,no,0,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
493,DK,T3,DK 2305702 T3,124-437-140-025-575,2014-06-16,2014,DK 10180389 T,2005-01-28,US 54066104 P;;EP 05722727 A,2004-01-30,"Polypeptider med cellulolytisk forøgende aktivitet og polynukleotider, der koder for disse",,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPES DE LEON ALFREDO,,https://lens.org/124-437-140-025-575,Granted Patent,no,0,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C11D3/386;;C07H21/04;;C07K14/37;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
494,ES,T3,ES 2472669 T3,135-707-718-033-325,2014-07-02,2014,ES 10180304 T,2005-01-28,US 54066104 P,2004-01-30,Polipéptidos con actividad de mejora celulolítica y polinucleótidos que los codifican,"Polipéptido aislado con actividad de mejora celulolítica, y con una secuencia de aminoácidos que tiene al menos 85%, más preferiblemente al menos 90%, de la forma más preferible al menos 95%, e incluso de forma más preferible al menos 97% de identidad con los aminoácidos 18 a 240 de la SEC ID nº: 4.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/135-707-718-033-325,Granted Patent,no,0,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C11D3/386;;C07H21/04;;C07K14/37;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
495,US,B2,US 10544195 B2,043-235-706-555-937,2020-01-28,2020,US 201816156251 A,2018-10-10,US 201816156251 A;;US 201715689443 A;;US 201615188731 A;;US 201414500520 A;;US 201213650954 A;;US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/043-235-706-555-937,Granted Patent,yes,16,1,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C12P19/02;;C07H21/04;;C07K14/37;;C11D3/386;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N1/21;;C12N9/42;;C12N15/52;;C12N15/63;;C12N15/74;;C12P7/06;;C12P7/14;;C12P19/14;;C12P21/06,,20,5,000-757-614-552-999;;027-341-230-117-147;;162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604,14538158;;10.1016/s0734-9750(97)00006-2;;10.1111/j.1432-1033.1990.tb15664.x;;2176602;;10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197,"Anonymous, Genseq, Access No. ADM97934, 2004.;;Bhat et al., Cellulose degrading enzymes and their potential industrial applications, Biotechnology Advances, vol. 15, Nos. 3/4 pp. 583-620, 1997.;;Galagan et al., 2000, Uniprot, Access No. Q9P3R7.;;Galagan et al., 2003, Uniprot Access No. Q7RV41.;;Galagan et al., 2003, Uniprot Access No. Q7SCJ5.;;Schnorr et al., 2004, EBI Access No. ADM97932.;;Schnorr et al., 2004, EBI Access No. ADM97936.;;Schnorr et al., 2004, GSP Access No. ADM97937.;;Galagan et al., 2003, Uniprot Access No. Q873G1.;;Altenschmidt et al., Evidence that enzymes of a novel aerobic 2-amino-benzoate metabolism in denitrifying Pseudomonas are coded on a small plasmid, Eur. J. Biochem., 1990, v. 194, pp. 647-653.;;Saloheimo et al., cDNA cloning of a trichoderma reesei cellulase and demonstration of endoglucanase activity by expression in yeast, Eur. J. Biochemistry., 1997, v. 249, pp. 584-591.;;Lev Sophie et al., A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection, Plant Cell, 2003, v. 15, pp. 835-844.;;Galagan et al., The genome sequence of the filamentous fungus Neurospora crassa, Nature, 2003, v. 422, pp. 359-868.;;DATABASE UNIPROT 1 January 1900 (1900-01-01), GALAGAN J E, ET AL: ""HYPOTHETICAL PROTEIN NCU08760.1"", XP002415905, Database accession no. Q7RWN7;;Brown—Curr Protocols Molec Biology 2.10.1-2.10.16.;;Schulte et al, 2003, GenBank Access No. BX842681.;;Schulte et al., 2011, GenCore, SEQ ID No. 3, U.S. Appl. No. 12/760,186, Accession No. Q9P3R7.;;Blast, Basic Local Alignment Search Tool.;;Morgenstern et al., Sep. 12, 2014, Briefings in Functional Genomics, pp. 1-11.;;Sencore, U.S. Appl. No. 12/760,186, 2011, Seq IDs.",ACTIVE
496,EP,A1,EP 2308890 A1,114-227-993-618-390,2011-04-13,2011,EP 10180279 A,2005-01-28,EP 05722727 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPES DE LEON ALFREDO,,https://lens.org/114-227-993-618-390,Patent Application,yes,95,0,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C11D7/42;;C12N1/21;;C12N9/42;;C12N15/74;;C12N15/82;;C12P7/06;;C12P7/10;;C12P21/06;;D21C1/00,,142,108,162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604;;000-757-614-552-999;;014-625-826-302-514;;127-544-305-672-969;;076-132-223-936-79X;;118-711-156-754-483;;044-160-688-806-618;;058-145-297-843-203;;038-383-743-124-048;;082-474-862-036-218;;009-304-049-487-981;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;054-167-555-136-715;;046-475-261-047-666;;023-969-505-910-047;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;017-950-663-195-977;;003-307-199-216-170;;060-909-037-461-654;;034-499-320-202-349;;010-606-868-765-729;;004-720-259-087-901;;058-313-563-307-746;;009-052-884-271-430;;168-467-332-279-864;;023-207-730-709-584;;044-918-409-011-81X;;000-743-569-588-265;;043-692-295-433-161;;001-807-171-352-291;;053-608-860-045-291;;017-893-128-543-273;;122-107-077-421-078;;056-172-488-299-694;;015-652-210-164-846;;130-374-497-909-295;;036-168-690-647-51X;;031-015-979-474-454;;021-946-971-259-170;;024-708-797-947-714;;015-065-490-448-969;;013-458-224-516-628;;008-437-576-847-072;;014-774-168-809-047;;001-824-374-248-456;;175-295-822-939-63X;;045-548-779-820-017;;029-940-225-165-635;;031-097-124-288-463;;050-772-251-736-949;;090-877-130-256-158;;039-117-124-686-257;;114-153-099-971-73X;;058-030-884-026-400;;014-708-690-338-262;;000-371-756-809-284;;136-261-375-157-758;;056-201-471-905-934;;023-907-179-348-058;;022-715-862-716-318;;001-150-252-595-427;;066-958-649-977-052;;046-589-579-918-068;;062-094-540-176-015;;028-862-168-091-90X;;009-052-884-271-430,10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197;;14538158;;10.1016/s0734-9750(97)00006-2;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;10.1201/9780203752456-10;;10.1016/s0065-2164(08)70598-7;;10.1007/3-540-49194-5_9;;10533436;;10.1016/0141-0229(95)00157-3;;10.1093/bioinformatics/5.2.151;;2720464;;pmc393452;;6572363;;10.1073/pnas.80.3.726;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;10.1016/1046-5928(91)90057-p;;1821793;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1016/s0958-1669(05)80029-1;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1016/0960-8524(94)90214-3;;10.1007/bf02920289;;10.1016/c2009-0-02655-5;;10.1351/pac198759020257;;10.1016/0003-2697(72)90301-6;;5031119;;10.1016/0014-5793(82)81092-2;;10.1016/0014-5793(85)81260-6;;10.1016/s0021-9258(18)69254-3;;3093475;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-#;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-;;11930943;;10.1016/s0168-1656(97)00073-4;;9246788;;3843705;;10.1016/0003-2697(85)90442-7;;10514248;;10.1021/bp990109e;;10.1016/0141-0229(80)90063-0;;10.1016/0141-0229(85)90114-0;;10.1002/bit.260250106;;18548538;;10.1007/bf02786945;;10.1021/bp990110d;;10514251;;pmc120791;;10.1128/mmbr.66.3.506-577.2002;;12209002;;12172602;;10.1007/s00253-002-1046-0;;10.1016/0032-9592(95)80001-8;;18576101;;10.1007/bf02920444;;15286988;;10.1002/bit.20156;;10.2166/wst.1997.0573;;10.1016/s0961-9534(97)00020-2;;10.1007/bf02918984;;8391777;;9572962;;10.1128/aem.64.5.1852-1859.1998;;pmc106241;;18600763;;10.1002/bit.260380311;;10.1002/(sici)1097-0290(19980420)58:2/3<204::aid-bit13>3.0.co;2-c;;10191391;;17791346;;10.1126/science.267.5195.240;;pmc168273;;10.1128/aem.62.12.4465-4470.1996;;8953718;;3141761;;10.1128/mr.52.3.305-317.1988;;pmc373146;;10.1201/9780203752456-7;;10.1046/j.1432-1327.1999.nomen.x;;10491110;;8462873;;10.1016/0378-1119(93)90328-z;;7763981;;10.1271/bbb.57.1095;;10.1021/ba-1979-0181.ch014;;10.1002/1522-2683()22:5<919::aid-elps919>3.0.co;2-u;;10.1002/1522-2683()22:5<919::aid-elps919>3.3.co;2-l;;11332760;;10.1016/0166-0934(92)90168-d;;1322932;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;pmc50453;;1438297;;10.1073/pnas.89.22.10915;;9051728;;10.1093/protein/10.1.1;;10.1093/bioinformatics/17.9.847;;11590104;;12230035;;10.1093/bib/3.3.265;;pmc135756;;12136088;;10.1093/nar/gkf436;;10.1007/s002940050512;;10654091;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/0003-2697(72)90301-6;;5031119,"SALOHEIMO M ET AL: ""CDNA CLONING OF A TRICHODERMA REESEI CELLULASE AND DEMONSTRATION OFENDOGLUCANASE ACTIVITY BY EXPRESSION IN YEAST"", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 249, no. 2, October 1997 (1997-10-01), pages 584 - 591, XP002053367, ISSN: 0014-2956;;LEV SOPHIE ET AL: ""A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection."", PLANT CELL, vol. 15, no. 4, April 2003 (2003-04-01), pages 835 - 844, XP002415198, ISSN: 1040-4651;;GALAGAN J E ET AL: ""The genome sequence of the filamentous fungus Neurospora crassa"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 422, no. 6934, 24 April 2003 (2003-04-24), pages 859 - 868, XP002365858, ISSN: 0028-0836;;BHAT M K ET AL: ""Cellulose degrading enzymes and their potential industrial applications"", BIOTECHNOLOGY ADVANCES, ELSEVIER PUBLISHING, BARKING, GB, vol. 15, no. 3-4, 1 January 1997 (1997-01-01), pages 583 - 620, XP004089630, ISSN: 0734-9750, DOI: 10.1016/S0734-9750(97)00006-2;;HENRISSAT B.: ""A classification of glycosyl hydrolases based on amino-acid sequence similarities"", BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT B; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BIOCHEM. J., vol. 316, 1996, pages 695 - 696;;HSU, T.-A.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Pretreatment of biomass"", pages: 179 - 212;;GHOSH, P.; SINGH, A.: ""Physicochemical and biological treatments for enzymatic/microbial conversion of lignocellulosic biomass"", DV. APPL. MICROBIOL., vol. 39, 1993, pages 295 - 333;;MCMILLAN, J. D.: ""Pretreating lignocellulosic biomass: a review, in Enzymatic Conversion of Biomass for Fuels Production"", 1994, AMERICAN CHEMICAL SOCIETY;;GONG, C. S.; CAO, N. J.; DU, J.; TSAO, G. T.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Ethanol production from renewable resources"", pages: 207 - 241;;OLSSON, L.; HAHN-HAGERDAL, B.: ""Fermentation of lignocellulosic hydrolysates for ethanol production"", ENZ. MICROB. TECH., vol. 18, 1996, pages 312 - 331;;VALLANDER, L.; ERIKSSON, K.-E. L.: ""Production of ethanol from lignocellulosic materials: State of the art"", ADV. BIOCHEM. ENG.LBIOTECHNOL., vol. 42, 1990, pages 63 - 95;;HIGGINS, CABIOS, vol. 5, 1989, pages 151 - 153;;WATERMAN ET AL., ADV. MATH., vol. 20, 1976, pages 367;;WILBUR; LIPMAN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 80, 1983, pages 726 - 730;;BOLTON; MCCARTHY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 48, 1962, pages 1390;;H. NEURATH; R.L. HILL: ""The Proteins"", 1979, ACADEMIC PRESS;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEM., vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;INNIS ET AL.: ""PCR: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;SMITH ET AL., JOURNAL OF MOLECULAR BIOLOGY, vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETTERS, vol. 309, 1992, pages 59 - 64;;VILLA-KAMAROFF ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 80, 1983, pages 21 - 25;;""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOLECULAR CELLULAR BIOLOGY, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOLECULAR GENERAL GENETICS, vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZIN, JOURNAL OF BACTERIOLOGY, vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, JOURNAL OF MOLECULAR BIOLOGY, vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER A; THORNE, JOURNAL OF BACTERIOLOGY, vol. 169, 1987, pages 5771 - 5278;;HAWKSWORTH ET AL.: ""Ainsworth and Bisby's Dictionary of The Fungi"", 1995, CAB INTERNATIONAL, UNIVERSITY PRESS;;""Biology and Activities of Yeast"", 1980, SOC. APP. BACTERIOL.;;YELTON ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1984, pages 1470 - 1474;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;BECKER; GUARENTE: ""Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., article ""Guide to Yeast Genetics and Molecular Biology"", pages: 182 - 187;;ITO ET AL., JOURNAL OF BACTERIOLOGY, vol. 153, 1983, pages 163;;HINNEN ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1920;;""Protein Purification"", 1989, VCH PUBLISHERS;;TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MO. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS; CORUZZI, ANN. REV. GENET, vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., JOURNAL OF PLANT PHYSIOLOGY, vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOLOGY, vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOLECULAR BIOLOGY, vol. 26, 1994, pages 85 - 93;;KAGAYA ET AL., MOLECULAR AND GENERAL GENETICS, vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOLECULAR BIOLOGY, vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIOLTECHNOLOGY, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOLECULAR BIOLOGY, vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT JOURNAL, vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CURRENT OPINION BIOTECHNOLOGY, vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH ET AL., PLANT MOLECULAR BIOLOGY, vol. 21, 1993, pages 415 - 428;;WISELOGEL ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 1 05 - 118;;WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16;;LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24/25, 1990, pages 695 - 719;;MOSIER ET AL.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Recent Progress in Bioconversion of Lignocellulosics"", pages: 23 - 40;;""More Gene Manipulations in Fungi"", 1991, ACADEMIC PRESS;;BAILEY, J.E.; OLLIS, D.F.: ""Biochemical Engineering Fundamentals"", 1986, MCGRAW-HILL BOOK COMPANY;;GHOSE, PURE AND APPL. CHEM., vol. 59, 1987, pages 257 - 268;;LEVER ET AL., ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279;;VAN TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156;;VAN TILBEURGH; CLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288;;HIMMEL ET AL., J. BIOL. CHEM., vol. 261, 1986, pages 12948 - 12955;;VENTURI ET AL., J. BASIC MICROBIOL., vol. 42, 2002, pages 55 - 66;;BRIGHAM ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 119 - 141;;LEE, JOURNAL OF BIOTECHNOLOGY, vol. 56, 1997, pages 1 - 24;;P.K. SMITH ET AL., ANAL. BIOCHEM., vol. 150, 1985, pages 76;;LYND, L. R.; WYMAN, C. E.; GERNGROSS, T. U.: ""Biocommodity Engineering, Biotechnol. Prog."", vol. 15, 1999, pages: 777 - 793;;PHILIPPIDIS, G. P.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Cellulose bioconversion technology"", pages: 179 - 212;;RYU, D. D. Y.; MANDELS, M.: ""Cellulases: biosynthesis and applications"", ENZ. MICROB. TECHNOL., vol. 2, 1980, pages 91 - 102;;GUSAKOV, A. V.; SINITSYN, A. P.: ""Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical model for a batch reactor process"", ENZ. MICROB. TECHNOL., vol. 7, 1985, pages 346 - 352;;RYU, S. K.; LEE, J. M.: ""Bioconversion of waste cellulose by using an attrition bioreactor"", BIOTECHNOL. BIOENG., vol. 25, 1983, pages 53 - 65;;GUSAKOV, A. V.; SINITSYN, A. P.; DAVYDKIN, I. Y.; DAVYDKIN, V. Y.; PROTAS, O. V.: ""Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field"", APPL. BIOCHEM. BIOTECHNOL., vol. 56, 1996, pages 141 - 153;;SHEEHAN, J.; HIMMEL, M.: ""Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol"", BIOTECHNOL. PROG., vol. 15, 1999, pages 817 - 827;;LYND, L. R.; WEIMER, P. J.; VAN ZYL, W. H.; PRETORIUS, I. S.: ""Microbial cellulose utilization: Fundamentals and biotechnology"", MICROBIOL. MOL. BIOL. REVIEWS, vol. 66, 2002, pages 506 - 577;;SILVEIRA, M. M.; JONAS, R.: ""The biotechnological production of sorbitol"", APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 400 - 408;;NIGAM, P.; SINGH, D.: ""Processes for fermentative production of xylitol - a sugar substitute"", PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124;;EZEJI, T. C.; QURESHI, N.; BLASCHEK, H. P.: ""Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping"", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603;;CHEN, R.; LEE, Y. Y.: ""Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass"", APPL. BIOCHEM. BIOTECHNOL., vol. 63-65, 1997, pages 435 - 448;;RICHARD, A.; MARGARITIS, A.: ""Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515;;KATAOKA, N.; A. MIYA; K. KIRIYAMA: ""Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria"", WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 41 - 47;;GUNASEELAN V.N., BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114;;CHEN, Z.; HO, N. W. Y.: ""Cloning and improving the expression of Pichia stipitis xylose reductase gene in Saccharomyces cerevisiae"", APPL. BIOCHEM. BIOTECHNOL., vol. 39-40, 1993, pages 135 - 147;;HO, N. W. Y.; CHEN, Z; BRAINARD, A. P.: ""Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose"", APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 1852 - 1859;;BEALL, D. S.; OHTA, K.; INGRAM, L. 0.: ""Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli"", BIOTECH. BIOENG., vol. 38, 1991, pages 296 - 303;;INGRAM, L. 0.; GOMES, P. F.; LAI, X.; MONIRUZZAMAN, M.; WOOD, B. E.; YOMANO, L. P.; YORK, S. W.: ""Metabolic engineering of bacteria for ethanol production"", BIOTECHNOL. BIOENG., vol. 58, 1998, pages 204 - 214;;ZHANG, M.; EDDY, C.; DEANDA, K.; FINKELSTEIN, M.; PICATAGGIO, S.: ""Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis"", SCIENCE, vol. 267, 1995, pages 240 - 243;;DEANDA, K.; ZHANG, M.; EDDY, C.; PICATAGGIO, S.: ""Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering"", APPL. ENVIRON. MICROBIOL., vol. 62, 1996, pages 4465 - 4470;;""The Alcohol Textbook"", 1999, NOTTINGHAM UNIVERSITY PRESS;;WONG, K.K.Y.; TAN, L. U. L.; SADDLER, J. N.: ""Multiplicity of ?-1,4-xylanase in microorganisms: Functions and applications"", MICROBIOL. REV., vol. 52, 1988, pages 305 - 317;;TENKANEN, M.; POUTANEN, K.: ""Xylans and Xylanases"", 1992, ELSEVIER, article ""Significance of esterases in the degradation of xylans"", pages: 203 - 212;;COUGHLAN, M. P.; HAZLEWOOD, G. P., HEMICELLULOSE AND HEMICELLULASES, 1993;;BRIGHAM, J. S.; ADNEY, W. S.; HIMMEL, M. E.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Hemicellulases: Diversity and applications"", pages: 119 - 141;;""Enzyme Nomenclature"", 1992, ACADEMIC PRESS;;EUR. J. BIOCHEM., vol. 223, 1994, pages 1 - 5;;EUR. J. BIOCHEM., vol. 232, 1995, pages 1 - 6;;EUR. J. BIOCHEM., vol. 237, 1996, pages 1 - 5;;EUR. J. BIOCHEM., vol. 250, 1997, pages 1 - 6;;EUR. J. BIOCHEM., vol. 264, 1999, pages 610 - 650;;KOAZE ET AL., AGR. BIOL. CHEM. JAPAN, vol. 28, 1964, pages 216;;YOSHIDA, J. AGR. CHEM. SOC. JAPAN, vol. 28, 1954, pages 66;;HAYASHIDA ET AL., AGRIC. BIOL. CHEM., vol. 42, 1977, pages 927 - 933;;""Handbook of Proteolytic Enzymes"", 1998, ACADEMIC PRESS;;BERKA ET AL., GENE, vol. 96, 1990, pages 313;;BERKA ET AL., GENE, vol. 125, 1993, pages 195 - 198;;GOMI ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 57, 1993, pages 1095 - 1100;;DARTOIS ET AL., BIOCHEMICA ET BIOPHYSICA ACTA, vol. 1131, 1993, pages 253 - 360;;MONTENECOURT; EVELEIGH, ADV. CHEM. SER., vol. 181, 1979, pages 289 - 301;;MALONE ET AL., ELECTROPHORESIS, vol. 22, 2001, pages 919 - 932;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;ALTSCHUL, J. MOL. BIOL., vol. 215, 1990, pages 403 - 410;;HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 10915 - 10919;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;ZDOBNOV; APWEILER, BIOINFORMATICS, vol. 17, 2001, pages 847 - 848;;SIGRIST ET AL., BRIEF BIOINFORM., vol. 3, 2002, pages 265 - 274;;KATOH ET AL., NUCLEIC ACIDS RESEARCH, vol. 30, 2002, pages 3059;;CHRISTENSEN ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 1419 - 1422;;CUMMINGS ET AL., CURRENT GENETICS, vol. 36, 1999, pages 371 - 82;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;LEVER, M.: ""A new reaction for colorimetric determination of carbohydrates"", ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279",DISCONTINUED
497,US,A1,US 2020/0148730 A1,168-157-325-059-739,2020-05-14,2020,US 201916717778 A,2019-12-17,US 201916717778 A;;US 201816156251 A;;US 201715689443 A;;US 201615188731 A;;US 201414500520 A;;US 201213650954 A;;US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides Having Cellulolytic Enhancing Activity And Nucleic Acids Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/168-157-325-059-739,Patent Application,yes,3,0,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N1/21;;C12N9/42;;C12N15/52;;C12N15/63;;C12N15/74;;C12P7/06;;C12P7/14;;C12P19/02;;C12P19/14;;C12P21/06,,0,0,,,,DISCONTINUED
498,WO,A3,WO 2006/089003 A3,005-764-311-323-563,2006-12-07,2006,US 2006/0005435 W,2006-02-15,US 65355905 P,2005-02-16,UNIVERSAL DENTAL X-RAY SENSOR HOLDER,"A dental x-ray sensor holder includes at least two clamping faces wherein at least one of the faces includes at least one and preferably a plurality of resiliently deformable gripping protrusions. The clamping faces are positioned in a moveable, spaced opposing relation, such that the faces may be physically moved together to physically impinge the x-ray sensor therebetween.",DENTSPLY INT INC;;FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,,https://lens.org/005-764-311-323-563,Search Report,yes,7,0,11,11,0,A61B6/4283;;G03B42/042;;A61B6/512,G03B42/04;;A61B6/14,,1,0,,,"JOSEPH A. BLAES: ""Eezee-Grip Digital Sensor Holder by Dentsply Rinn"", DENTAL ECONOMICS, November 2005 (2005-11-01), XP002381053, Retrieved from the Internet <URL:http://de.pennnet.com/articles/article_display.cfm?Section=ARCHI&C=Dept&ARTICLE_ID=242750&KEYWORDS=Isolite%20&p=54> [retrieved on 20060516]",PENDING
499,JP,A,JP 2013081790 A,050-192-942-529-980,2013-05-09,2013,JP 2012268303 A,2012-12-07,US 65355905 P,2005-02-16,UNIVERSAL DENTAL X-RAY SENSOR HOLDER,"PROBLEM TO BE SOLVED: To provide a dental sensor holder useful especially for digital dental X-ray sensors of various sizes and shapes.SOLUTION: The dental X-ray sensor holder includes at least two clamping faces wherein at least one of the clamping faces includes at least one and preferably a plurality of resiliently deformable gripping protrusions. The clamping faces are positioned in a moveable, spaced opposing relation, such that the faces may be physically moved together to physically impinge the X-ray sensor therebetween.",DENTSPLY INT INC,FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,,https://lens.org/050-192-942-529-980,Patent Application,no,3,0,11,11,0,A61B6/4283;;G03B42/042;;A61B6/512,A61B6/14,,0,0,,,,ACTIVE
500,EP,A2,EP 1848340 A2,101-766-768-515-222,2007-10-31,2007,EP 06720799 A,2006-02-15,US 2006/0005435 W;;US 65355905 P,2005-02-16,UNIVERSAL DENTAL X-RAY SENSOR HOLDER,,DENTSPLY INT INC,FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,,https://lens.org/101-766-768-515-222,Patent Application,yes,0,0,11,11,0,A61B6/4283;;G03B42/042;;A61B6/512,A61B6/14;;G03B42/04,,0,0,,,,ACTIVE
501,DK,T3,DK 1713825 T3,192-632-763-587-478,2012-11-05,2012,DK 05722727 T,2005-01-28,US 54066104 P;;US 2005/0003525 W,2004-01-30,Polypeptider med cellulolytisk forøgende aktivitet og polynukleotider der koder for samme,,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/192-632-763-587-478,Granted Patent,no,0,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12N15/82;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
502,US,B2,US 9410165 B2,193-435-558-208-313,2016-08-09,2016,US 201414500520 A,2014-09-29,US 201414500520 A;;US 201213650954 A;;US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/193-435-558-208-313,Granted Patent,yes,11,3,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C12N9/42;;C07H21/04;;C07K14/37;;C11D3/386;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N1/21;;C12N15/52;;C12N15/63;;C12N15/74;;C12P7/06;;C12P7/14;;C12P19/02;;C12P19/14;;C12P21/06,,16,5,000-757-614-552-999;;027-341-230-117-147;;162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604,14538158;;10.1016/s0734-9750(97)00006-2;;10.1111/j.1432-1033.1990.tb15664.x;;2176602;;10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197,"Genseq, Access No. ADM97934, 2004.;;Bhat et al., Cellulose degrading enzymes and their potential industrial applications, Biotechnology Advances, vol. 15, Nos. 3/4 pp. 583-620, 1997.;;Galagan et al., 2000, Uniprot, Access No. Q9P3R7.;;Galagan et al., 2003, Uniprot Access No. Q7RV41.;;Galagan et al., 2003, Uniprot Access No. Q7SCJ5.;;Schnorr et al., 2004, EBI Access No. ADM97932.;;Schnorr et al., 2004, EBI Access No. ADM97936.;;Schnorr et al., 2004, GSP Access No. ADM97937.;;Galagan et al., 2003, Uniprot Access No. Q873G1.;;Altenschmidt et al., Evidence that enzymes of a novel aerobic 2-amino-benzoate metabolism in denitrifying Pseudomonas are coded on a small plasmid, Eur. J. Biochem., 1990, v. 194, pp. 647-653.;;Saloheimo et al., cDNA cloning of a trichoderma reesei cellulase and demonstration of endoglucanase activity by expression in yeast, Eur. J. Biochemistry., 1997, v. 249, pp. 584-591.;;Lev Sophie et al., A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection, Plant Cell, 2003, v. 15, pp. 835-844.;;Galagan et al., The genome sequence of the filamentous fungus Neurospora crassa, Nature, 2003, v. 422, pp. 859-868.;;Galagan et al., 2003, UniProt, XP002415905, Accession No. Q7RWN7.;;Brown-Curr Protocols Molec Biology 2.10.1-2.10.16, (1993).;;Schulte et al, 2003, GenBank Access No. BX842681.",INACTIVE
503,WO,A2,WO 2006/089003 A2,048-733-817-982-88X,2006-08-24,2006,US 2006/0005435 W,2006-02-15,US 65355905 P,2005-02-16,UNIVERSAL DENTAL X-RAY SENSOR HOLDER,"A dental x-ray sensor holder includes at least two clamping faces wherein at least one of the faces includes at least one and preferably a plurality of resiliently deformable gripping protrusions. The clamping faces are positioned in a moveable, spaced opposing relation, such that the faces may be physically moved together to physically impinge the x-ray sensor therebetween.",DENTSPLY INT INC;;FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,,https://lens.org/048-733-817-982-88X,Patent Application,yes,0,5,11,11,0,A61B6/4283;;G03B42/042;;A61B6/512,G03B42/04;;A61B6/14,,0,0,,,,PENDING
504,ES,T3,ES 2468366 T3,094-008-647-931-970,2014-06-16,2014,ES 10180399 T,2005-01-28,US 54066104 P,2004-01-30,Polipéptidos con actividad de mejora celulolítica y polinucleótidos que los codifican,"Polipéptido aislado con actividad de mejora celulolítica y una secuencia de aminoácidos que tiene al menos 85%, incluso más preferiblemente al menos 90%, de la forma más preferible al menos 95%, e incluso de la foma más preferible al menos 97% de identidad con los aminoácidos 19 a 226 de la SEC ID nº: 8.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPES DE LEON ALFREDO,,https://lens.org/094-008-647-931-970,Granted Patent,no,0,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
505,ES,T3,ES 2469840 T3,094-097-285-079-940,2014-06-20,2014,ES 10180414 T,2005-01-28,US 54066104 P,2004-01-30,Polipéptidos con actividad de mejora celulolítica y polinucleótidos que los codifican,"Polipéptido aislado con actividad de mejora celulolítica, y con una secuencia de aminoácidos que tiene al menos 85%, incluso más preferiblemente al menos 90%, y más preferiblemente al menos 95%, e incluso más preferiblemente al menos 97% de identidad con los aminoácidos 20 a 304 de la SEC ID nº: 10.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/094-097-285-079-940,Granted Patent,no,0,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
506,EP,A1,EP 2314605 A1,157-279-146-597-159,2011-04-27,2011,EP 10180304 A,2005-01-28,EP 05722727 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/157-279-146-597-159,Patent Application,yes,94,0,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C11D3/386;;C07H21/04;;C07K14/37;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,143,107,162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604;;014-625-826-302-514;;127-544-305-672-969;;076-132-223-936-79X;;118-711-156-754-483;;044-160-688-806-618;;058-145-297-843-203;;038-383-743-124-048;;082-474-862-036-218;;009-304-049-487-981;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;054-167-555-136-715;;046-475-261-047-666;;023-969-505-910-047;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;017-950-663-195-977;;003-307-199-216-170;;060-909-037-461-654;;034-499-320-202-349;;010-606-868-765-729;;058-313-563-307-746;;009-052-884-271-430;;168-467-332-279-864;;023-207-730-709-584;;044-918-409-011-81X;;000-743-569-588-265;;043-692-295-433-161;;001-807-171-352-291;;053-608-860-045-291;;017-893-128-543-273;;122-107-077-421-078;;056-172-488-299-694;;015-652-210-164-846;;130-374-497-909-295;;036-168-690-647-51X;;031-015-979-474-454;;021-946-971-259-170;;024-708-797-947-714;;015-065-490-448-969;;013-458-224-516-628;;008-437-576-847-072;;014-774-168-809-047;;001-824-374-248-456;;175-295-822-939-63X;;045-548-779-820-017;;029-940-225-165-635;;031-097-124-288-463;;018-434-146-384-724;;050-772-251-736-949;;090-877-130-256-158;;039-117-124-686-257;;114-153-099-971-73X;;058-030-884-026-400;;014-708-690-338-262;;000-371-756-809-284;;136-261-375-157-758;;056-201-471-905-934;;023-907-179-348-058;;022-715-862-716-318;;001-150-252-595-427;;066-958-649-977-052;;046-589-579-918-068;;062-094-540-176-015;;028-862-168-091-90X;;009-052-884-271-430,10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;10.1201/9780203752456-10;;10.1016/s0065-2164(08)70598-7;;10.1007/3-540-49194-5_9;;10533436;;10.1016/0141-0229(95)00157-3;;10.1093/bioinformatics/5.2.151;;2720464;;pmc393452;;6572363;;10.1073/pnas.80.3.726;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;10.1016/1046-5928(91)90057-p;;1821793;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1016/s0958-1669(05)80029-1;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1016/0960-8524(94)90214-3;;10.1007/bf02920289;;10.1351/pac198759020257;;10.1016/0003-2697(72)90301-6;;5031119;;10.1016/0014-5793(82)81092-2;;10.1016/0014-5793(85)81260-6;;10.1016/s0021-9258(18)69254-3;;3093475;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-#;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-;;11930943;;10.1016/s0168-1656(97)00073-4;;9246788;;3843705;;10.1016/0003-2697(85)90442-7;;10514248;;10.1021/bp990109e;;10.1016/0141-0229(80)90063-0;;10.1016/0141-0229(85)90114-0;;10.1002/bit.260250106;;18548538;;10.1007/bf02786945;;10.1021/bp990110d;;10514251;;pmc120791;;10.1128/mmbr.66.3.506-577.2002;;12209002;;12172602;;10.1007/s00253-002-1046-0;;10.1016/0032-9592(95)80001-8;;18576101;;10.1007/bf02920444;;15286988;;10.1002/bit.20156;;10.2166/wst.1997.0573;;10.1016/s0961-9534(97)00020-2;;10.1007/bf02918984;;8391777;;9572962;;10.1128/aem.64.5.1852-1859.1998;;pmc106241;;18600763;;10.1002/bit.260380311;;10.1002/(sici)1097-0290(19980420)58:2/3<204::aid-bit13>3.0.co;2-c;;10191391;;17791346;;10.1126/science.267.5195.240;;pmc168273;;10.1128/aem.62.12.4465-4470.1996;;8953718;;10.1007/s00253-002-1092-7;;12382043;;3141761;;10.1128/mr.52.3.305-317.1988;;pmc373146;;10.1201/9780203752456-7;;10.1046/j.1432-1327.1999.nomen.x;;10491110;;8462873;;10.1016/0378-1119(93)90328-z;;7763981;;10.1271/bbb.57.1095;;10.1021/ba-1979-0181.ch014;;10.1002/1522-2683()22:5<919::aid-elps919>3.0.co;2-u;;10.1002/1522-2683()22:5<919::aid-elps919>3.3.co;2-l;;11332760;;10.1016/0166-0934(92)90168-d;;1322932;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;pmc50453;;1438297;;10.1073/pnas.89.22.10915;;9051728;;10.1093/protein/10.1.1;;10.1093/bioinformatics/17.9.847;;11590104;;12230035;;10.1093/bib/3.3.265;;pmc135756;;12136088;;10.1093/nar/gkf436;;10.1007/s002940050512;;10654091;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/0003-2697(72)90301-6;;5031119,"SALOHEIMO M ET AL: ""CDNA CLONING OF A TRICHODERMA REESEI CELLULASE AND DEMONSTRATION OFENDOGLUCANASE ACTIVITY BY EXPRESSION IN YEAST"", EUROPEAN JOURNAL OF BIOCHEMISTRY, BLACKWELL PUBLISHING, BERLIN, DE, vol. 249, no. 2, 1 October 1997 (1997-10-01), pages 584 - 591, XP002053367, ISSN: 0014-2956, DOI: 10.1111/J.1432-1033.1997.00584.X;;LEV SOPHIE ET AL: ""A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection"", PLANT CELL, AMERICAN SOCIETY OF PLANT PHYSIOLOGISTS, ROCKVILLE, MD, US, vol. 15, no. 4, 1 April 2003 (2003-04-01), pages 835 - 844, XP002415198, ISSN: 1040-4651, DOI: 10.1105/TPC.010546;;GALAGAN J E ET AL: ""The genome sequence of the filamentous fungus Neurospora crassa"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 422, no. 6934, 24 April 2003 (2003-04-24), pages 859 - 868, XP002365858, ISSN: 0028-0836, DOI: 10.1038/NATURE01554;;DATABASE UniProt [online] 1 October 2000 (2000-10-01), ""SubName: Full=Related to cel1 protein;"", XP002618590, retrieved from EBI accession no. UNIPROT:Q9P3R7 Database accession no. Q9P3R7;;HENRISSAT B.: ""A classification of glycosyl hydrolases based on amino-acid sequence similarities"", BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT B.; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BIOCHEM. J., vol. 316, 1996, pages 695 - 696;;HSU, T.-A.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Pretreatment of biomass"", pages: 179 - 212;;GHOSH, P.; SINGH, A.: ""Physicochemical and biological treatments for enzymatic/microbial conversion of lignocellulosic biomass"", ADV. APPL. MICROBIOL., vol. 39, 1993, pages 295 - 333;;MCMILLAN, J. D.: ""Enzymatic Conversion of Biomass for Fuels Production"", 1994, AMERICAN CHEMICAL SOCIETY, article ""Pretreating lignocellulosic biomass: a review"";;GONG, C. S.; CAO, N. J.; DU, J.; TSAO, G. T.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Ethanol production from renewable resources"", pages: 207 - 241;;OLSSON, L.; HAHN-HAGERDAL, B.: ""Fermentation of lignocellulosic hydrolysates for ethanol production"", ENZ. MICROB. TECH., vol. 18, 1996, pages 312 - 331;;VALLANDER, L.; ERIKSSON, K.-E. L.: ""Production of ethanol from lignocellulosic materials: State of the art"", ADV. BIOCHEM. ENG.LBIOTECHNOL., vol. 42, 1990, pages 63 - 95;;HIGGINS, CABIOS, vol. 5, 1989, pages 151 - 153;;WATERMAN ET AL., ADV. MATH., vol. 20, 1976, pages 367;;WILBUR; LIPMAN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 80, 1983, pages 726 - 730;;BOLTON; MCCARTHY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 48, 1962, pages 1390;;H. NEURATH; R.L. HILL: ""The Proteins"", 1979, ACADEMIC PRESS;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEM., vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;INNIS ET AL.: ""PCR: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;SMITH ET AL., JOURNAL OF MOLECULAR BIOLOGY, vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETTERS, vol. 309, 1992, pages 59 - 64;;VILLA-KAMAROFF ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 80, 1983, pages 21 - 25;;""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOLECULAR CELLULAR BIOLOGY, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOLECULAR GENERAL GENETICS, vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZIN, JOURNAL OF BACTERIOLOGY, vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, JOURNAL OF MOLECULAR BIOLOGY, vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER; THORNE, JOURNAL OF BACTERIOLOGY, vol. 169, 1987, pages 5771 - 5278;;HAWKSWORTH ET AL.: ""Ainsworth and Bisby's Dictionary of The Fungi"", 1995, UNIVERSITY PRESS;;SKINNER, F.A., PASSMORE, S.M., AND DAVENPORT, R.R.,: ""Soc. App. Bacteriol. Symposium Series No. 9"", 1980, article ""Biology and Activities of Yeast"";;YELTON ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1984, pages 1470 - 1474;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;BECKER; GUARENTE: ""Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., pages: 182 - 187;;ITO ET AL., JOURNAL OF BACTERIOLOGY, vol. 153, 1983, pages 163;;HINNEN ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1920;;J.-C. JANSON AND LARS RYDEN: ""Protein Purification"", 1989, VCH PUBLISHERS;;TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MO. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS; CORUZZI, ANN. REV. GENET., vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., JOURNAL OF PLANT PHYSIOLOGY, vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOLOGY, vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOLECULAR BIOLOGY, vol. 26, 1994, pages 85 - 93;;KAGAYA ET AL., MOLECULAR AND GENERAL GENETICS, vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOLECULAR BIOLOGY, vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIOLTECHNOLOGY, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOLECULAR BIOLOGY, vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT JOURNAL, vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CURRENT OPINION BIOTECHNOLOGY, vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH ET AL., PLANT MOLECULAR BIOLOGY, vol. 21, 1993, pages 415 - 428;;WISELOGEL ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 1 05 - 118;;WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16;;LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24/25, 1990, pages 695 - 719;;MOSIER ET AL.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Recent Progress in Bioconversion of Lignocellulosics"", pages: 23 - 40;;BENNETT, J.W. AND LASURE, L.: ""More Gene Manipulations in Fungi"", 1991, ACADEMIC PRESS;;BAILEY, J.E.; OLLIS, D.F.: ""Biochemical Engineering Fundamentals"", 1986, MCGRAW-HILL BOOK COMPANY;;GHOSE, PURE AND APPL. CHEM., vol. 59, 1987, pages 257 - 268;;LEVER ET AL., ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279;;VAN TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156;;VAN TILBEURGH; CLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288;;HIMMEL ET AL., J. BIOL. CHEM., vol. 261, 1986, pages 12948 - 12955;;VENTURI ET AL., J. BASIC MICROBIOL., vol. 42, 2002, pages 55 - 66;;BRIGHAM ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 119 - 141;;LEE, JOURNAL OF BIOTECHNOLOGY, vol. 56, 1997, pages 1 - 24;;P.K. SMITH ET AL., ANAL. BIOCHEM., vol. 150, 1985, pages 76;;LYND, L. R.; WYMAN, C. E.; GERNGROSS, T. U., BIOCOMMODITY ENGINEERING, BIOTECHNOL. PROG., vol. 15, 1999, pages 777 - 793;;PHILIPPIDIS, G. P.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Cellulose bioconversion technology"", pages: 179 - 212;;RYU, D. D. Y.; MANDELS, M.: ""Cellulases: biosynthesis and applications"", ENZ. MICROB. TECHNOL., vol. 2, 1980, pages 91 - 102;;GUSAKOV, A. V.; SINITSYN, A. P.: ""Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical model for a batch reactor process"", ENZ. MICROB. TECHNOL., vol. 7, 1985, pages 346 - 352;;RYU, S. K.; LEE, J. M.: ""Bioconversion of waste cellulose by using an attrition bioreactor"", BIOTECHNOL. BIOENG., vol. 25, 1983, pages 53 - 65;;GUSAKOV, A. V.; SINITSYN, A. P.; DAVYDKIN, I. Y.; DAVYDKIN, V. Y.; PROTAS, O. V.: ""Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field"", APPL. BIOCHEM. BIOTECHNOL., vol. 56, 1996, pages 141 - 153;;SHEEHAN, J.; HIMMEL, M.: ""Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol"", BIOTECHNOL. PROG., vol. 15, 1999, pages 817 - 827;;LYND, L. R.; WEIMER, P. J.; VAN ZYL, W. H.; PRETORIUS, I. S.: ""Microbial cellulose utilization: Fundamentals and biotechnology"", MICROBIOL. MOL. BIOL. REVIEWS, vol. 66, 2002, pages 506 - 577;;SILVEIRA, M. M.; JONAS, R.: ""The biotechnological production of sorbitol"", APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 400 - 408;;NIGAM, P.; SINGH, D.: ""Processes for fermentative production of xylitol - a sugar substitute"", PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124;;EZEJI, T. C.; QURESHI, N.; BLASCHEK, H. P.: ""Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping"", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603;;CHEN, R.; LEE, Y. Y.: ""Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass"", APPL. BIOCHEM. BIOTECHNOL., vol. 63-65, 1997, pages 435 - 448;;RICHARD, A.; MARGARITIS, A.: ""Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515;;KATAOKA, N.; A. MIYA; K. KIRIYAMA: ""Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria"", WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 41 - 47;;GUNASEELAN V.N., BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114;;CHEN, Z.; HO, N. W. Y.: ""Cloning and improving the expression of Pichia stipitis xylose reductase gene in Saccharomyces cerevisiae"", APPL. BIOCHEM. BIOTECHNOL., vol. 39-40, 1993, pages 135 - 147;;HO, N. W. Y.; CHEN, Z; BRAINARD, A. P.: ""Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose"", APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 1852 - 1859;;BEALL, D. S.; OHTA, K.; INGRAM, L. 0.: ""Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli"", BIOTECH. BIOENG., vol. 38, 1991, pages 296 - 303;;INGRAM, L. 0.; GOMES, P. F.; LAI, X.; MONIRUZZAMAN, M.; WOOD, B. E.; YOMANO, L. P.; YORK, S. W.: ""Metabolic engineering of bacteria for ethanol production"", BIOTECHNOL. BIOENG., vol. 58, 1998, pages 204 - 214;;ZHANG, M.; EDDY, C.; DEANDA, K.; FINKELSTEIN, M.; PICATAGGIO, S.: ""Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis"", SCIENCE, vol. 267, 1995, pages 240 - 243;;DEANDA, K.; ZHANG, M.; EDDY, C.; PICATAGGIO, S.: ""Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering"", APPL. ENVIRON. MICROBIOL., vol. 62, 1996, pages 4465 - 4470;;K. JACQUES, T.P. LYONS AND D.R. KELSALL,: ""The Alcohol Textbook"", 1999, NOTTINGHAM UNIVERSITY PRESS;;ALFENORE ET AL.: ""Improving ethanol production and viability of Saccharomyces cerevisiae by a vitamin feeding strategy during fed-batch process"", 2002, SPRINGER-VERLAG;;WONG, K.K.Y.; TAN, L. U. L.; SADDLER, J. N.: ""Multiplicity of 13-1 A-xylanase in microorganisms: Functions and applications"", MICROBIOL. REV., vol. 52, 1988, pages 305 - 317;;TENKANEN, M.; POUTANEN, K.: ""Xylans and Xylanases"", 1992, ELSEVIER, article ""Significance of esterases in the degradation of xylans"", pages: 203 - 212;;COUGHLAN, M. P.; HAZLEWOOD, G. P., HEMICELLULOSE AND HEMICELLULASES, 1993;;BRIGHAM, J. S.; ADNEY, W. S.; HIMMEL, M. E.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Hemicellulases: Diversity and applications"", pages: 119 - 141;;""Enzyme Nomenclature"", vol. 1, 2, 3,, 1992, ACADEMIC PRESS;;EUR. J. BIOCHEM., vol. 223, 1994, pages 1 - 5;;EUR. J. BIOCHEM., vol. 232, 1995, pages 1 - 6;;EUR. J. BIOCHEM., vol. 237, 1996, pages 1 - 5;;EUR. J. BIOCHEM., vol. 250, 1997, pages 1 - 6;;EUR. J. BIOCHEM., vol. 264, 1999, pages 610 - 650;;KOAZE ET AL., AGR. BIOL. CHEM. JAPAN, vol. 28, 1964, pages 216;;YOSHIDA, J. AGR. CHEM. SOC. JAPAN, vol. 28, 1954, pages 66;;HAYASHIDA ET AL., AGRIC. BIOL. CHEM., vol. 42, 1977, pages 927 - 933;;A.J. BARRETT, N.D. RAWLINGS AND J.F. WOESSNER,: ""Handbook of Proteolytic Enzymes"", 1998, ACADEMIC PRESS;;BERKA ET AL., GENE, vol. 96, 1990, pages 313;;BERKA ET AL., GENE, vol. 125, 1993, pages 195 - 198;;GOMI ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 57, 1993, pages 1095 - 1100;;DARTOIS ET AL., BIOCHEMICA ET BIOPHYSICA ACTA, vol. 1131, 1993, pages 253 - 360;;MONTENECOURT; EVELEIGH, ADV. CHEM. SER., vol. 181, 1979, pages 289 - 301;;MALONE ET AL., ELECTROPHORESIS, vol. 22, 2001, pages 919 - 932;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;ALTSCHUL, J. MOL. BIOL., vol. 215, 1990, pages 403 - 410;;HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 10915 - 10919;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;ZDOBNOV; APWEILER, BIOINFORMATICS, vol. 17, 2001, pages 847 - 848;;SIGRIST ET AL., BRIEF BIOINFORM., vol. 3, 2002, pages 265 - 274;;KATOH ET AL., NUCLEIC ACIDS RESEARCH, vol. 30, 2002, pages 3059;;CHRISTENSEN ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 1419 - 1422;;CUMMINGS ET AL., CURRENT GENETICS, vol. 36, 1999, pages 371 - 82;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;LEVER, M.: ""A new reaction for colorimetric determination of carbohydrates"", ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279",ACTIVE
507,US,A1,US 2005/0191736 A1,175-581-140-374-018,2005-09-01,2005,US 4612405 A,2005-01-28,US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity andpolynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES BIOTECH INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,NOVOZYMES INC (2005-02-09),https://lens.org/175-581-140-374-018,Patent Application,yes,1,47,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07H21/04;;C07K14/37;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06,435/161;;435/69.1;;435/209;;435/252.3;;435/320.1;;536/23.2,0,0,,,,ACTIVE
508,EP,A2,EP 1713825 A2,171-595-430-861-588,2006-10-25,2006,EP 05722727 A,2005-01-28,US 2005/0003525 W;;US 54066104 P,2004-01-30,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/171-595-430-861-588,Patent Application,yes,0,0,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12N15/82;;C12P7/06;;C12P21/06;;D21C1/00,,0,0,,,,ACTIVE
509,EP,B1,EP 1713825 B1,032-076-179-040-266,2012-08-01,2012,EP 05722727 A,2005-01-28,US 2005/0003525 W;;US 54066104 P,2004-01-30,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,,NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/032-076-179-040-266,Granted Patent,yes,5,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12N15/82;;C12P7/06;;C12P21/06;;D21C1/00,,4,0,,,"SALOHEIMO M ET AL: ""CDNA CLONING OF A TRICHODERMA REESEI CELLULASE AND DEMONSTRATION OFENDOGLUCANASE ACTIVITY BY EXPRESSION IN YEAST"" EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 249, no. 2, October 1997 (1997-10), pages 584-591, XP002053367 ISSN: 0014-2956;;LEV SOPHIE ET AL: ""A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection."" PLANT CELL, vol. 15, no. 4, April 2003 (2003-04), pages 835-844, XP002415198 ISSN: 1040-4651;;GALAGAN J E ET AL: ""The genome sequence of the filamentous fungus Neurospora crassa"" NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 422, no. 6934, 24 April 2003 (2003-04-24), pages 859-868, XP002365858 ISSN: 0028-0836 -& DATABASE UniProt 15 December 2003 (2003-12-15), XP002415905 retrieved from UNIPROT accession no. Q7RWN7 Database accession no. Q7RWN7;;ALTENSCHMIDT ET AL: 'Evidence that enzymes of a novel aerobic 2-amino-benzoate metabolism in denitrifying Pseudomonas are coded on a small plasmid' EUR J BIOCHEM. vol. 194, 1990, pages 647 - 653, XP002993916",ACTIVE
510,WO,A2,WO 2005/074647 A2,194-195-534-130-247,2005-08-18,2005,US 2005/0003525 W,2005-01-28,US 54066104 P,2004-01-30,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/194-195-534-130-247,Patent Application,yes,93,378,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07H21/04;;C07K14/37;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06,,116,98,014-625-826-302-514;;127-544-305-672-969;;118-711-156-754-483;;038-383-743-124-048;;082-474-862-036-218;;009-304-049-487-981;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;054-167-555-136-715;;046-475-261-047-666;;023-969-505-910-047;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;017-950-663-195-977;;003-307-199-216-170;;060-909-037-461-654;;034-499-320-202-349;;010-606-868-765-729;;058-313-563-307-746;;009-052-884-271-430;;168-467-332-279-864;;023-207-730-709-584;;044-918-409-011-81X;;000-743-569-588-265;;043-692-295-433-161;;001-807-171-352-291;;053-608-860-045-291;;017-893-128-543-273;;122-107-077-421-078;;056-172-488-299-694;;015-652-210-164-846;;130-374-497-909-295;;036-168-690-647-51X;;031-015-979-474-454;;021-946-971-259-170;;024-708-797-947-714;;015-065-490-448-969;;013-458-224-516-628;;008-437-576-847-072;;014-774-168-809-047;;001-824-374-248-456;;175-295-822-939-63X;;045-548-779-820-017;;029-940-225-165-635;;031-097-124-288-463;;050-772-251-736-949;;039-117-124-686-257;;114-153-099-971-73X;;058-030-884-026-400;;014-708-690-338-262;;000-371-756-809-284;;056-201-471-905-934;;023-907-179-348-058;;022-715-862-716-318;;001-150-252-595-427;;066-958-649-977-052;;046-589-579-918-068;;028-862-168-091-90X;;136-261-375-157-758;;009-052-884-271-430,10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;10.1016/s0065-2164(08)70598-7;;10.1093/bioinformatics/5.2.151;;2720464;;pmc393452;;6572363;;10.1073/pnas.80.3.726;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;10.1016/1046-5928(91)90057-p;;1821793;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1016/s0958-1669(05)80029-1;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1016/0960-8524(94)90214-3;;10.1007/bf02920289;;10.1351/pac198759020257;;10.1016/0003-2697(72)90301-6;;5031119;;10.1016/0014-5793(82)81092-2;;10.1016/0014-5793(85)81260-6;;10.1016/s0021-9258(18)69254-3;;3093475;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-#;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-;;11930943;;10.1016/s0168-1656(97)00073-4;;9246788;;3843705;;10.1016/0003-2697(85)90442-7;;10514248;;10.1021/bp990109e;;10.1016/0141-0229(80)90063-0;;10.1016/0141-0229(85)90114-0;;10.1002/bit.260250106;;18548538;;10.1007/bf02786945;;10.1021/bp990110d;;10514251;;pmc120791;;10.1128/mmbr.66.3.506-577.2002;;12209002;;12172602;;10.1007/s00253-002-1046-0;;10.1016/0032-9592(95)80001-8;;18576101;;10.1007/bf02920444;;15286988;;10.1002/bit.20156;;10.2166/wst.1997.0573;;10.1016/s0961-9534(97)00020-2;;10.1007/bf02918984;;8391777;;9572962;;10.1128/aem.64.5.1852-1859.1998;;pmc106241;;18600763;;10.1002/bit.260380311;;10.1002/(sici)1097-0290(19980420)58:2/3<204::aid-bit13>3.0.co;2-c;;10191391;;17791346;;10.1126/science.267.5195.240;;pmc168273;;10.1128/aem.62.12.4465-4470.1996;;8953718;;3141761;;10.1128/mr.52.3.305-317.1988;;pmc373146;;10.1046/j.1432-1327.1999.nomen.x;;10491110;;8462873;;10.1016/0378-1119(93)90328-z;;7763981;;10.1271/bbb.57.1095;;10.1021/ba-1979-0181.ch014;;10.1002/1522-2683()22:5<919::aid-elps919>3.0.co;2-u;;10.1002/1522-2683()22:5<919::aid-elps919>3.3.co;2-l;;11332760;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;pmc50453;;1438297;;10.1073/pnas.89.22.10915;;9051728;;10.1093/protein/10.1.1;;10.1093/bioinformatics/17.9.847;;11590104;;12230035;;10.1093/bib/3.3.265;;pmc135756;;12136088;;10.1093/nar/gkf436;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/0166-0934(92)90168-d;;1322932;;10.1016/0003-2697(72)90301-6;;5031119,"HENRISSAT B.: ""A classification of glycosyl hydrolases based on amino-acid sequence similarities"", BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT B.; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BIOCHEM. J., vol. 316, 1996, pages 695 - 696;;GHOSH, P.; SINGH, A.: ""Physicochemical and biological treatments for enzymatic/microbial conversion of lignocellulosic biomass"", ADV. APPL. MICROBIOL., vol. 39, 1993, pages 295 - 333;;VALLANDER, L.; ERIKSSON, K.-E. L.: ""Production of ethanol from lignocellulosic materials: State of the art"", ADV. BIOCHEM. ENG.LBIOTECHNOL., vol. 42, 1990, pages 63 - 95;;HIGGINS, CABIOS, vol. 5, 1989, pages 151 - 153;;WATERMAN ET AL., ADV. MATH., vol. 20, 1976, pages 367;;WILBUR; LIPMAN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 80, 1983, pages 726 - 730;;BOLTON; MCCARTHY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 48, 1962, pages 1390;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEM, vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;SMITH ET AL., JOURNAL OF MOLECULAR BIOLOGY, vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETTERS, vol. 309, 1992, pages 59 - 64;;VILLA-KAMAROFF ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 80, 1983, pages 21 - 25;;""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOLECULAR CELLULAR BIOLOGY, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOLECULAR GENERAL GENETICS, vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZIN, JOURNAL OF BACTERIOLOGY, vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, JOURNAL OF MOLECULAR BIOLOGY, vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER; THORNE, JOURNAL OF BACTERIOLOGY, vol. 169, 1987, pages 5771 - 5278;;YELTON ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1984, pages 1470 - 1474;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;ITO ET AL., JOURNAL OF BACTERIOLOGY, vol. 153, 1983, pages 163;;HINNEN ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1920;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MO. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS; CORUZZI, ANN. REV. GENET., vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., JOURNAL OF PLANT PHYSIOLOGY, vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOLOGY, vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOLECULAR BIOLOGY, vol. 26, 1994, pages 85 - 93;;KAGAYA ET AL., MOLECULAR AND GENERAL GENETICS, vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOLECULAR BIOLOGY, vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIOLTECHNOLOAV, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOLECULAR BIOLOGY, vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT JOURNAL, vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CURRENT OPINION BIOTECHNOLOGY, vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH ET AL., PLANT MOLECULAR BIOLOGY, vol. 21, 1993, pages 415 - 428;;WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16;;LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24, no. 25, 1990, pages 695 - 719;;GHOSE, PURE AND APPL. CHEM., vol. 59, 1987, pages 257 - 268;;LEVER ET AL., ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279;;VAN TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156;;VAN TILBEURGH; CLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288;;HIMMEL ET AL., J. BIOL. CHEM., vol. 261, 1986, pages 12948 - 12955;;VENTURI ET AL., J. BASIC MICROBIOL., vol. 42, 2002, pages 55 - 66;;LEE, JOURNAL OF BIOTECHNOLOGY, vol. 56, 1997, pages 1 - 24;;P.K. SMITH ET AL., ANAL. BIOCHEM., vol. 150, 1985, pages 76;;LYND, L. R.; WYMAN, C. E.; GERNGROSS, T. U., BIOCOMMODITY ENGINEERING, BIOTECHNOL. PROG., vol. 15, 1999, pages 777 - 793;;RYU, D. D. Y.; MANDELS, M.: ""Cellulases: biosynthesis and applications"", ENZ. MICROB. TECHNOL., vol. 2, 1980, pages 91 - 102;;GUSAKOV, A. V.; SINITSYN, A. P.: ""Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical model for a batch reactor process"", ENZ. MICROB. TECHNOL., vol. 7, 1985, pages 346 - 352;;RYU, S. K.; LEE, J. M: ""Bioconversion of waste cellulose by using an attrition bioreactor"", BIOTECHNOL. BIOENG., vol. 25, 1983, pages 53 - 65;;GUSAKOV, A. V.; SINITSYN, A. P.; DAVYDKIN, I. Y.; DAVYDKIN, V. Y.; PROTAS, O. V.: ""Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field"", APPL. BIOCHEM. BIOTECHNOL., vol. 56, 1996, pages 141 - 153;;SHEEHAN, J.; HIMMEL, M.: ""Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol"", BIOTECHNOL. PROG., vol. 15, 1999, pages 817 - 827;;LYND, L. R.; WEIMER, P. J.; VAN ZYL, W. H.; PRETORIUS, I. S.: ""Microbial cellulose utilization: Fundamentals and biotechnology"", MICROBIOL. MOL. BIOL. REVIEWS, vol. 66, 2002, pages 506 - 577;;SILVEIRA, M. M.; JONAS, R.: ""The biotechnological production of sorbitol"", APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 400 - 408;;NIGAM, P.; SINGH, D.: ""Processes for fermentative production of xylitol - a sugar substitute"", PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124;;EZEJI, T. C.; QURESHI, N.; BLASCHEK, H. P.: ""Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping"", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603;;CHEN, R.; LEE, Y. Y.: ""Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass"", APPL. BIOCHEM. BIOTECHNOL., vol. 63-65, 1997, pages 435 - 448;;RICHARD, A.; MARGARITIS, A.: ""Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515;;KATAOKA, N.; A. MIYA; K. KIRIYAMA: ""Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria"", WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 41 - 47;;GUNASEELAN V.N., BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114;;CHEN, Z.; HO, N. W. Y.: ""Cloning and improving the expression of Pichia stipitis xylose reductase gene in Saccharomyces cerevisiae"", APPL. BIOCHEM. BIOTECHNOL., vol. 39-40, 1993, pages 135 - 147;;HO, N. W. Y.; CHEN, Z, BRAINARD, A. P.: ""Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose"", APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 1852 - 1859;;BEALL, D. S.; OHTA, K.; INGRAM, L. 0.: ""Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli"", BIOTECH. BIOENG., vol. 38, 1991, pages 296 - 303;;INGRAM, L. 0.; GOMES, P. F.; LAI, X.; MONIRUZZAMAN, M.; WOOD, B. E.; YOMANO, L. P.; YORK, S. W.: ""Metabolic engineering of bacteria for ethanol production"", BIOTECHNOL. BIOENG., vol. 58, 1998, pages 204 - 214;;ZHANG, M.; EDDY, C.; DEANDA, K.; FINKELSTEIN, M.; PICATAGGIO, S.: ""Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis"", SCIENCE, vol. 267, 1995, pages 240 - 243;;DEANDA, K.; ZHANG, M.; EDDY, C.; PICATAGGIO, S.: ""Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering"", APPL. ENVIRON. MICROBIOL., vol. 62, 1996, pages 4465 - 4470;;WONG, K.K.Y.; TAN, L. U. L.; SADDLER, J. N.: ""Multiplicity of P-1,4-xylanase in microorganisms: Functions and applications"", MICROBIOL. REV., vol. 52, 1988, pages 305 - 317;;COUGHLAN, M. P.; HAZLEWOOD, G. P., HEMICELLULOSE AND HEMICELLULASES, 1993;;EUR. J. BIOCHEM., vol. 223, 1994, pages 1 - 5;;EUR. J. BIOCHEM., vol. 232, 1995, pages 1 - 6;;EUR. J. BIOCHEM., vol. 237, 1996, pages 1 - 5;;EUR. J. BIOCHEM., vol. 250, 1997, pages 1 - 6;;EUR. J. BIOCHEM., vol. 264, 1999, pages 610 - 650;;YOSHIDA, J. AGR. CHEM. SOC. JAPAN, vol. 28, 1954, pages 66;;HAYASHIDA ET AL., AGRIC. BIOL. CHEM., vol. 42, 1977, pages 927 - 933;;BERKA ET AL., GENE, vol. 96, 1990, pages 313;;BERKA ET AL., GENE, vol. 125, 1993, pages 195 - 198;;GOMI ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 57, 1993, pages 1095 - 1100;;DARTOIS ET AL., BIOCHEMICA ET BIOPHYSICA ACTA, vol. 1131, 1993, pages 253 - 360;;MONTENECOURT; EVELEIGH, ADV. CHEM. SER., vol. 181, 1979, pages 289 - 301;;MALONE ET AL., ELECTROPHORESIS, vol. 22, 2001, pages 919 - 932;;D'ALESSIO ET AL., FOCUS®, vol. 14, 1992, pages 76;;ALTSCHUL, J. MOL. BIOL., vol. 215, 1990, pages 403 - 410;;HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 10915 - 10919;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;ZDOBNOV; APWEILER, BIOINFORMATICS, vol. 17, 2001, pages 847 - 848;;SIGRIST ET AL., BRIEF BIOINFORM., vol. 3, 2002, pages 265 - 274;;KATOH ET AL., NUCLEIC ACIDS RESEARCH, vol. 30, 2002, pages 3059;;CHRISTENSEN ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 1419 - 1422;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;LEVER, M.: ""A new reaction for colorimetric determination of carbohydrates"", ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279;;See also references of EP 1713825A4",PENDING
511,US,A1,US 2016/0289279 A1,108-975-820-400-496,2016-10-06,2016,US 201615188731 A,2016-06-21,US 201615188731 A;;US 201414500520 A;;US 201213650954 A;;US 76018610 A;;US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides Having Cellulolytic Enhancing Activity And Nucleic Acids Encoding Same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/108-975-820-400-496,Patent Application,yes,0,0,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P7/14;;C12P19/02;;C12P19/14;;C12P21/06,,0,0,,,,ACTIVE
512,EP,A1,EP 2301958 A1,114-974-899-147-552,2011-03-30,2011,EP 10180399 A,2005-01-28,EP 05722727 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPES DE LEON ALFREDO,,https://lens.org/114-974-899-147-552,Patent Application,yes,94,1,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,145,107,162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604;;014-625-826-302-514;;127-544-305-672-969;;076-132-223-936-79X;;118-711-156-754-483;;044-160-688-806-618;;058-145-297-843-203;;038-383-743-124-048;;082-474-862-036-218;;009-304-049-487-981;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;054-167-555-136-715;;046-475-261-047-666;;023-969-505-910-047;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;017-950-663-195-977;;003-307-199-216-170;;060-909-037-461-654;;034-499-320-202-349;;010-606-868-765-729;;058-313-563-307-746;;009-052-884-271-430;;168-467-332-279-864;;023-207-730-709-584;;044-918-409-011-81X;;000-743-569-588-265;;043-692-295-433-161;;001-807-171-352-291;;053-608-860-045-291;;017-893-128-543-273;;122-107-077-421-078;;056-172-488-299-694;;015-652-210-164-846;;130-374-497-909-295;;036-168-690-647-51X;;031-015-979-474-454;;021-946-971-259-170;;024-708-797-947-714;;015-065-490-448-969;;013-458-224-516-628;;008-437-576-847-072;;014-774-168-809-047;;001-824-374-248-456;;175-295-822-939-63X;;045-548-779-820-017;;029-940-225-165-635;;031-097-124-288-463;;018-434-146-384-724;;050-772-251-736-949;;090-877-130-256-158;;039-117-124-686-257;;114-153-099-971-73X;;058-030-884-026-400;;014-708-690-338-262;;000-371-756-809-284;;136-261-375-157-758;;056-201-471-905-934;;023-907-179-348-058;;022-715-862-716-318;;001-150-252-595-427;;066-958-649-977-052;;046-589-579-918-068;;062-094-540-176-015;;028-862-168-091-90X;;009-052-884-271-430,10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;10.1201/9780203752456-10;;10.1016/s0065-2164(08)70598-7;;10.1007/3-540-49194-5_9;;10533436;;10.1016/0141-0229(95)00157-3;;10.1093/bioinformatics/5.2.151;;2720464;;pmc393452;;6572363;;10.1073/pnas.80.3.726;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;10.1016/1046-5928(91)90057-p;;1821793;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1016/s0958-1669(05)80029-1;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1016/0960-8524(94)90214-3;;10.1007/bf02920289;;10.1351/pac198759020257;;10.1016/0003-2697(72)90301-6;;5031119;;10.1016/0014-5793(82)81092-2;;10.1016/0014-5793(85)81260-6;;10.1016/s0021-9258(18)69254-3;;3093475;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-#;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-;;11930943;;10.1016/s0168-1656(97)00073-4;;9246788;;3843705;;10.1016/0003-2697(85)90442-7;;10514248;;10.1021/bp990109e;;10.1016/0141-0229(80)90063-0;;10.1016/0141-0229(85)90114-0;;10.1002/bit.260250106;;18548538;;10.1007/bf02786945;;10.1021/bp990110d;;10514251;;pmc120791;;10.1128/mmbr.66.3.506-577.2002;;12209002;;12172602;;10.1007/s00253-002-1046-0;;10.1016/0032-9592(95)80001-8;;18576101;;10.1007/bf02920444;;15286988;;10.1002/bit.20156;;10.2166/wst.1997.0573;;10.1016/s0961-9534(97)00020-2;;10.1007/bf02918984;;8391777;;9572962;;10.1128/aem.64.5.1852-1859.1998;;pmc106241;;18600763;;10.1002/bit.260380311;;10.1002/(sici)1097-0290(19980420)58:2/3<204::aid-bit13>3.0.co;2-c;;10191391;;17791346;;10.1126/science.267.5195.240;;pmc168273;;10.1128/aem.62.12.4465-4470.1996;;8953718;;10.1007/s00253-002-1092-7;;12382043;;3141761;;10.1128/mr.52.3.305-317.1988;;pmc373146;;10.1201/9780203752456-7;;10.1046/j.1432-1327.1999.nomen.x;;10491110;;8462873;;10.1016/0378-1119(93)90328-z;;7763981;;10.1271/bbb.57.1095;;10.1021/ba-1979-0181.ch014;;10.1002/1522-2683()22:5<919::aid-elps919>3.0.co;2-u;;10.1002/1522-2683()22:5<919::aid-elps919>3.3.co;2-l;;11332760;;10.1016/0166-0934(92)90168-d;;1322932;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;pmc50453;;1438297;;10.1073/pnas.89.22.10915;;9051728;;10.1093/protein/10.1.1;;10.1093/bioinformatics/17.9.847;;11590104;;12230035;;10.1093/bib/3.3.265;;pmc135756;;12136088;;10.1093/nar/gkf436;;10.1007/s002940050512;;10654091;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/0003-2697(72)90301-6;;5031119,"SALOHEIMO M ET AL: ""CDNA CLONING OF A TRICHODERMA REESEI CELLULASE AND DEMONSTRATION OFENDOGLUCANASE ACTIVITY BY EXPRESSION IN YEAST"", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 249, no. 2, October 1997 (1997-10-01), pages 584 - 591, XP002053367, ISSN: 0014-2956;;LEV SOPHIE ET AL: ""A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection."", PLANT CELL, vol. 15, no. 4, April 2003 (2003-04-01), pages 835 - 844, XP002415198, ISSN: 1040-4651;;GALAGAN J E ET AL: ""The genome sequence of the filamentous fungus Neurospora crassa"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 422, no. 6934, 24 April 2003 (2003-04-24), pages 859 - 868, XP002365858, ISSN: 0028-0836;;HENRISSAT B.: ""A classification of glycosyl hydrolases based on amino-acid sequence similarities"", BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT B.; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BIOCHEM. J., vol. 316, 1996, pages 695 - 696;;HSU, T.-A.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Pretreatment of biomass"", pages: 179 - 212;;GHOSH, P.; SINGH, A.: ""Physicochemical and biological treatments for enzymatic/microbial conversion of lignocellulosic biomass"", ADV. APPL. MICROBIOL., vol. 39, 1993, pages 295 - 333;;MCMILLAN, J. D.: ""Enzymatic Conversion of Biomass for Fuels Production"", 1994, AMERICAN CHEMICAL SOCIETY, article ""Pretreating lignocellulosic biomass: a review"";;GONG, C. S.; CAO, N. J.; DU, J.; TSAO, G. T.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Ethanol production from renewable resources"", pages: 207 - 241;;OLSSON, L.; HAHN-HAGERDAL, B.: ""Fermentation of lignocellulosic hydrolysates for ethanol production"", ENZ. MICROB. TECH., vol. 18, 1996, pages 312 - 331;;VALLANDER, L.; ERIKSSON, K.-E. L.: ""Production of ethanol from lignocellulosic materials: State of the art"", ADV. BIOCHEM. ENG.LBIOTECHNOL., vol. 42, 1990, pages 63 - 95;;HIGGINS, CABIOS, vol. 5, 1989, pages 151 - 153;;WATERMAN ET AL., ADV. MATH., vol. 20, 1976, pages 367;;WILBUR; LIPMAN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 80, 1983, pages 726 - 730;;J. SAMBROOK; E.F. FRITSCH; T. MANIATUS: ""Molecular Cloning, A Laboratory Manual"", 1989, COLD SPRING HARBOR;;BOLTON; MCCARTHY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 48, 1962, pages 1390;;H. NEURATH; R.L. HILL: ""The Proteins"", 1979, ACADEMIC PRESS;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEM., vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;INNIS ET AL.: ""PCR: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;SMITH ET AL., JOURNAL OF MOLECULAR BIOLOGY, vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETTERS, vol. 309, 1992, pages 59 - 64;;VILLA-KAMAROFF ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 80, 1983, pages 21 - 25;;""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOLECULAR CELLULAR BIOLOGY, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOLECULAR GENERAL GENETICS, vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZIN, JOURNAL OF BACTERIOLOGY, vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, JOURNAL OF MOLECULAR BIOLOGY, vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER; THORNE, JOURNAL OF BACTERIOLOGY, vol. 169, 1987, pages 5771 - 5278;;HAWKSWORTH ET AL.: ""Ainsworth and Bisby's Dictionary of The Fungi"", 1995, CAB INTERNATIONAL, UNIVERSITY PRESS;;SKINNER, F.A., PASSMORE, S.M., AND DAVENPORT, R.R.,: ""Biology and Activities of Yeast"", 1980, SOC. APP. BACTERIOL.;;YELTON ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1984, pages 1470 - 1474;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;BECKER; GUARENTE: ""Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., article ""Guide to Yeast Genetics and Molecular Biology"", pages: 182 - 187;;ITO ET AL., JOURNAL OF BACTERIOLOGY, vol. 153, 1983, pages 163;;HINNEN ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1920;;J.-C. JANSON AND LARS RYDEN: ""Protein Purification"", 1989, VCH PUBLISHERS;;TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MO. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS; CORUZZI, ANN. REV. GENET, vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., JOURNAL OF PLANT PHYSIOLOGY, vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOLOGY, vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOLECULAR BIOLOGY, vol. 26, 1994, pages 85 - 93;;KAGAYA ET AL., MOLECULAR AND GENERAL GENETICS, vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOLECULAR BIOLOGY, vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIOLTECHNOLOGY, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOLECULAR BIOLOGY, vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT JOURNAL, vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CURRENT OPINION BIOTECHNOLOGY, vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH ET AL., PLANT MOLECULAR BIOLOGY, vol. 21, no. 41, 1993, pages 5 - 428;;WISELOGEL ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 1 05 - 118;;WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16;;LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24/25, 1990, pages 695 - 719;;MOSIER ET AL.: ""Recent Progress in Bioconversion of Lignocellulosics"", 1999, article ""R"";;T. SCHEPER,: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, SPRINGER-VERLAG, pages: 23 - 40;;BENNETT, J.W. AND LASURE, L.: ""More Gene Manipulations in Fungi"", 1991, ACADEMIC PRESS;;BAILEY, J.E.; OLLIS, D.F.: ""Biochemical Engineering Fundamentals"", 1986, MCGRAW-HILL BOOK COMPANY;;GHOSE, PURE AND APPL. CHEM., vol. 59, 1987, pages 257 - 268;;LEVER ET AL., ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279;;VAN TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156;;VAN TILBEURGH; CLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288;;HIMMEL ET AL., J. BIOL. CHEM., vol. 261, 1986, pages 12948 - 12955;;VENTURI ET AL., J. BASIC MICROBIOL., vol. 42, 2002, pages 55 - 66;;BRIGHAM ET AL.: ""Handbook on Bioethanol"", TAYLOR & FRANCIS, pages: 119 - 141;;LEE, JOURNAL OF BIOTECHNOLOGY, vol. 56, 1997, pages 1 - 24;;P.K. SMITH ET AL., ANAL. BIOCHEM., vol. 150, 1985, pages 76;;LYND, L. R.; WYMAN, C. E.; GERNGROSS, T. U., BIOCOMMODITY ENGINEERING, BIOTECHNOL. PROG., vol. 15, 1999, pages 777 - 793;;PHILIPPIDIS, G. P.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Cellulose bioconversion technology"", pages: 179 - 212;;RYU, D. D. Y.; MANDELS, M.: ""Cellulases: biosynthesis and applications"", ENZ. MICROB. TECHNOL., vol. 2, 1980, pages 91 - 102;;GUSAKOV, A. V.; SINITSYN, A. P.: ""Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical model for a batch reactor process"", ENZ. MICROB. TECHNOL., vol. 7, 1985, pages 346 - 352;;RYU, S. K.; LEE, J. M.: ""Bioconversion of waste cellulose by using an attrition bioreactor"", BIOTECHNOL. BIOENG., vol. 25, 1983, pages 53 - 65;;GUSAKOV, A. V.; SINITSYN, A. P.; DAVYDKIN, I. Y.; DAVYDKIN, V. Y.; PROTAS, O. V.: ""Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field"", APPL. BIOCHEM. BIOTECHNOL., vol. 56, 1996, pages 141 - 153;;SHEEHAN, J.; HIMMEL, M.: ""Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol"", BIOTECHNOL. PROG., vol. 15, 1999, pages 817 - 827;;LYND, L. R.; WEIMER, P. J.; VAN ZYL, W. H.; PRETORIUS, I. S.: ""Microbial cellulose utilization: Fundamentals and biotechnology"", MICROBIOL. MOL. BIOL. REVIEWS, vol. 66, 2002, pages 506 - 577;;SILVEIRA, M. M.; JONAS, R.: ""The biotechnological production of sorbitol"", APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 400 - 408;;NIGAM, P.; SINGH, D.: ""Processes for fermentative production of xylitol - a sugar substitute"", PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124;;EZEJI, T. C.; QURESHI, N.; BLASCHEK, H. P.: ""Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping"", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603;;CHEN, R.; LEE, Y. Y.: ""Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass"", APPL. BIOCHEM. BIOTECHNOL., vol. 63-65, 1997, pages 435 - 448;;RICHARD, A.; MARGARITIS, A.: ""Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515;;KATAOKA, N.; A. MIYA; K. KIRIYAMA: ""Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria"", WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 41 - 47;;GUNASEELAN V.N., BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114;;CHEN, Z.; HO, N. W. Y.: ""Cloning and improving the expression of Pichia stipitis xylose reductase gene in Saccharomyces cerevisiae"", APPL. BIOCHEM. BIOTECHNOL., vol. 39-40, 1993, pages 135 - 147;;HO, N. W. Y.; CHEN, Z; BRAINARD, A. P.: ""Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose"", APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 1852 - 1859;;BEALL, D. S.; OHTA, K.; INGRAM, L. 0.: ""Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli"", BIOTECH. BIOENG., vol. 38, 1991, pages 296 - 303;;INGRAM, L. 0.; GOMES, P. F.; LAI, X.; MONIRUZZAMAN, M.; WOOD, B. E.; YOMANO, L. P.; YORK, S. W.: ""Metabolic engineering of bacteria for ethanol production"", BIOTECHNOL. BIOENG, vol. 58, 1998, pages 204 - 214;;ZHANG, M.; EDDY, C.; DEANDA, K.; FINKELSTEIN, M.; PICATAGGIO, S.: ""Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis"", SCIENCE, vol. 267, 1995, pages 240 - 243;;DEANDA, K.; ZHANG, M.; EDDY, C.; PICATAGGIO, S.: ""Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering"", APPL. ENVIRON. MICROBIOL., vol. 62, 1996, pages 4465 - 4470;;K. JACQUES, T.P. LYONS AND D.R. KELSALL,: ""The Alcohol Textbook"", 1999, NOTTINGHAM UNIVERSITY PRESS;;ALFENORE ET AL.: ""Improving ethanol production and viability of Saccharomyces cerevisiae by a vitamin feeding strategy during fed-batch process"", 2002, SPRINGER-VERLAG;;WONG, K.K.Y.; TAN, L. U. L.; SADDLER, J. N.: ""Multiplicity of 13-1 A-xylanase in microorganisms: Functions and applications"", MICROBIOL. REV., vol. 52, 1988, pages 305 - 317;;TENKANEN, M.; POUTANEN, K.: ""Xylans and Xylanases"", 1992, ELSEVIER, article ""Significance of esterases in the degradation of xylans"", pages: 203 - 212;;COUGHLAN, M. P.; HAZLEWOOD, G. P., HEMICELLULOSE AND HEMICELLULASES, 1993;;BRIGHAM, J. S.; ADNEY, W. S.; HIMMEL, M. E.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Hemicellulases: Diversity and applications"", pages: 119 - 141;;""Enzyme Nomenclature"", 1992, ACADEMIC PRESS;;EUR. J. BIOCHEM., vol. 223, 1994, pages 1 - 5;;EUR. J. BIOCHEM., vol. 232, 1995, pages 1 - 6;;EUR. J. BIOCHEM., vol. 237, 1996, pages 1 - 5;;EUR. J. BIOCHEM., vol. 250, 1997, pages 1 - 6;;EUR. J. BIOCHEM., vol. 264, 1999, pages 610 - 650;;KOAZE ET AL., AGR. BIOL. CHEM. JAPAN, vol. 28, 1964, pages 216;;YOSHIDA, J. AGR. CHEM. SOC. JAPAN, vol. 28, 1954, pages 66;;HAYASHIDA ET AL., AGRIC. BIOL. CHEM., vol. 42, 1977, pages 927 - 933;;A.J. BARRETT, N.D. RAWLINGS AND J.F. WOESSNER: ""Handbook of Proteolytic Enzymes"", 1998, ACADEMIC PRESS;;BERKA ET AL., GENE, vol. 96, 1990, pages 313;;BERKA ET AL., GENE, vol. 125, 1993, pages 195 - 198;;GOMI ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 57, 1993, pages 1095 - 1100;;BRIGHAM ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 119 - 141;;DARTOIS ET AL., BIOCHEMICA ET BIOPHYSICA ACTA, vol. 1131, 1993, pages 253 - 360;;MONTENECOURT; EVELEIGH, ADV. CHEM. SER., vol. 181, 1979, pages 289 - 301;;MALONE ET AL., ELECTROPHORESIS, vol. 22, 2001, pages 919 - 932;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;ALTSCHUL, J. MOL. BIOL., vol. 215, 1990, pages 403 - 410;;HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 10915 - 10919;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;ZDOBNOV; APWEILER, BIOINFORMATICS, vol. 17, 2001, pages 847 - 848;;SIGRIST ET AL., BRIEF BIOINFORM., vol. 3, 2002, pages 265 - 274;;KATOH ET AL., NUCLEIC ACIDS RESEARCH, vol. 30, 2002, pages 3059;;CHRISTENSEN ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 1419 - 1422;;CUMMINGS ET AL., CURRENT GENETICS, vol. 36, 1999, pages 371 - 82;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;LEVER, M.: ""A new reaction for colorimetric determination of carbohydrates"", ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279",ACTIVE
513,WO,A3,WO 2005/074647 A3,137-045-643-503-056,2006-02-09,2006,US 2005/0003525 W,2005-01-28,US 54066104 P,2004-01-30,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/137-045-643-503-056,Search Report,yes,2,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07H21/04;;C07K14/37;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06,,2,1,027-341-230-117-147,10.1111/j.1432-1033.1990.tb15664.x;;2176602,"ALTENSCHMIDT ET AL: ""Evidence that enzymes of a novel aerobic 2-amino-benzoate metabolism in denitrifying Pseudomonas are coded on a small plasmid"", EUR J BIOCHEM., vol. 194, 1990, pages 647 - 653, XP002993916;;See also references of EP 1713825A4",PENDING
514,CN,A,CN 108728428 A,173-506-109-119-411,2018-11-02,2018,CN 201810383829 A,2005-01-28,US 54066104 P;;CN 200580010730 A,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES BIOTECH INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/173-506-109-119-411,Patent Application,no,2,0,47,47,0,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C12N9/42;;C07H21/04;;C07K14/37;;C11D3/386;;C11D7/42;;C12N1/21;;C12N15/56;;C12N15/74;;C12P7/06;;C12P19/14;;C12P21/06,,2,0,,,"MARKKU SALOHEIMO等: ""cDNA cloning of a Trichoderma reesei cellulase and demonstration of endoglucanase activity by expression in yeast"", 《EUROPEAN JOURNAL OF BIOCHEMISTRY》;;SOPHIE LEV等: ""A Mitogen-Activated Protein Kinase Pathway Modulates the Expression of Two Cellulase Genes in Cochliobolus heterostrophus during Plant Infection"", 《THE PLANT CELL》",DISCONTINUED
515,US,A1,US 2008/0206815 A1,020-647-156-033-70X,2008-08-28,2008,US 5319308 A,2008-03-21,US 5319308 A;;US 4612405 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/020-647-156-033-70X,Patent Application,yes,1,9,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C12P21/04;;C07H21/04;;C07K14/37;;C11D3/386;;C12N1/21;;C12N5/06;;C12N9/42;;C12N15/00;;C12N15/11;;C12N15/74;;C12P7/06;;C12P21/06,435/69.1;;536/23.2;;435/320.1;;435/325,0,0,,,,INACTIVE
516,CN,A,CN 113564147 A,079-050-980-889-070,2021-10-29,2021,CN 202110834873 A,2005-01-28,US 54066104 P;;CN 200580010730 A,2004-01-30,POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/079-050-980-889-070,Patent Application,no,4,0,47,47,0,C11D3/38645;;C12P19/14;;C12Y302/01021;;C12N9/2445;;C07K14/37;;C11D3/38645;;C12N15/52;;C12N15/63;;C12N9/2437;;Y02E50/10;;C12N15/52;;C12N15/63;;C12N1/14;;C12N1/16;;C12N1/20;;C12N1/12;;C12Y302/01021;;C12N9/2445;;Y02E50/10;;C07K14/37;;C11D3/38645;;C12N9/2437;;C12P7/14;;C12P19/02;;C12P19/14;;C12P2201/00;;C12P2203/00,C12N9/42;;C07H21/04;;C07K14/37;;C11D3/386;;C11D7/42;;C12N1/21;;C12N15/56;;C12N15/74;;C12P7/06;;C12P19/02;;C12P19/14;;C12P21/06,,1,0,,,"石军, 陈安国: ""木聚糖酶生产与应用研究进展"", 饲料工业, no. 09, pages 40 - 43",PENDING
517,CA,C,CA 2598183 C,023-853-254-724-527,2015-03-31,2015,CA 2598183 A,2006-02-15,US 65355905 P;;US 2006/0005435 W,2005-02-16,UNIVERSAL DENTAL X-RAY SENSOR HOLDER,"A dental x-ray sensor holder includes at least two clamping faces wherein at least one of the faces includes at least one and preferably a plurality of resiliently deformable gripping protrusions. The clamping faces are positioned in a moveable, spaced opposing relation, such that the faces may be physically moved together to physically impinge the x-ray sensor therebetween.",DENTSPLY INT INC,FENSKE LAWRENCE JON;;FALENDYSZ GREGORY;;MILLER JOHN AARON;;SUTRINA THOMAS ALBERT;;CHENG CUNJIANG;;BROWN KIMBERLY CLEMENTZ,,https://lens.org/023-853-254-724-527,Granted Patent,no,0,0,11,11,0,A61B6/4283;;G03B42/042;;A61B6/512,A61B6/14;;G03B42/04,,0,0,,,,ACTIVE
518,EP,A1,EP 2305703 A1,157-868-580-096-918,2011-04-06,2011,EP 10180414 A,2005-01-28,EP 05722727 A;;US 54066104 P,2004-01-30,Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",NOVOZYMES INC,BROWN KIMBERLY;;HARRIS PAUL;;ZARETSKY ELIZABETH;;RE EDWARD;;VLASENKO ELENA;;MCFARLAND KEITH;;LOPEZ DE LEON ALFREDO,,https://lens.org/157-868-580-096-918,Patent Application,yes,95,0,47,47,78,C07K14/37;;C07K14/37;;C11D3/38645;;C11D3/38645;;C11D3/38645;;C12N1/12;;C12N1/14;;C12N1/16;;C12N1/20;;C12N9/2437;;C12N9/2437;;C12N9/2445;;C12N9/2445;;C12N15/52;;C12N15/52;;C12N15/63;;C12N15/63;;C12P7/14;;C12P19/02;;C12P19/14;;C12P19/14;;C12P2201/00;;C12P2203/00;;C12Y302/01021;;C12Y302/01021;;Y02E50/10;;Y02E50/10,C07K14/37;;C07H21/04;;C11D3/386;;C12N1/21;;C12N9/42;;C12N15/74;;C12P7/06;;C12P21/06;;D21C1/00,,141,106,162-096-376-612-739;;002-005-360-072-282;;068-301-509-352-604;;014-625-826-302-514;;127-544-305-672-969;;076-132-223-936-79X;;118-711-156-754-483;;044-160-688-806-618;;058-145-297-843-203;;038-383-743-124-048;;082-474-862-036-218;;009-304-049-487-981;;018-694-084-068-187;;070-817-840-532-786;;021-301-666-722-431;;046-475-261-047-666;;023-969-505-910-047;;021-693-018-511-818;;056-456-509-029-170;;016-273-136-051-718;;097-970-813-772-582;;017-122-411-657-318;;054-167-555-136-715;;046-475-261-047-666;;023-969-505-910-047;;065-114-602-989-551;;101-171-874-734-776;;078-076-853-526-487;;012-080-214-127-41X;;128-525-405-434-397;;025-503-543-967-624;;014-838-854-923-114;;149-091-707-097-038;;155-753-457-046-234;;090-618-767-716-24X;;002-193-169-654-963;;081-998-197-866-158;;010-074-043-858-352;;038-624-922-825-362;;038-856-203-382-553;;043-147-746-491-691;;033-982-759-745-167;;068-401-154-984-319;;076-236-763-995-914;;062-087-232-646-614;;097-200-397-021-737;;050-373-967-507-684;;013-581-712-699-455;;105-547-095-395-400;;070-120-044-127-392;;055-808-270-016-270;;062-937-946-424-704;;031-698-500-840-834;;026-889-729-874-814;;024-592-311-652-595;;055-516-536-418-02X;;010-918-686-135-366;;017-950-663-195-977;;003-307-199-216-170;;060-909-037-461-654;;034-499-320-202-349;;010-606-868-765-729;;004-720-259-087-901;;058-313-563-307-746;;009-052-884-271-430;;168-467-332-279-864;;023-207-730-709-584;;044-918-409-011-81X;;000-743-569-588-265;;043-692-295-433-161;;001-807-171-352-291;;053-608-860-045-291;;017-893-128-543-273;;122-107-077-421-078;;056-172-488-299-694;;015-652-210-164-846;;130-374-497-909-295;;036-168-690-647-51X;;031-015-979-474-454;;021-946-971-259-170;;024-708-797-947-714;;015-065-490-448-969;;013-458-224-516-628;;008-437-576-847-072;;014-774-168-809-047;;001-824-374-248-456;;175-295-822-939-63X;;045-548-779-820-017;;029-940-225-165-635;;031-097-124-288-463;;050-772-251-736-949;;090-877-130-256-158;;039-117-124-686-257;;114-153-099-971-73X;;058-030-884-026-400;;000-371-756-809-284;;136-261-375-157-758;;056-201-471-905-934;;023-907-179-348-058;;022-715-862-716-318;;001-150-252-595-427;;066-958-649-977-052;;046-589-579-918-068;;062-094-540-176-015;;028-862-168-091-90X;;009-052-884-271-430,10.1111/j.1432-1033.1997.00584.x;;9370370;;pmc152332;;12671080;;10.1105/tpc.010546;;10.1038/nature01554;;12712197;;10.1042/bj2800309;;1747104;;pmc1130547;;10.1042/bj3160695;;8687420;;pmc1217404;;10.1201/9780203752456-10;;10.1016/s0065-2164(08)70598-7;;10.1007/3-540-49194-5_9;;10533436;;10.1016/0141-0229(95)00157-3;;10.1093/bioinformatics/5.2.151;;2720464;;pmc393452;;6572363;;10.1073/pnas.80.3.726;;13870855;;10.1073/pnas.48.8.1390;;pmc220964;;10.1126/science.2471267;;2471267;;10.1074/jbc.271.9.4699;;8617735;;1549776;;10.1126/science.1549776;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;10.1126/science.3388019;;3388019;;10.1073/pnas.86.7.2152;;2928323;;pmc286869;;10.1016/0378-1119(86)90398-7;;3803923;;10.1089/dna.1988.7.127;;3282853;;10.1038/12884;;10471932;;10.1016/1046-5928(91)90057-p;;1821793;;1569578;;10.1016/0022-2836(92)90457-u;;1511746;;10.1016/0014-5793(92)80739-4;;358198;;pmc392859;;10.1073/pnas.75.8.3727;;6337371;;10.1073/pnas.80.1.21;;pmc393301;;6154310;;10.1038/scientificamerican0480-74;;10.1002/yea.320080602;;1502852;;7565751;;pmc230850;;10.1128/mcb.15.11.5983;;pmc372902;;10.1128/mmbr.57.1.109-137.1993;;10.1128/mr.57.1.109-137.1993;;8464403;;10.1016/0378-1119(91)90104-j;;2013411;;pmc306460;;10.1093/nar/15.22.9163;;2825130;;10.1007/bf00267940;;107388;;13787458;;10.1128/jb.81.5.823-829.1961;;pmc279096;;4994568;;10.1016/0022-2836(71)90460-8;;3273636;;pmc213936;;10.1128/jb.169.11.5271-5278.1987;;3117774;;pmc344858;;6324193;;10.1073/pnas.81.5.1470;;2670677;;10.1016/0378-1119(89)90322-3;;10.1128/jb.153.1.163-168.1983;;pmc217353;;6336730;;10.1016/0092-8674(80)90136-1;;7407912;;1313711;;10.1007/bf00020010;;1821763;;10.1105/tpc.3.11.1155;;10.2307/3869223;;pmc160082;;2088170;;10.1146/annurev.ge.24.120190.001423;;10.1007/bf00014441;;8204824;;10.1093/oxfordjournals.pcp.a029449;;10.1016/s0176-1617(98)80034-5;;10.1093/oxfordjournals.pcp.a029457;;9816677;;10.1104/pp.102.3.991;;pmc158873;;8278540;;7948908;;10.1007/bf00039522;;7476869;;10.1007/bf02191706;;10.1007/bf00047399;;8343596;;17820660;;10.1126/science.244.4910.1293;;10.1038/338274a0;;10.1007/bf00015604;;1600167;;10.1111/j.1365-313x.1992.00275.x;;10.1016/s0958-1669(05)80029-1;;10.1038/nbt0692-667;;10.1007/bf00028800;;8443339;;10.1016/0960-8524(94)90214-3;;10.1007/bf02920289;;10.1016/c2009-0-02655-5;;10.1351/pac198759020257;;10.1016/0003-2697(72)90301-6;;5031119;;10.1016/0014-5793(82)81092-2;;10.1016/0014-5793(85)81260-6;;10.1016/s0021-9258(18)69254-3;;3093475;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-#;;10.1002/1521-4028(200203)42:1<55::aid-jobm55>3.0.co;2-;;11930943;;10.1016/s0168-1656(97)00073-4;;9246788;;3843705;;10.1016/0003-2697(85)90442-7;;10514248;;10.1021/bp990109e;;10.1016/0141-0229(80)90063-0;;10.1016/0141-0229(85)90114-0;;10.1002/bit.260250106;;18548538;;10.1007/bf02786945;;10.1021/bp990110d;;10514251;;pmc120791;;10.1128/mmbr.66.3.506-577.2002;;12209002;;12172602;;10.1007/s00253-002-1046-0;;10.1016/0032-9592(95)80001-8;;18576101;;10.1007/bf02920444;;15286988;;10.1002/bit.20156;;10.2166/wst.1997.0573;;10.1016/s0961-9534(97)00020-2;;10.1007/bf02918984;;8391777;;9572962;;10.1128/aem.64.5.1852-1859.1998;;pmc106241;;18600763;;10.1002/bit.260380311;;10.1002/(sici)1097-0290(19980420)58:2/3<204::aid-bit13>3.0.co;2-c;;10191391;;17791346;;10.1126/science.267.5195.240;;pmc168273;;10.1128/aem.62.12.4465-4470.1996;;8953718;;3141761;;10.1128/mr.52.3.305-317.1988;;pmc373146;;10.1201/9780203752456-7;;10.1046/j.1432-1327.1999.nomen.x;;10491110;;8462873;;10.1016/0378-1119(93)90328-z;;7763981;;10.1271/bbb.57.1095;;10.1002/1522-2683()22:5<919::aid-elps919>3.0.co;2-u;;10.1002/1522-2683()22:5<919::aid-elps919>3.3.co;2-l;;11332760;;10.1016/0166-0934(92)90168-d;;1322932;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;pmc50453;;1438297;;10.1073/pnas.89.22.10915;;9051728;;10.1093/protein/10.1.1;;10.1093/bioinformatics/17.9.847;;11590104;;12230035;;10.1093/bib/3.3.265;;pmc135756;;12136088;;10.1093/nar/gkf436;;10.1007/s002940050512;;10654091;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;10.1016/0003-2697(72)90301-6;;5031119,"SALOHEIMO M ET AL: ""CDNA CLONING OF A TRICHODERMA REESEI CELLULASE AND DEMONSTRATION OFENDOGLUCANASE ACTIVITY BY EXPRESSION IN YEAST"", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 249, no. 2, October 1997 (1997-10-01), pages 584 - 591, XP002053367, ISSN: 0014-2956;;LEV SOPHIE ET AL: ""A mitogen-activated protein kinase pathway modulates the expression of two cellulase genes in Cochliobolus heterostrophus during plant infection."", PLANT CELL, vol. 15, no. 4, April 2003 (2003-04-01), pages 835 - 844, XP002415198, ISSN: 1040-4651;;GALAGAN J E ET AL: ""The genome sequence of the filamentous fungus Neurospora crassa"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 422, no. 6934, 24 April 2003 (2003-04-24), pages 859 - 868, XP002365858, ISSN: 0028-0836;;HENRISSAT B.: ""A classification of glycosyl hydrolases based on amino-acid sequence similarities"", BIOCHEM. J., vol. 280, 1991, pages 309 - 316;;HENRISSAT B.; BAIROCH A.: ""Updating the sequence-based classification of glycosyl hydrolases"", BIOCHEM. J., vol. 316, 1996, pages 695 - 696;;HSU, T.-A.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Pretreatment of biomass"", pages: 179 - 212;;GHOSH, P.; SINGH, A.: ""Physicochemical and biological treatments for enzymatic/microbial conversion of lignocellulosic biomass"", ADV. APPL. MICROBIOL., vol. 39, 1993, pages 295 - 333;;MCMILLAN, J. D.: ""Enzymatic Conversion of Biomass for Fuels Production"", 1994, AMERICAN CHEMICAL SOCIETY, article ""Pretreating lignocellulosic biomass: a review"";;GONG, C. S.; CAO, N. J.; DU, J.; TSAO, G. T.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Ethanol production from renewable resources"", pages: 207 - 241;;OLSSON, L.; HAHN-HAGERDAL, B.: ""Fermentation of lignocellulosic hydrolysates for ethanol production"", ENZ. MICROB. TECH., vol. 18, 1996, pages 312 - 331;;VALLANDER, L.; ERIKSSON, K.-E. L.: ""Production of ethanol from lignocellulosic materials: State of the art"", ADV. BIOCHEM. ENG.LBIOTECHNOL., vol. 42, 1990, pages 63 - 95;;HIGGINS, CABIOS, vol. 5, 1989, pages 151 - 153;;WATERMAN ET AL., ADV. MATH., vol. 20, 1976, pages 367;;WILBUR; LIPMAN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 80, 1983, pages 726 - 730;;J. SAMBROOK; E.F. FRITSCH; T. MANIATUS: ""Molecular Cloning, A Laboratory Manual"", 1989, COLD SPRING HARBOR;;BOLTON; MCCARTHY, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 48, 1962, pages 1390;;H. NEURATH; R.L. HILL: ""The Proteins"", 1979, ACADEMIC PRESS;;CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085;;HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708;;DE VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312;;SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETT., vol. 309, 1992, pages 59 - 64;;REIDHAAR-OLSON; SAUER, SCIENCE, vol. 241, 1988, pages 53 - 57;;BOWIE; SAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156;;LOWMAN ET AL., BIOCHEM., vol. 30, 1991, pages 10832 - 10837;;DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145;;NER ET AL., DNA, vol. 7, 1988, pages 127;;NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896;;INNIS ET AL.: ""PCR: A Guide to Methods and Application"", 1990, ACADEMIC PRESS;;FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107;;SMITH ET AL., JOURNAL OF MOLECULAR BIOLOGY, vol. 224, 1992, pages 899 - 904;;WLODAVER ET AL., FEBS LETTERS, vol. 309, 1992, pages 59 - 64;;VILLA-KAMAROFF ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 3727 - 3731;;DEBOER ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 80, 1983, pages 21 - 25;;""Useful proteins from recombinant bacteria"", SCIENTIFIC AMERICAN, vol. 242, 1980, pages 74 - 94;;ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488;;GUO; SHERMAN, MOLECULAR CELLULAR BIOLOGY, vol. 15, 1995, pages 5983 - 5990;;SIMONEN; PALVA, MICROBIOLOGICAL REVIEWS, vol. 57, 1993, pages 109 - 137;;GEMS ET AL., GENE, vol. 98, 1991, pages 61 - 67;;CULLEN ET AL., NUCLEIC ACIDS RESEARCH, vol. 15, 1987, pages 9163 - 9175;;CHANG; COHEN, MOLECULAR GENERAL GENETICS, vol. 168, 1979, pages 111 - 115;;YOUNG; SPIZIZIN, JOURNAL OF BACTERIOLOGY, vol. 81, 1961, pages 823 - 829;;DUBNAU; DAVIDOFF-ABELSON, JOURNAL OF MOLECULAR BIOLOGY, vol. 56, 1971, pages 209 - 221;;SHIGEKAWA; DOWER, BIOTECHNIQUES, vol. 6, 1988, pages 742 - 751;;KOEHLER; THORNE, JOURNAL OF BACTERIOLOGY, vol. 169, 1987, pages 5771 - 5278;;HAWKSWORTH ET AL.: ""Ainsworth and Bisby's Dictionary of The Fungi"", 1995, CAB INTERNATIONAL, UNIVERSITY PRESS;;""Soc. App. Bacteriol."", 1980, article ""Biology and Activities of Yeast"";;YELTON ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, 1984, pages 1470 - 1474;;MALARDIER ET AL., GENE, vol. 78, 1989, pages 147 - 156;;BECKER; GUARENTE: ""Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology"", vol. 194, ACADEMIC PRESS, INC., pages: 182 - 187;;ITO ET AL., JOURNAL OF BACTERIOLOGY, vol. 153, 1983, pages 163;;HINNEN ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 75, 1978, pages 1920;;""Protein Purification"", 1989, VCH PUBLISHERS;;TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506;;FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294;;CHRISTENSEN ET AL., PLANT MO. BIOL., vol. 18, 1992, pages 675 - 689;;ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165;;EDWARDS; CORUZZI, ANN. REV. GENET, vol. 24, 1990, pages 275 - 303;;ITO ET AL., PLANT MOL. BIOL., vol. 24, 1994, pages 863 - 878;;WU ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 885 - 889;;CONRAD ET AL., JOURNAL OF PLANT PHYSIOLOGY, vol. 152, 1998, pages 708 - 711;;CHEN ET AL., PLANT AND CELL PHYSIOLOGY, vol. 39, 1998, pages 935 - 941;;KYOZUKA ET AL., PLANT PHYSIOLOGY, vol. 102, 1993, pages 991 - 1000;;MITRA; HIGGINS, PLANT MOLECULAR BIOLOGY, vol. 26, 1994, pages 85 - 93;;KAGAYA ET AL., MOLECULAR AND GENERAL GENETICS, vol. 248, 1995, pages 668 - 674;;XU ET AL., PLANT MOLECULAR BIOLOGY, vol. 22, 1993, pages 573 - 588;;GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293;;POTRYKUS, BIOLTECHNOLOGY, vol. 8, 1990, pages 535;;SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274;;HOOYKAS; SCHILPEROORT, PLANT MOLECULAR BIOLOGY, vol. 19, 1992, pages 15 - 38;;CHRISTOU, PLANT JOURNAL, vol. 2, 1992, pages 275 - 281;;SHIMAMOTO, CURRENT OPINION BIOTECHNOLOGY, vol. 5, 1994, pages 158 - 162;;VASIL ET AL., BIOLTECHNOLOGY, vol. 10, 1992, pages 667 - 674;;OMIRULLEH ET AL., PLANT MOLECULAR BIOLOGY, vol. 21, 1993, pages 415 - 428;;""Handbook on Bioethanol"", TAYLOR & FRANCIS, pages: 1 05 - 118;;WYMAN, BIORESOURCE TECHNOLOGY, vol. 50, 1994, pages 3 - 16;;LYND, APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 24/25, 1990, pages 695 - 719;;MOSIER ET AL.: ""Advances in Biochemical Engineering/Biotechnology"", vol. 65, 1999, SPRINGER-VERLAG, article ""Recent Progress in Bioconversion of Lignocellulosics"", pages: 23 - 40;;""More Gene Manipulations in Fungi"", 1991, ACADEMIC PRESS;;BAILEY, J.E.; OLLIS, D.F.: ""Biochemical Engineering Fundamentals"", 1986, MCGRAW-HILL BOOK COMPANY;;GHOSE, PURE AND APPL. CHEM., vol. 59, 1987, pages 257 - 268;;LEVER ET AL., ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279;;VAN TILBEURGH ET AL., FEBS LETTERS, vol. 149, 1982, pages 152 - 156;;VAN TILBEURGH; CLAEYSSENS, FEBS LETTERS, vol. 187, 1985, pages 283 - 288;;HIMMEL ET AL., J. BIOL. CHEM., vol. 261, 1986, pages 12948 - 12955;;VENTURI ET AL., J. BASIC MICROBIOL., vol. 42, 2002, pages 55 - 66;;BRIGHAM ET AL.: ""Handbook on Bioethanol"", 1995, TAYLOR & FRANCIS, pages: 119 - 141;;LEE, JOURNAL OF BIOTECHNOLOGY, vol. 56, 1997, pages 1 - 24;;P.K. SMITH ET AL., ANAL. BIOCHEM., vol. 150, 1985, pages 76;;LYND, L. R.; WYMAN, C. E.; GERNGROSS, T. U., BIOCOMMODITY ENGINEERING, BIOTECHNOL. PROG., vol. 15, 1999, pages 777 - 793;;PHILIPPIDIS, G. P.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Cellulose bioconversion technology"", pages: 179 - 212;;RYU, D. D. Y.; MANDELS, M.: ""Cellulases: biosynthesis and applications"", ENZ. MICROB. TECHNOL., vol. 2, 1980, pages 91 - 102;;GUSAKOV, A. V.; SINITSYN, A. P.: ""Kinetics of the enzymatic hydrolysis of cellulose: 1. A mathematical model for a batch reactor process"", ENZ. MICROB. TECHNOL., vol. 7, 1985, pages 346 - 352;;RYU, S. K.; LEE, J. M.: ""Bioconversion of waste cellulose by using an attrition bioreactor"", BIOTECHNOL. BIOENG., vol. 25, 1983, pages 53 - 65;;GUSAKOV, A. V.; SINITSYN, A. P.; DAVYDKIN, . Y.; DAVYDKIN, V. Y.; PROTAS, O. V.: ""Enhancement of enzymatic cellulose hydrolysis using a novel type of bioreactor with intensive stirring induced by electromagnetic field"", APPL. BIOCHEM. BIOTECHNOL., vol. 56, 1996, pages 141 - 153;;SHEEHAN, J.; HIMMEL, M.: ""Enzymes, energy and the environment: A strategic perspective on the U.S. Department of Energy's research and development activities for bioethanol"", BIOTECHNOL. PROG., vol. 15, 1999, pages 817 - 827;;LYND, L. R.; WEIMER, P. J.; VAN ZYL, W. H.; PRETORIUS, . S.: ""Microbial cellulose utilization: Fundamentals and biotechnology"", MICROBIOL. MOL. BIOL. REVIEWS, vol. 66, 2002, pages 506 - 577;;SILVEIRA, M. M.; JONAS, R.: ""The biotechnological production of sorbitol"", APPL. MICROBIOL. BIOTECHNOL., vol. 59, 2002, pages 400 - 408;;NIGAM, P.; SINGH, D.: ""Processes for fermentative production of xylitol - a sugar substitute"", PROCESS BIOCHEMISTRY, vol. 30, no. 2, 1995, pages 117 - 124;;EZEJI, T. C.; QURESHI, N.; BLASCHEK, H. P.: ""Production of acetone, butanol and ethanol by Clostridium beijerinckii BA101 and in situ recovery by gas stripping"", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 19, no. 6, 2003, pages 595 - 603;;CHEN, R.; LEE, Y. Y.: ""Membrane-mediated extractive fermentation for lactic acid production from cellulosic biomass"", APPL. BIOCHEM. BIOTECHNOL., vol. 63-65, 1997, pages 435 - 448;;RICHARD, A.; MARGARITIS, A.: ""Empirical modeling of batch fermentation kinetics for poly(glutamic acid) production and other microbial biopolymers"", BIOTECHNOLOGY AND BIOENGINEERING, vol. 87, no. 4, 2004, pages 501 - 515;;KATAOKA, N.; A. MIYA; K. KIRIYAMA: ""Studies on hydrogen production by continuous culture system of hydrogen-producing anaerobic bacteria"", WATER SCIENCE AND TECHNOLOGY, vol. 36, no. 6-7, 1997, pages 41 - 47;;GUNASEELAN V.N., BIOMASS AND BIOENERGY, vol. 13, no. 1-2, 1997, pages 83 - 114;;CHEN, Z.; HO, N. W. Y.: ""Cloning and improving the expression of Pichia stipitis xylose reductase gene in Saccharomyces cerevisiae"", APPL. BIOCHEM. BIOTECHNOL., vol. 39-40, 1993, pages 135 - 147;;HO, N. W. Y.; CHEN, Z; BRAINARD, A. P.: ""Genetically engineered Saccharomyces yeast capable of effectively cofermenting glucose and xylose"", APPL. ENVIRON. MICROBIOL., vol. 64, 1998, pages 1852 - 1859;;BEALL, D. S.; OHTA, K.; INGRAM, L. O.: ""Parametric studies of ethanol production from xylose and other sugars by recombinant Escherichia coli"", BIOTECH. BIOENG., vol. 38, 1991, pages 296 - 303;;INGRAM, L. O.; GOMES, P. F.; LAI, X.; MONIRUZZAMAN, M.; WOOD, B. E.; YOMANO, L. P.; YORK, S. W.: ""Metabolic engineering of bacteria for ethanol production"", BIOTECHNOL. BIOENG., vol. 58, 1998, pages 204 - 214;;ZHANG, M.; EDDY, C.; DEANDA, K.; FINKELSTEIN, M.; PICATAGGIO, S.: ""Metabolic engineering of a pentose metabolism pathway in ethanologenic Zymomonas mobilis"", SCIENCE, vol. 267, 1995, pages 240 - 243;;DEANDA, K.; ZHANG, M.; EDDY, C.; PICATAGGIO, S.: ""Development of an arabinose-fermenting Zymomonas mobilis strain by metabolic pathway engineering"", APPL. ENVIRON. MICROBIOL., vol. 62, 1996, pages 4465 - 4470;;WONG, K.K.Y.; TAN, L. U. L.; SADDLER, J. N.: ""Multiplicity of 13-1 A-xylanase in microorganisms: Functions and applications"", MICROBIOL. REV., vol. 52, 1988, pages 305 - 317;;TENKANEN, M.; POUTANEN, K.: ""Xylans and Xylanases"", 1992, ELSEVIER, article ""Significance of esterases in the degradation of xylans"", pages: 203 - 212;;COUGHLAN, M. P.; HAZLEWOOD, G. P., HEMICELLULOSE AND HEMICELLULASES, 1993;;BRIGHAM, J. S.; ADNEY, W. S.; HIMMEL, M. E.: ""Handbook on Bioethanol: Production and Utilization"", 1996, TAYLOR & FRANCIS, article ""Hemicellulases: Diversity and applications"", pages: 119 - 141;;""Enzyme Nomenclature"", 1992, ACADEMIC PRESS;;EUR. J. BIOCHEM., vol. 223, 1994, pages 1 - 5;;EUR. J. BIOCHEM., vol. 232, 1995, pages 1 - 6;;EUR. J. BIOCHEM., vol. 237, 1996, pages 1 - 5;;EUR. J. BIOCHEM., vol. 250, 1997, pages 1 - 6;;EUR. J. BIOCHEM., vol. 264, 1999, pages 610 - 650;;KOAZE ET AL., AGR. BIOL. CHEM. JAPAN, vol. 28, 1964, pages 216;;YOSHIDA, J. AGR. CHEM. SOC. JAPAN, vol. 28, 1954, pages 66;;HAYASHIDA ET AL., AGRIC. BIOL. CHEM., vol. 42, 1977, pages 927 - 933;;""Handbook of Proteolytic Enzymes"", 1998, ACADEMIC PRESS;;BERKA ET AL., GENE, vol. 96, 1990, pages 313;;BERKA ET AL., GENE, vol. 125, 1993, pages 195 - 198;;GOMI ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 57, 1993, pages 1095 - 1100;;DARTOIS ET AL., BIOCHEMICA ET BIOPHYSICA ACTA, vol. 1131, 1993, pages 253 - 360;;EVELEIGH, ADV. CHEM. SER., vol. 181, 1979, pages 289 - 301;;MALONE ET AL., ELECTROPHORESIS, vol. 22, 2001, pages 919 - 932;;GIESECKE ET AL., JOURNAL OF VIROLOGY METHODS, vol. 38, 1992, pages 47 - 60;;ALTSCHUL, J. MOL. BIOL., vol. 215, 1990, pages 403 - 410;;HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 10915 - 10919;;NIELSEN ET AL., PROTEIN ENGINEERING, vol. 10, 1997, pages 1 - 6;;ZDOBNOV; APWEILER, BIOINFORMATICS, vol. 17, 2001, pages 847 - 848;;SIGRIST ET AL., BRIEF BIOINFORM., vol. 3, 2002, pages 265 - 274;;KATOH ET AL., NUCLEIC ACIDS RESEARCH, vol. 30, 2002, pages 3059;;CHRISTENSEN ET AL., BIOLTECHNOLOGY, vol. 6, 1988, pages 1419 - 1422;;CUMMINGS ET AL., CURRENT GENETICS, vol. 36, 1999, pages 371 - 82;;ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402;;LEVER, M.: ""A new reaction for colorimetric determination of carbohydrates"", ANAL. BIOCHEM., vol. 47, 1972, pages 273 - 279",ACTIVE
519,AT,T1,AT E310091 T1,140-596-382-681-979,2005-12-15,2005,AT 97944627 T,1997-10-03,US 72688096 A;;US 75753496 A;;US 9717977 W,1996-10-04,CARBOXYPEPTIDASEN AUS ASPERGILLUS ORYZAE UND DIESE KODIERENDE NUKLEINSÄUREN,"The present invention relates to polypeptides having carboxypeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to methods of obtaining protein hydrolysates useful as flavor improving agents.",NOVOZYMES INC;;NOVOZYMES AS,BLINKOVSKY ALEXANDER;;BERKA RANDY;;REY MICHAEL;;GOLIGHTLY ELIZABETH;;KLOTZ ALAN;;MATHISEN THOMAS ERIK;;DAMBMANN CLAUS;;BROWN KIMBERLY,,https://lens.org/140-596-382-681-979,Granted Patent,no,0,0,9,30,0,A23J3/341;;A23J3/346;;C12N9/48;;A23L27/24,C12N15/09;;A23J3/34;;A23L27/24;;C12N1/21;;C12N9/48;;C12N15/00;;C12N15/57;;C12R1/19;;C12R1/66,,0,0,,,,EXPIRED
520,WO,A1,WO 1998/014599 A1,037-528-134-755-184,1998-04-09,1998,US 9717977 W,1997-10-03,US 72688096 A;;US 75753496 A,1996-10-04,CARBOXYPEPTIDASES FROM ASPERGILLUS ORYZAE AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to polypeptides having carboxypeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to methods of obtaining protein hydrolysates useful as flavor improving agents.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS,BLINKOVSKY ALEXANDER;;BERKA RANDY;;REY MICHAEL;;GOLIGHTLY ELIZABETH;;KLOTZ ALAN;;MATHISEN THOMAS ERIK;;DAMBMANN CLAUS;;BROWN KIMBERLY,,https://lens.org/037-528-134-755-184,Patent Application,yes,1,12,9,30,12,A23J3/341;;A23J3/346;;C12N9/48;;A23L27/24,A23J3/34;;A23L27/24;;C12N1/21;;C12N9/48;;C12N15/00;;C12N15/57;;C12R1/19;;C12N15/09;;C12R1/66,,5,1,021-606-161-847-746,10.1016/0014-5793(93)80371-z;;8224168,"CHOI M.R. ET AL.: ""Partial characterization of A. oryzae cell wall fraction-bound enzyme related to immobilized biocatalyst"", J. FERM. BIOTECH., vol. 72, no. 3, 1991, pages 214 - 216, XP002054228;;SVENDSEN I. ET AL.: ""The primary structure of carboxypeptidase S1 from Penicillium janthinellum"", FEBS LETTERS, vol. 333, no. 1/2, October 1993 (1993-10-01), pages 39 - 43, XP002054506;;DATABASE WPI Week 7918, 1979 Derwent World Patents Index; AN 79-34115b, XP002054568;;DATABASE WPI Week 7344, 1973 Derwent World Patents Index; AN 73-67261u, XP002054569;;AZARENKOVA N.M. ET AL.: ""Isolation and properties of acid carboxypeptidase from Aspergillus oryzae"", BIOCHEMISTRY (BIOKHIMIYA), vol. 41, no. 1/1, 10 July 1976 (1976-07-10), pages 15 - 21, XP002054229",PATENTED
521,EP,A1,EP 0871746 A1,027-908-334-544-818,1998-10-21,1998,EP 97944627 A,1997-10-03,US 9717977 W;;US 72688096 A;;US 75753496 A,1996-10-04,CARBOXYPEPTIDASES FROM ASPERGILLUS ORYZAE AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to polypeptides having carboxypeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to methods of obtaining protein hydrolysates useful as flavor improving agents.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS,BLINKOVSKY ALEXANDER;;BERKA RANDY;;REY MICHAEL;;GOLIGHTLY ELIZABETH;;KLOTZ ALAN;;MATHISEN THOMAS ERIK;;DAMBMANN CLAUS;;BROWN KIMBERLY,"NOVO NORDISK BIOTECH, INC. (2001-01-24);;NOVOZYMES, INC. (2005-06-22);;NOVOZYMES A/S (2005-06-22);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/027-908-334-544-818,Patent Application,yes,0,0,9,30,0,A23J3/341;;A23J3/346;;C12N9/48;;A23L27/24,C12N15/09;;A23J3/34;;A23L27/24;;C12N1/21;;C12N9/48;;C12N15/00;;C12N15/57;;C12R1/19;;C12R1/66,,0,0,,,,EXPIRED
522,EP,B1,EP 0871746 B1,165-091-894-058-367,2005-11-16,2005,EP 97944627 A,1997-10-03,US 9717977 W;;US 72688096 A;;US 75753496 A,1996-10-04,CARBOXYPEPTIDASES FROM ASPERGILLUS ORYZAE AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to polypeptides having carboxypeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to methods of obtaining protein hydrolysates useful as flavor improving agents.",NOVOZYMES INC;;NOVOZYMES AS,BLINKOVSKY ALEXANDER;;BERKA RANDY;;REY MICHAEL;;GOLIGHTLY ELIZABETH;;KLOTZ ALAN;;MATHISEN THOMAS ERIK;;DAMBMANN CLAUS;;BROWN KIMBERLY,"NOVO NORDISK BIOTECH, INC. (2001-01-24);;NOVOZYMES, INC. (2005-06-22);;NOVOZYMES A/S (2005-06-22);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/165-091-894-058-367,Granted Patent,yes,1,0,9,30,0,A23J3/341;;A23J3/346;;C12N9/48;;A23L27/24,C12N15/09;;A23J3/34;;A23L27/24;;C12N1/21;;C12N9/48;;C12N15/00;;C12N15/57;;C12R1/19;;C12R1/66,,5,0,,,"CHOI M.R. ET AL.: ""Partial characterization of A. oryzae cell wall fraction-bound enzyme related to immobilized biocatalyst"" J. FERM. BIOTECH., vol. 72, no. 3, 1991, pages 214-216, XP002054228;;SVENDSEN I. ET AL.: ""The primary structure of carboxypeptidase S1 from Penicillium janthinellum"" FEBS LETTERS, vol. 333, no. 1/2, October 1993, pages 39-43, XP002054506 cited in the application;;DATABASE WPI Week 7918 1979 Derwent Publications Ltd., London, GB; AN 79-34115b XP002054568 -& JP 54 037 894 A (TANABE SEIYAKU) , 20 March 1979;;DATABASE WPI Week 7344 1973 Derwent Publications Ltd., London, GB; AN 73-67261u XP002054569 -& JP 48 035 459 B (KIKKOMAN SHOYU KK);;AZARENKOVA N.M. ET AL.: ""Isolation and properties of acid carboxypeptidase from Aspergillus oryzae"" BIOCHEMISTRY (BIOKHIMIYA), vol. 41, no. 1/1, 10 July 1976, pages 15-21, XP002054229 cited in the application",EXPIRED
523,AU,A,AU 1997/046080 A,049-897-120-281-212,1998-04-24,1998,AU 1997/046080 A,1997-10-03,US 72688096 A;;US 75753496 A;;US 9717977 W,1996-10-04,Carboxypeptidases from aspergillus oryzae and nucleic acids encoding same,"The present invention relates to polypeptides having carboxypeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to methods of obtaining protein hydrolysates useful as flavor improving agents.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS,BLINKOVSKY ALEXANDER;;BERKA RANDY;;REY MICHAEL;;GOLIGHTLY ELIZABETH;;KLOTZ ALAN;;MATHISEN THOMAS ERIK;;DAMBMANN CLAUS;;BROWN KIMBERLY,,https://lens.org/049-897-120-281-212,Patent Application,no,0,0,9,30,0,A23J3/341;;A23J3/346;;C12N9/48;;A23L27/24,C12N15/09;;A23J3/34;;A23L27/24;;C12N1/21;;C12N9/48;;C12N15/00;;C12N15/57;;C12R1/19;;C12R1/66,,0,0,,,,PENDING
524,EP,A2,EP 0984703 A2,132-658-560-517-460,2000-03-15,2000,EP 98922343 A,1998-05-15,DK 146597 A;;US 9809998 W;;US 85788697 A;;US 6289397 P;;US 6971997 P,1997-05-16,METHODS OF PRODUCING PROTEIN HYDROLYSATES,"The present invention relates to methods of producing protein hydrolysates, comprising adding to a proteinaceous material one or more aminopeptidase(s) having glycine releasing properties and one or more additional proteases wherein the amount of glycine produced is greater than the amount of glycine produced by the one or more additional proteases alone under the same conditions.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS;;ASAHI CHEMICAL IND,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;MATHIANSEN THOMAS E;;KOFOD LENE V;;FUJII MIKIO;;MARUMOTA CHIGUSA,"NOVO NORDISK BIOTECH, INC. (2001-01-24);;NOVOZYMES, INC. (2006-07-03);;NOVOZYMES A/S (2006-07-03);;ASAHI CHEMICAL INDUSTRY CO., LTD. (2005-07-15);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/132-658-560-517-460,Patent Application,yes,0,0,9,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;C12P21/06;;A23L27/21;;A21D2/267;;A23J3/34;;A21D2/268;;C12N9/48;;C12P21/06;;A23L27/21,A21D2/26;;A23J3/34;;A23L27/21;;C12N9/48;;C12P21/06,,0,0,,,,EXPIRED
525,AU,A,AU 1999/013328 A,006-612-768-369-602,1999-07-05,1999,AU 1999/013328 A,1998-11-13,DK 146597 A;;DK 67098 A;;DK 9800495 W;;US 6971997 P,1997-12-16,Polypeptides having aminopeptidase activity and nucleic acids encoding same,,JAPAN TOBACCO INC;;NOVOZYMES AS;;NOVOZYMES INC,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKO;;MARUMOTO CHIGUSA,"NOVOZYMES A/S, NOVOZYMES BIOTECH, INC., JAPAN TOBA (2002-12-05)",https://lens.org/006-612-768-369-602,Patent Application,no,0,0,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,,0,0,,,,EXPIRED
526,DE,D1,DE 69833784 D1,182-672-275-577-602,2006-05-04,2006,DE 69833784 T,1998-11-13,DK 146597 A;;US 6971997 P;;DK 67098 A;;DK 9800495 W,1997-12-16,POLYPEPTIDE MIT AMINOPEPTIDASEAKTIVITÄT UND FÜR DIESE KODIERENDE NUKLEINSÄUREN,,NOVOZYMES AS;;NOVOZYMES INC;;JAPAN TOBACCO INC,BLINKOVSKY ALEXANDER;;BYUN S;;KLOTZ V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKO;;MARUMOTO CHIGUSA;;KOFOD VENKE,,https://lens.org/182-672-275-577-602,Granted Patent,no,0,0,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N9/48;;C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/50;;C12P21/06,,0,0,,,,EXPIRED
527,DE,T2,DE 69833784 T2,024-739-693-291-687,2006-10-19,2006,DE 69833784 T,1998-11-13,DK 146597 A;;US 6971997 P;;DK 67098 A;;DK 9800495 W,1997-12-16,POLYPEPTIDE MIT AMINOPEPTIDASE-AKTIVITÄT UND FÜR DIESE CODIERENDE NUKLEINSÄUREN,,NOVOZYMES AS;;NOVOZYMES INC;;JAPAN TOBACCO INC,BLINKOVSKY ALEXANDER;;BYUN S;;KLOTZ V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKO;;MARUMOTO CHIGUSA;;KOFOD VENKE,,https://lens.org/024-739-693-291-687,Granted Patent,no,0,0,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N9/48;;C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/50;;C12P21/06,,0,0,,,,EXPIRED
528,WO,A3,WO 1998/051163 A3,148-157-555-791-348,1999-02-04,1999,US 9809998 W,1998-05-15,DK 146597 A;;US 85788697 A;;US 6289397 P;;US 6971997 P,1997-05-16,METHODS OF PRODUCING PROTEIN HYDROLYSATES,"The present invention relates to methods of producing protein hydrolysates, comprising adding to a proteinaceous material one or more aminopeptidase(s) having glycine releasing properties and one or more additional proteases wherein the amount of glycine produced is greater than the amount of glycine produced by the one or more additional proteases alone under the same conditions.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS;;ASAHI CHEMICAL IND,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;MATHIANSEN THOMAS E;;KOFOD LENE V;;FUJII MIKIO;;MARUMOTA CHIGUSA,,https://lens.org/148-157-555-791-348,Search Report,yes,4,0,9,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;C12P21/06;;A23L27/21;;A21D2/267;;A23J3/34;;A21D2/268;;C12N9/48;;C12P21/06;;A23L27/21,A21D2/26;;A23J3/34;;A23L27/21;;C12N9/48;;C12P21/06,,2,0,,,"DATABASE WPI Section Ch Week 9527, Derwent World Patents Index; Class D13, AN 95-202827, XP002079423;;DATABASE WPI Section Ch Derwent World Patents Index; Class D13, AN 73-67261U, XP002054569",PATENTED
529,US,B1,US 6465209 B1,088-009-790-507-643,2002-10-15,2002,US 7995598 A,1998-05-15,US 7995598 A;;DK 146597 A;;US 85788697 A;;US 6971997 P;;US 6289397 P,1997-05-16,Methods of producing protein hydrolysates,"
    The present invention relates to methods of producing protein hydrolysates, comprising adding to a proteinaceous material one or more aminopeptidase(s) having glycine releasing properties and one or more additional proteases wherein the amount of glycine produced is greater than the amount of glycine produced by the one or more additional proteases alone under the same conditions. 
",NOVOZYMES BIOTECH INC;;NOVOZYMES AS;;JAPAN TOBACCO INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;MATHIASEN THOMAS E;;KOFOD LENE V;;FUJII MIKIO;;MARUMOTO CHIGUSA,NOVO NORDISK A/S (1998-07-29);;JAPAN TOBACCO INC (1998-07-29);;NOVOZYMES INC (2005-08-29);;NOVOZYMES A/S (2001-10-29);;ASAHI CHEMICAL INDUSTRY CO. LTD (1998-07-28);;NOVOZYMES BIOTECH INC (1998-05-26),https://lens.org/088-009-790-507-643,Granted Patent,yes,7,31,9,52,11,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;C12P21/06;;A23L27/21;;A21D2/267;;A23J3/34;;A21D2/268;;C12N9/48;;C12P21/06;;A23L27/21,A21D2/26;;A23J3/34;;A23L27/21;;C12N9/48;;C12P21/06,435/68.1;;435/71.1;;435/71.2,0,0,,,,EXPIRED
530,US,B1,US 6187578 B1,107-929-917-932-401,2001-02-13,2001,US 94371497 A,1997-10-03,US 94371497 A;;DK 58596 A;;DK 9700230 W;;US 75753496 A;;US 72688096 A,1996-05-20,Carboxypeptidases and nucleic acids encoding the same,"The present invention relates to polypeptides having carboxypeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing the polypeptides. The present invention further relates to methods of obtaining protein hydrolysates useful as flavor improving agents.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS,BLINKOVSKY ALEXANDER;;BERKA RANDY;;REY MICHAEL;;GOLIGHTLY ELIZABETH;;KLOTZ ALAN;;MATHISEN THOMAS ERIK;;DAMBMANN CLAUS;;BROWN KIMBERLY M,NOVO NORDISK A/S (1998-01-26);;NOVOZYMES INC (2005-08-29);;NOVOZYMES A/S (2001-10-29);;NOVOZYMES BIOTECH INC (1997-10-09),https://lens.org/107-929-917-932-401,Granted Patent,yes,1,15,3,30,12,A23J3/341;;A23J3/341;;A23J3/346;;A23J3/346;;A23K20/147;;A23K20/147;;A23L27/21;;A23L27/21;;A23L27/22;;A23L27/22;;A23L27/24;;A23L27/24;;A23V2002/00;;A23V2002/00;;C12N9/48;;C12N9/48;;C12N9/62;;C12N9/62;;C12Y304/11001;;C12Y304/11001;;C12Y304/11004;;C12Y304/11004;;C12Y304/15001;;C12Y304/15001;;C12Y304/15005;;C12Y304/15005;;C12Y304/16002;;C12Y304/16002;;C12Y304/16005;;C12Y304/16005;;C12Y304/16006;;C12Y304/16006;;C12Y304/17001;;C12Y304/17001;;C12Y304/17002;;C12Y304/17002;;C12Y304/17003;;C12Y304/17003;;C12Y304/17004;;C12Y304/17004;;C12Y304/17006;;C12Y304/17006;;C12Y304/17011;;C12Y304/17011;;C12Y304/21004;;C12Y304/21004;;C12Y304/21019;;C12Y304/21019;;C12Y304/21026;;C12Y304/21026;;C12Y304/2105;;C12Y304/2105;;C12Y304/21057;;C12Y304/21057;;C12Y304/22025;;C12Y304/22025;;C12Y304/24033;;C12Y304/24033;;C12Y305/01043;;C12Y305/01043;;C12Y305/01044;;C12Y305/01044,A23J3/34;;A23K1/16;;A23L27/21;;A23L27/22;;A23L27/24;;C12N9/48;;C12N9/62;;C12N15/57,435/212,7,4,140-847-232-736-165;;027-142-102-041-588;;140-847-232-736-165;;021-606-161-847-746,10.1016/0922-338x(91)90220-b;;4644317;;10.1093/oxfordjournals.jbchem.a129967;;10.1016/0922-338x(91)90220-b;;10.1016/0014-5793(93)80371-z;;8224168,"Choi et al. ""Partial characterization ofAspergillus oryzae cell wall fraction-bound enzyme related to immobilized biocatalyst"" Journal of Fermentation and Bioengineering, 1991,vol. 72, No. 3, pp. 216-216), Aug. 15, 1991.;;Ichishima et al., J. Biochem., 1972, vol. 72, pp. 1045-1048.;;Choi et al., Journal of Fermentation and Bioengineering, vol. 72 No. 3, pp. 214-216. (1991).;;Azarenkova et al., Biochemistry, vol. 41, No. 1/1, pp. 15-21 (1976).;;Svensen et al., FEBS Letters, vol. 333, No. 1/2, pp. 39-43 (1993).;;Database WPI, XP 002054568, JP 54 037 894 (Tanabe Seiyaku) No Date Provided.;;Database WPI, XP 002054569 JP 48 035 459 (Kikkoman Shoyu KK) No Date Provided).",EXPIRED
531,KR,A,KR 20050046012 A,019-816-105-963-025,2005-05-17,2005,KR 20057006392 A,2005-04-13,DK 146597 A;;DK 67098 A;;US 6971997 P,1997-12-16,POLYPEPTIDES HAVING SIGNAL PEPTIDE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES INC;;JAPAN TOBACCO INC;;NOVOZYMES AS,FUJII MIKO;;MARUMOTO CHIGUSA;;BYUN TONY S;;BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;KLOTZ ALAN V;;SLOMA ALAN;;TANG MARIA,,https://lens.org/019-816-105-963-025,Patent Application,no,0,0,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,,0,0,,,,INACTIVE
532,EP,B1,EP 0984703 B1,003-031-491-505-397,2003-04-09,2003,EP 98922343 A,1998-05-15,DK 146597 A;;US 9809998 W;;US 85788697 A;;US 6289397 P;;US 6971997 P,1997-05-16,METHODS OF PRODUCING PROTEIN HYDROLYSATES,"The present invention relates to methods of producing protein hydrolysates, comprising adding to a proteinaceous material one or more aminopeptidase(s) having glycine releasing properties and one or more additional proteases wherein the amount of glycine produced is greater than the amount of glycine produced by the one or more additional proteases alone under the same conditions.",NOVOZYMES BIOTECH INC;;NOVOZYMES AS;;ASAHI CHEMICAL IND,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;MATHIANSEN THOMAS E;;KOFOD LENE V;;FUJII MIKIO;;MARUMOTA CHIGUSA,"NOVO NORDISK BIOTECH, INC. (2001-01-24);;NOVOZYMES, INC. (2006-07-03);;NOVOZYMES A/S (2006-07-03);;ASAHI CHEMICAL INDUSTRY CO., LTD. (2005-07-15);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/003-031-491-505-397,Granted Patent,yes,4,2,9,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;C12P21/06;;A23L27/21;;A21D2/267;;A23J3/34;;A21D2/268;;C12N9/48;;C12P21/06;;A23L27/21,A21D2/26;;A23J3/34;;A23L27/21;;C12N9/48;;C12P21/06,,2,0,,,"DATABASE WPI Section Ch, Week 9527 Derwent Publications Ltd., London, GB; Class D13, AN 95-202827 XP002079423 & JP 07 115964 A (AJINOMOTO KK) , 9 May 1995;;DATABASE WPI Section Ch, Derwent Publications Ltd., London, GB; Class D13, AN 73-67261U XP002054569 & JP 48 035459 B (KIKKOMAN SHOYU CO LTD)",EXPIRED
533,AT,T1,AT E236537 T1,060-983-238-371-01X,2003-04-15,2003,AT 98922343 T,1998-05-15,DK 146597 A;;US 85788697 A;;US 6289397 P;;US 6971997 P;;US 9809998 W,1997-05-16,VERFAHREN ZUR ERZEUGUNG VON PROTEINHYDROLYSATEN,"The present invention relates to methods of producing protein hydrolysates, comprising adding to a proteinaceous material one or more aminopeptidase(s) having glycine releasing properties and one or more additional proteases wherein the amount of glycine produced is greater than the amount of glycine produced by the one or more additional proteases alone under the same conditions.",NOVOZYMES BIOTECH INC;;NOVOZYMES AS;;ASAHI CHEMICAL IND,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;MATHIANSEN THOMAS E;;KOFOD LENE V;;FUJII MIKIO;;MARUMOTA CHIGUSA,,https://lens.org/060-983-238-371-01X,Granted Patent,no,0,0,9,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;C12P21/06;;A23L27/21;;A21D2/267;;A23J3/34;;A21D2/268;;C12N9/48;;C12P21/06;;A23L27/21,A21D2/26;;A23J3/34;;A23L27/21;;C12N9/48;;C12P21/06,,0,0,,,,DISCONTINUED
534,AU,A,AU 1998/074914 A,159-770-766-265-975,1998-12-08,1998,AU 1998/074914 A,1998-05-15,DK 146597 A;;US 85788697 A;;US 6289397 P;;US 6971997 P;;US 9809998 W,1997-05-16,Methods of producing protein hydrolysates,"The present invention relates to methods of producing protein hydrolysates, comprising adding to a proteinaceous material one or more aminopeptidase(s) having glycine releasing properties and one or more additional proteases wherein the amount of glycine produced is greater than the amount of glycine produced by the one or more additional proteases alone under the same conditions.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS;;ASAHI CHEMICAL IND,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;MATHIANSEN THOMAS E;;KOFOD LENE V;;FUJII MIKIO;;MARUMOTA CHIGUSA,,https://lens.org/159-770-766-265-975,Patent Application,no,0,0,9,52,0,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;C12P21/06;;A23L27/21;;A21D2/267;;A23J3/34;;A21D2/268;;C12N9/48;;C12P21/06;;A23L27/21,A21D2/26;;A23J3/34;;A23L27/21;;C12N9/48;;C12P21/06,,0,0,,,,DISCONTINUED
535,WO,A2,WO 1998/051163 A2,165-973-700-928-702,1998-11-19,1998,US 9809998 W,1998-05-15,DK 146597 A;;US 85788697 A;;US 6289397 P;;US 6971997 P,1997-05-16,METHODS OF PRODUCING PROTEIN HYDROLYSATES,"The present invention relates to methods of producing protein hydrolysates, comprising adding to a proteinaceous material one or more aminopeptidase(s) having glycine releasing properties and one or more additional proteases wherein the amount of glycine produced is greater than the amount of glycine produced by the one or more additional proteases alone under the same conditions.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS;;ASAHI CHEMICAL IND,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY;;MATHIANSEN THOMAS E;;KOFOD LENE V;;FUJII MIKIO;;MARUMOTA CHIGUSA,,https://lens.org/165-973-700-928-702,Patent Application,no,0,15,9,52,11,A21D2/267;;A21D2/268;;A23J3/34;;C12N9/48;;C12P21/06;;A23L27/21;;A21D2/267;;A23J3/34;;A21D2/268;;C12N9/48;;C12P21/06;;A23L27/21,A21D2/26;;A23J3/34;;A23L27/21;;C12N9/48;;C12P21/06,,0,0,,,,PATENTED
536,WO,A1,WO 1999/031226 A1,168-545-378-913-18X,1999-06-24,1999,DK 9800495 W,1998-11-13,DK 146597 A;;DK 67098 A;;US 6971997 P,1997-12-16,POLYPEPTIDES HAVING AMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK AS;;NOVO NORDISK BIOTECH INC;;ASAHI CHEMICAL IND,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKO;;MARUMOTO CHIGUSA,,https://lens.org/168-545-378-913-18X,Patent Application,yes,3,1,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,A23J3/34;;C12N15/09;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,,3,1,030-709-116-002-240,10.3168/jds.s0022-0302(95)76614-0,"BIOLOGICAL ABSTRACTS, 1 January 1900, Philadelphia, PA, US; abstract no. 1995:09683282, GOBBETTI M, CORSETTI A FOX P F: ""Purification and Charact erization of Intracellular Aminopeptidase from Pseudomonas Fluorescens ATCC 948"" XP002962641;;DATABASE WPI 1 January 1900 Derwent World Patents Index; AN 1995-202827, XP002962642, ""New Microbe FERM-P- 13458 Obtd. by Mutating Bacillus Alvei - is Used for Prepn. of Protein Hydrolysate Contg. Glutamic Acid, Alanine and for Prepn. of Protein Hydrolysate Contg. Glutamic Acid, Alan ine and Glycine"";;BIOLOGICAL ABSTRACTS, 1 January 1900, Philadelphia, PA, US; abstract no. 1992:08800538, TELESNINA G N, ET AL.: ""Isolation of Xanthomo nas-Rubrilineans Protoplasts and Their Use in Study of Aminopeptidase Localization"" XP002962643",PATENTED
537,WO,A3,WO 1998/051163 A3,086-599-994-552-550,1998-11-19,1998,US US9809998,1998-05-15,"US 08/8/057,886;;US 60/0/062,893;;US 60/0/069,719;;DK 1465/97",1997-05-16,METHODS OF PRODUCING PROTEIN HYDROLYSATES,"The present invention relates to methods of producing protein hydrolysates, comprising adding to a proteinaceous material one or more aminopeptidase(s) having glycine releasing properties and one or more additional proteases wherein the amount of glycine produced is greater than the amount of glycine produced by the one or more additional proteases alone under the same conditions.","NOVO NORDISK BIOTECH, INC.;;NOVO NORDISK A/S;;ASAHI CHEMICAL INDUSTRY CO., LTD.","BLINKOVSKY, Alexander;;BROWN, Kimberly;;GOLIGHTLY, Elizabeth;;BYUN, Tony;;MATHIANSEN, Thomas, E.;;KOFOD, Lene, V.;;FUJII, Mikio;;MARUMOTA, Chigusa",,https://lens.org/086-599-994-552-550,Search Report,yes,0,0,1,1,0,,A21D2/26;;A23J3/34;;A23L1/227;;C12N9/48;;C12P21/06,,0,0,,,,UNKNOWN
538,US,B1,US 6184020 B1,046-555-879-137-84X,2001-02-06,2001,US 19210498 A,1998-11-13,US 19210498 A;;DK 146597 A;;DK 67098 A;;US 6971997 P,1997-12-16,Polypeptides having aminopeptidase activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS;;JAPAN TOBACCO INC,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKIO;;MARUMOTO CHIGUSA,NOVO NORDISK A/S (1999-01-19);;JAPAN TOBACCO INC (1998-11-18);;NOVOZYMES INC (2005-08-29);;NOVOZYMES A/S (2001-10-29);;NOVOZYMES BIOTECH INC (1998-11-18),https://lens.org/046-555-879-137-84X,Granted Patent,yes,5,64,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,A23J3/34;;C12N15/09;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,435/212;;435/219;;536/23.2;;536/23.7,6,5,071-340-618-860-317;;030-709-116-002-240;;067-675-830-257-822;;135-641-017-754-235;;065-463-260-187-764,10.1007/bf01570145;;10.3168/jds.s0022-0302(95)76614-0;;1417307;;10.1016/s0021-9258(18)83527-x;;2651436;;1569059;;10.1016/s0021-9258(18)42400-3,"Nakada et al., 1972, Agricultural & Biological Chemistry 37: 757-765, 767-774, and 775-782.;;Kwon et al., 1996, Journal of Industrial Microbiology 17: 30-35.;;Gobbetti et al., 1995, Journal of Dairy Science 78: 44-54.;;Telesnina et al., 1992, Antibiotiki I Khimioterapija 37: 14-16.;;Chang and Smith 1989, Journal of Biological Chemistry 264: 6979-6983.;;Chang et al., 1992, Journal of Biological Chemistry 267: 8007-8011.",EXPIRED
539,WO,A1,WO 2022/187703 A1,141-753-932-191-257,2022-09-09,2022,US 2022/0019019 W,2022-03-04,US 202163157244 P,2021-03-05,SYSTEM AND METHOD FOR REAL-TIME VARIABLE RESOLUTION MICROSCOPE SLIDE IMAGING,"The present invention provides a system and method for capturing images during review of a microscope slide. In certain embodiments, such system and method allow for the capture of images and construction of a composited microscope mosaic image within the workflow of the slide reviewer, such as a pathologist reviewing a tissue sample. In certain embodiments, said mosaic images are whole slide images constructed by and capable of being viewed at variable resolutions and magnifications corresponding to the review of the original microscope slide by the slide reviewer.",THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND,ASHMAN KIMBERLY LORAIN;;BROWN JONATHON QUINCY;;LICORISH CODY MAURICE;;SUMMA BRIAN MARK;;WENK CAROLA;;ZHUGE HUIMIN;;COOPER MAX,,https://lens.org/141-753-932-191-257,Patent Application,yes,5,0,2,2,0,G06V20/693,G06V20/69;;G06V10/40,,0,0,,,,PENDING
540,IN,B,IN 187836 B,136-968-779-687-164,2002-06-29,2002,IN 1063MA1998 A,1998-05-18,US 85788697 A,1997-05-16,Methods of producing protein hydrolysates,,NOVO NORDISK AS;;NOVO NORDISK BIOTECH INC;;JAPAN TOBACCO INC,BLINKOVSKY ALEXANDER;;BROWN KIMBERLY;;GOLIGHTLY ELIZABETH;;BYUN TONY S;;MATHIASEN THOMAS E;;KOFOD LENE V;;FUJII MIKIO;;MARUMOTA CHIGUSA,,https://lens.org/136-968-779-687-164,Granted Patent,no,0,0,2,52,0,A21D2/265;;A21D2/268;;A21D8/042;;A23J3/34;;C12N9/48;;C12P21/06;;A23K20/147;;A23K20/142;;A23K20/189;;A23L27/24;;A21D2/265;;A21D2/268;;A23J3/34;;C12N9/48;;C12P21/06;;A21D8/042;;A23K20/189;;A23K20/147;;A23K20/142;;A23L27/24,C07B41/00,,0,0,,,,EXPIRED
541,EP,A1,EP 4302278 A1,068-992-734-570-259,2024-01-10,2024,EP 22764191 A,2022-03-04,US 202163157244 P;;US 2022/0019019 W,2021-03-05,SYSTEM AND METHOD FOR REAL-TIME VARIABLE RESOLUTION MICROSCOPE SLIDE IMAGING,,THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND,ASHMAN KIMBERLY LORAIN;;BROWN JONATHON QUINCY;;LICORISH CODY MAURICE;;SUMMA BRIAN MARK;;WENK CAROLA;;ZHUGE HUIMIN;;COOPER MAX SEBASTIAN,,https://lens.org/068-992-734-570-259,Patent Application,yes,0,0,2,2,0,G06V20/693,G06V20/69;;G06V10/40,,0,0,,,,PENDING
542,ZA,B,ZA 201200363 B,173-768-855-109-944,2014-06-25,2014,ZA 201200363 A,2012-01-17,EP 09165558 A;;US 22587809 P;;NL 2010050456 W,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,,AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/173-768-855-109-944,Granted Patent,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,A61K/;;C07K/;;A61P/;;C12N/,,0,0,,,,ACTIVE
543,EA,B1,EA 031447 B1,048-252-545-964-997,2019-01-31,2019,EA 201390967 A,2010-07-15,EP 09165558 A;;US 22587809 P;;NL 2010050456 W,2009-07-15,ANTIBODIES THAT BIND WITH SDR PROTEINS AND METHODS OF USE THEREOF,The invention concerns antibodies with improved characteristics that are capable of specifically binding with SDR proteins of different bacteria. Said antibodies are fully human antibodies and can be used in therapy of patients.,AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/048-252-545-964-997,Granted Patent,no,4,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,13,13,031-626-846-075-129;;099-559-652-967-591;;043-714-998-563-59X;;013-331-795-309-026;;049-960-678-150-173;;070-922-203-323-177;;066-252-194-757-349;;015-570-097-945-448;;013-323-148-570-367;;020-296-196-517-635;;006-565-688-923-344;;036-993-296-085-707;;024-192-636-936-032,10.1099/00221287-146-7-1535;;10878118;;10.1016/j.vetimm.2009.05.012;;19540000;;18809660;;pmc2583566;;10.1128/iai.00874-08;;17027124;;10.1016/j.vaccine.2006.09.043;;17078388;;pmc1610062;;10.1128/aac.00407-06;;17005843;;15728889;;10.1128/aac.49.3.959-962.2005;;pmc549258;;10.1128/iai.74.4.2145-2153.2006;;pmc1418917;;16552044;;14573361;;10.1016/j.tibtech.2003.08.007;;9373310;;10.1016/s1380-2933(96)00045-0;;10.1016/s0140-6736(02)11875-7;;12493294;;12493293;;10.1016/s0140-6736(02)11874-5;;10.1111/j.1574-6968.1991.tb04845.x;;10.1016/0378-1097(91)90426-b;;pmc267543;;10.1128/jcm.27.6.1286-1291.1989;;2473994,"MCCREA K.W, ET AL: ""The serine-aspartate repeat (Sdr) protein family in staphylococcus epidermidis"", JOURNAL OF GENERAL MICROBIOLOGY, vol. 146, no. 7, 1 July 2000 (2000-07-01), pages 1535 - 1546, XP002955253, ISSN: 1350-0872;;YIN RONG-LAN, ET AL: ""Construction and immunogenicity of a DNA vaccine containing clumping factor A of Staphylococcus aureus and bovine IL18."", VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, ELSEVIER BV, AMSTERDAM, NL, vol. 132, no. 2-4, 15 December 2009 (2009-12-15), Amsterdam, NL, pages 270 - 274, XP002601812, ISSN: 0165-2427, DOI: 10.1016/J.VETIMM.2009.05.012;;TUCHSCHERR LORENA P N, ET AL: ""Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice."", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 76, no. 12, 1 December 2008 (2008-12-01), US, pages 5738 - 5744, XP002601813, ISSN: 0019-9567, DOI: 10.1128/IAI.00874-08;;GAUDREAU, M.C. LACASSE, P. TALBOT, B.G.: ""Protective immune responses to a multi-gene DNA vaccine against Staphylococcus aureus"", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 25, no. 5, 8 December 2006 (2006-12-08), AMSTERDAM, NL, pages 814 - 824, XP005798871, ISSN: 0264-410X, DOI: 10.1016/j.vaccine.2006.09.043;;JOHN JOSEPH F JR: ""Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection"", CURRENT OPINION IN MOLECULAR THERAPEUTICS, CURRENT DRUGS, LONDON, GB, vol. 8, no. 5, 1 October 2006 (2006-10-01), London, GB, pages 455 - 460, XP009138964, ISSN: 1464-8431;;HETHERINGTON SETH, ET AL: ""Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysis."", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 50, no. 10, 1 October 2006 (2006-10-01), US, pages 3499 - 3500, XP002601814, ISSN: 0066-4804, DOI: 10.1128/AAC.00407-06;;REILLEY SANDRA, ET AL: ""Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers."", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 49, no. 3, 1 March 2005 (2005-03-01), US, pages 959 - 962, XP002601815, ISSN: 0066-4804, DOI: 10.1128/AAC.49.3.959-962.2005;;SCHAFFER ADAM C ET AL: ""Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model."", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 74, no. 4, 1 April 2006 (2006-04-01), US, pages 2145 - 2153, XP002462561, ISSN: 0019-9567, DOI: 10.1128/IAI.74.4.2145-2153.2006;;HOLT, L.J. HERRING, C. JESPERS, L.S. WOOLVEN, B.P. TOMLINSON, I.M.: ""Domain antibodies: proteins for therapy"", TRENDS IN BIOTECHNOLOGY., ELSEVIER PUBLICATIONS, CAMBRIDGE., GB, vol. 21, no. 11, 1 November 2003 (2003-11-01), GB, pages 484 - 490, XP004467495, ISSN: 0167-7799, DOI: 10.1016/j.tibtech.2003.08.007;;DAVIES, J. RIECHMANN, L.: ""Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding"", IMMUNOTECHNOLOGY., ELSEVIER SCIENCE PUBLISHERS BV., NL, vol. 2, no. 3, 1 September 1996 (1996-09-01), NL, pages 169 - 179, XP004070292, ISSN: 1380-2933, DOI: 10.1016/S1380-2933(96)00045-0;;ELLIOTT, T. WASHINGTON, T. LAMBERT, P.: ""Antibody response to Staphylococcal slime and lipoteichoic acid"", LANCET, ELSEVIER, AMSTERDAM, NL, vol. 360, no. 9349, 14 December 2002 (2002-12-14), AMSTERDAM, NL, pages 1977, XP004795241, ISSN: 0140-6736, DOI: 10.1016/S0140-6736(02)11874-5;;HAMMONDS, S.J. ; EASTERBROOK, T.J. ; MCILLMURRAY, M.B.: ""Differentiation of enterococci from other group D streptococci by means of a specific monoclonal antibody"", FEMS MICROBIOLOGY LETTERS, WILEY-BLACKWELL PUBLISHING LTD., GB, vol. 82, no. 1, 15 July 1991 (1991-07-15), GB, pages 91 - 94, XP023971357, ISSN: 0378-1097, DOI: 10.1111/j.1574-6968.1991.tb04845.x;;H.I.WERGELAND ET AL.: ""Antibodies to Staphylococcal Peptidoglycan and its Peptide Epitopes, Techoic Acid, and Lipotechoic Acid in Sera from Blood Donors and Patients with Staphylococcal Infections."", JOURNAL OF CLINICAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 27., no. 06., 1 June 1989 (1989-06-01), US, pages 1286 - 1291., XP002120750, ISSN: 0095-1137",ACTIVE
544,US,A1,US 2017/0067880 A1,097-943-426-847-43X,2017-03-09,2017,US 201615246301 A,2016-08-24,US 201615246301 A;;EP 09165558 A;;US 201514728826 A;;US 201313786215 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/097-943-426-847-43X,Patent Application,yes,0,0,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,G01N33/50;;C07K16/12;;G01N33/68,,0,0,,,,INACTIVE
545,CA,A1,CA 2315274 A1,114-901-301-840-305,1999-06-24,1999,CA 2315274 A,1998-11-13,DK 146597 A;;DK 67098 A;;DK 9800495 W;;US 6971997 P,1997-12-16,POLYPEPTIDES HAVING AMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",JAPAN TOBACCO INC;;NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS,KOFOD LENE VENKE;;FUJII MIKO;;MARUMOTO CHIGUSA;;SLOMA ALAN;;TANG MARIA;;BROWN KIMBERLY;;KLOTZ ALAN V;;BYUN TONY S;;BLINKOVSKY ALEXANDER,,https://lens.org/114-901-301-840-305,Patent Application,no,0,0,25,52,9,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,,0,0,,,,EXPIRED
546,CN,A,CN 102666583 A,169-419-104-074-488,2012-09-12,2012,CN 201080041138 A,2010-07-15,NL 2010050456 W;;EP 09165558 A;;US 22587809 P,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV;;GENENTECH INC,TIM BEAUMONT;;JEROEN KWAKKENBOS MARK;;BROWN ERIC J;;HIROSHI MORISAKI JOHN;;HAZENBOS WOUTER L W;;SANJEEV MARIATHASAN;;KIMBERLY KAJIHARA;;YI XIA,,https://lens.org/169-419-104-074-488,Patent Application,no,3,2,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,A61K39/395;;C07K16/12;;A61P31/04;;C12N15/13,,0,0,,,,INACTIVE
547,AU,B2,AU 755387 B2,175-068-233-161-305,2002-12-12,2002,AU 1999/013328 A,1998-11-13,DK 146597 A;;DK 67098 A;;DK 9800495 W;;US 6971997 P,1997-12-16,Polypeptides having aminopeptidase activity and nucleic acids encoding same,,NOVOZYMES AS;;NOVOZYMES BIOTECH INC;;JAPAN TOBACCO INC,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKO;;MARUMOTO CHIGUSA;;KOFOD LENE VENKE,"NOVOZYMES A/S, NOVOZYMES BIOTECH, INC., JAPAN TOBA (2002-12-05)",https://lens.org/175-068-233-161-305,Granted Patent,no,0,0,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,,0,0,,,,EXPIRED
548,BR,A,BR 9813608 A,191-342-888-154-279,2000-10-17,2000,BR 9813608 A,1998-11-13,DK 146597 A;;DK 67098 A;;DK 9800495 W;;US 6971997 P,1997-12-16,"Polipeptìdeo isolado, sequências de ácido nucleico isolado e mutante, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, processos para produzir uma sequência de ácido nucleico mutante, para produzir um polipeptìdeo, para produzir um mutante de uma célula originária e para produzir uma proteìna, e, célula mutante","""POLIPEPTìDEO ISOLADO, SEQUêNCIAS DE áCIDO NUCLEICO ISOLADO E MUTANTE, CONSTRUçãO DE áCIDO NUCLEICO, VETOR DE EXPRESSãO RECOMBINANTE , CéLULA HOSPEDEIRA RECOMBINANTE, PROCESSOS PARA PRODUZIR UMA SEQUêNCIA DE áCIDO NUCLEICO MUTANTE, PARA PRODUZIR UM POLIPEPTìDEO, PARA PRODUZIR UM MUTANTE DE UMA CéLULA ORIGINáRIA E PARA PRODUZIR UMA PROTEìNA, E, CéLULA MUTANTE"" A presente invenção refere-se a polipeptídeos isolados tendo atividade de aminopeptidase e sequências de ácido nucleico isolado codificando os polipeptídeos. A invenção também se refere a construções de ácido nucleico, vetores e células hospedeiras compreendendo as sequências de ácido nucleico assim como processos para produzir e usar os polipeptídeos.",NOVO NORDISK A S NOVO NORDISK;;JAPAN TOBACCO INC,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKO;;MARUMOTO CHIGUSA;;KOFOD LENE V,,https://lens.org/191-342-888-154-279,Patent Application,no,0,0,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,,0,0,,,,EXPIRED
549,EP,A2,EP 2454284 A2,005-476-477-924-119,2012-05-23,2012,EP 10734844 A,2010-07-15,NL 2010050456 W;;EP 09165558 A;;US 22587809 P;;EP 10734844 A,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,,AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/005-476-477-924-119,Patent Application,yes,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,ACTIVE
550,US,A1,US 2013/0253175 A1,040-488-131-328-878,2013-09-26,2013,US 201313786206 A,2013-03-05,US 201313786206 A;;EP 09165558 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/040-488-131-328-878,Patent Application,yes,6,6,63,65,64,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12,530/389.5;;530/391.7,1,1,003-774-698-863-009,pmc349879;;10.1073/pnas.77.8.4539;;6933502,Gilliland et al (PNAS. 1980. 77(8): 4539-4543),ACTIVE
551,AU,A1,AU 2016/250398 A1,061-031-043-475-263,2016-11-17,2016,AU 2016/250398 A,2016-10-27,AU 2016/250398 A;;AU 2010/271582 A;;EP 09165558 A;;US 22587809 P;;NL 2010050456 W,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic 5 applications in human individuals. 8339810_1 (GHMatters) P89303.AU.1",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/061-031-043-475-263,Patent Application,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,INACTIVE
552,JP,A,JP 2016135771 A,078-440-948-979-030,2016-07-28,2016,JP 2016001939 A,2016-01-07,EP 09165558 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA-SPECIFIC BINDING COMPOUND,"PROBLEM TO BE SOLVED: To provide an improved binding compound that specifically binds to Gram-positive bacteria.SOLUTION: The invention provides an isolated antibody that any Gram-positive bacteria selected from Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenesis, Staphylococcus epidermis and Bacillus licheniformis but not to Streptococcus pneumoniae or Streptococcus mutans. In certain embodiments, the antibody is human antibody, and Staphylococcus aureus is methicillin resistant Staphylococcus aureus (MRSA), methicillin-sensitive Staphylococcus aureus (MSSA), or vancomycin intermediate sensitive Staphylococcus aureus (VISA).SELECTED DRAWING: None",AIMM THERAPEUTICS BV;;GENENTECH INC,TIM BEAUMONT;;MARK JEROEN KWAKKENBOS;;ERIC J BROWN;;JOHN HIROSHI MORISAKI;;WOUTER L W HAZENBOS;;SANJEEV MARIATHASAN;;KIMBERLY KAJIHARA;;XIA YI,,https://lens.org/078-440-948-979-030,Patent Application,no,6,0,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/02;;A61K39/085;;A61K39/09;;A61K48/00;;A61P31/04;;A61P37/06;;C12N1/02;;C12N1/15;;C12N1/19;;C12N1/20;;C12N1/21;;C12N5/10;;C12N15/09;;C12P21/08;;C12Q1/68,,4,1,094-235-678-116-274,pmc523036;;10.1128/iai.72.11.6237-6244.2004;;15501749,"Y.LIU, ET AL., INFECTION AND IMMUNITY, 2004, 72(11), PP6237-6244, JPN6017002992, ISSN: 0004028485;;MICROBIOLOGY, 2000, 146, PP1535-1546, JPN6015035675, ISSN: 0004028486;;TRENDS IN MICROBIOLOGY, 1998, 6(12), PP484-488, JPN6015035686, ISSN: 0004028487;;EXPERIMENTAL DERMATOLOGY, vol. 20, JPN6015035676, June 2011 (2011-06-01), pages 464 - 467, ISSN: 0003655787",PENDING
553,WO,A3,WO 2011/008092 A3,126-868-967-294-949,2011-05-26,2011,NL 2010050456 W,2010-07-15,EP 09165558 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV;;GENENTECH INC;;BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/126-868-967-294-949,Search Report,yes,4,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,A61K39/395;;C07K16/12;;A61P31/04;;C12N15/13,,13,13,031-626-846-075-129;;099-559-652-967-591;;043-714-998-563-59X;;013-331-795-309-026;;049-960-678-150-173;;070-922-203-323-177;;066-252-194-757-349;;015-570-097-945-448;;013-323-148-570-367;;020-296-196-517-635;;006-565-688-923-344;;036-993-296-085-707;;024-192-636-936-032,10.1099/00221287-146-7-1535;;10878118;;10.1016/j.vetimm.2009.05.012;;19540000;;18809660;;pmc2583566;;10.1128/iai.00874-08;;17027124;;10.1016/j.vaccine.2006.09.043;;17078388;;pmc1610062;;10.1128/aac.00407-06;;17005843;;15728889;;10.1128/aac.49.3.959-962.2005;;pmc549258;;10.1128/iai.74.4.2145-2153.2006;;pmc1418917;;16552044;;14573361;;10.1016/j.tibtech.2003.08.007;;9373310;;10.1016/s1380-2933(96)00045-0;;10.1016/s0140-6736(02)11875-7;;12493294;;12493293;;10.1016/s0140-6736(02)11874-5;;10.1111/j.1574-6968.1991.tb04845.x;;10.1016/0378-1097(91)90426-b;;pmc267543;;10.1128/jcm.27.6.1286-1291.1989;;2473994,"MCCREA K W ET AL: ""The serine-aspartate repeat (Sdr) protein family in staphylococcus epidermidis"", MICROBIOLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, READING, GB, vol. 146, no. 7, 1 July 2000 (2000-07-01), pages 1535 - 1546, XP002955253, ISSN: 1350-0872;;YIN RONG-LAN ET AL: ""Construction and immunogenicity of a DNA vaccine containing clumping factor A of Staphylococcus aureus and bovine IL18."", VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY 15 DEC 2009 LNKD- PUBMED:19540000, vol. 132, no. 2-4, December 2009 (2009-12-01), pages 270 - 274, XP002601812, ISSN: 1873-2534;;TUCHSCHERR LORENA P N ET AL: ""Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice."", INFECTION AND IMMUNITY DEC 2008 LNKD- PUBMED:18809660, vol. 76, no. 12, December 2008 (2008-12-01), pages 5738 - 5744, XP002601813, ISSN: 1098-5522;;GAUDREAU ET AL: ""Protective immune responses to a multi-gene DNA vaccine against Staphylococcus aureus"", VACCINE, ELSEVIER LTD, GB LNKD- DOI:10.1016/J.VACCINE.2006.09.043, vol. 25, no. 5, 8 December 2006 (2006-12-08), pages 814 - 824, XP005798871, ISSN: 0264-410X;;JOHN JOSEPH F JR: ""Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection"", CURRENT OPINION IN MOLECULAR THERAPEUTICS, CURRENT DRUGS, LONDON, GB, vol. 8, no. 5, 1 October 2006 (2006-10-01), pages 455 - 460, XP009138964, ISSN: 1464-8431;;HETHERINGTON SETH ET AL: ""Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysis."", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY OCT 2006 LNKD- PUBMED:17005843, vol. 50, no. 10, October 2006 (2006-10-01), pages 3499 - 3500, XP002601814, ISSN: 0066-4804;;REILLEY SANDRA ET AL: ""Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers."", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY MAR 2005 LNKD- PUBMED:15728889, vol. 49, no. 3, March 2005 (2005-03-01), pages 959 - 962, XP002601815, ISSN: 0066-4804;;SCHAFFER ADAM C ET AL: ""Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model"", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US LNKD- DOI:10.1128/IAI.74.4.2145-2153.2006, vol. 74, no. 4, 1 April 2006 (2006-04-01), pages 2145 - 2153, XP002462561, ISSN: 0019-9567;;HOLT L J ET AL: ""Domain antibodies: proteins for therapy"", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 21, no. 11, 1 November 2003 (2003-11-01), pages 484 - 490, XP004467495, ISSN: 0167-7799;;DAVIES J ET AL: ""Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding"", IMMUNOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, vol. 2, no. 3, 1 September 1996 (1996-09-01), pages 169 - 179, XP004070292, ISSN: 1380-2933;;ELLIOTT T ET AL: ""Antibody response to Staphylococcal slime and lipoteichoic acid"", LANCET THE, LANCET LIMITED. LONDON, GB, vol. 360, no. 9349, 14 December 2002 (2002-12-14), pages 1977, XP004795241, ISSN: 0140-6736;;HAMMONDS S J ET AL: ""Differentiation of enterococci from other group D streptococci by means of a specific monoclonal antibody"", FEMS MICROBIOLOGY LETTERS, BLACKWELL PUBLISHING, AMSTERDAM, NL, vol. 82, no. 1, 15 July 1991 (1991-07-15), pages 91 - 94, XP023971357, ISSN: 0378-1097, [retrieved on 19910715];;WERGELAND H I ET AL: ""Antibodies to Staphylococcal Peptidoglycan and its Peptide Epitopes, Techoic Acid, and Lipotechoic Acid in Sera from Blood Donors and Patients with Staphylococcal Infections"", JOURNAL OF CLINICAL MICROBIOLOGY, WASHINGTON, DC, US, vol. 27, no. 6, 1 June 1989 (1989-06-01), pages 1286 - 1291, XP002120750, ISSN: 0095-1137",PENDING
554,ES,T3,ES 2673323 T3,145-107-506-338-18X,2018-06-21,2018,ES 10734844 T,2010-07-15,EP 09165558 A;;US 22587809 P;;NL 2010050456 W,2009-07-15,Compuestos de unión específica a bacterias gram positivas,"Un anticuerpo aislado o una parte funcional del mismo que pueden unirse a una especie de Staphylococcus, que comprende: (a) una secuencia de CDR1 de cadena pesada RFAMS (SEQ ID NO:1), y (b) una secuencia de CDR2 de cadena pesada SINNGNNPYYARSVQY (SEQ ID NO:2), y (c) una secuencia de CDR3 de cadena pesada DHPSSGWPTFDS (SEQ ID NO:3), y (d) una secuencia de CDR1 de cadena ligera RASENVGDWLA (SEQ ID NO:4), y (e) una secuencia de CDR2 de cadena ligera KTSILES (SEQ ID NO:5), y (f) una secuencia de CDR3 de cadena ligera QHYXRFPYT(SEQ ID NO:6), en la que X es I o M.",AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/145-107-506-338-18X,Granted Patent,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,ACTIVE
555,CA,C,CA 2315274 C,154-386-798-604-777,2009-01-27,2009,CA 2315274 A,1998-11-13,DK 146597 A;;DK 67098 A;;DK 9800495 W;;US 6971997 P,1997-12-16,POLYPEPTIDES HAVING AMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",JAPAN TOBACCO INC;;NOVO NORDISK BIOTECH INC;;NOVO NORDISK AS,KOFOD LENE VENKE;;MARUMOTO CHIGUSA;;TANG MARIA;;BROWN KIMBERLY;;SLOMA ALAN;;BYUN TONY S;;KLOTZ ALAN V;;FUJII MIKIO;;BLINKOVSKY ALEXANDER,,https://lens.org/154-386-798-604-777,Granted Patent,no,0,0,25,52,9,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N9/48;;C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/50;;C12N9/52;;C12N15/57;;C12N15/63;;C12P21/02;;C12P21/06,,0,0,,,,EXPIRED
556,WO,A4,WO 2011/008092 A4,176-476-009-145-828,2011-07-07,2011,NL 2010050456 W,2010-07-15,EP 09165558 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV;;GENENTECH INC;;BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/176-476-009-145-828,Patent Application,yes,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,PENDING
557,US,A1,US 2012/0157665 A1,090-062-317-163-296,2012-06-21,2012,US 201113305659 A,2011-11-28,US 201113305659 A;;EP 09165558 A;;US 83735810 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",BEAUMONT TIM;;KWAKKENBOS MARK J;;BROWN ERIC J;;MORISAKI JOHN H;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,BEAUMONT TIM;;KWAKKENBOS MARK J;;BROWN ERIC J;;MORISAKI JOHN H;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/090-062-317-163-296,Patent Application,yes,0,6,63,65,59,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;C12N5/10,530/387.3;;530/389.5;;435/340,12,11,027-477-313-726-928;;095-334-545-560-259;;014-113-432-888-031;;045-942-104-775-903;;051-707-000-800-833;;031-100-076-670-370;;001-779-867-387-972;;013-142-717-038-23X;;008-028-186-790-704;;022-530-831-805-202;;046-574-565-227-862,10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10.1006/jmbi.1996.0548;;8876650;;12218124;;10.4049/jimmunol.169.6.3076;;12850000;;10.1016/s0006-291x(03)01131-8;;12079396;;10.1016/s0022-2836(02)00264-4;;16989900;;10.1016/j.molimm.2006.08.001;;10.1006/jmbi.1999.3192;;10543973;;10556035;;10.1006/jmbi.1999.3141;;8234256;;10.1073/pnas.90.21.10056;;pmc47712;;10.1038/13590;;10504677;;3709526;;pmc1166865;;10.1002/j.1460-2075.1986.tb04288.x,"Rudikoff et al (Proc Natl Acad Sci USA 1982 Vol 79 page 1979).;;MacCallum et al. J. Mol. Biol. (1996) 262,732-745,;;De Pascalis et al. The Journal of Immunology (2002) 169, 3076-3084;;Casset et al. (2003) BBRC 307, 198-205;;Vajdos et al. (2002) 320, 415-428;;Holm et al. (2007) 44, 1075-1084;;Chen et al. J. Mol. Bio. (1999) 293, 865-881;;Wu et al. J. Mol. Biol. (1999) 294, 151-162.;;Mikayama et al. (Nov.1993. Proc.Natl.Acad.Sci. USA, vol. 90 : 10056-10060);;Rudinger et al. (June 1976. Peptide Hormones. Biol.Council. pages 5-7);;Greenspan et al (Nature Biotechnology 7: 936-937, 1999),;;Chothia et al (THE EMBO JOURNAL, 1986, 5/4:823-26)",INACTIVE
558,US,B2,US 6673571 B2,104-291-611-786-502,2004-01-06,2004,US 95718901 A,2001-09-19,US 95718901 A;;DK 146597 A;;DK 67098 A;;US 19210498 A;;US 6971997 P;;US 54344600 A,1997-12-16,Polypeptides having aminopeptidase activity and nucleic acids encoding same,"
    The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides. 
",NOVOZYMES BIOTECH INC,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKIO;;MARUMOTO CHIGUSA;;KOFOD LENE VENKE,NOVOZYMES INC (2005-08-29),https://lens.org/104-291-611-786-502,Granted Patent,yes,5,0,25,52,9,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,A23J3/34;;C12N1/15;;C12N1/19;;C12N15/09;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,435/69.1;;435/183;;435/252.3;;435/252.31;;435/252.33;;435/320.1;;536/23.1;;536/23.2,6,5,071-340-618-860-317;;030-709-116-002-240;;067-675-830-257-822;;135-641-017-754-235;;065-463-260-187-764,10.1007/bf01570145;;10.3168/jds.s0022-0302(95)76614-0;;1417307;;10.1016/s0021-9258(18)83527-x;;2651436;;1569059;;10.1016/s0021-9258(18)42400-3,"Nakada et al., 1972, Agricultural & Biological Chemistry 37: 757-765, 767-774, and 775-782.;;Kwon et al., 1996, Journal of Industrial Microbiology 17: 30-35.;;Gobbetti et al., 1995, Journal of Dairy Science 78: 44-54.;;Telesnina et al., 1992, Antibiotiki I Khimioterapija 37: 14-16.;;Chang and Smith 1989, Journal of Biological Chemistry 264: 6979-6983.;;Chang et al., 1992, Journal of Biological Chemistry 267: 8007-8011.",EXPIRED
559,US,A9,US 2016/0168232 A9,127-695-428-146-692,2016-06-16,2016,US 201313786206 A,2013-03-05,US 201313786206 A;;EP 09165558 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/127-695-428-146-692,Amended Application,yes,0,0,63,65,64,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12,,0,0,,,,ACTIVE
560,AU,B2,AU 2016/250398 B2,064-795-730-772-576,2018-09-27,2018,AU 2016/250398 A,2016-10-27,AU 2016/250398 A;;AU 2010/271582 A;;EP 09165558 A;;US 22587809 P;;NL 2010050456 W,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic 5 applications in human individuals. 8339810_1 (GHMatters) P89303.AU.1",AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/064-795-730-772-576,Granted Patent,no,2,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,INACTIVE
561,US,B2,US 8617556 B2,081-131-550-051-709,2013-12-31,2013,US 201113305659 A,2011-11-28,US 201113305659 A;;EP 09165558 A;;US 83735810 A;;US 22587809 P,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI;;GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/081-131-550-051-709,Granted Patent,yes,12,11,63,65,64,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,A61K39/40,424/165.1;;424/130.1;;424/164.1;;424/178.1;;424/183.1;;530/387.1,37,34,027-477-313-726-928;;095-334-545-560-259;;014-113-432-888-031;;045-942-104-775-903;;051-707-000-800-833;;031-100-076-670-370;;001-779-867-387-972;;013-142-717-038-23X;;008-028-186-790-704;;022-530-831-805-202;;046-574-565-227-862;;020-296-196-517-635;;087-464-706-073-810;;006-565-688-923-344;;013-331-795-309-026;;004-162-543-606-074;;036-993-296-085-707;;070-922-203-323-177;;013-323-148-570-367;;025-682-930-155-032;;049-960-678-150-173;;020-447-476-598-180;;120-309-713-911-530;;031-626-846-075-129;;064-715-862-322-072;;046-372-239-038-614;;066-252-194-757-349;;007-990-945-290-343;;015-570-097-945-448;;060-444-328-354-958;;043-714-998-563-59X;;099-559-652-967-591;;079-519-098-180-465;;024-192-636-936-032,10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10.1006/jmbi.1996.0548;;8876650;;12218124;;10.4049/jimmunol.169.6.3076;;12850000;;10.1016/s0006-291x(03)01131-8;;12079396;;10.1016/s0022-2836(02)00264-4;;16989900;;10.1016/j.molimm.2006.08.001;;10.1006/jmbi.1999.3192;;10543973;;10556035;;10.1006/jmbi.1999.3141;;8234256;;10.1073/pnas.90.21.10056;;pmc47712;;10.1038/13590;;10504677;;3709526;;pmc1166865;;10.1002/j.1460-2075.1986.tb04288.x;;9373310;;10.1016/s1380-2933(96)00045-0;;18354204;;pmc2396731;;10.4049/jimmunol.180.7.4805;;10.1016/s0140-6736(02)11875-7;;12493294;;12493293;;10.1016/s0140-6736(02)11874-5;;17027124;;10.1016/j.vaccine.2006.09.043;;8757870;;pmc174224;;10.1128/iai.64.8.3318-3325.1996;;10.1111/j.1574-6968.1991.tb04845.x;;10.1016/0378-1097(91)90426-b;;pmc1610062;;10.1128/aac.00407-06;;17005843;;14573361;;10.1016/j.tibtech.2003.08.007;;10.1182/blood.v94.8.2637.420k22_2637_2646;;10515867;;17078388;;pmc257375;;10.1128/iai.60.9.3664-3672.1992;;1500175;;20023635;;10.1038/nm.2071;;pmc2861345;;10.1099/00221287-146-7-1535;;10878118;;16914702;;10.1056/nejmoa055356;;10.1128/iai.64.1.380-383.1996;;pmc173774;;8557371;;15728889;;10.1128/aac.49.3.959-962.2005;;pmc549258;;10.1038/ni1172;;15711548;;10.1128/iai.74.4.2145-2153.2006;;pmc1418917;;16552044;;pmc155362;;10.1101/gad.929302;;11914273;;18809660;;pmc2583566;;10.1128/iai.00874-08;;10.1016/j.vetimm.2009.05.012;;19540000;;10.1038/nrmicro1861;;18327271;;pmc267543;;10.1128/jcm.27.6.1286-1291.1989;;2473994,"Rudikoff et al (Proc Natl Acad Sci USA 1982 vol. 79 p. 1979).;;MacCallum et al. J. Mol. Biol. (1996) 262,732-745.;;De Pascalis et al. The Journal of Immunology (2002) 169, 3076-3084.;;Casset et al. (2003) BBRC 307, 198-205.;;Vajdos et al. (2002) 320, 415-428.;;Holm et al. (2007) 44, 1075-1084.;;Chen et al. J. Mol. Bio. (1999) 293, 865-881.;;Wu et al. J. Mol. Biol. (1999) 294, 151-162.;;Mikayama et al. (Nov. 1993. Proc.Natl.Acad.Sci. USA, vol. 90 : 10056-10060).;;Rudinger et al. (Jun. 1976. Peptide Hormones. Biol.Council. pp. 5-7).;;Greenspan et al (Nature Biotechnology 7: 936-937, 1999).;;Chothia et al (The EMBO Journal, 1986, 5/4:823-26).;;Davies, J. et al. (Sep. 1, 1996). ""Affinity Improvement of Single Antibody VH Domains: Residues in all Three Hypervariable Regions Affect Antigen Binding,"" Immunotechnology 2(3):169-179.;;Diehl, S.A. et al. (2008). ""STAT3-Mediated Up-Regulation of BLIMP1 is Coordinated With BCL6 Down-Regulation to Control Human Plasma Cell Differentiation,"" J Immunol 180:4805-4815.;;Elliott, T. et al. (Dec. 14, 2002). ""Antibody Response to Staphylococcal Slime and Lipoteichoic Acid,"" The Lancet 360(9349):1977.;;Gaudreau, M-C. et al. (Dec. 8, 2006, e-pub. Sep. 22, 2006). ""Protective Immune Responses to a Multi-Gene DNA Vaccine Against Staphylococcus aureus,"" Vaccine 25:814-824.;;Greenberg, J.W. et al. (Aug. 1996). ""Influence of Lipoteichoic Acid Structure on Recognition by the Macrophage Scavenger Receptor,"" Infection and Immunity 64(8):3318-3325.;;Hammonds, S.J. et al. (Jul. 15, 1991, e-pub. Mar. 27, 2006). ""Differentiation of Enterococci From Other Group D Streptococci by Means of a Specific Monoclonal Antibody,"" FEMS Microbiology Letters 82(1):91-94.;;Hetherington, S. et al. (Oct. 2006). ""Phase I Dose Escalation Study to Evaluate the Safety and Pharmacokinetic Profile of Tefibazumab in Subjects with End-Stage Renal Disease Requiring Hemodialysis,"" Antimicrobial Agents and Chemotherapy 50(10):3499-3500.;;Holt, L.J. et al. (Nov. 1, 2003). ""Domain Antibodies: Proteins for Therapy,"" TRENDS in Biotechnology 21(11):484-490.;;International Search Report mailed on Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, ten pages.;;Jaleco, A.C. et al. (Oct. 15, 1999). ""Genetic Modification of Human B-Cell Development: B Cell Development is Inhibited by the Dominant Negative Helix Loop Helix Factor Id3,"" Blood 94(8):2637-2646.;;John, J.F., Jr. (Oct. 1, 2006). ""Drug Evaluation:Tefibazumab-A Monoclonal Antibody Against Staphylococcal Infection,"" Current Opinion in Molecular Therapeutics 8(5):455-460.;;Kabat, E.A. et al. (1991). Sequences of Proteins of Immunological Interest, 5th Ed. Public Health Service National Institute of Health, Bethesda, MD, p. xiii-xcvi.;;Keller, R. et al. (Sep. 1992). ""Macrophage Response to Bacteria: Induction of Marked Secretory and Cellular Activities by Lipoteichoic Acids,"" Infect. Immun. 60(9):3664-3672.;;Kwakkenbos, M.J. et al. (Jan. 2010, e-pub. Dec. 20, 2009). ""Generation of Stable Monoclonal Antibody-Producing B Cell Receptor-Positive Human Memory B Cells by Genetic Programming,"" Nat. Med. 16(1):123-128.;;McCrea, K.W. et al. (Jul. 1, 2000). ""The Serine-Aspartate Repeat (Sdr) Protein Family in Staphylococcus epidermidis,"" Microbiology 146:1535-1546.;;Moran, G.J. et al. (Aug. 17, 2006). ""Methicillin-Resistant S. aureus Infections Among Patients in the Emergency Department,"" NEMJ 355(7):666-674.;;Polotsky, V.Y. et al. (Jan. 1996). ""Interaction of Human Mannose-Binding Protein with Lipoteichoic Acids,"" Infection and Immunity 64(1):380-383.;;Reilley, S. et al. (Mar. 2005). ""Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers,"" Antimicrobial Agents and Chemotherapy 49(3):959-962.;;Scheeren, F.A. et al. (Mar. 2005, e-pub. Feb. 13, 2005). ""STAT5 Regulates the Self-Renewal Capacity and Differentiation of Human Memory B Cells and Controls Bcl-6 Expression,"" Nat. Immunol. 6(3):303-313.;;Schaffer, A. et al. (Apr. 2006). ""Immunization with Staphylococcus aureus Clumping Factor 8, A Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model,"" Infection and Immunity 74(4):2145-2153.;;Shvarts, A. et al. (2002). ""A Senescence Rescue Screen Identifies BCL6 as an Inhibitor of Anti-Proliferative p19ARF-p53 Signaling,"" Genes Dev. 16:681-686.;;Tuchscherr, L.P.N. et al. (Dec. 2008, e-pub. Sep. 22, 2008). ""Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphyloccus aureus in Mice,"" Infection and Immunity 76(12):5738-5744.;;Yin, R-L. et al. (Dec. 15, 2009). ""Construction and Immunogenicity of a DNA Vaccine Containing Clumping Factor A of Staphylococcus aureus and Bovine IL18,"" Veterinary Immunology and Immunopathology 132:270-274.;;Weidenmaier, C. et al. (Apr. 2008, e-pub. Mar. 10, 2008). ""Teichoic Acids and Related Cell-Wall Glycopolymers in Gram-Positive Physiology and Host Interactions,"" Nat Rev. Microbiol. 6(4):276-287.;;Wergeland, H.I. et al. (Jun. 1, 1989). ""Antibodies to Staphylococcal Peptidoglycan and its Peptide Epitopes, Teichoic Acid, and Lipotechoic Acid in Sera From Blood Donors and Patients with Staphylococcal Infections,"" Journal of Clinical Microbiology 27(6):1286-1291.",INACTIVE
562,US,B2,US 9688745 B2,124-179-486-824-981,2017-06-27,2017,US 201514981643 A,2015-12-28,US 201514981643 A;;EP 09165558 A;;US 201314103715 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/124-179-486-824-981,Granted Patent,yes,82,0,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/00;;C07K16/12,,51,48,020-645-047-874-076;;088-581-950-418-154;;094-943-853-156-212;;009-483-512-107-343;;045-942-104-775-903;;001-779-867-387-972;;046-574-565-227-862;;020-296-196-517-635;;014-113-432-888-031;;087-464-706-073-810;;057-413-214-597-900;;006-565-688-923-344;;033-261-430-402-230;;013-331-795-309-026;;003-774-698-863-009;;018-689-993-180-794;;004-162-543-606-074;;022-530-831-805-202;;009-251-924-862-043;;036-993-296-085-707;;070-922-203-323-177;;031-100-076-670-370;;013-323-148-570-367;;025-682-930-155-032;;049-960-678-150-173;;020-447-476-598-180;;120-309-713-911-530;;095-334-545-560-259;;031-626-846-075-129;;005-037-911-432-607;;008-028-186-790-704;;064-715-862-322-072;;046-372-239-038-614;;066-252-194-757-349;;027-477-313-726-928;;063-710-398-275-735;;007-990-945-290-343;;015-570-097-945-448;;060-444-328-354-958;;043-714-998-563-59X;;051-707-000-800-833;;079-519-098-180-465;;024-192-636-936-032;;013-142-717-038-23X;;099-559-652-967-591;;023-878-463-952-471;;094-235-678-116-274;;087-750-056-648-711,10.1016/s0966-842x(98)01400-0;;10036727;;10.4049/jimmunol.164.3.1432;;10640759;;17472965;;10.1074/jbc.m610940200;;10.1073/pnas.89.10.4285;;1350088;;pmc49066;;12850000;;10.1016/s0006-291x(03)01131-8;;10.1006/jmbi.1999.3192;;10543973;;3709526;;pmc1166865;;10.1002/j.1460-2075.1986.tb04288.x;;9373310;;10.1016/s1380-2933(96)00045-0;;12218124;;10.4049/jimmunol.169.6.3076;;18354204;;pmc2396731;;10.4049/jimmunol.180.7.4805;;10.1128/cdli.12.3.387-398.2005;;pmc1065207;;15753252;;10.1016/s0140-6736(02)11875-7;;12493294;;12493293;;10.1016/s0140-6736(02)11874-5;;1560463;;10.1016/0022-2836(92)91010-m;;17027124;;10.1016/j.vaccine.2006.09.043;;pmc349879;;10.1073/pnas.77.8.4539;;6933502;;10.1016/j.vetmic.2009.03.030;;19372010;;8757870;;pmc174224;;10.1128/iai.64.8.3318-3325.1996;;10.1038/13590;;10504677;;pmc308922;;10.1128/iai.71.12.6864-6870.2003;;14638774;;10.1111/j.1574-6968.1991.tb04845.x;;10.1016/0378-1097(91)90426-b;;pmc1610062;;10.1128/aac.00407-06;;17005843;;16989900;;10.1016/j.molimm.2006.08.001;;14573361;;10.1016/j.tibtech.2003.08.007;;10.1182/blood.v94.8.2637.420k22_2637_2646;;10515867;;17078388;;pmc257375;;10.1128/iai.60.9.3664-3672.1992;;1500175;;20023635;;10.1038/nm.2071;;pmc2861345;;10.1006/jmbi.1996.0548;;8876650;;10.1099/00221287-146-7-1535;;10878118;;10.1099/13500872-141-4-937;;7773396;;8234256;;10.1073/pnas.90.21.10056;;pmc47712;;16914702;;10.1056/nejmoa055356;;10.1128/iai.64.1.380-383.1996;;pmc173774;;8557371;;15728889;;10.1128/aac.49.3.959-962.2005;;pmc549258;;10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10.1007/978-1-349-02718-7_1;;10.1038/ni1172;;15711548;;10.1128/iai.74.4.2145-2153.2006;;pmc1418917;;16552044;;pmc155362;;10.1101/gad.929302;;11914273;;18809660;;pmc2583566;;10.1128/iai.00874-08;;12079396;;10.1016/s0022-2836(02)00264-4;;10.1038/nrmicro1861;;18327271;;pmc267543;;10.1128/jcm.27.6.1286-1291.1989;;2473994;;10556035;;10.1006/jmbi.1999.3141;;10.1016/j.vetimm.2009.05.012;;19540000;;pmc3794999;;10.1371/journal.ppat.1003653;;24130480;;pmc523036;;10.1128/iai.72.11.6237-6244.2004;;15501749;;10.1111/j.1600-0625.2011.01276.x;;21585554,"Foster et al. “Surface Protein Adhesin of Staphylococcus Aureus,” Trends Micro. 6(12):484-488, (Dec. 1998).;;Tamura et al. “Structurai Correlates of an Anticarcinoma Antibody: Identification of Specificity-Determining Residues (SDRs) and Development of a Minimally Immunogenic Antibody Variant by Retention of SDRs Only,” J Immunol. 164:1432-1441, (Feb. 2000).;;Arrecubieta, C. et al. (Jun. 29, 2007). “SdrF, a Staphylococcus epidermidis Surface Protein, Binds Type I Collagen,” JBC 282(26):18767-18776.;;Carter, P. et al. (May 1992). “Humanization of Anti-p185HER2 Antibody for Human Cancer Therapy,” Proc. Natl. Acad. Sci. USA 89:4285-4289.;;Casset, F. et al. (Jul. 18, 2003) “A Peptide Mimetic of an Anti-CD4 Monoclonal Antibody by Rational Design,” Biochem. Biophy.s Res. Commun. 307(1):198-205.;;Chen, Y. et al. (Nov. 5, 1999). “Selection and Analysis of an Optimized Anti-VEGF Antibody: Crystal Structure of an Affinity-Matured Fab in Complex With Antigen,” J. Mol. Bio. 293(4):865-881.;;Chothia, C. et al (1986). “The Relation Between the Divergence of Sequence and Structure in Proteins,” The EMBO Journal 5(4):823-826.;;Davies, J. et al. (Sep. 1, 1996). “Affinity Improvement of Single Antibody VH Domains: Residues in all Three Hypervariable Regions Affect Antigen Binding,” Immunotechnology 2(3):169-179.;;De Pascalis, R. et al. (Sep. 15, 2002). “Grafting of “Abbreviated” Complementarity-Determining Regions Containing Specificity-Determining Residues Essential for Ligand Contact to Engineer a Less Immunogenic Humanized Monoclonal Antibody,” The Journal of Immunology 169(6):3076-3084.;;Diehl, S.A. et al. (2008). “Stats-Mediated Up-Regulation of BLIMP1 is Coordianted With BCL6 Down-Reguation to Control Huamn Plasma Cell Differentiation,” The Journal of Immunology 180:4805-4815.;;Dryla, A. et al. (Mar. 2005). “Comparison of Antibody Repertoires Against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients,” Clinical and Diagnostic Laboratory Immunology 12(3):387-398.;;Elliott, T. et al. (Dec. 14, 2002). “Antibody Response to Staphylococcal Slime and Lipoteichoic Acid,” The Lancet 360(9349):1977.;;Foote, J. et al. (1992). “Antibody Framework Residues Affecting the Conformation of the Hypervariable Loops,” J. Mol. Biol. 224:487-499.;;Gaudreau, M-C. et al. (Dec. 8, 2006, e-pub. Sep. 22, 2006). “Protective Immune Responses to a Multi-Gene DNA Vaccine Against Staphylococcus aureus,” Vaccine 25:814-824.;;Gilliland, D.G. et al. (1980). “Antibody-directed cytotoxic agents: Use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells,” Proc Natl Acad Sci, 70(8):4539-4543.;;Geoghegan, J.A. et al. (2009). “Staphylococcus pseudintermedius Expresses Surface Proteins That Closely Resemble Those From Staphylococcus aureus,” Veterinary Microbiology 138:345-352.;;Greenberg, J.W. et al. (Aug. 1996). “Influence of Lipoteichoic Acid Structure on Recognition by the Macrophage Scanenger Receptor,” Infection and Immunity 64(8):3318-3325.;;Greenspan. N.S. et al (Oct. 1999). “Defining Epitopes: It's Not as Easy as it Seems,” Nature Biotechnology 17(10):936-937.;;Hall, A.E. et al. (Dec. 2003). “Characterization of a Protective Monoclonal Antibody Recognizing Staphylococcus aureus MSCRAMM Protein Clumping Factor A,” Infection and Immunity 71(12):6864-6870.;;Hammonds, S.J. et al. (Jul. 15, 1991). “Differentiation of Enterococci From Other Group D Streptococci by Means of a Specific Monoclonal Antibody,” FEMS Microbiology Letters 82:91-94.;;Hetherington, S. et al. (Oct. 2006). “Phase I Dose Escalation Study to Evaluate the Safety and Pharmacokinetic Profile of Tefibazumab in Subjects with End-Stage Renal Disease Requiring Hemodialysis,” Antimicrobial Agents and Chemotherapy 50(10):3499-3500.;;Holm, P. et al. (Feb. 2007). “Functional Mapping and Single Chain Construction of the Anti-Cytokeratin 8 Monoclonal Antibody TS1,” Molecular Immunology 44:(6):1075-1084.;;Holt, L.J. et al. (Nov. 1, 2003). “Domain Antibodies: Proteins for Therapy,” TRENDS in Biotechnology 21(11):484-490.;;International Search Report mailed on Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, ten pages.;;Jaleco, A.C. et al. (Oct. 15, 1999). “Genetic Modification of Human B-Cell Development: B Cell Development is Inhibited by the Dominant Negative Helix Loop Helix Factor Id3,” Blood 94(8):2637-2646.;;John, J.F., Jr. et al. (Oct. 1, 2006). “Drug Evaluation:Tefibazumab—A Monoclonal Antibody Against Staphylococcal Infection,” Current Opinion in Molecular Therapeutics 8(5):455-460.;;Kabat, E.A. et al. (1991). Sequences of Proteins of Immunological Interest, 5th Ed. Public Health Service National Institute of Health, Bethesda, MD, Table of Contents, pp. xiii-scvi.;;Keller, R. et al. (Sep. 1992). “Macrophage Response to Bacteria: Induction of Marked Secretory and Cellular Activities by Lipoteichoic Acids,” Infect. Immun. 60(9):3664-3672.;;Kwakkenbos, M.J. et al. (Jan. 2010, e-pub. Dec. 20, 2009). “Generation of Stable Monoclonal Antibody-Producing B Cell Receptor-Positive Human Memory B Cells by Genetic Programming,” Nat. Med. 16(1):123-128.;;MacCallum, R.M. et al. (Oct. 11, 1996). Antibody-Antigen Interactions: Contact Analysis and Binding Site Topography, J. Mol. Bioi. 262(5):732-745.;;McCrea, K.W. et al. (Jul. 1, 2000). “The Serine-Aspartate Repeat (Sdr) Protein Family in Staphylococcus epidermidis,” Microbiology 146:1535-1546.;;McDevitt, D. et al. (1995). “Variation in the Size of the Repeat Region of the Fibrinogen Receptor (Clumping Factor) of Staphylococcus aureus Strains,” Microbiology 141:937-943.;;Mikayama, T. et al. (Nov. 1, 1993). “Molecular Cloning and Functional Expression of a cDNA Encoding Glycosylation-Inhibiting Factor,” Proc.Nati.Acad.Sci. USA 90(21):10056-10060.;;Moran, G.J. et al. (Aug. 17, 2006). “Methicillin-Resistant S. aureus Infections Among Patients in the Emergency Department,” NEMJ 355(7):666-674.;;Polotsky, V.Y. et al. (Jan. 1996). “Interaction of Human Mannose-Binding Protein with Lipoteichoic Acids,” Infection and Immunity 64(1):380-383.;;Reilley, S. et al. (Mar. 2005). “Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers,” Antimicrobial Agents and Chemotherapy 49(3):959-962.;;Rudikoff, S.et al (Mar. 1982). “Single Amino Acid Substitution Altering Antigen-Binding Specificity,” Proc Natl Acad Sci USA 79(6):1979-1983.;;Rudinger, J. et al. (Jun. 1976). “Characteristics of the Amino Acids as Components of a Peptide Hormone Sequence,” Chapter 1 in Peptide Hormones, University Park Press, Baltimore, MD, Bioi.Council. pp. 5-7.;;Scheeren, F.A. et al. (Mar. 2005, e-pub. Feb. 13, 2005). “STAT5 Regulates the Self-Renewal Capacity and Differentiation of Human Memory B Cells and Controls Bcl-6 Expression,” Nat. Immunol. 6(3):303-313.;;Schaffer, A. et al. (Apr. 1, 2006). “Immunication with Staphylococcus aureus Clumping Factor 8, A Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model,” Infection and Immunity 74(4):2145-2153.;;Shvarts, A. et al. (2002). “A Senescence Rescue Screen Identifies BCL6 as an Inhibitor of Anti-Proliferative p19ARF-p53 Signaling,” Genes Dev. 16:681-686.;;Tuchscherr, L.P.N. et al. (Dec. 2008, e-pub. Sep. 22, 2008). “Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphyloccus aureus in Mice,” Infection and Immunity 76(12):5738-5744.;;Vajdos, F.F. et al. (2002). “Comprehensive Functional Maps of the Antigen-Binding Site of an Anti-Erbb2 Antibody Obtained With Shotgun Scanning Mutagenesis,”J. Mol. Biol. 320:415-428.;;Weidenmaier, C. et al. (Apr. 2008, e-pub. Mar. 10, 2008). “Teichoic Acids and Related Cell-Wall Glycopolymers in Gram-Positive Physiology and Host Interactions,” Nat Rev. Microbiol. 6(4):276-287.;;Wergeland, H.I. et al. (Jun. 1, 1989). “Antibodies to Staphylococcal Peptidoglycan nd its Peptide Epitopes, Techoic Acid, and Lipotechoic Acid in Sera From Blood Donors and Patients with Staphylococcal Infections,” Journal of Clinical Microbiology 27(6):1286-1291.;;Wu, H. et al. (Nov. 19, 1999).“Humanization of a Murine Monoclonal Antibody by Simultaneous Optimization of Framework and CDR Residues,” J. Mol. Biol. 294(1):151-162.;;Yin, R-L. et al. (Dec. 15, 2009). “Construction and Immunogenicity of a DNA Vaccine Containing Clumping Factor A of Staphylococcus aureus and Bovine IL18,” Veterinary Immunology and Immunopathology 132:270-274.;;Written Opinion mailed on Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, twelve pages.;;Hazenbos, W. L. W. et al. (2013). “Novel Staphylococcal Glycosyltransferase SdgA and SdgB Mediate Immunogenicity and Protection of Virulence-Associated Cell Wall Proteins,” PLOS, 9(10): e1003653, pp. 1-18.;;Liu et al. “SdrX, a Serine-Aspartate Repeat Protein Expressed by Staphylococcus capitis with Collagen VI Binding Activity,” Infection and Immunity 72(11):6273-6244, (Nov. 2004).;;Tsutsumi et al. “Morphological and Functional Differences in Coculture System of Keratinocytes and Dorsal-Root-Ganglion-Derived Cells Depending on Time of Seeding,” Experimental Dermatology 20:464-467, (2011).",INACTIVE
563,TW,A,TW 201107470 A,009-004-012-663-406,2011-03-01,2011,TW 99123405 A,2010-07-15,EP 09165558 A;;US 22587809 P,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPIUTICS B V;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/009-004-012-663-406,Patent of Addition,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C12N15/13;;A61K39/395;;A61P31/04;;C07K14/46,,0,0,,,,INACTIVE
564,MX,A,MX 2012000625 A,079-896-702-574-270,2012-03-26,2012,MX 2012000625 A,2010-07-15,US 22587809 P;;EP 09165558 A;;NL 0150456 W,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS.,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV,XIA YI;;MARIATHASAN SANJEEV;;BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;KAJIHARA KIMBERLY,,https://lens.org/079-896-702-574-270,Patent Application,no,0,0,1,65,0,,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,ACTIVE
565,AU,A2,AU 2010/271582 A2,173-379-801-480-810,2013-05-16,2013,AU 2010/271582 A,2010-07-15,EP 09165558 A;;US 22587809 P;;NL 2010050456 W,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/173-379-801-480-810,Patent Application,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,INACTIVE
566,EP,A1,EP 1042457 A1,040-617-087-454-153,2000-10-11,2000,EP 98956817 A,1998-11-13,DK 9800495 W;;DK 146597 A;;DK 67098 A;;US 6971997 P,1997-12-16,POLYPEPTIDES HAVING AMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,,NOVO NORDISK AS;;NOVO NORDISK BIOTECH INC;;JAPAN TOBACCO INC,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKO;;MARUMOTO CHIGUSA;;KOFOD LENE VENKE,"NOVO NORDISK BIOTECH, INC. (2001-01-24);;JAPAN TOBACCO INC. (2007-10-30);;NOVOZYMES, INC. (2005-06-22);;NOVOZYMES A/S (2005-06-22);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/040-617-087-454-153,Patent Application,yes,0,0,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,,0,0,,,,EXPIRED
567,US,B2,US 9399673 B2,104-519-785-136-882,2016-07-26,2016,US 201313786206 A,2013-03-05,US 201313786206 A;;EP 09165558 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/104-519-785-136-882,Granted Patent,yes,67,6,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12,,46,43,003-774-698-863-009;;045-942-104-775-903;;001-779-867-387-972;;046-574-565-227-862;;020-296-196-517-635;;014-113-432-888-031;;087-464-706-073-810;;006-565-688-923-344;;013-331-795-309-026;;004-162-543-606-074;;022-530-831-805-202;;036-993-296-085-707;;070-922-203-323-177;;031-100-076-670-370;;013-323-148-570-367;;025-682-930-155-032;;049-960-678-150-173;;020-447-476-598-180;;120-309-713-911-530;;095-334-545-560-259;;031-626-846-075-129;;008-028-186-790-704;;064-715-862-322-072;;046-372-239-038-614;;066-252-194-757-349;;027-477-313-726-928;;063-710-398-275-735;;007-990-945-290-343;;015-570-097-945-448;;060-444-328-354-958;;043-714-998-563-59X;;051-707-000-800-833;;079-519-098-180-465;;024-192-636-936-032;;013-142-717-038-23X;;099-559-652-967-591;;018-689-993-180-794;;005-037-911-432-607;;009-483-512-107-343;;033-261-430-402-230;;094-943-853-156-212;;057-413-214-597-900;;009-251-924-862-043,pmc349879;;10.1073/pnas.77.8.4539;;6933502;;12850000;;10.1016/s0006-291x(03)01131-8;;10.1006/jmbi.1999.3192;;10543973;;3709526;;pmc1166865;;10.1002/j.1460-2075.1986.tb04288.x;;9373310;;10.1016/s1380-2933(96)00045-0;;12218124;;10.4049/jimmunol.169.6.3076;;18354204;;pmc2396731;;10.4049/jimmunol.180.7.4805;;10.1016/s0140-6736(02)11875-7;;12493294;;12493293;;10.1016/s0140-6736(02)11874-5;;17027124;;10.1016/j.vaccine.2006.09.043;;8757870;;pmc174224;;10.1128/iai.64.8.3318-3325.1996;;10.1038/13590;;10504677;;10.1111/j.1574-6968.1991.tb04845.x;;10.1016/0378-1097(91)90426-b;;pmc1610062;;10.1128/aac.00407-06;;17005843;;16989900;;10.1016/j.molimm.2006.08.001;;14573361;;10.1016/j.tibtech.2003.08.007;;10.1182/blood.v94.8.2637.420k22_2637_2646;;10515867;;17078388;;pmc257375;;10.1128/iai.60.9.3664-3672.1992;;1500175;;20023635;;10.1038/nm.2071;;pmc2861345;;10.1006/jmbi.1996.0548;;8876650;;10.1099/00221287-146-7-1535;;10878118;;8234256;;10.1073/pnas.90.21.10056;;pmc47712;;16914702;;10.1056/nejmoa055356;;10.1128/iai.64.1.380-383.1996;;pmc173774;;8557371;;15728889;;10.1128/aac.49.3.959-962.2005;;pmc549258;;10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10.1007/978-1-349-02718-7_1;;10.1038/ni1172;;15711548;;10.1128/iai.74.4.2145-2153.2006;;pmc1418917;;16552044;;pmc155362;;10.1101/gad.929302;;11914273;;18809660;;pmc2583566;;10.1128/iai.00874-08;;12079396;;10.1016/s0022-2836(02)00264-4;;10.1038/nrmicro1861;;18327271;;pmc267543;;10.1128/jcm.27.6.1286-1291.1989;;2473994;;10556035;;10.1006/jmbi.1999.3141;;10.1016/j.vetimm.2009.05.012;;19540000;;10.1016/j.vetmic.2009.03.030;;19372010;;10.1099/13500872-141-4-937;;7773396;;10.1073/pnas.89.10.4285;;1350088;;pmc49066;;1560463;;10.1016/0022-2836(92)91010-m;;17472965;;10.1074/jbc.m610940200;;10.1128/cdli.12.3.387-398.2005;;pmc1065207;;15753252;;pmc308922;;10.1128/iai.71.12.6864-6870.2003;;14638774,"Gilliland et al (PNAS. 1980. 77(8): 4539-4543).;;Casset, F. et al. (Jul. 18, 2003) ""A Peptide Mimetic of an Anti-CD4 Monoclonal Antibody by Rational Design,"" Biochem. Biophy.s Res. Commun. 307(1):198-205.;;Chen, Y. et al. (Nov. 5, 1999). ""Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen,"" J.. Mol. Bio. 293(4):865-881.;;Chothia, C. et al (1986). ""The relation between the divergence of sequence and structure in proteins,"" The EMBO Journal 5(4):823-826.;;Davies, J. et al. (Sep. 1, 1996). ""Affinity Improvement of Single Antibody VH Domains: Residues in all Three Hypervariable Regions Affect Antigen Binding,"" Immunotechnology 2(3):169-179.;;De Pascalis, R. et al. (Sep. 15, 2002). ""Grafting of ""abbreviated"" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody,"" The Journal of Immunology 169(6):3076-3084.;;Diehl, S.A. et al. (2008). ""STAT3-Mediated Up-Regulation of BLIMP1 is Cooridanted With BCL6 Down-Reguation to Control Huamn Plasma Cell Differentiation,"" J Immunol 180:4805-4815.;;Elliott, T. et al. (Dec. 14, 2002). ""Antibody Response to Staphylococcal Slime and Lipoteichoic Acid,"" The Lancet 360(9349):1977.;;Gaudreau, M-C. et al. (Dec. 8, 2006, e-pub. Sep. 22, 2006). ""Protective Immune Responses to a Multi-Gene DNA Vaccine Against Staphylococcus aureus,"" Vaccine 25:814-824.;;Greenberg, J.W. et al. (Aug. 1996). ""Influence of Lipoteichoic Acid Structure on Recognition by the Macrophage Scanenger Receptor,"" Infection and Immunity 64(8):3318-3325.;;Greenspan. N.S. et al (Oct. 1999). ""Defining epitopes: Its Not as Easy as it Seems,"" Nature Biotechnology 17(10):936-937.;;Hammonds, S.J. et al. (Jul. 15, 1991). ""Differentiation of Enterococci From Other Group D Streptococci by Means of a Specific Monoclonal Antibody,"" FEMS Microbiology Letters 82:91-94.;;Hetherington, S. et al. (Oct. 2006). ""Phase I Dose Escalation Study to Evaluate the Safety and Pharmacokinetic Profile of Tefibazumab in Subjects with End-Stage Renal Disease Requiring Hemodialysis,"" Antimicrobial Agents and Chemotherapy 50(10):3499-3500.;;Holm, P. et al. (Feb. 2007). ""Functional Mapping and Single Chain Construction of the Anti-Cytokeratin 8 Monoclonal Antibody TS1,"" Mol. Immunol. 44:(6):1075-1084.;;Holt, L.J. et al. (Nov. 1, 2003). ""Domain Antibodies: Proteins for Therapy,"" TRENDS in Biotechnology 21(11):484-490.;;International Search Report mailed on Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, ten pages.;;Jaleco, A.C. et al. (Oct. 15, 1999). ""Genetic Modification of Human B-Cell Development: B Cell Development is Inhibited by the Dominant Negative Helix Loop Helix Factor Id3,"" Blood 94(8):2637-2646.;;John, J.F., Jr. et al. (Oct. 1, 2006). ""Drug Evaluation:Tefibazumab-A Monoclonal Antibody Against Staphylococcal Infection,"" Current Opinion in Molecular Therapeutics 8(5):455-460.;;Kabat et al. (1991). Sequences of Proteins of Immunological Interest, 5th Ed. Public Health Service National Institute of Health, Bethesda, MD, Table of Contents, pp. xiii-scvi.;;Keller, R. et al. (Sep. 1992). ""Macrophage Response to Bacteria: Induction of Marked Secretory and Cellular Activities by Lipoteichoic Acids,"" Infect. Immun. 60(9):3664-3672.;;Kwakkenbos, M.J. et al. (Jan. 2010, e-pub. Dec. 20, 2009). ""Generation of Stable Monoclonal Antibody-Producing B Cell Receptor-Positive Human Memory B Cells by Genetic Programming,"" Nat. Med. 16(1):123-128.;;Maccallum, R.M. et al. (Oct. 11, 1996). ""Antibody-Antigen Interactions: Contact Analysis and Binding Site Topography,"" J. Mol. Bioi. 262(5):732-745.;;McCrea, K.W. et al. (Jul. 1, 2000). ""The Serine-Aspartate Repeat (Sdr) Protein Family in Staphylococcus epidermidis,"" Microbiology 146:1535-1546.;;Mikayama, T. et al. (Nov. 1, 1993). ""Molecular Cloning and Functional Expression of a cDNA Encoding Glycosylation-lnhibiting Factor,"" Proc.Nati.Acad.Sci. USA 90(21):10056-10060.;;Moran, G.J. et al. (Aug. 17, 2006). ""Methicillin-Resistant S. aureus Infections Among Patients in the Emergency Department,"" NEMJ 355(7):666-674.;;Polotsky, V.Y. et al. (Jan. 1996). ""Interaction of Human Mannose-Binding Protein with Lipoteichoic Acids,"" Infection and Immunity 64(1):380-383.;;Reilley, S. et al. (Mar. 2005). ""Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers,"" Antimicrobial Agents and Chemotherapy 49(3):959-962.;;Rudikoff , S.et al (Mar. 1982). ""Single Amino Acid Substitution Altering Antigen-binding Specificity,"" Proc Natl Acad Sci USA 79(6):1979-1983.;;Rudinger, J. et al. (Jun. 1976). ""Characteristics of the Amino Acids as Components of a Peptide Hormone Sequence,"" Chapter 1 in Peptide Hormones, University Park Press, Baltimore, MD, Bioi.Council. pp. 5-7.;;Scheeren, F.A. et al. (Mar. 2005, e-pub. Feb. 13, 2005). ""STATS Regulates the Self-Renewal Capacity and Differentiation of Human Memory B Cells and Controls Bcl-6 Expression,"" Nat. Immunol. 6(3):303-313.;;Schaffer, A. et al. (Apr. 1, 2006). ""Immunication with Staphylococcus aureus Clumping Factor 8, A Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model,"" Infection and Immunity 74(4):2145-2153.;;Shvarts, A. et al. (2002). ""A Senescence Rescue Screen Identifies BCL6 as an Inhibitor of Anti-Proliferative p19ARF-p53 Signaling,"" Genes Dev. 16:681-686.;;Tuchscherr, L.P.N. et al. (Dec. 2008, e-pub. Sep. 22, 2008). ""Antibodies to Capsular Polysaccharide and Clumping Factor a Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphyloccus aureus in Mice,"" Infection and Immunity 76(12):5738-5744.;;Vajdos, F.F. et al. (2002). ""Comprehensive Functional Maps of the Antigen-Binding Site of an Anti-ErbB2 Antibody Obtained With Shotgun Scanning Mutagenesis,"" J. Mol. Biol. 320:415-428.;;Weidenmaier, C. et al. (Apr. 2008, e-pub. Mar. 10, 2008). ""Teichoic Acids and Related Cell-Wall Glycopolymers in Gram-Positive Physiology and Host Interactions,"" Nat Rev. Microbiol. 6(4):276-287.;;Wergeland, H.I. et al. (Jun. 1, 1989). ""Antibodies to Staphylococcal Peptidoglycan nd its Peptide Epitopes, Techoic Acid, and Lipotechoic Acid in Sera From Blood Donors and Patients with Staphylococcal Infections,"" Journal of Clinical Microbiology 27(6):1286-1291.;;Wu, H. et al. (Nov. 19, 1999).""Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues,"" J. Mol. Biol. 294(1):151-162.;;Yin, R-L. et al. (Dec. 15, 2009). ""Construction and Immunogenicity of a DNA Vaccine Containing Clumping Factor a of Staphylococcus aureus and Bovine IL18,"" Veterinary Immunology and Immunopathology 132:270-274.;;Written Opinion mailed on Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, twelve pages.;;Geoghegan et al. ""Staphylococcus pseudintermedius expresses surface proteins that closely resemble those from Staphylococcus aureus,"" Veterinary Microbiology 138:345-352 (2009).;;McDevitt et al. ""Variation in the size of the repeat region of the fibrinogen receptor (clumping factor) of Staphylococcus aureus strains,"" Microbiology 141:937-943 (1995).;;Carter et al. ""Humanization of Anti-p185HER2 Antibody for Human Cancer Therapy,"" Proc. Natl. Acad. Sci. USA 89:4285-4289, (May 1992).;;Foote et al. ""Antibody Framework Residues Affecting the Conformation of the Hypervariable Loops,"" J. Mol. Biol. 224:487-499, (1992).;;Arrecubieta, C. et al. (Jun. 29, 2007). ""SdrF, a Staphylococcus epidermidis Surface Protein, Binds Type I Collagen,"" JBC 282(26):18767-18776.;;Dryla, A. et al. (Mar. 2005). ""Comparison of Antibody Repertoires Against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients,"" Clinical and Diagnostic Laboratory Immunology 12(3):387-398.;;Hall, A.E. et al. (Dec. 2003). ""Characterization of a Protective Monoclonal Antibody Recognizing Staphylococcus aureus MSCRAMM Protein Clumping Factor A,"" Infection and Immunity 71(12):6864-6870.",ACTIVE
568,ZA,B,ZA 201400644 B,131-026-186-152-462,2015-10-28,2015,ZA 201400644 A,2014-01-27,EP 09165558 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,,GENENTECH INC;;AIMM THERAPEUTICS BV,XIA YI;;KAJIHARA KIMBERLY;;MARIATHASAN SANJEEV;;HAZENBOS WOUTER L W;;MORISAKI JOHN HIROSHI;;BROWN ERIC J;;KWAKKENBOS MARK JEROEN;;BEAUMONT TIM,,https://lens.org/131-026-186-152-462,Granted Patent,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,,,0,0,,,,ACTIVE
569,US,A1,US 2018/0292391 A1,193-745-157-667-66X,2018-10-11,2018,US 201815900589 A,2018-02-20,US 201815900589 A;;EP 09165558 A;;US 201615246301 A;;US 201514728826 A;;US 201313786215 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/193-745-157-667-66X,Patent Application,yes,0,1,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,G01N33/50;;C07K16/12;;G01N33/68,,0,0,,,,DISCONTINUED
570,NZ,A,NZ 616921 A,093-648-638-096-933,2015-06-26,2015,NZ 61692110 A,2010-07-15,US 22587809 P;;EP 09165558 A;;NZ 59806310 A,2009-07-15,Gram-positive bacteria specific binding compounds,"Disclosed is an antibody or a functional part thereof that binds to a serine-aspartate (SD) repeat dependent epitope on a SD repeat (SDR) protein expressed by a Staphylococcus species, wherein the antibody or functional part thereof is coupled to a cytotoxic agent to form an antibody-drug conjugate. Also disclosed is the use of the disclosed antibody-drug conjugate in the preparation of a medicament and/or prophylactic agent for treating and/or preventing a Gram-positive bacterium-related disorder in an individual.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;BROWN ERIC J;;HAZENBOS WOUTER L W;;KWAKKENBOS MARK JEROEN;;MARIATHASAN SANJEEV;;XIA YI;;KAJIHARA KIMBERLY;;MORISAKI JOHN HIROSHI,,https://lens.org/093-648-638-096-933,Patent Application,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,DISCONTINUED
571,BR,A8,BR 112012000953 A8,117-618-360-375-963,2017-12-26,2017,BR 112012000953 A,2010-07-15,NL 2010050456 W;;EP 09165558 A;;US 22587809 P,2009-07-15,"anticorpos de ligação a bactérias gram-positivas, sequência de ácido nucleico,seus usos e seu método de produção, células isolada ou produtora de anticorpo isolado ou recombinante, composições, e método de isolamento de bactérias",,AIMM THERAPEUTICS BV;;GENENTECH INC,ERIC J BROWN;;JOHN HIROSHI MORISAKI;;KIMBERLY KAJIHARA;;MARK JEROEN KWAKKENBOS;;SANJEEV MARIATHASAN;;TIM BEAUMONT;;WOUTER L W HAZENBROS;;YI XIA,,https://lens.org/117-618-360-375-963,Patent Application,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,A61K39/395;;A61P31/04;;C07K16/12;;C12N15/13,,0,0,,,,DISCONTINUED
572,TW,B,TW I502068 B,161-283-767-942-070,2015-10-01,2015,TW 99123405 A,2010-07-15,EP 09165558 A;;US 22587809 P,2009-07-15,Gram-positive bacteria specific binding compounds,,AIMM THERAPIUTICS B V;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/161-283-767-942-070,Granted Patent,no,3,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,,,1,1,031-626-846-075-129,10.1099/00221287-146-7-1535;;10878118,Kirk W. McCrea et al. The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis. Microbiology July 2000 vol. 146 no. 7 1535-1546.,INACTIVE
573,US,B2,US 9458228 B2,016-720-494-873-086,2016-10-04,2016,US 201514728826 A,2015-06-02,US 201514728826 A;;EP 09165558 A;;US 201313786215 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/016-720-494-873-086,Granted Patent,yes,68,2,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12,,47,44,094-943-853-156-212;;057-413-214-597-900;;009-251-924-862-043;;009-483-512-107-343;;033-261-430-402-230;;045-942-104-775-903;;001-779-867-387-972;;046-574-565-227-862;;020-296-196-517-635;;014-113-432-888-031;;087-464-706-073-810;;006-565-688-923-344;;013-331-795-309-026;;003-774-698-863-009;;018-689-993-180-794;;004-162-543-606-074;;022-530-831-805-202;;036-993-296-085-707;;070-922-203-323-177;;031-100-076-670-370;;013-323-148-570-367;;025-682-930-155-032;;049-960-678-150-173;;020-447-476-598-180;;120-309-713-911-530;;095-334-545-560-259;;031-626-846-075-129;;005-037-911-432-607;;008-028-186-790-704;;064-715-862-322-072;;046-372-239-038-614;;066-252-194-757-349;;027-477-313-726-928;;063-710-398-275-735;;007-990-945-290-343;;015-570-097-945-448;;060-444-328-354-958;;043-714-998-563-59X;;051-707-000-800-833;;079-519-098-180-465;;024-192-636-936-032;;013-142-717-038-23X;;099-559-652-967-591;;088-581-950-418-154,17472965;;10.1074/jbc.m610940200;;10.1128/cdli.12.3.387-398.2005;;pmc1065207;;15753252;;pmc308922;;10.1128/iai.71.12.6864-6870.2003;;14638774;;10.1073/pnas.89.10.4285;;1350088;;pmc49066;;1560463;;10.1016/0022-2836(92)91010-m;;12850000;;10.1016/s0006-291x(03)01131-8;;10.1006/jmbi.1999.3192;;10543973;;3709526;;pmc1166865;;10.1002/j.1460-2075.1986.tb04288.x;;9373310;;10.1016/s1380-2933(96)00045-0;;12218124;;10.4049/jimmunol.169.6.3076;;18354204;;pmc2396731;;10.4049/jimmunol.180.7.4805;;10.1016/s0140-6736(02)11875-7;;12493294;;12493293;;10.1016/s0140-6736(02)11874-5;;17027124;;10.1016/j.vaccine.2006.09.043;;pmc349879;;10.1073/pnas.77.8.4539;;6933502;;10.1016/j.vetmic.2009.03.030;;19372010;;8757870;;pmc174224;;10.1128/iai.64.8.3318-3325.1996;;10.1038/13590;;10504677;;10.1111/j.1574-6968.1991.tb04845.x;;10.1016/0378-1097(91)90426-b;;pmc1610062;;10.1128/aac.00407-06;;17005843;;16989900;;10.1016/j.molimm.2006.08.001;;14573361;;10.1016/j.tibtech.2003.08.007;;10.1182/blood.v94.8.2637.420k22_2637_2646;;10515867;;17078388;;pmc257375;;10.1128/iai.60.9.3664-3672.1992;;1500175;;20023635;;10.1038/nm.2071;;pmc2861345;;10.1006/jmbi.1996.0548;;8876650;;10.1099/00221287-146-7-1535;;10878118;;10.1099/13500872-141-4-937;;7773396;;8234256;;10.1073/pnas.90.21.10056;;pmc47712;;16914702;;10.1056/nejmoa055356;;10.1128/iai.64.1.380-383.1996;;pmc173774;;8557371;;15728889;;10.1128/aac.49.3.959-962.2005;;pmc549258;;10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10.1007/978-1-349-02718-7_1;;10.1038/ni1172;;15711548;;10.1128/iai.74.4.2145-2153.2006;;pmc1418917;;16552044;;pmc155362;;10.1101/gad.929302;;11914273;;18809660;;pmc2583566;;10.1128/iai.00874-08;;12079396;;10.1016/s0022-2836(02)00264-4;;10.1038/nrmicro1861;;18327271;;pmc267543;;10.1128/jcm.27.6.1286-1291.1989;;2473994;;10556035;;10.1006/jmbi.1999.3141;;10.1016/j.vetimm.2009.05.012;;19540000;;10.4049/jimmunol.164.3.1432;;10640759,"Arrecubieta, C. et al. (Jun. 29, 2007). ""SdrF, a Staphylococcus epidermidis Surface Protein, Binds Type I Collagen,"" JBC 282(26):18767-18776.;;Dryla, A. et al. (Mar. 2005). ""Comparison of Antibody Repertoires Against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients,"" Clinical and Diagnostic Laboratory Immunology 12(3):387-398.;;Hall, A.E. et al. (Dec. 2003). ""Characterization of a Protective Monoclonal Antibody Recognizing Staphylococcus aureus MSCRAMM Protein Clumping Factor A,"" Infection and Immunity 71(12):6864-6870.;;Carter et al. ""Humanization of Anti-p185HER2 Antibody for Human Cancer Therapy,"" Proc. Natl. Acad. Sci. USA 89:4285-4289, (May 1992).;;Foote et al. ""Antibody Framework Residues Affecting the Conformation of the Hypervariable Loops,"" J. Mol. Biol. 224:487-499, (1992).;;Casset, F. et al. (Jul. 18, 2003) ""A peptide mimetic of an anti-CD4 monoclonal antibody by rational design,"" Biochem. Biophy.s Res. Commun. 307(1):198-205.;;Chen, Y. et al. (Nov. 5, 1999). ""Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen,"" J.. Mol. Bio. 293(4):865-881.;;Chothia, C. et al (1986). ""The relation between the divergence of sequence and structure in proteins,"" The EMBO Journal 5(4):823-826.;;Davies, J. et al. (Sep. 1, 1996). ""Affinity Improvement of Single Antibody VH Domains: Residues in all Three Hypervariable Regions Affect Antigen Binding,"" Immunotechnology 2(3):169-179.;;De Pascalis, R. et al. (Sep. 15, 2002). ""Grafting of ""abbreviated"" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody,"" The Journal of Immunology 169(6):3076-3084.;;Diehl, S.A. et al. (2008). ""STAT3-Mediated Up-Regulation of BLIMP1 is Cooridanted With BCL6 Down-Reguation to Control Huamn Plasma Cell Differentiation,"" J Immunol 180:4805-4815.;;Elliott, T. et al. (Dec. 14, 2002). ""Antibody Response to Staphylococcal Slime and Lipoteichoic Acid,"" The Lancet 360(9349):1977.;;Gaudreau, M-C. et al. (Dec. 8, 2006, e-pub. Sep. 22, 2006). ""Protective Immune Responses to a Multi-Gene DNA Vaccine Against Staphylococcus aureus,"" Vaccine 25:814-824.;;Gilliland et al. (1980). ""Antibody-directed cytotoxic agents: Use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells,"" Proc Natl Acad Sci, 70(8):4539-4543.;;Geoghegan et al. ""Staphylococcus pseudintermedius expresses surface proteins that closely resemble those from Staphylococcus aureus,"" Veterinary Microbiology 138:345-352 (2009).;;Greenberg, J.W. et al. (Aug. 1996). ""Influence of Lipoteichoic Acid Structure on Recognition by the Macrophage Scanenger Receptor,"" Infection and Immunity 64(8):3318-3325.;;Greenspan. N.S. et al (Oct. 1999). ""Defining epitopes: Its not as easy as it seems,"" Nature Biotechnology 17(10):936-937.;;Hammonds, S.J. et al. (Jul. 15, 1991). ""Differentiation of Enterococci From Other Group D Streptococci by Means of a Specific Monoclonal Antibody,"" FEMS Microbiology Letters 82:91-94.;;Hetherington, S. et al. (Oct. 2006). ""Phase I Dose Escalation Study to Evaluate the Safety and Pharmacokinetic Profile of Tefibazumab in Subjects with End-Stage Renal Disease Requiring Hemodialysis,"" Antimicrobial Agents and Chemotherapy 50(10):3499-3500.;;Holm, P. et al. (Feb. 2007). ""Functional mapping and single chain construction of the anti-cytokeratin 8 monoclonal antibody TS1,"" 44:(6):1075-1084.;;Holt, L.J. et al. (Nov. 1, 2003). ""Domain Antibodies: Proteins for Therapy,"" TRENDS in Biotechnology 21(11):484-490.;;International Search Report mailed on Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, ten pages.;;Jaleco, A.C. et al. (Oct. 15, 1999). ""Genetic Modification of Human B-Cell Development: B Cell Development is Inhibited by the Dominant Negative Helix Loop Helix Factor Id3,"" Blood 94(8):2637-2646.;;John, J.F., Jr. et al. (Oct. 1, 2006). ""Drug Evaluation:Tefibazumab-A Monoclonal Antibody Against Staphylococcal Infection,"" Current Opinion in Molecular Therapeutics 8(5):455-460.;;Kabat et al. (1991). Sequences of Proteins of Immunological Interest, 5th Ed. Public Health Service National Institute of Health, Bethesda, MD, Table of Contents, pp. xiii-scvi.;;Keller, R. et al. (Sep. 1992). ""Macrophage Response to Bacteria: Induction of Marked Secretory and Cellular Activities by Lipoteichoic Acids,"" Infect. Immun. 60(9):3664-3672.;;Kwakkenbos, M.J. et al. (Jan. 2010, e-pub. Dec. 20, 2009). ""Generation of Stable Monoclonal Antibody-Producing B Cell Receptor-Positive Human Memory B Cells by Genetic Programming,"" Nat. Med. 16(1):123-128.;;MacCallum, R.M. et al. (Oct. 11, 1996). Antibody-antigen interactions: contact analysis and binding site topography, J. Mol. Biol. 262(5):732-745.;;McCrea, K.W. et al. (Jul. 1, 2000). ""The Serine-Aspartate Repeat (Sdr) Protein Family in Staphylococcus epidermidis,"" Microbiology 146:1535-1546.;;McDevitt et al. ""Variation in the size of the repeat region of the fibrinogen receptor (clumping factor) of Staphylococcus aureus strains,"" Microbiology 141:937-943 (1995).;;Mikayama, T. et al. (Nov. 1, 1993). ""Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor,"" Proc.Nati.Acad.Sci. USA 90(21):10056-10060.;;Moran, G.J. et al. (Aug. 17, 2006). ""Methicillin-Resistant S. aureus Infections Among Patients in the Emergency Department,"" NEMJ 355(7):666-674.;;Polotsky, V.Y. et al. (Jan. 1996). ""Interaction of Human Mannose-Binding Protein with Lipoteichoic Acids,"" Infection and Immunity 64(1):380-383.;;Reilley, S. et al. (Mar. 2005). ""Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers,"" Antimicrobial Agents and Chemotherapy 49(3):959-962.;;Rudikoff , S.et al (Mar. 1982). ""Single amino acid substitution altering antigen-binding specificity,"" Proc Natl Acad Sci USA 79(6):1979-1983.;;Rudinger, J. et al. (Jun. 1976). ""Characteristics of the Amino Acids as Components of a Peptide Hormone Sequence,"" Chapter 1 in Peptide Hormones, University Park Press, Baltimore, MD, Bioi.Council. pp. 5-7.;;Scheeren, F.A. et al. (Mar. 2005, e-pub. Feb. 13, 2005). ""STAT5 Regulates the Self-Renewal Capacity and Differentiation of Human Memory B Cells and Controls Bcl-6 Expression,"" Nat. Immunol. 6(3):303-313.;;Schaffer, A. et al. (Apr. 1, 2006). ""Immunication with Staphylococcus aureus Clumping Factor 8, a Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model,"" Infection and Immunity 74(4):2145-2153.;;Shvarts, A. et al. (2002). ""A Senescence Rescue Screen Identifies BCL6 as an Inhibitor of Anti-Proliferative p19ARF-p53 Signaling,"" Genes Dev. 16:681-686.;;Tuchscherr, L.P.N. et al. (Dec. 2008, e-pub. Sep. 22, 2008). ""Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphyloccus aureus in Mice,"" Infection and Immunity 76(12):5738-5744.;;Vajdos, F.F. et al. (2002). ""Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis,""J. Mol. Biol. 320:415-428.;;Weidenmaier, C. et al. (Apr. 2008, e-pub. Mar. 10, 2008). ""Teichoic Acids and Related Cell-Wall Glycopolymers in Gram-Positive Physiology and Host Interactions,"" Nat Rev. Microbiol. 6(4):276-287.;;Wergeland, H.I. et al. (Jun. 1, 1989). ""Antibodies to Staphylococcal Peptidoglycan nd its Peptide Epitopes, Techoic Acid, and Lipotechoic Acid in Sera From Blood Donors and Patients with Staphylococcal Infections,"" Journal of Clinical Microbiology 27(6):1286-1291.;;Wu, H. et al. (Nov. 19, 1999).""Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues,"" J. Mol. Biol. 294(1):151-162.;;Yin, R-L. et al. (Dec. 15, 2009). ""Construction and Immunogenicity of a DNA Vaccine Containing Clumping Factor A of Staphylococcus aureus and Bovine IL18,"" Veterinary Immunology and Immunopathology 132:270-274.;;Written Opinion mailed on Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, twelve pages.;;Tamura et al. ""Structural Correlates of an Anticarcinoma Antibody: Identification of Specificity-Determining Residues (SDRs) and Development of a Minimally Immunogenic Antibody Variant by Retention of SDRs Only,"" J Immunol. 164:1432-1441, (Feb. 2000).",INACTIVE
574,HU,T2,HU E038277 T2,111-965-537-037-467,2018-10-29,2018,HU E10734844 A,2010-07-15,EP 09165558 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,,AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/111-965-537-037-467,Amended Patent,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61P31/04;;C12N15/13,,0,0,,,,PENDING
575,US,A1,US 2016/0222096 A1,153-386-724-290-676,2016-08-04,2016,US 201514981643 A,2015-12-28,US 201514981643 A;;EP 09165558 A;;US 201314103715 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/153-386-724-290-676,Patent Application,yes,0,0,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12,,0,0,,,,INACTIVE
576,US,A1,US 2015/0376266 A1,020-071-777-330-863,2015-12-31,2015,US 201514728826 A,2015-06-02,US 201514728826 A;;EP 09165558 A;;US 201313786215 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/020-071-777-330-863,Patent Application,yes,0,0,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12,,0,0,,,,INACTIVE
577,SG,A,SG 10201704269R A,033-914-452-123-190,2017-06-29,2017,SG 10201704269R A,2010-07-15,EP 09165558 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,,AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/033-914-452-123-190,Unknown,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,,,0,0,,,,PENDING
578,US,B2,US 9927428 B2,068-631-257-249-476,2018-03-27,2018,US 201615246301 A,2016-08-24,US 201615246301 A;;EP 09165558 A;;US 201514728826 A;;US 201313786215 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/068-631-257-249-476,Granted Patent,yes,73,0,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,G01N33/53;;C07K16/12;;G01N33/50;;G01N33/68,,52,49,094-235-678-116-274;;087-750-056-648-711;;094-943-853-156-212;;009-483-512-107-343;;045-942-104-775-903;;001-779-867-387-972;;046-574-565-227-862;;020-296-196-517-635;;014-113-432-888-031;;087-464-706-073-810;;057-413-214-597-900;;006-565-688-923-344;;033-261-430-402-230;;020-645-047-874-076;;013-331-795-309-026;;003-774-698-863-009;;018-689-993-180-794;;004-162-543-606-074;;022-530-831-805-202;;009-251-924-862-043;;036-993-296-085-707;;023-878-463-952-471;;070-922-203-323-177;;031-100-076-670-370;;013-323-148-570-367;;025-682-930-155-032;;049-960-678-150-173;;020-447-476-598-180;;120-309-713-911-530;;095-334-545-560-259;;031-626-846-075-129;;005-037-911-432-607;;008-028-186-790-704;;064-715-862-322-072;;046-372-239-038-614;;066-252-194-757-349;;027-477-313-726-928;;063-710-398-275-735;;015-570-097-945-448;;007-990-945-290-343;;060-444-328-354-958;;088-581-950-418-154;;043-714-998-563-59X;;051-707-000-800-833;;079-519-098-180-465;;024-192-636-936-032;;013-142-717-038-23X;;099-559-652-967-591;;027-370-453-427-057,pmc523036;;10.1128/iai.72.11.6237-6244.2004;;15501749;;10.1111/j.1600-0625.2011.01276.x;;21585554;;17472965;;10.1074/jbc.m610940200;;10.1073/pnas.89.10.4285;;1350088;;pmc49066;;12850000;;10.1016/s0006-291x(03)01131-8;;10.1006/jmbi.1999.3192;;10543973;;3709526;;pmc1166865;;10.1002/j.1460-2075.1986.tb04288.x;;9373310;;10.1016/s1380-2933(96)00045-0;;12218124;;10.4049/jimmunol.169.6.3076;;18354204;;pmc2396731;;10.4049/jimmunol.180.7.4805;;10.1128/cdli.12.3.387-398.2005;;pmc1065207;;15753252;;10.1016/s0140-6736(02)11875-7;;12493294;;12493293;;10.1016/s0140-6736(02)11874-5;;1560463;;10.1016/0022-2836(92)91010-m;;10.1016/s0966-842x(98)01400-0;;10036727;;17027124;;10.1016/j.vaccine.2006.09.043;;pmc349879;;10.1073/pnas.77.8.4539;;6933502;;10.1016/j.vetmic.2009.03.030;;19372010;;8757870;;pmc174224;;10.1128/iai.64.8.3318-3325.1996;;10.1038/13590;;10504677;;pmc308922;;10.1128/iai.71.12.6864-6870.2003;;14638774;;10.1111/j.1574-6968.1991.tb04845.x;;10.1016/0378-1097(91)90426-b;;pmc3794999;;10.1371/journal.ppat.1003653;;24130480;;pmc1610062;;10.1128/aac.00407-06;;17005843;;16989900;;10.1016/j.molimm.2006.08.001;;14573361;;10.1016/j.tibtech.2003.08.007;;10.1182/blood.v94.8.2637.420k22_2637_2646;;10515867;;17078388;;pmc257375;;10.1128/iai.60.9.3664-3672.1992;;1500175;;20023635;;10.1038/nm.2071;;pmc2861345;;10.1006/jmbi.1996.0548;;8876650;;10.1099/00221287-146-7-1535;;10878118;;10.1099/13500872-141-4-937;;7773396;;8234256;;10.1073/pnas.90.21.10056;;pmc47712;;16914702;;10.1056/nejmoa055356;;10.1128/iai.64.1.380-383.1996;;pmc173774;;8557371;;15728889;;10.1128/aac.49.3.959-962.2005;;pmc549258;;10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10.1007/978-1-349-02718-7_1;;10.1128/iai.74.4.2145-2153.2006;;pmc1418917;;16552044;;10.1038/ni1172;;15711548;;pmc155362;;10.1101/gad.929302;;11914273;;10.4049/jimmunol.164.3.1432;;10640759;;18809660;;pmc2583566;;10.1128/iai.00874-08;;12079396;;10.1016/s0022-2836(02)00264-4;;10.1038/nrmicro1861;;18327271;;pmc267543;;10.1128/jcm.27.6.1286-1291.1989;;2473994;;10556035;;10.1006/jmbi.1999.3141;;10.1016/j.vetimm.2009.05.012;;19540000;;9887257;;10.1006/jmbi.1998.2396,"Liu et al. “SdrX, a Serine-Aspartate Repeat Protein Expressed by Staphylococcus capitis with Collagen VI Binding Activity,” Infection and Immunity 72(11):6273-6244, (Nov. 2004).;;Tsutsumi et al. “Morphological and Functional Differences in Coculture System of Keratinocytes and Dorsal-Root-Ganglion-Derived Cells Depending on Time of Seeding,” Experimental Dermatology 20:464-467, (2011).;;Arrecubieta, C. et al. (Jun. 29, 2007). “SdrF, a Staphylococcus epidermidis Surface Protein, Binds Type I Collagen,” JBC 282(26):18767-18776.;;Carter et al. (May 1992). “Humanization of Anti-p185HER2 Antibody for Human Cancer Therapy,” Proc. Natl. Acad. Sci. USA 89:4285-4289.;;Casset, F. et al. (Jul. 18, 2003) “A peptide mimetic of an anti-CD4 monoclonal antibody by rational design,” Biochem. Biophy.s Res. Commun. 307(1):198-205.;;Chen, Y. et al. (Nov. 5, 1999). “Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen,” J.. Mol. Bio. 293(4):865-881.;;Chothia, C. et al (1986). “The relation between the divergence of sequence and structure in proteins,” The EMBO Journal 5(4):823-826.;;Davies, J. et al. (Sep. 1, 1996). “Affinity Improvement of Single Antibody VH Domains: Residues in all Three Hypervariable Regions Affect Antigen Binding,” Immunotechnology 2(3):169-179.;;De Pascalis, R. et al. (Sep. 15, 2002). “Grafting of “abbreviated” complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody,” The Journal of Immunology 169(6):3076-3084.;;Diehl, S.A. et al. (2008). “STAT3-Mediated Up-Regulation of BLIMP1 is Cooridanted With BCL6 Down-Reguation to Control Huamn Plasma Cell Differentiation,” J Immunol 180:4805-4815.;;Dryla, A. et al. (Mar. 2005). “Comparison of Antibody Repertoires Against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients,” Clinical and Diagnostic Laboratory Immunology 12(3):387-398.;;Elliott, T. et al. (Dec. 14, 2002). “Antibody Response to Staphylococcal Slime and Lipoteichoic Acid,” The Lancet 360(9349):1977.;;Foote et al. “Antibody Framework Residues Affecting the Conformation of the Hypervariable Loops,” J. Mol. Biol. 224:487-499, (1992).;;Foster et al. “Surface Protein Adhesin of Staphylococcus aureus,” Trends Micro. 6(12):484-488, (Dec. 1998).;;Gaudreau, M-C. et al. (Dec. 8, 2006, e-pub. Sep. 22, 2006). “Protective Immune Responses to a Multi-Gene DNA Vaccine Against Staphylococcus aureus,” Vaccine 25:814-824.;;Gilliland et al. (1980). “Antibody-directed cytotoxic agents: Use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells,” Proc Natl Acad Sci, 70(8):4539-4543.;;Geoghegan et al. “Staphylococcus pseudintermedius expresses surface proteins that closely resemble those from Staphylococcus aureus,” Veterinary Microbiology 138:345-352 (2009).;;Greenberg, J.W. et al. (Aug. 1996). “Influence of Lipoteichoic Acid Structure on Recognition by the Macrophage Scanenger Receptor,” Infection and Immunity 64(8):3318-3325.;;Greenspan. N. S. et al (Oct. 1999). “Defining epitopes: It's not as easy as it seems,” Nature Biotechnology 17(10):936-937.;;Hall, A.E. et al. (Dec. 2003). “Characterization of a Protective Monoclonal Antibody Recognizing Staphylococcus aureus MSCRAMM Protein Clumping Factor A,” Infection and Immunity 71(12):6864-6870.;;Hammonds, S.J. et al. (Jul. 15, 1991). “Differentiation of Enterococci From Other Group D Streptococci by Means of a Specific Monoclonal Antibody,” FEMS Microbiology Letters 82:91-94.;;Hazenbos, W. L. W. et al. (2013). “Novel Staphylococcal Glycosyltransferase SdgA and SdgB Mediate Immunogenicity and Protection of Virulence-Associated Cell Wall Proteins,” PLOS, 9(10): e1003653, pp. 1-18.;;Hetherington, S. et al. (Oct. 2006). “Phase I Dose Escalation Study to Evaluate the Safety and Pharmacokinetic Profile of Tefibazumab in Subjects with End-Stage Renal Disease Requiring Hemodialysis,” Antimicrobial Agents and Chemotherapy 50(10):3499-3500.;;Holm, P. et al. (Feb. 2007). “Functional mapping and single chain construction of the anti-cytokeratin 8 monoclonal antibody TS1,” 44:(6):1075-1084.;;Holt, L.J. et al. (Nov. 1, 2003). “Domain Antibodies: Proteins for Therapy,” TRENDS in Biotechnology 21(11):484-490.;;International Search Report dated Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, ten pages.;;Jaleco, A.G. et al. (Oct. 15, 1999). “Genetic Modification of Human B-Cell Development: B Cell Development is Inhibited by the Dominant Negative Helix Loop Helix Factor Id3,” Blood 94(8):2637-2646.;;John, J.F., Jr. et al. (Oct. 1, 2006). “Drug Evaluation:Tefibazumab—A Monoclonal Antibody Against Staphylococcal Infection,” Current Opinion in Molecular Therapeutics 8(5):455-460.;;Kabat et al. (1991). Sequences of Proteins of Immunological Interest, 5th Ed. Public Health Service National Institute of Health, Bethesda, MD, Table of Contents, pp. xiii-scvi.;;Keller, R. et al. (Sep. 1992). “Macrophage Response to Bacteria: Induction of Marked Secretory and Cellular Activities by Lipoteichoic Acids,” Infect. Immun. 60(9):3664-3672.;;Kwakkenbos, M.J. et al. (Jan. 2010, e-pub. Dec. 20, 2009). “Generation of Stable Monoclonal Antibody-Producing B Cell Receptor-Positive Human Memory B Cells by Genetic Programming,” Nat. Med. 16(1):123-128.;;MacCallum, R.M. et al. (Oct. 11, 1996). Antibody-antigen interactions: contact analysis and binding site topography, J. Mol. Bioi. 262(5):732-745.;;McCrea, K.W. et al. (Jul. 1, 2000). “The Serine-Aspartate Repeat (SDR) Protein Family in Staphylococcus epidermidis,” Microbiology 146:1535-1546.;;McDevitt et al. “Variation in the size of the repeat region of the fibrinogen receptor (clumping factor) of Staphylococcus aureus strains,” Microbiology 141:937-943 (1995).;;Mikayama, T. et al. (Nov. 1, 1993). “Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor,” Proc.Nati.Acad.Sci. USA 90(21):10056-10060.;;Moran, G.J. et al. (Aug. 17, 2006). “Methicillin-Resistant S. aureus Infections Among Patients in the Emergency Department,” NEMJ 355(7):666-674.;;Polotsky, V.Y. et al. (Jan. 1996). “Interaction of Human Mannose-Binding Protein with Lipoteichoic Acids,” Infection and Immunity 64(1):380-383.;;Reilley, S. et al. (Mar. 2005). “Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers,” Antimicrobial Agents and Chemotherapy 49(3):959-962.;;Rudikoff , S.et al (Mar. 1982). “Single amino acid substitution altering antigen-binding specificity,” Proc Natl Acad Sci USA 79(6):1979-1983.;;Rudinger, J. et al. (Jun. 1976). “Characteristics of the Amino Acids as Components of a Peptide Hormone Sequence,” Chapter 1 in Peptide Hormones, University Park Press, Baltimore, MD, Bioi.Council. pp. 5-7.;;Schaffer, A. et al. (Apr. 1, 2006). “Immunication with Staphylococcus aureus Clumping Factor 8, a Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model,” Infection and Immunity 74(4):2145-2153.;;Scheeren, F.A. et al. (Mar. 2005, e-pub. Feb. 13, 2005). “STAT5 Regulates the Self-Renewal Capacity and Differentiation of Human Memory B Cells and Controls Bcl-6 Expression, ” Nat. Immunol. 6(3):303-313.;;Shvarts, A. et al. (2002). “A Senescence Rescue Screen Identifies BCL6 as an Inhibitor of Anti-Proliferative p19ARF-p53 Signaling,” Genes Dev. 16:681-686.;;Tamura et al. “Structural Correlates of an Anticarcinoma Antibody: Identification of Specificity-Determining Residues (SDRs) and Development of a Minimally Immunogenic Antibody Variant by Retention of SDRs Only,” J Immunol. 164:1432-1441, (Feb. 2000).;;Tuchscherr, L.P.N. et al. (Dec. 2008, e-pub. Sep. 22, 2008). “Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphyloccus aureus in Mice,” Infection and Immunity 76(12):5738-5744.;;Vajdos, F.F. et al. (2002). “Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis,”J. Mol. Biol. 320:415-428.;;Weidenmaier, C. et al. (Apr. 2008, e-pub. Mar. 10, 2008). “Teichoic Acids and Related Cell-Wall Glycopolymers in Gram-Positive Physiology and Host Interactions,” Nat Rev. Microbiol. 6(4):276-287.;;Wergeland, H.I. et al. (Jun. 1, 1989). “Antibodies to Staphylococcal Peptidoglycan nd its Peptide Epitopes, Techoic Acid, and Lipotechoic Acid in Sera From Blood Donors and Patients with Staphylococcal Infections,” Journal of Clinical Microbiology 27(6):1286-1291.;;Wu, H. et al. (Nov. 19, 1999).“Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues,” J. Mol. Biol. 294(1):151-162.;;Yin, R-L. et al. (Dec. 15, 2009). “Construction and Immunogenicity of a DNA Vaccine Containing Clumping Factor A of Staphylococcus aureus and Bovine IL18,” Veterinary Immunology and Immunopathology 132:270-274.;;Written Opinion dated Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, twelve pages.;;Dewildt, R.M.T. et al. (Jan. 22, 1999) “Analysis of Heavy and Light Chain Pairings Indicates That Receptor Editing Shapes the Human Antibody Repertoire,” Journal of Molecular Biology 285(3):895-901.",INACTIVE
579,US,A1,US 2013/0261293 A1,129-404-296-378-861,2013-10-03,2013,US 201313786215 A,2013-03-05,US 201313786215 A;;EP 09165558 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/129-404-296-378-861,Patent Application,yes,0,6,63,65,64,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12,536/23.53,0,0,,,,INACTIVE
580,JP,A,JP 2018134089 A,158-382-662-481-904,2018-08-30,2018,JP 2018072444 A,2018-04-04,EP 09165558 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"PROBLEM TO BE SOLVED: To provide improved binding compounds that are fully human and specifically bind to gram-positive bacteria.SOLUTION: The invention provides isolated antibodies that have the ability to bind to all gram-positive bacteria selected from the group consisting of S. aureus, S. faecalis, S. pyogenes, S. epidermidis, and B. licheniformis, and do not bind to S. pneumonia or S. mutans.SELECTED DRAWING: None",AIMM THERAPEUTICS BV;;GENENTECH INC,TIM BEAUMONT;;MARK JEROEN KWAKKENBOS;;ERIC J BROWN;;JOHN HIROSHI MORISAKI;;WOUTER L W HAZENBOS;;SANJEEV MARIATHASAN;;KIMBERLY KAJIHARA;;XIA YI,,https://lens.org/158-382-662-481-904,Patent Application,no,0,1,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C12N15/13;;A61K31/7088;;A61K39/02;;A61K39/085;;A61K39/09;;A61K39/395;;A61K48/00;;A61P31/04;;A61P37/04;;C07K16/12;;C12N1/02;;C12N1/15;;C12N1/19;;C12N1/20;;C12N1/21;;C12N5/10;;C12P21/08;;C12Q1/68;;G01N33/569,,0,0,,,,PENDING
581,US,A1,US 2002/0177210 A1,175-617-010-135-256,2002-11-28,2002,US 95718901 A,2001-09-19,US 95718901 A;;DK 146597 A;;DK 67098 A;;US 19210498 A;;US 6971997 P;;US 54344600 A,1997-12-16,Polypeptides having aminopeptidase activity and nucleic acids encoding same,"
   The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides. 
",NOVOZYMES BIOTECH INC,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKIO;;MARUMOTO CHIGUSA;;KOFOD LENE VENKE,NOVOZYMES INC (2005-08-29),https://lens.org/175-617-010-135-256,Patent Application,yes,0,0,25,52,9,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N15/09;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,435/226;;435/69.1;;435/320.1;;435/325;;536/23.2,0,0,,,,EXPIRED
582,MX,B,MX 350234 B,186-565-692-106-096,2017-08-30,2017,MX 2014012186 A,2010-07-15,US 22587809 P;;EP 09165558 A;;NL 2010050456 W,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS.,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV,XIA YI;;MARIATHASAN SANJEEV;;BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;KAJIHARA KIMBERLY,,https://lens.org/186-565-692-106-096,Granted Patent,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;G01N33/00,,0,0,,,,ACTIVE
583,DK,T3,DK 2454284 T3,115-641-111-850-99X,2018-07-02,2018,DK 10734844 T,2010-07-15,US 22587809 P;;EP 09165558 A;;NL 2010050456 W,2009-07-15,GRAMPOSITIVE BAKTERIER-SPECIFIKT BINDENDE FORBINDELSER,,AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/115-641-111-850-99X,Granted Patent,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,ACTIVE
584,CN,A,CN 105440133 A,119-479-188-629-321,2016-03-30,2016,CN 201510639968 A,2010-07-15,EP 09165558 A;;US 22587809 P;;CN 201080041138 A,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The invention relates to Gram-positive bacteria specific binding compounds. The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/119-479-188-629-321,Patent Application,no,3,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/40;;A61P31/04;;C12N5/10;;C12N15/13;;C12Q1/14;;C12Q1/68;;G01N33/569,,0,0,,,,DISCONTINUED
585,NZ,A,NZ 598063 A,120-561-201-293-702,2014-07-25,2014,NZ 59806310 A,2010-07-15,NL 2010050456 W;;US 22587809 P;;EP 09165558 A,2009-07-15,Gram-positive bacteria specific binding compounds,"Disclosed is an isolated antibody comprising: a)a heavy chain CDR1 sequence RFAMS (SEQ ID NO:1); b)a heavy chain CDR2 sequence STNNGNNPYYARSVQY (SEQ ID NO:2) or SINSGNNPYYARSVQY (SEQ ID NO:60); c)a heavy chain CDR3 sequence DHPSSGWPTFDS (SEQ ID NO:3); d)a light chain CDR1 sequence RASENVGDWLA (SEQ ID NO:4); e)a light chain CDR2 sequence KTSILES (SEQ ID NO:5); and f)a light chain CDR3 sequence having at least 88% identity to QHYXRFPYT, wherein X is any amino acid. Also disclosed is the use of said antibody in the manufacture of a medicament for treating gram-positive bacterium related disorders.",GENENTECH INC AIMM THERAPEUTICS B V,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,"AIMM THERAPEUTICS B.V., NL (2012-09-28);;GENENTECH, INC., US (2012-09-28)",https://lens.org/120-561-201-293-702,Patent Application,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,DISCONTINUED
586,EP,B1,EP 1042457 B1,171-629-075-813-532,2006-03-08,2006,EP 98956817 A,1998-11-13,DK 9800495 W;;DK 146597 A;;DK 67098 A;;US 6971997 P,1997-12-16,POLYPEPTIDES HAVING AMINOPEPTIDASE ACTIVITY AND NUCLEIC ACIDS ENCODING SAME,,NOVOZYMES AS;;NOVOZYMES INC;;JAPAN TOBACCO INC,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKO;;MARUMOTO CHIGUSA;;KOFOD LENE VENKE,"NOVO NORDISK BIOTECH, INC. (2001-01-24);;JAPAN TOBACCO INC. (2007-10-30);;NOVOZYMES, INC. (2005-06-22);;NOVOZYMES A/S (2005-06-22);;NOVOZYMES BIOTECH, INC. (2001-11-21)",https://lens.org/171-629-075-813-532,Granted Patent,yes,3,0,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N9/48;;C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/50;;C12P21/06,,3,0,,,"DIALOG INFORMATION SERVICES, File 5, BIOSIS, Dialog Accession No. 11538200, Biosis Accession No. 09683282, GOBBETTI M. et al., ""Purification and Characterization of Intracellular Aminopeptidase from Pseudomonas Fluorescens ATCC 948""; & JOURNAL OF DAIRY SCIENCE, 78(1), 1995, 44-54. XP002962641;;FILE WPI, Derwent Acc. No. 1995-202827, AJINOMOTO K.K., ""New Microbe FERM-P-13458 Obtd. by Mutating Bacillus Alvei - is Used for Prepn. of Protein Hydrolysate Contg. Glutamic Acid, Alanine and for Prepn. of Protein Hydrolysate Contg. Glutamic Acid, Alanine and Glycine"" XP002962642 & JP,A,07 115 964;;DIALOG INFORMATION SERVICES, File 5, BIOSIS, Dialog Accession No. 10089889, Biosis Accession No. 08800538, TELESNINA G.N. et al., ""Isolation of Xanthomonas-Rubrilineans Protoplasts and Their Use in Study of Aminopeptidase Localization""; XP002962643; & ANTIBIOT KHIMOTER 37(4), 1992, 14-16",EXPIRED
587,WO,A2,WO 2011/008092 A2,173-299-394-482-316,2011-01-20,2011,NL 2010050456 W,2010-07-15,EP 09165558 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV;;GENENTECH INC;;BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/173-299-394-482-316,Patent Application,yes,7,47,63,65,58,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12,,11,9,064-715-862-322-072;;060-444-328-354-958;;025-682-930-155-032;;007-990-945-290-343;;087-464-706-073-810;;020-447-476-598-180;;046-372-239-038-614;;004-162-543-606-074;;079-519-098-180-465,16914702;;10.1056/nejmoa055356;;pmc155362;;10.1101/gad.929302;;11914273;;10.1182/blood.v94.8.2637.420k22_2637_2646;;10515867;;10.1038/ni1172;;15711548;;18354204;;pmc2396731;;10.4049/jimmunol.180.7.4805;;pmc257375;;10.1128/iai.60.9.3664-3672.1992;;1500175;;10.1128/iai.64.1.380-383.1996;;pmc173774;;8557371;;8757870;;pmc174224;;10.1128/iai.64.8.3318-3325.1996;;10.1038/nrmicro1861;;18327271,"MORAN ET AL., NEMJ, vol. 355, 2006, pages 666 - 674;;SHVARTS A. ET AL., GENES DEV, vol. 16, 2002, pages 681 - 686;;JALECO A.C. ET AL., BLOOD, vol. 94, 1999, pages 2637 - 2646;;SCHEEREN F.A. ET AL., NAT IMMUNOL, vol. 6, 2005, pages 303 - 313;;DIEHL S.A. ET AL., J IMMUNOL, vol. 180, 2008, pages 4805 - 4815;;KWAKKENBOS M. ET AL., NAT MED IN PRESS, 2009;;KELLER R. ET AL., INFECT IMMUN, vol. 60, 1992, pages 3664 - 3672;;POLOTSKY V.Y. ET AL., INFECTION AND IMMUNITY, vol. 64, 1996, pages 380 - 383;;GREENBERG J.W. ET AL., INFECTION AND IMMUNITY, vol. 64, 1996, pages 3318 - 3325;;WEIDENMAIER C. ET AL., NAT REV MICROBIOL, vol. 6, 2008, pages 276 - 287;;KWAKKENBOS M ET AL., NAT MED, 2009",PENDING
588,CA,A1,CA 2768204 A1,010-170-404-643-796,2011-01-20,2011,CA 2768204 A,2010-07-15,EP 09165558 A;;US 22587809 P;;NL 2010050456 W,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/010-170-404-643-796,Patent Application,no,0,0,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,DISCONTINUED
589,BR,A2,BR 112012000953 A2,120-239-162-444-639,2016-11-22,2016,BR 112012000953 A,2010-07-15,NL 2010050456 W;;EP 09165558 A;;US 22587809 P,2009-07-15,compostos de ligação específica a bactérias gram-positivas,,AIMMTHERAPEUTICS B V;;GENENTECH INC,BROWN ERIC J;;MORISAKI JOHN HIROSHI;;KAJIHARA KIMBERLY;;KWAKKENBOS MARK JEROEN;;MARIATHASAN SANJEEV;;BEAUMONT TIM;;HAZENBROS WOUTER L W;;XIA YI,,https://lens.org/120-239-162-444-639,Patent Application,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,A61K39/395;;A61P31/04;;C07K16/12;;C12N15/13,,0,0,,,,DISCONTINUED
590,US,A1,US 2011/0020323 A1,103-786-093-809-740,2011-01-27,2011,US 83735810 A,2010-07-15,US 83735810 A;;EP 09165558 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",BEAUMONT TIM;;KWAKKENBOS MARK J;;BROWN ERIC J;;MORISAKI JOHN H;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,BEAUMONT TIM;;KWAKKENBOS MARK J;;BROWN ERIC J;;MORISAKI JOHN H;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,AIMM THERAPEUTICS B.V (2010-10-06);;GENENTECH INC (2010-10-01),https://lens.org/103-786-093-809-740,Patent Application,yes,2,16,63,65,58,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,A61K39/395;;A61P31/04;;C07H21/04;;C07K16/00;;C07K16/12;;C12N1/20;;C12N5/10;;C12P21/06;;G01N33/569,424/130.1;;435/7.33;;435/69.6;;435/328;;435/252.1;;530/387.1;;536/23.53,0,0,,,,DISCONTINUED
591,US,B2,US 9266943 B2,145-537-463-834-801,2016-02-23,2016,US 201314103715 A,2013-12-11,US 201314103715 A;;EP 09165558 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/145-537-463-834-801,Granted Patent,yes,65,2,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,A61K39/40;;C07K16/12,,43,40,045-942-104-775-903;;001-779-867-387-972;;046-574-565-227-862;;020-296-196-517-635;;014-113-432-888-031;;087-464-706-073-810;;006-565-688-923-344;;013-331-795-309-026;;004-162-543-606-074;;022-530-831-805-202;;036-993-296-085-707;;070-922-203-323-177;;031-100-076-670-370;;013-323-148-570-367;;025-682-930-155-032;;049-960-678-150-173;;020-447-476-598-180;;120-309-713-911-530;;095-334-545-560-259;;031-626-846-075-129;;008-028-186-790-704;;064-715-862-322-072;;046-372-239-038-614;;066-252-194-757-349;;027-477-313-726-928;;063-710-398-275-735;;007-990-945-290-343;;015-570-097-945-448;;060-444-328-354-958;;043-714-998-563-59X;;051-707-000-800-833;;079-519-098-180-465;;024-192-636-936-032;;013-142-717-038-23X;;099-559-652-967-591;;018-689-993-180-794;;005-037-911-432-607;;003-774-698-863-009;;009-483-512-107-343;;033-261-430-402-230,12850000;;10.1016/s0006-291x(03)01131-8;;10.1006/jmbi.1999.3192;;10543973;;3709526;;pmc1166865;;10.1002/j.1460-2075.1986.tb04288.x;;9373310;;10.1016/s1380-2933(96)00045-0;;12218124;;10.4049/jimmunol.169.6.3076;;18354204;;pmc2396731;;10.4049/jimmunol.180.7.4805;;10.1016/s0140-6736(02)11875-7;;12493294;;12493293;;10.1016/s0140-6736(02)11874-5;;17027124;;10.1016/j.vaccine.2006.09.043;;8757870;;pmc174224;;10.1128/iai.64.8.3318-3325.1996;;10.1038/13590;;10504677;;10.1111/j.1574-6968.1991.tb04845.x;;10.1016/0378-1097(91)90426-b;;pmc1610062;;10.1128/aac.00407-06;;17005843;;16989900;;10.1016/j.molimm.2006.08.001;;14573361;;10.1016/j.tibtech.2003.08.007;;10.1182/blood.v94.8.2637.420k22_2637_2646;;10515867;;17078388;;pmc257375;;10.1128/iai.60.9.3664-3672.1992;;1500175;;20023635;;10.1038/nm.2071;;pmc2861345;;10.1006/jmbi.1996.0548;;8876650;;10.1099/00221287-146-7-1535;;10878118;;8234256;;10.1073/pnas.90.21.10056;;pmc47712;;16914702;;10.1056/nejmoa055356;;10.1128/iai.64.1.380-383.1996;;pmc173774;;8557371;;15728889;;10.1128/aac.49.3.959-962.2005;;pmc549258;;10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10.1007/978-1-349-02718-7_1;;10.1038/ni1172;;15711548;;10.1128/iai.74.4.2145-2153.2006;;pmc1418917;;16552044;;pmc155362;;10.1101/gad.929302;;11914273;;18809660;;pmc2583566;;10.1128/iai.00874-08;;12079396;;10.1016/s0022-2836(02)00264-4;;10.1038/nrmicro1861;;18327271;;pmc267543;;10.1128/jcm.27.6.1286-1291.1989;;2473994;;10556035;;10.1006/jmbi.1999.3141;;10.1016/j.vetimm.2009.05.012;;19540000;;10.1016/j.vetmic.2009.03.030;;19372010;;10.1099/13500872-141-4-937;;7773396;;pmc349879;;10.1073/pnas.77.8.4539;;6933502;;10.1073/pnas.89.10.4285;;1350088;;pmc49066;;1560463;;10.1016/0022-2836(92)91010-m,"Casset, F. et al. (Jul. 18, 2003) ""A Peptide Mimetic of an Anti-CD4 Monoclonal Antibody by Rational Design,"" Biochem. Biophy.s Res. Commun. 307(1):198-205.;;Chen, Y. et al. (Nov. 5, 1999). ""Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen,"" J.. Mol. Bio. 293(4):865-881.;;Chothia, C. et al (1986). ""The relation between the divergence of sequence and structure in proteins,"" The EMBO Journal 5(4):823-826.;;Davies, J. et al. (Sep. 1, 1996). ""Affinity Improvement of Single Antibody VH Domains: Residues in all Three Hypervariable Regions Affect Antigen Binding,"" Immunotechnology 2(3):169-179.;;De Pascalis, R. et al. (Sep. 15, 2002). ""Grafting of ""abbreviated"" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody,"" The Journal of Immunology 169(6):3076-3084.;;Diehl, S.A. et al. (2008). ""STAT3-Mediated Up-Regulation of BLIMP1 is Cooridanted With BCL6 Down-Reguation to Control Huamn Plasma Cell Differentiation,"" J Immunol 180:4805-4815.;;Elliott, T. et al. (Dec. 14, 2002). ""Antibody Response to Staphylococcal Slime and Lipoteichoic Acid,"" The Lancet 360(9349):1977.;;Gaudreau, M-C. et al. (Dec. 8, 2006, e-pub. Sep. 22, 2006). ""Protective Immune Responses to a Multi-Gene DNA Vaccine Against Staphylococcus aureus,"" Vaccine 25:814-824.;;Greenberg, J.W. et al. (Aug. 1996). ""Influence of Lipoteichoic Acid Structure on Recognition by the Macrophage Scanenger Receptor,"" Infection and Immunity 64(8):3318-3325.;;Greenspan. N.S. et al (Oct. 1999). ""Defining epitopes: It's Not as Easy as it Seems,"" Nature Biotechnology 17(10):936-937.;;Hammonds, S.J. et al. (Jul. 15, 1991). ""Differentiation of Enterococci From Other Group D Streptococci by Means of a Specific Monoclonal Antibody,"" FEMS Microbiology Letters 82:91-94.;;Hetherington, S. et al. (Oct. 2006). ""Phase I Dose Escalation Study to Evaluate the Safety and Pharmacokinetic Profile of Tefibazumab in Subjects with End-Stage Renal Disease Requiring Hemodialysis,"" Antimicrobial Agents and Chemotherapy 50(10):3499-3500.;;Holm, P. et al. (Feb. 2007). ""Functional Mapping and Single Chain Construction of the Anti-Cytokeratin 8 Monoclonal Antibody TS1,"" Mol. Immunol. 44:(6):1075-1084.;;Holt, L.J. et al. (Nov. 1, 2003). ""Domain Antibodies: Proteins for Therapy,"" Trends in Biotechnology 21(11):484-490.;;International Search Report mailed on Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, ten pages.;;Jaleco, A.C. et al. (Oct. 15, 1999). ""Genetic Modification of Human B-Cell Development: B Cell Development is Inhibited by the Dominant Negative Helix Loop Helix Factor Id3,"" Blood 94(8):2637-2646.;;John, J.F., Jr. et al. (Oct. 1, 2006). ""Drug Evaluation:Tefibazumab-A Monoclonal Antibody Against Staphylococcal Infection,"" Current Opinion in Molecular Therapeutics 8(5):455-460.;;Kabat et al. (1991). Sequences of Proteins of Immunological Interest, 5th Ed. Public Health Service National Institute of Health, Bethesda, MD, Table of Contents, pp. xiii-scvi.;;Keller, R. et al. (Sep. 1992). ""Macrophage Response to Bacteria: Induction of Marked Secretory and Cellular Activities by Lipoteichoic Acids,"" Infect. Immun. 60(9):3664-3672.;;Kwakkenbos, M.J. et al. (Jan. 2010, e-pub. Dec. 20, 2009). ""Generation of Stable Monoclonal Antibody-Producing B Cell Receptor-Positive Human Memory B Cells by Genetic Programming,"" Nat. Med. 16(1):123-128.;;MacCallum, R.M. et al. (Oct. 11, 1996). Antibody-Antigen Interactions: Contact Analysis and Binding Site Topography,' J. Mol. Bioi. 262(5):732-745.;;McCrea, K.W. et al. (Jul. 1, 2000). ""The Serine-Aspartate Repeat (Sdr) Protein Family in Staphylococcus epidermidis,"" Microbiology 146:1535-1546.;;Mikayama, T. et al. (Nov. 1, 1993). ""Molecular Cloning and Functional Expression of a cDNA Encoding Glycosylation-lnhibiting Factor,"" Proc.Nati.Acad.Sci. USA 90(21):10056-10060.;;Moran, G.J. et al. (Aug. 17, 2006). ""Methicillin-Resistant S. aureus Infections Among Patients in the Emergency Department,"" NEMJ 355(7):666-674.;;Polotsky, V.Y. et al. (Jan. 1996). ""Interaction of Human Mannose-Binding Protein with Lipoteichoic Acids,"" Infection and Immunity 64(1):380-383.;;Reilley, S. et al. (Mar. 2005). ""Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers,"" Antimicrobial Agents and Chemotherapy 49(3):959-962.;;Rudikoff , S.et al (Mar. 1982). ""Single Amino Acid Substitution Altering Antigen-binding Specificity,"" Proc Natl Acad Sci USA 79(6):1979-1983.;;Rudinger, J. et al. (Jun. 1976). ""Characteristics of the Amino Acids as Components of a Peptide Hormone Sequence,"" Chapter 1 in Peptide Hormones, University Park Press, Baltimore, MD, Bioi.Council. pp. 5-7.;;Scheeren, F.A. et al. (Mar. 2005, e-pub. Feb. 13, 2005). ""STAT5 Regulates the Self-Renewal Capacity and Differentiation of Human Memory B Cells and Controls Bcl-6 Expression, "" Nat. Immunol. 6(3):303-313.;;Schaffer, A. et al. (Apr. 1, 2006). ""Immunication with Staphylococcus aureus Clumping Factor 8, A Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model,"" Infection and Immunity 74(4):2145-2153.;;Shvarts, A. et al. (2002). ""A Senescence Rescue Screen Identifies BCL6 as an Inhibitor of Anti-Proliferative p. 19ARF -p. 53 Signaling,"" Genes Dev. 16:681-686.;;Tuchscherr, L.P.N. et al. (Dec. 2008, e-pub. Sep. 22, 2008). ""Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphyloccus aureus in Mice,"" Infection and Immunity 76(12):5738-5744.;;Vajdos, F.F. et al. (2002). ""Comprehensive Functional Maps of the Antigen-Binding Site of an Anti-ErbB2 Antibody Obtained With Shotgun Scanning Mutagenesis,""J. Mol. Biol. 320:415-428.;;Weidenmaier, C. et al. (Apr. 2008, e-pub. Mar. 10, 2008). ""Teichoic Acids and Related Cell-Wall Glycopolymers in Gram-Positive Physiology and Host Interactions,"" Nat Rev. Microbiol. 6(4):276-287.;;Wergeland, H.I. et al. (Jun. 1, 1989). ""Antibodies to Staphylococcal Peptidoglycan nd its Peptide Epitopes, Techoic Acid, and Lipotechoic Acid in Sera From Blood Donors and Patients with Staphylococcal Infections,"" Journal of Clinical Microbiology 27(6):1286-1291.;;Wu, H. et al. (Nov. 19, 1999).""Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues,"" J. Mol. Biol. 294(1):151-162.;;Yin, R-L. et al. (Dec. 15, 2009). ""Construction and Immunogenicity of a DNA Vaccine Containing Clumping Factor A of Staphylococcus aureus and Bovine IL18,"" Veterinary Immunology and Immunopathology 132:270-274.;;Written Opinion mailed on Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, twelve pages.;;Geoghegan et al. ""Staphylococcus pseudintermedius expresses surface proteins that closely resemble those from Staphylococcus aureus,"" Veterinary Microbiology 138:345-352 (2009).;;McDevitt et al. ""Variation in the size of the repeat region of the fibrinogen receptor (clumping factor) of Staphylococcus aureus strains,"" Microbiology 141:937-943 (1995).;;Gilliland et al. (1980). ""Antibody-directed cytotoxic agents: Use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells,"" Proc Natl Acad Sci, 70(8):4539-4543.;;Carter et al. ""Humanization of anti-p185HER2 Antibody for Human Cancer Therapy,"" Proc. Natl. Acad. Sci. USA 89:4285-4289, (May 1992).;;Foote et al. ""Antibody Framework Residues Affecting The Conformation of The Hypervariable Loops,"" J. Mol. Biol. 224:487-499, (1992).",ACTIVE
592,SG,A1,SG 177653 A1,082-092-147-550-767,2012-02-28,2012,SG 2012002622 A,2010-07-15,EP 09165558 A;;US 22587809 P;;NL 2010050456 W,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/082-092-147-550-767,Patent Application,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,,,0,0,,,,PENDING
593,US,B1,US 6303360 B1,090-155-278-334-592,2001-10-16,2001,US 54344600 A,2000-04-05,US 54344600 A;;DK 146597 A;;DK 67098 A;;US 19210498 A;;US 6971997 P,1997-12-16,Polypeptides having aminopeptidase activity and nucleic acids encoding same,"The present invention relates to isolated polypeptides having aminopeptidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.",NOVOZYMES BIOTECH INC;;NOVOZYMES AS;;JAPAN TOBACCO INC,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKIO;;MARUMOTO CHIGUSA;;KOFOD LENE VENKE,NOVO NORDISK A/S (2000-06-01);;JAPAN TOBACCO INC (2000-04-13);;NOVOZYMES INC (2005-08-29);;NOVOZYMES A/S (2001-10-29);;NOVOZYMES BIOTECH INC (2000-04-13),https://lens.org/090-155-278-334-592,Granted Patent,yes,5,0,25,52,9,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,A23J3/34;;C12N1/15;;C12N1/19;;C12N15/09;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,435/212;;435/219;;435/252.33;;435/320.1;;536/23.2;;536/23.7;;536/23.1,6,5,071-340-618-860-317;;030-709-116-002-240;;067-675-830-257-822;;135-641-017-754-235;;065-463-260-187-764,10.1007/bf01570145;;10.3168/jds.s0022-0302(95)76614-0;;1417307;;10.1016/s0021-9258(18)83527-x;;2651436;;1569059;;10.1016/s0021-9258(18)42400-3,"Nakada et al., 1972, Agricultural & Biological Chemistry 37: 757-765, 767-774, and 775-782.;;Kwon et al., 1996, Journal of Industrial Microbiology 17: 30-35.;;Gobbetti et al., 1995, Journal of Dairy Science 78: 44-54.;;Telesnina et al., 1992, Antibiotiki I Khimioterapija 37: 14-16.;;Chang and Smith 1989, Journal of Biological Chemistry 264: 6979-6983.;;Chang et al., 1992, Journal of Biological Chemistry 267: 8007-8011.",EXPIRED
594,AT,T1,AT E319818 T1,098-948-677-979-735,2006-03-15,2006,AT 98956817 T,1998-11-13,DK 146597 A;;US 6971997 P;;DK 67098 A,1997-12-16,POLYPEPTIDE MIT AMINOPEPTIDASEAKTIVITÄT UND FÜR DIESE KODIERENDE NUKLEINSÄUREN,,NOVOZYMES AS;;NOVOZYMES INC;;JAPAN TOBACCO INC,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKO;;MARUMOTO CHIGUSA;;KOFOD LENE VENKE,,https://lens.org/098-948-677-979-735,Granted Patent,no,0,0,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/48;;C12N9/50;;C12P21/06,,0,0,,,,EXPIRED
595,US,A1,US 2014/0235828 A1,006-041-029-621-054,2014-08-21,2014,US 201314103715 A,2013-12-11,US 201314103715 A;;EP 09165558 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV;;GENENTECH INC;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/006-041-029-621-054,Patent Application,yes,0,1,63,65,66,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12,530/387.3;;530/389.5;;530/387.9;;435/331,0,0,,,,ACTIVE
596,AU,B2,AU 2010/271582 B2,018-330-125-371-768,2016-07-28,2016,AU 2010/271582 A,2010-07-15,EP 09165558 A;;US 22587809 P;;NL 2010050456 W,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/018-330-125-371-768,Granted Patent,no,1,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,INACTIVE
597,TW,A,TW 201610153 A,105-609-038-605-652,2016-03-16,2016,TW 104126578 A,2010-07-15,EP 09165558 A;;US 22587809 P,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPIUTICS B V;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/105-609-038-605-652,Patent of Addition,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C12N15/13;;A61K39/395;;A61P31/04;;C07K14/46,,0,0,,,,PENDING
598,TR,T4,TR 201809128 T4,108-815-195-464-220,2018-07-23,2018,TR 201809128 T,2010-07-15,EP 09165558 A;;US 22587809 P,2009-07-15,Gram-pozitif bakterilere spesifik bağlanan bileşikler.,"Bu buluş, Gram-pozitif bakterilere spesifik olarak bağlanabilen gelişmiş bağlanma bileşikleri ortaya koymaktadır. Tamamen insan menşeli olup bu sayede insanlara yönelik terapötik uygulamalarda kullanılabilecek olan bağlanma bileşikleri sunulmaktadır.",AIMM THERAPEUTICS BV;;GENENTECH INC,TIM BEAUMONT;;MARK JEROEN KWAKKENBOS;;J ERIC BROWN;;JOHN HIROSHI MORISAKI;;L W WOUTER HAZENBOS;;SANJEEV MARIATHASAN;;KIMBERLY KAJIHARA;;YI XIA,,https://lens.org/108-815-195-464-220,Granted Patent,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,A61K39/395;;A61P31/04;;C07K16/12;;C12N15/13,,0,0,,,,ACTIVE
599,KR,A,KR 20120065326 A,124-942-506-013-729,2012-06-20,2012,KR 20127003839 A,2010-07-15,EP 09165558 A;;US 22587809 P;;NL 2010050456 W,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,,GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/124-942-506-013-729,Patent Application,no,0,0,63,65,56,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/40;;A61P31/04;;C12N15/13,,0,0,,,,ACTIVE
600,BR,B1,BR 9813608 B1,120-526-515-189-074,2011-11-01,2011,BR 9813608 A,1998-11-13,DK 146597 A;;DK 67098 A;;DK 9800495 W;;US 6971997 P,1997-12-16,"célula hospedeira de bacillus transgênica, e, processo para produzir um polipeptìdeo tendo atividade aminopeptidase.",,,BLINKOVSKY ALEXANDER;;BYUN TONY S;;KLOTZ ALAN V;;SLOMA ALAN;;BROWN KIMBERLY;;TANG MARIA;;FUJII MIKO;;MARUMOTO CHIGUSA;;KOFOD LENE V,,https://lens.org/120-526-515-189-074,Granted Patent,no,0,0,25,52,0,A23J3/34;;C12N9/48;;C12P21/06;;C12N9/48;;A23J3/34;;C12N9/48;;C12P21/06,C12N9/48;;C12N15/09;;A23J3/34;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/50;;C12P21/06,,0,0,,,,EXPIRED
601,US,B2,US 9090677 B2,137-729-811-002-152,2015-07-28,2015,US 201313786215 A,2013-03-05,US 201313786215 A;;EP 09165558 A;;US 201113305659 A;;US 83735810 A;;US 22587809 P,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",GENENTECH INC;;AIMM THERAPEUTICS BV,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/137-729-811-002-152,Granted Patent,yes,62,5,63,65,64,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07H21/04;;C07K16/12,,40,37,018-689-993-180-794;;005-037-911-432-607;;045-942-104-775-903;;001-779-867-387-972;;046-574-565-227-862;;020-296-196-517-635;;014-113-432-888-031;;087-464-706-073-810;;006-565-688-923-344;;013-331-795-309-026;;004-162-543-606-074;;022-530-831-805-202;;036-993-296-085-707;;070-922-203-323-177;;031-100-076-670-370;;013-323-148-570-367;;025-682-930-155-032;;049-960-678-150-173;;020-447-476-598-180;;120-309-713-911-530;;095-334-545-560-259;;031-626-846-075-129;;008-028-186-790-704;;064-715-862-322-072;;046-372-239-038-614;;066-252-194-757-349;;027-477-313-726-928;;063-710-398-275-735;;007-990-945-290-343;;015-570-097-945-448;;060-444-328-354-958;;043-714-998-563-59X;;051-707-000-800-833;;079-519-098-180-465;;024-192-636-936-032;;013-142-717-038-23X;;099-559-652-967-591,10.1016/j.vetmic.2009.03.030;;19372010;;10.1099/13500872-141-4-937;;7773396;;12850000;;10.1016/s0006-291x(03)01131-8;;10.1006/jmbi.1999.3192;;10543973;;3709526;;pmc1166865;;10.1002/j.1460-2075.1986.tb04288.x;;9373310;;10.1016/s1380-2933(96)00045-0;;12218124;;10.4049/jimmunol.169.6.3076;;18354204;;pmc2396731;;10.4049/jimmunol.180.7.4805;;10.1016/s0140-6736(02)11875-7;;12493294;;12493293;;10.1016/s0140-6736(02)11874-5;;17027124;;10.1016/j.vaccine.2006.09.043;;8757870;;pmc174224;;10.1128/iai.64.8.3318-3325.1996;;10.1038/13590;;10504677;;10.1111/j.1574-6968.1991.tb04845.x;;10.1016/0378-1097(91)90426-b;;pmc1610062;;10.1128/aac.00407-06;;17005843;;16989900;;10.1016/j.molimm.2006.08.001;;14573361;;10.1016/j.tibtech.2003.08.007;;10.1182/blood.v94.8.2637.420k22_2637_2646;;10515867;;17078388;;pmc257375;;10.1128/iai.60.9.3664-3672.1992;;1500175;;20023635;;10.1038/nm.2071;;pmc2861345;;10.1006/jmbi.1996.0548;;8876650;;10.1099/00221287-146-7-1535;;10878118;;8234256;;10.1073/pnas.90.21.10056;;pmc47712;;16914702;;10.1056/nejmoa055356;;10.1128/iai.64.1.380-383.1996;;pmc173774;;8557371;;15728889;;10.1128/aac.49.3.959-962.2005;;pmc549258;;10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10.1007/978-1-349-02718-7_1;;10.1038/ni1172;;15711548;;10.1128/iai.74.4.2145-2153.2006;;pmc1418917;;16552044;;pmc155362;;10.1101/gad.929302;;11914273;;18809660;;pmc2583566;;10.1128/iai.00874-08;;12079396;;10.1016/s0022-2836(02)00264-4;;10.1038/nrmicro1861;;18327271;;pmc267543;;10.1128/jcm.27.6.1286-1291.1989;;2473994;;10556035;;10.1006/jmbi.1999.3141;;10.1016/j.vetimm.2009.05.012;;19540000,"Geoghegan et al. ""Staphylococcus pseudintermedius expresses surface proteins that closely resemble those from Staphylococcus aureus,"" Veterinary Microbiology 138:345-352 (2009).;;McDevitt et al. ""Variation in the size of the repeat region of the fibrinogen receptor (clumping factor) of Staphylococcus aureus strains,"" Microbiology 141:937-943 (1995).;;Casset, F. et al. (Jul. 18, 2003) ""A Peptide Mimetic of an Anti-CD4 Monoclonal Antibody by Rational Design,"" Biochem. Biophy.s Res. Commun. 307(1):198-205.;;Chen, Y. et al. (Nov. 5, 1999). ""Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen,"" J.. Mol. Bio. 293(4):865-881.;;Chothia, C. et al (1986). ""The relation between the divergence of sequence and structure in proteins,"" The EMBO Journal 5(4):823-826.;;Davies, J. et al. (Sep. 1, 1996). ""Affinity Improvement of Single Antibody VH Domains: Residues in all Three Hypervariable Regions Affect Antigen Binding,"" Immunotechnology 2(3):169-179.;;De Pascalis, R. et al. (Sep. 15, 2002). ""Grafting of ""abbreviated"" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody,"" The Journal of Immunology 169(6):3076-3084.;;Diehl, S.A. et al. (2008). ""STAT3-Mediated Up-Regulation of BLIMP1 is Cooridanted With BCL6 Down-Reguation to Control Huamn Plasma Cell Differentiation,"" J Immunol 180:4805-4815.;;Elliott, T. et al. (Dec. 14, 2002). ""Antibody Response to Staphylococcal Slime and Lipoteichoic Acid,"" The Lancet 360(9349):1977.;;Gaudreau, M-C. et al. (Dec. 8, 2006, e-pub. Sep. 22, 2006). ""Protective Immune Responses to a Multi-Gene DNA Vaccine Against Staphylococcus aureus,"" Vaccine 25:814-824.;;Greenberg, J.W. et al. (Aug. 1996). ""Influence of Lipoteichoic Acid Structure on Recognition by the Macrophage Scanenger Receptor,"" Infection and Immunity 64(8):3318-3325.;;Greenspan. N.S. et al (Oct. 1999). ""Defining epitopes: Its Not as Easy as it Seems,"" Nature Biotechnology 17(10):936-937.;;Hammonds, S.J. et al. (Jul. 15, 1991). ""Differentiation of Enterococci From Other Group D Streptococci by Means of a Specific Monoclonal Antibody,"" FEMS Microbiology Letters 82:91-94.;;Hetherington, S. et al. (Oct. 2006). ""Phase I Dose Escalation Study to Evaluate the Safety and Pharmacokinetic Profile of Tefibazumab in Subjects with End-Stage Renal Disease Requiring Hemodialysis,"" Antimicrobial Agents and Chemotherapy 50(10):3499-3500.;;Holm, P. et al. (Feb. 2007). ""Functional Mapping and Single Chain Construction of the Anti-Cytokeratin 8 Monoclonal Antibody TS1,"" Mol. Immunol. 44:(6):1075-1084.;;Holt, L.J. et al. (Nov. 1, 2003). ""Domain Antibodies: Proteins for Therapy,"" TRENDS in Biotechnology 21(11):484-490.;;International Search Report mailed on Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, ten pages.;;Jaleco, A.C. et al. (Oct. 15, 1999). ""Genetic Modification of Human B-Cell Development: B Cell Development is Inhibited by the Dominant Negative Helix Loop Helix Factor Id3,"" Blood 94(8):2637-2646.;;John, J.F., Jr. et al. (Oct. 1, 2006). ""Drug Evaluation:Tefibazumab-A Monoclonal Antibody Against Staphylococcal Infection,"" Current Opinion in Molecular Therapeutics 8(5):455-460.;;Kabat et al. (1991). Sequences of Proteins of Immunological Interest, 5th Ed. Public Health Service National Institute of Health, Bethesda, MD, Table of Contents, pp. xiii-scvi.;;Keller, R. et al. (Sep. 1992). ""Macrophage Response to Bacteria: Induction of Marked Secretory and Cellular Activities by Lipoteichoic Acids,"" Infect. Immun. 60(9):3664-3672.;;Kwakkenbos, M.J. et al. (Jan. 2010, e-pub. Dec. 20, 2009). ""Generation of Stable Monoclonal Antibody-Producing B Cell Receptor-Positive Human Memory B Cells by Genetic Programming,"" Nat. Med. 16(1):123-128.;;MacCallum, R.M. et al. (Oct. 11, 1996). Antibody-Antigen Interactions: Contact Analysis and Binding Site Topography, J. Mol. Bioi. 262(5):732-745.;;McCrea, K.W. et al. (Jul. 1, 2000). ""The Serine-Aspartate Repeat (Sdr) Protein Family in Staphylococcus epidermidis,"" Microbiology 146:1535-1546.;;Mikayama, T. et al. (Nov. 1, 1993). ""Molecular Cloning and Functional Expression of a cDNA Encoding Glycosylation-lnhibiting Factor,"" Proc.Nati.Acad.Sci. USA 90(21):10056-10060.;;Moran, G.J. et al. (Aug. 17, 2006). ""Methicillin-Resistant S. aureus Infections Among Patients in the Emergency Department,"" NEMJ 355(7):666-674.;;Polotsky, V.Y. et al. (Jan. 1996). ""Interaction of Human Mannose-Binding Protein with Lipoteichoic Acids,"" Infection and Immunity 64(1):380-383.;;Reilley, S. et al. (Mar. 2005). ""Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers,"" Antimicrobial Agents and Chemotherapy 49(3):959-962.;;Rudikoff , S.et al (Mar. 1982). ""Single Amino Acid Substitution Altering Antigen-binding Specificity,"" Proc Natl Acad Sci USA 79(6):1979-1983.;;Rudinger, J. et al. (Jun. 1976). ""Characteristics of the Amino Acids as Components of a Peptide Hormone Sequence,"" Chapter 1 in Peptide Hormones, University Park Press, Baltimore, MD, Bioi.Council. pp. 5-7.;;Scheeren, F.A. et al. (Mar. 2005, e-pub. Feb. 13, 2005). ""STAT5 Regulates the Self-Renewal Capacity and Differentiation of Human Memory B Cells and Controls Bcl-6 Expression, "" Nat. Immunol. 6(3):303-313.;;Schaffer, A. et al. (Apr. 1, 2006). ""Immunication with Staphylococcus aureus Clumping Factor 8, a Major Determinant in Nasal Carriage, Reduces Nasal Colonization in a Murine Model,"" Infection and Immunity 74(4):2145-2153.;;Shvarts, A. et al. (2002). ""A Senescence Rescue Screen Identifies BCL6 as an Inhibitor of Anti-Proliferative p19ARF-p53 Signaling,"" Genes Dev. 16:681-686.;;Tuchscherr, L.P.N. et al. (Dec. 2008, e-pub. Sep. 22, 2008). ""Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants of Staphyloccus aureus in Mice,"" Infection and Immunity 76(12):5738-5744.;;Vajdos, F.F. et al. (2002). ""Comprehensive Functional Maps of the Antigen-Binding Site of an Anti-ErbB2 Antibody Obtained With Shotgun Scanning Mutagenesis,"" J. Mol. Biol. 320:415-428.;;Weidenmaier, C. et al. (Apr. 2008, e-pub. Mar. 10, 2008). ""Teichoic Acids and Related Cell-Wall Glycopolymers in Gram-Positive Physiology and Host Interactions,"" Nat Rev. Microbiol. 6(4):276-287.;;Wergeland, H.I. et al. (Jun. 1, 1989). ""Antibodies to Staphylococcal Peptidoglycan nd its Peptide Epitopes, Techoic Acid, and Lipotechoic Acid in Sera From Blood Donors and Patients with Staphylococcal Infections,"" Journal of Clinical Microbiology 27(6):1286-1291.;;Wu, H. et al. (Nov. 19, 1999).""Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues,"" J. Mol. Biol. 294(1):151-162.;;Yin, R-L. et al. (Dec. 15, 2009). ""Construction and Immunogenicity of a DNA Vaccine Containing Clumping Factor A of Staphylococcus aureus and Bovine IL18,"" Veterinary Immunology and Immunopathology 132:270-274.;;Written Opinion mailed on Apr. 1, 2011, for PCT Application No. PCT/NL2010/050456, filed on Jul. 15, 2010, twelve pages.",INACTIVE
602,EP,B1,EP 2454284 B1,147-832-939-571-58X,2018-04-11,2018,EP 10734844 A,2010-07-15,NL 2010050456 W;;EP 09165558 A;;US 22587809 P;;EP 10734844 A,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,,AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/147-832-939-571-58X,Granted Patent,yes,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,1,1,023-878-463-952-471,pmc3794999;;10.1371/journal.ppat.1003653;;24130480,"WOUTER L. W. HAZENBOS ET AL: ""Novel Staphylococcal Glycosyltransferases SdgA and SdgB Mediate Immunogenicity and Protection of Virulence-Associated Cell Wall Proteins"", PLOS PATHOGENS, vol. 9, no. 10, 10 October 2013 (2013-10-10), pages e1003653, XP055141193, DOI: 10.1371/journal.ppat.1003653",ACTIVE
603,AU,A1,AU 2010/271582 A1,036-134-730-254-548,2012-03-01,2012,AU 2010/271582 A,2010-07-15,EP 09165558 A;;US 22587809 P;;NL 2010050456 W,2009-07-15,Gram-positive bacteria specific binding compounds,"The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.",AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/036-134-730-254-548,Patent Application,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,INACTIVE
604,PL,T3,PL 2454284 T3,093-660-922-870-908,2018-09-28,2018,PL 10734844 T,2010-07-15,EP 09165558 A;;US 22587809 P;;EP 10734844 A;;NL 2010050456 W,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,,AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/093-660-922-870-908,Patent Application,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/12;;A61K39/395;;A61P31/04;;C12N15/13,,0,0,,,,PENDING
605,SI,T1,SI 2454284 T1,156-393-721-326-64X,2018-07-31,2018,SI 201031701 T,2010-07-15,EP 09165558 A;;US 22587809 P;;NL 2010050456 W;;EP 10734844 A,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,,AIMM THERAPEUTICS BV;;GENENTECH INC,BEAUMONT TIM;;KWAKKENBOS MARK JEROEN;;BROWN ERIC J;;MORISAKI JOHN HIROSHI;;HAZENBOS WOUTER L W;;MARIATHASAN SANJEEV;;KAJIHARA KIMBERLY;;XIA YI,,https://lens.org/156-393-721-326-64X,Granted Patent,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C07K16/00;;A61K39/00;;A61P31/00;;C12N15/00,,0,0,,,,ACTIVE
606,US,A1,US 2023/0346880 A1,039-296-372-009-403,2023-11-02,2023,US 202318175379 A,2023-02-27,US 202318175379 A;;US 202263314334 P,2022-02-25,TOPICAL FORMULATIONS FOR TREATMENT OF HYPERGRANULATION TISSUE,"The present disclosure describes compositions for reducing hypergranulation tissue and methods of their use. The compositions comprise bacitracin, polymyxin b, and triamcinolone.",UNIV SOUTH FLORIDA,LAUN JAKE;;WEST WILLIAM;;WRIGHT BENJAMIN;;MAREK JENNA;;BODNAR MICHAEL;;BROWN MAYNELL KIMBERLY;;TAYLOR LORYN;;HERNANDEZ PEREZ FERNANDO A;;SMITH JR DAVID J,,https://lens.org/039-296-372-009-403,Patent Application,yes,0,0,1,1,0,A61P17/02;;A61K31/573;;A61K38/12;;A61K9/0014;;A61K9/06;;A61K38/12;;A61K31/573;;A61P17/02;;A61K9/06;;A61K9/0014,A61K38/12;;A61K9/00;;A61K9/06;;A61K31/573;;A61P17/02,,0,0,,,,PENDING
607,HK,A1,HK 1243931 A1,057-355-879-788-696,2018-07-27,2018,HK 18103430 A,2018-03-12,US 201462087184 P;;US 2015/0063510 W,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,,HOFFMANN LA ROCHE,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XU MIN,,https://lens.org/057-355-879-788-696,Patent Application,no,0,0,14,14,0,A61K31/395;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61P31/04;;A61K47/6889;;A61K47/6809;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K31/395;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K47/6803;;A61K47/6809;;A61K47/6835;;A61K47/6889;;A61P31/04;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/6809;;A61K31/4468;;A61K31/496;;A61K39/40,A61K/;;A61P/,,0,0,,,,PENDING
608,WO,A1,WO 2016/090038 A1,148-010-836-980-114,2016-06-09,2016,US 2015/0063510 W,2015-12-02,US 201462087184 P,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,The invention provides anti-Staphylococcus aureus antibody rifamycin antibiotic conjugates and methods of using same.,GENENTECH INC;;HOFFMANN LA ROCHE,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XU MIN,,https://lens.org/148-010-836-980-114,Patent Application,yes,84,14,14,14,170,A61K31/395;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61P31/04;;A61K47/6889;;A61K47/6809;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K31/395;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K47/6803;;A61K47/6809;;A61K47/6835;;A61K47/6889;;A61P31/04;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/6809;;A61K31/4468;;A61K31/496;;A61K39/40,A61K47/48,,147,96,026-795-551-710-945;;002-515-588-243-244;;022-433-619-753-009;;006-595-189-352-126;;131-416-911-051-810;;005-191-254-952-375;;053-831-356-798-94X;;073-953-289-633-23X;;072-784-835-278-714;;031-095-043-325-307;;017-513-564-354-260;;012-353-409-475-976;;004-256-930-202-106;;005-522-690-579-734;;053-740-822-676-285;;030-790-931-421-530;;092-890-446-683-93X;;046-783-448-716-481;;083-071-649-888-913;;016-716-200-807-517;;023-115-865-713-224;;108-567-706-608-928;;015-239-659-590-870;;045-556-293-127-132;;050-959-366-576-084;;011-174-345-245-142;;049-134-753-209-354;;095-334-545-560-259;;068-264-897-850-380;;104-214-218-664-008;;072-509-376-457-062;;010-488-381-022-259;;156-501-805-490-709;;008-274-774-541-556;;027-781-613-832-489;;070-280-057-407-994;;012-268-510-926-843;;037-445-639-149-821;;009-275-403-380-31X;;002-490-451-363-036;;001-779-867-387-972;;044-522-255-085-902;;040-912-152-710-03X;;029-806-225-784-498;;049-127-089-462-072;;020-991-471-575-245;;049-127-089-462-072;;003-338-632-019-904;;007-603-263-950-700;;087-412-910-091-181;;008-587-496-850-953;;065-430-968-783-392;;021-430-782-622-770;;011-496-944-971-738;;012-586-088-349-473;;030-790-931-421-530;;056-856-992-620-755;;071-507-202-086-016;;105-585-673-955-762;;021-880-031-964-84X;;047-094-213-620-162;;031-120-105-336-16X;;120-079-078-809-391;;105-030-562-969-986;;039-841-667-603-953;;061-295-123-907-192;;023-607-007-385-464;;066-617-857-912-127;;072-389-563-856-866;;023-343-819-824-657;;068-257-624-898-885;;116-075-018-919-051;;023-115-865-713-224;;060-265-896-490-751;;095-843-764-156-972;;113-394-540-007-150;;071-015-994-878-474;;007-103-177-089-431;;037-765-704-863-929;;012-240-302-857-981;;003-257-945-556-183;;030-928-860-626-158;;089-633-612-001-004;;007-256-696-206-828;;023-878-463-952-471;;015-699-154-128-071;;033-089-532-103-483;;049-127-089-462-072;;020-991-471-575-245;;007-256-696-206-828;;038-456-792-888-743;;007-365-891-683-729;;031-933-089-611-974;;021-773-286-469-003;;004-272-966-072-139;;032-182-896-544-669,9709046;;10.1056/nejm199808203390806;;19035777;;10.1086/595011;;20731576;;10.1086/653519;;20598637;;10.1016/j.coph.2010.06.006;;10.1038/nrmicro2508;;21297670;;14907971;;10.1084/jem.95.2.209;;pmc2212057;;10725730;;10.4049/jimmunol.164.7.3713;;13664874;;pmc2136963;;10.1084/jem.110.1.123;;pmc2730847;;19604261;;10.1111/j.1365-2249.2009.03950.x;;10.3389/fcimb.2012.00043;;pmc3417557;;22919634;;pmc3395108;;21365763;;10.1002/emmm.201100123;;13319588;;10.1084/jem.103.6.713;;pmc2136597;;10.1093/cid/cir124;;21460309;;16914701;;10.1056/nejmoa053783;;20200036;;10.1093/jac/dkq050;;12556219;;10.1517/13543784.12.2.255;;20025606;;10.2174/156800909790192365;;18536555;;10.1097/ppo.0b013e318172d704;;10.1021/ar700108g;;17705444;;10.1016/j.coph.2005.04.008;;15951239;;12121142;;10.1021/bc025536j;;12728922;;10.4049/jimmunol.170.9.4854;;10.4049/jimmunol.150.3.880;;8423344;;10.1016/s1074-7613(00)00006-6;;10933393;;10.1038/363446a0;;8502296;;8784342;;10.1038/nsb0996-733;;10.1016/0022-2836(87)90412-8;;3681981;;10.1006/jmbi.1996.0548;;8876650;;10.4049/jimmunol.117.2.587;;950463;;10.1016/s0167-5699(97)01172-9;;9425738;;10.1038/nbt0797-637;;9219265;;14699147;;10.1074/jbc.c300470200;;10.1146/annurev.immunol.9.1.457;;10.1146/annurev.iy.09.040191.002325;;1910686;;9435247;;pmc18475;;10.1073/pnas.95.2.652;;11861619;;10.1146/annurev.immunol.20.103001.114744;;9107305;;10.1016/s0022-1759(97)00002-1;;15037082;;10.3410/f.1020100.229441;;10.1016/j.jmb.2004.01.007;;10.1016/0003-9861(86)90031-7;;2428310;;16609957;;10.1002/bit.20880;;17161664;;10.1016/j.jchromb.2006.11.018;;10.1006/jmbi.1999.3192;;10543973;;9377574;;10.1016/0169-409x(93)90004-n;;22208984;;10.1016/b978-0-12-416039-2.00006-9;;10.1016/j.jmb.2006.02.040;;16563430;;10.1128/jvi.02127-10;;21147924;;pmc3028881;;10.1016/j.jmb.2006.02.040;;16563430;;10.1038/nbt.1480;;18641636;;10.1182/blood-2009-02-205500;;19633198;;10.1016/j.jim.2007.12.011;;18230399;;886304;;10.1099/0022-1317-36-1-59;;10.1095/biolreprod23.1.243;;6774781;;10.1111/j.1749-6632.1982.tb23161.x;;7046561;;pmc162768;;10.1128/aac.39.7.1489;;7492091;;pmc2567451;;10.1073/pnas.0802822105;;18787125;;12556219;;10.1517/13543784.12.2.255;;10.1128/aac.38.5.1118;;8067748;;pmc188160;;11157898;;10.1093/jac/47.2.153;;10.1097/00001813-200104000-00002;;11335786;;8431020;;pmc187606;;10.1128/aac.37.1.67;;15264863;;10.1021/bc049969t;;10.1021/jo016187+;;11895404;;10.1016/s0040-4039(97)01158-1;;10.1021/jo00121a070;;8983339;;10.1021/bc950092v;;10.1016/s0960-894x(02)00361-x;;12127540;;10.1016/s0968-0896(03)00057-9;;12659762;;10.1517/13543776.15.9.1087;;10.1016/s0960-894x(99)00381-9;;10465553;;9383424;;10.1016/1074-5521(95)90272-4;;10.1021/jo00310a019;;6387121;;10.1021/jm00377a012;;12121142;;10.1021/bc025536j;;16644914;;10.1093/protein/gzl013;;10.1158/1078-0432.ccr-04-0789;;15501986;;10.1021/bc00014a008;;1325188;;10.1001/archinte.163.17.2066;;14504120;;10.1080/00365540500372846;;16338832;;17143318;;10.1038/nrmicro1557;;10.1016/s0140-6736(00)74210-3;;10.1111/j.1749-6632.2011.06330.x;;22191526;;10.1111/j.1749-6632.2011.06323.x;;22191530;;6933450;;pmc349762;;10.1073/pnas.77.7.4030;;19252857;;10.1007/978-1-59745-554-1_13;;pmc3794999;;10.1371/journal.ppat.1003653;;24130480;;2649959;;10.1093/clinids/11.2.213;;19223616;;pmc2681564;;10.1128/aac.01605-07;;10.1016/j.jmb.2006.02.040;;16563430;;10.1128/jvi.02127-10;;21147924;;pmc3028881;;19252857;;10.1007/978-1-59745-554-1_13;;19917746;;10.1128/aac.00886-09;;pmc2812130;;7690420;;pmc238040;;10.1128/jvi.67.10.6179-6191.1993;;3881765;;10.1073/pnas.82.2.488;;pmc397064;;pmc4031760;;24226776;;10.1038/nature12790;;10.1038/nbt832;;12778055;;10452801;;10.1006/abio.1999.4203,"LOWY, F.D.: ""Staphylococcus aureus infections"", N ENGL J MED, vol. 339, 1998, pages 520 - 532;;BOUCHER, H.W. ET AL.: ""Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America"", CLIN INFECT DIS, vol. 48, 2009, pages 1 - 12;;BOUCHER, H.; MILLER, L.G.; RAZONABLE, R.R.: ""Serious infections caused by methicillin-resistant Staphylococcus aureus"", CLIN INFECT DIS, vol. 51, no. 2, 2010, pages 183 - 197;;NANNINI, E.; MURRAY, B.E.; ARIAS, C.A.: ""Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus"", CURR OPIN PHARMACOL, vol. 10, 2010, pages 516 - 521;;THWAITES, G.E.; GANT, V.: ""Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?"", NAT REV MICROBIOL, vol. 9, 2011, pages 215 - 222;;ROGERS, D.E.; TOMPSETT, R.: ""The survival of staphylococci within human leukocytes"", J. EXP. MED, vol. 95, 1952, pages 209 - 230;;GRESHAM, H.D. ET AL.: ""Survival of Staphylococcus aureus inside neutrophils contributes to infection"", J IMMUNOL, vol. 164, 2000, pages 3713 - 3722;;KAPRAL, F.A.; SHAYEGANI, M.G.: ""Intracellular survival of staphylococci"", JEXP MED, vol. 110, 1959, pages 123 - 138;;ANWAR, S. ET AL.: ""The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes"", CLIN EXP IMMUNOL, vol. 157, 2009, pages 216 - 224;;FRAUNHOLZ, M.; SINHA, B.: ""Intracellular Staphylococcus aureus: live-in and let die"", FRONT CELL INFECT MICROBIOL, vol. 2, 2012, pages 43;;GARZONI, C.; KELLEY, W.L.: ""Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus"", EMBO MOL MED, vol. 3, 2011, pages 115 - 117;;ROGERS, D.E.: ""Studies on Bacterimia: Mechanisms Relating to the Persistence of Bacteremia in Rabbits Following the Intravanous Injection of Staphylococci"", JEM, vol. 103, 1956, pages 713;;KULLAR, R.; DAVIS, S.L.; LEVINE, D.P.; RYBAK, M.J.: ""Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets"", CLINICAL INFECTIOUS DISEASES : AN OFFICIAL PUBLICATION OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA, vol. 52, 2011, pages 975 - 981;;FOWLER, V.G., JR. ET AL.: ""Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus"", THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 355, 2006, pages 653 - 665;;YOON, Y.K.; KIM, J.Y.; PARK, D.W.; SOHN, J.W.; KIM, M.J.: ""Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin"", THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 65, 2010, pages 1015 - 1018;;ROTHSTEIN, D.M. ET AL., EXPERT OPIN. INVEST. DRUGS, vol. 12, no. 2, 2003, pages 255 - 271;;TEICHER, B.A., CURR. CANCER DRUG TARGETS, vol. 9, 2009, pages 982 - 1004;;CARTER, P.J.; SENTER P.D., THE CANCER J., vol. 14, no. 3, 2008, pages 154 - 169;;CHARI, R.V., ACC. CHEM. RES., vol. 41, 2008, pages 98 - 107;;POLAKIS P., CURR. OPIN. PHARMACOL., vol. 5, 2005, pages 382 - 387;;SAMBROOK ET AL.: ""Molecular Cloning: A Laboratory Manual, 3rd edition"", 2001, COLD SPRING HARBOR LABORATORY PRESS;;F.M. AUSUBEL, ET AL.: ""Current Protocols in Molecular Biology"", 2003;;.: ""Methods in Enzymology"", ACADEMIC PRESS, INC.;;M.J. MACPHERSON, B.D. HAMES AND G.R. TAYLOR: ""PCR 2: A Practical Approach"", 1995;;HARLOW AND LANE,: ""Antibodies, A Laboratory Manual, and Animal Cell Culture"", 1988;;M.J. GAIT,: ""Oligonucleotide Synthesis"", 1984;;.: ""Methods in Molecular Biology"", HUMANA PRESS;;J.E. CELLIS,: ""Cell Biology: A Laboratory Notebook"", 1998, ACADEMIC PRESS;;R.I. FRESHNEY: ""Animal Cell Culture"", 1987;;J.P. MATHER; P.E. ROBERTS: ""Introduction to Cell and Tissue Culture"", 1998, PLENUM PRESS;;A. DOYLE, J.B. GRIFFITHS, AND D.G. NEWELL,: ""Cell and Tissue Culture: Laboratory Procedures"", August 1993, J. WILEY AND SONS;;D.M. WEIR AND C.C. BLACKWELL,: ""Handbook of Experimental Immunology"", .;;J.M. MILLER AND M.P. CALOS,: ""Gene Transfer Vectors for Mammalian Cells"", 1987;;MULLIS ET AL.,: ""PCR: The Polymerase Chain Reaction"", 1994;;J.E. COLIGAN ET AL.,: ""Current Protocols in Immunology"", 1991;;""Short Protocols in Molecular Biology"", 1999, WILEY AND SONS;;C.A. JANEWAY; P. TRAVERS, IMMUNOBIOLOGY, 1997;;P. FINCH, ANTIBODIES, 1997;;D. CATTY.,: ""Antibodies: A Practical Approach"", 1988, IRL PRESS;;P. SHEPHERD AND C. DEAN,: ""Monoclonal Antibodies: A Practical Approach"", 2000, OXFORD UNIVERSITY PRESS;;E. HARLOW; D. LANE: ""Using Antibodies: A Laboratory Manual"", 1999, COLD SPRING HARBOR LABORATORY PRESS;;M. ZANETTI AND J. D. CAPRA,: ""The Antibodies"", 1995, HARWOOD ACADEMIC PUBLISHERS;;V.T. DEVITA ET AL.,: ""Cancer: Principles and Practice of Oncology"", 1993, J.B. LIPPINCOTT COMPANY;;SINGLETON ET AL.: ""Dictionary of Microbiology and Molecular Biology, 2nd Ed.,"", 1994, J. WILEY & SONS;;JANEWAY, C.; TRAVERS, P.; WALPORT, M.; SHLOMCHIK: ""Immunobiology, 5th Ed."", 2001, GARLAND PUBLISHING;;DUBOWCHIK ET AL., BIOCONJ. CHEM., vol. 13, 2002, pages 855 - 869;;MILLER ET AL., J. OF IMMUNOLOGY, vol. 170, 2003, pages 4854 - 4861;;KINDT ET AL.: ""Kuby Immunology, 6th ed.,"", 2007, W.H. FREEMAN AND CO., pages: 91;;PORTOLANO ET AL., J. IMMUNOL., vol. 150, 1993, pages 880 - 887;;CLARKSON ET AL., NATURE, vol. 352, 1991, pages 624 - 628;;XU ET AL., IMMUNITY, vol. 13, 2000, pages 37 - 45;;JOHNSON; WU: ""Methods in Molecular Biology"", vol. 248, 2003, HUMAN PRESS, pages: 1 - 25;;HAMERS-CASTERMAN ET AL., NATURE, vol. 363, 1993, pages 446 - 448;;SHERIFF ET AL., NATURE STRUCT. BIOL., vol. 3, 1996, pages 733 - 736;;KABAT ET AL.: ""Sequences of Proteins of Immunological Interest 5th Ed."", 1991, NATIONAL INSTITUTES OF HEALTH;;CHOTHIA; LESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;MACCALLUM ET AL., J. MOL. BIOL., vol. 262, 1996, pages 732 - 745;;KABAT ET AL.: ""Sequences of Proteins of Immunological Interest Fifth Edition,"", vol. 1-3, 1991, NIH PUBLICATION 91-3242;;GUYER ET AL., J. IMMUNOL., vol. 117, 1976, pages 587;;KIM ET AL., J. IMMUNOL., vol. 24, 1994, pages 249;;GHETIE; WARD, IMMUNOL. TODAY, vol. 18, no. 12, 1997, pages 592 - 8;;GHETIE ET AL., NATURE BIOTECHNOLOGY, vol. 15, no. 7, 1997, pages 637 - 40;;HINTON ET AL., J. BIOL. CHEM., vol. 279, no. 8, 2004, pages 6213 - 6;;SHIELDS ET AL., J. BIOL. CHEM., vol. 9, no. 2, 2001, pages 6591 - 6604;;RAVETCH; KINET, ANNU. REV. IMMUNOL., vol. 9, 1991, pages 457 - 92;;CLYNES ET AL., PNAS USA, vol. 95, 1998, pages 652 - 656;;D. UNDERHILL; A OZINSKY: ""Phagocytosis of Microbes: complexity in Action"", ANNUAL REVIEW OF IMMUNOLOGY, vol. 20, 2002, pages 825;;GAZZANO-SANTORO ET AL., J. IMMUNOL. METHODS, vol. 202, 1996, pages 163;;WRIGHT ET AL., TIBTECH, vol. 15, 1997, pages 26 - 32;;OKAZAKI ET AL., J. MOL. BIOL., vol. 336, 2004, pages 1239 - 1249;;YAMANE-OHNUKI ET AL., BIOTECH. BIOENG., vol. 87, 2004, pages 614;;RIPKA ET AL., ARCH. BIOCHEM. BIOPHYS., vol. 249, 1986, pages 533 - 545;;KANDA, Y. ET AL., BIOTECHNOL. BIOENG., vol. 94, no. 4, 2006, pages 680 - 688;;FLATMAN ET AL., J. CHROMATOGR. B, vol. 848, 2007, pages 79 - 87;;CHEN ET AL., J. MOL. BIOL., vol. 293, 1999, pages 865 - 881;;PRESTA ET AL., CANCER RES., vol. 57, 1997, pages 4593 - 4599;;PAQUETTE, LEO A.: ""Principles of Modern Heterocyclic Chemistry"", 1968, W.A. BENJAMIN, article ""Chapters 1, 3, 4, 6, 7, and 9"";;""The Chemistry of Heterocyclic Compounds, A series of Monographs"", 1950, JOHN WILEY & SONS, article ""Volumes 13, 14, 16, 19, and 28"";;J. AM. CHEM. SOC., vol. 82, 1960, pages 5566;;VINCENT LEE: ""Peptide and Protein Drug Delivery"", 1991, MARCEL DEKKER, INC., pages: 247 - 301;;JONES, A., ADV. DRUG DELIVERY REV., vol. 10, 1993, pages 29 - 90;;S. P. PARKER,: ""McGraw-Hill Dictionary of Chemical Terms"", 1984, MCGRAW-HILL BOOK COMPANY;;ELIEL, E.; WILEN, S.: ""Stereochemistry of Organic Compounds"", 1994, JOHN WILEY & SONS, INC.;;T. W. GREENE: ""Protective Groups in Organic Synthesis"", 1991, JOHN WILEY & SONS;;LYON, R. ET AL., METHODS IN ENZYM., vol. 502, 2012, pages 123 - 138;;MEIJER PJ ET AL., J MOL BIOL., vol. 358, no. 3, 2006, pages 764 - 72;;LANTTO J ET AL., J VIROL., vol. 85, no. 4, 2011, pages 1820 - 33;;MEIJER, P.J. ET AL.: ""Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing"", JOURNAL OF MOLECULAR BIOLOGY, vol. 358, 2006, pages 764 - 772;;JUNUTULA ET AL., NATURE BIOTECH., vol. 26, no. 8, 2008, pages 925 - 932;;DORNAN ET AL., BLOOD, vol. 114, no. 13, 2009, pages 2721 - 2729;;SHEN ET AL., NATURE BIOTECH., vol. 30, no. 2, 2012, pages 184 - 191;;JUNUTULA ET AL., JOUR OF IMMUN. METHODS, vol. 332, 2008, pages 41 - 52;;GRAHAM ET AL., J. GEN VIROL., vol. 36, 1977, pages 59;;MATHER, BIOL. REPROD., vol. 23, 1980, pages 243 - 251;;MATHER ET AL.,, ANNALS N. Y. ACAD. SCI., vol. 383, 1982, pages 44 - 68;;YAZAKI; WU: ""Methods in Molecular Biology"", vol. 248, 2003, HUMANA PRESS, pages: 255 - 268;;FUJII ET AL., ANTIMICROB. AGENTS CHEMOTHER., vol. 39, 1995, pages 1489 - 1492;;FEKLISTOV ET AL., PROC NATL ACAD SCI USA, vol. 105, no. 39, 2008, pages 14820 - 5;;ROTHSTEIN ET AL., EXPERT OPIN. INVESTIG. DRUGS, vol. 12, no. 2, 2003, pages 255 - 271;;FUJII ET AL., ANTIMICROB. AGENTS CHEMOTHER., vol. 38, 1994, pages 1118 - 1122;;WICHELHAUS ET AL., J. ANTIMICROB. CHEMOTHER., vol. 47, 2001, pages 153 - 156;;SELIGSON ET AL., ANTI-CANCER DRUGS, vol. 12, 2001, pages 305 - 13;;CHEM. PHARM. BULL., vol. 41, 1993, pages 148;;TOMIOKA ET AL., ANTIMICROB. AGENTS CHEMOTHER., vol. 37, 1993, pages 67;;KLUSSMAN ET AL., BIOCONJUGATE CHEMISTRY, vol. 15, no. 4, 2004, pages 765 - 773;;TOKI ET AL., J. ORG. CHEM., vol. 67, 2002, pages 1866 - 1872;;DUBOWCHIK ET AL., TETRAHEDRON LETTERS, vol. 38, 1997, pages 5257 - 60;;WALKER, M.A., J. ORG. CHEM., vol. 60, 1995, pages 5352 - 5355;;FRISCH ET AL., BIOCONJUGATE CHEM., vol. 7, 1996, pages 180 - 186;;SUN ET AL., BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 12, 2002, pages 2213 - 2215;;SUN ET AL., BIOORGANIC & MEDICINAL CHEMISTRY, vol. 11, 2003, pages 1761 - 1768;;HAMANN ET AL., EXPERT OPIN. THER. PATENTS, vol. 15, 2005, pages 1087 - 1103;;HAY ET AL., BIOORG. MED. CHEM. LETT., vol. 9, 1999, pages 2237;;RODRIGUES ET AL., CHEMISTRY BIOLOGY, vol. 2, 1995, pages 223;;STORM ET AL., J. AMER. CHEM. SOC., vol. 94, 1972, pages 5815;;AMSBERRY ET AL., J. ORG. CHEM., vol. 55, 1990, pages 5867;;KINGSBURY ET AL., J. MED. CHEM., vol. 27, 1984, pages 1447;;DUBOWCHIK ET AL., BIOCONJUGATE CHEM., vol. 13, no. 4, 2002, pages 855 - 869;;MCDONAGH ET AL., PROT. ENGR. DESIGN & SELECTION, vol. 19, no. 7, 2006, pages 299 - 307;;HAMBLETT ET AL., CLIN. CANCER RES., vol. 10, 2004, pages 7063 - 7070;;HAMBLETT, K.J. ET AL.: ""Effect of drug loading on the pharmacology, pharmacokinetics, and toxicity of an anti-CD30 antibody-drug conjugate"", AMERICAN ASSOCIATION FOR CANCER RESEARCH, 2004 ANNUAL MEETING, vol. 45, 27 March 2004 (2004-03-27);;ALLEY, S.C. ET AL.: ""Controlling the location of drug attachment in antibody-drug conjugates"", AMERICAN ASSOCIATION FOR CANCER RESEARCH, 2004 ANNUAL MEETING, vol. 45, 27 March 2004 (2004-03-27);;GEOGHEGAN; STROH, BIOCONJUGATE CHEM., vol. 3, 1992, pages 138 - 146;;FOWLER ET AL., ARCH. INTERN. MED., vol. 163, 2003, pages 2066 - 2072;;KHATIB ET AL., SCAND. J. INFECT. DIS., vol. 38, 2006, pages 7 - 14;;LEWIS K: ""Persister cells, dormancy and infectious disease"", NATURE REVIEWS MICROBIOLOGY, vol. 5, no. 1, 2007, pages 48 - 56;;BIGGER JW: ""Treatment of staphylococcal infections with penicillin by intermittent sterilization"", LANCET, vol. 244, no. 6320, 14 October 1944 (1944-10-14), pages 497 - 500;;SHAW, K.; BARBACHYN, M., ANN. N.Y. ACAD. SCI., vol. 1241, 2011, pages 48 - 70;;SUTCLIFFE, J., ANN. N.Y. ACAD. SCI., vol. 1241, 2011, pages 122 - 152;;OSOL, A.: ""Remington's Pharmaceutical Sciences 16th edition"", 1980;;EPSTEIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 3688;;HWANG ET AL., PROC. NATL ACAD. SCI. USA, vol. 77, 1980, pages 4030;;MEIJER, P.J.; NIELSEN, L.S.; LANTTO, J.; JENSEN, A.: ""Human antibody repertoires"", METHODS MOL BIOL, vol. 525, 2009, pages 261 - 277;;HAZENBOS, W.L. ET AL.: ""Novel staphylococcal glycosyltransferases SdgA and SdgB mediate immunogenicity and protection of virulence-associated cell wall proteins"", PLOS PATHOG, vol. 9, 2013, pages L003653;;FISCHER, R. ET AL., BIOCONJUG CHEM, vol. 21, 2010, pages 64 - 73;;ANDRE BRYSKIER: ""Antimicrobial Agents"", 2005, ASM PRESS;;VANDENBROEK, P.V.: ""Antimicrobial Drugs, Microorganisms, and Phagocytes"", REVIEWS OF INFECTIOUS DISEASES, vol. 11, 1989, pages 213 - 245;;SANDBERG, A.; HESSLER, J.H.; SKOV, R.L.; BLOM, J.; FRIMODT-MOLLER, N.: ""Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model"", ANTIMICROB AGENTS CHEMOTHER, vol. 53, 2009, pages 1874 - 1883;;MEIJER PJ ET AL., JOURNAL OF MOLECULAR BIOLOGY, vol. 358, 2006, pages 764 - 772;;LANTTO J ET AL., J VIROL., vol. 85, no. 4, February 2011 (2011-02-01), pages 1820 - 33;;MEIJER PJ ET AL., METHODS IN MOLECULAR BIOLOGY, vol. 525, 2009, pages 261 - 277,XIV;;TATTEVIN P. ET AL., ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 54, 2010, pages 610 - 613;;NAKAMURA GR ET AL., J VIROL, vol. 67, 1993, pages 6179 - 6191;;KUNKEL, T.A.: ""Rapid and efficient site-specific mutagenesis without phenotypic selection"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 82, no. 2, 1985, pages 488 - 492;;CONLON, B.P. ET AL., NATURE, vol. 503, 2013, pages 365 - 370;;DORONINA ET AL., NAT. BIOTECHNOL., vol. 21, 2003, pages 778 - 784;;GETZ ET AL., ANAL. BIOCHEM., vol. 273, 1999, pages 73 - 80",PENDING
609,EP,A1,EP 3226911 A1,177-659-714-915-777,2017-10-11,2017,EP 15820347 A,2015-12-02,US 201462087184 P;;US 2015/0063510 W,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,,HOFFMANN LA ROCHE,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XU MIN,,https://lens.org/177-659-714-915-777,Patent Application,yes,0,0,14,14,0,A61K31/395;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61P31/04;;A61K47/6889;;A61K47/6809;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K31/395;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K47/6803;;A61K47/6809;;A61K47/6835;;A61K47/6889;;A61P31/04;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/6809;;A61K31/4468;;A61K31/496;;A61K39/40,A61K47/69,,0,0,,,,DISCONTINUED
610,KR,A,KR 20170086536 A,115-240-462-777-889,2017-07-26,2017,KR 20177014576 A,2015-12-02,US 201462087184 P;;US 2015/0063510 W,2014-12-03,- ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,본 발명은 항-스타필로코커스 아우레우스 항체 리파마이신 항생제 접합체 및 이를 사용하는 방법을 제공한다.,GENENTECH INC,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XU MIN,,https://lens.org/115-240-462-777-889,Patent Application,no,0,0,14,14,0,A61K31/395;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61P31/04;;A61K47/6889;;A61K47/6809;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K31/395;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K47/6803;;A61K47/6809;;A61K47/6835;;A61K47/6889;;A61P31/04;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/6809;;A61K31/4468;;A61K31/496;;A61K39/40,A61K47/50;;A61K31/395,,0,0,,,,PENDING
611,BR,A2,BR 112017011325 A2,169-823-573-361-249,2020-07-21,2020,BR 112017011325 A,2015-12-02,US 2015/0063510 W;;US 201462087184 P,2014-12-03,"?composto de conjugado anticorpo?antibiótico, composição, método de tratamento de uma infecção, método para matar staph aureus, processo para produzir o conjugado, kit para o tratamento de uma infecção, intermediários antibiótico-ligante e ligante-droga?",a invenção provê conjugados de anticorpo anti-staphylococcus aureus - antibiótico rifamicina e métodos de utilização dos mesmos.,GENENTECH INC,BINQING WEI;;ERIC BROWN;;ISIDRO HOTZEL;;KIMBERLY KAJIHARA;;LEANNA STABEN;;MIN XU;;SANJEEV MARIATHASAN;;SOPHIE M LEHAR;;THOMAS PILLOW;;VISHAL VERMA;;WOUTER HAZENBOS,,https://lens.org/169-823-573-361-249,Patent Application,no,0,0,14,14,0,A61K31/395;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61P31/04;;A61K47/6889;;A61K47/6809;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K31/395;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K47/6803;;A61K47/6809;;A61K47/6835;;A61K47/6889;;A61P31/04;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/6809;;A61K31/4468;;A61K31/496;;A61K39/40,,,0,0,,,,DISCONTINUED
612,RU,C2,RU 2731055 C2,161-688-952-314-709,2020-08-28,2020,RU 2017118793 A,2015-12-02,US 201462087184 P;;US 2015/0063510 W,2014-12-03,CONJUGATES OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS WITH RIFAMYCIN AND USE THEREOF,"FIELD: biotechnology.SUBSTANCE: described is a group of inventions comprising an antibody-antibiotic conjugate compound for treating a bacterial infection caused by one or more of Staphylococcus aureus, Staphylococcus saprophytics or Staphylococcus simulans, containing WTA (teichoic acid of cell wall) β antibody, a pharmaceutical composition for treating a bacterial infection caused by one or more of Staphylococcus aureus, Staphylococcus saprophyticus or Staphylococcus simulans, method of treating bacterial infection in a patient infected with one or more of Staphylococcus aureus, Staphylococcus saprophyticus or Staphylococcus simulans, method for destroying intracellular Staphylococcus aureus in cells of a Staphylococcus aureus infected patient without killing host cells, a method for preparing an antibody-antibiotic conjugate compound, a kit for treating an infection, caused by Staphylococcus aureus, Staphylococcus saprophyticus and/or Staphylococcus simulans, and an antibiotic linker intermediate for preparing the antibody-antibiotic conjugate.EFFECT: invention extends the range of products for treating a bacterial infection caused by one or more of Staphylococcus aureus, Staphylococcus saprophyticus or Staphylococcus simulans.29 cl, 17 dwg, 6 tbl, 21 ex",GENENTECH INC,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XU MIN,,https://lens.org/161-688-952-314-709,Granted Patent,no,6,0,14,14,0,A61K31/395;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61P31/04;;A61K47/6889;;A61K47/6809;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K31/395;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K47/6803;;A61K47/6809;;A61K47/6835;;A61K47/6889;;A61P31/04;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/6809;;A61K31/4468;;A61K31/496;;A61K39/40,A61K47/00;;A61K31/395;;A61K47/68;;A61P31/04,,0,0,,,,ACTIVE
613,CA,A1,CA 2965540 A1,004-146-329-314-329,2016-06-09,2016,CA 2965540 A,2015-12-02,US 201462087184 P;;US 2015/0063510 W,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,The invention provides anti-Staphylococcus aureus antibody rifamycin antibiotic conjugates and methods of using same.,GENENTECH INC,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XU MIN,,https://lens.org/004-146-329-314-329,Patent Application,no,0,0,14,14,170,A61K31/395;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61P31/04;;A61K47/6889;;A61K47/6809;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K31/395;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K47/6803;;A61K47/6809;;A61K47/6835;;A61K47/6889;;A61P31/04;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/6809;;A61K31/4468;;A61K31/496;;A61K39/40,C07K16/12;;A61K47/68;;A61P31/04;;C07K16/46,,0,0,,,,DISCONTINUED
614,US,A1,US 2018/0021450 A1,034-748-916-082-32X,2018-01-25,2018,US 201715611985 A,2017-06-02,US 201715611985 A;;US 2015/0063510 W;;US 201462087184 P,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,The invention provides anti- Staphylococcus aureus antibody rifamycin antibiotic conjugates and methods of using same.,GENENTECH INC,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XU MIN,,https://lens.org/034-748-916-082-32X,Patent Application,yes,7,4,14,14,170,A61K31/395;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61P31/04;;A61K47/6889;;A61K47/6809;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K31/395;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K47/6803;;A61K47/6809;;A61K47/6835;;A61K47/6889;;A61P31/04;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/6809;;A61K31/4468;;A61K31/496;;A61K39/40,A61K47/68;;A61K31/4468;;A61K31/496;;A61K39/40,,3,2,047-940-327-709-894;;082-596-938-068-845,7796805;;10.1002/j.1460-2075.1995.tb07278.x;;pmc398397;;10.4049/jimmunol.152.1.146;;8254187,"Chen et al, (The EMBO Journal, 14(12):2784-2794, 1995).;;Kussie et al (Journal of Immunology, 152:146-152, 1994, Table I);;Bendig (Methods: A Companion to Methods in Enzymology 1995; 8:83-93)",DISCONTINUED
615,MX,A,MX 2017007055 A,130-559-466-340-631,2017-11-08,2017,MX 2017007055 A,2015-12-02,US 201462087184 P;;US 2015/0063510 W,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF.,The invention provides anti-Staphylococcus aureus antibody rifamycin antibiotic conjugates and methods of using same.,GENENTECH INC,ISIDRO HOTZEL;;ERIC BROWN;;WOUTER HAZENBOS;;VISHAL VERMA;;BINQING WEI;;LEANNA STABEN;;THOMAS PILLOW;;MIN XU;;KIMBERLY KAJIHARA;;SANJEEV MARIATHASAN;;SOPHIE M LEHAR,,https://lens.org/130-559-466-340-631,Patent Application,no,0,0,14,14,0,A61K31/395;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61P31/04;;A61K47/6889;;A61K47/6809;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K31/395;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K47/6803;;A61K47/6809;;A61K47/6835;;A61K47/6889;;A61P31/04;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/6809;;A61K31/4468;;A61K31/496;;A61K39/40,A61K47/50,,0,0,,,,PENDING
616,CN,A,CN 107206102 A,028-761-478-058-600,2017-09-26,2017,CN 201580075298 A,2015-12-02,US 201462087184 P;;US 2015/0063510 W,2014-12-03,Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereof,The invention provides anti-Staphylococcus aureus antibody rifamycin antibiotic conjugates and methods of using same.,GENENTECH INC,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XU MIN,,https://lens.org/028-761-478-058-600,Patent Application,no,3,1,14,14,0,A61K31/395;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61P31/04;;A61K47/6889;;A61K47/6809;;A61K47/6835;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K31/395;;A61K31/4468;;A61K31/496;;A61K39/40;;A61K47/6803;;A61K47/6809;;A61K47/6835;;A61K47/6889;;A61P31/04;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/6809;;A61K31/4468;;A61K31/496;;A61K39/40,A61K47/68;;A61K31/395;;A61P31/04,,0,0,,,,DISCONTINUED
617,US,B2,US 8506477 B2,088-424-262-775-853,2013-08-13,2013,US 88821607 A,2007-07-31,US 88821607 A;;US 83477606 P,2006-08-01,System and method for endoscopic treatment of tissue,"An improved ligating system with a ligating barrel having an adjustable diameter for use with endoscopes of varying sizes is disclosed. The adjustable diameter may be provided by a collet, a flexible helical band, a plurality of screws, or a tapered elastomeric section.",WALLER DAVID F;;BROWN HILBERT D;;CHILTON PATRICIA J;;HARDIN DAVID M;;INGRAM KIMBERLY K;;KENNEDY II KENNETH C;;SURTI VIHAR C;;YOUNT MARCIE G;;COOK MEDICAL TECHNOLOGIES LLC,WALLER DAVID F;;BROWN HILBERT D;;CHILTON PATRICIA J;;HARDIN DAVID M;;INGRAM KIMBERLY K;;KENNEDY II KENNETH C;;SURTI VIHAR C;;YOUNT MARCIE G,COOK MEDICAL TECHNOLOGIES LLC (2013-06-25),https://lens.org/088-424-262-775-853,Granted Patent,yes,29,13,11,11,0,A61B17/12013;;A61B2017/12018;;A61B2017/00296;;A61B17/12013;;A61B2017/12018;;A61B2017/00296,A61B1/04;;A61B1/00,600/127;;600/104;;600/129,0,0,,,,ACTIVE
618,CA,A1,CA 2659326 A1,103-378-486-136-804,2008-02-07,2008,CA 2659326 A,2007-07-31,US 83477606 P;;US 2007/0017086 W,2006-08-01,IMPROVED SYSTEM AND METHOD FOR ENDOSCOPIC TREATMENT OF TISSUE,"An improved Iigating system with a Iigating barrel having an adjustable d iameter for use with endoscopes of varying sizes is disclosed. The adjustabl e diameter may be provided by a collet, a flexible helical band, a plurality of screws, or a tapered elastomeric section.",WILSON COOK MEDICAL INC,SURTI VIHAR C;;CHILTON PATRICIA J;;INGRAM KIMBERLY K;;WALLER DAVID F;;YOUNT MARCIE G;;KENNEDY KENNETH C II;;BROWN HILBERT D;;HARDIN DAVID M,,https://lens.org/103-378-486-136-804,Patent Application,no,0,0,11,11,0,A61B17/12013;;A61B2017/12018;;A61B2017/00296;;A61B17/12013;;A61B2017/12018;;A61B2017/00296,A61B17/12,,0,0,,,,ACTIVE
619,AU,A1,AU 2007/281567 A1,136-091-065-032-790,2008-02-07,2008,AU 2007/281567 A,2007-07-31,US 83477606 P;;US 2007/0017086 W,2006-08-01,Improved system and method for endoscopic treatment of tissue,,WILSON COOK MEDICAL INC,HARDIN DAVID M;;CHILTON PATRICIA J;;SURTI VIHAR C;;INGRAM KIMBERLY K;;BROWN HILBERT D;;YOUNT MARCIE G;;WALLER DAVID F;;KENNEDY KENNETH C II,COOK MEDICAL TECHNOLOGIES LLC (2012-08-23),https://lens.org/136-091-065-032-790,Patent Application,no,0,0,11,11,0,A61B17/12013;;A61B2017/12018;;A61B2017/00296;;A61B17/12013;;A61B2017/12018;;A61B2017/00296,A61B17/12,,0,0,,,,INACTIVE
620,HK,A1,HK 1244230 A1,163-168-762-884-851,2018-08-03,2018,HK 18103816 A,2018-03-19,US 201462087213 P;;US 2015/0063515 W,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,,HOFFMANN LA ROCHE,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XIA YI;;XU MIN,,https://lens.org/163-168-762-884-851,Patent Application,no,0,0,14,14,0,A61K47/6889;;A61K47/6835;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21,A61K/;;A61P/,,0,0,,,,PENDING
621,BR,A2,BR 112017011478 A2,083-243-855-354-697,2018-02-27,2018,BR 112017011478 A,2015-12-02,US 2015/0063515 W;;US 201462087213 P,2014-12-03,"composto de conjugado anticorpo-antibiótico, conjugado anticorpo-antibiótico, composição farmacêutica, métodos de tratamento de uma infecção bacteriana e para exterminar staph aureus, processo para a preparação do composto, kit e intermediário antibiótico-ligante",a invenção proporciona conjugados antibióticos de anticorpo rf1 e métodos de utilização dos mesmos.,GENENTECH INC,BINQING WEI;;ERIC BROWN;;ISIDRO HOTZEL;;KIMBERLY KAJIHARA;;LEANNA STABEN;;MIN XU;;SANJEEV MARIATHASAN;;SOPHIE M LEHAR;;THOMAS PILLOW;;VISHAL VERMA;;WOUTER HAZENBOS;;YI XIA,,https://lens.org/083-243-855-354-697,Patent Application,no,0,0,14,14,0,A61K47/6889;;A61K47/6835;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21,,,0,0,,,,DISCONTINUED
622,MX,A,MX 2017007231 A,197-432-140-483-766,2017-11-08,2017,MX 2017007231 A,2015-12-02,US 201462087213 P;;US 2015/0063515 W,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF.,The invention provides rF1 antibody antibiotic conjugates and methods of using same.,GENENTECH INC,YI XIA;;ISIDRO HOTZEL;;ERIC BROWN;;WOUTER HAZENBOS;;VISHAL VERMA;;BINQING WEI;;LEANNA STABEN;;THOMAS PILLOW;;MIN XU;;KIMBERLY KAJIHARA;;SANJEEV MARIATHASAN;;SOPHIE M LEHAR,,https://lens.org/197-432-140-483-766,Patent Application,no,0,0,14,14,0,A61K47/6889;;A61K47/6835;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21,A61K47/50;;A61K47/00;;A61K47/64,,0,0,,,,PENDING
623,EP,B1,EP 2073725 B1,073-128-798-240-477,2015-05-06,2015,EP 07836355 A,2007-07-31,US 2007/0017086 W;;US 83477606 P,2006-08-01,IMPROVED SYSTEM AND METHOD FOR ENDOSCOPIC TREATMENT OF TISSUE,,COOK MEDICAL TECHNOLOGIES LLC,SURTI VIHAR C;;INGRAM KIMBERLY K;;YOUNT MARCIE G;;HARDIN DAVID M;;BROWN HILBERT D;;KENNEDY KENNETH C II;;WALLER DAVID F;;CHILTON PATRICIA J,COOK MEDICAL TECHNOLOGIES LLC (2012-01-25),https://lens.org/073-128-798-240-477,Granted Patent,yes,7,0,11,11,0,A61B17/12013;;A61B2017/12018;;A61B2017/00296;;A61B17/12013;;A61B2017/12018;;A61B2017/00296,A61B17/12,,0,0,,,,INACTIVE
624,US,A1,US 2008/0108874 A1,131-125-893-421-493,2008-05-08,2008,US 88821607 A,2007-07-31,US 88821607 A;;US 83477606 P,2006-08-01,System and method for endoscopic treatment of tissue,"An improved ligating system with a ligating barrel having an adjustable diameter for use with endoscopes of varying sizes is disclosed. The adjustable diameter may be provided by a collet, a flexible helical band, a plurality of screws, or a tapered elastomeric section.",WALLER DAVID F;;BROWN HILBERT D;;CHILTON PATRICIA J;;HARDIN DAVID M;;INGRAM KIMBERLY K;;KENNEDY KENNETH C II;;SURTI VIHAR C;;YOUNT MARCIE G,WALLER DAVID F;;BROWN HILBERT D;;CHILTON PATRICIA J;;HARDIN DAVID M;;INGRAM KIMBERLY K;;KENNEDY KENNETH C II;;SURTI VIHAR C;;YOUNT MARCIE G,COOK MEDICAL TECHNOLOGIES LLC (2013-06-25),https://lens.org/131-125-893-421-493,Patent Application,yes,21,8,11,11,0,A61B17/12013;;A61B2017/12018;;A61B2017/00296;;A61B17/12013;;A61B2017/12018;;A61B2017/00296,A61B1/06;;A61B1/00;;A61B17/10,600/178;;600/127;;606/140,0,0,,,,ACTIVE
625,US,A1,US 2018/0125995 A1,147-166-565-393-157,2018-05-10,2018,US 201715612193 A,2017-06-02,US 201715612193 A;;US 2015/0063515 W;;US 201462087213 P,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,The invention provides rF1 antibody antibiotic conjugates and methods of using same.,GENENTECH INC,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XIA YI;;XU MIN,,https://lens.org/147-166-565-393-157,Patent Application,yes,4,2,14,14,28,A61K47/6889;;A61K47/6835;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21,A61K47/68;;A61K31/5383;;A61K45/06;;A61P31/04;;C07K16/12,,3,2,047-940-327-709-894;;082-596-938-068-845,7796805;;10.1002/j.1460-2075.1995.tb07278.x;;pmc398397;;10.4049/jimmunol.152.1.146;;8254187,"Chen et al, (The EMBO Journal, 14(12):2784-2794, 1995).;;Kussie et al (Journal of Immunology, 152:146-152, 1994;;Bendig (Methods: A Companion to Methods in Enzymology 1995; 8:83-93)",DISCONTINUED
626,CN,A,CN 107249642 A,060-989-890-311-373,2017-10-13,2017,CN 201580075250 A,2015-12-02,US 201462087213 P;;US 2015/0063515 W,2014-12-03,Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereof,The invention provides rF1 antibody antibiotic conjugates and methods of using same.,HOFFMANN LA ROCHE,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XIA YI;;XU MIN,,https://lens.org/060-989-890-311-373,Patent Application,no,3,2,14,14,0,A61K47/6889;;A61K47/6835;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21,A61K47/68;;A61K31/395;;A61P31/04,,0,0,,,,DISCONTINUED
627,WO,A9,WO 2016/090040 A9,103-365-770-788-049,2017-06-29,2017,US 2015/0063515 W,2015-12-02,US 201462087213 P,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,The invention provides rF1 antibody antibiotic conjugates and methods of using same.,GENENTECH INC;;HOFFMANN LA ROCHE,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XIA YI;;XU MIN,,https://lens.org/103-365-770-788-049,Search Report,yes,0,0,14,14,0,A61K47/6889;;A61K47/6835;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21,A61K47/48,,0,0,,,,PENDING
628,EP,A2,EP 2073725 A2,120-285-941-727-088,2009-07-01,2009,EP 07836355 A,2007-07-31,US 2007/0017086 W;;US 83477606 P,2006-08-01,IMPROVED SYSTEM AND METHOD FOR ENDOSCOPIC TREATMENT OF TISSUE,,WILSON COOK MEDICAL INC,SURTI VIHAR C;;INGRAM KIMBERLY K;;YOUNT MARCIE G;;HARDIN DAVID M;;BROWN HILBERT D;;KENNEDY KENNETH C II;;WALLER DAVID F;;CHILTON PATRICIA J,COOK MEDICAL TECHNOLOGIES LLC (2012-01-25),https://lens.org/120-285-941-727-088,Patent Application,yes,0,2,11,11,0,A61B17/12013;;A61B2017/12018;;A61B2017/00296;;A61B17/12013;;A61B2017/12018;;A61B2017/00296,A61B17/12,,0,0,,,,INACTIVE
629,EP,A1,EP 3226908 A1,101-136-057-240-836,2017-10-11,2017,EP 15816304 A,2015-12-02,US 201462087213 P;;US 2015/0063515 W,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,,HOFFMANN LA ROCHE,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XIA YI;;XU MIN,,https://lens.org/101-136-057-240-836,Patent Application,yes,0,0,14,14,0,A61K47/6889;;A61K47/6835;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21,A61K47/50,,0,0,,,,PENDING
630,WO,A2,WO 2008/016592 A2,102-645-027-480-38X,2008-02-07,2008,US 2007/0017086 W,2007-07-31,US 83477606 P,2006-08-01,IMPROVED SYSTEM AND METHOD FOR ENDOSCOPIC TREATMENT OF TISSUE,"An improved Iigating system with a Iigating barrel having an adjustable diameter for use with endoscopes of varying sizes is disclosed. The adjustable diameter may be provided by a collet, a flexible helical band, a plurality of screws, or a tapered elastomeric section.",WILSON COOK MEDICAL INC;;SURTI VIHAR C;;INGRAM KIMBERLY K;;YOUNT MARCIE G;;HARDIN DAVID M;;BROWN HILBERT D;;KENNEDY KENNETH C II;;WALLER DAVID F;;CHILTON PATRICIA J,SURTI VIHAR C;;INGRAM KIMBERLY K;;YOUNT MARCIE G;;HARDIN DAVID M;;BROWN HILBERT D;;KENNEDY KENNETH C II;;WALLER DAVID F;;CHILTON PATRICIA J,,https://lens.org/102-645-027-480-38X,Patent Application,yes,0,12,11,11,0,A61B17/12013;;A61B2017/12018;;A61B2017/00296;;A61B17/12013;;A61B2017/12018;;A61B2017/00296,A61B17/12,,0,0,,,,PENDING
631,CA,C,CA 2659326 C,022-013-319-985-114,2011-02-15,2011,CA 2659326 A,2007-07-31,US 83477606 P;;US 2007/0017086 W,2006-08-01,IMPROVED SYSTEM AND METHOD FOR ENDOSCOPIC TREATMENT OF TISSUE,"An improved Iigating system with a Iigating barrel having an adjustable diameter for use with endoscopes of varying sizes is disclosed. The adjustable diameter may be provided by a collet, a flexible helical band, a plurality of screws, or a tapered elastomeric section.",WILSON COOK MEDICAL INC,SURTI VIHAR C;;INGRAM KIMBERLY K;;YOUNT MARCIE G;;HARDIN DAVID M;;BROWN HILBERT D;;KENNEDY KENNETH C II;;WALLER DAVID F;;CHILTON PATRICIA J,,https://lens.org/022-013-319-985-114,Granted Patent,no,0,0,11,11,0,A61B17/12013;;A61B2017/12018;;A61B2017/00296;;A61B17/12013;;A61B2017/12018;;A61B2017/00296,A61B17/12,,0,0,,,,ACTIVE
632,WO,A3,WO 2008/016592 A3,011-544-256-832-279,2008-04-03,2008,US 2007/0017086 W,2007-07-31,US 83477606 P,2006-08-01,IMPROVED SYSTEM AND METHOD FOR ENDOSCOPIC TREATMENT OF TISSUE,"An improved Iigating system with a Iigating barrel having an adjustable diameter for use with endoscopes of varying sizes is disclosed. The adjustable diameter may be provided by a collet, a flexible helical band, a plurality of screws, or a tapered elastomeric section.",WILSON COOK MEDICAL INC;;SURTI VIHAR C;;INGRAM KIMBERLY K;;YOUNT MARCIE G;;HARDIN DAVID M;;BROWN HILBERT D;;KENNEDY KENNETH C II;;WALLER DAVID F;;CHILTON PATRICIA J,SURTI VIHAR C;;INGRAM KIMBERLY K;;YOUNT MARCIE G;;HARDIN DAVID M;;BROWN HILBERT D;;KENNEDY KENNETH C II;;WALLER DAVID F;;CHILTON PATRICIA J,,https://lens.org/011-544-256-832-279,Search Report,yes,3,0,11,11,0,A61B17/12013;;A61B2017/12018;;A61B2017/00296;;A61B17/12013;;A61B2017/12018;;A61B2017/00296,A61B17/12,,0,0,,,,PENDING
633,AU,B2,AU 2007/281567 B2,063-469-399-254-479,2012-11-15,2012,AU 2007/281567 A,2007-07-31,US 83477606 P;;US 2007/0017086 W,2006-08-01,Improved system and method for endoscopic treatment of tissue,"An improved Iigating system with a Iigating barrel having an adjustable diameter for use with endoscopes of varying sizes is disclosed. The adjustable diameter may be provided by a collet, a flexible helical band, a plurality of screws, or a tapered elastomeric section.",COOK MEDICAL TECHNOLOGIES LLC,KENNEDY II KENNETH C;;SURTI VIHAR C;;BROWN HILBERT D;;CHILTON PATRICIA J;;YOUNT MARCIE G;;INGRAM KIMBERLY K;;WALLER DAVID F;;HARDIN DAVID M,COOK MEDICAL TECHNOLOGIES LLC (2012-08-23),https://lens.org/063-469-399-254-479,Granted Patent,no,2,0,11,11,0,A61B17/12013;;A61B2017/12018;;A61B2017/00296;;A61B17/12013;;A61B2017/12018;;A61B2017/00296,A61B17/12,,0,0,,,,INACTIVE
634,KR,A,KR 20170086542 A,073-459-011-992-859,2017-07-26,2017,KR 20177015225 A,2015-12-02,US 201462087213 P;;US 2015/0063515 W,2014-12-03,- ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,본 발명은 rF1 항체 항생제 콘주게이트 및 이를 사용하는 방법을 제공한다.,GENENTECH INC,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XIA YI;;XU MIN,,https://lens.org/073-459-011-992-859,Patent Application,no,0,0,14,14,0,A61K47/6889;;A61K47/6835;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21,A61K47/50;;A61K31/395,,0,0,,,,PENDING
635,CA,A1,CA 2966211 A1,190-569-463-155-241,2016-06-09,2016,CA 2966211 A,2015-12-02,US 201462087213 P;;US 2015/0063515 W,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,The invention provides rF1 antibody antibiotic conjugates and methods of using same.,GENENTECH INC,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XIA YI;;XU MIN,,https://lens.org/190-569-463-155-241,Patent Application,no,0,0,14,14,28,A61K47/6889;;A61K47/6835;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21,C07K16/12;;C07K16/00;;C07K16/44,,0,0,,,,DISCONTINUED
636,WO,A1,WO 2016/090040 A1,114-037-242-825-113,2016-06-09,2016,US 2015/0063515 W,2015-12-02,US 201462087213 P,2014-12-03,ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF,The invention provides rF1 antibody antibiotic conjugates and methods of using same.,GENENTECH INC;;HOFFMANN LA ROCHE,BROWN ERIC;;HAZENBOS WOUTER;;HOTZEL ISIDRO;;KAJIHARA KIMBERLY;;LEHAR SOPHIE M;;MARIATHASAN SANJEEV;;PILLOW THOMAS;;STABEN LEANNA;;VERMA VISHAL;;WEI BINQING;;XIA YI;;XU MIN,,https://lens.org/114-037-242-825-113,Patent Application,yes,75,11,14,14,28,A61K47/6889;;A61K47/6835;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K47/6889;;A61K47/6803;;A61K47/6835;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61P31/04;;A61K31/5383;;A61K45/06;;C07K16/1271;;C07K2317/21,A61K47/48,,141,88,002-515-588-243-244;;013-556-010-103-237;;026-795-551-710-945;;020-645-047-874-076;;007-954-335-176-131;;031-626-846-075-129;;063-010-577-510-617;;006-595-189-352-126;;131-416-911-051-810;;005-191-254-952-375;;053-831-356-798-94X;;073-953-289-633-23X;;072-784-835-278-714;;031-095-043-325-307;;017-513-564-354-260;;012-353-409-475-976;;004-256-930-202-106;;005-522-690-579-734;;053-740-822-676-285;;030-790-931-421-530;;092-890-446-683-93X;;046-783-448-716-481;;083-071-649-888-913;;016-716-200-807-517;;023-115-865-713-224;;108-567-706-608-928;;015-239-659-590-870;;045-556-293-127-132;;050-959-366-576-084;;011-174-345-245-142;;049-134-753-209-354;;095-334-545-560-259;;068-264-897-850-380;;104-214-218-664-008;;072-509-376-457-062;;010-488-381-022-259;;156-501-805-490-709;;008-274-774-541-556;;027-781-613-832-489;;070-280-057-407-994;;012-268-510-926-843;;037-445-639-149-821;;009-275-403-380-31X;;002-490-451-363-036;;001-779-867-387-972;;044-522-255-085-902;;040-912-152-710-03X;;029-806-225-784-498;;011-496-944-971-738;;012-586-088-349-473;;030-790-931-421-530;;056-856-992-620-755;;071-507-202-086-016;;105-585-673-955-762;;021-880-031-964-84X;;047-094-213-620-162;;031-120-105-336-16X;;120-079-078-809-391;;105-030-562-969-986;;039-841-667-603-953;;061-295-123-907-192;;023-607-007-385-464;;066-617-857-912-127;;072-389-563-856-866;;023-343-819-824-657;;068-257-624-898-885;;116-075-018-919-051;;023-115-865-713-224;;060-265-896-490-751;;095-843-764-156-972;;113-394-540-007-150;;071-015-994-878-474;;007-103-177-089-431;;037-765-704-863-929;;012-240-302-857-981;;003-257-945-556-183;;030-928-860-626-158;;089-633-612-001-004;;015-699-154-128-071;;033-089-532-103-483;;120-309-713-911-530;;007-365-891-683-729;;038-456-792-888-743;;004-272-966-072-139;;003-338-632-019-904;;007-603-263-950-700;;087-412-910-091-181;;032-182-896-544-669,19035777;;10.1086/595011;;10.1038/nrmicro2200;;pmc2871281;;19680247;;9709046;;10.1056/nejm199808203390806;;10.1016/s0966-842x(98)01400-0;;10036727;;19525403;;pmc2747682;;10.1096/fj.09-135467;;10.1099/00221287-146-7-1535;;10878118;;9350863;;10.1046/j.1365-2958.1997.5291896.x;;20598637;;10.1016/j.coph.2010.06.006;;10.1038/nrmicro2508;;21297670;;14907971;;10.1084/jem.95.2.209;;pmc2212057;;10725730;;10.4049/jimmunol.164.7.3713;;13664874;;pmc2136963;;10.1084/jem.110.1.123;;pmc2730847;;19604261;;10.1111/j.1365-2249.2009.03950.x;;10.3389/fcimb.2012.00043;;pmc3417557;;22919634;;pmc3395108;;21365763;;10.1002/emmm.201100123;;13319588;;10.1084/jem.103.6.713;;pmc2136597;;10.1093/cid/cir124;;21460309;;16914701;;10.1056/nejmoa053783;;20200036;;10.1093/jac/dkq050;;12556219;;10.1517/13543784.12.2.255;;20025606;;10.2174/156800909790192365;;18536555;;10.1097/ppo.0b013e318172d704;;10.1021/ar700108g;;17705444;;10.1016/j.coph.2005.04.008;;15951239;;12121142;;10.1021/bc025536j;;12728922;;10.4049/jimmunol.170.9.4854;;10.4049/jimmunol.150.3.880;;8423344;;10.1016/s1074-7613(00)00006-6;;10933393;;10.1038/363446a0;;8502296;;8784342;;10.1038/nsb0996-733;;10.1016/0022-2836(87)90412-8;;3681981;;10.1006/jmbi.1996.0548;;8876650;;10.4049/jimmunol.117.2.587;;950463;;10.1016/s0167-5699(97)01172-9;;9425738;;10.1038/nbt0797-637;;9219265;;14699147;;10.1074/jbc.c300470200;;10.1146/annurev.immunol.9.1.457;;10.1146/annurev.iy.09.040191.002325;;1910686;;9435247;;pmc18475;;10.1073/pnas.95.2.652;;11861619;;10.1146/annurev.immunol.20.103001.114744;;9107305;;10.1016/s0022-1759(97)00002-1;;15037082;;10.3410/f.1020100.229441;;10.1016/j.jmb.2004.01.007;;10.1016/0003-9861(86)90031-7;;2428310;;16609957;;10.1002/bit.20880;;17161664;;10.1016/j.jchromb.2006.11.018;;10.1006/jmbi.1999.3192;;10543973;;9377574;;10.1016/0169-409x(93)90004-n;;22208984;;10.1016/b978-0-12-416039-2.00006-9;;pmc162768;;10.1128/aac.39.7.1489;;7492091;;pmc2567451;;10.1073/pnas.0802822105;;18787125;;12556219;;10.1517/13543784.12.2.255;;10.1128/aac.38.5.1118;;8067748;;pmc188160;;11157898;;10.1093/jac/47.2.153;;10.1097/00001813-200104000-00002;;11335786;;8431020;;pmc187606;;10.1128/aac.37.1.67;;15264863;;10.1021/bc049969t;;10.1021/jo016187+;;11895404;;10.1016/s0040-4039(97)01158-1;;10.1021/jo00121a070;;8983339;;10.1021/bc950092v;;10.1016/s0960-894x(02)00361-x;;12127540;;10.1016/s0968-0896(03)00057-9;;12659762;;10.1517/13543776.15.9.1087;;10.1016/s0960-894x(99)00381-9;;10465553;;9383424;;10.1016/1074-5521(95)90272-4;;10.1021/jo00310a019;;6387121;;10.1021/jm00377a012;;12121142;;10.1021/bc025536j;;16644914;;10.1093/protein/gzl013;;10.1158/1078-0432.ccr-04-0789;;15501986;;10.1021/bc00014a008;;1325188;;10.1001/archinte.163.17.2066;;14504120;;10.1080/00365540500372846;;16338832;;17143318;;10.1038/nrmicro1557;;10.1016/s0140-6736(00)74210-3;;10.1111/j.1749-6632.2011.06330.x;;22191526;;10.1111/j.1749-6632.2011.06323.x;;22191530;;6933450;;pmc349762;;10.1073/pnas.77.7.4030;;2649959;;10.1093/clinids/11.2.213;;19223616;;pmc2681564;;10.1128/aac.01605-07;;20023635;;10.1038/nm.2071;;pmc2861345;;7690420;;pmc238040;;10.1128/jvi.67.10.6179-6191.1993;;19917746;;10.1128/aac.00886-09;;pmc2812130;;10.1038/nbt832;;12778055;;10.1038/nbt.1480;;18641636;;10.1182/blood-2009-02-205500;;19633198;;10.1016/j.jim.2007.12.011;;18230399;;10452801;;10.1006/abio.1999.4203,"BOUCHER, H.W. ET AL., CLIN INFECT DIS, vol. 48, 2009, pages 1 - 12;;CHAMBERS, HF; DELEO FR, NATURE REVIEWS MICROBIOLOGY, vol. 7, 2009, pages 629 - 641;;LOWY, F.D., NENGL J MED, vol. 339, 1998, pages 520 - 532;;FOSTER TJ; HOOK M, TRENDS MICROBIOL, vol. 6, 1998, pages 484 - 488;;CHENG AG ET AL., FASEB JOURNAL, vol. 23, 2009, pages 3393 - 3404;;MCCREA KW ET AL.: ""The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis."", MICROBIOLOGY, vol. 146, 2000, pages 1535 - 1546;;HARTFORD 0 ET AL., MOL MICROBIOL, vol. 25, 1997, pages 1065 - 1076;;HAZENBOS ET AL., PLOS PATHOGENS, vol. 9, no. 10, 2013, pages 1 - 18;;BOUCHER, H.; MILLER, L.G.; RAZONABLE, R.R., CLIN INFECT DIS, vol. 51, no. 2, 2010, pages 183 - 197;;NANNINI, E.; MURRAY, B.E.; ARIAS, C.A., CURR OPIN PHARMACOL, vol. 10, 2010, pages 516 - 521;;THWAITES, G.E.; GANT, V., NAT REV MICROBIOL, vol. 9, 2011, pages 215 - 222;;ROGERS, D.E.; TOMPSETT, R., J. EXP. MED, vol. 95, 1952, pages 209 - 230;;GRESHAM, H.D. ET AL., JLMMUNOL, vol. 164, 2000, pages 3713 - 3722;;KAPRAL, F.A.; SHAYEGANI, M.G., JEXP MED, vol. 110, 1959, pages 123 - 138;;ANWAR, S. ET AL., CLIN EXP IMMUNOL, vol. 157, 2009, pages 216 - 224;;FRAUNHOLZ, M.; SINHA, B., FRONT CELL INFECT MICROBIOL, vol. 2, 2012, pages 43;;GARZONI, C.; KELLEY, W.L, EMBO MOL MED, vol. 3, 2011, pages 115 - 117;;ROGERS, D.E., JEM, vol. 103, 1956, pages 713;;KULLAR, R.; DAVIS, S.L.; LEVINE, D.P.; RYBAK, M.J.: ""Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets"", CLINICAL INFECTIOUS DISEASES : AN OFFICIAL PUBLICATION OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA, vol. 52, 2011, pages 975 - 981;;FOWLER, V.G., JR. ET AL.: ""Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus"", THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 355, 2006, pages 653 - 665;;YOON, Y.K.; KIM, J.Y.; PARK, D.W.; SOHN, J.W.; KIM, M.J.: ""Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin"", THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 65, 2010, pages 1015 - 1018;;ROTHSTEIN, D.M. ET AL., EXPERT OPIN. INVEST. DRUGS, vol. 12, no. 2, 2003, pages 255 - 271;;TEICHER, B.A., CURR. CANCER DRUG TARGETS, vol. 9, 2009, pages 982 - 1004;;CARTER, P.J.; SENTER P.D., THE CAUCERJ., vol. 14, no. 3, 2008, pages 154 - 169;;CHARI, R.V., ACC. CHEM. RES., vol. 41, 2008, pages 98 - 107;;POLAKIS P., CURR. OPIN. PHARMACOL, vol. 5, 2005, pages 382 - 387;;SAMBROOK ET AL.: ""Molecular Cloning: A Laboratory Manual"", 2001, COLD SPRING HARBOR LABORATORY PRESS;;F.M. AUSUBEL, ET AL: ""Current Protocols in Molecular Biology"", 2003;;""Methods in Enzymology"", ACADEMIC PRESS, INC.;;HARLOW AND LANE: ""PCR 2: A Practical Approach"", 1995;;R.I. FRESHNEY: ""Antibodies, A Laboratory Manual, and Animal Cell Culture"", 1988;;""Oligonucleotide Synthesis"", 1984;;""Methods in Molecular Biology"", HUMANA PRESS;;""Cell Biology: A Laboratory Notebook"", 1998, ACADEMIC PRESS;;J.P. MATHER; P.E. ROBERTS: ""Introduction to Cell and Tissue Culture"", 1998, PLENUM PRESS;;""Cell and Tissue Culture: Laboratory Procedures"", 1993, J. WILEY AND SONS;;""Handbook ofExperimental Immunology"";;""Gene Transfer Vectors for Mammalian Cells"", 1987;;""PCR: The Polymerase Chain Reaction"", 1994;;""Current Protocols in Immunology"", 1991;;""Short Protocols in Molecular Biology"", 1999, WILEY AND SONS;;C.A. JANEWAY; P. TRAVERS, IMMUNOBIOLOGY, 1997;;P. FINCH, ANTIBODIES, 1997;;""Antibodies: A Practical Approach"", 1988, IRL PRESS;;""Monoclonal Antibodies: A Practical Approach"", 2000, OXFORD UNIVERSITY PRESS;;E. HARLOW; D. LANE: ""Using Antibodies: A Laboratory Manual"", 1999, COLD SPRING HARBOR LABORATORY PRESS;;""The Antibodies"", 1995, HARWOOD ACADEMIC PUBLISHERS;;""Cancer: Principles and Practice of Oncology"", 1993, J.B. LIPPINCOTT COMPANY;;SINGLETON ET AL.: ""Dictionary ofmicrobiology and Molecular Biology"", 1994, J. WILEY & SONS;;JANEWAY, C.; TRAVERS, P.; WALPORT, M.; SHLOMCHIK: ""Immunobiology"", 2001, GARLAND PUBLISHING;;DUBOWCHIK ET AL., BIOCONJ. CHEM, vol. 13, 2002, pages 855 - 869;;MCCREA KW ET AL.: ""The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis"", MICROBIOLOGY, vol. 146, 2000, pages 1535 - 1546;;MILLER ET AL., J. OF IMMUNOLOGY, vol. 170, 2003, pages 4854 - 4861;;JANEWAY, C.; TRAVERS, P.; WALPORT, M.; SHLOMCHIK: ""Immuno Biology"", 2001, GARLAND PUBLISHING;;KINDT ET AL.: ""Kuby Immunology"", 2007, W.H. FREEMAN AND CO., pages: 91;;PORTOLANO ET AL., J. IMMUNOL., vol. 150, 1993, pages 880 - 887;;CLARKSON ET AL., NATURE, vol. 352, 1991, pages 624 - 628;;XU ET AL., IMMUNITY, vol. 13, 2000, pages 37 - 45;;JOHNSON; WU: ""Methods in Molecular Biology"", vol. 248, 2003, HUMAN PRESS, pages: 1 - 25;;HAMERS-CASTERMAN ET AL., NATURE, vol. 363, 1993, pages 446 - 448;;SHERIFF ET AL., NATURE STRUCT. BIOL, vol. 3, 1996, pages 733 - 736;;KABAT ET AL.: ""Sequences of Proteins of Immunological Interest"", 1991, NATIONAL INSTITUTES OF HEALTH;;CHOTHIA; LESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917;;MACCALLUM ET AL., J. MOL. BIOL., vol. 262, 1996, pages 732 - 745;;KABAT ET AL.: ""Sequences of Proteins of Immunological Interest"", vol. 1-3, 1991, NIH PUBLICATION 91-3242;;GUYER ET AL., J. IMMUNOL., vol. 117, 1976, pages 587;;KIM ET AL., J. IMMUNOL., vol. 24, 1994, pages 249;;GHETIE; WARD, IMMUNOL. TODAY, vol. 18, no. 12, 1997, pages 592 - 8;;GHETIE ET AL., NATURE BIOTECHNOLOGY, vol. 15, no. 7, 1997, pages 637 - 40;;HINTON ET AL., J. BIOL. CHEM, vol. 279, no. 8, 2004, pages 6213 - 6;;SHIELDS ET AL., J. BIOL. CHEM., vol. 9, no. 2, 2001, pages 6591 - 6604;;RAVETCH; KINET, ANNU. REV. IMMUNOL., vol. 9, 1991, pages 457 - 92;;CLYNES ET AL., PNAS USA, vol. 95, 1998, pages 652 - 656;;D. UNDERHILL; A OZINSKY, ANNUAL REVIEW OF IMMUNOLOGY, vol. 20, no. 825, 2002;;GAZZANO-SANTORO ET AL., J. IMMUNOL. METHODS, vol. 202, 1996, pages 163;;WRIGHT ET AL., TIBTECH, vol. 15, 1997, pages 26 - 32;;OKAZAKI ET AL., J. MOL. BIOL., vol. 336, 2004, pages 1239 - 1249;;YAMANE-OHNUKI ET AL., BIOTECH. BIOENG., vol. 87, 2004, pages 614;;RIPKA ET AL., ARCH. BIOCHEM. BIOPHYS, vol. 249, 1986, pages 533 - 545;;KANDA, Y. ET AL., BIOTECHNOL. BIOENG., vol. 94, no. 4, 2006, pages 680 - 688;;FLATMAN ET AL., J. CHROMATOGR. B, vol. 848, 2007, pages 79 - 87;;CHEN ET AL., J. MOL. BIOL., vol. 293, 1999, pages 865 - 881;;PRESTA ET AL., CANCER RES., vol. 57, 1997, pages 4593 - 4599;;PAQUETTE, LEO A.: ""Principles of Modern Heterocyclic Chemistry"", 1968, W.A. BENJAMIN;;""The Chemistry of Heterocyclic Compounds, A series of Monographs"", vol. 13,14,16, 1950, JOHN WILEY & SONS;;J. AM. CHEM. SOC., vol. 82, 1960, pages 5566;;""Peptide and Protein Drug Delivery"", 1991, MARCEL DEKKER, INC, pages: 247 - 301;;JONES, A., ADV. DRUG DELIVERY REV., vol. 10, 1993, pages 29 - 90;;""McGraw-Hill Dictionary of Chemical Terms"", 1984, MCGRAW-HILL BOOK COMPANY;;ELIEL, E.; WILEN, S.: ""Stereochemistry of Organic Compounds"", 1994, JOHN WILEY & SONS, INC.;;T. W. GREENE: ""Protective Groups in Organic Synthesis"", 1991, JOHN WILEY & SONS;;LYON, R. ET AL., METHODS IN ENZYM, vol. 502, 2012, pages 123 - 138;;FUJII ET AL., ANTIMICROB. AGENTS CHEMOTHER, vol. 39, 1995, pages 1489 - 1492;;FEKLISTOV ET AL., PROC NATL ACAD SCI USA, vol. 105, no. 39, 2008, pages 14820 - 14825;;ROTHSTEIN ET AL., EXPERT OPIN. INVESTIG. DRUGS, vol. 12, no. 2, 2003, pages 255 - 271;;FUJII ET AL., ANTIMICROB. AGENTS CHEMOTHER, vol. 38, 1994, pages 1118 - 1122;;WICHELHAUS ET AL., J. ANTIMICROB. CHEMOTHER., vol. 47, 2001, pages 153 - 156;;SELIGSON ET AL., ANTI-CANCER DRUGS, vol. 12, 2001, pages 305 - 13;;CHEM. PHARM. BULL., vol. 41, 1993, pages 148;;TOMIOKA ET AL., ANTIMICROB. AGENTS CHEMOTHER., vol. 37, 1993, pages 67;;KLUSSMAN ET AL., BIOCONJUGATE CHEMISTRY, vol. 15, no. 4, 2004, pages 765 - 773;;TOKI ET AL., J. ORG. CHEM., vol. 67, 2002, pages 1866 - 1872;;DUBOWCHIK ET AL., TETRAHEDRON LETTERS, vol. 38, 1997, pages 5257 - 60;;WALKER, M.A., J. ORG. CHEM., vol. 60, 1995, pages 5352 - 5355;;FRISCH ET AL., BIOCONJUGATE CHEM, vol. 7, 1996, pages 180 - 186;;SUN ET AL., BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 12, 2002, pages 2213 - 2215;;SUN ET AL., BIOORGANIC & MEDICINAL CHEMISTRY, vol. 11, 2003, pages 1761 - 1768;;HAMANN ET AL., EXPERT OPIN. THER. PATENTS, vol. 15, 2005, pages 1087 - 1103;;HAY ET AL., BIOORG. MED. CHEM. LETT., vol. 9, 1999, pages 2237;;RODRIGUES ET AL., CHEMISTRY BIOLOGY, vol. 2, 1995, pages 223;;STORM ET AL., J. AMER. CHEM. SOC., vol. 94, 1972, pages 5815;;AMSBERRY ET AL., J. ORG. CHEM., vol. 55, 1990, pages 5867;;KINGSBURY ET AL., J. MED. CHEM., vol. 27, 1984, pages 1447;;DUBOWCHIK ET AL., BIOCONJUGATE CHEM, vol. 13, no. 4, 2002, pages 855 - 869;;MCDONAGH ET AL., PROT. ENGR. DESIGN & SELECTION, vol. 19, no. 7, 2006, pages 299 - 307;;HAMBLETT ET AL., CLIN. CANCER RES., vol. 10, 2004, pages 7063 - 7070;;HAMBLETT, K.J. ET AL.: ""Effect of drug loading on the pharmacology, pharmacokinetics, and toxicity of an anti-CD30 antibody-drug conjugate"", ABSTRACT NO. 624, AMERICAN ASSOCIATION FOR CANCER RESEARCH, 2004 ANNUAL MEETING, vol. 45, 27 March 2004 (2004-03-27);;ALLEY, S.C. ET AL.: ""Controlling the location of drug attachment in antibody-drug conjugates"", ABSTRACT NO. 627, AMERICAN ASSOCIATION FOR CANCER RESEARCH, 2004 ANNUAL MEETING, vol. 45, 27 March 2004 (2004-03-27);;GEOGHEGAN; STROH, BIOCONJUGATE CHEM, vol. 3, 1992, pages 138 - 146;;FOWLER ET AL., ARCH. INTERN. MED, vol. 163, 2003, pages 2066 - 2072;;KHATIB ET AL., SCAND. J. INFECT. DIS., vol. 38, 2006, pages 7 - 14;;LEWIS K: ""Persister cells, dormancy and infectious disease"", NATURE REVIEWS MICROBIOLOGY, vol. 5, no. 1, 2007, pages 48 - 56, XP009164216, DOI: doi:10.1038/nrmicro1557;;BIGGER JW: ""Treatment of staphylococcal infections with penicillin by intermittent sterilization"", LANCET, vol. 244, no. 6320, 14 October 1944 (1944-10-14), pages 497 - 500;;SHAW, K.; BARBACHYN, M., ANN. N.Y. ACAD. SCI, vol. 1241, 2011, pages 48 - 70;;SUTCLIFFE, J., ANN. N.Y. ACAD. SCI, vol. 1241, 2011, pages 122 - 152;;""Remington's Pharmaceutical Sciences"", 1980;;EPSTEIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 3688;;HWANG ET AL., PROC. NATL ACAD. SCI. USA, vol. 77, 1980, pages 4030;;ANDRE BRYSKIER: ""Antimicrobial Agents"", 2005, ASM PRESS;;VANDENBROEK, P.V.: ""Antimicrobial Drugs, Microorganisms, and Phagocytes"", REVIEWS OF INFECTIOUS DISEASES, vol. 11, 1989, pages 213 - 245;;SANDBERG, A.; HESSLER, J.H.; SKOV, R.L.; BLOM, J.; FRIMODT-MOLLER, N.: ""Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model"", ANTIMICROB AGENTS CHEMOTHER, vol. 53, 2009, pages 1874 - 1883;;KWAKKENBOS MJ ET AL., NAT MED, vol. 16, 2010, pages 123 - 128;;HAZENBOS ET AL., PLOS PATHOGENS, vol. 9, no. 10, pages 1 - 18;;NAKAMURA GR ET AL., J VIROL, vol. 67, 1993, pages 6179 - 6191;;TATTEVIN P ET AL., ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 54, 2010, pages 610 - 613;;DORONINA ET AL., NAT. BIOTECHNOL., vol. 21, 2003, pages 778 - 784;;THIOMABS - JUNUTULA ET AL., NATURE BIOTECH., vol. 26, no. 8, 2008, pages 925 - 932;;DORNAN ET AL., BLOOD, vol. 114, no. 13, 2009, pages 2721 - 2729;;SHEN ET AL., NATURE BIOTECH., vol. 30, no. 2, 2012, pages 184 - 191;;JUNUTULA ET AL., JOUR OF IMMUN. METHODS, vol. 332, 2008, pages 41 - 52;;GETZ ET AL., ANAL. BIOCHEM., vol. 273, 1999, pages 73 - 80",PENDING
637,HK,A1,HK 1222418 A1,175-645-490-762-272,2017-06-30,2017,HK 16110533 A,2016-09-05,EP 09165558 A;;US 22587809 P,2009-07-15,GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS,,AIMM THERAPEUTICS BV,BEAUMONT TIM T;;KWAKKENBOS MARK JEROEN MJ;;BROWN ERIC J EJ;;MORISAKI JOHN HIROSHI JH;;HAZENBOS WOUTER L W WLW;;MARIATHASAN SANJEEV S;;KAJIHARA KIMBERLY K;;XIA YI Y,,https://lens.org/175-645-490-762-272,Patent Application,no,0,0,63,65,0,C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;A61P31/00;;A61P31/04;;A61P37/04;;A61P37/06;;C07K16/1278;;C07K2317/21;;C07K2317/52;;C07K2317/56;;C07K2317/565;;C07K16/1271;;C07K2317/567;;G01N33/5091;;G01N33/6854;;G01N33/6893;;G01N2469/10;;G01N2800/26,C12Q/;;A61K/;;A61P/;;G01N/,,0,0,,,,PENDING
638,US,B2,US 9321220 B2,105-378-265-490-079,2016-04-26,2016,US 75933310 A,2010-04-13,US 75933310 A,2010-04-13,Automated bias-ply preparation device and process,"A material preparation device is provided. The material preparation device includes a bias-ply assembly, a feedstock assembly and an application head. The bias-ply assembly is configured to pass a bias-ply backing material along a first path. The feedstock assembly is configured to pass a feedstock along a second path that crosses the first path at a select angle. The feedstock includes resin pre-impregnated fiber reinforced material (pre-preg) having the fibers at a first orientation relative to an edge of the feedstock. The application head is configured to transfer the pre-preg from the feedstock to the bias-ply backing material at a location where the first path crosses the second path to form a bias-ply with the fibers of the pre-preg having a second different orientation relative to an edge of the formed bias-ply.",SLACK JASON;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM;;ORBITAL ATK INC,SLACK JASON;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,ACCUDYNE SYSTEMS INC (2010-04-12);;NORTHROP GRUMMAN INNOVATION SYSTEMS LLC (2020-07-31);;NORTHROP GRUMMAN SYSTEMS CORPORATION (2021-01-11),https://lens.org/105-378-265-490-079,Granted Patent,yes,34,2,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B32B41/00;;B29C70/20;;B29C70/22;;B29C70/38;;B29C70/50;;B29C70/54;;B29K105/24,,9,1,000-021-273-043-974,10.1023/a:1022817909276,"Accudyne Systems, Inc. ""Three New Composite Machines"". [online] [retrieved on Mar. 23, 2010] retrieved at .;;European Communication: Partial European Search Report for European Patent Application EP10189022.6, mailed Aug. 18, 2011.;;U.S. Appl. No. 12/701,126, filed Feb. 5, 2010, Turner.;;Translation of Office Action from Japanese Patent Application No. 2010-266467, mailed Oct. 24, 2012, 4 pages.;;Japanese Decision of Rejection for Japanese Patent Application No. 2010-266467 mailed Jul. 29, 2013, 5 pages.;;Strobel, Market al., A Comparison of Corona-Treated and Flame-Treated Polypropylene Films. Plasmas and Polymers, vol. 8, No. 1 (Mar. 2003), pp. 61-95.;;Zander, Nicole et al., Oxidation of Polyethylene: A Comparison of Plasma and Ultraviolet Ozone Processing Techniques. Army Research Laboratory, Aberdeen Proving Ground, MD 21005-5069, ARL-TR-4701 (Jan. 2009), 21 pages.;;Office Action for Japanese Patent Application No. 2013-223432, issued Aug. 3, 2015, 10 pages.;;Author Omitted; ""Comments of Third Party""; Japanese Patent Application No. 2013-223432; received by the Esquire Commissioner of the Japanese Patent Office on Dec. 23, 2015; 8 pages.",ACTIVE
639,DK,T3,DK 2377673 T3,166-884-965-529-581,2016-03-14,2016,DK 10189022 T,2010-10-27,US 75933310 A,2010-04-13,Fremgangsmåde til fremstilling af et diagonallag,,ORBITAL ATK INC,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,,https://lens.org/166-884-965-529-581,Granted Patent,no,0,0,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B29C70/20;;B29C70/22;;B29C70/38;;B29C70/50;;B29C70/54;;B29K105/24,,0,0,,,,ACTIVE
640,JP,A,JP 2014073911 A,147-024-165-831-986,2014-04-24,2014,JP 2013223432 A,2013-10-28,US 75933310 A,2010-04-13,MATERIAL PREPARATION DEVICE,"PROBLEM TO BE SOLVED: To provide automated bias-ply material preparation device and process.SOLUTION: A material preparation device 100 includes a bias-ply assembly 105, a feedstock assembly 103 and an application head 130. The bias-ply assembly 105 is configured to pass a bias-ply backing material 146 along a first path. The feedstock assembly 103 is configured to pass a feedstock along a second path that crosses the first path at a select angle. The feedstock includes resin pre-impregnated fiber reinforced material (prepreg) having the fibers at a first orientation relative to an edge of the feedstock. The application head 130 is configured to transfer the pre-preg from the feedstock to the bias-ply backing material 146 at a location where the first path crosses the second path to form a bias-ply 158 with the fibers of the pre-preg having a second different orientation relative to an edge of the formed bias-ply 158.",ALLIANT TECHSYST INC,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,,https://lens.org/147-024-165-831-986,Patent Application,no,15,1,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B65H23/185,,0,0,,,,ACTIVE
641,JP,A,JP 2011219269 A,149-875-817-611-160,2011-11-04,2011,JP 2010266467 A,2010-11-30,US 75933310 A,2010-04-13,AUTOMATED BIAS-PLY PREPARATION DEVICE AND METHOD,"PROBLEM TO BE SOLVED: To provide an automated bias-ply preparation device and a method.SOLUTION: The material preparation device 100 includes a bias-ply assembly 105, a raw-material assembly 103 and an application head 130. The bias-ply assembly 105 passes a bias-ply backing material 146 along a first path. The raw-material assembly 103 passes a raw-material along a second path that crosses the first path at a select angle. The raw-material includes a resin pre-impregnated fiber reinforced material (pre-preg) having fibers at a first orientation relative to an edge of the raw-material. The application head 130 is transfers the pre-preg from the raw-material to the bias-ply backing material 146 at a location where the first path crosses the second path to form a bias-ply 158 with the fibers of the pre-preg having a second different orientation relative to an edge of the formed bias-ply 158.",ALLIANT TECHSYST INC,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,,https://lens.org/149-875-817-611-160,Patent Application,no,6,4,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B65H37/04,,0,0,,,,PENDING
642,EP,B1,EP 2377673 B1,163-780-925-506-400,2015-12-23,2015,EP 10189022 A,2010-10-27,US 75933310 A,2010-04-13,A method of forming a bias-ply,,ORBITAL ATK INC,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,"ORBITAL ATK, INC. (2015-10-21)",https://lens.org/163-780-925-506-400,Granted Patent,yes,7,0,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B29C70/20;;B29C70/22;;B29C70/38;;B29C70/50;;B29C70/54;;B29K105/24,,0,0,,,,INACTIVE
643,US,A1,US 2019/0118496 A1,125-768-561-329-887,2019-04-25,2019,US 201816221052 A,2018-12-14,US 201816221052 A;;US 201615137832 A;;US 75933310 A,2010-04-13,MATERIAL PREPARATION DEVICE AND RELATED METHODS,Material preparation devices and related methods include a material or substrate assembly and an application assembly for applying a fiber material.,NORTHROP GRUMMAN INNOVATION SYSTEMS INC,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,NORTHROP GRUMMAN INNOVATION SYSTEMS LLC (2020-07-31);;NORTHROP GRUMMAN SYSTEMS CORPORATION (2021-01-11),https://lens.org/125-768-561-329-887,Patent Application,yes,2,3,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B29C70/54;;B29C70/20;;B29C70/22;;B29C70/38;;B29C70/50,,0,0,,,,ACTIVE
644,US,A1,US 2011/0247743 A1,113-743-423-868-448,2011-10-13,2011,US 75933310 A,2010-04-13,US 75933310 A,2010-04-13,AUTOMATED BIAS-PLY PREPARATION DEVICE AND PROCESS,"A material preparation device is provided. The material preparation device includes a bias-ply assembly, a feedstock assembly and an application head. The bias-ply assembly is configured to pass a bias-ply backing material along a first path. The feedstock assembly is configured to pass a feedstock along a second path that crosses the first path at a select angle. The feedstock includes resin pre-impregnated fiber reinforced material (pre-preg) having the fibers at a first orientation relative to an edge of the feedstock. The application head is configured to transfer the pre-preg from the feedstock to the bias-ply backing material at a location where the first path crosses the second path to form a bias-ply with the fibers of the pre-preg having a second different orientation relative to an edge of the formed bias-ply.",ALLIANT TECHSYSTEMS INC,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,ACCUDYNE SYSTEMS INC (2010-04-12);;NORTHROP GRUMMAN INNOVATION SYSTEMS LLC (2020-07-31);;NORTHROP GRUMMAN SYSTEMS CORPORATION (2021-01-11),https://lens.org/113-743-423-868-448,Patent Application,yes,2,16,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B32B37/02;;B32B38/04;;B32B38/10,156/64;;156/362;;156/360;;156/363;;156/250;;156/248,0,0,,,,ACTIVE
645,EP,A3,EP 2377673 A3,180-817-898-700-744,2012-01-04,2012,EP 10189022 A,2010-10-27,US 75933310 A,2010-04-13,Automated bias-ply preparation device and process,"A material preparation device (100) is provided. The material preparation device (100) includes a bias-ply assembly (105), a feedstock assembly and an application head (130). The bias-ply assembly (105) is configured to pass a bias-ply backing (146) material along a first path. The feedstock assembly (103) is configured to pass a feedstock (116) along a second path that crosses the first path at a select angle. The feedstock (116) includes resin pre-impregnated fiber reinforced material (pre-preg,300) having the fibers at a first orientation relative to an edge of the feedstock (116). The application head (130) is configured to transfer the pre-preg (300) from the feedstock (116) to the bias-ply backing material (146) at a location where the first path crosses the second path to form a bias-ply (158) with the fibers of the pre-preg (300) having a second different orientation relative to an edge of the formed bias-ply (158).
",ALLIANT TECHSYSTEMS INC,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,"ORBITAL ATK, INC. (2015-10-21)",https://lens.org/180-817-898-700-744,Search Report,yes,2,0,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B29C70/20;;B29C70/22;;B29C70/38;;B29C70/50,,0,0,,,,INACTIVE
646,ES,T3,ES 2558140 T3,041-874-888-248-927,2016-02-02,2016,ES 10189022 T,2010-10-27,US 75933310 A,2010-04-13,Método para formar una lona cruzada,"Un método para formar una lona cruzada (158, 640) con un dispositivo (100) de preparación de material automático, comprendiendo el método: colocar un tramo de material (146, 622) de soporte de lona cruzada, teniendo el material (146, 622) de soporte de lona cruzada una anchura seleccionada; colocar un tramo de materia prima (116) que tiene un material de soporte de materia prima y una capa de material de pre-preg reforzado, cruzando la materia prima (116) una porción seleccionada de la anchura del material (146, 622) de soporte de lona cruzada a lo largo de una primera sección del material (146, 622) de soporte de lona cruzada según un ángulo seleccionado; transferir el pre-preg (300, 660) desde el material de soporte de materia prima directamente sobre la primera sección del material (146, 622) de soporte de lona cruzada; y cortar el pre-preg (300, 660) del pre-preg (300, 660) transferido sobre la primera sección de material (146, 622) de soporte de lona cruzada sin cortar el material de soporte de materia prima con un cortador (120) automático para formar una lona cruzada (158, 640) que tiene pre-preg (300, 660) con fibras seleccionadas según una orientación seleccionada con relación a un borde de la lona cruzada (158, 640) formada.",ORBITAL ATK INC,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,,https://lens.org/041-874-888-248-927,Granted Patent,no,0,0,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B29C70/20;;B29C70/22;;B29C70/38;;B29C70/50;;B29C70/54;;B29K105/24,,0,0,,,,ACTIVE
647,US,B2,US 10155348 B2,182-051-557-966-671,2018-12-18,2018,US 201615137832 A,2016-04-25,US 201615137832 A;;US 75933310 A,2010-04-13,Material preparation device,"A material preparation device is provided. The material preparation device includes a bias-ply assembly, a feedstock assembly and an application head. The bias-ply assembly is configured to pass a bias-ply backing material along a first path. The feedstock assembly is configured to pass a feedstock along a second path that crosses the first path at a select angle. The feedstock includes resin pre-impregnated fiber-reinforced material (pre-preg) having the fibers at a first orientation relative to an edge of the feedstock. The application head is configured to transfer the pre-preg from the feedstock to the bias-ply backing material at a location where the first path crosses the second path to form a bias-ply with the fibers of the pre-preg having a second, different orientation relative to an edge of the formed bias-ply.",ORBITAL ATK INC;;NORTHROP GRUMMAN INNOVATION SYSTEMS INC,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,NORTHROP GRUMMAN INNOVATION SYSTEMS LLC (2020-07-31);;NORTHROP GRUMMAN SYSTEMS CORPORATION (2021-01-11),https://lens.org/182-051-557-966-671,Granted Patent,yes,40,0,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B32B41/00;;B29C70/20;;B29C70/22;;B29C70/38;;B29C70/50;;B29C70/54;;B29K105/24,,11,1,000-021-273-043-974,10.1023/a:1022817909276,"Author Omitted; “Comments of Third Party”; Japanese Patent Application No. 2013-223432; received by the Esquire Commissioner of the Japanese Patent Office on Dec. 23, 2015; 8 pages.;;Accudyne Systems, Inc. “Three New Composite Machines”. [online] [retrieved on Mar. 23, 2010] retrieved at <http://accudyne.com/>.;;European Communication: Partial European Search Report for European Patent Application EP10189022.6, dated Aug. 18, 2011.;;Japanese Decision of Rejection for Japanese Patent Application No. 2010-266467 dated Jul. 29, 2013, 5 pages.;;Office Action for Japanese Patent Application No. 2013-223432, dated Aug. 3, 2015, 10 pages.;;Translation of Office Action from Japanese Patent Application No. 2010-266467, dated Oct. 24, 2012, 4 pages.;;Strobel, Market Al., A Comparison of Corona-Treated and Flame-Treated Polypropylene Films. Plasmas and Polymers, vol. 8, No. 1 (Mar. 2003), pp. 61-95.;;Zander, Nicole et al., Oxidation of Polyethylene: A Comparison of Plasma and Ultraviolet Ozone Processing Techniques. Army Research Laboratory, Aberdeen Proving Ground, MD 21005-5069, ARL-TR-4701 (Jan. 2009), 21 pages.;;Notice of Opposition Enclosure “Facts and Arguments”, filed with Opposition to: European Patent No. 2 377 673 B1 of Opponent Spandern Uwe, dated Sep. 22, 2016, 15 pages.;;European Patent Office Notice of Opposition to a European Patent No. EP2377673; filed by Representative of Opponent Spandern Uwe, dated Sep. 22, 2016, 5 pages.;;Communication pursuant to Article 94(3) EPC in European Application No. 15186191.1, dated Jan. 31, 2018 (5 pages).",ACTIVE
648,EP,A2,EP 2377673 A2,014-762-019-903-840,2011-10-19,2011,EP 10189022 A,2010-10-27,US 75933310 A,2010-04-13,A method of forming a bias-ply,"A material preparation device (100) is provided. The material preparation device (100) includes a bias-ply assembly (105), a feedstock assembly and an application head (130). The bias-ply assembly (105) is configured to pass a bias-ply backing (146) material along a first path. The feedstock assembly (103) is configured to pass a feedstock (116) along a second path that crosses the first path at a select angle. The feedstock (116) includes resin pre-impregnated fiber reinforced material (pre-preg,300) having the fibers at a first orientation relative to an edge of the feedstock (116). The application head (130) is configured to transfer the pre-preg (300) from the feedstock (116) to the bias-ply backing material (146) at a location where the first path crosses the second path to form a bias-ply (158) with the fibers of the pre-preg (300) having a second different orientation relative to an edge of the formed bias-ply (158).
",ALLIANT TECHSYSTEMS INC,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,"ORBITAL ATK, INC. (2015-10-21)",https://lens.org/014-762-019-903-840,Patent Application,yes,1,15,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B29C70/20;;B29C70/22;;B29C70/38;;B29C70/50;;B29C70/54;;B29K105/24,,0,0,,,,INACTIVE
649,US,A1,US 2016/0236426 A1,080-512-098-015-56X,2016-08-18,2016,US 201615137832 A,2016-04-25,US 201615137832 A;;US 75933310 A,2010-04-13,MATERIAL PREPARATION DEVICE,"A material preparation device is provided. The material preparation device includes a bias-ply assembly, a feedstock assembly and an application head. The bias-ply assembly is configured to pass a bias-ply backing material along a first path. The feedstock assembly is configured to pass a feedstock along a second path that crosses the first path at a select angle. The feedstock includes resin pre-impregnated fiber-reinforced material (pre-preg) having the fibers at a first orientation relative to an edge of the feedstock. The application head is configured to transfer the pre-preg from the feedstock to the bias-ply backing material at a location where the first path crosses the second path to form a bias-ply with the fibers of the pre-preg having a second, different orientation relative to an edge of the formed bias-ply.",ORBITAL ATK INC,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,NORTHROP GRUMMAN INNOVATION SYSTEMS LLC (2020-07-31);;NORTHROP GRUMMAN SYSTEMS CORPORATION (2021-01-11),https://lens.org/080-512-098-015-56X,Patent Application,yes,0,3,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B29C70/54;;B29C70/50,,0,0,,,,ACTIVE
650,US,B2,US 10987882 B2,076-946-737-425-121,2021-04-27,2021,US 201816221052 A,2018-12-14,US 201816221052 A;;US 201615137832 A;;US 75933310 A,2010-04-13,Material preparation device and related methods,Material preparation devices and related methods include a material or substrate assembly and an application assembly for applying a fiber material.,NORTHROP GRUMMAN INNOVATION SYSTEMS INC;;NORTHROP GRUMMAN SYSTEMS CORP,SLACK JASON K;;MADSEN CHRISTOPHER J;;JONES DON C;;BENSON VERNON M;;TURNER PETER G;;COPE RALPH DOUGLAS;;FERRARA KIMBERLY ANN;;JOHNSON ANTHONY DALE;;CASE MICHAEL JAMES;;BROWN JESSE PAUL;;GARGEL JAMES;;COPE STEVEN ANDREW;;TARRY KYLE PUTNAM,NORTHROP GRUMMAN INNOVATION SYSTEMS LLC (2020-07-31);;NORTHROP GRUMMAN SYSTEMS CORPORATION (2021-01-11),https://lens.org/076-946-737-425-121,Granted Patent,yes,42,0,17,17,0,B29C70/545;;B29C70/545;;B29C70/20;;B29C70/20;;B29C70/22;;B29C70/22;;B29C70/38;;B29C70/38;;B29C70/50;;B29C70/50;;B29C2793/0072;;B29C2793/0072;;B29C2793/0081;;B29C2793/0081;;B29K2105/243;;B29K2105/243;;Y10T156/1052;;Y10T156/1052,B32B41/00;;B29C70/20;;B29C70/22;;B29C70/38;;B29C70/50;;B29C70/54;;B29K105/24,,14,1,000-021-273-043-974,10.1023/a:1022817909276,"Zander, Nicole et al., Oxidation of Polyethylene: A Comparison of Plasma and Ultraviolet Ozone Processing Techniques. Army Research Laboratory, Aberdeen Proving Ground, MD 21005-5069, ARL-TR-4701 (Jan. 2009), 21 pages.;;U.S. Appl. No. filed Feb. 5, 2010, Turner., U.S. Appl. No. 12/701,126.;;Translation of Office Action from Japanese Patent Application No. 2010-266467, dated Oct. 24, 2012, 4 pages.;;Strobel, Market al., A Comparison of Corona-Treated and Flame-Treated Polypropylene Films. Plasmas and Polymers, vol. 8, No. 1 (Mar. 2003), pp. 61-95.;;Office Action for Japanese Patent Application No. 2013-223432, dated Aug. 3, 2015, 10 pages.;;Notice of Opposition Enclosure “Facts and Arguments”, filed with Opposition to: European Patent No. 2 377 673 B1 of Opponent Spandem Uwe, dated Sep. 22, 2016, 15 pages.;;Japanese Decision of Rejection for Japanese Patent Application No. 2010-266467 dated Jul. 29, 2013, 5 pages.;;European Patent Office Notice of Opposition to a European Patent No. EP2377673; filed by Representative of Opponent Spandem Uwe, dated Sep. 22, 2016, 5 pages.;;European Communication: Partial European Search Report for European Patent Application EP10189022.6, dated Aug. 18, 2011.;;Communication pursuant to Article 94(3) EPC in European Application No. 15186191.1, dated Jan. 31, 2018 (5 pages).;;Author Omitted; “Comments of Third Party”; Japanese Patent Application No. 2013-223432; received by the Esquire Commissioner of the Japanese Patent Office on Dec. 23, 2015; 8 pages.;;Accudyne Systems, Inc. “Three New Composite Machines”. [online] [retrieved on Mar. 23, 2010] retrieved at <http://accudyne.com/>.;;European Communication pursuant to Article 94(3) EPC for European Application No. 15186191.1, dated Apr. 5, 2019, 5 pages.;;European Communication pursuant to Article 94(3) EPC for European Application No. 15186191.1, dated Mar. 17, 2020, 4 pages.",ACTIVE
651,US,A1,US 2023/0241876 A1,153-038-347-570-988,2023-08-03,2023,US 202118015626 A,2021-07-13,US 202118015626 A;;US 202163143169 P;;US 202063106927 P;;US 202063052123 P;;IB 2021056312 W,2020-07-15,"CONFORMABLE SHEET ARTICLES, CONSTRUCTIONS, AND METHODS OF USING THE SAME","Conformable sheet article made from paper and useful, for example, in packaging, tapes, and craft article, and methods of making and using such sheet articles are disclosed.",3M INNOVATIVE PROPERTIES COMPANY,NIRMAL MANOJ;;BROWN MARY L;;SCHULTZ KIMBERLY C M;;JOHNSON MITCHELL A F;;CORRIGAN THOMAS R;;FLEMING PATRICK R;;SANOCKI STEPHEN M;;LE JIMMY M;;MAHONEY STEVEN L;;JANSEN CHARLES E;;BRANSCOMB MATT R;;GAO YAOHUA;;BRIGHT ELIZABETH R;;KADOMA IGNATIUS A;;ZELINSKY JEFFREY E,COMPANY 3M IP (2022-03-09),https://lens.org/153-038-347-570-988,Patent Application,yes,0,0,3,3,0,B32B3/28;;B32B3/30;;B32B7/12;;B32B15/12;;B32B15/20;;B32B27/10;;B32B27/32;;B32B29/08;;B32B29/005;;B32B2307/7163;;B32B2439/00;;B32B2255/12;;B32B2255/26;;B32B2262/02;;B32B2262/101;;B65D81/03;;B65D65/14;;B65D65/42;;B32B3/28;;B32B3/30;;B32B7/12;;B32B15/12;;B32B15/20;;B32B27/10;;B32B27/32;;B32B29/002;;B32B29/08;;B32B2255/12;;B32B2405/00;;B32B2553/00,B32B29/00;;B32B3/28;;B32B3/30;;B32B7/12;;B32B15/12;;B32B15/20;;B32B27/10;;B32B27/32;;B32B29/08,,0,0,,,,PENDING
652,WO,A1,WO 2022/013754 A1,131-356-296-930-474,2022-01-20,2022,IB 2021056312 W,2021-07-13,US 202063052123 P;;US 202063106927 P;;US 202163143169 P,2020-07-15,"CONFORMABLE SHEET ARTICLES, CONSTRUCTIONS, AND METHODS OF USING THE SAME","Conformable sheet article made from paper and useful, for example, in packaging, tapes, and craft article, and methods of making and using such sheet articles are disclosed.",3M INNOVATIVE PROPERTIES CO,NIRMAL MANOJ;;BROWN MARY L;;SCHULTZ KIMBERLY C M;;JOHNSON MITCHELL A F;;CORRIGAN THOMAS R;;FLEMING PATRICK R;;SANOCKI STEPHEN M;;LE JIMMY M;;MAHONEY STEVEN L;;JANSEN CHARLES E;;BRANSCOMB MATT R;;GAO YAOHUA;;BRIGHT ELIZABETH R;;KADOMA IGNATIUS A;;ZELINSKY JEFFREY E,,https://lens.org/131-356-296-930-474,Patent Application,yes,7,0,3,3,0,B32B3/28;;B32B3/30;;B32B7/12;;B32B15/12;;B32B15/20;;B32B27/10;;B32B27/32;;B32B29/08;;B32B29/005;;B32B2307/7163;;B32B2439/00;;B32B2255/12;;B32B2255/26;;B32B2262/02;;B32B2262/101;;B65D81/03;;B65D65/14;;B65D65/42;;B32B3/28;;B32B3/30;;B32B7/12;;B32B15/12;;B32B15/20;;B32B27/10;;B32B27/32;;B32B29/002;;B32B29/08;;B32B2255/12;;B32B2405/00;;B32B2553/00,B32B3/28;;B32B3/30;;B32B7/12;;B32B15/12;;B32B15/20;;B32B27/10;;B32B27/32;;B32B29/00;;B32B29/08;;B65D81/02;;B65D81/03,,1,1,010-019-820-924-210,10.1177/0040517513512402,"A. O. SAGEMAN-FURNASP. GOSWAMIG. MENONS. J. RUSSELL: ""The Sphereprint: An approach to quantifying the conformability of flexible materials"", TEXTILE RESEARCH JOURNAL, vol. 84, no. 8, 2014, pages 793 - 807",PENDING
653,EP,A1,EP 4182164 A1,082-516-441-282-747,2023-05-24,2023,EP 21751623 A,2021-07-13,US 202063052123 P;;US 202063106927 P;;US 202163143169 P;;IB 2021056312 W,2020-07-15,"CONFORMABLE SHEET ARTICLES, CONSTRUCTIONS, AND METHODS OF USING THE SAME",,3M INNOVATIVE PROPERTIES COMPANY,NIRMAL MANOJ;;BROWN MARY L;;SCHULTZ KIMBERLY C M;;JOHNSON MITCHELL A F;;CORRIGAN THOMAS R;;FLEMING PATRICK R;;SANOCKI STEPHEN M;;LE JIMMY M;;MAHONEY STEVEN L;;JANSEN CHARLES E;;BRANSCOMB MATT R;;GAO YAOHUA;;BRIGHT ELIZABETH R;;KADOMA IGNATIUS A;;ZELINSKY JEFFREY E,,https://lens.org/082-516-441-282-747,Patent Application,yes,0,0,3,3,0,B32B3/28;;B32B3/30;;B32B7/12;;B32B15/12;;B32B15/20;;B32B27/10;;B32B27/32;;B32B29/08;;B32B29/005;;B32B2307/7163;;B32B2439/00;;B32B2255/12;;B32B2255/26;;B32B2262/02;;B32B2262/101;;B65D81/03;;B65D65/14;;B65D65/42;;B32B3/28;;B32B3/30;;B32B7/12;;B32B15/12;;B32B15/20;;B32B27/10;;B32B27/32;;B32B29/002;;B32B29/08;;B32B2255/12;;B32B2405/00;;B32B2553/00,B32B3/28;;B32B3/30;;B32B7/12;;B32B15/12;;B32B15/20;;B32B27/10;;B32B27/32;;B32B29/00;;B32B29/08;;B65D81/02;;B65D81/03,,0,0,,,,PENDING
654,US,A1,US 2015/0120615 A1,014-786-602-844-696,2015-04-30,2015,US 201314067846 A,2013-10-30,US 201314067846 A,2013-10-30,UNIFIED CATALOG MANAGEMENT OF BUSINESS PRODUCTS AND SERVICES,"A unified catalog of products and services is described. In one implementation, a method may include receiving an indication of products, offered by a business, that are to be provided to a customer of the business, where the products are defined in a catalog based on a hierarchical product model. The method further includes determining pricing information relating to the products, the determination of the pricing information including: identifying, based on the catalog, a plurality of pricing formulas associated with the plurality of products, and applying the pricing formulas to determine the pricing information.",VERIZON PATENT & LICENSING INC,GOPAL CHETAN;;NATARAJAN SWAMINATHAN K;;SHAN DONGXU;;GUNALAN JAGAN MOHAN;;ZENG DINGLI;;MENON GOPAN G;;ALWIN JOYCE;;RAJARAMAN SIVARAMAKRISHNAN;;RAMAMOORTHY SUBRAMANIAN;;KARUNANIDHI SIVABHARATHI;;BOEHM KENNETH RICHARD;;JUGO KRISTINE ANNE D;;HABERMAN KIMBERLY ENG;;STEEL MARIA LIZA D;;CHEN CHARLES C;;ZHANG MINGJUN;;AGARWAL DINESH;;XU JUNKE;;CLARK ERIN ARNOLD;;IYER KRISHNAKUMAR N;;BLEILE SCOTT G;;BROWN SCOT AARON;;HASANUZZAMAN FAIZ M;;WALSH ANN CECELIA;;ALAPATT PAUL,VERIZON PATENT AND LICENSING INC (2013-07-25),https://lens.org/014-786-602-844-696,Patent Application,yes,1,0,1,1,0,G06Q30/0283;;G06Q30/0283,G06Q30/02,705/400,0,0,,,,DISCONTINUED
